	Dataset	dataset_name	chip_id	replicate_group_id	organism	sample_type	generic_sample_type	final_cell_type	parental_cell_type	sex	labelling	name	description	number of samples	sample types	platform	project	species	Detection threshold	Platform_Category	Platform_Colour	Platform_Symbol	display_metadata	tier1	tier2	tier3	celltype	Blood_Cluster
1674120023_A;1000	1000	Watkins	1674120023_A	61230-190	Homo sapiens	B lymphocyte	CL:0000542		lymphocyte	male		Watkins	"Hematopoiesis is a carefully controlled process that is regulated by complex networks of transcription factors that are, in part, controlled by signals resulting from ligand binding to cell-surface receptors. To further understand hematopoiesis, we have compared gene expression profiles of human erythroblasts, megakaryocytes, B cells, cytotoxic and helper T cells, natural killer cells, granulocytes, and monocytes using whole genome microarrays. A bioinformatics analysis of these data was performed focusing on transcription factors, immunoglobulin superfamily members, and lineage-specific transcripts. We observed that the numbers of lineage-specific genes varies by 2 orders of magnitude, ranging from 5 for cytotoxic T cells to 878 for granulocytes. In addition, we have identified novel coexpression patterns for key transcription factors involved in hematopoiesis (eg, GATA3-GFI1 and GATA2-KLF1). This study represents the most comprehensive analysis of gene expression in hematopoietic cells to date and has identified genes that play key roles in lineage commitment and cell function. The data, which are freely accessible, will be invaluable for future studies on hematopoiesis and the role of specific genes and will also aid the understanding of the recent genome-wide association studies. [Abstract from original publiction; Blood. 2009 May 7;113(19):e1-9. Epub 2009 Feb 19. Watkins_2009_19228925]"	50	"MK, erythroblast, B lymphocyte, Th, Tc, granulocyte, monocyte, NK"	Microarray (Illumina HumanWG-6 V2)	leukomics	Homo sapiens	5	Illumina V2	"rgb(0,0,0)"	circle	CD19 B Cell  adult	lymphoid	B Cell	adult	B cell	Lymphocyte
1674120023_B;1000	1000	Watkins	1674120023_B	63130-660	Homo sapiens	granulocyte	CL:0000094		granulocyte	male		Watkins	"Hematopoiesis is a carefully controlled process that is regulated by complex networks of transcription factors that are, in part, controlled by signals resulting from ligand binding to cell-surface receptors. To further understand hematopoiesis, we have compared gene expression profiles of human erythroblasts, megakaryocytes, B cells, cytotoxic and helper T cells, natural killer cells, granulocytes, and monocytes using whole genome microarrays. A bioinformatics analysis of these data was performed focusing on transcription factors, immunoglobulin superfamily members, and lineage-specific transcripts. We observed that the numbers of lineage-specific genes varies by 2 orders of magnitude, ranging from 5 for cytotoxic T cells to 878 for granulocytes. In addition, we have identified novel coexpression patterns for key transcription factors involved in hematopoiesis (eg, GATA3-GFI1 and GATA2-KLF1). This study represents the most comprehensive analysis of gene expression in hematopoietic cells to date and has identified genes that play key roles in lineage commitment and cell function. The data, which are freely accessible, will be invaluable for future studies on hematopoiesis and the role of specific genes and will also aid the understanding of the recent genome-wide association studies. [Abstract from original publiction; Blood. 2009 May 7;113(19):e1-9. Epub 2009 Feb 19. Watkins_2009_19228925]"	50	"MK, erythroblast, B lymphocyte, Th, Tc, granulocyte, monocyte, NK"	Microarray (Illumina HumanWG-6 V2)	leukomics	Homo sapiens	5	Illumina V2	"rgb(0,0,0)"	circle	CD166b+ Neutrophil:Eosinophil 80:20 Granulocyte  neonatal	myeloid	Granulocyte	adult	granulocyte	Circulating Monocyte & Granulocyte
1674120023_C;1000	1000	Watkins	1674120023_C	63130-561	Homo sapiens	NK	CL:0000623		natural killer cell	male		Watkins	"Hematopoiesis is a carefully controlled process that is regulated by complex networks of transcription factors that are, in part, controlled by signals resulting from ligand binding to cell-surface receptors. To further understand hematopoiesis, we have compared gene expression profiles of human erythroblasts, megakaryocytes, B cells, cytotoxic and helper T cells, natural killer cells, granulocytes, and monocytes using whole genome microarrays. A bioinformatics analysis of these data was performed focusing on transcription factors, immunoglobulin superfamily members, and lineage-specific transcripts. We observed that the numbers of lineage-specific genes varies by 2 orders of magnitude, ranging from 5 for cytotoxic T cells to 878 for granulocytes. In addition, we have identified novel coexpression patterns for key transcription factors involved in hematopoiesis (eg, GATA3-GFI1 and GATA2-KLF1). This study represents the most comprehensive analysis of gene expression in hematopoietic cells to date and has identified genes that play key roles in lineage commitment and cell function. The data, which are freely accessible, will be invaluable for future studies on hematopoiesis and the role of specific genes and will also aid the understanding of the recent genome-wide association studies. [Abstract from original publiction; Blood. 2009 May 7;113(19):e1-9. Epub 2009 Feb 19. Watkins_2009_19228925]"	50	"MK, erythroblast, B lymphocyte, Th, Tc, granulocyte, monocyte, NK"	Microarray (Illumina HumanWG-6 V2)	leukomics	Homo sapiens	5	Illumina V2	"rgb(0,0,0)"	circle	CD56+ NK  adult	lymphoid	NK	adult	natural killer cell	Lymphocyte
1674120023_D;1000	1000	Watkins	1674120023_D	61230-040	Homo sapiens	Th	CL:0000542		lymphocyte	male		Watkins	"Hematopoiesis is a carefully controlled process that is regulated by complex networks of transcription factors that are, in part, controlled by signals resulting from ligand binding to cell-surface receptors. To further understand hematopoiesis, we have compared gene expression profiles of human erythroblasts, megakaryocytes, B cells, cytotoxic and helper T cells, natural killer cells, granulocytes, and monocytes using whole genome microarrays. A bioinformatics analysis of these data was performed focusing on transcription factors, immunoglobulin superfamily members, and lineage-specific transcripts. We observed that the numbers of lineage-specific genes varies by 2 orders of magnitude, ranging from 5 for cytotoxic T cells to 878 for granulocytes. In addition, we have identified novel coexpression patterns for key transcription factors involved in hematopoiesis (eg, GATA3-GFI1 and GATA2-KLF1). This study represents the most comprehensive analysis of gene expression in hematopoietic cells to date and has identified genes that play key roles in lineage commitment and cell function. The data, which are freely accessible, will be invaluable for future studies on hematopoiesis and the role of specific genes and will also aid the understanding of the recent genome-wide association studies. [Abstract from original publiction; Blood. 2009 May 7;113(19):e1-9. Epub 2009 Feb 19. Watkins_2009_19228925]"	50	"MK, erythroblast, B lymphocyte, Th, Tc, granulocyte, monocyte, NK"	Microarray (Illumina HumanWG-6 V2)	leukomics	Homo sapiens	5	Illumina V2	"rgb(0,0,0)"	circle	CD4+ T Cell  adult	lymphoid	T Cell	adult	CD4+ T cell	Lymphocyte
1674120023_E;1000	1000	Watkins	1674120023_E	63130-081	Homo sapiens	Tc	CL:0000542		lymphocyte	male		Watkins	"Hematopoiesis is a carefully controlled process that is regulated by complex networks of transcription factors that are, in part, controlled by signals resulting from ligand binding to cell-surface receptors. To further understand hematopoiesis, we have compared gene expression profiles of human erythroblasts, megakaryocytes, B cells, cytotoxic and helper T cells, natural killer cells, granulocytes, and monocytes using whole genome microarrays. A bioinformatics analysis of these data was performed focusing on transcription factors, immunoglobulin superfamily members, and lineage-specific transcripts. We observed that the numbers of lineage-specific genes varies by 2 orders of magnitude, ranging from 5 for cytotoxic T cells to 878 for granulocytes. In addition, we have identified novel coexpression patterns for key transcription factors involved in hematopoiesis (eg, GATA3-GFI1 and GATA2-KLF1). This study represents the most comprehensive analysis of gene expression in hematopoietic cells to date and has identified genes that play key roles in lineage commitment and cell function. The data, which are freely accessible, will be invaluable for future studies on hematopoiesis and the role of specific genes and will also aid the understanding of the recent genome-wide association studies. [Abstract from original publiction; Blood. 2009 May 7;113(19):e1-9. Epub 2009 Feb 19. Watkins_2009_19228925]"	50	"MK, erythroblast, B lymphocyte, Th, Tc, granulocyte, monocyte, NK"	Microarray (Illumina HumanWG-6 V2)	leukomics	Homo sapiens	5	Illumina V2	"rgb(0,0,0)"	circle	CD8+ T Cell  adult	lymphoid	T Cell	adult	CD8+ T cell	Lymphocyte
1674120023_F;1000	1000	Watkins	1674120023_F	61230-145	Homo sapiens	monocyte	CL:0000576		monocyte	male		Watkins	"Hematopoiesis is a carefully controlled process that is regulated by complex networks of transcription factors that are, in part, controlled by signals resulting from ligand binding to cell-surface receptors. To further understand hematopoiesis, we have compared gene expression profiles of human erythroblasts, megakaryocytes, B cells, cytotoxic and helper T cells, natural killer cells, granulocytes, and monocytes using whole genome microarrays. A bioinformatics analysis of these data was performed focusing on transcription factors, immunoglobulin superfamily members, and lineage-specific transcripts. We observed that the numbers of lineage-specific genes varies by 2 orders of magnitude, ranging from 5 for cytotoxic T cells to 878 for granulocytes. In addition, we have identified novel coexpression patterns for key transcription factors involved in hematopoiesis (eg, GATA3-GFI1 and GATA2-KLF1). This study represents the most comprehensive analysis of gene expression in hematopoietic cells to date and has identified genes that play key roles in lineage commitment and cell function. The data, which are freely accessible, will be invaluable for future studies on hematopoiesis and the role of specific genes and will also aid the understanding of the recent genome-wide association studies. [Abstract from original publiction; Blood. 2009 May 7;113(19):e1-9. Epub 2009 Feb 19. Watkins_2009_19228925]"	50	"MK, erythroblast, B lymphocyte, Th, Tc, granulocyte, monocyte, NK"	Microarray (Illumina HumanWG-6 V2)	leukomics	Homo sapiens	5	Illumina V2	"rgb(0,0,0)"	circle	CD14+ Monocyte  neonatal	myeloid	Monocyte	adult	monocyte	Circulating Monocyte & Granulocyte
1674120053_A;1000	1000	Watkins	1674120053_A	63171-191	Homo sapiens	B lymphocyte	CL:0000542		lymphocyte	male		Watkins	"Hematopoiesis is a carefully controlled process that is regulated by complex networks of transcription factors that are, in part, controlled by signals resulting from ligand binding to cell-surface receptors. To further understand hematopoiesis, we have compared gene expression profiles of human erythroblasts, megakaryocytes, B cells, cytotoxic and helper T cells, natural killer cells, granulocytes, and monocytes using whole genome microarrays. A bioinformatics analysis of these data was performed focusing on transcription factors, immunoglobulin superfamily members, and lineage-specific transcripts. We observed that the numbers of lineage-specific genes varies by 2 orders of magnitude, ranging from 5 for cytotoxic T cells to 878 for granulocytes. In addition, we have identified novel coexpression patterns for key transcription factors involved in hematopoiesis (eg, GATA3-GFI1 and GATA2-KLF1). This study represents the most comprehensive analysis of gene expression in hematopoietic cells to date and has identified genes that play key roles in lineage commitment and cell function. The data, which are freely accessible, will be invaluable for future studies on hematopoiesis and the role of specific genes and will also aid the understanding of the recent genome-wide association studies. [Abstract from original publiction; Blood. 2009 May 7;113(19):e1-9. Epub 2009 Feb 19. Watkins_2009_19228925]"	50	"MK, erythroblast, B lymphocyte, Th, Tc, granulocyte, monocyte, NK"	Microarray (Illumina HumanWG-6 V2)	leukomics	Homo sapiens	5	Illumina V2	"rgb(0,0,0)"	circle	CD19 B Cell  adult	lymphoid	B Cell	adult	B cell	Lymphocyte
1674120053_B;1000	1000	Watkins	1674120053_B	61271-144	Homo sapiens	monocyte	CL:0000576		monocyte	male		Watkins	"Hematopoiesis is a carefully controlled process that is regulated by complex networks of transcription factors that are, in part, controlled by signals resulting from ligand binding to cell-surface receptors. To further understand hematopoiesis, we have compared gene expression profiles of human erythroblasts, megakaryocytes, B cells, cytotoxic and helper T cells, natural killer cells, granulocytes, and monocytes using whole genome microarrays. A bioinformatics analysis of these data was performed focusing on transcription factors, immunoglobulin superfamily members, and lineage-specific transcripts. We observed that the numbers of lineage-specific genes varies by 2 orders of magnitude, ranging from 5 for cytotoxic T cells to 878 for granulocytes. In addition, we have identified novel coexpression patterns for key transcription factors involved in hematopoiesis (eg, GATA3-GFI1 and GATA2-KLF1). This study represents the most comprehensive analysis of gene expression in hematopoietic cells to date and has identified genes that play key roles in lineage commitment and cell function. The data, which are freely accessible, will be invaluable for future studies on hematopoiesis and the role of specific genes and will also aid the understanding of the recent genome-wide association studies. [Abstract from original publiction; Blood. 2009 May 7;113(19):e1-9. Epub 2009 Feb 19. Watkins_2009_19228925]"	50	"MK, erythroblast, B lymphocyte, Th, Tc, granulocyte, monocyte, NK"	Microarray (Illumina HumanWG-6 V2)	leukomics	Homo sapiens	5	Illumina V2	"rgb(0,0,0)"	circle	CD14+ Monocyte  neonatal	myeloid	Monocyte	adult	monocyte	Circulating Monocyte & Granulocyte
1674120053_C;1000	1000	Watkins	1674120053_C	63171-661	Homo sapiens	granulocyte	CL:0000094		granulocyte	male		Watkins	"Hematopoiesis is a carefully controlled process that is regulated by complex networks of transcription factors that are, in part, controlled by signals resulting from ligand binding to cell-surface receptors. To further understand hematopoiesis, we have compared gene expression profiles of human erythroblasts, megakaryocytes, B cells, cytotoxic and helper T cells, natural killer cells, granulocytes, and monocytes using whole genome microarrays. A bioinformatics analysis of these data was performed focusing on transcription factors, immunoglobulin superfamily members, and lineage-specific transcripts. We observed that the numbers of lineage-specific genes varies by 2 orders of magnitude, ranging from 5 for cytotoxic T cells to 878 for granulocytes. In addition, we have identified novel coexpression patterns for key transcription factors involved in hematopoiesis (eg, GATA3-GFI1 and GATA2-KLF1). This study represents the most comprehensive analysis of gene expression in hematopoietic cells to date and has identified genes that play key roles in lineage commitment and cell function. The data, which are freely accessible, will be invaluable for future studies on hematopoiesis and the role of specific genes and will also aid the understanding of the recent genome-wide association studies. [Abstract from original publiction; Blood. 2009 May 7;113(19):e1-9. Epub 2009 Feb 19. Watkins_2009_19228925]"	50	"MK, erythroblast, B lymphocyte, Th, Tc, granulocyte, monocyte, NK"	Microarray (Illumina HumanWG-6 V2)	leukomics	Homo sapiens	5	Illumina V2	"rgb(0,0,0)"	circle	CD166b+ Neutrophil:Eosinophil 85:15 Granulocyte  neonatal	myeloid	Granulocyte	adult	granulocyte	Circulating Monocyte & Granulocyte
1674120053_D;1000	1000	Watkins	1674120053_D	61271-080	Homo sapiens	Tc	CL:0000542		lymphocyte	male		Watkins	"Hematopoiesis is a carefully controlled process that is regulated by complex networks of transcription factors that are, in part, controlled by signals resulting from ligand binding to cell-surface receptors. To further understand hematopoiesis, we have compared gene expression profiles of human erythroblasts, megakaryocytes, B cells, cytotoxic and helper T cells, natural killer cells, granulocytes, and monocytes using whole genome microarrays. A bioinformatics analysis of these data was performed focusing on transcription factors, immunoglobulin superfamily members, and lineage-specific transcripts. We observed that the numbers of lineage-specific genes varies by 2 orders of magnitude, ranging from 5 for cytotoxic T cells to 878 for granulocytes. In addition, we have identified novel coexpression patterns for key transcription factors involved in hematopoiesis (eg, GATA3-GFI1 and GATA2-KLF1). This study represents the most comprehensive analysis of gene expression in hematopoietic cells to date and has identified genes that play key roles in lineage commitment and cell function. The data, which are freely accessible, will be invaluable for future studies on hematopoiesis and the role of specific genes and will also aid the understanding of the recent genome-wide association studies. [Abstract from original publiction; Blood. 2009 May 7;113(19):e1-9. Epub 2009 Feb 19. Watkins_2009_19228925]"	50	"MK, erythroblast, B lymphocyte, Th, Tc, granulocyte, monocyte, NK"	Microarray (Illumina HumanWG-6 V2)	leukomics	Homo sapiens	5	Illumina V2	"rgb(0,0,0)"	circle	CD8+ T Cell  adult	lymphoid	T Cell	adult	CD8+ T cell	Lymphocyte
1674120053_E;1000	1000	Watkins	1674120053_E	63171-561	Homo sapiens	NK	CL:0000623		natural killer cell	male		Watkins	"Hematopoiesis is a carefully controlled process that is regulated by complex networks of transcription factors that are, in part, controlled by signals resulting from ligand binding to cell-surface receptors. To further understand hematopoiesis, we have compared gene expression profiles of human erythroblasts, megakaryocytes, B cells, cytotoxic and helper T cells, natural killer cells, granulocytes, and monocytes using whole genome microarrays. A bioinformatics analysis of these data was performed focusing on transcription factors, immunoglobulin superfamily members, and lineage-specific transcripts. We observed that the numbers of lineage-specific genes varies by 2 orders of magnitude, ranging from 5 for cytotoxic T cells to 878 for granulocytes. In addition, we have identified novel coexpression patterns for key transcription factors involved in hematopoiesis (eg, GATA3-GFI1 and GATA2-KLF1). This study represents the most comprehensive analysis of gene expression in hematopoietic cells to date and has identified genes that play key roles in lineage commitment and cell function. The data, which are freely accessible, will be invaluable for future studies on hematopoiesis and the role of specific genes and will also aid the understanding of the recent genome-wide association studies. [Abstract from original publiction; Blood. 2009 May 7;113(19):e1-9. Epub 2009 Feb 19. Watkins_2009_19228925]"	50	"MK, erythroblast, B lymphocyte, Th, Tc, granulocyte, monocyte, NK"	Microarray (Illumina HumanWG-6 V2)	leukomics	Homo sapiens	5	Illumina V2	"rgb(0,0,0)"	circle	CD56+ NK  adult	lymphoid	NK	adult	natural killer cell	Lymphocyte
1674120053_F;1000	1000	Watkins	1674120053_F	61271-040	Homo sapiens	Th	CL:0000542		lymphocyte	male		Watkins	"Hematopoiesis is a carefully controlled process that is regulated by complex networks of transcription factors that are, in part, controlled by signals resulting from ligand binding to cell-surface receptors. To further understand hematopoiesis, we have compared gene expression profiles of human erythroblasts, megakaryocytes, B cells, cytotoxic and helper T cells, natural killer cells, granulocytes, and monocytes using whole genome microarrays. A bioinformatics analysis of these data was performed focusing on transcription factors, immunoglobulin superfamily members, and lineage-specific transcripts. We observed that the numbers of lineage-specific genes varies by 2 orders of magnitude, ranging from 5 for cytotoxic T cells to 878 for granulocytes. In addition, we have identified novel coexpression patterns for key transcription factors involved in hematopoiesis (eg, GATA3-GFI1 and GATA2-KLF1). This study represents the most comprehensive analysis of gene expression in hematopoietic cells to date and has identified genes that play key roles in lineage commitment and cell function. The data, which are freely accessible, will be invaluable for future studies on hematopoiesis and the role of specific genes and will also aid the understanding of the recent genome-wide association studies. [Abstract from original publiction; Blood. 2009 May 7;113(19):e1-9. Epub 2009 Feb 19. Watkins_2009_19228925]"	50	"MK, erythroblast, B lymphocyte, Th, Tc, granulocyte, monocyte, NK"	Microarray (Illumina HumanWG-6 V2)	leukomics	Homo sapiens	5	Illumina V2	"rgb(0,0,0)"	circle	CD4+ T Cell  adult	lymphoid	T Cell	adult	CD4+ T cell	Lymphocyte
1674120078_A;1000	1000	Watkins	1674120078_A	63112-661	Homo sapiens	granulocyte	CL:0000094		granulocyte	male		Watkins	"Hematopoiesis is a carefully controlled process that is regulated by complex networks of transcription factors that are, in part, controlled by signals resulting from ligand binding to cell-surface receptors. To further understand hematopoiesis, we have compared gene expression profiles of human erythroblasts, megakaryocytes, B cells, cytotoxic and helper T cells, natural killer cells, granulocytes, and monocytes using whole genome microarrays. A bioinformatics analysis of these data was performed focusing on transcription factors, immunoglobulin superfamily members, and lineage-specific transcripts. We observed that the numbers of lineage-specific genes varies by 2 orders of magnitude, ranging from 5 for cytotoxic T cells to 878 for granulocytes. In addition, we have identified novel coexpression patterns for key transcription factors involved in hematopoiesis (eg, GATA3-GFI1 and GATA2-KLF1). This study represents the most comprehensive analysis of gene expression in hematopoietic cells to date and has identified genes that play key roles in lineage commitment and cell function. The data, which are freely accessible, will be invaluable for future studies on hematopoiesis and the role of specific genes and will also aid the understanding of the recent genome-wide association studies. [Abstract from original publiction; Blood. 2009 May 7;113(19):e1-9. Epub 2009 Feb 19. Watkins_2009_19228925]"	50	"MK, erythroblast, B lymphocyte, Th, Tc, granulocyte, monocyte, NK"	Microarray (Illumina HumanWG-6 V2)	leukomics	Homo sapiens	5	Illumina V2	"rgb(0,0,0)"	circle	CD166b+ Neutrophil:Eosinophil 85:15 Granulocyte  neonatal	myeloid	Granulocyte	adult	granulocyte	Circulating Monocyte & Granulocyte
1674120078_B;1000	1000	Watkins	1674120078_B	63112-080	Homo sapiens	Tc	CL:0000542		lymphocyte	male		Watkins	"Hematopoiesis is a carefully controlled process that is regulated by complex networks of transcription factors that are, in part, controlled by signals resulting from ligand binding to cell-surface receptors. To further understand hematopoiesis, we have compared gene expression profiles of human erythroblasts, megakaryocytes, B cells, cytotoxic and helper T cells, natural killer cells, granulocytes, and monocytes using whole genome microarrays. A bioinformatics analysis of these data was performed focusing on transcription factors, immunoglobulin superfamily members, and lineage-specific transcripts. We observed that the numbers of lineage-specific genes varies by 2 orders of magnitude, ranging from 5 for cytotoxic T cells to 878 for granulocytes. In addition, we have identified novel coexpression patterns for key transcription factors involved in hematopoiesis (eg, GATA3-GFI1 and GATA2-KLF1). This study represents the most comprehensive analysis of gene expression in hematopoietic cells to date and has identified genes that play key roles in lineage commitment and cell function. The data, which are freely accessible, will be invaluable for future studies on hematopoiesis and the role of specific genes and will also aid the understanding of the recent genome-wide association studies. [Abstract from original publiction; Blood. 2009 May 7;113(19):e1-9. Epub 2009 Feb 19. Watkins_2009_19228925]"	50	"MK, erythroblast, B lymphocyte, Th, Tc, granulocyte, monocyte, NK"	Microarray (Illumina HumanWG-6 V2)	leukomics	Homo sapiens	5	Illumina V2	"rgb(0,0,0)"	circle	CD8+ T Cell  adult	lymphoid	T Cell	adult	CD8+ T cell	Lymphocyte
1674120078_C;1000	1000	Watkins	1674120078_C	63112-560	Homo sapiens	NK	CL:0000623		natural killer cell	male		Watkins	"Hematopoiesis is a carefully controlled process that is regulated by complex networks of transcription factors that are, in part, controlled by signals resulting from ligand binding to cell-surface receptors. To further understand hematopoiesis, we have compared gene expression profiles of human erythroblasts, megakaryocytes, B cells, cytotoxic and helper T cells, natural killer cells, granulocytes, and monocytes using whole genome microarrays. A bioinformatics analysis of these data was performed focusing on transcription factors, immunoglobulin superfamily members, and lineage-specific transcripts. We observed that the numbers of lineage-specific genes varies by 2 orders of magnitude, ranging from 5 for cytotoxic T cells to 878 for granulocytes. In addition, we have identified novel coexpression patterns for key transcription factors involved in hematopoiesis (eg, GATA3-GFI1 and GATA2-KLF1). This study represents the most comprehensive analysis of gene expression in hematopoietic cells to date and has identified genes that play key roles in lineage commitment and cell function. The data, which are freely accessible, will be invaluable for future studies on hematopoiesis and the role of specific genes and will also aid the understanding of the recent genome-wide association studies. [Abstract from original publiction; Blood. 2009 May 7;113(19):e1-9. Epub 2009 Feb 19. Watkins_2009_19228925]"	50	"MK, erythroblast, B lymphocyte, Th, Tc, granulocyte, monocyte, NK"	Microarray (Illumina HumanWG-6 V2)	leukomics	Homo sapiens	5	Illumina V2	"rgb(0,0,0)"	circle	CD56+ NK  adult	lymphoid	NK	adult	natural killer cell	Lymphocyte
1674120078_D;1000	1000	Watkins	1674120078_D	63112-041	Homo sapiens	Th	CL:0000542		lymphocyte	male		Watkins	"Hematopoiesis is a carefully controlled process that is regulated by complex networks of transcription factors that are, in part, controlled by signals resulting from ligand binding to cell-surface receptors. To further understand hematopoiesis, we have compared gene expression profiles of human erythroblasts, megakaryocytes, B cells, cytotoxic and helper T cells, natural killer cells, granulocytes, and monocytes using whole genome microarrays. A bioinformatics analysis of these data was performed focusing on transcription factors, immunoglobulin superfamily members, and lineage-specific transcripts. We observed that the numbers of lineage-specific genes varies by 2 orders of magnitude, ranging from 5 for cytotoxic T cells to 878 for granulocytes. In addition, we have identified novel coexpression patterns for key transcription factors involved in hematopoiesis (eg, GATA3-GFI1 and GATA2-KLF1). This study represents the most comprehensive analysis of gene expression in hematopoietic cells to date and has identified genes that play key roles in lineage commitment and cell function. The data, which are freely accessible, will be invaluable for future studies on hematopoiesis and the role of specific genes and will also aid the understanding of the recent genome-wide association studies. [Abstract from original publiction; Blood. 2009 May 7;113(19):e1-9. Epub 2009 Feb 19. Watkins_2009_19228925]"	50	"MK, erythroblast, B lymphocyte, Th, Tc, granulocyte, monocyte, NK"	Microarray (Illumina HumanWG-6 V2)	leukomics	Homo sapiens	5	Illumina V2	"rgb(0,0,0)"	circle	CD4+ T Cell  adult	lymphoid	T Cell	adult	CD4+ T cell	Lymphocyte
1674120078_E;1000	1000	Watkins	1674120078_E	61212-190	Homo sapiens	B lymphocyte	CL:0000542		lymphocyte	male		Watkins	"Hematopoiesis is a carefully controlled process that is regulated by complex networks of transcription factors that are, in part, controlled by signals resulting from ligand binding to cell-surface receptors. To further understand hematopoiesis, we have compared gene expression profiles of human erythroblasts, megakaryocytes, B cells, cytotoxic and helper T cells, natural killer cells, granulocytes, and monocytes using whole genome microarrays. A bioinformatics analysis of these data was performed focusing on transcription factors, immunoglobulin superfamily members, and lineage-specific transcripts. We observed that the numbers of lineage-specific genes varies by 2 orders of magnitude, ranging from 5 for cytotoxic T cells to 878 for granulocytes. In addition, we have identified novel coexpression patterns for key transcription factors involved in hematopoiesis (eg, GATA3-GFI1 and GATA2-KLF1). This study represents the most comprehensive analysis of gene expression in hematopoietic cells to date and has identified genes that play key roles in lineage commitment and cell function. The data, which are freely accessible, will be invaluable for future studies on hematopoiesis and the role of specific genes and will also aid the understanding of the recent genome-wide association studies. [Abstract from original publiction; Blood. 2009 May 7;113(19):e1-9. Epub 2009 Feb 19. Watkins_2009_19228925]"	50	"MK, erythroblast, B lymphocyte, Th, Tc, granulocyte, monocyte, NK"	Microarray (Illumina HumanWG-6 V2)	leukomics	Homo sapiens	5	Illumina V2	"rgb(0,0,0)"	circle	CD19 B Cell  adult	lymphoid	B Cell	adult	B cell	Lymphocyte
1674120078_F;1000	1000	Watkins	1674120078_F	61212-142	Homo sapiens	monocyte	CL:0000576		monocyte	male		Watkins	"Hematopoiesis is a carefully controlled process that is regulated by complex networks of transcription factors that are, in part, controlled by signals resulting from ligand binding to cell-surface receptors. To further understand hematopoiesis, we have compared gene expression profiles of human erythroblasts, megakaryocytes, B cells, cytotoxic and helper T cells, natural killer cells, granulocytes, and monocytes using whole genome microarrays. A bioinformatics analysis of these data was performed focusing on transcription factors, immunoglobulin superfamily members, and lineage-specific transcripts. We observed that the numbers of lineage-specific genes varies by 2 orders of magnitude, ranging from 5 for cytotoxic T cells to 878 for granulocytes. In addition, we have identified novel coexpression patterns for key transcription factors involved in hematopoiesis (eg, GATA3-GFI1 and GATA2-KLF1). This study represents the most comprehensive analysis of gene expression in hematopoietic cells to date and has identified genes that play key roles in lineage commitment and cell function. The data, which are freely accessible, will be invaluable for future studies on hematopoiesis and the role of specific genes and will also aid the understanding of the recent genome-wide association studies. [Abstract from original publiction; Blood. 2009 May 7;113(19):e1-9. Epub 2009 Feb 19. Watkins_2009_19228925]"	50	"MK, erythroblast, B lymphocyte, Th, Tc, granulocyte, monocyte, NK"	Microarray (Illumina HumanWG-6 V2)	leukomics	Homo sapiens	5	Illumina V2	"rgb(0,0,0)"	circle	CD14+ Monocyte  neonatal	myeloid	Monocyte	adult	monocyte	Circulating Monocyte & Granulocyte
1674120079_A;1000	1000	Watkins	1674120079_A	61262-080	Homo sapiens	Tc	CL:0000542		lymphocyte	male		Watkins	"Hematopoiesis is a carefully controlled process that is regulated by complex networks of transcription factors that are, in part, controlled by signals resulting from ligand binding to cell-surface receptors. To further understand hematopoiesis, we have compared gene expression profiles of human erythroblasts, megakaryocytes, B cells, cytotoxic and helper T cells, natural killer cells, granulocytes, and monocytes using whole genome microarrays. A bioinformatics analysis of these data was performed focusing on transcription factors, immunoglobulin superfamily members, and lineage-specific transcripts. We observed that the numbers of lineage-specific genes varies by 2 orders of magnitude, ranging from 5 for cytotoxic T cells to 878 for granulocytes. In addition, we have identified novel coexpression patterns for key transcription factors involved in hematopoiesis (eg, GATA3-GFI1 and GATA2-KLF1). This study represents the most comprehensive analysis of gene expression in hematopoietic cells to date and has identified genes that play key roles in lineage commitment and cell function. The data, which are freely accessible, will be invaluable for future studies on hematopoiesis and the role of specific genes and will also aid the understanding of the recent genome-wide association studies. [Abstract from original publiction; Blood. 2009 May 7;113(19):e1-9. Epub 2009 Feb 19. Watkins_2009_19228925]"	50	"MK, erythroblast, B lymphocyte, Th, Tc, granulocyte, monocyte, NK"	Microarray (Illumina HumanWG-6 V2)	leukomics	Homo sapiens	5	Illumina V2	"rgb(0,0,0)"	circle	CD8+ T Cell  adult	lymphoid	T Cell	adult	CD8+ T cell	Lymphocyte
1674120079_B;1000	1000	Watkins	1674120079_B	61262-041	Homo sapiens	Th	CL:0000542		lymphocyte	male		Watkins	"Hematopoiesis is a carefully controlled process that is regulated by complex networks of transcription factors that are, in part, controlled by signals resulting from ligand binding to cell-surface receptors. To further understand hematopoiesis, we have compared gene expression profiles of human erythroblasts, megakaryocytes, B cells, cytotoxic and helper T cells, natural killer cells, granulocytes, and monocytes using whole genome microarrays. A bioinformatics analysis of these data was performed focusing on transcription factors, immunoglobulin superfamily members, and lineage-specific transcripts. We observed that the numbers of lineage-specific genes varies by 2 orders of magnitude, ranging from 5 for cytotoxic T cells to 878 for granulocytes. In addition, we have identified novel coexpression patterns for key transcription factors involved in hematopoiesis (eg, GATA3-GFI1 and GATA2-KLF1). This study represents the most comprehensive analysis of gene expression in hematopoietic cells to date and has identified genes that play key roles in lineage commitment and cell function. The data, which are freely accessible, will be invaluable for future studies on hematopoiesis and the role of specific genes and will also aid the understanding of the recent genome-wide association studies. [Abstract from original publiction; Blood. 2009 May 7;113(19):e1-9. Epub 2009 Feb 19. Watkins_2009_19228925]"	50	"MK, erythroblast, B lymphocyte, Th, Tc, granulocyte, monocyte, NK"	Microarray (Illumina HumanWG-6 V2)	leukomics	Homo sapiens	5	Illumina V2	"rgb(0,0,0)"	circle	CD4+ T Cell  adult	lymphoid	T Cell	adult	CD4+ T cell	Lymphocyte
1674120079_C;1000	1000	Watkins	1674120079_C	63162-561	Homo sapiens	NK	CL:0000623		natural killer cell	male		Watkins	"Hematopoiesis is a carefully controlled process that is regulated by complex networks of transcription factors that are, in part, controlled by signals resulting from ligand binding to cell-surface receptors. To further understand hematopoiesis, we have compared gene expression profiles of human erythroblasts, megakaryocytes, B cells, cytotoxic and helper T cells, natural killer cells, granulocytes, and monocytes using whole genome microarrays. A bioinformatics analysis of these data was performed focusing on transcription factors, immunoglobulin superfamily members, and lineage-specific transcripts. We observed that the numbers of lineage-specific genes varies by 2 orders of magnitude, ranging from 5 for cytotoxic T cells to 878 for granulocytes. In addition, we have identified novel coexpression patterns for key transcription factors involved in hematopoiesis (eg, GATA3-GFI1 and GATA2-KLF1). This study represents the most comprehensive analysis of gene expression in hematopoietic cells to date and has identified genes that play key roles in lineage commitment and cell function. The data, which are freely accessible, will be invaluable for future studies on hematopoiesis and the role of specific genes and will also aid the understanding of the recent genome-wide association studies. [Abstract from original publiction; Blood. 2009 May 7;113(19):e1-9. Epub 2009 Feb 19. Watkins_2009_19228925]"	50	"MK, erythroblast, B lymphocyte, Th, Tc, granulocyte, monocyte, NK"	Microarray (Illumina HumanWG-6 V2)	leukomics	Homo sapiens	5	Illumina V2	"rgb(0,0,0)"	circle	CD56+ NK  adult	lymphoid	NK	adult	natural killer cell	Lymphocyte
1674120079_D;1000	1000	Watkins	1674120079_D	61262-141	Homo sapiens	monocyte	CL:0000576		monocyte	male		Watkins	"Hematopoiesis is a carefully controlled process that is regulated by complex networks of transcription factors that are, in part, controlled by signals resulting from ligand binding to cell-surface receptors. To further understand hematopoiesis, we have compared gene expression profiles of human erythroblasts, megakaryocytes, B cells, cytotoxic and helper T cells, natural killer cells, granulocytes, and monocytes using whole genome microarrays. A bioinformatics analysis of these data was performed focusing on transcription factors, immunoglobulin superfamily members, and lineage-specific transcripts. We observed that the numbers of lineage-specific genes varies by 2 orders of magnitude, ranging from 5 for cytotoxic T cells to 878 for granulocytes. In addition, we have identified novel coexpression patterns for key transcription factors involved in hematopoiesis (eg, GATA3-GFI1 and GATA2-KLF1). This study represents the most comprehensive analysis of gene expression in hematopoietic cells to date and has identified genes that play key roles in lineage commitment and cell function. The data, which are freely accessible, will be invaluable for future studies on hematopoiesis and the role of specific genes and will also aid the understanding of the recent genome-wide association studies. [Abstract from original publiction; Blood. 2009 May 7;113(19):e1-9. Epub 2009 Feb 19. Watkins_2009_19228925]"	50	"MK, erythroblast, B lymphocyte, Th, Tc, granulocyte, monocyte, NK"	Microarray (Illumina HumanWG-6 V2)	leukomics	Homo sapiens	5	Illumina V2	"rgb(0,0,0)"	circle	CD14+ Monocyte  neonatal	myeloid	Monocyte	adult	monocyte	Circulating Monocyte & Granulocyte
1674120079_E;1000	1000	Watkins	1674120079_E	63162-660	Homo sapiens	granulocyte	CL:0000094		granulocyte	male		Watkins	"Hematopoiesis is a carefully controlled process that is regulated by complex networks of transcription factors that are, in part, controlled by signals resulting from ligand binding to cell-surface receptors. To further understand hematopoiesis, we have compared gene expression profiles of human erythroblasts, megakaryocytes, B cells, cytotoxic and helper T cells, natural killer cells, granulocytes, and monocytes using whole genome microarrays. A bioinformatics analysis of these data was performed focusing on transcription factors, immunoglobulin superfamily members, and lineage-specific transcripts. We observed that the numbers of lineage-specific genes varies by 2 orders of magnitude, ranging from 5 for cytotoxic T cells to 878 for granulocytes. In addition, we have identified novel coexpression patterns for key transcription factors involved in hematopoiesis (eg, GATA3-GFI1 and GATA2-KLF1). This study represents the most comprehensive analysis of gene expression in hematopoietic cells to date and has identified genes that play key roles in lineage commitment and cell function. The data, which are freely accessible, will be invaluable for future studies on hematopoiesis and the role of specific genes and will also aid the understanding of the recent genome-wide association studies. [Abstract from original publiction; Blood. 2009 May 7;113(19):e1-9. Epub 2009 Feb 19. Watkins_2009_19228925]"	50	"MK, erythroblast, B lymphocyte, Th, Tc, granulocyte, monocyte, NK"	Microarray (Illumina HumanWG-6 V2)	leukomics	Homo sapiens	5	Illumina V2	"rgb(0,0,0)"	circle	CD166b+ Neutrophil:Eosinophil 70:30 Granulocyte  neonatal	myeloid	Granulocyte	adult	granulocyte	Circulating Monocyte & Granulocyte
1674120079_F;1000	1000	Watkins	1674120079_F	61262-190	Homo sapiens	B lymphocyte	CL:0000542		lymphocyte	male		Watkins	"Hematopoiesis is a carefully controlled process that is regulated by complex networks of transcription factors that are, in part, controlled by signals resulting from ligand binding to cell-surface receptors. To further understand hematopoiesis, we have compared gene expression profiles of human erythroblasts, megakaryocytes, B cells, cytotoxic and helper T cells, natural killer cells, granulocytes, and monocytes using whole genome microarrays. A bioinformatics analysis of these data was performed focusing on transcription factors, immunoglobulin superfamily members, and lineage-specific transcripts. We observed that the numbers of lineage-specific genes varies by 2 orders of magnitude, ranging from 5 for cytotoxic T cells to 878 for granulocytes. In addition, we have identified novel coexpression patterns for key transcription factors involved in hematopoiesis (eg, GATA3-GFI1 and GATA2-KLF1). This study represents the most comprehensive analysis of gene expression in hematopoietic cells to date and has identified genes that play key roles in lineage commitment and cell function. The data, which are freely accessible, will be invaluable for future studies on hematopoiesis and the role of specific genes and will also aid the understanding of the recent genome-wide association studies. [Abstract from original publiction; Blood. 2009 May 7;113(19):e1-9. Epub 2009 Feb 19. Watkins_2009_19228925]"	50	"MK, erythroblast, B lymphocyte, Th, Tc, granulocyte, monocyte, NK"	Microarray (Illumina HumanWG-6 V2)	leukomics	Homo sapiens	5	Illumina V2	"rgb(0,0,0)"	circle	CD19 B Cell  adult	lymphoid	B Cell	adult	B cell	Lymphocyte
1674120084_A;1000	1000	Watkins	1674120084_A	63169-561	Homo sapiens	NK	CL:0000623		natural killer cell	female		Watkins	"Hematopoiesis is a carefully controlled process that is regulated by complex networks of transcription factors that are, in part, controlled by signals resulting from ligand binding to cell-surface receptors. To further understand hematopoiesis, we have compared gene expression profiles of human erythroblasts, megakaryocytes, B cells, cytotoxic and helper T cells, natural killer cells, granulocytes, and monocytes using whole genome microarrays. A bioinformatics analysis of these data was performed focusing on transcription factors, immunoglobulin superfamily members, and lineage-specific transcripts. We observed that the numbers of lineage-specific genes varies by 2 orders of magnitude, ranging from 5 for cytotoxic T cells to 878 for granulocytes. In addition, we have identified novel coexpression patterns for key transcription factors involved in hematopoiesis (eg, GATA3-GFI1 and GATA2-KLF1). This study represents the most comprehensive analysis of gene expression in hematopoietic cells to date and has identified genes that play key roles in lineage commitment and cell function. The data, which are freely accessible, will be invaluable for future studies on hematopoiesis and the role of specific genes and will also aid the understanding of the recent genome-wide association studies. [Abstract from original publiction; Blood. 2009 May 7;113(19):e1-9. Epub 2009 Feb 19. Watkins_2009_19228925]"	50	"MK, erythroblast, B lymphocyte, Th, Tc, granulocyte, monocyte, NK"	Microarray (Illumina HumanWG-6 V2)	leukomics	Homo sapiens	5	Illumina V2	"rgb(0,0,0)"	circle	CD56+ NK  adult	lymphoid	NK	adult	natural killer cell	Lymphocyte
1674120084_B;1000	1000	Watkins	1674120084_B	63169-661	Homo sapiens	granulocyte	CL:0000094		granulocyte	female		Watkins	"Hematopoiesis is a carefully controlled process that is regulated by complex networks of transcription factors that are, in part, controlled by signals resulting from ligand binding to cell-surface receptors. To further understand hematopoiesis, we have compared gene expression profiles of human erythroblasts, megakaryocytes, B cells, cytotoxic and helper T cells, natural killer cells, granulocytes, and monocytes using whole genome microarrays. A bioinformatics analysis of these data was performed focusing on transcription factors, immunoglobulin superfamily members, and lineage-specific transcripts. We observed that the numbers of lineage-specific genes varies by 2 orders of magnitude, ranging from 5 for cytotoxic T cells to 878 for granulocytes. In addition, we have identified novel coexpression patterns for key transcription factors involved in hematopoiesis (eg, GATA3-GFI1 and GATA2-KLF1). This study represents the most comprehensive analysis of gene expression in hematopoietic cells to date and has identified genes that play key roles in lineage commitment and cell function. The data, which are freely accessible, will be invaluable for future studies on hematopoiesis and the role of specific genes and will also aid the understanding of the recent genome-wide association studies. [Abstract from original publiction; Blood. 2009 May 7;113(19):e1-9. Epub 2009 Feb 19. Watkins_2009_19228925]"	50	"MK, erythroblast, B lymphocyte, Th, Tc, granulocyte, monocyte, NK"	Microarray (Illumina HumanWG-6 V2)	leukomics	Homo sapiens	5	Illumina V2	"rgb(0,0,0)"	circle	CD166b+ Neutrophil:Eosinophil 80:20 Granulocyte  neonatal	myeloid	Granulocyte	adult	granulocyte	Circulating Monocyte & Granulocyte
1674120084_C;1000	1000	Watkins	1674120084_C	61269-190	Homo sapiens	B lymphocyte	CL:0000542		lymphocyte	female		Watkins	"Hematopoiesis is a carefully controlled process that is regulated by complex networks of transcription factors that are, in part, controlled by signals resulting from ligand binding to cell-surface receptors. To further understand hematopoiesis, we have compared gene expression profiles of human erythroblasts, megakaryocytes, B cells, cytotoxic and helper T cells, natural killer cells, granulocytes, and monocytes using whole genome microarrays. A bioinformatics analysis of these data was performed focusing on transcription factors, immunoglobulin superfamily members, and lineage-specific transcripts. We observed that the numbers of lineage-specific genes varies by 2 orders of magnitude, ranging from 5 for cytotoxic T cells to 878 for granulocytes. In addition, we have identified novel coexpression patterns for key transcription factors involved in hematopoiesis (eg, GATA3-GFI1 and GATA2-KLF1). This study represents the most comprehensive analysis of gene expression in hematopoietic cells to date and has identified genes that play key roles in lineage commitment and cell function. The data, which are freely accessible, will be invaluable for future studies on hematopoiesis and the role of specific genes and will also aid the understanding of the recent genome-wide association studies. [Abstract from original publiction; Blood. 2009 May 7;113(19):e1-9. Epub 2009 Feb 19. Watkins_2009_19228925]"	50	"MK, erythroblast, B lymphocyte, Th, Tc, granulocyte, monocyte, NK"	Microarray (Illumina HumanWG-6 V2)	leukomics	Homo sapiens	5	Illumina V2	"rgb(0,0,0)"	circle	CD19 B Cell  adult	lymphoid	B Cell	adult	B cell	Lymphocyte
1674120084_D;1000	1000	Watkins	1674120084_D	63169-144	Homo sapiens	monocyte	CL:0000576		monocyte	female		Watkins	"Hematopoiesis is a carefully controlled process that is regulated by complex networks of transcription factors that are, in part, controlled by signals resulting from ligand binding to cell-surface receptors. To further understand hematopoiesis, we have compared gene expression profiles of human erythroblasts, megakaryocytes, B cells, cytotoxic and helper T cells, natural killer cells, granulocytes, and monocytes using whole genome microarrays. A bioinformatics analysis of these data was performed focusing on transcription factors, immunoglobulin superfamily members, and lineage-specific transcripts. We observed that the numbers of lineage-specific genes varies by 2 orders of magnitude, ranging from 5 for cytotoxic T cells to 878 for granulocytes. In addition, we have identified novel coexpression patterns for key transcription factors involved in hematopoiesis (eg, GATA3-GFI1 and GATA2-KLF1). This study represents the most comprehensive analysis of gene expression in hematopoietic cells to date and has identified genes that play key roles in lineage commitment and cell function. The data, which are freely accessible, will be invaluable for future studies on hematopoiesis and the role of specific genes and will also aid the understanding of the recent genome-wide association studies. [Abstract from original publiction; Blood. 2009 May 7;113(19):e1-9. Epub 2009 Feb 19. Watkins_2009_19228925]"	50	"MK, erythroblast, B lymphocyte, Th, Tc, granulocyte, monocyte, NK"	Microarray (Illumina HumanWG-6 V2)	leukomics	Homo sapiens	5	Illumina V2	"rgb(0,0,0)"	circle	CD14+ Monocyte  neonatal	myeloid	Monocyte	adult	monocyte	Circulating Monocyte & Granulocyte
1674120084_E;1000	1000	Watkins	1674120084_E	61269-081	Homo sapiens	Tc	CL:0000542		lymphocyte	female		Watkins	"Hematopoiesis is a carefully controlled process that is regulated by complex networks of transcription factors that are, in part, controlled by signals resulting from ligand binding to cell-surface receptors. To further understand hematopoiesis, we have compared gene expression profiles of human erythroblasts, megakaryocytes, B cells, cytotoxic and helper T cells, natural killer cells, granulocytes, and monocytes using whole genome microarrays. A bioinformatics analysis of these data was performed focusing on transcription factors, immunoglobulin superfamily members, and lineage-specific transcripts. We observed that the numbers of lineage-specific genes varies by 2 orders of magnitude, ranging from 5 for cytotoxic T cells to 878 for granulocytes. In addition, we have identified novel coexpression patterns for key transcription factors involved in hematopoiesis (eg, GATA3-GFI1 and GATA2-KLF1). This study represents the most comprehensive analysis of gene expression in hematopoietic cells to date and has identified genes that play key roles in lineage commitment and cell function. The data, which are freely accessible, will be invaluable for future studies on hematopoiesis and the role of specific genes and will also aid the understanding of the recent genome-wide association studies. [Abstract from original publiction; Blood. 2009 May 7;113(19):e1-9. Epub 2009 Feb 19. Watkins_2009_19228925]"	50	"MK, erythroblast, B lymphocyte, Th, Tc, granulocyte, monocyte, NK"	Microarray (Illumina HumanWG-6 V2)	leukomics	Homo sapiens	5	Illumina V2	"rgb(0,0,0)"	circle	CD8+ T Cell  adult	lymphoid	T Cell	adult	CD8+ T cell	Lymphocyte
1674120084_F;1000	1000	Watkins	1674120084_F	61269-041	Homo sapiens	Th	CL:0000542		lymphocyte	female		Watkins	"Hematopoiesis is a carefully controlled process that is regulated by complex networks of transcription factors that are, in part, controlled by signals resulting from ligand binding to cell-surface receptors. To further understand hematopoiesis, we have compared gene expression profiles of human erythroblasts, megakaryocytes, B cells, cytotoxic and helper T cells, natural killer cells, granulocytes, and monocytes using whole genome microarrays. A bioinformatics analysis of these data was performed focusing on transcription factors, immunoglobulin superfamily members, and lineage-specific transcripts. We observed that the numbers of lineage-specific genes varies by 2 orders of magnitude, ranging from 5 for cytotoxic T cells to 878 for granulocytes. In addition, we have identified novel coexpression patterns for key transcription factors involved in hematopoiesis (eg, GATA3-GFI1 and GATA2-KLF1). This study represents the most comprehensive analysis of gene expression in hematopoietic cells to date and has identified genes that play key roles in lineage commitment and cell function. The data, which are freely accessible, will be invaluable for future studies on hematopoiesis and the role of specific genes and will also aid the understanding of the recent genome-wide association studies. [Abstract from original publiction; Blood. 2009 May 7;113(19):e1-9. Epub 2009 Feb 19. Watkins_2009_19228925]"	50	"MK, erythroblast, B lymphocyte, Th, Tc, granulocyte, monocyte, NK"	Microarray (Illumina HumanWG-6 V2)	leukomics	Homo sapiens	5	Illumina V2	"rgb(0,0,0)"	circle	CD4+ T Cell  adult	lymphoid	T Cell	adult	CD4+ T cell	Lymphocyte
1674120085_A;1000	1000	Watkins	1674120085_A	63182-661	Homo sapiens	granulocyte	CL:0000094		granulocyte	female		Watkins	"Hematopoiesis is a carefully controlled process that is regulated by complex networks of transcription factors that are, in part, controlled by signals resulting from ligand binding to cell-surface receptors. To further understand hematopoiesis, we have compared gene expression profiles of human erythroblasts, megakaryocytes, B cells, cytotoxic and helper T cells, natural killer cells, granulocytes, and monocytes using whole genome microarrays. A bioinformatics analysis of these data was performed focusing on transcription factors, immunoglobulin superfamily members, and lineage-specific transcripts. We observed that the numbers of lineage-specific genes varies by 2 orders of magnitude, ranging from 5 for cytotoxic T cells to 878 for granulocytes. In addition, we have identified novel coexpression patterns for key transcription factors involved in hematopoiesis (eg, GATA3-GFI1 and GATA2-KLF1). This study represents the most comprehensive analysis of gene expression in hematopoietic cells to date and has identified genes that play key roles in lineage commitment and cell function. The data, which are freely accessible, will be invaluable for future studies on hematopoiesis and the role of specific genes and will also aid the understanding of the recent genome-wide association studies. [Abstract from original publiction; Blood. 2009 May 7;113(19):e1-9. Epub 2009 Feb 19. Watkins_2009_19228925]"	50	"MK, erythroblast, B lymphocyte, Th, Tc, granulocyte, monocyte, NK"	Microarray (Illumina HumanWG-6 V2)	leukomics	Homo sapiens	5	Illumina V2	"rgb(0,0,0)"	circle	CD166b+ Neutrophil:Eosinophil 70:30 Granulocyte  neonatal	myeloid	Granulocyte	adult	granulocyte	Circulating Monocyte & Granulocyte
1674120085_B;1000	1000	Watkins	1674120085_B	63182-142	Homo sapiens	monocyte	CL:0000576		monocyte	female		Watkins	"Hematopoiesis is a carefully controlled process that is regulated by complex networks of transcription factors that are, in part, controlled by signals resulting from ligand binding to cell-surface receptors. To further understand hematopoiesis, we have compared gene expression profiles of human erythroblasts, megakaryocytes, B cells, cytotoxic and helper T cells, natural killer cells, granulocytes, and monocytes using whole genome microarrays. A bioinformatics analysis of these data was performed focusing on transcription factors, immunoglobulin superfamily members, and lineage-specific transcripts. We observed that the numbers of lineage-specific genes varies by 2 orders of magnitude, ranging from 5 for cytotoxic T cells to 878 for granulocytes. In addition, we have identified novel coexpression patterns for key transcription factors involved in hematopoiesis (eg, GATA3-GFI1 and GATA2-KLF1). This study represents the most comprehensive analysis of gene expression in hematopoietic cells to date and has identified genes that play key roles in lineage commitment and cell function. The data, which are freely accessible, will be invaluable for future studies on hematopoiesis and the role of specific genes and will also aid the understanding of the recent genome-wide association studies. [Abstract from original publiction; Blood. 2009 May 7;113(19):e1-9. Epub 2009 Feb 19. Watkins_2009_19228925]"	50	"MK, erythroblast, B lymphocyte, Th, Tc, granulocyte, monocyte, NK"	Microarray (Illumina HumanWG-6 V2)	leukomics	Homo sapiens	5	Illumina V2	"rgb(0,0,0)"	circle	CD14+ Monocyte  neonatal	myeloid	Monocyte	adult	monocyte	Circulating Monocyte & Granulocyte
1674120085_C;1000	1000	Watkins	1674120085_C	61282-040	Homo sapiens	Th	CL:0000542		lymphocyte	female		Watkins	"Hematopoiesis is a carefully controlled process that is regulated by complex networks of transcription factors that are, in part, controlled by signals resulting from ligand binding to cell-surface receptors. To further understand hematopoiesis, we have compared gene expression profiles of human erythroblasts, megakaryocytes, B cells, cytotoxic and helper T cells, natural killer cells, granulocytes, and monocytes using whole genome microarrays. A bioinformatics analysis of these data was performed focusing on transcription factors, immunoglobulin superfamily members, and lineage-specific transcripts. We observed that the numbers of lineage-specific genes varies by 2 orders of magnitude, ranging from 5 for cytotoxic T cells to 878 for granulocytes. In addition, we have identified novel coexpression patterns for key transcription factors involved in hematopoiesis (eg, GATA3-GFI1 and GATA2-KLF1). This study represents the most comprehensive analysis of gene expression in hematopoietic cells to date and has identified genes that play key roles in lineage commitment and cell function. The data, which are freely accessible, will be invaluable for future studies on hematopoiesis and the role of specific genes and will also aid the understanding of the recent genome-wide association studies. [Abstract from original publiction; Blood. 2009 May 7;113(19):e1-9. Epub 2009 Feb 19. Watkins_2009_19228925]"	50	"MK, erythroblast, B lymphocyte, Th, Tc, granulocyte, monocyte, NK"	Microarray (Illumina HumanWG-6 V2)	leukomics	Homo sapiens	5	Illumina V2	"rgb(0,0,0)"	circle	CD4+ T Cell  adult	lymphoid	T Cell	adult	CD4+ T cell	Lymphocyte
1674120085_D;1000	1000	Watkins	1674120085_D	61282-080	Homo sapiens	Tc	CL:0000542		lymphocyte	female		Watkins	"Hematopoiesis is a carefully controlled process that is regulated by complex networks of transcription factors that are, in part, controlled by signals resulting from ligand binding to cell-surface receptors. To further understand hematopoiesis, we have compared gene expression profiles of human erythroblasts, megakaryocytes, B cells, cytotoxic and helper T cells, natural killer cells, granulocytes, and monocytes using whole genome microarrays. A bioinformatics analysis of these data was performed focusing on transcription factors, immunoglobulin superfamily members, and lineage-specific transcripts. We observed that the numbers of lineage-specific genes varies by 2 orders of magnitude, ranging from 5 for cytotoxic T cells to 878 for granulocytes. In addition, we have identified novel coexpression patterns for key transcription factors involved in hematopoiesis (eg, GATA3-GFI1 and GATA2-KLF1). This study represents the most comprehensive analysis of gene expression in hematopoietic cells to date and has identified genes that play key roles in lineage commitment and cell function. The data, which are freely accessible, will be invaluable for future studies on hematopoiesis and the role of specific genes and will also aid the understanding of the recent genome-wide association studies. [Abstract from original publiction; Blood. 2009 May 7;113(19):e1-9. Epub 2009 Feb 19. Watkins_2009_19228925]"	50	"MK, erythroblast, B lymphocyte, Th, Tc, granulocyte, monocyte, NK"	Microarray (Illumina HumanWG-6 V2)	leukomics	Homo sapiens	5	Illumina V2	"rgb(0,0,0)"	circle	CD8+ T Cell  adult	lymphoid	T Cell	adult	CD8+ T cell	Lymphocyte
1674120085_E;1000	1000	Watkins	1674120085_E	63182-562	Homo sapiens	NK	CL:0000623		natural killer cell	female		Watkins	"Hematopoiesis is a carefully controlled process that is regulated by complex networks of transcription factors that are, in part, controlled by signals resulting from ligand binding to cell-surface receptors. To further understand hematopoiesis, we have compared gene expression profiles of human erythroblasts, megakaryocytes, B cells, cytotoxic and helper T cells, natural killer cells, granulocytes, and monocytes using whole genome microarrays. A bioinformatics analysis of these data was performed focusing on transcription factors, immunoglobulin superfamily members, and lineage-specific transcripts. We observed that the numbers of lineage-specific genes varies by 2 orders of magnitude, ranging from 5 for cytotoxic T cells to 878 for granulocytes. In addition, we have identified novel coexpression patterns for key transcription factors involved in hematopoiesis (eg, GATA3-GFI1 and GATA2-KLF1). This study represents the most comprehensive analysis of gene expression in hematopoietic cells to date and has identified genes that play key roles in lineage commitment and cell function. The data, which are freely accessible, will be invaluable for future studies on hematopoiesis and the role of specific genes and will also aid the understanding of the recent genome-wide association studies. [Abstract from original publiction; Blood. 2009 May 7;113(19):e1-9. Epub 2009 Feb 19. Watkins_2009_19228925]"	50	"MK, erythroblast, B lymphocyte, Th, Tc, granulocyte, monocyte, NK"	Microarray (Illumina HumanWG-6 V2)	leukomics	Homo sapiens	5	Illumina V2	"rgb(0,0,0)"	circle	CD56+ NK  adult	lymphoid	NK	adult	natural killer cell	Lymphocyte
1674120085_F;1000	1000	Watkins	1674120085_F	63182-191	Homo sapiens	B lymphocyte	CL:0000542		lymphocyte	female		Watkins	"Hematopoiesis is a carefully controlled process that is regulated by complex networks of transcription factors that are, in part, controlled by signals resulting from ligand binding to cell-surface receptors. To further understand hematopoiesis, we have compared gene expression profiles of human erythroblasts, megakaryocytes, B cells, cytotoxic and helper T cells, natural killer cells, granulocytes, and monocytes using whole genome microarrays. A bioinformatics analysis of these data was performed focusing on transcription factors, immunoglobulin superfamily members, and lineage-specific transcripts. We observed that the numbers of lineage-specific genes varies by 2 orders of magnitude, ranging from 5 for cytotoxic T cells to 878 for granulocytes. In addition, we have identified novel coexpression patterns for key transcription factors involved in hematopoiesis (eg, GATA3-GFI1 and GATA2-KLF1). This study represents the most comprehensive analysis of gene expression in hematopoietic cells to date and has identified genes that play key roles in lineage commitment and cell function. The data, which are freely accessible, will be invaluable for future studies on hematopoiesis and the role of specific genes and will also aid the understanding of the recent genome-wide association studies. [Abstract from original publiction; Blood. 2009 May 7;113(19):e1-9. Epub 2009 Feb 19. Watkins_2009_19228925]"	50	"MK, erythroblast, B lymphocyte, Th, Tc, granulocyte, monocyte, NK"	Microarray (Illumina HumanWG-6 V2)	leukomics	Homo sapiens	5	Illumina V2	"rgb(0,0,0)"	circle	CD19 B Cell  adult	lymphoid	B Cell	adult	B cell	Lymphocyte
1674120108_A;1000	1000	Watkins	1674120108_A	61218-044	Homo sapiens	Th	CL:0000542		lymphocyte	female		Watkins	"Hematopoiesis is a carefully controlled process that is regulated by complex networks of transcription factors that are, in part, controlled by signals resulting from ligand binding to cell-surface receptors. To further understand hematopoiesis, we have compared gene expression profiles of human erythroblasts, megakaryocytes, B cells, cytotoxic and helper T cells, natural killer cells, granulocytes, and monocytes using whole genome microarrays. A bioinformatics analysis of these data was performed focusing on transcription factors, immunoglobulin superfamily members, and lineage-specific transcripts. We observed that the numbers of lineage-specific genes varies by 2 orders of magnitude, ranging from 5 for cytotoxic T cells to 878 for granulocytes. In addition, we have identified novel coexpression patterns for key transcription factors involved in hematopoiesis (eg, GATA3-GFI1 and GATA2-KLF1). This study represents the most comprehensive analysis of gene expression in hematopoietic cells to date and has identified genes that play key roles in lineage commitment and cell function. The data, which are freely accessible, will be invaluable for future studies on hematopoiesis and the role of specific genes and will also aid the understanding of the recent genome-wide association studies. [Abstract from original publiction; Blood. 2009 May 7;113(19):e1-9. Epub 2009 Feb 19. Watkins_2009_19228925]"	50	"MK, erythroblast, B lymphocyte, Th, Tc, granulocyte, monocyte, NK"	Microarray (Illumina HumanWG-6 V2)	leukomics	Homo sapiens	5	Illumina V2	"rgb(0,0,0)"	circle	CD4+ T Cell  adult	lymphoid	T Cell	adult	CD4+ T cell	Lymphocyte
1674120108_B;1000	1000	Watkins	1674120108_B	61218-083	Homo sapiens	Tc	CL:0000542		lymphocyte	female		Watkins	"Hematopoiesis is a carefully controlled process that is regulated by complex networks of transcription factors that are, in part, controlled by signals resulting from ligand binding to cell-surface receptors. To further understand hematopoiesis, we have compared gene expression profiles of human erythroblasts, megakaryocytes, B cells, cytotoxic and helper T cells, natural killer cells, granulocytes, and monocytes using whole genome microarrays. A bioinformatics analysis of these data was performed focusing on transcription factors, immunoglobulin superfamily members, and lineage-specific transcripts. We observed that the numbers of lineage-specific genes varies by 2 orders of magnitude, ranging from 5 for cytotoxic T cells to 878 for granulocytes. In addition, we have identified novel coexpression patterns for key transcription factors involved in hematopoiesis (eg, GATA3-GFI1 and GATA2-KLF1). This study represents the most comprehensive analysis of gene expression in hematopoietic cells to date and has identified genes that play key roles in lineage commitment and cell function. The data, which are freely accessible, will be invaluable for future studies on hematopoiesis and the role of specific genes and will also aid the understanding of the recent genome-wide association studies. [Abstract from original publiction; Blood. 2009 May 7;113(19):e1-9. Epub 2009 Feb 19. Watkins_2009_19228925]"	50	"MK, erythroblast, B lymphocyte, Th, Tc, granulocyte, monocyte, NK"	Microarray (Illumina HumanWG-6 V2)	leukomics	Homo sapiens	5	Illumina V2	"rgb(0,0,0)"	circle	CD8+ T Cell  adult	lymphoid	T Cell	adult	CD8+ T cell	Lymphocyte
1674120108_C;1000	1000	Watkins	1674120108_C	63118-141	Homo sapiens	monocyte	CL:0000576		monocyte	female		Watkins	"Hematopoiesis is a carefully controlled process that is regulated by complex networks of transcription factors that are, in part, controlled by signals resulting from ligand binding to cell-surface receptors. To further understand hematopoiesis, we have compared gene expression profiles of human erythroblasts, megakaryocytes, B cells, cytotoxic and helper T cells, natural killer cells, granulocytes, and monocytes using whole genome microarrays. A bioinformatics analysis of these data was performed focusing on transcription factors, immunoglobulin superfamily members, and lineage-specific transcripts. We observed that the numbers of lineage-specific genes varies by 2 orders of magnitude, ranging from 5 for cytotoxic T cells to 878 for granulocytes. In addition, we have identified novel coexpression patterns for key transcription factors involved in hematopoiesis (eg, GATA3-GFI1 and GATA2-KLF1). This study represents the most comprehensive analysis of gene expression in hematopoietic cells to date and has identified genes that play key roles in lineage commitment and cell function. The data, which are freely accessible, will be invaluable for future studies on hematopoiesis and the role of specific genes and will also aid the understanding of the recent genome-wide association studies. [Abstract from original publiction; Blood. 2009 May 7;113(19):e1-9. Epub 2009 Feb 19. Watkins_2009_19228925]"	50	"MK, erythroblast, B lymphocyte, Th, Tc, granulocyte, monocyte, NK"	Microarray (Illumina HumanWG-6 V2)	leukomics	Homo sapiens	5	Illumina V2	"rgb(0,0,0)"	circle	CD14+ Monocyte  neonatal	myeloid	Monocyte	adult	monocyte	Circulating Monocyte & Granulocyte
1674120108_D;1000	1000	Watkins	1674120108_D	63118-191	Homo sapiens	B lymphocyte	CL:0000542		lymphocyte	female		Watkins	"Hematopoiesis is a carefully controlled process that is regulated by complex networks of transcription factors that are, in part, controlled by signals resulting from ligand binding to cell-surface receptors. To further understand hematopoiesis, we have compared gene expression profiles of human erythroblasts, megakaryocytes, B cells, cytotoxic and helper T cells, natural killer cells, granulocytes, and monocytes using whole genome microarrays. A bioinformatics analysis of these data was performed focusing on transcription factors, immunoglobulin superfamily members, and lineage-specific transcripts. We observed that the numbers of lineage-specific genes varies by 2 orders of magnitude, ranging from 5 for cytotoxic T cells to 878 for granulocytes. In addition, we have identified novel coexpression patterns for key transcription factors involved in hematopoiesis (eg, GATA3-GFI1 and GATA2-KLF1). This study represents the most comprehensive analysis of gene expression in hematopoietic cells to date and has identified genes that play key roles in lineage commitment and cell function. The data, which are freely accessible, will be invaluable for future studies on hematopoiesis and the role of specific genes and will also aid the understanding of the recent genome-wide association studies. [Abstract from original publiction; Blood. 2009 May 7;113(19):e1-9. Epub 2009 Feb 19. Watkins_2009_19228925]"	50	"MK, erythroblast, B lymphocyte, Th, Tc, granulocyte, monocyte, NK"	Microarray (Illumina HumanWG-6 V2)	leukomics	Homo sapiens	5	Illumina V2	"rgb(0,0,0)"	circle	CD19 B Cell  adult	lymphoid	B Cell	adult	B cell	Lymphocyte
1674120108_E;1000	1000	Watkins	1674120108_E	63118-560	Homo sapiens	NK	CL:0000623		natural killer cell	female		Watkins	"Hematopoiesis is a carefully controlled process that is regulated by complex networks of transcription factors that are, in part, controlled by signals resulting from ligand binding to cell-surface receptors. To further understand hematopoiesis, we have compared gene expression profiles of human erythroblasts, megakaryocytes, B cells, cytotoxic and helper T cells, natural killer cells, granulocytes, and monocytes using whole genome microarrays. A bioinformatics analysis of these data was performed focusing on transcription factors, immunoglobulin superfamily members, and lineage-specific transcripts. We observed that the numbers of lineage-specific genes varies by 2 orders of magnitude, ranging from 5 for cytotoxic T cells to 878 for granulocytes. In addition, we have identified novel coexpression patterns for key transcription factors involved in hematopoiesis (eg, GATA3-GFI1 and GATA2-KLF1). This study represents the most comprehensive analysis of gene expression in hematopoietic cells to date and has identified genes that play key roles in lineage commitment and cell function. The data, which are freely accessible, will be invaluable for future studies on hematopoiesis and the role of specific genes and will also aid the understanding of the recent genome-wide association studies. [Abstract from original publiction; Blood. 2009 May 7;113(19):e1-9. Epub 2009 Feb 19. Watkins_2009_19228925]"	50	"MK, erythroblast, B lymphocyte, Th, Tc, granulocyte, monocyte, NK"	Microarray (Illumina HumanWG-6 V2)	leukomics	Homo sapiens	5	Illumina V2	"rgb(0,0,0)"	circle	CD56+ NK  adult	lymphoid	NK	adult	natural killer cell	Lymphocyte
1674120108_F;1000	1000	Watkins	1674120108_F	63118-660	Homo sapiens	granulocyte	CL:0000094		granulocyte	female		Watkins	"Hematopoiesis is a carefully controlled process that is regulated by complex networks of transcription factors that are, in part, controlled by signals resulting from ligand binding to cell-surface receptors. To further understand hematopoiesis, we have compared gene expression profiles of human erythroblasts, megakaryocytes, B cells, cytotoxic and helper T cells, natural killer cells, granulocytes, and monocytes using whole genome microarrays. A bioinformatics analysis of these data was performed focusing on transcription factors, immunoglobulin superfamily members, and lineage-specific transcripts. We observed that the numbers of lineage-specific genes varies by 2 orders of magnitude, ranging from 5 for cytotoxic T cells to 878 for granulocytes. In addition, we have identified novel coexpression patterns for key transcription factors involved in hematopoiesis (eg, GATA3-GFI1 and GATA2-KLF1). This study represents the most comprehensive analysis of gene expression in hematopoietic cells to date and has identified genes that play key roles in lineage commitment and cell function. The data, which are freely accessible, will be invaluable for future studies on hematopoiesis and the role of specific genes and will also aid the understanding of the recent genome-wide association studies. [Abstract from original publiction; Blood. 2009 May 7;113(19):e1-9. Epub 2009 Feb 19. Watkins_2009_19228925]"	50	"MK, erythroblast, B lymphocyte, Th, Tc, granulocyte, monocyte, NK"	Microarray (Illumina HumanWG-6 V2)	leukomics	Homo sapiens	5	Illumina V2	"rgb(0,0,0)"	circle	CD166b+ Neutrophil:Eosinophil 82:18 Granulocyte  neonatal	myeloid	Granulocyte	adult	granulocyte	Circulating Monocyte & Granulocyte
1714460289_A;1000	1000	Watkins	1714460289_A	40-2339-MK	Homo sapiens	MK	CL:0000556		megakaryocyte			Watkins	"Hematopoiesis is a carefully controlled process that is regulated by complex networks of transcription factors that are, in part, controlled by signals resulting from ligand binding to cell-surface receptors. To further understand hematopoiesis, we have compared gene expression profiles of human erythroblasts, megakaryocytes, B cells, cytotoxic and helper T cells, natural killer cells, granulocytes, and monocytes using whole genome microarrays. A bioinformatics analysis of these data was performed focusing on transcription factors, immunoglobulin superfamily members, and lineage-specific transcripts. We observed that the numbers of lineage-specific genes varies by 2 orders of magnitude, ranging from 5 for cytotoxic T cells to 878 for granulocytes. In addition, we have identified novel coexpression patterns for key transcription factors involved in hematopoiesis (eg, GATA3-GFI1 and GATA2-KLF1). This study represents the most comprehensive analysis of gene expression in hematopoietic cells to date and has identified genes that play key roles in lineage commitment and cell function. The data, which are freely accessible, will be invaluable for future studies on hematopoiesis and the role of specific genes and will also aid the understanding of the recent genome-wide association studies. [Abstract from original publiction; Blood. 2009 May 7;113(19):e1-9. Epub 2009 Feb 19. Watkins_2009_19228925]"	50	"MK, erythroblast, B lymphocyte, Th, Tc, granulocyte, monocyte, NK"	Microarray (Illumina HumanWG-6 V2)	leukomics	Homo sapiens	5	Illumina V2	"rgb(0,0,0)"	circle	megakaryocyte	myeloid progenitor	MK	neonatal	megakaryocyte	Progenitor
1714460289_B;1000	1000	Watkins	1714460289_B	40-2339-EB	Homo sapiens	erythroblast	CL:0000765		erythroblast			Watkins	"Hematopoiesis is a carefully controlled process that is regulated by complex networks of transcription factors that are, in part, controlled by signals resulting from ligand binding to cell-surface receptors. To further understand hematopoiesis, we have compared gene expression profiles of human erythroblasts, megakaryocytes, B cells, cytotoxic and helper T cells, natural killer cells, granulocytes, and monocytes using whole genome microarrays. A bioinformatics analysis of these data was performed focusing on transcription factors, immunoglobulin superfamily members, and lineage-specific transcripts. We observed that the numbers of lineage-specific genes varies by 2 orders of magnitude, ranging from 5 for cytotoxic T cells to 878 for granulocytes. In addition, we have identified novel coexpression patterns for key transcription factors involved in hematopoiesis (eg, GATA3-GFI1 and GATA2-KLF1). This study represents the most comprehensive analysis of gene expression in hematopoietic cells to date and has identified genes that play key roles in lineage commitment and cell function. The data, which are freely accessible, will be invaluable for future studies on hematopoiesis and the role of specific genes and will also aid the understanding of the recent genome-wide association studies. [Abstract from original publiction; Blood. 2009 May 7;113(19):e1-9. Epub 2009 Feb 19. Watkins_2009_19228925]"	50	"MK, erythroblast, B lymphocyte, Th, Tc, granulocyte, monocyte, NK"	Microarray (Illumina HumanWG-6 V2)	leukomics	Homo sapiens	5	Illumina V2	"rgb(0,0,0)"	circle	erythroblast	myeloid progenitor	MP	neonatal	erythroblast	Progenitor
1714460297_A;1000	1000	Watkins	1714460297_A	40-2167-MK	Homo sapiens	MK	CL:0000556		megakaryocyte			Watkins	"Hematopoiesis is a carefully controlled process that is regulated by complex networks of transcription factors that are, in part, controlled by signals resulting from ligand binding to cell-surface receptors. To further understand hematopoiesis, we have compared gene expression profiles of human erythroblasts, megakaryocytes, B cells, cytotoxic and helper T cells, natural killer cells, granulocytes, and monocytes using whole genome microarrays. A bioinformatics analysis of these data was performed focusing on transcription factors, immunoglobulin superfamily members, and lineage-specific transcripts. We observed that the numbers of lineage-specific genes varies by 2 orders of magnitude, ranging from 5 for cytotoxic T cells to 878 for granulocytes. In addition, we have identified novel coexpression patterns for key transcription factors involved in hematopoiesis (eg, GATA3-GFI1 and GATA2-KLF1). This study represents the most comprehensive analysis of gene expression in hematopoietic cells to date and has identified genes that play key roles in lineage commitment and cell function. The data, which are freely accessible, will be invaluable for future studies on hematopoiesis and the role of specific genes and will also aid the understanding of the recent genome-wide association studies. [Abstract from original publiction; Blood. 2009 May 7;113(19):e1-9. Epub 2009 Feb 19. Watkins_2009_19228925]"	50	"MK, erythroblast, B lymphocyte, Th, Tc, granulocyte, monocyte, NK"	Microarray (Illumina HumanWG-6 V2)	leukomics	Homo sapiens	5	Illumina V2	"rgb(0,0,0)"	circle	megakaryocyte	myeloid progenitor	MK	neonatal	megakaryocyte	Progenitor
1714460297_B;1000	1000	Watkins	1714460297_B	40-2167-EB	Homo sapiens	erythroblast	CL:0000765		erythroblast			Watkins	"Hematopoiesis is a carefully controlled process that is regulated by complex networks of transcription factors that are, in part, controlled by signals resulting from ligand binding to cell-surface receptors. To further understand hematopoiesis, we have compared gene expression profiles of human erythroblasts, megakaryocytes, B cells, cytotoxic and helper T cells, natural killer cells, granulocytes, and monocytes using whole genome microarrays. A bioinformatics analysis of these data was performed focusing on transcription factors, immunoglobulin superfamily members, and lineage-specific transcripts. We observed that the numbers of lineage-specific genes varies by 2 orders of magnitude, ranging from 5 for cytotoxic T cells to 878 for granulocytes. In addition, we have identified novel coexpression patterns for key transcription factors involved in hematopoiesis (eg, GATA3-GFI1 and GATA2-KLF1). This study represents the most comprehensive analysis of gene expression in hematopoietic cells to date and has identified genes that play key roles in lineage commitment and cell function. The data, which are freely accessible, will be invaluable for future studies on hematopoiesis and the role of specific genes and will also aid the understanding of the recent genome-wide association studies. [Abstract from original publiction; Blood. 2009 May 7;113(19):e1-9. Epub 2009 Feb 19. Watkins_2009_19228925]"	50	"MK, erythroblast, B lymphocyte, Th, Tc, granulocyte, monocyte, NK"	Microarray (Illumina HumanWG-6 V2)	leukomics	Homo sapiens	5	Illumina V2	"rgb(0,0,0)"	circle	erythroblast	myeloid progenitor	MP	neonatal	erythroblast	Progenitor
1714460297_C;1000	1000	Watkins	1714460297_C	40-2267-MK	Homo sapiens	MK	CL:0000556		megakaryocyte			Watkins	"Hematopoiesis is a carefully controlled process that is regulated by complex networks of transcription factors that are, in part, controlled by signals resulting from ligand binding to cell-surface receptors. To further understand hematopoiesis, we have compared gene expression profiles of human erythroblasts, megakaryocytes, B cells, cytotoxic and helper T cells, natural killer cells, granulocytes, and monocytes using whole genome microarrays. A bioinformatics analysis of these data was performed focusing on transcription factors, immunoglobulin superfamily members, and lineage-specific transcripts. We observed that the numbers of lineage-specific genes varies by 2 orders of magnitude, ranging from 5 for cytotoxic T cells to 878 for granulocytes. In addition, we have identified novel coexpression patterns for key transcription factors involved in hematopoiesis (eg, GATA3-GFI1 and GATA2-KLF1). This study represents the most comprehensive analysis of gene expression in hematopoietic cells to date and has identified genes that play key roles in lineage commitment and cell function. The data, which are freely accessible, will be invaluable for future studies on hematopoiesis and the role of specific genes and will also aid the understanding of the recent genome-wide association studies. [Abstract from original publiction; Blood. 2009 May 7;113(19):e1-9. Epub 2009 Feb 19. Watkins_2009_19228925]"	50	"MK, erythroblast, B lymphocyte, Th, Tc, granulocyte, monocyte, NK"	Microarray (Illumina HumanWG-6 V2)	leukomics	Homo sapiens	5	Illumina V2	"rgb(0,0,0)"	circle	megakaryocyte	myeloid progenitor	MK	neonatal	megakaryocyte	Progenitor
1714460297_D;1000	1000	Watkins	1714460297_D	40-2267-EB	Homo sapiens	erythroblast	CL:0000765		erythroblast			Watkins	"Hematopoiesis is a carefully controlled process that is regulated by complex networks of transcription factors that are, in part, controlled by signals resulting from ligand binding to cell-surface receptors. To further understand hematopoiesis, we have compared gene expression profiles of human erythroblasts, megakaryocytes, B cells, cytotoxic and helper T cells, natural killer cells, granulocytes, and monocytes using whole genome microarrays. A bioinformatics analysis of these data was performed focusing on transcription factors, immunoglobulin superfamily members, and lineage-specific transcripts. We observed that the numbers of lineage-specific genes varies by 2 orders of magnitude, ranging from 5 for cytotoxic T cells to 878 for granulocytes. In addition, we have identified novel coexpression patterns for key transcription factors involved in hematopoiesis (eg, GATA3-GFI1 and GATA2-KLF1). This study represents the most comprehensive analysis of gene expression in hematopoietic cells to date and has identified genes that play key roles in lineage commitment and cell function. The data, which are freely accessible, will be invaluable for future studies on hematopoiesis and the role of specific genes and will also aid the understanding of the recent genome-wide association studies. [Abstract from original publiction; Blood. 2009 May 7;113(19):e1-9. Epub 2009 Feb 19. Watkins_2009_19228925]"	50	"MK, erythroblast, B lymphocyte, Th, Tc, granulocyte, monocyte, NK"	Microarray (Illumina HumanWG-6 V2)	leukomics	Homo sapiens	5	Illumina V2	"rgb(0,0,0)"	circle	erythroblast	myeloid progenitor	MP	neonatal	erythroblast	Progenitor
1714460297_E;1000	1000	Watkins	1714460297_E	40-2513-MK	Homo sapiens	MK	CL:0000556		megakaryocyte			Watkins	"Hematopoiesis is a carefully controlled process that is regulated by complex networks of transcription factors that are, in part, controlled by signals resulting from ligand binding to cell-surface receptors. To further understand hematopoiesis, we have compared gene expression profiles of human erythroblasts, megakaryocytes, B cells, cytotoxic and helper T cells, natural killer cells, granulocytes, and monocytes using whole genome microarrays. A bioinformatics analysis of these data was performed focusing on transcription factors, immunoglobulin superfamily members, and lineage-specific transcripts. We observed that the numbers of lineage-specific genes varies by 2 orders of magnitude, ranging from 5 for cytotoxic T cells to 878 for granulocytes. In addition, we have identified novel coexpression patterns for key transcription factors involved in hematopoiesis (eg, GATA3-GFI1 and GATA2-KLF1). This study represents the most comprehensive analysis of gene expression in hematopoietic cells to date and has identified genes that play key roles in lineage commitment and cell function. The data, which are freely accessible, will be invaluable for future studies on hematopoiesis and the role of specific genes and will also aid the understanding of the recent genome-wide association studies. [Abstract from original publiction; Blood. 2009 May 7;113(19):e1-9. Epub 2009 Feb 19. Watkins_2009_19228925]"	50	"MK, erythroblast, B lymphocyte, Th, Tc, granulocyte, monocyte, NK"	Microarray (Illumina HumanWG-6 V2)	leukomics	Homo sapiens	5	Illumina V2	"rgb(0,0,0)"	circle	megakaryocyte	myeloid progenitor	MK	neonatal	megakaryocyte	Progenitor
1714460297_F;1000	1000	Watkins	1714460297_F	40-2513-EB	Homo sapiens	erythroblast	CL:0000765		erythroblast			Watkins	"Hematopoiesis is a carefully controlled process that is regulated by complex networks of transcription factors that are, in part, controlled by signals resulting from ligand binding to cell-surface receptors. To further understand hematopoiesis, we have compared gene expression profiles of human erythroblasts, megakaryocytes, B cells, cytotoxic and helper T cells, natural killer cells, granulocytes, and monocytes using whole genome microarrays. A bioinformatics analysis of these data was performed focusing on transcription factors, immunoglobulin superfamily members, and lineage-specific transcripts. We observed that the numbers of lineage-specific genes varies by 2 orders of magnitude, ranging from 5 for cytotoxic T cells to 878 for granulocytes. In addition, we have identified novel coexpression patterns for key transcription factors involved in hematopoiesis (eg, GATA3-GFI1 and GATA2-KLF1). This study represents the most comprehensive analysis of gene expression in hematopoietic cells to date and has identified genes that play key roles in lineage commitment and cell function. The data, which are freely accessible, will be invaluable for future studies on hematopoiesis and the role of specific genes and will also aid the understanding of the recent genome-wide association studies. [Abstract from original publiction; Blood. 2009 May 7;113(19):e1-9. Epub 2009 Feb 19. Watkins_2009_19228925]"	50	"MK, erythroblast, B lymphocyte, Th, Tc, granulocyte, monocyte, NK"	Microarray (Illumina HumanWG-6 V2)	leukomics	Homo sapiens	5	Illumina V2	"rgb(0,0,0)"	circle	erythroblast	myeloid progenitor	MP	neonatal	erythroblast	Progenitor
3998755167_A;6612	6612	Minoda	3998755167_A	CD141+ polyIC+R848 rep 1	Homo sapiens	CD141+ polyIC+R848	CL:0002394		CD141+ dendritic cell			Minoda	"Human immune cell subsets develop in immunodeficient mice following reconstitution with human CD34+ hematopoietic stem cells. These ""humanized"" mice are useful models to study human immunology and human-tropic infections, autoimmunity, and cancer. However, some human immune cell subsets are unable to fully develop or acquire full functional capacity due to a lack of cross-reactivity of many growth factors and cytokines between species. Conventional dendritic cells (cDCs) in mice are categorized into cDC1, which mediate T helper (Th)1 and CD8+ T cell responses, and cDC2, which mediate Th2 and Th17 responses. The likely human equivalents are CD141+ DC and CD1c+ DC subsets for mouse cDC1 and cDC2, respectively, but the extent of any interspecies differences is poorly characterized. Here, we exploit the fact that human CD141+ DC and CD1c+ DC develop in humanized mice, to further explore their equivalency in vivo. Global transcriptome analysis of CD141+ DC and CD1c+ DC isolated from humanized mice demonstrated that they closely resemble those in human blood. Activation of DC subsets in vivo, with the TLR3 ligand poly I:C, and the TLR7/8 ligand R848 revealed that a core panel of genes consistent with DC maturation status were upregulated by both subsets. R848 specifically upregulated genes associated with Th17 responses by CD1c+ DC, while poly I:C upregulated IFN- genes specifically by CD141+ DC. MYCL expression, known to be essential for CD8+ T cell priming by mouse DC, was specifically induced in CD141+ DC after activation. Concomitantly, CD141+ DC were superior to CD1c+ DC in their ability to prime nave antigen-specific CD8+ T cells. Thus, CD141+ DC and CD1c+ DC share a similar activation profiles in vivo but also have induce unique signatures that support specialized roles in CD8+ T cell priming and Th17 responses, respectively. In combination, these data demonstrate that humanized mice provide an attractive and tractable model to study human DC in vitro and in vivo. Abstract from Front Immunol. 2017 Oct 30;8:1419. doi: 10.3389/fimmu.2017.01419."	19	"CD141 untreated, CD141+ polyIC, CD141+ R848, CD141+ polyIC+R848, CD1c untreated, CD1c+ polyIC, CD1c+ R848, CD1c+ polyIC+R848"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.6	Illumina V4	"rgb(146,0,0)"	diamond	TRDC HLA-DR+ CD141+ polyIC + R848 2h humanised mouse	myeloid	TRDC	humanised mouse	CD141+ dendritic cell	Mixed
3998755167_D;6612	6612	Minoda	3998755167_D	CD1c+ R848 rep 1	Homo sapiens	CD1c+ R848	CL:0002399		CD1c+ dendritic cell			Minoda	"Human immune cell subsets develop in immunodeficient mice following reconstitution with human CD34+ hematopoietic stem cells. These ""humanized"" mice are useful models to study human immunology and human-tropic infections, autoimmunity, and cancer. However, some human immune cell subsets are unable to fully develop or acquire full functional capacity due to a lack of cross-reactivity of many growth factors and cytokines between species. Conventional dendritic cells (cDCs) in mice are categorized into cDC1, which mediate T helper (Th)1 and CD8+ T cell responses, and cDC2, which mediate Th2 and Th17 responses. The likely human equivalents are CD141+ DC and CD1c+ DC subsets for mouse cDC1 and cDC2, respectively, but the extent of any interspecies differences is poorly characterized. Here, we exploit the fact that human CD141+ DC and CD1c+ DC develop in humanized mice, to further explore their equivalency in vivo. Global transcriptome analysis of CD141+ DC and CD1c+ DC isolated from humanized mice demonstrated that they closely resemble those in human blood. Activation of DC subsets in vivo, with the TLR3 ligand poly I:C, and the TLR7/8 ligand R848 revealed that a core panel of genes consistent with DC maturation status were upregulated by both subsets. R848 specifically upregulated genes associated with Th17 responses by CD1c+ DC, while poly I:C upregulated IFN- genes specifically by CD141+ DC. MYCL expression, known to be essential for CD8+ T cell priming by mouse DC, was specifically induced in CD141+ DC after activation. Concomitantly, CD141+ DC were superior to CD1c+ DC in their ability to prime nave antigen-specific CD8+ T cells. Thus, CD141+ DC and CD1c+ DC share a similar activation profiles in vivo but also have induce unique signatures that support specialized roles in CD8+ T cell priming and Th17 responses, respectively. In combination, these data demonstrate that humanized mice provide an attractive and tractable model to study human DC in vitro and in vivo. Abstract from Front Immunol. 2017 Oct 30;8:1419. doi: 10.3389/fimmu.2017.01419."	19	"CD141 untreated, CD141+ polyIC, CD141+ R848, CD141+ polyIC+R848, CD1c untreated, CD1c+ polyIC, CD1c+ R848, CD1c+ polyIC+R848"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.6	Illumina V4	"rgb(146,0,0)"	diamond	TRDC HLA-DR+ CD1c+ R848 2h humanised mouse	myeloid	TRDC	humanised mouse	CD1c+ dendritic cell	Mixed
3998755167_F;6612	6612	Minoda	3998755167_F	CD141+ polyIC+R848 rep 2	Homo sapiens	CD141+ polyIC+R848	CL:0002394		CD141+ dendritic cell			Minoda	"Human immune cell subsets develop in immunodeficient mice following reconstitution with human CD34+ hematopoietic stem cells. These ""humanized"" mice are useful models to study human immunology and human-tropic infections, autoimmunity, and cancer. However, some human immune cell subsets are unable to fully develop or acquire full functional capacity due to a lack of cross-reactivity of many growth factors and cytokines between species. Conventional dendritic cells (cDCs) in mice are categorized into cDC1, which mediate T helper (Th)1 and CD8+ T cell responses, and cDC2, which mediate Th2 and Th17 responses. The likely human equivalents are CD141+ DC and CD1c+ DC subsets for mouse cDC1 and cDC2, respectively, but the extent of any interspecies differences is poorly characterized. Here, we exploit the fact that human CD141+ DC and CD1c+ DC develop in humanized mice, to further explore their equivalency in vivo. Global transcriptome analysis of CD141+ DC and CD1c+ DC isolated from humanized mice demonstrated that they closely resemble those in human blood. Activation of DC subsets in vivo, with the TLR3 ligand poly I:C, and the TLR7/8 ligand R848 revealed that a core panel of genes consistent with DC maturation status were upregulated by both subsets. R848 specifically upregulated genes associated with Th17 responses by CD1c+ DC, while poly I:C upregulated IFN- genes specifically by CD141+ DC. MYCL expression, known to be essential for CD8+ T cell priming by mouse DC, was specifically induced in CD141+ DC after activation. Concomitantly, CD141+ DC were superior to CD1c+ DC in their ability to prime nave antigen-specific CD8+ T cells. Thus, CD141+ DC and CD1c+ DC share a similar activation profiles in vivo but also have induce unique signatures that support specialized roles in CD8+ T cell priming and Th17 responses, respectively. In combination, these data demonstrate that humanized mice provide an attractive and tractable model to study human DC in vitro and in vivo. Abstract from Front Immunol. 2017 Oct 30;8:1419. doi: 10.3389/fimmu.2017.01419."	19	"CD141 untreated, CD141+ polyIC, CD141+ R848, CD141+ polyIC+R848, CD1c untreated, CD1c+ polyIC, CD1c+ R848, CD1c+ polyIC+R848"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.6	Illumina V4	"rgb(146,0,0)"	diamond	TRDC HLA-DR+ CD141+ polyIC + R848 2h humanised mouse	myeloid	TRDC	humanised mouse	CD141+ dendritic cell	Mixed
3998755167_G;6612	6612	Minoda	3998755167_G	CD1c untreated rep 1	Homo sapiens	CD1c untreated	CL:0002399		CD1c+ dendritic cell			Minoda	"Human immune cell subsets develop in immunodeficient mice following reconstitution with human CD34+ hematopoietic stem cells. These ""humanized"" mice are useful models to study human immunology and human-tropic infections, autoimmunity, and cancer. However, some human immune cell subsets are unable to fully develop or acquire full functional capacity due to a lack of cross-reactivity of many growth factors and cytokines between species. Conventional dendritic cells (cDCs) in mice are categorized into cDC1, which mediate T helper (Th)1 and CD8+ T cell responses, and cDC2, which mediate Th2 and Th17 responses. The likely human equivalents are CD141+ DC and CD1c+ DC subsets for mouse cDC1 and cDC2, respectively, but the extent of any interspecies differences is poorly characterized. Here, we exploit the fact that human CD141+ DC and CD1c+ DC develop in humanized mice, to further explore their equivalency in vivo. Global transcriptome analysis of CD141+ DC and CD1c+ DC isolated from humanized mice demonstrated that they closely resemble those in human blood. Activation of DC subsets in vivo, with the TLR3 ligand poly I:C, and the TLR7/8 ligand R848 revealed that a core panel of genes consistent with DC maturation status were upregulated by both subsets. R848 specifically upregulated genes associated with Th17 responses by CD1c+ DC, while poly I:C upregulated IFN- genes specifically by CD141+ DC. MYCL expression, known to be essential for CD8+ T cell priming by mouse DC, was specifically induced in CD141+ DC after activation. Concomitantly, CD141+ DC were superior to CD1c+ DC in their ability to prime nave antigen-specific CD8+ T cells. Thus, CD141+ DC and CD1c+ DC share a similar activation profiles in vivo but also have induce unique signatures that support specialized roles in CD8+ T cell priming and Th17 responses, respectively. In combination, these data demonstrate that humanized mice provide an attractive and tractable model to study human DC in vitro and in vivo. Abstract from Front Immunol. 2017 Oct 30;8:1419. doi: 10.3389/fimmu.2017.01419."	19	"CD141 untreated, CD141+ polyIC, CD141+ R848, CD141+ polyIC+R848, CD1c untreated, CD1c+ polyIC, CD1c+ R848, CD1c+ polyIC+R848"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.6	Illumina V4	"rgb(146,0,0)"	diamond	TRDC HLA-DR+ CD1c+  humanised mouse	myeloid	TRDC	humanised mouse	CD1c+ dendritic cell	Mixed
3998755167_H;6612	6612	Minoda	3998755167_H	CD1c+ polyIC+R848 rep 2	Homo sapiens	CD1c+ polyIC+R848	CL:0002399		CD1c+ dendritic cell			Minoda	"Human immune cell subsets develop in immunodeficient mice following reconstitution with human CD34+ hematopoietic stem cells. These ""humanized"" mice are useful models to study human immunology and human-tropic infections, autoimmunity, and cancer. However, some human immune cell subsets are unable to fully develop or acquire full functional capacity due to a lack of cross-reactivity of many growth factors and cytokines between species. Conventional dendritic cells (cDCs) in mice are categorized into cDC1, which mediate T helper (Th)1 and CD8+ T cell responses, and cDC2, which mediate Th2 and Th17 responses. The likely human equivalents are CD141+ DC and CD1c+ DC subsets for mouse cDC1 and cDC2, respectively, but the extent of any interspecies differences is poorly characterized. Here, we exploit the fact that human CD141+ DC and CD1c+ DC develop in humanized mice, to further explore their equivalency in vivo. Global transcriptome analysis of CD141+ DC and CD1c+ DC isolated from humanized mice demonstrated that they closely resemble those in human blood. Activation of DC subsets in vivo, with the TLR3 ligand poly I:C, and the TLR7/8 ligand R848 revealed that a core panel of genes consistent with DC maturation status were upregulated by both subsets. R848 specifically upregulated genes associated with Th17 responses by CD1c+ DC, while poly I:C upregulated IFN- genes specifically by CD141+ DC. MYCL expression, known to be essential for CD8+ T cell priming by mouse DC, was specifically induced in CD141+ DC after activation. Concomitantly, CD141+ DC were superior to CD1c+ DC in their ability to prime nave antigen-specific CD8+ T cells. Thus, CD141+ DC and CD1c+ DC share a similar activation profiles in vivo but also have induce unique signatures that support specialized roles in CD8+ T cell priming and Th17 responses, respectively. In combination, these data demonstrate that humanized mice provide an attractive and tractable model to study human DC in vitro and in vivo. Abstract from Front Immunol. 2017 Oct 30;8:1419. doi: 10.3389/fimmu.2017.01419."	19	"CD141 untreated, CD141+ polyIC, CD141+ R848, CD141+ polyIC+R848, CD1c untreated, CD1c+ polyIC, CD1c+ R848, CD1c+ polyIC+R848"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.6	Illumina V4	"rgb(146,0,0)"	diamond	TRDC HLA-DR+ CD1c+ polyIC+R848 2h humanised mouse	myeloid	TRDC	humanised mouse	CD1c+ dendritic cell	Mixed
3998755167_I;6612	6612	Minoda	3998755167_I	CD141+ polyIC rep 1	Homo sapiens	CD141+ polyIC	CL:0002394		CD141+ dendritic cell			Minoda	"Human immune cell subsets develop in immunodeficient mice following reconstitution with human CD34+ hematopoietic stem cells. These ""humanized"" mice are useful models to study human immunology and human-tropic infections, autoimmunity, and cancer. However, some human immune cell subsets are unable to fully develop or acquire full functional capacity due to a lack of cross-reactivity of many growth factors and cytokines between species. Conventional dendritic cells (cDCs) in mice are categorized into cDC1, which mediate T helper (Th)1 and CD8+ T cell responses, and cDC2, which mediate Th2 and Th17 responses. The likely human equivalents are CD141+ DC and CD1c+ DC subsets for mouse cDC1 and cDC2, respectively, but the extent of any interspecies differences is poorly characterized. Here, we exploit the fact that human CD141+ DC and CD1c+ DC develop in humanized mice, to further explore their equivalency in vivo. Global transcriptome analysis of CD141+ DC and CD1c+ DC isolated from humanized mice demonstrated that they closely resemble those in human blood. Activation of DC subsets in vivo, with the TLR3 ligand poly I:C, and the TLR7/8 ligand R848 revealed that a core panel of genes consistent with DC maturation status were upregulated by both subsets. R848 specifically upregulated genes associated with Th17 responses by CD1c+ DC, while poly I:C upregulated IFN- genes specifically by CD141+ DC. MYCL expression, known to be essential for CD8+ T cell priming by mouse DC, was specifically induced in CD141+ DC after activation. Concomitantly, CD141+ DC were superior to CD1c+ DC in their ability to prime nave antigen-specific CD8+ T cells. Thus, CD141+ DC and CD1c+ DC share a similar activation profiles in vivo but also have induce unique signatures that support specialized roles in CD8+ T cell priming and Th17 responses, respectively. In combination, these data demonstrate that humanized mice provide an attractive and tractable model to study human DC in vitro and in vivo. Abstract from Front Immunol. 2017 Oct 30;8:1419. doi: 10.3389/fimmu.2017.01419."	19	"CD141 untreated, CD141+ polyIC, CD141+ R848, CD141+ polyIC+R848, CD1c untreated, CD1c+ polyIC, CD1c+ R848, CD1c+ polyIC+R848"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.6	Illumina V4	"rgb(146,0,0)"	diamond	TRDC HLA-DR+ CD141+ polyIC 2h humanised mouse	myeloid	TRDC	humanised mouse	CD141+ dendritic cell	Mixed
3998755167_J;6612	6612	Minoda	3998755167_J	CD141 untreated rep 2	Homo sapiens	CD141 untreated	CL:0002394		CD141+ dendritic cell			Minoda	"Human immune cell subsets develop in immunodeficient mice following reconstitution with human CD34+ hematopoietic stem cells. These ""humanized"" mice are useful models to study human immunology and human-tropic infections, autoimmunity, and cancer. However, some human immune cell subsets are unable to fully develop or acquire full functional capacity due to a lack of cross-reactivity of many growth factors and cytokines between species. Conventional dendritic cells (cDCs) in mice are categorized into cDC1, which mediate T helper (Th)1 and CD8+ T cell responses, and cDC2, which mediate Th2 and Th17 responses. The likely human equivalents are CD141+ DC and CD1c+ DC subsets for mouse cDC1 and cDC2, respectively, but the extent of any interspecies differences is poorly characterized. Here, we exploit the fact that human CD141+ DC and CD1c+ DC develop in humanized mice, to further explore their equivalency in vivo. Global transcriptome analysis of CD141+ DC and CD1c+ DC isolated from humanized mice demonstrated that they closely resemble those in human blood. Activation of DC subsets in vivo, with the TLR3 ligand poly I:C, and the TLR7/8 ligand R848 revealed that a core panel of genes consistent with DC maturation status were upregulated by both subsets. R848 specifically upregulated genes associated with Th17 responses by CD1c+ DC, while poly I:C upregulated IFN- genes specifically by CD141+ DC. MYCL expression, known to be essential for CD8+ T cell priming by mouse DC, was specifically induced in CD141+ DC after activation. Concomitantly, CD141+ DC were superior to CD1c+ DC in their ability to prime nave antigen-specific CD8+ T cells. Thus, CD141+ DC and CD1c+ DC share a similar activation profiles in vivo but also have induce unique signatures that support specialized roles in CD8+ T cell priming and Th17 responses, respectively. In combination, these data demonstrate that humanized mice provide an attractive and tractable model to study human DC in vitro and in vivo. Abstract from Front Immunol. 2017 Oct 30;8:1419. doi: 10.3389/fimmu.2017.01419."	19	"CD141 untreated, CD141+ polyIC, CD141+ R848, CD141+ polyIC+R848, CD1c untreated, CD1c+ polyIC, CD1c+ R848, CD1c+ polyIC+R848"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.6	Illumina V4	"rgb(146,0,0)"	diamond	TRDC HLA-DR+ CD141+  humanised mouse	myeloid	TRDC	humanised mouse	CD141+ dendritic cell	Mixed
3998755167_K;6612	6612	Minoda	3998755167_K	CD1c+ polyIC rep 1	Homo sapiens	CD1c+ polyIC	CL:0002399		CD1c+ dendritic cell			Minoda	"Human immune cell subsets develop in immunodeficient mice following reconstitution with human CD34+ hematopoietic stem cells. These ""humanized"" mice are useful models to study human immunology and human-tropic infections, autoimmunity, and cancer. However, some human immune cell subsets are unable to fully develop or acquire full functional capacity due to a lack of cross-reactivity of many growth factors and cytokines between species. Conventional dendritic cells (cDCs) in mice are categorized into cDC1, which mediate T helper (Th)1 and CD8+ T cell responses, and cDC2, which mediate Th2 and Th17 responses. The likely human equivalents are CD141+ DC and CD1c+ DC subsets for mouse cDC1 and cDC2, respectively, but the extent of any interspecies differences is poorly characterized. Here, we exploit the fact that human CD141+ DC and CD1c+ DC develop in humanized mice, to further explore their equivalency in vivo. Global transcriptome analysis of CD141+ DC and CD1c+ DC isolated from humanized mice demonstrated that they closely resemble those in human blood. Activation of DC subsets in vivo, with the TLR3 ligand poly I:C, and the TLR7/8 ligand R848 revealed that a core panel of genes consistent with DC maturation status were upregulated by both subsets. R848 specifically upregulated genes associated with Th17 responses by CD1c+ DC, while poly I:C upregulated IFN- genes specifically by CD141+ DC. MYCL expression, known to be essential for CD8+ T cell priming by mouse DC, was specifically induced in CD141+ DC after activation. Concomitantly, CD141+ DC were superior to CD1c+ DC in their ability to prime nave antigen-specific CD8+ T cells. Thus, CD141+ DC and CD1c+ DC share a similar activation profiles in vivo but also have induce unique signatures that support specialized roles in CD8+ T cell priming and Th17 responses, respectively. In combination, these data demonstrate that humanized mice provide an attractive and tractable model to study human DC in vitro and in vivo. Abstract from Front Immunol. 2017 Oct 30;8:1419. doi: 10.3389/fimmu.2017.01419."	19	"CD141 untreated, CD141+ polyIC, CD141+ R848, CD141+ polyIC+R848, CD1c untreated, CD1c+ polyIC, CD1c+ R848, CD1c+ polyIC+R848"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.6	Illumina V4	"rgb(146,0,0)"	diamond	TRDC HLA-DR+ CD1c+ polyIC 2h humanised mouse	myeloid	TRDC	humanised mouse	CD1c+ dendritic cell	Mixed
3998755170_B;6612	6612	Minoda	3998755170_B	CD141 untreated rep 3	Homo sapiens	CD141 untreated	CL:0002394		CD141+ dendritic cell			Minoda	"Human immune cell subsets develop in immunodeficient mice following reconstitution with human CD34+ hematopoietic stem cells. These ""humanized"" mice are useful models to study human immunology and human-tropic infections, autoimmunity, and cancer. However, some human immune cell subsets are unable to fully develop or acquire full functional capacity due to a lack of cross-reactivity of many growth factors and cytokines between species. Conventional dendritic cells (cDCs) in mice are categorized into cDC1, which mediate T helper (Th)1 and CD8+ T cell responses, and cDC2, which mediate Th2 and Th17 responses. The likely human equivalents are CD141+ DC and CD1c+ DC subsets for mouse cDC1 and cDC2, respectively, but the extent of any interspecies differences is poorly characterized. Here, we exploit the fact that human CD141+ DC and CD1c+ DC develop in humanized mice, to further explore their equivalency in vivo. Global transcriptome analysis of CD141+ DC and CD1c+ DC isolated from humanized mice demonstrated that they closely resemble those in human blood. Activation of DC subsets in vivo, with the TLR3 ligand poly I:C, and the TLR7/8 ligand R848 revealed that a core panel of genes consistent with DC maturation status were upregulated by both subsets. R848 specifically upregulated genes associated with Th17 responses by CD1c+ DC, while poly I:C upregulated IFN- genes specifically by CD141+ DC. MYCL expression, known to be essential for CD8+ T cell priming by mouse DC, was specifically induced in CD141+ DC after activation. Concomitantly, CD141+ DC were superior to CD1c+ DC in their ability to prime nave antigen-specific CD8+ T cells. Thus, CD141+ DC and CD1c+ DC share a similar activation profiles in vivo but also have induce unique signatures that support specialized roles in CD8+ T cell priming and Th17 responses, respectively. In combination, these data demonstrate that humanized mice provide an attractive and tractable model to study human DC in vitro and in vivo. Abstract from Front Immunol. 2017 Oct 30;8:1419. doi: 10.3389/fimmu.2017.01419."	19	"CD141 untreated, CD141+ polyIC, CD141+ R848, CD141+ polyIC+R848, CD1c untreated, CD1c+ polyIC, CD1c+ R848, CD1c+ polyIC+R848"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.6	Illumina V4	"rgb(146,0,0)"	diamond	TRDC HLA-DR+ CD141+  humanised mouse	myeloid	TRDC	humanised mouse	CD141+ dendritic cell	Mixed
3998755170_C;6612	6612	Minoda	3998755170_C	CD1c + polyIC rep 2	Homo sapiens	CD1c+ polyIC	CL:0002399		CD1c+ dendritic cell			Minoda	"Human immune cell subsets develop in immunodeficient mice following reconstitution with human CD34+ hematopoietic stem cells. These ""humanized"" mice are useful models to study human immunology and human-tropic infections, autoimmunity, and cancer. However, some human immune cell subsets are unable to fully develop or acquire full functional capacity due to a lack of cross-reactivity of many growth factors and cytokines between species. Conventional dendritic cells (cDCs) in mice are categorized into cDC1, which mediate T helper (Th)1 and CD8+ T cell responses, and cDC2, which mediate Th2 and Th17 responses. The likely human equivalents are CD141+ DC and CD1c+ DC subsets for mouse cDC1 and cDC2, respectively, but the extent of any interspecies differences is poorly characterized. Here, we exploit the fact that human CD141+ DC and CD1c+ DC develop in humanized mice, to further explore their equivalency in vivo. Global transcriptome analysis of CD141+ DC and CD1c+ DC isolated from humanized mice demonstrated that they closely resemble those in human blood. Activation of DC subsets in vivo, with the TLR3 ligand poly I:C, and the TLR7/8 ligand R848 revealed that a core panel of genes consistent with DC maturation status were upregulated by both subsets. R848 specifically upregulated genes associated with Th17 responses by CD1c+ DC, while poly I:C upregulated IFN- genes specifically by CD141+ DC. MYCL expression, known to be essential for CD8+ T cell priming by mouse DC, was specifically induced in CD141+ DC after activation. Concomitantly, CD141+ DC were superior to CD1c+ DC in their ability to prime nave antigen-specific CD8+ T cells. Thus, CD141+ DC and CD1c+ DC share a similar activation profiles in vivo but also have induce unique signatures that support specialized roles in CD8+ T cell priming and Th17 responses, respectively. In combination, these data demonstrate that humanized mice provide an attractive and tractable model to study human DC in vitro and in vivo. Abstract from Front Immunol. 2017 Oct 30;8:1419. doi: 10.3389/fimmu.2017.01419."	19	"CD141 untreated, CD141+ polyIC, CD141+ R848, CD141+ polyIC+R848, CD1c untreated, CD1c+ polyIC, CD1c+ R848, CD1c+ polyIC+R848"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.6	Illumina V4	"rgb(146,0,0)"	diamond	TRDC HLA-DR+ CD1c+ polyIC 2h humanised mouse	myeloid	TRDC	humanised mouse	CD1c+ dendritic cell	Mixed
3998755170_D;6612	6612	Minoda	3998755170_D	CD1c untreated rep 3	Homo sapiens	CD1c untreated	CL:0002399		CD1c+ dendritic cell			Minoda	"Human immune cell subsets develop in immunodeficient mice following reconstitution with human CD34+ hematopoietic stem cells. These ""humanized"" mice are useful models to study human immunology and human-tropic infections, autoimmunity, and cancer. However, some human immune cell subsets are unable to fully develop or acquire full functional capacity due to a lack of cross-reactivity of many growth factors and cytokines between species. Conventional dendritic cells (cDCs) in mice are categorized into cDC1, which mediate T helper (Th)1 and CD8+ T cell responses, and cDC2, which mediate Th2 and Th17 responses. The likely human equivalents are CD141+ DC and CD1c+ DC subsets for mouse cDC1 and cDC2, respectively, but the extent of any interspecies differences is poorly characterized. Here, we exploit the fact that human CD141+ DC and CD1c+ DC develop in humanized mice, to further explore their equivalency in vivo. Global transcriptome analysis of CD141+ DC and CD1c+ DC isolated from humanized mice demonstrated that they closely resemble those in human blood. Activation of DC subsets in vivo, with the TLR3 ligand poly I:C, and the TLR7/8 ligand R848 revealed that a core panel of genes consistent with DC maturation status were upregulated by both subsets. R848 specifically upregulated genes associated with Th17 responses by CD1c+ DC, while poly I:C upregulated IFN- genes specifically by CD141+ DC. MYCL expression, known to be essential for CD8+ T cell priming by mouse DC, was specifically induced in CD141+ DC after activation. Concomitantly, CD141+ DC were superior to CD1c+ DC in their ability to prime nave antigen-specific CD8+ T cells. Thus, CD141+ DC and CD1c+ DC share a similar activation profiles in vivo but also have induce unique signatures that support specialized roles in CD8+ T cell priming and Th17 responses, respectively. In combination, these data demonstrate that humanized mice provide an attractive and tractable model to study human DC in vitro and in vivo. Abstract from Front Immunol. 2017 Oct 30;8:1419. doi: 10.3389/fimmu.2017.01419."	19	"CD141 untreated, CD141+ polyIC, CD141+ R848, CD141+ polyIC+R848, CD1c untreated, CD1c+ polyIC, CD1c+ R848, CD1c+ polyIC+R848"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.6	Illumina V4	"rgb(146,0,0)"	diamond	TRDC HLA-DR+ CD1c+  humanised mouse	myeloid	TRDC	humanised mouse	CD1c+ dendritic cell	Mixed
3998755170_E;6612	6612	Minoda	3998755170_E	CD141+ R848 rep 2	Homo sapiens	CD141+ R848	CL:0002394		CD141+ dendritic cell			Minoda	"Human immune cell subsets develop in immunodeficient mice following reconstitution with human CD34+ hematopoietic stem cells. These ""humanized"" mice are useful models to study human immunology and human-tropic infections, autoimmunity, and cancer. However, some human immune cell subsets are unable to fully develop or acquire full functional capacity due to a lack of cross-reactivity of many growth factors and cytokines between species. Conventional dendritic cells (cDCs) in mice are categorized into cDC1, which mediate T helper (Th)1 and CD8+ T cell responses, and cDC2, which mediate Th2 and Th17 responses. The likely human equivalents are CD141+ DC and CD1c+ DC subsets for mouse cDC1 and cDC2, respectively, but the extent of any interspecies differences is poorly characterized. Here, we exploit the fact that human CD141+ DC and CD1c+ DC develop in humanized mice, to further explore their equivalency in vivo. Global transcriptome analysis of CD141+ DC and CD1c+ DC isolated from humanized mice demonstrated that they closely resemble those in human blood. Activation of DC subsets in vivo, with the TLR3 ligand poly I:C, and the TLR7/8 ligand R848 revealed that a core panel of genes consistent with DC maturation status were upregulated by both subsets. R848 specifically upregulated genes associated with Th17 responses by CD1c+ DC, while poly I:C upregulated IFN- genes specifically by CD141+ DC. MYCL expression, known to be essential for CD8+ T cell priming by mouse DC, was specifically induced in CD141+ DC after activation. Concomitantly, CD141+ DC were superior to CD1c+ DC in their ability to prime nave antigen-specific CD8+ T cells. Thus, CD141+ DC and CD1c+ DC share a similar activation profiles in vivo but also have induce unique signatures that support specialized roles in CD8+ T cell priming and Th17 responses, respectively. In combination, these data demonstrate that humanized mice provide an attractive and tractable model to study human DC in vitro and in vivo. Abstract from Front Immunol. 2017 Oct 30;8:1419. doi: 10.3389/fimmu.2017.01419."	19	"CD141 untreated, CD141+ polyIC, CD141+ R848, CD141+ polyIC+R848, CD1c untreated, CD1c+ polyIC, CD1c+ R848, CD1c+ polyIC+R848"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.6	Illumina V4	"rgb(146,0,0)"	diamond	TRDC HLA-DR+ CD141+ R848 2h humanised mouse	myeloid	TRDC	humanised mouse	CD141+ dendritic cell	Mixed
3998755170_F;6612	6612	Minoda	3998755170_F	CD141+ polyIC rep 3	Homo sapiens	CD141+ polyIC	CL:0002394		CD141+ dendritic cell			Minoda	"Human immune cell subsets develop in immunodeficient mice following reconstitution with human CD34+ hematopoietic stem cells. These ""humanized"" mice are useful models to study human immunology and human-tropic infections, autoimmunity, and cancer. However, some human immune cell subsets are unable to fully develop or acquire full functional capacity due to a lack of cross-reactivity of many growth factors and cytokines between species. Conventional dendritic cells (cDCs) in mice are categorized into cDC1, which mediate T helper (Th)1 and CD8+ T cell responses, and cDC2, which mediate Th2 and Th17 responses. The likely human equivalents are CD141+ DC and CD1c+ DC subsets for mouse cDC1 and cDC2, respectively, but the extent of any interspecies differences is poorly characterized. Here, we exploit the fact that human CD141+ DC and CD1c+ DC develop in humanized mice, to further explore their equivalency in vivo. Global transcriptome analysis of CD141+ DC and CD1c+ DC isolated from humanized mice demonstrated that they closely resemble those in human blood. Activation of DC subsets in vivo, with the TLR3 ligand poly I:C, and the TLR7/8 ligand R848 revealed that a core panel of genes consistent with DC maturation status were upregulated by both subsets. R848 specifically upregulated genes associated with Th17 responses by CD1c+ DC, while poly I:C upregulated IFN- genes specifically by CD141+ DC. MYCL expression, known to be essential for CD8+ T cell priming by mouse DC, was specifically induced in CD141+ DC after activation. Concomitantly, CD141+ DC were superior to CD1c+ DC in their ability to prime nave antigen-specific CD8+ T cells. Thus, CD141+ DC and CD1c+ DC share a similar activation profiles in vivo but also have induce unique signatures that support specialized roles in CD8+ T cell priming and Th17 responses, respectively. In combination, these data demonstrate that humanized mice provide an attractive and tractable model to study human DC in vitro and in vivo. Abstract from Front Immunol. 2017 Oct 30;8:1419. doi: 10.3389/fimmu.2017.01419."	19	"CD141 untreated, CD141+ polyIC, CD141+ R848, CD141+ polyIC+R848, CD1c untreated, CD1c+ polyIC, CD1c+ R848, CD1c+ polyIC+R848"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.6	Illumina V4	"rgb(146,0,0)"	diamond	TRDC HLA-DR+ CD141+ polyIC 2h humanised mouse	myeloid	TRDC	humanised mouse	CD141+ dendritic cell	Mixed
3998755170_G;6612	6612	Minoda	3998755170_G	CD1c+ R848 rep 2	Homo sapiens	CD1c+ R848	CL:0002399		CD1c+ dendritic cell			Minoda	"Human immune cell subsets develop in immunodeficient mice following reconstitution with human CD34+ hematopoietic stem cells. These ""humanized"" mice are useful models to study human immunology and human-tropic infections, autoimmunity, and cancer. However, some human immune cell subsets are unable to fully develop or acquire full functional capacity due to a lack of cross-reactivity of many growth factors and cytokines between species. Conventional dendritic cells (cDCs) in mice are categorized into cDC1, which mediate T helper (Th)1 and CD8+ T cell responses, and cDC2, which mediate Th2 and Th17 responses. The likely human equivalents are CD141+ DC and CD1c+ DC subsets for mouse cDC1 and cDC2, respectively, but the extent of any interspecies differences is poorly characterized. Here, we exploit the fact that human CD141+ DC and CD1c+ DC develop in humanized mice, to further explore their equivalency in vivo. Global transcriptome analysis of CD141+ DC and CD1c+ DC isolated from humanized mice demonstrated that they closely resemble those in human blood. Activation of DC subsets in vivo, with the TLR3 ligand poly I:C, and the TLR7/8 ligand R848 revealed that a core panel of genes consistent with DC maturation status were upregulated by both subsets. R848 specifically upregulated genes associated with Th17 responses by CD1c+ DC, while poly I:C upregulated IFN- genes specifically by CD141+ DC. MYCL expression, known to be essential for CD8+ T cell priming by mouse DC, was specifically induced in CD141+ DC after activation. Concomitantly, CD141+ DC were superior to CD1c+ DC in their ability to prime nave antigen-specific CD8+ T cells. Thus, CD141+ DC and CD1c+ DC share a similar activation profiles in vivo but also have induce unique signatures that support specialized roles in CD8+ T cell priming and Th17 responses, respectively. In combination, these data demonstrate that humanized mice provide an attractive and tractable model to study human DC in vitro and in vivo. Abstract from Front Immunol. 2017 Oct 30;8:1419. doi: 10.3389/fimmu.2017.01419."	19	"CD141 untreated, CD141+ polyIC, CD141+ R848, CD141+ polyIC+R848, CD1c untreated, CD1c+ polyIC, CD1c+ R848, CD1c+ polyIC+R848"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.6	Illumina V4	"rgb(146,0,0)"	diamond	TRDC HLA-DR+ CD1c+ R848 2h humanised mouse	myeloid	TRDC	humanised mouse	CD1c+ dendritic cell	Mixed
3998755170_H;6612	6612	Minoda	3998755170_H	CD1c+ polyIC rep 3	Homo sapiens	CD1c+ polyIC	CL:0002399		CD1c+ dendritic cell			Minoda	"Human immune cell subsets develop in immunodeficient mice following reconstitution with human CD34+ hematopoietic stem cells. These ""humanized"" mice are useful models to study human immunology and human-tropic infections, autoimmunity, and cancer. However, some human immune cell subsets are unable to fully develop or acquire full functional capacity due to a lack of cross-reactivity of many growth factors and cytokines between species. Conventional dendritic cells (cDCs) in mice are categorized into cDC1, which mediate T helper (Th)1 and CD8+ T cell responses, and cDC2, which mediate Th2 and Th17 responses. The likely human equivalents are CD141+ DC and CD1c+ DC subsets for mouse cDC1 and cDC2, respectively, but the extent of any interspecies differences is poorly characterized. Here, we exploit the fact that human CD141+ DC and CD1c+ DC develop in humanized mice, to further explore their equivalency in vivo. Global transcriptome analysis of CD141+ DC and CD1c+ DC isolated from humanized mice demonstrated that they closely resemble those in human blood. Activation of DC subsets in vivo, with the TLR3 ligand poly I:C, and the TLR7/8 ligand R848 revealed that a core panel of genes consistent with DC maturation status were upregulated by both subsets. R848 specifically upregulated genes associated with Th17 responses by CD1c+ DC, while poly I:C upregulated IFN- genes specifically by CD141+ DC. MYCL expression, known to be essential for CD8+ T cell priming by mouse DC, was specifically induced in CD141+ DC after activation. Concomitantly, CD141+ DC were superior to CD1c+ DC in their ability to prime nave antigen-specific CD8+ T cells. Thus, CD141+ DC and CD1c+ DC share a similar activation profiles in vivo but also have induce unique signatures that support specialized roles in CD8+ T cell priming and Th17 responses, respectively. In combination, these data demonstrate that humanized mice provide an attractive and tractable model to study human DC in vitro and in vivo. Abstract from Front Immunol. 2017 Oct 30;8:1419. doi: 10.3389/fimmu.2017.01419."	19	"CD141 untreated, CD141+ polyIC, CD141+ R848, CD141+ polyIC+R848, CD1c untreated, CD1c+ polyIC, CD1c+ R848, CD1c+ polyIC+R848"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.6	Illumina V4	"rgb(146,0,0)"	diamond	TRDC HLA-DR+ CD1c+ polyIC 2h humanised mouse	myeloid	TRDC	humanised mouse	CD1c+ dendritic cell	Mixed
3998755170_I;6612	6612	Minoda	3998755170_I	CD141+ polyIC+R848 rep 3	Homo sapiens	CD141+ polyIC+R848	CL:0002394		CD141+ dendritic cell			Minoda	"Human immune cell subsets develop in immunodeficient mice following reconstitution with human CD34+ hematopoietic stem cells. These ""humanized"" mice are useful models to study human immunology and human-tropic infections, autoimmunity, and cancer. However, some human immune cell subsets are unable to fully develop or acquire full functional capacity due to a lack of cross-reactivity of many growth factors and cytokines between species. Conventional dendritic cells (cDCs) in mice are categorized into cDC1, which mediate T helper (Th)1 and CD8+ T cell responses, and cDC2, which mediate Th2 and Th17 responses. The likely human equivalents are CD141+ DC and CD1c+ DC subsets for mouse cDC1 and cDC2, respectively, but the extent of any interspecies differences is poorly characterized. Here, we exploit the fact that human CD141+ DC and CD1c+ DC develop in humanized mice, to further explore their equivalency in vivo. Global transcriptome analysis of CD141+ DC and CD1c+ DC isolated from humanized mice demonstrated that they closely resemble those in human blood. Activation of DC subsets in vivo, with the TLR3 ligand poly I:C, and the TLR7/8 ligand R848 revealed that a core panel of genes consistent with DC maturation status were upregulated by both subsets. R848 specifically upregulated genes associated with Th17 responses by CD1c+ DC, while poly I:C upregulated IFN- genes specifically by CD141+ DC. MYCL expression, known to be essential for CD8+ T cell priming by mouse DC, was specifically induced in CD141+ DC after activation. Concomitantly, CD141+ DC were superior to CD1c+ DC in their ability to prime nave antigen-specific CD8+ T cells. Thus, CD141+ DC and CD1c+ DC share a similar activation profiles in vivo but also have induce unique signatures that support specialized roles in CD8+ T cell priming and Th17 responses, respectively. In combination, these data demonstrate that humanized mice provide an attractive and tractable model to study human DC in vitro and in vivo. Abstract from Front Immunol. 2017 Oct 30;8:1419. doi: 10.3389/fimmu.2017.01419."	19	"CD141 untreated, CD141+ polyIC, CD141+ R848, CD141+ polyIC+R848, CD1c untreated, CD1c+ polyIC, CD1c+ R848, CD1c+ polyIC+R848"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.6	Illumina V4	"rgb(146,0,0)"	diamond	TRDC HLA-DR+ CD141+ polyIC + R848 2h humanised mouse	myeloid	TRDC	humanised mouse	CD141+ dendritic cell	Mixed
3998755170_J;6612	6612	Minoda	3998755170_J	CD141+ R848 rep 3	Homo sapiens	CD141+ R848	CL:0002394		CD141+ dendritic cell			Minoda	"Human immune cell subsets develop in immunodeficient mice following reconstitution with human CD34+ hematopoietic stem cells. These ""humanized"" mice are useful models to study human immunology and human-tropic infections, autoimmunity, and cancer. However, some human immune cell subsets are unable to fully develop or acquire full functional capacity due to a lack of cross-reactivity of many growth factors and cytokines between species. Conventional dendritic cells (cDCs) in mice are categorized into cDC1, which mediate T helper (Th)1 and CD8+ T cell responses, and cDC2, which mediate Th2 and Th17 responses. The likely human equivalents are CD141+ DC and CD1c+ DC subsets for mouse cDC1 and cDC2, respectively, but the extent of any interspecies differences is poorly characterized. Here, we exploit the fact that human CD141+ DC and CD1c+ DC develop in humanized mice, to further explore their equivalency in vivo. Global transcriptome analysis of CD141+ DC and CD1c+ DC isolated from humanized mice demonstrated that they closely resemble those in human blood. Activation of DC subsets in vivo, with the TLR3 ligand poly I:C, and the TLR7/8 ligand R848 revealed that a core panel of genes consistent with DC maturation status were upregulated by both subsets. R848 specifically upregulated genes associated with Th17 responses by CD1c+ DC, while poly I:C upregulated IFN- genes specifically by CD141+ DC. MYCL expression, known to be essential for CD8+ T cell priming by mouse DC, was specifically induced in CD141+ DC after activation. Concomitantly, CD141+ DC were superior to CD1c+ DC in their ability to prime nave antigen-specific CD8+ T cells. Thus, CD141+ DC and CD1c+ DC share a similar activation profiles in vivo but also have induce unique signatures that support specialized roles in CD8+ T cell priming and Th17 responses, respectively. In combination, these data demonstrate that humanized mice provide an attractive and tractable model to study human DC in vitro and in vivo. Abstract from Front Immunol. 2017 Oct 30;8:1419. doi: 10.3389/fimmu.2017.01419."	19	"CD141 untreated, CD141+ polyIC, CD141+ R848, CD141+ polyIC+R848, CD1c untreated, CD1c+ polyIC, CD1c+ R848, CD1c+ polyIC+R848"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.6	Illumina V4	"rgb(146,0,0)"	diamond	TRDC HLA-DR+ CD141+ R848 2h humanised mouse	myeloid	TRDC	humanised mouse	CD141+ dendritic cell	Mixed
3998755170_K;6612	6612	Minoda	3998755170_K	CD1c+ polyIC+R848 rep 3	Homo sapiens	CD1c+ polyIC+R848	CL:0002399		CD1c+ dendritic cell			Minoda	"Human immune cell subsets develop in immunodeficient mice following reconstitution with human CD34+ hematopoietic stem cells. These ""humanized"" mice are useful models to study human immunology and human-tropic infections, autoimmunity, and cancer. However, some human immune cell subsets are unable to fully develop or acquire full functional capacity due to a lack of cross-reactivity of many growth factors and cytokines between species. Conventional dendritic cells (cDCs) in mice are categorized into cDC1, which mediate T helper (Th)1 and CD8+ T cell responses, and cDC2, which mediate Th2 and Th17 responses. The likely human equivalents are CD141+ DC and CD1c+ DC subsets for mouse cDC1 and cDC2, respectively, but the extent of any interspecies differences is poorly characterized. Here, we exploit the fact that human CD141+ DC and CD1c+ DC develop in humanized mice, to further explore their equivalency in vivo. Global transcriptome analysis of CD141+ DC and CD1c+ DC isolated from humanized mice demonstrated that they closely resemble those in human blood. Activation of DC subsets in vivo, with the TLR3 ligand poly I:C, and the TLR7/8 ligand R848 revealed that a core panel of genes consistent with DC maturation status were upregulated by both subsets. R848 specifically upregulated genes associated with Th17 responses by CD1c+ DC, while poly I:C upregulated IFN- genes specifically by CD141+ DC. MYCL expression, known to be essential for CD8+ T cell priming by mouse DC, was specifically induced in CD141+ DC after activation. Concomitantly, CD141+ DC were superior to CD1c+ DC in their ability to prime nave antigen-specific CD8+ T cells. Thus, CD141+ DC and CD1c+ DC share a similar activation profiles in vivo but also have induce unique signatures that support specialized roles in CD8+ T cell priming and Th17 responses, respectively. In combination, these data demonstrate that humanized mice provide an attractive and tractable model to study human DC in vitro and in vivo. Abstract from Front Immunol. 2017 Oct 30;8:1419. doi: 10.3389/fimmu.2017.01419."	19	"CD141 untreated, CD141+ polyIC, CD141+ R848, CD141+ polyIC+R848, CD1c untreated, CD1c+ polyIC, CD1c+ R848, CD1c+ polyIC+R848"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.6	Illumina V4	"rgb(146,0,0)"	diamond	TRDC HLA-DR+ CD1c+ polyIC+R848 2h humanised mouse	myeloid	TRDC	humanised mouse	CD1c+ dendritic cell	Mixed
3998755170_L;6612	6612	Minoda	3998755170_L	CD1c+ R848 rep 3	Homo sapiens	CD1c+ R848	CL:0002399		CD1c+ dendritic cell			Minoda	"Human immune cell subsets develop in immunodeficient mice following reconstitution with human CD34+ hematopoietic stem cells. These ""humanized"" mice are useful models to study human immunology and human-tropic infections, autoimmunity, and cancer. However, some human immune cell subsets are unable to fully develop or acquire full functional capacity due to a lack of cross-reactivity of many growth factors and cytokines between species. Conventional dendritic cells (cDCs) in mice are categorized into cDC1, which mediate T helper (Th)1 and CD8+ T cell responses, and cDC2, which mediate Th2 and Th17 responses. The likely human equivalents are CD141+ DC and CD1c+ DC subsets for mouse cDC1 and cDC2, respectively, but the extent of any interspecies differences is poorly characterized. Here, we exploit the fact that human CD141+ DC and CD1c+ DC develop in humanized mice, to further explore their equivalency in vivo. Global transcriptome analysis of CD141+ DC and CD1c+ DC isolated from humanized mice demonstrated that they closely resemble those in human blood. Activation of DC subsets in vivo, with the TLR3 ligand poly I:C, and the TLR7/8 ligand R848 revealed that a core panel of genes consistent with DC maturation status were upregulated by both subsets. R848 specifically upregulated genes associated with Th17 responses by CD1c+ DC, while poly I:C upregulated IFN- genes specifically by CD141+ DC. MYCL expression, known to be essential for CD8+ T cell priming by mouse DC, was specifically induced in CD141+ DC after activation. Concomitantly, CD141+ DC were superior to CD1c+ DC in their ability to prime nave antigen-specific CD8+ T cells. Thus, CD141+ DC and CD1c+ DC share a similar activation profiles in vivo but also have induce unique signatures that support specialized roles in CD8+ T cell priming and Th17 responses, respectively. In combination, these data demonstrate that humanized mice provide an attractive and tractable model to study human DC in vitro and in vivo. Abstract from Front Immunol. 2017 Oct 30;8:1419. doi: 10.3389/fimmu.2017.01419."	19	"CD141 untreated, CD141+ polyIC, CD141+ R848, CD141+ polyIC+R848, CD1c untreated, CD1c+ polyIC, CD1c+ R848, CD1c+ polyIC+R848"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.6	Illumina V4	"rgb(146,0,0)"	diamond	TRDC HLA-DR+ CD1c+ R848 2h humanised mouse	myeloid	TRDC	humanised mouse	CD1c+ dendritic cell	Mixed
5645810003_A;6646	6646	Fairfax	5645810003_A	152_CD14	Homo sapiens	nave CD14+	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+  adult	myeloid	Monocyte	adult	monocyte	Circulating Monocyte & Granulocyte
5645810003_F;6646	6646	Fairfax	5645810003_F	153_CD14	Homo sapiens	nave CD14+	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+  adult	myeloid	Monocyte	adult	monocyte	Circulating Monocyte & Granulocyte
5645810003_G;6646	6646	Fairfax	5645810003_G	188_CD14	Homo sapiens	nave CD14+	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+  adult	myeloid	Monocyte	adult	monocyte	Circulating Monocyte & Granulocyte
5645810003_H;6646	6646	Fairfax	5645810003_H	165_CD14	Homo sapiens	nave CD14+	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+  adult	myeloid	Monocyte	adult	monocyte	Circulating Monocyte & Granulocyte
5645810031_D;6646	6646	Fairfax	5645810031_D	277_CD14	Homo sapiens	nave CD14+	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+  adult	myeloid	Monocyte	adult	monocyte	Circulating Monocyte & Granulocyte
5645810031_H;6646	6646	Fairfax	5645810031_H	206_CD14	Homo sapiens	nave CD14+	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+  adult	myeloid	Monocyte	adult	monocyte	Circulating Monocyte & Granulocyte
5645810035_A;6646	6646	Fairfax	5645810035_A	196_CD14	Homo sapiens	nave CD14+	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+  adult	myeloid	Monocyte	adult	monocyte	Circulating Monocyte & Granulocyte
5645810035_C;6646	6646	Fairfax	5645810035_C	208_CD14	Homo sapiens	nave CD14+	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+  adult	myeloid	Monocyte	adult	monocyte	Circulating Monocyte & Granulocyte
5645810035_G;6646	6646	Fairfax	5645810035_G	232_CD14	Homo sapiens	nave CD14+	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+  adult	myeloid	Monocyte	adult	monocyte	Circulating Monocyte & Granulocyte
5655508004_B;6646	6646	Fairfax	5655508004_B	76_CD14	Homo sapiens	nave CD14+	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+  adult	myeloid	Monocyte	adult	monocyte	Circulating Monocyte & Granulocyte
5655508009_A;6646	6646	Fairfax	5655508009_A	53_CD14	Homo sapiens	nave CD14+	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+  adult	myeloid	Monocyte	adult	monocyte	Circulating Monocyte & Granulocyte
5655508016_I;6646	6646	Fairfax	5655508016_I	55_CD14	Homo sapiens	nave CD14+	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+  adult	myeloid	Monocyte	adult	monocyte	Circulating Monocyte & Granulocyte
5655508017_E;6646	6646	Fairfax	5655508017_E	80_CD14	Homo sapiens	nave CD14+	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+  adult	myeloid	Monocyte	adult	monocyte	Circulating Monocyte & Granulocyte
5655508017_G;6646	6646	Fairfax	5655508017_G	92_CD14	Homo sapiens	nave CD14+	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+  adult	myeloid	Monocyte	adult	monocyte	Circulating Monocyte & Granulocyte
5655508017_I;6646	6646	Fairfax	5655508017_I	9_CD14	Homo sapiens	nave CD14+	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+  adult	myeloid	Monocyte	adult	monocyte	Circulating Monocyte & Granulocyte
5655508047_F;6646	6646	Fairfax	5655508047_F	11_CD14	Homo sapiens	nave CD14+	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+  adult	myeloid	Monocyte	adult	monocyte	Circulating Monocyte & Granulocyte
5655508047_J;6646	6646	Fairfax	5655508047_J	35_CD14	Homo sapiens	nave CD14+	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+  adult	myeloid	Monocyte	adult	monocyte	Circulating Monocyte & Granulocyte
5655508047_L;6646	6646	Fairfax	5655508047_L	47_CD14	Homo sapiens	nave CD14+	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+  adult	myeloid	Monocyte	adult	monocyte	Circulating Monocyte & Granulocyte
5655508048_F;6646	6646	Fairfax	5655508048_F	60_CD14	Homo sapiens	nave CD14+	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+  adult	myeloid	Monocyte	adult	monocyte	Circulating Monocyte & Granulocyte
5655508048_I;6646	6646	Fairfax	5655508048_I	12_CD14	Homo sapiens	nave CD14+	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+  adult	myeloid	Monocyte	adult	monocyte	Circulating Monocyte & Granulocyte
5655508053_L;6646	6646	Fairfax	5655508053_L	143_CD14	Homo sapiens	nave CD14+	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+  adult	myeloid	Monocyte	adult	monocyte	Circulating Monocyte & Granulocyte
5655508054_K;6646	6646	Fairfax	5655508054_K	120_CD14	Homo sapiens	nave CD14+	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+  adult	myeloid	Monocyte	adult	monocyte	Circulating Monocyte & Granulocyte
5666194006_A;6646	6646	Fairfax	5666194006_A	250_CD14	Homo sapiens	nave CD14+	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+  adult	myeloid	Monocyte	adult	monocyte	Circulating Monocyte & Granulocyte
5666194006_F;6646	6646	Fairfax	5666194006_F	251_CD14	Homo sapiens	nave CD14+	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+  adult	myeloid	Monocyte	adult	monocyte	Circulating Monocyte & Granulocyte
5666194007_A;6646	6646	Fairfax	5666194007_A	204_CD14	Homo sapiens	nave CD14+	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+  adult	myeloid	Monocyte	adult	monocyte	Circulating Monocyte & Granulocyte
5666194007_E;6646	6646	Fairfax	5666194007_E	228_CD14	Homo sapiens	nave CD14+	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+  adult	myeloid	Monocyte	adult	monocyte	Circulating Monocyte & Granulocyte
5666194007_L;6646	6646	Fairfax	5666194007_L	236_CD14	Homo sapiens	nave CD14+	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+  adult	myeloid	Monocyte	adult	monocyte	Circulating Monocyte & Granulocyte
5666194008_I;6646	6646	Fairfax	5666194008_I	201_CD14	Homo sapiens	nave CD14+	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+  adult	myeloid	Monocyte	adult	monocyte	Circulating Monocyte & Granulocyte
5666194022_D;6646	6646	Fairfax	5666194022_D	181_CD14	Homo sapiens	nave CD14+	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+  adult	myeloid	Monocyte	adult	monocyte	Circulating Monocyte & Granulocyte
5666194022_J;6646	6646	Fairfax	5666194022_J	122_CD14	Homo sapiens	nave CD14+	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+  adult	myeloid	Monocyte	adult	monocyte	Circulating Monocyte & Granulocyte
5666194024_A;6646	6646	Fairfax	5666194024_A	146_CD14	Homo sapiens	nave CD14+	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+  adult	myeloid	Monocyte	adult	monocyte	Circulating Monocyte & Granulocyte
5666194024_G;6646	6646	Fairfax	5666194024_G	182_CD14	Homo sapiens	nave CD14+	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+  adult	myeloid	Monocyte	adult	monocyte	Circulating Monocyte & Granulocyte
5666194025_F;6646	6646	Fairfax	5666194025_F	101_CD14	Homo sapiens	nave CD14+	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+  adult	myeloid	Monocyte	adult	monocyte	Circulating Monocyte & Granulocyte
5666194025_G;6646	6646	Fairfax	5666194025_G	136_CD14	Homo sapiens	nave CD14+	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+  adult	myeloid	Monocyte	adult	monocyte	Circulating Monocyte & Granulocyte
5666194025_K;6646	6646	Fairfax	5666194025_K	160_CD14	Homo sapiens	nave CD14+	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+  adult	myeloid	Monocyte	adult	monocyte	Circulating Monocyte & Granulocyte
5666194026_A;6646	6646	Fairfax	5666194026_A	149_CD14	Homo sapiens	nave CD14+	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+  adult	myeloid	Monocyte	adult	monocyte	Circulating Monocyte & Granulocyte
5666194027_G;6646	6646	Fairfax	5666194027_G	139_CD14	Homo sapiens	nave CD14+	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+  adult	myeloid	Monocyte	adult	monocyte	Circulating Monocyte & Granulocyte
5666194027_H;6646	6646	Fairfax	5666194027_H	116_CD14	Homo sapiens	nave CD14+	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+  adult	myeloid	Monocyte	adult	monocyte	Circulating Monocyte & Granulocyte
6898368066_G;6646	6646	Fairfax	6898368066_G	204_LPS_24	Homo sapiens	LPS 24hr	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+ LPS 24h adult	myeloid	Monocyte	adult	monocyte	Macrophage
6898368066_J;6646	6646	Fairfax	6898368066_J	198_LPS_2	Homo sapiens	LPS 2hr	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+ LPS 2h adult	myeloid	Monocyte	adult	monocyte	Macrophage
6898368069_D;6646	6646	Fairfax	6898368069_D	71_LPS_24	Homo sapiens	LPS 24hr	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+ LPS 24h adult	myeloid	Monocyte	adult	monocyte	Macrophage
6898368069_K;6646	6646	Fairfax	6898368069_K	88_LPS_2	Homo sapiens	LPS 2hr	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+ LPS 2h adult	myeloid	Monocyte	adult	monocyte	Macrophage
6898368080_A;6646	6646	Fairfax	6898368080_A	196_LPS_2	Homo sapiens	LPS 2hr	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+ LPS 2h adult	myeloid	Monocyte	adult	monocyte	Macrophage
6898368082_C;6646	6646	Fairfax	6898368082_C	228_LPS_24	Homo sapiens	LPS 24hr	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+ LPS 24h adult	myeloid	Monocyte	adult	monocyte	Macrophage
6898368082_D;6646	6646	Fairfax	6898368082_D	81_LPS_2	Homo sapiens	LPS 2hr	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+ LPS 2h adult	myeloid	Monocyte	adult	monocyte	Macrophage
6898376063_E;6646	6646	Fairfax	6898376063_E	101_IFN	Homo sapiens	IFNg 24hr	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+ IFN-gamma 24h adult	myeloid	Monocyte	adult	monocyte	Macrophage
6898376067_J;6646	6646	Fairfax	6898376067_J	208_IFN	Homo sapiens	IFNg 24hr	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+ IFN-gamma 24h adult	myeloid	Monocyte	adult	monocyte	Macrophage
6898376081_C;6646	6646	Fairfax	6898376081_C	232_LPS_2	Homo sapiens	LPS 2hr	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+ LPS 2h adult	myeloid	Monocyte	adult	monocyte	Macrophage
6898376081_J;6646	6646	Fairfax	6898376081_J	214_IFN	Homo sapiens	IFNg 24hr	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+ IFN-gamma 24h adult	myeloid	Monocyte	adult	monocyte	Macrophage
6898376095_A;6646	6646	Fairfax	6898376095_A	106_LPS_24	Homo sapiens	LPS 24hr	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+ LPS 24h adult	myeloid	Monocyte	adult	monocyte	Macrophage
6898376095_B;6646	6646	Fairfax	6898376095_B	282_IFN	Homo sapiens	IFNg 24hr	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+ IFN-gamma 24h adult	myeloid	Monocyte	adult	monocyte	Macrophage
6898376095_G;6646	6646	Fairfax	6898376095_G	189_IFN	Homo sapiens	IFNg 24hr	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+ IFN-gamma 24h adult	myeloid	Monocyte	adult	monocyte	Macrophage
6898376095_I;6646	6646	Fairfax	6898376095_I	245_IFN	Homo sapiens	IFNg 24hr	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+ IFN-gamma 24h adult	myeloid	Monocyte	adult	monocyte	Macrophage
6898376096_J;6646	6646	Fairfax	6898376096_J	255_IFN	Homo sapiens	IFNg 24hr	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+ IFN-gamma 24h adult	myeloid	Monocyte	adult	monocyte	Macrophage
6991010031_L;6646	6646	Fairfax	6991010031_L	148_IFN	Homo sapiens	IFNg 24hr	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+ IFN-gamma 24h adult	myeloid	Monocyte	adult	monocyte	Macrophage
6991010045_A;6646	6646	Fairfax	6991010045_A	282_LPS_24	Homo sapiens	LPS 24hr	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+ LPS 24h adult	myeloid	Monocyte	adult	monocyte	Macrophage
6991010045_I;6646	6646	Fairfax	6991010045_I	93_IFN	Homo sapiens	IFNg 24hr	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+ IFN-gamma 24h adult	myeloid	Monocyte	adult	monocyte	Macrophage
6991010045_K;6646	6646	Fairfax	6991010045_K	230_LPS_24	Homo sapiens	LPS 24hr	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+ LPS 24h adult	myeloid	Monocyte	adult	monocyte	Macrophage
7466516008_B;6646	6646	Fairfax	7466516008_B	175_LPS_2	Homo sapiens	LPS 2hr	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+ LPS 2h adult	myeloid	Monocyte	adult	monocyte	Macrophage
7466516012_F;6646	6646	Fairfax	7466516012_F	176_LPS_24	Homo sapiens	LPS 24hr	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+ LPS 24h adult	myeloid	Monocyte	adult	monocyte	Macrophage
7466516012_L;6646	6646	Fairfax	7466516012_L	221_LPS_24	Homo sapiens	LPS 24hr	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+ LPS 24h adult	myeloid	Monocyte	adult	monocyte	Macrophage
7466516013_A;6646	6646	Fairfax	7466516013_A	118_LPS_24	Homo sapiens	LPS 24hr	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+ LPS 24h adult	myeloid	Monocyte	adult	monocyte	Macrophage
7466516017_B;6646	6646	Fairfax	7466516017_B	272_LPS_24	Homo sapiens	LPS 24hr	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+ LPS 24h adult	myeloid	Monocyte	adult	monocyte	Macrophage
7466516034_K;6646	6646	Fairfax	7466516034_K	190_LPS_24	Homo sapiens	LPS 24hr	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+ LPS 24h adult	myeloid	Monocyte	adult	monocyte	Macrophage
7466516037_C;6646	6646	Fairfax	7466516037_C	2_LPS_2	Homo sapiens	LPS 2hr	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+ LPS 2h adult	myeloid	Monocyte	adult	monocyte	Macrophage
7466516038_B;6646	6646	Fairfax	7466516038_B	261_LPS_24	Homo sapiens	LPS 24hr	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+ LPS 24h adult	myeloid	Monocyte	adult	monocyte	Macrophage
7466516038_G;6646	6646	Fairfax	7466516038_G	276_UT_24	Homo sapiens	media 24hr	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+ media 24h adult	myeloid	Monocyte	adult	monocyte	Macrophage
7466516038_L;6646	6646	Fairfax	7466516038_L	257_LPS_24	Homo sapiens	LPS 24hr	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+ LPS 24h adult	myeloid	Monocyte	adult	monocyte	Macrophage
7466516041_D;6646	6646	Fairfax	7466516041_D	68_LPS_24	Homo sapiens	LPS 24hr	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+ LPS 24h adult	myeloid	Monocyte	adult	monocyte	Macrophage
7509352048_J;6646	6646	Fairfax	7509352048_J	131_IFN	Homo sapiens	IFNg 24hr	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+ IFN-gamma 24h adult	myeloid	Monocyte	adult	monocyte	Macrophage
7509352048_K;6646	6646	Fairfax	7509352048_K	185_UT_24	Homo sapiens	media 24hr	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+ media 24h adult	myeloid	Monocyte	adult	monocyte	Macrophage
7509352079_E;6646	6646	Fairfax	7509352079_E	191_LPS_24	Homo sapiens	media 24hr	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+ media 24h adult	myeloid	Monocyte	adult	monocyte	Macrophage
7509352079_G;6646	6646	Fairfax	7509352079_G	194_IFN	Homo sapiens	IFNg 24hr	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+ IFN-gamma 24h adult	myeloid	Monocyte	adult	monocyte	Macrophage
7509352085_H;6646	6646	Fairfax	7509352085_H	5_LPS_2	Homo sapiens	LPS 2hr	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+ LPS 2h adult	myeloid	Monocyte	adult	monocyte	Macrophage
7509379004_E;6646	6646	Fairfax	7509379004_E	273_LPS_2	Homo sapiens	LPS 2hr	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+ LPS 2h adult	myeloid	Monocyte	adult	monocyte	Macrophage
7509379004_H;6646	6646	Fairfax	7509379004_H	170_UT_24	Homo sapiens	media 24hr	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+ media 24h adult	myeloid	Monocyte	adult	monocyte	Macrophage
7509379004_I;6646	6646	Fairfax	7509379004_I	123_LPS_24	Homo sapiens	LPS 24hr	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+ LPS 24h adult	myeloid	Monocyte	adult	monocyte	Macrophage
7509379008_C;6646	6646	Fairfax	7509379008_C	170_IFN	Homo sapiens	IFNg 24hr	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+ IFN-gamma 24h adult	myeloid	Monocyte	adult	monocyte	Macrophage
7509379010_K;6646	6646	Fairfax	7509379010_K	198_LPS_24	Homo sapiens	LPS 24hr	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+ LPS 24h adult	myeloid	Monocyte	adult	monocyte	Macrophage
7509379012_B;6646	6646	Fairfax	7509379012_B	174_LPS_24	Homo sapiens	LPS 24hr	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+ LPS 24h adult	myeloid	Monocyte	adult	monocyte	Macrophage
7509379012_I;6646	6646	Fairfax	7509379012_I	220_LPS_24	Homo sapiens	LPS 24hr	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+ LPS 24h adult	myeloid	Monocyte	adult	monocyte	Macrophage
7509379014_J;6646	6646	Fairfax	7509379014_J	161_LPS_24	Homo sapiens	LPS 24hr	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+ LPS 24h adult	myeloid	Monocyte	adult	monocyte	Macrophage
7509379082_C;6646	6646	Fairfax	7509379082_C	246_LPS_24	Homo sapiens	LPS 24hr	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+ LPS 24h adult	myeloid	Monocyte	adult	monocyte	Macrophage
7509379090_L;6646	6646	Fairfax	7509379090_L	281_LPS_2	Homo sapiens	LPS 2hr	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+ LPS 2h adult	myeloid	Monocyte	adult	monocyte	Macrophage
7509379091_A;6646	6646	Fairfax	7509379091_A	140_LPS_24	Homo sapiens	LPS 24hr	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+ LPS 24h adult	myeloid	Monocyte	adult	monocyte	Macrophage
7509379091_K;6646	6646	Fairfax	7509379091_K	169_LPS_2	Homo sapiens	LPS 2hr	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+ LPS 2h adult	myeloid	Monocyte	adult	monocyte	Macrophage
7509379096_A;6646	6646	Fairfax	7509379096_A	154_IFN	Homo sapiens	IFNg 24hr	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+ IFN-gamma 24h adult	myeloid	Monocyte	adult	monocyte	Macrophage
7509379107_D;6646	6646	Fairfax	7509379107_D	155_IFN	Homo sapiens	IFNg 24hr	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+ IFN-gamma 24h adult	myeloid	Monocyte	adult	monocyte	Macrophage
7509379107_H;6646	6646	Fairfax	7509379107_H	174_LPS_2	Homo sapiens	LPS 2hr	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+ LPS 2h adult	myeloid	Monocyte	adult	monocyte	Macrophage
7649558052_G;6646	6646	Fairfax	7649558052_G	149_LPS_24	Homo sapiens	LPS 24hr	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+ LPS 24h adult	myeloid	Monocyte	adult	monocyte	Macrophage
7656766006_E;6646	6646	Fairfax	7656766006_E	211_LPS_24	Homo sapiens	LPS 24hr	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+ LPS 24h adult	myeloid	Monocyte	adult	monocyte	Macrophage
7656766010_G;6646	6646	Fairfax	7656766010_G	121_IFN	Homo sapiens	IFNg 24hr	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+ IFN-gamma 24h adult	myeloid	Monocyte	adult	monocyte	Macrophage
7656766010_J;6646	6646	Fairfax	7656766010_J	10_IFN	Homo sapiens	IFNg 24hr	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+ IFN-gamma 24h adult	myeloid	Monocyte	adult	monocyte	Macrophage
9249896031_D;6646	6646	Fairfax	9249896031_D	377_CD14	Homo sapiens	nave CD14+	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+  adult	myeloid	Monocyte	adult	monocyte	Circulating Monocyte & Granulocyte
9249896042_E;6646	6646	Fairfax	9249896042_E	425_LPS_2	Homo sapiens	LPS 2hr	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+ LPS 2h adult	myeloid	Monocyte	adult	monocyte	Macrophage
9249896042_L;6646	6646	Fairfax	9249896042_L	359_CD14	Homo sapiens	nave CD14+	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+  adult	myeloid	Monocyte	adult	monocyte	Circulating Monocyte & Granulocyte
9249896068_D;6646	6646	Fairfax	9249896068_D	304_LPS_24	Homo sapiens	LPS 24hr	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+ LPS 24h adult	myeloid	Monocyte	adult	monocyte	Macrophage
9249896082_E;6646	6646	Fairfax	9249896082_E	323_LPS_2	Homo sapiens	LPS 2hr	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+ LPS 2h adult	myeloid	Monocyte	adult	monocyte	Macrophage
9252616020_G;6646	6646	Fairfax	9252616020_G	312_IFN	Homo sapiens	IFNg 24hr	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+ IFN-gamma 24h adult	myeloid	Monocyte	adult	monocyte	Macrophage
9252616020_I;6646	6646	Fairfax	9252616020_I	425_IFN	Homo sapiens	IFNg 24hr	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+ IFN-gamma 24h adult	myeloid	Monocyte	adult	monocyte	Macrophage
9252616020_J;6646	6646	Fairfax	9252616020_J	311_LPS_2	Homo sapiens	LPS 2hr	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+ LPS 2h adult	myeloid	Monocyte	adult	monocyte	Macrophage
9252616022_C;6646	6646	Fairfax	9252616022_C	316_CD14	Homo sapiens	nave CD14+	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+  adult	myeloid	Monocyte	adult	monocyte	Circulating Monocyte & Granulocyte
9252616022_H;6646	6646	Fairfax	9252616022_H	400_LPS_24	Homo sapiens	LPS 24hr	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+ LPS 24h adult	myeloid	Monocyte	adult	monocyte	Macrophage
9252616022_L;6646	6646	Fairfax	9252616022_L	384_IFN	Homo sapiens	IFNg 24hr	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+ IFN-gamma 24h adult	myeloid	Monocyte	adult	monocyte	Macrophage
9252616034_E;6646	6646	Fairfax	9252616034_E	413_CD14	Homo sapiens	nave CD14+	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+  adult	myeloid	Monocyte	adult	monocyte	Circulating Monocyte & Granulocyte
9252616057_A;6646	6646	Fairfax	9252616057_A	340_IFN	Homo sapiens	IFNg 24hr	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+ IFN-gamma 24h adult	myeloid	Monocyte	adult	monocyte	Macrophage
9252616057_K;6646	6646	Fairfax	9252616057_K	380_IFN	Homo sapiens	IFNg 24hr	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+ IFN-gamma 24h adult	myeloid	Monocyte	adult	monocyte	Macrophage
9252616058_B;6646	6646	Fairfax	9252616058_B	423_LPS_24	Homo sapiens	LPS 24hr	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+ LPS 24h adult	myeloid	Monocyte	adult	monocyte	Macrophage
9252616058_C;6646	6646	Fairfax	9252616058_C	423_IFN	Homo sapiens	IFNg 24hr	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+ IFN-gamma 24h adult	myeloid	Monocyte	adult	monocyte	Macrophage
9252616058_I;6646	6646	Fairfax	9252616058_I	396_LPS_24	Homo sapiens	LPS 24hr	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+ LPS 24h adult	myeloid	Monocyte	adult	monocyte	Macrophage
9252616073_A;6646	6646	Fairfax	9252616073_A	319_LPS_24	Homo sapiens	LPS 24hr	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+ LPS 24h adult	myeloid	Monocyte	adult	monocyte	Macrophage
9252616087_I;6646	6646	Fairfax	9252616087_I	396_IFN	Homo sapiens	IFNg 24hr	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+ IFN-gamma 24h adult	myeloid	Monocyte	adult	monocyte	Macrophage
9252616094_B;6646	6646	Fairfax	9252616094_B	325_CD14	Homo sapiens	nave CD14+	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+  adult	myeloid	Monocyte	adult	monocyte	Circulating Monocyte & Granulocyte
9252616094_C;6646	6646	Fairfax	9252616094_C	349_LPS_24	Homo sapiens	LPS 24hr	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+ LPS 24h adult	myeloid	Monocyte	adult	monocyte	Macrophage
9252616094_G;6646	6646	Fairfax	9252616094_G	294_LPS_2	Homo sapiens	LPS 2hr	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+ LPS 2h adult	myeloid	Monocyte	adult	monocyte	Macrophage
9252616095_G;6646	6646	Fairfax	9252616095_G	344_CD14	Homo sapiens	nave CD14+	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+  adult	myeloid	Monocyte	adult	monocyte	Circulating Monocyte & Granulocyte
9252616097_D;6646	6646	Fairfax	9252616097_D	321_LPS_2	Homo sapiens	LPS 2hr	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+ LPS 2h adult	myeloid	Monocyte	adult	monocyte	Macrophage
9252616097_E;6646	6646	Fairfax	9252616097_E	337_LPS_2	Homo sapiens	LPS 2hr	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+ LPS 2h adult	myeloid	Monocyte	adult	monocyte	Macrophage
9252616099_B;6646	6646	Fairfax	9252616099_B	340_LPS_24	Homo sapiens	LPS 24hr	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+ LPS 24h adult	myeloid	Monocyte	adult	monocyte	Macrophage
9252616099_C;6646	6646	Fairfax	9252616099_C	414_CD14	Homo sapiens	nave CD14+	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+  adult	myeloid	Monocyte	adult	monocyte	Circulating Monocyte & Granulocyte
9252616099_E;6646	6646	Fairfax	9252616099_E	368_CD14	Homo sapiens	nave CD14+	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+  adult	myeloid	Monocyte	adult	monocyte	Circulating Monocyte & Granulocyte
9257622042_E;6646	6646	Fairfax	9257622042_E	362_LPS_2	Homo sapiens	LPS 2hr	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+ LPS 2h adult	myeloid	Monocyte	adult	monocyte	Macrophage
9257622095_H;6646	6646	Fairfax	9257622095_H	414_LPS_2	Homo sapiens	LPS 2hr	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+ LPS 2h adult	myeloid	Monocyte	adult	monocyte	Macrophage
9257622098_C;6646	6646	Fairfax	9257622098_C	328_LPS_2	Homo sapiens	LPS 2hr	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+ LPS 2h adult	myeloid	Monocyte	adult	monocyte	Macrophage
9257622098_L;6646	6646	Fairfax	9257622098_L	409_CD14	Homo sapiens	nave CD14+	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+  adult	myeloid	Monocyte	adult	monocyte	Circulating Monocyte & Granulocyte
9257622100_A;6646	6646	Fairfax	9257622100_A	354_CD14	Homo sapiens	nave CD14+	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+  adult	myeloid	Monocyte	adult	monocyte	Circulating Monocyte & Granulocyte
9257622100_D;6646	6646	Fairfax	9257622100_D	327_UT_24	Homo sapiens	media 24hr	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+ media 24h adult	myeloid	Monocyte	adult	monocyte	Macrophage
9257622100_H;6646	6646	Fairfax	9257622100_H	417_IFN	Homo sapiens	IFNg 24hr	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+ IFN-gamma 24h adult	myeloid	Monocyte	adult	monocyte	Macrophage
9257622100_J;6646	6646	Fairfax	9257622100_J	377_IFN	Homo sapiens	IFNg 24hr	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+ IFN-gamma 24h adult	myeloid	Monocyte	adult	monocyte	Macrophage
9257631006_D;6646	6646	Fairfax	9257631006_D	293_CD14	Homo sapiens	nave CD14+	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+  adult	myeloid	Monocyte	adult	monocyte	Circulating Monocyte & Granulocyte
9257631019_L;6646	6646	Fairfax	9257631019_L	399_LPS_24	Homo sapiens	LPS 24hr	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+ LPS 24h adult	myeloid	Monocyte	adult	monocyte	Macrophage
9257631026_F;6646	6646	Fairfax	9257631026_F	401_IFN	Homo sapiens	IFNg 24hr	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+ IFN-gamma 24h adult	myeloid	Monocyte	adult	monocyte	Macrophage
9257631026_K;6646	6646	Fairfax	9257631026_K	344_IFN	Homo sapiens	IFNg 24hr	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+ IFN-gamma 24h adult	myeloid	Monocyte	adult	monocyte	Macrophage
9257631027_D;6646	6646	Fairfax	9257631027_D	324_UT_24	Homo sapiens	media 24hr	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+ media 24h adult	myeloid	Monocyte	adult	monocyte	Macrophage
9257631027_J;6646	6646	Fairfax	9257631027_J	298_LPS_24	Homo sapiens	LPS 24hr	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+ LPS 24h adult	myeloid	Monocyte	adult	monocyte	Macrophage
9257631031_C;6646	6646	Fairfax	9257631031_C	372_LPS_2	Homo sapiens	LPS 2hr	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+ LPS 2h adult	myeloid	Monocyte	adult	monocyte	Macrophage
9257631032_B;6646	6646	Fairfax	9257631032_B	430_LPS_24	Homo sapiens	media 24hr	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+ media 24h adult	myeloid	Monocyte	adult	monocyte	Macrophage
9257631032_F;6646	6646	Fairfax	9257631032_F	371_LPS_2	Homo sapiens	LPS 2hr	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+ LPS 2h adult	myeloid	Monocyte	adult	monocyte	Macrophage
9257631036_G;6646	6646	Fairfax	9257631036_G	346_IFN	Homo sapiens	IFNg 24hr	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+ IFN-gamma 24h adult	myeloid	Monocyte	adult	monocyte	Macrophage
9257631045_F;6646	6646	Fairfax	9257631045_F	419_IFN	Homo sapiens	IFNg 24hr	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+ IFN-gamma 24h adult	myeloid	Monocyte	adult	monocyte	Macrophage
9257631053_J;6646	6646	Fairfax	9257631053_J	392_CD14	Homo sapiens	nave CD14+	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+  adult	myeloid	Monocyte	adult	monocyte	Circulating Monocyte & Granulocyte
9257631056_D;6646	6646	Fairfax	9257631056_D	367_LPS_2	Homo sapiens	LPS 2hr	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+ LPS 2h adult	myeloid	Monocyte	adult	monocyte	Macrophage
9257631069_F;6646	6646	Fairfax	9257631069_F	424_IFN	Homo sapiens	IFNg 24hr	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+ IFN-gamma 24h adult	myeloid	Monocyte	adult	monocyte	Macrophage
9259561002_B;6646	6646	Fairfax	9259561002_B	413_LPS_2	Homo sapiens	LPS 2hr	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+ LPS 2h adult	myeloid	Monocyte	adult	monocyte	Macrophage
9259561002_G;6646	6646	Fairfax	9259561002_G	341_IFN	Homo sapiens	IFNg 24hr	CL:0000576		monocyte			Fairfax	"To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon- (IFN-) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN- cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants. Abstract from Science. 2014 Mar 7;343(6175):1246949. doi: 10.1126/science.1246949."	1448	"nave CD14+, media 24hr, LPS 2hr, LPS 24hr, IFNg 24hr"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	4.2	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+ IFN-gamma 24h adult	myeloid	Monocyte	adult	monocyte	Macrophage
A;7002	7002	Lindstedt	A	tonsil plasmacytoid dendritic cell 1	Homo sapiens	tonsil pDC	CL:0000784		plasmacytoid dendritic cell			Lindstedt	"Human dendritic cells (DCs) are a distinct but heterogeneous lineage of APCs operating as the link between innate and adaptive immune responses, with the function to either maintain tolerance or trigger immunity. The DC lineage consists of several subpopulations with unique phenotypes; however, their functional characteristics and transcriptional similarities remain largely unknown. To further characterize the phenotypes and transcriptomes of the subsets, we purified myeloid CD16(+), blood DC Ag 1(+) (BDCA1(+)), and BDCA3(+) DC populations, as well as plasmacytoid CD123(+) DCs, from tonsillar tissue and peripheral blood. Transcriptional profiling and hierarchical clustering visualized that BDCA1(+) DCs clustered with BDCA3(+) DCs, whereas CD16(+) DCs and CD123(+) DCs clustered as distinct populations in blood. Differential expression levels of chemokines, ILs, and pattern recognition receptors were demonstrated, which emphasize innate DC subset specialization. Even though highly BDCA1(+) and BDCA3(+) DC-specific gene expression was identified in blood, the BDCA1(+) DCs and BDCA3(+) DCs from tonsils displayed similar transcriptional activity, most likely due to the pathogenic or inflammatory maturational signals present in tonsillar tissues. Of note, plasmacytoid DCs displayed less plasticity in their transcriptional activity compared with myeloid DCs. The data demonstrated a functionally distinct association of each of the seven subsets based on their signatures, involving regulatory genes in adaptive and innate immunity. Abstract from the Journal of Immunology. 2005 Oct 15;175(8):4839-46."	21	"CD16+ monocyte, blood BDCA1+ DC, tonsil BDCA1+ DC, blood BDCA3+ DC, tonsil BDCA3+ DC, blood pDC, tonsil pDC"	Microarray (Affymetrix HG-U133_Plus_2 (GPL570 and A-AFFY-44))		Homo sapiens	3.6	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	tonsil pDC CD123+  adult	myeloid	TRDC	adult	plasmacytoid dendritic cell	Mixed
B;7002	7002	Lindstedt	B	tonsil plasmacytoid dendritic cell 2	Homo sapiens	tonsil pDC	CL:0000784		plasmacytoid dendritic cell			Lindstedt	"Human dendritic cells (DCs) are a distinct but heterogeneous lineage of APCs operating as the link between innate and adaptive immune responses, with the function to either maintain tolerance or trigger immunity. The DC lineage consists of several subpopulations with unique phenotypes; however, their functional characteristics and transcriptional similarities remain largely unknown. To further characterize the phenotypes and transcriptomes of the subsets, we purified myeloid CD16(+), blood DC Ag 1(+) (BDCA1(+)), and BDCA3(+) DC populations, as well as plasmacytoid CD123(+) DCs, from tonsillar tissue and peripheral blood. Transcriptional profiling and hierarchical clustering visualized that BDCA1(+) DCs clustered with BDCA3(+) DCs, whereas CD16(+) DCs and CD123(+) DCs clustered as distinct populations in blood. Differential expression levels of chemokines, ILs, and pattern recognition receptors were demonstrated, which emphasize innate DC subset specialization. Even though highly BDCA1(+) and BDCA3(+) DC-specific gene expression was identified in blood, the BDCA1(+) DCs and BDCA3(+) DCs from tonsils displayed similar transcriptional activity, most likely due to the pathogenic or inflammatory maturational signals present in tonsillar tissues. Of note, plasmacytoid DCs displayed less plasticity in their transcriptional activity compared with myeloid DCs. The data demonstrated a functionally distinct association of each of the seven subsets based on their signatures, involving regulatory genes in adaptive and innate immunity. Abstract from the Journal of Immunology. 2005 Oct 15;175(8):4839-46."	21	"CD16+ monocyte, blood BDCA1+ DC, tonsil BDCA1+ DC, blood BDCA3+ DC, tonsil BDCA3+ DC, blood pDC, tonsil pDC"	Microarray (Affymetrix HG-U133_Plus_2 (GPL570 and A-AFFY-44))		Homo sapiens	3.6	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	tonsil pDC CD123+  adult	myeloid	TRDC	adult	plasmacytoid dendritic cell	Mixed
C;7002	7002	Lindstedt	C	tonsil plasmacytoid dendritic cell 3	Homo sapiens	tonsil pDC	CL:0000784		plasmacytoid dendritic cell			Lindstedt	"Human dendritic cells (DCs) are a distinct but heterogeneous lineage of APCs operating as the link between innate and adaptive immune responses, with the function to either maintain tolerance or trigger immunity. The DC lineage consists of several subpopulations with unique phenotypes; however, their functional characteristics and transcriptional similarities remain largely unknown. To further characterize the phenotypes and transcriptomes of the subsets, we purified myeloid CD16(+), blood DC Ag 1(+) (BDCA1(+)), and BDCA3(+) DC populations, as well as plasmacytoid CD123(+) DCs, from tonsillar tissue and peripheral blood. Transcriptional profiling and hierarchical clustering visualized that BDCA1(+) DCs clustered with BDCA3(+) DCs, whereas CD16(+) DCs and CD123(+) DCs clustered as distinct populations in blood. Differential expression levels of chemokines, ILs, and pattern recognition receptors were demonstrated, which emphasize innate DC subset specialization. Even though highly BDCA1(+) and BDCA3(+) DC-specific gene expression was identified in blood, the BDCA1(+) DCs and BDCA3(+) DCs from tonsils displayed similar transcriptional activity, most likely due to the pathogenic or inflammatory maturational signals present in tonsillar tissues. Of note, plasmacytoid DCs displayed less plasticity in their transcriptional activity compared with myeloid DCs. The data demonstrated a functionally distinct association of each of the seven subsets based on their signatures, involving regulatory genes in adaptive and innate immunity. Abstract from the Journal of Immunology. 2005 Oct 15;175(8):4839-46."	21	"CD16+ monocyte, blood BDCA1+ DC, tonsil BDCA1+ DC, blood BDCA3+ DC, tonsil BDCA3+ DC, blood pDC, tonsil pDC"	Microarray (Affymetrix HG-U133_Plus_2 (GPL570 and A-AFFY-44))		Homo sapiens	3.6	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	tonsil pDC CD123+  adult	myeloid	TRDC	adult	plasmacytoid dendritic cell	Mixed
FANTOM-14;7079	7079	Kurowska-Stolarska	FANTOM-14	FANTOM-14Gut CD206+	Homo sapiens	Gut CD206+	CL:0000235		macrophage			Kurowska-Stolarska	Kurowska-Stolarska_2016_S4M-7079_PRIVATE	33	"Gut CD206-, Gut CD206+, synovium CD206-, synovium CD206+"	RNASeq (Illumina NextSeq 500 hg19)		Homo sapiens		RNASeq	"rgb(0,146,146)"	cross	TRM Gut CD206+  adult	myeloid	TRM	adult	macrophage	Macrophage
FANTOM-15;7079	7079	Kurowska-Stolarska	FANTOM-15	FANTOM-15Gut CD206-	Homo sapiens	Gut CD206-	CL:0000235		macrophage			Kurowska-Stolarska	Kurowska-Stolarska_2016_S4M-7079_PRIVATE	33	"Gut CD206-, Gut CD206+, synovium CD206-, synovium CD206+"	RNASeq (Illumina NextSeq 500 hg19)		Homo sapiens		RNASeq	"rgb(0,146,146)"	cross	TRM Gut CD206-  adult	myeloid	myeloid	adult	macrophage	Macrophage
FANTOM-16;7079	7079	Kurowska-Stolarska	FANTOM-16	FANTOM-16Gut CD206+	Homo sapiens	Gut CD206+	CL:0000235		macrophage			Kurowska-Stolarska	Kurowska-Stolarska_2016_S4M-7079_PRIVATE	33	"Gut CD206-, Gut CD206+, synovium CD206-, synovium CD206+"	RNASeq (Illumina NextSeq 500 hg19)		Homo sapiens		RNASeq	"rgb(0,146,146)"	cross	TRM Gut CD206+  adult	myeloid	myeloid	adult	macrophage	Macrophage
FANTOM-17;7079	7079	Kurowska-Stolarska	FANTOM-17	FANTOM-17Gut CD206-	Homo sapiens	Gut CD206-	CL:0000235		macrophage			Kurowska-Stolarska	Kurowska-Stolarska_2016_S4M-7079_PRIVATE	33	"Gut CD206-, Gut CD206+, synovium CD206-, synovium CD206+"	RNASeq (Illumina NextSeq 500 hg19)		Homo sapiens		RNASeq	"rgb(0,146,146)"	cross	TRM Gut CD206-  adult	myeloid	myeloid	adult	macrophage	Macrophage
FANTOM-18;7079	7079	Kurowska-Stolarska	FANTOM-18	FANTOM-18Gut CD206+	Homo sapiens	Gut CD206+	CL:0000235		macrophage			Kurowska-Stolarska	Kurowska-Stolarska_2016_S4M-7079_PRIVATE	33	"Gut CD206-, Gut CD206+, synovium CD206-, synovium CD206+"	RNASeq (Illumina NextSeq 500 hg19)		Homo sapiens		RNASeq	"rgb(0,146,146)"	cross	TRM Gut CD206+  adult	myeloid	myeloid	adult	macrophage	Macrophage
FANTOM-19;7079	7079	Kurowska-Stolarska	FANTOM-19	FANTOM-19Gut CD206-	Homo sapiens	Gut CD206-	CL:0000235		macrophage			Kurowska-Stolarska	Kurowska-Stolarska_2016_S4M-7079_PRIVATE	33	"Gut CD206-, Gut CD206+, synovium CD206-, synovium CD206+"	RNASeq (Illumina NextSeq 500 hg19)		Homo sapiens		RNASeq	"rgb(0,146,146)"	cross	TRM Gut CD206-  adult	myeloid	myeloid	adult	macrophage	Macrophage
FANTOM-20;7079	7079	Kurowska-Stolarska	FANTOM-20	FANTOM-20Gut CD206+	Homo sapiens	Gut CD206+	CL:0000235		macrophage			Kurowska-Stolarska	Kurowska-Stolarska_2016_S4M-7079_PRIVATE	33	"Gut CD206-, Gut CD206+, synovium CD206-, synovium CD206+"	RNASeq (Illumina NextSeq 500 hg19)		Homo sapiens		RNASeq	"rgb(0,146,146)"	cross	TRM Gut CD206+  adult	myeloid	myeloid	adult	macrophage	Macrophage
FANTOM-24;7079	7079	Kurowska-Stolarska	FANTOM-24	FANTOM-24Synovial RA CD206+	Homo sapiens	synovium CD206+	CL:0000235		macrophage			Kurowska-Stolarska	Kurowska-Stolarska_2016_S4M-7079_PRIVATE	33	"Gut CD206-, Gut CD206+, synovium CD206-, synovium CD206+"	RNASeq (Illumina NextSeq 500 hg19)		Homo sapiens		RNASeq	"rgb(0,146,146)"	cross	TRM synovium CD206+ RA adult	myeloid	myeloid	adult	macrophage	Macrophage
FANTOM10;7079	7079	Kurowska-Stolarska	FANTOM10	FANTOM10Gut CD206+	Homo sapiens	Gut CD206+	CL:0000235		macrophage			Kurowska-Stolarska	Kurowska-Stolarska_2016_S4M-7079_PRIVATE	33	"Gut CD206-, Gut CD206+, synovium CD206-, synovium CD206+"	RNASeq (Illumina NextSeq 500 hg19)		Homo sapiens		RNASeq	"rgb(0,146,146)"	cross	TRM Gut CD206+  adult	myeloid	myeloid	adult	macrophage	Macrophage
FANTOM11;7079	7079	Kurowska-Stolarska	FANTOM11	FANTOM11Gut CD206-	Homo sapiens	Gut CD206-	CL:0000235		macrophage			Kurowska-Stolarska	Kurowska-Stolarska_2016_S4M-7079_PRIVATE	33	"Gut CD206-, Gut CD206+, synovium CD206-, synovium CD206+"	RNASeq (Illumina NextSeq 500 hg19)		Homo sapiens		RNASeq	"rgb(0,146,146)"	cross	TRM Gut CD206-  adult	myeloid	myeloid	adult	macrophage	Macrophage
FANTOM12;7079	7079	Kurowska-Stolarska	FANTOM12	FANTOM12Gut CD206+	Homo sapiens	Gut CD206+	CL:0000235		macrophage			Kurowska-Stolarska	Kurowska-Stolarska_2016_S4M-7079_PRIVATE	33	"Gut CD206-, Gut CD206+, synovium CD206-, synovium CD206+"	RNASeq (Illumina NextSeq 500 hg19)		Homo sapiens		RNASeq	"rgb(0,146,146)"	cross	TRM Gut CD206+  adult	myeloid	myeloid	adult	macrophage	Macrophage
FANTOM13;7079	7079	Kurowska-Stolarska	FANTOM13	FANTOM13Gut CD206-	Homo sapiens	Gut CD206-	CL:0000235		macrophage			Kurowska-Stolarska	Kurowska-Stolarska_2016_S4M-7079_PRIVATE	33	"Gut CD206-, Gut CD206+, synovium CD206-, synovium CD206+"	RNASeq (Illumina NextSeq 500 hg19)		Homo sapiens		RNASeq	"rgb(0,146,146)"	cross	TRM Gut CD206-  adult	myeloid	myeloid	adult	macrophage	Macrophage
FANTOM21;7079	7079	Kurowska-Stolarska	FANTOM21	FANTOM21Synovial RA CD206-	Homo sapiens	synovium CD206-	CL:0000235		macrophage			Kurowska-Stolarska	Kurowska-Stolarska_2016_S4M-7079_PRIVATE	33	"Gut CD206-, Gut CD206+, synovium CD206-, synovium CD206+"	RNASeq (Illumina NextSeq 500 hg19)		Homo sapiens		RNASeq	"rgb(0,146,146)"	cross	TRM synovium CD206- RA adult	myeloid	myeloid	adult	macrophage	Macrophage
FANTOM22;7079	7079	Kurowska-Stolarska	FANTOM22	FANTOM22Synovial RA CD206+	Homo sapiens	synovium CD206+	CL:0000235		macrophage			Kurowska-Stolarska	Kurowska-Stolarska_2016_S4M-7079_PRIVATE	33	"Gut CD206-, Gut CD206+, synovium CD206-, synovium CD206+"	RNASeq (Illumina NextSeq 500 hg19)		Homo sapiens		RNASeq	"rgb(0,146,146)"	cross	TRM synovium CD206+ RA adult	myeloid	myeloid	adult	macrophage	Macrophage
FANTOM25;7079	7079	Kurowska-Stolarska	FANTOM25	FANTOM25Synovial RA CD206-	Homo sapiens	synovium CD206-	CL:0000235		macrophage			Kurowska-Stolarska	Kurowska-Stolarska_2016_S4M-7079_PRIVATE	33	"Gut CD206-, Gut CD206+, synovium CD206-, synovium CD206+"	RNASeq (Illumina NextSeq 500 hg19)		Homo sapiens		RNASeq	"rgb(0,146,146)"	cross	TRM synovium CD206- RA adult	myeloid	myeloid	adult	macrophage	Macrophage
FANTOM26;7079	7079	Kurowska-Stolarska	FANTOM26	FANTOM26Synovial RA CD206+	Homo sapiens	synovium CD206+	CL:0000235		macrophage			Kurowska-Stolarska	Kurowska-Stolarska_2016_S4M-7079_PRIVATE	33	"Gut CD206-, Gut CD206+, synovium CD206-, synovium CD206+"	RNASeq (Illumina NextSeq 500 hg19)		Homo sapiens		RNASeq	"rgb(0,146,146)"	cross	TRM synovium CD206+ RA adult	myeloid	myeloid	adult	macrophage	Macrophage
FANTOM27;7079	7079	Kurowska-Stolarska	FANTOM27	FANTOM27Synovial RA CD206-	Homo sapiens	synovium CD206-	CL:0000235		macrophage			Kurowska-Stolarska	Kurowska-Stolarska_2016_S4M-7079_PRIVATE	33	"Gut CD206-, Gut CD206+, synovium CD206-, synovium CD206+"	RNASeq (Illumina NextSeq 500 hg19)		Homo sapiens		RNASeq	"rgb(0,146,146)"	cross	TRM synovium CD206- RA adult	myeloid	myeloid	adult	macrophage	Macrophage
FANTOM28;7079	7079	Kurowska-Stolarska	FANTOM28	FANTOM28Synovial RA CD206+	Homo sapiens	synovium CD206+	CL:0000235		macrophage			Kurowska-Stolarska	Kurowska-Stolarska_2016_S4M-7079_PRIVATE	33	"Gut CD206-, Gut CD206+, synovium CD206-, synovium CD206+"	RNASeq (Illumina NextSeq 500 hg19)		Homo sapiens		RNASeq	"rgb(0,146,146)"	cross	TRM synovium CD206+ RA adult	myeloid	myeloid	adult	macrophage	Macrophage
FANTOM29;7079	7079	Kurowska-Stolarska	FANTOM29	FANTOM29Synovial RA CD206-	Homo sapiens	synovium CD206-	CL:0000235		macrophage			Kurowska-Stolarska	Kurowska-Stolarska_2016_S4M-7079_PRIVATE	33	"Gut CD206-, Gut CD206+, synovium CD206-, synovium CD206+"	RNASeq (Illumina NextSeq 500 hg19)		Homo sapiens		RNASeq	"rgb(0,146,146)"	cross	TRM synovium CD206- RA adult	myeloid	myeloid	adult	macrophage	Macrophage
FANTOM30;7079	7079	Kurowska-Stolarska	FANTOM30	FANTOM30Synovial RA CD206+	Homo sapiens	synovium CD206+	CL:0000235		macrophage			Kurowska-Stolarska	Kurowska-Stolarska_2016_S4M-7079_PRIVATE	33	"Gut CD206-, Gut CD206+, synovium CD206-, synovium CD206+"	RNASeq (Illumina NextSeq 500 hg19)		Homo sapiens		RNASeq	"rgb(0,146,146)"	cross	TRM synovium CD206+ RA adult	myeloid	myeloid	adult	macrophage	Macrophage
FANTOM31;7079	7079	Kurowska-Stolarska	FANTOM31	FANTOM31Synovial RA CD206-	Homo sapiens	synovium CD206-	CL:0000235		macrophage			Kurowska-Stolarska	Kurowska-Stolarska_2016_S4M-7079_PRIVATE	33	"Gut CD206-, Gut CD206+, synovium CD206-, synovium CD206+"	RNASeq (Illumina NextSeq 500 hg19)		Homo sapiens		RNASeq	"rgb(0,146,146)"	cross	TRM synovium CD206- RA adult	myeloid	myeloid	adult	macrophage	Macrophage
FANTOM32;7079	7079	Kurowska-Stolarska	FANTOM32	FANTOM32Synovial RA CD206+	Homo sapiens	synovium CD206+	CL:0000235		macrophage			Kurowska-Stolarska	Kurowska-Stolarska_2016_S4M-7079_PRIVATE	33	"Gut CD206-, Gut CD206+, synovium CD206-, synovium CD206+"	RNASeq (Illumina NextSeq 500 hg19)		Homo sapiens		RNASeq	"rgb(0,146,146)"	cross	TRM synovium CD206+ RA adult	myeloid	myeloid	adult	macrophage	Macrophage
FANTOM34;7079	7079	Kurowska-Stolarska	FANTOM34	FANTOM34Synovial RA CD206+	Homo sapiens	synovium CD206+	CL:0000235		macrophage			Kurowska-Stolarska	Kurowska-Stolarska_2016_S4M-7079_PRIVATE	33	"Gut CD206-, Gut CD206+, synovium CD206-, synovium CD206+"	RNASeq (Illumina NextSeq 500 hg19)		Homo sapiens		RNASeq	"rgb(0,146,146)"	cross	TRM synovium CD206+ RA adult	myeloid	myeloid	adult	macrophage	Macrophage
FANTOM35;7079	7079	Kurowska-Stolarska	FANTOM35	FANTOM35Synovial RA CD206-	Homo sapiens	synovium CD206-	CL:0000235		macrophage			Kurowska-Stolarska	Kurowska-Stolarska_2016_S4M-7079_PRIVATE	33	"Gut CD206-, Gut CD206+, synovium CD206-, synovium CD206+"	RNASeq (Illumina NextSeq 500 hg19)		Homo sapiens		RNASeq	"rgb(0,146,146)"	cross	TRM synovium CD206- RA adult	myeloid	myeloid	adult	macrophage	Macrophage
FANTOM36;7079	7079	Kurowska-Stolarska	FANTOM36	FANTOM36Synovial RA CD206+	Homo sapiens	synovium CD206+	CL:0000235		macrophage			Kurowska-Stolarska	Kurowska-Stolarska_2016_S4M-7079_PRIVATE	33	"Gut CD206-, Gut CD206+, synovium CD206-, synovium CD206+"	RNASeq (Illumina NextSeq 500 hg19)		Homo sapiens		RNASeq	"rgb(0,146,146)"	cross	TRM synovium CD206+ RA adult	myeloid	myeloid	adult	macrophage	Dendritic Cell
FANTOM6-1;7079	7079	Kurowska-Stolarska	FANTOM6-1	FANTOM6-1 Synovial OA CD206-	Homo sapiens	synovium CD206-	CL:0000235		macrophage			Kurowska-Stolarska	Kurowska-Stolarska_2016_S4M-7079_PRIVATE	33	"Gut CD206-, Gut CD206+, synovium CD206-, synovium CD206+"	RNASeq (Illumina NextSeq 500 hg19)		Homo sapiens		RNASeq	"rgb(0,146,146)"	cross	TRM synovium CD206- OA adult	myeloid	myeloid	adult	macrophage	Macrophage
FANTOM6-2;7079	7079	Kurowska-Stolarska	FANTOM6-2	FANTOM6-2Synovial OA CD206+	Homo sapiens	synovium CD206+	CL:0000235		macrophage			Kurowska-Stolarska	Kurowska-Stolarska_2016_S4M-7079_PRIVATE	33	"Gut CD206-, Gut CD206+, synovium CD206-, synovium CD206+"	RNASeq (Illumina NextSeq 500 hg19)		Homo sapiens		RNASeq	"rgb(0,146,146)"	cross	TRM synovium CD206+ OA adult	myeloid	myeloid	adult	macrophage	Macrophage
FANTOM6-3;7079	7079	Kurowska-Stolarska	FANTOM6-3	FANTOM6-3Synovial OA CD206-	Homo sapiens	synovium CD206-	CL:0000235		macrophage			Kurowska-Stolarska	Kurowska-Stolarska_2016_S4M-7079_PRIVATE	33	"Gut CD206-, Gut CD206+, synovium CD206-, synovium CD206+"	RNASeq (Illumina NextSeq 500 hg19)		Homo sapiens		RNASeq	"rgb(0,146,146)"	cross	TRM synovium CD206- OA adult	myeloid	myeloid	adult	macrophage	Macrophage
FANTOM6-4;7079	7079	Kurowska-Stolarska	FANTOM6-4	FANTOM6-4Synovial OA CD206+	Homo sapiens	synovium CD206+	CL:0000235		macrophage			Kurowska-Stolarska	Kurowska-Stolarska_2016_S4M-7079_PRIVATE	33	"Gut CD206-, Gut CD206+, synovium CD206-, synovium CD206+"	RNASeq (Illumina NextSeq 500 hg19)		Homo sapiens		RNASeq	"rgb(0,146,146)"	cross	TRM synovium CD206+ OA adult	myeloid	myeloid	adult	macrophage	Macrophage
FANTOM6-5;7079	7079	Kurowska-Stolarska	FANTOM6-5	FANTOM6-5Gut CD206-	Homo sapiens	Gut CD206-	CL:0000235		macrophage			Kurowska-Stolarska	Kurowska-Stolarska_2016_S4M-7079_PRIVATE	33	"Gut CD206-, Gut CD206+, synovium CD206-, synovium CD206+"	RNASeq (Illumina NextSeq 500 hg19)		Homo sapiens		RNASeq	"rgb(0,146,146)"	cross	TRM Gut CD206-  adult	myeloid	myeloid	adult	macrophage	Macrophage
FANTOM6-6;7079	7079	Kurowska-Stolarska	FANTOM6-6	FANTOM6-6Gut CD206+	Homo sapiens	Gut CD206+	CL:0000235		macrophage			Kurowska-Stolarska	Kurowska-Stolarska_2016_S4M-7079_PRIVATE	33	"Gut CD206-, Gut CD206+, synovium CD206-, synovium CD206+"	RNASeq (Illumina NextSeq 500 hg19)		Homo sapiens		RNASeq	"rgb(0,146,146)"	cross	TRM Gut CD206+  adult	myeloid	myeloid	adult	macrophage	Macrophage
FANTOM6-7;7079	7079	Kurowska-Stolarska	FANTOM6-7	FANTOM6-7 Gut CD206-	Homo sapiens	Gut CD206-	CL:0000235		macrophage			Kurowska-Stolarska	Kurowska-Stolarska_2016_S4M-7079_PRIVATE	33	"Gut CD206-, Gut CD206+, synovium CD206-, synovium CD206+"	RNASeq (Illumina NextSeq 500 hg19)		Homo sapiens		RNASeq	"rgb(0,146,146)"	cross	TRM Gut CD206-  adult	myeloid	myeloid	adult	macrophage	Circulating Monocyte & Granulocyte
FANTOM9;7079	7079	Kurowska-Stolarska	FANTOM9	FANTOM9Gut CD206-	Homo sapiens	Gut CD206-	CL:0000235		macrophage			Kurowska-Stolarska	Kurowska-Stolarska_2016_S4M-7079_PRIVATE	33	"Gut CD206-, Gut CD206+, synovium CD206-, synovium CD206+"	RNASeq (Illumina NextSeq 500 hg19)		Homo sapiens		RNASeq	"rgb(0,146,146)"	cross	TRM Gut CD206-  adult	myeloid	myeloid	adult	macrophage	Macrophage
GSM1004101;6237	6237	Reynier	GSM1004101	Lung subsegment instillated by Saline_Donor1	Homo sapiens	alveolar macrophage + saline 6hr	CL:0000235		macrophage	male		Reynier	"Lipopolysaccharide (LPS) is ubiquitous in the environment. Inhalation of LPS has been implicated in the pathogenesis and/or severity of several lung diseases, including pneumonia, chronic obstructive pulmonary disease and asthma. Alveolar macrophages are the main resident leukocytes exposed to inhaled antigens. To obtain insight into which innate immune pathways become activated within human alveolar macrophages upon exposure to LPS in vivo, we conducted a study in eight healthy humans, in which we instilled sterile saline into a lung segment by bronchoscope, followed by instillation of LPS into the contralateral lung. Six hours later, a bilateral bronchoalveolar lavage was performed and whole-genome transcriptional profiling was done on purified alveolar macrophages, comparing cells exposed to saline or LPS from the same individuals. LPS induced differential expression of 2,932 genes in alveolar macrophages; 1,520 genes were upregulated, whereas 1,440 genes were downregulated. A total of 26 biological functions were overrepresented in LPS-exposed macrophages; 44 canonical pathways affected by LPS were identified, among which the genes associated with the role of pattern recognition receptors in recognition of bacteria and viruses represented the top pathway. Other pathways included cellular immune response, signaling by tumor necrosis factor (receptor) family members, cytokine signaling and glucocorticoid receptor signaling. These results reveal for the first time a large number of functional pathways influenced by the biologically relevant challenge provided by LPS administered into the airways. These data can assist in identifying novel targets for therapeutic intervention in pulmonary diseases associated with LPS exposure, including pneumonia, asthma and chronic obstructive pulmonary disease."	14	"alveolar macrophage + saline 6hr, alveolar macrophage + LPS 6hr"	Microarray (Affymetrix HG-U133_Plus_2)		Homo sapiens	5	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	TRM CD71  saline 6hr adult	myeloid	myeloid	adult	alveolar macrophage	Macrophage
GSM1004102;6237	6237	Reynier	GSM1004102	Lung subsegment instillated by LPS_Donor1	Homo sapiens	alveolar macrophage + LPS 6hr	CL:0000235		macrophage	male		Reynier	"Lipopolysaccharide (LPS) is ubiquitous in the environment. Inhalation of LPS has been implicated in the pathogenesis and/or severity of several lung diseases, including pneumonia, chronic obstructive pulmonary disease and asthma. Alveolar macrophages are the main resident leukocytes exposed to inhaled antigens. To obtain insight into which innate immune pathways become activated within human alveolar macrophages upon exposure to LPS in vivo, we conducted a study in eight healthy humans, in which we instilled sterile saline into a lung segment by bronchoscope, followed by instillation of LPS into the contralateral lung. Six hours later, a bilateral bronchoalveolar lavage was performed and whole-genome transcriptional profiling was done on purified alveolar macrophages, comparing cells exposed to saline or LPS from the same individuals. LPS induced differential expression of 2,932 genes in alveolar macrophages; 1,520 genes were upregulated, whereas 1,440 genes were downregulated. A total of 26 biological functions were overrepresented in LPS-exposed macrophages; 44 canonical pathways affected by LPS were identified, among which the genes associated with the role of pattern recognition receptors in recognition of bacteria and viruses represented the top pathway. Other pathways included cellular immune response, signaling by tumor necrosis factor (receptor) family members, cytokine signaling and glucocorticoid receptor signaling. These results reveal for the first time a large number of functional pathways influenced by the biologically relevant challenge provided by LPS administered into the airways. These data can assist in identifying novel targets for therapeutic intervention in pulmonary diseases associated with LPS exposure, including pneumonia, asthma and chronic obstructive pulmonary disease."	14	"alveolar macrophage + saline 6hr, alveolar macrophage + LPS 6hr"	Microarray (Affymetrix HG-U133_Plus_2)		Homo sapiens	5	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	TRM Alveolar lavage CD71  LPS 6hr adult	myeloid	myeloid	adult	alveolar macrophage	Macrophage
GSM1004103;6237	6237	Reynier	GSM1004103	Lung subsegment instillated by Saline_2	Homo sapiens	alveolar macrophage + saline 6hr	CL:0000235		macrophage	male		Reynier	"Lipopolysaccharide (LPS) is ubiquitous in the environment. Inhalation of LPS has been implicated in the pathogenesis and/or severity of several lung diseases, including pneumonia, chronic obstructive pulmonary disease and asthma. Alveolar macrophages are the main resident leukocytes exposed to inhaled antigens. To obtain insight into which innate immune pathways become activated within human alveolar macrophages upon exposure to LPS in vivo, we conducted a study in eight healthy humans, in which we instilled sterile saline into a lung segment by bronchoscope, followed by instillation of LPS into the contralateral lung. Six hours later, a bilateral bronchoalveolar lavage was performed and whole-genome transcriptional profiling was done on purified alveolar macrophages, comparing cells exposed to saline or LPS from the same individuals. LPS induced differential expression of 2,932 genes in alveolar macrophages; 1,520 genes were upregulated, whereas 1,440 genes were downregulated. A total of 26 biological functions were overrepresented in LPS-exposed macrophages; 44 canonical pathways affected by LPS were identified, among which the genes associated with the role of pattern recognition receptors in recognition of bacteria and viruses represented the top pathway. Other pathways included cellular immune response, signaling by tumor necrosis factor (receptor) family members, cytokine signaling and glucocorticoid receptor signaling. These results reveal for the first time a large number of functional pathways influenced by the biologically relevant challenge provided by LPS administered into the airways. These data can assist in identifying novel targets for therapeutic intervention in pulmonary diseases associated with LPS exposure, including pneumonia, asthma and chronic obstructive pulmonary disease."	14	"alveolar macrophage + saline 6hr, alveolar macrophage + LPS 6hr"	Microarray (Affymetrix HG-U133_Plus_2)		Homo sapiens	5	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	TRM Alveolar lavage CD71  saline 6hr adult	myeloid	myeloid	adult	alveolar macrophage	Macrophage
GSM1004104;6237	6237	Reynier	GSM1004104	Lung subsegment instillated by LPS_2	Homo sapiens	alveolar macrophage + LPS 6hr	CL:0000235		macrophage	male		Reynier	"Lipopolysaccharide (LPS) is ubiquitous in the environment. Inhalation of LPS has been implicated in the pathogenesis and/or severity of several lung diseases, including pneumonia, chronic obstructive pulmonary disease and asthma. Alveolar macrophages are the main resident leukocytes exposed to inhaled antigens. To obtain insight into which innate immune pathways become activated within human alveolar macrophages upon exposure to LPS in vivo, we conducted a study in eight healthy humans, in which we instilled sterile saline into a lung segment by bronchoscope, followed by instillation of LPS into the contralateral lung. Six hours later, a bilateral bronchoalveolar lavage was performed and whole-genome transcriptional profiling was done on purified alveolar macrophages, comparing cells exposed to saline or LPS from the same individuals. LPS induced differential expression of 2,932 genes in alveolar macrophages; 1,520 genes were upregulated, whereas 1,440 genes were downregulated. A total of 26 biological functions were overrepresented in LPS-exposed macrophages; 44 canonical pathways affected by LPS were identified, among which the genes associated with the role of pattern recognition receptors in recognition of bacteria and viruses represented the top pathway. Other pathways included cellular immune response, signaling by tumor necrosis factor (receptor) family members, cytokine signaling and glucocorticoid receptor signaling. These results reveal for the first time a large number of functional pathways influenced by the biologically relevant challenge provided by LPS administered into the airways. These data can assist in identifying novel targets for therapeutic intervention in pulmonary diseases associated with LPS exposure, including pneumonia, asthma and chronic obstructive pulmonary disease."	14	"alveolar macrophage + saline 6hr, alveolar macrophage + LPS 6hr"	Microarray (Affymetrix HG-U133_Plus_2)		Homo sapiens	5	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	TRM Alveolar lavage CD71  LPS 6hr adult	myeloid	myeloid	adult	alveolar macrophage	Macrophage
GSM1004105;6237	6237	Reynier	GSM1004105	Lung subsegment instillated by Saline_3	Homo sapiens	alveolar macrophage + saline 6hr	CL:0000235		macrophage	male		Reynier	"Lipopolysaccharide (LPS) is ubiquitous in the environment. Inhalation of LPS has been implicated in the pathogenesis and/or severity of several lung diseases, including pneumonia, chronic obstructive pulmonary disease and asthma. Alveolar macrophages are the main resident leukocytes exposed to inhaled antigens. To obtain insight into which innate immune pathways become activated within human alveolar macrophages upon exposure to LPS in vivo, we conducted a study in eight healthy humans, in which we instilled sterile saline into a lung segment by bronchoscope, followed by instillation of LPS into the contralateral lung. Six hours later, a bilateral bronchoalveolar lavage was performed and whole-genome transcriptional profiling was done on purified alveolar macrophages, comparing cells exposed to saline or LPS from the same individuals. LPS induced differential expression of 2,932 genes in alveolar macrophages; 1,520 genes were upregulated, whereas 1,440 genes were downregulated. A total of 26 biological functions were overrepresented in LPS-exposed macrophages; 44 canonical pathways affected by LPS were identified, among which the genes associated with the role of pattern recognition receptors in recognition of bacteria and viruses represented the top pathway. Other pathways included cellular immune response, signaling by tumor necrosis factor (receptor) family members, cytokine signaling and glucocorticoid receptor signaling. These results reveal for the first time a large number of functional pathways influenced by the biologically relevant challenge provided by LPS administered into the airways. These data can assist in identifying novel targets for therapeutic intervention in pulmonary diseases associated with LPS exposure, including pneumonia, asthma and chronic obstructive pulmonary disease."	14	"alveolar macrophage + saline 6hr, alveolar macrophage + LPS 6hr"	Microarray (Affymetrix HG-U133_Plus_2)		Homo sapiens	5	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	TRM Alveolar lavage CD71  saline 6hr adult	myeloid	myeloid	adult	alveolar macrophage	Macrophage
GSM1004106;6237	6237	Reynier	GSM1004106	Lung subsegment instillated by LPS_3	Homo sapiens	alveolar macrophage + LPS 6hr	CL:0000235		macrophage	male		Reynier	"Lipopolysaccharide (LPS) is ubiquitous in the environment. Inhalation of LPS has been implicated in the pathogenesis and/or severity of several lung diseases, including pneumonia, chronic obstructive pulmonary disease and asthma. Alveolar macrophages are the main resident leukocytes exposed to inhaled antigens. To obtain insight into which innate immune pathways become activated within human alveolar macrophages upon exposure to LPS in vivo, we conducted a study in eight healthy humans, in which we instilled sterile saline into a lung segment by bronchoscope, followed by instillation of LPS into the contralateral lung. Six hours later, a bilateral bronchoalveolar lavage was performed and whole-genome transcriptional profiling was done on purified alveolar macrophages, comparing cells exposed to saline or LPS from the same individuals. LPS induced differential expression of 2,932 genes in alveolar macrophages; 1,520 genes were upregulated, whereas 1,440 genes were downregulated. A total of 26 biological functions were overrepresented in LPS-exposed macrophages; 44 canonical pathways affected by LPS were identified, among which the genes associated with the role of pattern recognition receptors in recognition of bacteria and viruses represented the top pathway. Other pathways included cellular immune response, signaling by tumor necrosis factor (receptor) family members, cytokine signaling and glucocorticoid receptor signaling. These results reveal for the first time a large number of functional pathways influenced by the biologically relevant challenge provided by LPS administered into the airways. These data can assist in identifying novel targets for therapeutic intervention in pulmonary diseases associated with LPS exposure, including pneumonia, asthma and chronic obstructive pulmonary disease."	14	"alveolar macrophage + saline 6hr, alveolar macrophage + LPS 6hr"	Microarray (Affymetrix HG-U133_Plus_2)		Homo sapiens	5	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	TRM Alveolar lavage CD71  LPS 6hr adult	myeloid	myeloid	adult	alveolar macrophage	Macrophage
GSM1004107;6237	6237	Reynier	GSM1004107	Lung subsegment instillated by Saline_4	Homo sapiens	alveolar macrophage + saline 6hr	CL:0000235		macrophage	male		Reynier	"Lipopolysaccharide (LPS) is ubiquitous in the environment. Inhalation of LPS has been implicated in the pathogenesis and/or severity of several lung diseases, including pneumonia, chronic obstructive pulmonary disease and asthma. Alveolar macrophages are the main resident leukocytes exposed to inhaled antigens. To obtain insight into which innate immune pathways become activated within human alveolar macrophages upon exposure to LPS in vivo, we conducted a study in eight healthy humans, in which we instilled sterile saline into a lung segment by bronchoscope, followed by instillation of LPS into the contralateral lung. Six hours later, a bilateral bronchoalveolar lavage was performed and whole-genome transcriptional profiling was done on purified alveolar macrophages, comparing cells exposed to saline or LPS from the same individuals. LPS induced differential expression of 2,932 genes in alveolar macrophages; 1,520 genes were upregulated, whereas 1,440 genes were downregulated. A total of 26 biological functions were overrepresented in LPS-exposed macrophages; 44 canonical pathways affected by LPS were identified, among which the genes associated with the role of pattern recognition receptors in recognition of bacteria and viruses represented the top pathway. Other pathways included cellular immune response, signaling by tumor necrosis factor (receptor) family members, cytokine signaling and glucocorticoid receptor signaling. These results reveal for the first time a large number of functional pathways influenced by the biologically relevant challenge provided by LPS administered into the airways. These data can assist in identifying novel targets for therapeutic intervention in pulmonary diseases associated with LPS exposure, including pneumonia, asthma and chronic obstructive pulmonary disease."	14	"alveolar macrophage + saline 6hr, alveolar macrophage + LPS 6hr"	Microarray (Affymetrix HG-U133_Plus_2)		Homo sapiens	5	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	TRM Alveolar lavage CD71  saline 6hr adult	myeloid	myeloid	adult	alveolar macrophage	Macrophage
GSM1004108;6237	6237	Reynier	GSM1004108	Lung subsegment instillated by LPS_4	Homo sapiens	alveolar macrophage + LPS 6hr	CL:0000235		macrophage	male		Reynier	"Lipopolysaccharide (LPS) is ubiquitous in the environment. Inhalation of LPS has been implicated in the pathogenesis and/or severity of several lung diseases, including pneumonia, chronic obstructive pulmonary disease and asthma. Alveolar macrophages are the main resident leukocytes exposed to inhaled antigens. To obtain insight into which innate immune pathways become activated within human alveolar macrophages upon exposure to LPS in vivo, we conducted a study in eight healthy humans, in which we instilled sterile saline into a lung segment by bronchoscope, followed by instillation of LPS into the contralateral lung. Six hours later, a bilateral bronchoalveolar lavage was performed and whole-genome transcriptional profiling was done on purified alveolar macrophages, comparing cells exposed to saline or LPS from the same individuals. LPS induced differential expression of 2,932 genes in alveolar macrophages; 1,520 genes were upregulated, whereas 1,440 genes were downregulated. A total of 26 biological functions were overrepresented in LPS-exposed macrophages; 44 canonical pathways affected by LPS were identified, among which the genes associated with the role of pattern recognition receptors in recognition of bacteria and viruses represented the top pathway. Other pathways included cellular immune response, signaling by tumor necrosis factor (receptor) family members, cytokine signaling and glucocorticoid receptor signaling. These results reveal for the first time a large number of functional pathways influenced by the biologically relevant challenge provided by LPS administered into the airways. These data can assist in identifying novel targets for therapeutic intervention in pulmonary diseases associated with LPS exposure, including pneumonia, asthma and chronic obstructive pulmonary disease."	14	"alveolar macrophage + saline 6hr, alveolar macrophage + LPS 6hr"	Microarray (Affymetrix HG-U133_Plus_2)		Homo sapiens	5	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	TRM Alveolar lavage CD71  LPS 6hr adult	myeloid	myeloid	adult	alveolar macrophage	Macrophage
GSM1004109;6237	6237	Reynier	GSM1004109	Lung subsegment instillated by Saline_5	Homo sapiens	alveolar macrophage + saline 6hr	CL:0000235		macrophage	male		Reynier	"Lipopolysaccharide (LPS) is ubiquitous in the environment. Inhalation of LPS has been implicated in the pathogenesis and/or severity of several lung diseases, including pneumonia, chronic obstructive pulmonary disease and asthma. Alveolar macrophages are the main resident leukocytes exposed to inhaled antigens. To obtain insight into which innate immune pathways become activated within human alveolar macrophages upon exposure to LPS in vivo, we conducted a study in eight healthy humans, in which we instilled sterile saline into a lung segment by bronchoscope, followed by instillation of LPS into the contralateral lung. Six hours later, a bilateral bronchoalveolar lavage was performed and whole-genome transcriptional profiling was done on purified alveolar macrophages, comparing cells exposed to saline or LPS from the same individuals. LPS induced differential expression of 2,932 genes in alveolar macrophages; 1,520 genes were upregulated, whereas 1,440 genes were downregulated. A total of 26 biological functions were overrepresented in LPS-exposed macrophages; 44 canonical pathways affected by LPS were identified, among which the genes associated with the role of pattern recognition receptors in recognition of bacteria and viruses represented the top pathway. Other pathways included cellular immune response, signaling by tumor necrosis factor (receptor) family members, cytokine signaling and glucocorticoid receptor signaling. These results reveal for the first time a large number of functional pathways influenced by the biologically relevant challenge provided by LPS administered into the airways. These data can assist in identifying novel targets for therapeutic intervention in pulmonary diseases associated with LPS exposure, including pneumonia, asthma and chronic obstructive pulmonary disease."	14	"alveolar macrophage + saline 6hr, alveolar macrophage + LPS 6hr"	Microarray (Affymetrix HG-U133_Plus_2)		Homo sapiens	5	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	TRM Alveolar lavage CD71  saline 6hr adult	myeloid	myeloid	adult	alveolar macrophage	Macrophage
GSM1004110;6237	6237	Reynier	GSM1004110	Lung subsegment instillated by LPS_5	Homo sapiens	alveolar macrophage + LPS 6hr	CL:0000235		macrophage	male		Reynier	"Lipopolysaccharide (LPS) is ubiquitous in the environment. Inhalation of LPS has been implicated in the pathogenesis and/or severity of several lung diseases, including pneumonia, chronic obstructive pulmonary disease and asthma. Alveolar macrophages are the main resident leukocytes exposed to inhaled antigens. To obtain insight into which innate immune pathways become activated within human alveolar macrophages upon exposure to LPS in vivo, we conducted a study in eight healthy humans, in which we instilled sterile saline into a lung segment by bronchoscope, followed by instillation of LPS into the contralateral lung. Six hours later, a bilateral bronchoalveolar lavage was performed and whole-genome transcriptional profiling was done on purified alveolar macrophages, comparing cells exposed to saline or LPS from the same individuals. LPS induced differential expression of 2,932 genes in alveolar macrophages; 1,520 genes were upregulated, whereas 1,440 genes were downregulated. A total of 26 biological functions were overrepresented in LPS-exposed macrophages; 44 canonical pathways affected by LPS were identified, among which the genes associated with the role of pattern recognition receptors in recognition of bacteria and viruses represented the top pathway. Other pathways included cellular immune response, signaling by tumor necrosis factor (receptor) family members, cytokine signaling and glucocorticoid receptor signaling. These results reveal for the first time a large number of functional pathways influenced by the biologically relevant challenge provided by LPS administered into the airways. These data can assist in identifying novel targets for therapeutic intervention in pulmonary diseases associated with LPS exposure, including pneumonia, asthma and chronic obstructive pulmonary disease."	14	"alveolar macrophage + saline 6hr, alveolar macrophage + LPS 6hr"	Microarray (Affymetrix HG-U133_Plus_2)		Homo sapiens	5	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	TRM Alveolar lavage CD71  LPS 6hr adult	myeloid	myeloid	adult	alveolar macrophage	Macrophage
GSM1004111;6237	6237	Reynier	GSM1004111	Lung subsegment instillated by Saline_6	Homo sapiens	alveolar macrophage + saline 6hr	CL:0000235		macrophage	male		Reynier	"Lipopolysaccharide (LPS) is ubiquitous in the environment. Inhalation of LPS has been implicated in the pathogenesis and/or severity of several lung diseases, including pneumonia, chronic obstructive pulmonary disease and asthma. Alveolar macrophages are the main resident leukocytes exposed to inhaled antigens. To obtain insight into which innate immune pathways become activated within human alveolar macrophages upon exposure to LPS in vivo, we conducted a study in eight healthy humans, in which we instilled sterile saline into a lung segment by bronchoscope, followed by instillation of LPS into the contralateral lung. Six hours later, a bilateral bronchoalveolar lavage was performed and whole-genome transcriptional profiling was done on purified alveolar macrophages, comparing cells exposed to saline or LPS from the same individuals. LPS induced differential expression of 2,932 genes in alveolar macrophages; 1,520 genes were upregulated, whereas 1,440 genes were downregulated. A total of 26 biological functions were overrepresented in LPS-exposed macrophages; 44 canonical pathways affected by LPS were identified, among which the genes associated with the role of pattern recognition receptors in recognition of bacteria and viruses represented the top pathway. Other pathways included cellular immune response, signaling by tumor necrosis factor (receptor) family members, cytokine signaling and glucocorticoid receptor signaling. These results reveal for the first time a large number of functional pathways influenced by the biologically relevant challenge provided by LPS administered into the airways. These data can assist in identifying novel targets for therapeutic intervention in pulmonary diseases associated with LPS exposure, including pneumonia, asthma and chronic obstructive pulmonary disease."	14	"alveolar macrophage + saline 6hr, alveolar macrophage + LPS 6hr"	Microarray (Affymetrix HG-U133_Plus_2)		Homo sapiens	5	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	TRM Alveolar lavage CD71  saline 6hr adult	myeloid	myeloid	adult	alveolar macrophage	Macrophage
GSM1004112;6237	6237	Reynier	GSM1004112	Lung subsegment instillated by LPS_6	Homo sapiens	alveolar macrophage + LPS 6hr	CL:0000235		macrophage	male		Reynier	"Lipopolysaccharide (LPS) is ubiquitous in the environment. Inhalation of LPS has been implicated in the pathogenesis and/or severity of several lung diseases, including pneumonia, chronic obstructive pulmonary disease and asthma. Alveolar macrophages are the main resident leukocytes exposed to inhaled antigens. To obtain insight into which innate immune pathways become activated within human alveolar macrophages upon exposure to LPS in vivo, we conducted a study in eight healthy humans, in which we instilled sterile saline into a lung segment by bronchoscope, followed by instillation of LPS into the contralateral lung. Six hours later, a bilateral bronchoalveolar lavage was performed and whole-genome transcriptional profiling was done on purified alveolar macrophages, comparing cells exposed to saline or LPS from the same individuals. LPS induced differential expression of 2,932 genes in alveolar macrophages; 1,520 genes were upregulated, whereas 1,440 genes were downregulated. A total of 26 biological functions were overrepresented in LPS-exposed macrophages; 44 canonical pathways affected by LPS were identified, among which the genes associated with the role of pattern recognition receptors in recognition of bacteria and viruses represented the top pathway. Other pathways included cellular immune response, signaling by tumor necrosis factor (receptor) family members, cytokine signaling and glucocorticoid receptor signaling. These results reveal for the first time a large number of functional pathways influenced by the biologically relevant challenge provided by LPS administered into the airways. These data can assist in identifying novel targets for therapeutic intervention in pulmonary diseases associated with LPS exposure, including pneumonia, asthma and chronic obstructive pulmonary disease."	14	"alveolar macrophage + saline 6hr, alveolar macrophage + LPS 6hr"	Microarray (Affymetrix HG-U133_Plus_2)		Homo sapiens	5	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	TRM Alveolar lavage CD71  LPS 6hr adult	myeloid	myeloid	adult	alveolar macrophage	Macrophage
GSM1004113;6237	6237	Reynier	GSM1004113	Lung subsegment instillated by Saline_7	Homo sapiens	alveolar macrophage + saline 6hr	CL:0000235		macrophage	male		Reynier	"Lipopolysaccharide (LPS) is ubiquitous in the environment. Inhalation of LPS has been implicated in the pathogenesis and/or severity of several lung diseases, including pneumonia, chronic obstructive pulmonary disease and asthma. Alveolar macrophages are the main resident leukocytes exposed to inhaled antigens. To obtain insight into which innate immune pathways become activated within human alveolar macrophages upon exposure to LPS in vivo, we conducted a study in eight healthy humans, in which we instilled sterile saline into a lung segment by bronchoscope, followed by instillation of LPS into the contralateral lung. Six hours later, a bilateral bronchoalveolar lavage was performed and whole-genome transcriptional profiling was done on purified alveolar macrophages, comparing cells exposed to saline or LPS from the same individuals. LPS induced differential expression of 2,932 genes in alveolar macrophages; 1,520 genes were upregulated, whereas 1,440 genes were downregulated. A total of 26 biological functions were overrepresented in LPS-exposed macrophages; 44 canonical pathways affected by LPS were identified, among which the genes associated with the role of pattern recognition receptors in recognition of bacteria and viruses represented the top pathway. Other pathways included cellular immune response, signaling by tumor necrosis factor (receptor) family members, cytokine signaling and glucocorticoid receptor signaling. These results reveal for the first time a large number of functional pathways influenced by the biologically relevant challenge provided by LPS administered into the airways. These data can assist in identifying novel targets for therapeutic intervention in pulmonary diseases associated with LPS exposure, including pneumonia, asthma and chronic obstructive pulmonary disease."	14	"alveolar macrophage + saline 6hr, alveolar macrophage + LPS 6hr"	Microarray (Affymetrix HG-U133_Plus_2)		Homo sapiens	5	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	TRM Alveolar lavage CD71  saline 6hr adult	myeloid	myeloid	adult	alveolar macrophage	Macrophage
GSM1004114;6237	6237	Reynier	GSM1004114	Lung subsegment instillated by LPS_7	Homo sapiens	alveolar macrophage + LPS 6hr	CL:0000235		macrophage	male		Reynier	"Lipopolysaccharide (LPS) is ubiquitous in the environment. Inhalation of LPS has been implicated in the pathogenesis and/or severity of several lung diseases, including pneumonia, chronic obstructive pulmonary disease and asthma. Alveolar macrophages are the main resident leukocytes exposed to inhaled antigens. To obtain insight into which innate immune pathways become activated within human alveolar macrophages upon exposure to LPS in vivo, we conducted a study in eight healthy humans, in which we instilled sterile saline into a lung segment by bronchoscope, followed by instillation of LPS into the contralateral lung. Six hours later, a bilateral bronchoalveolar lavage was performed and whole-genome transcriptional profiling was done on purified alveolar macrophages, comparing cells exposed to saline or LPS from the same individuals. LPS induced differential expression of 2,932 genes in alveolar macrophages; 1,520 genes were upregulated, whereas 1,440 genes were downregulated. A total of 26 biological functions were overrepresented in LPS-exposed macrophages; 44 canonical pathways affected by LPS were identified, among which the genes associated with the role of pattern recognition receptors in recognition of bacteria and viruses represented the top pathway. Other pathways included cellular immune response, signaling by tumor necrosis factor (receptor) family members, cytokine signaling and glucocorticoid receptor signaling. These results reveal for the first time a large number of functional pathways influenced by the biologically relevant challenge provided by LPS administered into the airways. These data can assist in identifying novel targets for therapeutic intervention in pulmonary diseases associated with LPS exposure, including pneumonia, asthma and chronic obstructive pulmonary disease."	14	"alveolar macrophage + saline 6hr, alveolar macrophage + LPS 6hr"	Microarray (Affymetrix HG-U133_Plus_2)		Homo sapiens	5	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	TRM Alveolar lavage CD71  LPS 6hr adult	myeloid	myeloid	adult	alveolar macrophage	Macrophage
GSM1041380;6358	6358	Rapin	GSM1041380	HSC 1	Homo sapiens	HSC	CL:0000837		hematopoietic multipotent progenitor			Rapin	"Gene expression profiling has been used extensively to characterize cancer, identify novel subtypes, and improve patient stratification. However, it has largely failed to identify transcriptional programs that differ between cancer and corresponding normal cells and has not been efficient in identifying expression changes fundamental to disease etiology. Here we present a method that facilitates the comparison of any cancer sample to its nearest normal cellular counterpart, using acute myeloid leukemia (AML) as a model. We first generated a gene expression-based landscape of the normal hematopoietic hierarchy, using expression profiles from normal stem/progenitor cells, and next mapped the AML patient samples to this landscape. This allowed us to identify the closest normal counterpart of individual AML samples and determine gene expression changes between cancer and normal. We find the cancer vs normal method (CvN method) to be superior to conventional methods in stratifying AML patients with aberrant karyotype and in identifying common aberrant transcriptional programs with potential importance for AML etiology. Moreover, the CvN method uncovered a novel poor-outcome subtype of normal-karyotype AML, which allowed for the generation of a highly prognostic survival signature. Collectively, our CvN method holds great potential as a tool for the analysis of gene expression profiles of cancer patients."	34	"HSC, MPP, CMP, GMP, MEP, Early PM, Late PM, MY, MM, BC, PMN"	Microarray (Affymetrix HG-U133_Plus_2)		Homo sapiens	4.5	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	MHP Lin CD34+ CD38 CD90+ CD45RA  adult	hematopoietic multipotent progenitor	MHP	adult	hematopoietic multipotent progenitor	Progenitor
GSM1041381;6358	6358	Rapin	GSM1041381	HSC 2	Homo sapiens	HSC	CL:0000837		hematopoietic multipotent progenitor			Rapin	"Gene expression profiling has been used extensively to characterize cancer, identify novel subtypes, and improve patient stratification. However, it has largely failed to identify transcriptional programs that differ between cancer and corresponding normal cells and has not been efficient in identifying expression changes fundamental to disease etiology. Here we present a method that facilitates the comparison of any cancer sample to its nearest normal cellular counterpart, using acute myeloid leukemia (AML) as a model. We first generated a gene expression-based landscape of the normal hematopoietic hierarchy, using expression profiles from normal stem/progenitor cells, and next mapped the AML patient samples to this landscape. This allowed us to identify the closest normal counterpart of individual AML samples and determine gene expression changes between cancer and normal. We find the cancer vs normal method (CvN method) to be superior to conventional methods in stratifying AML patients with aberrant karyotype and in identifying common aberrant transcriptional programs with potential importance for AML etiology. Moreover, the CvN method uncovered a novel poor-outcome subtype of normal-karyotype AML, which allowed for the generation of a highly prognostic survival signature. Collectively, our CvN method holds great potential as a tool for the analysis of gene expression profiles of cancer patients."	34	"HSC, MPP, CMP, GMP, MEP, Early PM, Late PM, MY, MM, BC, PMN"	Microarray (Affymetrix HG-U133_Plus_2)		Homo sapiens	4.5	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	MHP Lin CD34+ CD38 CD90+ CD45RA  adult	hematopoietic multipotent progenitor	MHP	adult	hematopoietic multipotent progenitor	Progenitor
GSM1041382;6358	6358	Rapin	GSM1041382	HSC 3	Homo sapiens	HSC	CL:0000837		hematopoietic multipotent progenitor			Rapin	"Gene expression profiling has been used extensively to characterize cancer, identify novel subtypes, and improve patient stratification. However, it has largely failed to identify transcriptional programs that differ between cancer and corresponding normal cells and has not been efficient in identifying expression changes fundamental to disease etiology. Here we present a method that facilitates the comparison of any cancer sample to its nearest normal cellular counterpart, using acute myeloid leukemia (AML) as a model. We first generated a gene expression-based landscape of the normal hematopoietic hierarchy, using expression profiles from normal stem/progenitor cells, and next mapped the AML patient samples to this landscape. This allowed us to identify the closest normal counterpart of individual AML samples and determine gene expression changes between cancer and normal. We find the cancer vs normal method (CvN method) to be superior to conventional methods in stratifying AML patients with aberrant karyotype and in identifying common aberrant transcriptional programs with potential importance for AML etiology. Moreover, the CvN method uncovered a novel poor-outcome subtype of normal-karyotype AML, which allowed for the generation of a highly prognostic survival signature. Collectively, our CvN method holds great potential as a tool for the analysis of gene expression profiles of cancer patients."	34	"HSC, MPP, CMP, GMP, MEP, Early PM, Late PM, MY, MM, BC, PMN"	Microarray (Affymetrix HG-U133_Plus_2)		Homo sapiens	4.5	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	MHP Lin CD34+ CD38 CD90+ CD45RA  adult	hematopoietic multipotent progenitor	MHP	adult	hematopoietic multipotent progenitor	Progenitor
GSM1041383;6358	6358	Rapin	GSM1041383	HSC 4	Homo sapiens	HSC	CL:0000837		hematopoietic multipotent progenitor			Rapin	"Gene expression profiling has been used extensively to characterize cancer, identify novel subtypes, and improve patient stratification. However, it has largely failed to identify transcriptional programs that differ between cancer and corresponding normal cells and has not been efficient in identifying expression changes fundamental to disease etiology. Here we present a method that facilitates the comparison of any cancer sample to its nearest normal cellular counterpart, using acute myeloid leukemia (AML) as a model. We first generated a gene expression-based landscape of the normal hematopoietic hierarchy, using expression profiles from normal stem/progenitor cells, and next mapped the AML patient samples to this landscape. This allowed us to identify the closest normal counterpart of individual AML samples and determine gene expression changes between cancer and normal. We find the cancer vs normal method (CvN method) to be superior to conventional methods in stratifying AML patients with aberrant karyotype and in identifying common aberrant transcriptional programs with potential importance for AML etiology. Moreover, the CvN method uncovered a novel poor-outcome subtype of normal-karyotype AML, which allowed for the generation of a highly prognostic survival signature. Collectively, our CvN method holds great potential as a tool for the analysis of gene expression profiles of cancer patients."	34	"HSC, MPP, CMP, GMP, MEP, Early PM, Late PM, MY, MM, BC, PMN"	Microarray (Affymetrix HG-U133_Plus_2)		Homo sapiens	4.5	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	MHP Lin CD34+ CD38 CD90+ CD45RA  adult	hematopoietic multipotent progenitor	MHP	adult	hematopoietic multipotent progenitor	Progenitor
GSM1041386;6358	6358	Rapin	GSM1041386	CMP 1	Homo sapiens	CMP	CL:0000049		common myeloid progenitor			Rapin	"Gene expression profiling has been used extensively to characterize cancer, identify novel subtypes, and improve patient stratification. However, it has largely failed to identify transcriptional programs that differ between cancer and corresponding normal cells and has not been efficient in identifying expression changes fundamental to disease etiology. Here we present a method that facilitates the comparison of any cancer sample to its nearest normal cellular counterpart, using acute myeloid leukemia (AML) as a model. We first generated a gene expression-based landscape of the normal hematopoietic hierarchy, using expression profiles from normal stem/progenitor cells, and next mapped the AML patient samples to this landscape. This allowed us to identify the closest normal counterpart of individual AML samples and determine gene expression changes between cancer and normal. We find the cancer vs normal method (CvN method) to be superior to conventional methods in stratifying AML patients with aberrant karyotype and in identifying common aberrant transcriptional programs with potential importance for AML etiology. Moreover, the CvN method uncovered a novel poor-outcome subtype of normal-karyotype AML, which allowed for the generation of a highly prognostic survival signature. Collectively, our CvN method holds great potential as a tool for the analysis of gene expression profiles of cancer patients."	34	"HSC, MPP, CMP, GMP, MEP, Early PM, Late PM, MY, MM, BC, PMN"	Microarray (Affymetrix HG-U133_Plus_2)		Homo sapiens	4.5	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	CMP Lin CD34+ CD38+ CD45RA CD123+  adult	myeloid progenitor	CMP	adult	common myeloid progenitor	Progenitor
GSM1041387;6358	6358	Rapin	GSM1041387	CMP 2	Homo sapiens	CMP	CL:0000049		common myeloid progenitor			Rapin	"Gene expression profiling has been used extensively to characterize cancer, identify novel subtypes, and improve patient stratification. However, it has largely failed to identify transcriptional programs that differ between cancer and corresponding normal cells and has not been efficient in identifying expression changes fundamental to disease etiology. Here we present a method that facilitates the comparison of any cancer sample to its nearest normal cellular counterpart, using acute myeloid leukemia (AML) as a model. We first generated a gene expression-based landscape of the normal hematopoietic hierarchy, using expression profiles from normal stem/progenitor cells, and next mapped the AML patient samples to this landscape. This allowed us to identify the closest normal counterpart of individual AML samples and determine gene expression changes between cancer and normal. We find the cancer vs normal method (CvN method) to be superior to conventional methods in stratifying AML patients with aberrant karyotype and in identifying common aberrant transcriptional programs with potential importance for AML etiology. Moreover, the CvN method uncovered a novel poor-outcome subtype of normal-karyotype AML, which allowed for the generation of a highly prognostic survival signature. Collectively, our CvN method holds great potential as a tool for the analysis of gene expression profiles of cancer patients."	34	"HSC, MPP, CMP, GMP, MEP, Early PM, Late PM, MY, MM, BC, PMN"	Microarray (Affymetrix HG-U133_Plus_2)		Homo sapiens	4.5	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	CMP Lin CD34+ CD38+ CD45RA CD123+  adult	myeloid progenitor	CMP	adult	common myeloid progenitor	Progenitor
GSM1041388;6358	6358	Rapin	GSM1041388	CMP 3	Homo sapiens	CMP	CL:0000049		common myeloid progenitor			Rapin	"Gene expression profiling has been used extensively to characterize cancer, identify novel subtypes, and improve patient stratification. However, it has largely failed to identify transcriptional programs that differ between cancer and corresponding normal cells and has not been efficient in identifying expression changes fundamental to disease etiology. Here we present a method that facilitates the comparison of any cancer sample to its nearest normal cellular counterpart, using acute myeloid leukemia (AML) as a model. We first generated a gene expression-based landscape of the normal hematopoietic hierarchy, using expression profiles from normal stem/progenitor cells, and next mapped the AML patient samples to this landscape. This allowed us to identify the closest normal counterpart of individual AML samples and determine gene expression changes between cancer and normal. We find the cancer vs normal method (CvN method) to be superior to conventional methods in stratifying AML patients with aberrant karyotype and in identifying common aberrant transcriptional programs with potential importance for AML etiology. Moreover, the CvN method uncovered a novel poor-outcome subtype of normal-karyotype AML, which allowed for the generation of a highly prognostic survival signature. Collectively, our CvN method holds great potential as a tool for the analysis of gene expression profiles of cancer patients."	34	"HSC, MPP, CMP, GMP, MEP, Early PM, Late PM, MY, MM, BC, PMN"	Microarray (Affymetrix HG-U133_Plus_2)		Homo sapiens	4.5	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	CMP Lin CD34+ CD38+ CD45RA CD123+  adult	myeloid progenitor	CMP	adult	common myeloid progenitor	Progenitor
GSM1041389;6358	6358	Rapin	GSM1041389	GMP 1	Homo sapiens	GMP	CL:0000557		granulocyte monocyte progenitor			Rapin	"Gene expression profiling has been used extensively to characterize cancer, identify novel subtypes, and improve patient stratification. However, it has largely failed to identify transcriptional programs that differ between cancer and corresponding normal cells and has not been efficient in identifying expression changes fundamental to disease etiology. Here we present a method that facilitates the comparison of any cancer sample to its nearest normal cellular counterpart, using acute myeloid leukemia (AML) as a model. We first generated a gene expression-based landscape of the normal hematopoietic hierarchy, using expression profiles from normal stem/progenitor cells, and next mapped the AML patient samples to this landscape. This allowed us to identify the closest normal counterpart of individual AML samples and determine gene expression changes between cancer and normal. We find the cancer vs normal method (CvN method) to be superior to conventional methods in stratifying AML patients with aberrant karyotype and in identifying common aberrant transcriptional programs with potential importance for AML etiology. Moreover, the CvN method uncovered a novel poor-outcome subtype of normal-karyotype AML, which allowed for the generation of a highly prognostic survival signature. Collectively, our CvN method holds great potential as a tool for the analysis of gene expression profiles of cancer patients."	34	"HSC, MPP, CMP, GMP, MEP, Early PM, Late PM, MY, MM, BC, PMN"	Microarray (Affymetrix HG-U133_Plus_2)		Homo sapiens	4.5	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	GMP Lin CD34+ CD38+ CD45RA+ CD123+  adult	myeloid progenitor	myeloid	adult	granulocyte monocyte progenitor	Progenitor
GSM1041390;6358	6358	Rapin	GSM1041390	GMP 2	Homo sapiens	GMP	CL:0000557		granulocyte monocyte progenitor			Rapin	"Gene expression profiling has been used extensively to characterize cancer, identify novel subtypes, and improve patient stratification. However, it has largely failed to identify transcriptional programs that differ between cancer and corresponding normal cells and has not been efficient in identifying expression changes fundamental to disease etiology. Here we present a method that facilitates the comparison of any cancer sample to its nearest normal cellular counterpart, using acute myeloid leukemia (AML) as a model. We first generated a gene expression-based landscape of the normal hematopoietic hierarchy, using expression profiles from normal stem/progenitor cells, and next mapped the AML patient samples to this landscape. This allowed us to identify the closest normal counterpart of individual AML samples and determine gene expression changes between cancer and normal. We find the cancer vs normal method (CvN method) to be superior to conventional methods in stratifying AML patients with aberrant karyotype and in identifying common aberrant transcriptional programs with potential importance for AML etiology. Moreover, the CvN method uncovered a novel poor-outcome subtype of normal-karyotype AML, which allowed for the generation of a highly prognostic survival signature. Collectively, our CvN method holds great potential as a tool for the analysis of gene expression profiles of cancer patients."	34	"HSC, MPP, CMP, GMP, MEP, Early PM, Late PM, MY, MM, BC, PMN"	Microarray (Affymetrix HG-U133_Plus_2)		Homo sapiens	4.5	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	GMP Lin CD34+ CD38+ CD45RA+ CD123+  adult	myeloid progenitor	myeloid	adult	granulocyte monocyte progenitor	Progenitor
GSM1041391;6358	6358	Rapin	GSM1041391	GMP 3	Homo sapiens	GMP	CL:0000557		granulocyte monocyte progenitor			Rapin	"Gene expression profiling has been used extensively to characterize cancer, identify novel subtypes, and improve patient stratification. However, it has largely failed to identify transcriptional programs that differ between cancer and corresponding normal cells and has not been efficient in identifying expression changes fundamental to disease etiology. Here we present a method that facilitates the comparison of any cancer sample to its nearest normal cellular counterpart, using acute myeloid leukemia (AML) as a model. We first generated a gene expression-based landscape of the normal hematopoietic hierarchy, using expression profiles from normal stem/progenitor cells, and next mapped the AML patient samples to this landscape. This allowed us to identify the closest normal counterpart of individual AML samples and determine gene expression changes between cancer and normal. We find the cancer vs normal method (CvN method) to be superior to conventional methods in stratifying AML patients with aberrant karyotype and in identifying common aberrant transcriptional programs with potential importance for AML etiology. Moreover, the CvN method uncovered a novel poor-outcome subtype of normal-karyotype AML, which allowed for the generation of a highly prognostic survival signature. Collectively, our CvN method holds great potential as a tool for the analysis of gene expression profiles of cancer patients."	34	"HSC, MPP, CMP, GMP, MEP, Early PM, Late PM, MY, MM, BC, PMN"	Microarray (Affymetrix HG-U133_Plus_2)		Homo sapiens	4.5	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	GMP Lin CD34+ CD38+ CD45RA+ CD123+  adult	myeloid progenitor	myeloid	adult	granulocyte monocyte progenitor	Progenitor
GSM1041392;6358	6358	Rapin	GSM1041392	GMP 4	Homo sapiens	GMP	CL:0000557		granulocyte monocyte progenitor			Rapin	"Gene expression profiling has been used extensively to characterize cancer, identify novel subtypes, and improve patient stratification. However, it has largely failed to identify transcriptional programs that differ between cancer and corresponding normal cells and has not been efficient in identifying expression changes fundamental to disease etiology. Here we present a method that facilitates the comparison of any cancer sample to its nearest normal cellular counterpart, using acute myeloid leukemia (AML) as a model. We first generated a gene expression-based landscape of the normal hematopoietic hierarchy, using expression profiles from normal stem/progenitor cells, and next mapped the AML patient samples to this landscape. This allowed us to identify the closest normal counterpart of individual AML samples and determine gene expression changes between cancer and normal. We find the cancer vs normal method (CvN method) to be superior to conventional methods in stratifying AML patients with aberrant karyotype and in identifying common aberrant transcriptional programs with potential importance for AML etiology. Moreover, the CvN method uncovered a novel poor-outcome subtype of normal-karyotype AML, which allowed for the generation of a highly prognostic survival signature. Collectively, our CvN method holds great potential as a tool for the analysis of gene expression profiles of cancer patients."	34	"HSC, MPP, CMP, GMP, MEP, Early PM, Late PM, MY, MM, BC, PMN"	Microarray (Affymetrix HG-U133_Plus_2)		Homo sapiens	4.5	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	GMP Lin CD34+ CD38+ CD45RA+ CD123+  adult	myeloid progenitor	myeloid	adult	granulocyte monocyte progenitor	Progenitor
GSM1041393;6358	6358	Rapin	GSM1041393	GMP 5	Homo sapiens	GMP	CL:0000557		granulocyte monocyte progenitor			Rapin	"Gene expression profiling has been used extensively to characterize cancer, identify novel subtypes, and improve patient stratification. However, it has largely failed to identify transcriptional programs that differ between cancer and corresponding normal cells and has not been efficient in identifying expression changes fundamental to disease etiology. Here we present a method that facilitates the comparison of any cancer sample to its nearest normal cellular counterpart, using acute myeloid leukemia (AML) as a model. We first generated a gene expression-based landscape of the normal hematopoietic hierarchy, using expression profiles from normal stem/progenitor cells, and next mapped the AML patient samples to this landscape. This allowed us to identify the closest normal counterpart of individual AML samples and determine gene expression changes between cancer and normal. We find the cancer vs normal method (CvN method) to be superior to conventional methods in stratifying AML patients with aberrant karyotype and in identifying common aberrant transcriptional programs with potential importance for AML etiology. Moreover, the CvN method uncovered a novel poor-outcome subtype of normal-karyotype AML, which allowed for the generation of a highly prognostic survival signature. Collectively, our CvN method holds great potential as a tool for the analysis of gene expression profiles of cancer patients."	34	"HSC, MPP, CMP, GMP, MEP, Early PM, Late PM, MY, MM, BC, PMN"	Microarray (Affymetrix HG-U133_Plus_2)		Homo sapiens	4.5	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	GMP Lin CD34+ CD38+ CD45RA+ CD123+  adult	myeloid progenitor	myeloid	adult	granulocyte monocyte progenitor	Progenitor
GSM1041396;6358	6358	Rapin	GSM1041396	Early PM 1	Homo sapiens	Early PM	CL:0000836		promyelocyte			Rapin	"Gene expression profiling has been used extensively to characterize cancer, identify novel subtypes, and improve patient stratification. However, it has largely failed to identify transcriptional programs that differ between cancer and corresponding normal cells and has not been efficient in identifying expression changes fundamental to disease etiology. Here we present a method that facilitates the comparison of any cancer sample to its nearest normal cellular counterpart, using acute myeloid leukemia (AML) as a model. We first generated a gene expression-based landscape of the normal hematopoietic hierarchy, using expression profiles from normal stem/progenitor cells, and next mapped the AML patient samples to this landscape. This allowed us to identify the closest normal counterpart of individual AML samples and determine gene expression changes between cancer and normal. We find the cancer vs normal method (CvN method) to be superior to conventional methods in stratifying AML patients with aberrant karyotype and in identifying common aberrant transcriptional programs with potential importance for AML etiology. Moreover, the CvN method uncovered a novel poor-outcome subtype of normal-karyotype AML, which allowed for the generation of a highly prognostic survival signature. Collectively, our CvN method holds great potential as a tool for the analysis of gene expression profiles of cancer patients."	34	"HSC, MPP, CMP, GMP, MEP, Early PM, Late PM, MY, MM, BC, PMN"	Microarray (Affymetrix HG-U133_Plus_2)		Homo sapiens	4.5	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	MP LIN- FSChi SSCint CD34- CD15int CD49dhi CD33hi CD11b- CD16-  adult	myeloid progenitor	MP	adult	promyelocyte	Progenitor
GSM1041397;6358	6358	Rapin	GSM1041397	Early PM 2	Homo sapiens	Early PM	CL:0000836		promyelocyte			Rapin	"Gene expression profiling has been used extensively to characterize cancer, identify novel subtypes, and improve patient stratification. However, it has largely failed to identify transcriptional programs that differ between cancer and corresponding normal cells and has not been efficient in identifying expression changes fundamental to disease etiology. Here we present a method that facilitates the comparison of any cancer sample to its nearest normal cellular counterpart, using acute myeloid leukemia (AML) as a model. We first generated a gene expression-based landscape of the normal hematopoietic hierarchy, using expression profiles from normal stem/progenitor cells, and next mapped the AML patient samples to this landscape. This allowed us to identify the closest normal counterpart of individual AML samples and determine gene expression changes between cancer and normal. We find the cancer vs normal method (CvN method) to be superior to conventional methods in stratifying AML patients with aberrant karyotype and in identifying common aberrant transcriptional programs with potential importance for AML etiology. Moreover, the CvN method uncovered a novel poor-outcome subtype of normal-karyotype AML, which allowed for the generation of a highly prognostic survival signature. Collectively, our CvN method holds great potential as a tool for the analysis of gene expression profiles of cancer patients."	34	"HSC, MPP, CMP, GMP, MEP, Early PM, Late PM, MY, MM, BC, PMN"	Microarray (Affymetrix HG-U133_Plus_2)		Homo sapiens	4.5	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	MP LIN- FSChi SSCint CD34- CD15int CD49dhi CD33hi CD11b- CD16-  adult	myeloid progenitor	MP	adult	promyelocyte	Progenitor
GSM1041398;6358	6358	Rapin	GSM1041398	Early PM 3	Homo sapiens	Early PM	CL:0000836		promyelocyte			Rapin	"Gene expression profiling has been used extensively to characterize cancer, identify novel subtypes, and improve patient stratification. However, it has largely failed to identify transcriptional programs that differ between cancer and corresponding normal cells and has not been efficient in identifying expression changes fundamental to disease etiology. Here we present a method that facilitates the comparison of any cancer sample to its nearest normal cellular counterpart, using acute myeloid leukemia (AML) as a model. We first generated a gene expression-based landscape of the normal hematopoietic hierarchy, using expression profiles from normal stem/progenitor cells, and next mapped the AML patient samples to this landscape. This allowed us to identify the closest normal counterpart of individual AML samples and determine gene expression changes between cancer and normal. We find the cancer vs normal method (CvN method) to be superior to conventional methods in stratifying AML patients with aberrant karyotype and in identifying common aberrant transcriptional programs with potential importance for AML etiology. Moreover, the CvN method uncovered a novel poor-outcome subtype of normal-karyotype AML, which allowed for the generation of a highly prognostic survival signature. Collectively, our CvN method holds great potential as a tool for the analysis of gene expression profiles of cancer patients."	34	"HSC, MPP, CMP, GMP, MEP, Early PM, Late PM, MY, MM, BC, PMN"	Microarray (Affymetrix HG-U133_Plus_2)		Homo sapiens	4.5	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	MP LIN- FSChi SSCint CD34- CD15int CD49dhi CD33hi CD11b- CD16-  adult	myeloid progenitor	MP	adult	promyelocyte	Progenitor
GSM1041399;6358	6358	Rapin	GSM1041399	Late PM 1	Homo sapiens	Late PM	CL:0000836		promyelocyte			Rapin	"Gene expression profiling has been used extensively to characterize cancer, identify novel subtypes, and improve patient stratification. However, it has largely failed to identify transcriptional programs that differ between cancer and corresponding normal cells and has not been efficient in identifying expression changes fundamental to disease etiology. Here we present a method that facilitates the comparison of any cancer sample to its nearest normal cellular counterpart, using acute myeloid leukemia (AML) as a model. We first generated a gene expression-based landscape of the normal hematopoietic hierarchy, using expression profiles from normal stem/progenitor cells, and next mapped the AML patient samples to this landscape. This allowed us to identify the closest normal counterpart of individual AML samples and determine gene expression changes between cancer and normal. We find the cancer vs normal method (CvN method) to be superior to conventional methods in stratifying AML patients with aberrant karyotype and in identifying common aberrant transcriptional programs with potential importance for AML etiology. Moreover, the CvN method uncovered a novel poor-outcome subtype of normal-karyotype AML, which allowed for the generation of a highly prognostic survival signature. Collectively, our CvN method holds great potential as a tool for the analysis of gene expression profiles of cancer patients."	34	"HSC, MPP, CMP, GMP, MEP, Early PM, Late PM, MY, MM, BC, PMN"	Microarray (Affymetrix HG-U133_Plus_2)		Homo sapiens	4.5	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	MP LIN- FSChi SSChi CD34- CD15hi CD49dhi CD33hi CD11b- CD16-  adult	myeloid progenitor	MP	adult	promyelocyte	Progenitor
GSM1041400;6358	6358	Rapin	GSM1041400	Late PM 2	Homo sapiens	Late PM	CL:0000836		promyelocyte			Rapin	"Gene expression profiling has been used extensively to characterize cancer, identify novel subtypes, and improve patient stratification. However, it has largely failed to identify transcriptional programs that differ between cancer and corresponding normal cells and has not been efficient in identifying expression changes fundamental to disease etiology. Here we present a method that facilitates the comparison of any cancer sample to its nearest normal cellular counterpart, using acute myeloid leukemia (AML) as a model. We first generated a gene expression-based landscape of the normal hematopoietic hierarchy, using expression profiles from normal stem/progenitor cells, and next mapped the AML patient samples to this landscape. This allowed us to identify the closest normal counterpart of individual AML samples and determine gene expression changes between cancer and normal. We find the cancer vs normal method (CvN method) to be superior to conventional methods in stratifying AML patients with aberrant karyotype and in identifying common aberrant transcriptional programs with potential importance for AML etiology. Moreover, the CvN method uncovered a novel poor-outcome subtype of normal-karyotype AML, which allowed for the generation of a highly prognostic survival signature. Collectively, our CvN method holds great potential as a tool for the analysis of gene expression profiles of cancer patients."	34	"HSC, MPP, CMP, GMP, MEP, Early PM, Late PM, MY, MM, BC, PMN"	Microarray (Affymetrix HG-U133_Plus_2)		Homo sapiens	4.5	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	MP LIN- FSChi SSChi CD34- CD15hi CD49dhi CD33hi CD11b- CD16-  adult	myeloid progenitor	MP	adult	promyelocyte	Progenitor
GSM1041401;6358	6358	Rapin	GSM1041401	Late PM 3	Homo sapiens	Late PM	CL:0000836		promyelocyte			Rapin	"Gene expression profiling has been used extensively to characterize cancer, identify novel subtypes, and improve patient stratification. However, it has largely failed to identify transcriptional programs that differ between cancer and corresponding normal cells and has not been efficient in identifying expression changes fundamental to disease etiology. Here we present a method that facilitates the comparison of any cancer sample to its nearest normal cellular counterpart, using acute myeloid leukemia (AML) as a model. We first generated a gene expression-based landscape of the normal hematopoietic hierarchy, using expression profiles from normal stem/progenitor cells, and next mapped the AML patient samples to this landscape. This allowed us to identify the closest normal counterpart of individual AML samples and determine gene expression changes between cancer and normal. We find the cancer vs normal method (CvN method) to be superior to conventional methods in stratifying AML patients with aberrant karyotype and in identifying common aberrant transcriptional programs with potential importance for AML etiology. Moreover, the CvN method uncovered a novel poor-outcome subtype of normal-karyotype AML, which allowed for the generation of a highly prognostic survival signature. Collectively, our CvN method holds great potential as a tool for the analysis of gene expression profiles of cancer patients."	34	"HSC, MPP, CMP, GMP, MEP, Early PM, Late PM, MY, MM, BC, PMN"	Microarray (Affymetrix HG-U133_Plus_2)		Homo sapiens	4.5	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	MP LIN- FSChi SSChi CD34- CD15hi CD49dhi CD33hi CD11b- CD16-  adult	myeloid progenitor	MP	adult	promyelocyte	Mixed
GSM1041402;6358	6358	Rapin	GSM1041402	MY 1	Homo sapiens	MY	CL:0002193		myelocyte			Rapin	"Gene expression profiling has been used extensively to characterize cancer, identify novel subtypes, and improve patient stratification. However, it has largely failed to identify transcriptional programs that differ between cancer and corresponding normal cells and has not been efficient in identifying expression changes fundamental to disease etiology. Here we present a method that facilitates the comparison of any cancer sample to its nearest normal cellular counterpart, using acute myeloid leukemia (AML) as a model. We first generated a gene expression-based landscape of the normal hematopoietic hierarchy, using expression profiles from normal stem/progenitor cells, and next mapped the AML patient samples to this landscape. This allowed us to identify the closest normal counterpart of individual AML samples and determine gene expression changes between cancer and normal. We find the cancer vs normal method (CvN method) to be superior to conventional methods in stratifying AML patients with aberrant karyotype and in identifying common aberrant transcriptional programs with potential importance for AML etiology. Moreover, the CvN method uncovered a novel poor-outcome subtype of normal-karyotype AML, which allowed for the generation of a highly prognostic survival signature. Collectively, our CvN method holds great potential as a tool for the analysis of gene expression profiles of cancer patients."	34	"HSC, MPP, CMP, GMP, MEP, Early PM, Late PM, MY, MM, BC, PMN"	Microarray (Affymetrix HG-U133_Plus_2)		Homo sapiens	4.5	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	MY LIN- FSChi SSChi CD34- CD15hi CD49d+ CD33+ CD11bhi CD16-  adult	myeloid progenitor	MY	adult	myelocyte	Mixed
GSM1041403;6358	6358	Rapin	GSM1041403	MY 2	Homo sapiens	MY	CL:0002193		myelocyte			Rapin	"Gene expression profiling has been used extensively to characterize cancer, identify novel subtypes, and improve patient stratification. However, it has largely failed to identify transcriptional programs that differ between cancer and corresponding normal cells and has not been efficient in identifying expression changes fundamental to disease etiology. Here we present a method that facilitates the comparison of any cancer sample to its nearest normal cellular counterpart, using acute myeloid leukemia (AML) as a model. We first generated a gene expression-based landscape of the normal hematopoietic hierarchy, using expression profiles from normal stem/progenitor cells, and next mapped the AML patient samples to this landscape. This allowed us to identify the closest normal counterpart of individual AML samples and determine gene expression changes between cancer and normal. We find the cancer vs normal method (CvN method) to be superior to conventional methods in stratifying AML patients with aberrant karyotype and in identifying common aberrant transcriptional programs with potential importance for AML etiology. Moreover, the CvN method uncovered a novel poor-outcome subtype of normal-karyotype AML, which allowed for the generation of a highly prognostic survival signature. Collectively, our CvN method holds great potential as a tool for the analysis of gene expression profiles of cancer patients."	34	"HSC, MPP, CMP, GMP, MEP, Early PM, Late PM, MY, MM, BC, PMN"	Microarray (Affymetrix HG-U133_Plus_2)		Homo sapiens	4.5	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	MY LIN- FSChi SSChi CD34- CD15hi CD49d+ CD33+ CD11bhi CD16-  adult	myeloid progenitor	MY	adult	myelocyte	Mixed
GSM1041404;6358	6358	Rapin	GSM1041404	MM 1	Homo sapiens	MM	CL:0002192		metamyelocyte			Rapin	"Gene expression profiling has been used extensively to characterize cancer, identify novel subtypes, and improve patient stratification. However, it has largely failed to identify transcriptional programs that differ between cancer and corresponding normal cells and has not been efficient in identifying expression changes fundamental to disease etiology. Here we present a method that facilitates the comparison of any cancer sample to its nearest normal cellular counterpart, using acute myeloid leukemia (AML) as a model. We first generated a gene expression-based landscape of the normal hematopoietic hierarchy, using expression profiles from normal stem/progenitor cells, and next mapped the AML patient samples to this landscape. This allowed us to identify the closest normal counterpart of individual AML samples and determine gene expression changes between cancer and normal. We find the cancer vs normal method (CvN method) to be superior to conventional methods in stratifying AML patients with aberrant karyotype and in identifying common aberrant transcriptional programs with potential importance for AML etiology. Moreover, the CvN method uncovered a novel poor-outcome subtype of normal-karyotype AML, which allowed for the generation of a highly prognostic survival signature. Collectively, our CvN method holds great potential as a tool for the analysis of gene expression profiles of cancer patients."	34	"HSC, MPP, CMP, GMP, MEP, Early PM, Late PM, MY, MM, BC, PMN"	Microarray (Affymetrix HG-U133_Plus_2)		Homo sapiens	4.5	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	MM LIN- FSChi SSChi CD34- CD15hi CD49d- CD33- CD11bhi CD16-  adult	myeloid progenitor	MM	adult	metamyelocyte	Mixed
GSM1041405;6358	6358	Rapin	GSM1041405	MM 2	Homo sapiens	MM	CL:0002192		metamyelocyte			Rapin	"Gene expression profiling has been used extensively to characterize cancer, identify novel subtypes, and improve patient stratification. However, it has largely failed to identify transcriptional programs that differ between cancer and corresponding normal cells and has not been efficient in identifying expression changes fundamental to disease etiology. Here we present a method that facilitates the comparison of any cancer sample to its nearest normal cellular counterpart, using acute myeloid leukemia (AML) as a model. We first generated a gene expression-based landscape of the normal hematopoietic hierarchy, using expression profiles from normal stem/progenitor cells, and next mapped the AML patient samples to this landscape. This allowed us to identify the closest normal counterpart of individual AML samples and determine gene expression changes between cancer and normal. We find the cancer vs normal method (CvN method) to be superior to conventional methods in stratifying AML patients with aberrant karyotype and in identifying common aberrant transcriptional programs with potential importance for AML etiology. Moreover, the CvN method uncovered a novel poor-outcome subtype of normal-karyotype AML, which allowed for the generation of a highly prognostic survival signature. Collectively, our CvN method holds great potential as a tool for the analysis of gene expression profiles of cancer patients."	34	"HSC, MPP, CMP, GMP, MEP, Early PM, Late PM, MY, MM, BC, PMN"	Microarray (Affymetrix HG-U133_Plus_2)		Homo sapiens	4.5	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	MM LIN- FSChi SSChi CD34- CD15hi CD49d- CD33- CD11bhi CD16-  adult	myeloid progenitor	MM	adult	metamyelocyte	Mixed
GSM1041406;6358	6358	Rapin	GSM1041406	MM 3	Homo sapiens	MM	CL:0002192		metamyelocyte			Rapin	"Gene expression profiling has been used extensively to characterize cancer, identify novel subtypes, and improve patient stratification. However, it has largely failed to identify transcriptional programs that differ between cancer and corresponding normal cells and has not been efficient in identifying expression changes fundamental to disease etiology. Here we present a method that facilitates the comparison of any cancer sample to its nearest normal cellular counterpart, using acute myeloid leukemia (AML) as a model. We first generated a gene expression-based landscape of the normal hematopoietic hierarchy, using expression profiles from normal stem/progenitor cells, and next mapped the AML patient samples to this landscape. This allowed us to identify the closest normal counterpart of individual AML samples and determine gene expression changes between cancer and normal. We find the cancer vs normal method (CvN method) to be superior to conventional methods in stratifying AML patients with aberrant karyotype and in identifying common aberrant transcriptional programs with potential importance for AML etiology. Moreover, the CvN method uncovered a novel poor-outcome subtype of normal-karyotype AML, which allowed for the generation of a highly prognostic survival signature. Collectively, our CvN method holds great potential as a tool for the analysis of gene expression profiles of cancer patients."	34	"HSC, MPP, CMP, GMP, MEP, Early PM, Late PM, MY, MM, BC, PMN"	Microarray (Affymetrix HG-U133_Plus_2)		Homo sapiens	4.5	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	MM LIN- FSChi SSChi CD34- CD15hi CD49d- CD33- CD11bhi CD16-  adult	myeloid progenitor	MM	adult	metamyelocyte	Mixed
GSM1041407;6358	6358	Rapin	GSM1041407	BC 1	Homo sapiens	BC	CL:0000775		neutrophil			Rapin	"Gene expression profiling has been used extensively to characterize cancer, identify novel subtypes, and improve patient stratification. However, it has largely failed to identify transcriptional programs that differ between cancer and corresponding normal cells and has not been efficient in identifying expression changes fundamental to disease etiology. Here we present a method that facilitates the comparison of any cancer sample to its nearest normal cellular counterpart, using acute myeloid leukemia (AML) as a model. We first generated a gene expression-based landscape of the normal hematopoietic hierarchy, using expression profiles from normal stem/progenitor cells, and next mapped the AML patient samples to this landscape. This allowed us to identify the closest normal counterpart of individual AML samples and determine gene expression changes between cancer and normal. We find the cancer vs normal method (CvN method) to be superior to conventional methods in stratifying AML patients with aberrant karyotype and in identifying common aberrant transcriptional programs with potential importance for AML etiology. Moreover, the CvN method uncovered a novel poor-outcome subtype of normal-karyotype AML, which allowed for the generation of a highly prognostic survival signature. Collectively, our CvN method holds great potential as a tool for the analysis of gene expression profiles of cancer patients."	34	"HSC, MPP, CMP, GMP, MEP, Early PM, Late PM, MY, MM, BC, PMN"	Microarray (Affymetrix HG-U133_Plus_2)		Homo sapiens	4.5	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	band neutrophil  adult	myeloid	myeloid	adult	neutrophil	Circulating Monocyte & Granulocyte
GSM1041408;6358	6358	Rapin	GSM1041408	BC 2	Homo sapiens	BC	CL:0000775		neutrophil			Rapin	"Gene expression profiling has been used extensively to characterize cancer, identify novel subtypes, and improve patient stratification. However, it has largely failed to identify transcriptional programs that differ between cancer and corresponding normal cells and has not been efficient in identifying expression changes fundamental to disease etiology. Here we present a method that facilitates the comparison of any cancer sample to its nearest normal cellular counterpart, using acute myeloid leukemia (AML) as a model. We first generated a gene expression-based landscape of the normal hematopoietic hierarchy, using expression profiles from normal stem/progenitor cells, and next mapped the AML patient samples to this landscape. This allowed us to identify the closest normal counterpart of individual AML samples and determine gene expression changes between cancer and normal. We find the cancer vs normal method (CvN method) to be superior to conventional methods in stratifying AML patients with aberrant karyotype and in identifying common aberrant transcriptional programs with potential importance for AML etiology. Moreover, the CvN method uncovered a novel poor-outcome subtype of normal-karyotype AML, which allowed for the generation of a highly prognostic survival signature. Collectively, our CvN method holds great potential as a tool for the analysis of gene expression profiles of cancer patients."	34	"HSC, MPP, CMP, GMP, MEP, Early PM, Late PM, MY, MM, BC, PMN"	Microarray (Affymetrix HG-U133_Plus_2)		Homo sapiens	4.5	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	band neutrophil  adult	myeloid	myeloid	adult	neutrophil	Circulating Monocyte & Granulocyte
GSM1041409;6358	6358	Rapin	GSM1041409	BC 3	Homo sapiens	BC	CL:0000775		neutrophil			Rapin	"Gene expression profiling has been used extensively to characterize cancer, identify novel subtypes, and improve patient stratification. However, it has largely failed to identify transcriptional programs that differ between cancer and corresponding normal cells and has not been efficient in identifying expression changes fundamental to disease etiology. Here we present a method that facilitates the comparison of any cancer sample to its nearest normal cellular counterpart, using acute myeloid leukemia (AML) as a model. We first generated a gene expression-based landscape of the normal hematopoietic hierarchy, using expression profiles from normal stem/progenitor cells, and next mapped the AML patient samples to this landscape. This allowed us to identify the closest normal counterpart of individual AML samples and determine gene expression changes between cancer and normal. We find the cancer vs normal method (CvN method) to be superior to conventional methods in stratifying AML patients with aberrant karyotype and in identifying common aberrant transcriptional programs with potential importance for AML etiology. Moreover, the CvN method uncovered a novel poor-outcome subtype of normal-karyotype AML, which allowed for the generation of a highly prognostic survival signature. Collectively, our CvN method holds great potential as a tool for the analysis of gene expression profiles of cancer patients."	34	"HSC, MPP, CMP, GMP, MEP, Early PM, Late PM, MY, MM, BC, PMN"	Microarray (Affymetrix HG-U133_Plus_2)		Homo sapiens	4.5	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	band neutrophil  adult	myeloid	myeloid	adult	neutrophil	Circulating Monocyte & Granulocyte
GSM1041410;6358	6358	Rapin	GSM1041410	BC 4	Homo sapiens	BC	CL:0000775		neutrophil			Rapin	"Gene expression profiling has been used extensively to characterize cancer, identify novel subtypes, and improve patient stratification. However, it has largely failed to identify transcriptional programs that differ between cancer and corresponding normal cells and has not been efficient in identifying expression changes fundamental to disease etiology. Here we present a method that facilitates the comparison of any cancer sample to its nearest normal cellular counterpart, using acute myeloid leukemia (AML) as a model. We first generated a gene expression-based landscape of the normal hematopoietic hierarchy, using expression profiles from normal stem/progenitor cells, and next mapped the AML patient samples to this landscape. This allowed us to identify the closest normal counterpart of individual AML samples and determine gene expression changes between cancer and normal. We find the cancer vs normal method (CvN method) to be superior to conventional methods in stratifying AML patients with aberrant karyotype and in identifying common aberrant transcriptional programs with potential importance for AML etiology. Moreover, the CvN method uncovered a novel poor-outcome subtype of normal-karyotype AML, which allowed for the generation of a highly prognostic survival signature. Collectively, our CvN method holds great potential as a tool for the analysis of gene expression profiles of cancer patients."	34	"HSC, MPP, CMP, GMP, MEP, Early PM, Late PM, MY, MM, BC, PMN"	Microarray (Affymetrix HG-U133_Plus_2)		Homo sapiens	4.5	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	band neutrophil  adult	myeloid	myeloid	adult	neutrophil	Circulating Monocyte & Granulocyte
GSM1068613;6774	6774	Teles	GSM1068613	A6_media	Homo sapiens	monocyte	CL:0000576	monocyte	peripheral blood mononuclear cell			Teles	"Type I interferons (IFN- and IFN-) are important for protection against many viral infections, whereas type II interferon (IFN-) is essential for host defense against some bacterial and parasitic pathogens. Study of IFN responses in human leprosy revealed an inverse correlation between IFN- and IFN- gene expression programs. IFN- and its downstream vitamin D-dependent antimicrobial genes were preferentially expressed in self-healing tuberculoid lesions and mediated antimicrobial activity against the pathogen Mycobacterium leprae in vitro. In contrast, IFN- and its downstream genes, including interleukin-10 (IL-10), were induced in monocytes by M. leprae in vitro and preferentially expressed in disseminated and progressive lepromatous lesions. The IFN--induced macrophage vitamin D-dependent antimicrobial peptide response was inhibited by IFN- and by IL-10, suggesting that the differential production of IFNs contributes to protection versus pathogenesis in some human bacterial infections. Abstract fromScience. 2013 Mar 22;339(6126):1448-53. [Curator's note: Samples shown are monocytes isolated from stimulated PBMC only.]"	8	"monocyte, monocyte + IL10"	Microarray (Affymetrix HG-U133_Plus_2 (GPL570 and A-AFFY-44))		Homo sapiens	3.2	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	Monocyte CD14+ 24h media adult	myeloid	myeloid	adult	monocyte	Macrophage
GSM1068614;6774	6774	Teles	GSM1068614	A7_IL-10	Homo sapiens	monocyte + IL10	CL:0000576	monocyte	peripheral blood mononuclear cell			Teles	"Type I interferons (IFN- and IFN-) are important for protection against many viral infections, whereas type II interferon (IFN-) is essential for host defense against some bacterial and parasitic pathogens. Study of IFN responses in human leprosy revealed an inverse correlation between IFN- and IFN- gene expression programs. IFN- and its downstream vitamin D-dependent antimicrobial genes were preferentially expressed in self-healing tuberculoid lesions and mediated antimicrobial activity against the pathogen Mycobacterium leprae in vitro. In contrast, IFN- and its downstream genes, including interleukin-10 (IL-10), were induced in monocytes by M. leprae in vitro and preferentially expressed in disseminated and progressive lepromatous lesions. The IFN--induced macrophage vitamin D-dependent antimicrobial peptide response was inhibited by IFN- and by IL-10, suggesting that the differential production of IFNs contributes to protection versus pathogenesis in some human bacterial infections. Abstract fromScience. 2013 Mar 22;339(6126):1448-53. [Curator's note: Samples shown are monocytes isolated from stimulated PBMC only.]"	8	"monocyte, monocyte + IL10"	Microarray (Affymetrix HG-U133_Plus_2 (GPL570 and A-AFFY-44))		Homo sapiens	3.2	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	Monocyte CD14+ IL-10 24h adult	myeloid	myeloid	adult	monocyte	Macrophage
GSM1068615;6774	6774	Teles	GSM1068615	B6_media	Homo sapiens	monocyte	CL:0000576	monocyte	peripheral blood mononuclear cell			Teles	"Type I interferons (IFN- and IFN-) are important for protection against many viral infections, whereas type II interferon (IFN-) is essential for host defense against some bacterial and parasitic pathogens. Study of IFN responses in human leprosy revealed an inverse correlation between IFN- and IFN- gene expression programs. IFN- and its downstream vitamin D-dependent antimicrobial genes were preferentially expressed in self-healing tuberculoid lesions and mediated antimicrobial activity against the pathogen Mycobacterium leprae in vitro. In contrast, IFN- and its downstream genes, including interleukin-10 (IL-10), were induced in monocytes by M. leprae in vitro and preferentially expressed in disseminated and progressive lepromatous lesions. The IFN--induced macrophage vitamin D-dependent antimicrobial peptide response was inhibited by IFN- and by IL-10, suggesting that the differential production of IFNs contributes to protection versus pathogenesis in some human bacterial infections. Abstract fromScience. 2013 Mar 22;339(6126):1448-53. [Curator's note: Samples shown are monocytes isolated from stimulated PBMC only.]"	8	"monocyte, monocyte + IL10"	Microarray (Affymetrix HG-U133_Plus_2 (GPL570 and A-AFFY-44))		Homo sapiens	3.2	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	Monocyte CD14+ 24h media adult	myeloid	myeloid	adult	monocyte	Macrophage
GSM1068616;6774	6774	Teles	GSM1068616	B7_IL-10	Homo sapiens	monocyte + IL10	CL:0000576	monocyte	peripheral blood mononuclear cell			Teles	"Type I interferons (IFN- and IFN-) are important for protection against many viral infections, whereas type II interferon (IFN-) is essential for host defense against some bacterial and parasitic pathogens. Study of IFN responses in human leprosy revealed an inverse correlation between IFN- and IFN- gene expression programs. IFN- and its downstream vitamin D-dependent antimicrobial genes were preferentially expressed in self-healing tuberculoid lesions and mediated antimicrobial activity against the pathogen Mycobacterium leprae in vitro. In contrast, IFN- and its downstream genes, including interleukin-10 (IL-10), were induced in monocytes by M. leprae in vitro and preferentially expressed in disseminated and progressive lepromatous lesions. The IFN--induced macrophage vitamin D-dependent antimicrobial peptide response was inhibited by IFN- and by IL-10, suggesting that the differential production of IFNs contributes to protection versus pathogenesis in some human bacterial infections. Abstract fromScience. 2013 Mar 22;339(6126):1448-53. [Curator's note: Samples shown are monocytes isolated from stimulated PBMC only.]"	8	"monocyte, monocyte + IL10"	Microarray (Affymetrix HG-U133_Plus_2 (GPL570 and A-AFFY-44))		Homo sapiens	3.2	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	Monocyte CD14+ IL-10 24h adult	myeloid	myeloid	adult	monocyte	Macrophage
GSM1068617;6774	6774	Teles	GSM1068617	C6_media	Homo sapiens	monocyte	CL:0000576	monocyte	peripheral blood mononuclear cell			Teles	"Type I interferons (IFN- and IFN-) are important for protection against many viral infections, whereas type II interferon (IFN-) is essential for host defense against some bacterial and parasitic pathogens. Study of IFN responses in human leprosy revealed an inverse correlation between IFN- and IFN- gene expression programs. IFN- and its downstream vitamin D-dependent antimicrobial genes were preferentially expressed in self-healing tuberculoid lesions and mediated antimicrobial activity against the pathogen Mycobacterium leprae in vitro. In contrast, IFN- and its downstream genes, including interleukin-10 (IL-10), were induced in monocytes by M. leprae in vitro and preferentially expressed in disseminated and progressive lepromatous lesions. The IFN--induced macrophage vitamin D-dependent antimicrobial peptide response was inhibited by IFN- and by IL-10, suggesting that the differential production of IFNs contributes to protection versus pathogenesis in some human bacterial infections. Abstract fromScience. 2013 Mar 22;339(6126):1448-53. [Curator's note: Samples shown are monocytes isolated from stimulated PBMC only.]"	8	"monocyte, monocyte + IL10"	Microarray (Affymetrix HG-U133_Plus_2 (GPL570 and A-AFFY-44))		Homo sapiens	3.2	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	Monocyte CD14+ 24h media adult	myeloid	myeloid	adult	monocyte	Macrophage
GSM1068618;6774	6774	Teles	GSM1068618	C7_IL-10	Homo sapiens	monocyte + IL10	CL:0000576	monocyte	peripheral blood mononuclear cell			Teles	"Type I interferons (IFN- and IFN-) are important for protection against many viral infections, whereas type II interferon (IFN-) is essential for host defense against some bacterial and parasitic pathogens. Study of IFN responses in human leprosy revealed an inverse correlation between IFN- and IFN- gene expression programs. IFN- and its downstream vitamin D-dependent antimicrobial genes were preferentially expressed in self-healing tuberculoid lesions and mediated antimicrobial activity against the pathogen Mycobacterium leprae in vitro. In contrast, IFN- and its downstream genes, including interleukin-10 (IL-10), were induced in monocytes by M. leprae in vitro and preferentially expressed in disseminated and progressive lepromatous lesions. The IFN--induced macrophage vitamin D-dependent antimicrobial peptide response was inhibited by IFN- and by IL-10, suggesting that the differential production of IFNs contributes to protection versus pathogenesis in some human bacterial infections. Abstract fromScience. 2013 Mar 22;339(6126):1448-53. [Curator's note: Samples shown are monocytes isolated from stimulated PBMC only.]"	8	"monocyte, monocyte + IL10"	Microarray (Affymetrix HG-U133_Plus_2 (GPL570 and A-AFFY-44))		Homo sapiens	3.2	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	Monocyte CD14+ IL-10 24h adult	myeloid	myeloid	adult	monocyte	Macrophage
GSM1068619;6774	6774	Teles	GSM1068619	D6_media	Homo sapiens	monocyte	CL:0000576	monocyte	peripheral blood mononuclear cell			Teles	"Type I interferons (IFN- and IFN-) are important for protection against many viral infections, whereas type II interferon (IFN-) is essential for host defense against some bacterial and parasitic pathogens. Study of IFN responses in human leprosy revealed an inverse correlation between IFN- and IFN- gene expression programs. IFN- and its downstream vitamin D-dependent antimicrobial genes were preferentially expressed in self-healing tuberculoid lesions and mediated antimicrobial activity against the pathogen Mycobacterium leprae in vitro. In contrast, IFN- and its downstream genes, including interleukin-10 (IL-10), were induced in monocytes by M. leprae in vitro and preferentially expressed in disseminated and progressive lepromatous lesions. The IFN--induced macrophage vitamin D-dependent antimicrobial peptide response was inhibited by IFN- and by IL-10, suggesting that the differential production of IFNs contributes to protection versus pathogenesis in some human bacterial infections. Abstract fromScience. 2013 Mar 22;339(6126):1448-53. [Curator's note: Samples shown are monocytes isolated from stimulated PBMC only.]"	8	"monocyte, monocyte + IL10"	Microarray (Affymetrix HG-U133_Plus_2 (GPL570 and A-AFFY-44))		Homo sapiens	3.2	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	Monocyte CD14+ 24h media adult	myeloid	myeloid	adult	monocyte	Macrophage
GSM1068620;6774	6774	Teles	GSM1068620	D7_IL-10	Homo sapiens	monocyte + IL10	CL:0000576	monocyte	peripheral blood mononuclear cell			Teles	"Type I interferons (IFN- and IFN-) are important for protection against many viral infections, whereas type II interferon (IFN-) is essential for host defense against some bacterial and parasitic pathogens. Study of IFN responses in human leprosy revealed an inverse correlation between IFN- and IFN- gene expression programs. IFN- and its downstream vitamin D-dependent antimicrobial genes were preferentially expressed in self-healing tuberculoid lesions and mediated antimicrobial activity against the pathogen Mycobacterium leprae in vitro. In contrast, IFN- and its downstream genes, including interleukin-10 (IL-10), were induced in monocytes by M. leprae in vitro and preferentially expressed in disseminated and progressive lepromatous lesions. The IFN--induced macrophage vitamin D-dependent antimicrobial peptide response was inhibited by IFN- and by IL-10, suggesting that the differential production of IFNs contributes to protection versus pathogenesis in some human bacterial infections. Abstract fromScience. 2013 Mar 22;339(6126):1448-53. [Curator's note: Samples shown are monocytes isolated from stimulated PBMC only.]"	8	"monocyte, monocyte + IL10"	Microarray (Affymetrix HG-U133_Plus_2 (GPL570 and A-AFFY-44))		Homo sapiens	3.2	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	Monocyte CD14+ IL-10 24h adult	myeloid	myeloid	adult	monocyte	Macrophage
GSM1162510;6326	6326	Cramer-Morales	GSM1162510	"HSC normal, replicate 1"	Homo sapiens	HSC	CL:0000837		hematopoietic multipotent progenitor			Cramer-Morales	"Homologous recombination repair (HRR) protects cells from the lethal effect of spontaneous and therapy-induced DNA double-stand breaks. HRR usually depends on BRCA1/2-RAD51, and RAD52-RAD51 serves as back-up. To target HRR in tumor cells, a phenomenon called ""synthetic lethality"" was applied, which relies on the addiction of cancer cells to a single DNA repair pathway, whereas normal cells operate 2 or more mechanisms. Using mutagenesis and a peptide aptamer approach, we pinpointed phenylalanine 79 in RAD52 DNA binding domain I (RAD52-phenylalanine 79 [F79]) as a valid target to induce synthetic lethality in BRCA1- and/or BRCA2-deficient leukemias and carcinomas without affecting normal cells and tissues. Targeting RAD52-F79 disrupts the RAD52-DNA interaction, resulting in the accumulation of toxic DNA double-stand breaks in malignant cells, but not in normal counterparts. In addition, abrogation of RAD52-DNA interaction enhanced the antileukemia effect of already-approved drugs. BRCA-deficient status predisposing to RAD52-dependent synthetic lethality could be predicted by genetic abnormalities such as oncogenes BCR-ABL1 and PML-RAR, mutations in BRCA1 and/or BRCA2 genes, and gene expression profiles identifying leukemias displaying low levels of BRCA1 and/or BRCA2. We believe this work may initiate a personalized therapeutic approach in numerous patients with tumors displaying encoded and functional BRCA deficiency."	67	"HSC, AP-CML HSC, BC-CML HSC, CP-CML HSC, MPP, AP-CML MPP, BC-CML MPP, CMP, AP-CML CMP, BC-CML CMP, CP-CML CMP, GMP, AP-CML GMP, BC-CML GMP, CP-CML GMP, MEP, AP-CML MEP, BC-CML MEP, CP-CML MEP"	Microarray (Affymetrix HuGene-1_0-ST V1)	leukomics	Homo sapiens	4.71	HuGene	"rgb(0,109,219)"	diamond-open	MHP CD34+ 38- lin- CD45RA- CD90+ G-CSF treated donor adult	hematopoietic multipotent progenitor	MHP	adult	hematopoietic multipotent progenitor	Progenitor
GSM1162511;6326	6326	Cramer-Morales	GSM1162511	"MPP normal, replicate 1"	Homo sapiens	MPP	CL:0000837		hematopoietic multipotent progenitor			Cramer-Morales	"Homologous recombination repair (HRR) protects cells from the lethal effect of spontaneous and therapy-induced DNA double-stand breaks. HRR usually depends on BRCA1/2-RAD51, and RAD52-RAD51 serves as back-up. To target HRR in tumor cells, a phenomenon called ""synthetic lethality"" was applied, which relies on the addiction of cancer cells to a single DNA repair pathway, whereas normal cells operate 2 or more mechanisms. Using mutagenesis and a peptide aptamer approach, we pinpointed phenylalanine 79 in RAD52 DNA binding domain I (RAD52-phenylalanine 79 [F79]) as a valid target to induce synthetic lethality in BRCA1- and/or BRCA2-deficient leukemias and carcinomas without affecting normal cells and tissues. Targeting RAD52-F79 disrupts the RAD52-DNA interaction, resulting in the accumulation of toxic DNA double-stand breaks in malignant cells, but not in normal counterparts. In addition, abrogation of RAD52-DNA interaction enhanced the antileukemia effect of already-approved drugs. BRCA-deficient status predisposing to RAD52-dependent synthetic lethality could be predicted by genetic abnormalities such as oncogenes BCR-ABL1 and PML-RAR, mutations in BRCA1 and/or BRCA2 genes, and gene expression profiles identifying leukemias displaying low levels of BRCA1 and/or BRCA2. We believe this work may initiate a personalized therapeutic approach in numerous patients with tumors displaying encoded and functional BRCA deficiency."	67	"HSC, AP-CML HSC, BC-CML HSC, CP-CML HSC, MPP, AP-CML MPP, BC-CML MPP, CMP, AP-CML CMP, BC-CML CMP, CP-CML CMP, GMP, AP-CML GMP, BC-CML GMP, CP-CML GMP, MEP, AP-CML MEP, BC-CML MEP, CP-CML MEP"	Microarray (Affymetrix HuGene-1_0-ST V1)	leukomics	Homo sapiens	4.71	HuGene	"rgb(0,109,219)"	diamond-open	MPP Lin-CD34+CD38-CD90- G-CSF treated donor adult	hematopoietic multipotent progenitor	MPP	adult	hematopoietic multipotent progenitor	Progenitor
GSM1162512;6326	6326	Cramer-Morales	GSM1162512	"CMP normal, replicate 1"	Homo sapiens	CMP	CL:0000049		common myeloid progenitor			Cramer-Morales	"Homologous recombination repair (HRR) protects cells from the lethal effect of spontaneous and therapy-induced DNA double-stand breaks. HRR usually depends on BRCA1/2-RAD51, and RAD52-RAD51 serves as back-up. To target HRR in tumor cells, a phenomenon called ""synthetic lethality"" was applied, which relies on the addiction of cancer cells to a single DNA repair pathway, whereas normal cells operate 2 or more mechanisms. Using mutagenesis and a peptide aptamer approach, we pinpointed phenylalanine 79 in RAD52 DNA binding domain I (RAD52-phenylalanine 79 [F79]) as a valid target to induce synthetic lethality in BRCA1- and/or BRCA2-deficient leukemias and carcinomas without affecting normal cells and tissues. Targeting RAD52-F79 disrupts the RAD52-DNA interaction, resulting in the accumulation of toxic DNA double-stand breaks in malignant cells, but not in normal counterparts. In addition, abrogation of RAD52-DNA interaction enhanced the antileukemia effect of already-approved drugs. BRCA-deficient status predisposing to RAD52-dependent synthetic lethality could be predicted by genetic abnormalities such as oncogenes BCR-ABL1 and PML-RAR, mutations in BRCA1 and/or BRCA2 genes, and gene expression profiles identifying leukemias displaying low levels of BRCA1 and/or BRCA2. We believe this work may initiate a personalized therapeutic approach in numerous patients with tumors displaying encoded and functional BRCA deficiency."	67	"HSC, AP-CML HSC, BC-CML HSC, CP-CML HSC, MPP, AP-CML MPP, BC-CML MPP, CMP, AP-CML CMP, BC-CML CMP, CP-CML CMP, GMP, AP-CML GMP, BC-CML GMP, CP-CML GMP, MEP, AP-CML MEP, BC-CML MEP, CP-CML MEP"	Microarray (Affymetrix HuGene-1_0-ST V1)	leukomics	Homo sapiens	4.71	HuGene	"rgb(0,109,219)"	diamond-open	CMP CD34+ 38+ lin- CD123+ CD45RA - G-CSF treated donor adult	myeloid progenitor	CMP	adult	common myeloid progenitor	Progenitor
GSM1162513;6326	6326	Cramer-Morales	GSM1162513	"GMP normal, replicate 1"	Homo sapiens	GMP	CL:0000557		granulocyte monocyte progenitor			Cramer-Morales	"Homologous recombination repair (HRR) protects cells from the lethal effect of spontaneous and therapy-induced DNA double-stand breaks. HRR usually depends on BRCA1/2-RAD51, and RAD52-RAD51 serves as back-up. To target HRR in tumor cells, a phenomenon called ""synthetic lethality"" was applied, which relies on the addiction of cancer cells to a single DNA repair pathway, whereas normal cells operate 2 or more mechanisms. Using mutagenesis and a peptide aptamer approach, we pinpointed phenylalanine 79 in RAD52 DNA binding domain I (RAD52-phenylalanine 79 [F79]) as a valid target to induce synthetic lethality in BRCA1- and/or BRCA2-deficient leukemias and carcinomas without affecting normal cells and tissues. Targeting RAD52-F79 disrupts the RAD52-DNA interaction, resulting in the accumulation of toxic DNA double-stand breaks in malignant cells, but not in normal counterparts. In addition, abrogation of RAD52-DNA interaction enhanced the antileukemia effect of already-approved drugs. BRCA-deficient status predisposing to RAD52-dependent synthetic lethality could be predicted by genetic abnormalities such as oncogenes BCR-ABL1 and PML-RAR, mutations in BRCA1 and/or BRCA2 genes, and gene expression profiles identifying leukemias displaying low levels of BRCA1 and/or BRCA2. We believe this work may initiate a personalized therapeutic approach in numerous patients with tumors displaying encoded and functional BRCA deficiency."	67	"HSC, AP-CML HSC, BC-CML HSC, CP-CML HSC, MPP, AP-CML MPP, BC-CML MPP, CMP, AP-CML CMP, BC-CML CMP, CP-CML CMP, GMP, AP-CML GMP, BC-CML GMP, CP-CML GMP, MEP, AP-CML MEP, BC-CML MEP, CP-CML MEP"	Microarray (Affymetrix HuGene-1_0-ST V1)	leukomics	Homo sapiens	4.71	HuGene	"rgb(0,109,219)"	diamond-open	GMP CD34+ 38+ lin- CD123+ CD45RA+ G-CSF treated donor adult	myeloid progenitor	GMP	adult	granulocyte monocyte progenitor	Progenitor
GSM1162515;6326	6326	Cramer-Morales	GSM1162515	"HSC normal, replicate 2"	Homo sapiens	HSC	CL:0000837		hematopoietic multipotent progenitor			Cramer-Morales	"Homologous recombination repair (HRR) protects cells from the lethal effect of spontaneous and therapy-induced DNA double-stand breaks. HRR usually depends on BRCA1/2-RAD51, and RAD52-RAD51 serves as back-up. To target HRR in tumor cells, a phenomenon called ""synthetic lethality"" was applied, which relies on the addiction of cancer cells to a single DNA repair pathway, whereas normal cells operate 2 or more mechanisms. Using mutagenesis and a peptide aptamer approach, we pinpointed phenylalanine 79 in RAD52 DNA binding domain I (RAD52-phenylalanine 79 [F79]) as a valid target to induce synthetic lethality in BRCA1- and/or BRCA2-deficient leukemias and carcinomas without affecting normal cells and tissues. Targeting RAD52-F79 disrupts the RAD52-DNA interaction, resulting in the accumulation of toxic DNA double-stand breaks in malignant cells, but not in normal counterparts. In addition, abrogation of RAD52-DNA interaction enhanced the antileukemia effect of already-approved drugs. BRCA-deficient status predisposing to RAD52-dependent synthetic lethality could be predicted by genetic abnormalities such as oncogenes BCR-ABL1 and PML-RAR, mutations in BRCA1 and/or BRCA2 genes, and gene expression profiles identifying leukemias displaying low levels of BRCA1 and/or BRCA2. We believe this work may initiate a personalized therapeutic approach in numerous patients with tumors displaying encoded and functional BRCA deficiency."	67	"HSC, AP-CML HSC, BC-CML HSC, CP-CML HSC, MPP, AP-CML MPP, BC-CML MPP, CMP, AP-CML CMP, BC-CML CMP, CP-CML CMP, GMP, AP-CML GMP, BC-CML GMP, CP-CML GMP, MEP, AP-CML MEP, BC-CML MEP, CP-CML MEP"	Microarray (Affymetrix HuGene-1_0-ST V1)	leukomics	Homo sapiens	4.71	HuGene	"rgb(0,109,219)"	diamond-open	MHP CD34+ 38- lin- CD45RA- CD90+ G-CSF treated donor adult	hematopoietic multipotent progenitor	MHP	adult	hematopoietic multipotent progenitor	Progenitor
GSM1162516;6326	6326	Cramer-Morales	GSM1162516	"MPP normal, replicate 2"	Homo sapiens	MPP	CL:0000837		hematopoietic multipotent progenitor			Cramer-Morales	"Homologous recombination repair (HRR) protects cells from the lethal effect of spontaneous and therapy-induced DNA double-stand breaks. HRR usually depends on BRCA1/2-RAD51, and RAD52-RAD51 serves as back-up. To target HRR in tumor cells, a phenomenon called ""synthetic lethality"" was applied, which relies on the addiction of cancer cells to a single DNA repair pathway, whereas normal cells operate 2 or more mechanisms. Using mutagenesis and a peptide aptamer approach, we pinpointed phenylalanine 79 in RAD52 DNA binding domain I (RAD52-phenylalanine 79 [F79]) as a valid target to induce synthetic lethality in BRCA1- and/or BRCA2-deficient leukemias and carcinomas without affecting normal cells and tissues. Targeting RAD52-F79 disrupts the RAD52-DNA interaction, resulting in the accumulation of toxic DNA double-stand breaks in malignant cells, but not in normal counterparts. In addition, abrogation of RAD52-DNA interaction enhanced the antileukemia effect of already-approved drugs. BRCA-deficient status predisposing to RAD52-dependent synthetic lethality could be predicted by genetic abnormalities such as oncogenes BCR-ABL1 and PML-RAR, mutations in BRCA1 and/or BRCA2 genes, and gene expression profiles identifying leukemias displaying low levels of BRCA1 and/or BRCA2. We believe this work may initiate a personalized therapeutic approach in numerous patients with tumors displaying encoded and functional BRCA deficiency."	67	"HSC, AP-CML HSC, BC-CML HSC, CP-CML HSC, MPP, AP-CML MPP, BC-CML MPP, CMP, AP-CML CMP, BC-CML CMP, CP-CML CMP, GMP, AP-CML GMP, BC-CML GMP, CP-CML GMP, MEP, AP-CML MEP, BC-CML MEP, CP-CML MEP"	Microarray (Affymetrix HuGene-1_0-ST V1)	leukomics	Homo sapiens	4.71	HuGene	"rgb(0,109,219)"	diamond-open	MPP Lin-CD34+CD38-CD90- G-CSF treated donor adult	hematopoietic multipotent progenitor	MPP	adult	hematopoietic multipotent progenitor	Progenitor
GSM1162517;6326	6326	Cramer-Morales	GSM1162517	"CMP normal, replicate 2"	Homo sapiens	CMP	CL:0000049		common myeloid progenitor			Cramer-Morales	"Homologous recombination repair (HRR) protects cells from the lethal effect of spontaneous and therapy-induced DNA double-stand breaks. HRR usually depends on BRCA1/2-RAD51, and RAD52-RAD51 serves as back-up. To target HRR in tumor cells, a phenomenon called ""synthetic lethality"" was applied, which relies on the addiction of cancer cells to a single DNA repair pathway, whereas normal cells operate 2 or more mechanisms. Using mutagenesis and a peptide aptamer approach, we pinpointed phenylalanine 79 in RAD52 DNA binding domain I (RAD52-phenylalanine 79 [F79]) as a valid target to induce synthetic lethality in BRCA1- and/or BRCA2-deficient leukemias and carcinomas without affecting normal cells and tissues. Targeting RAD52-F79 disrupts the RAD52-DNA interaction, resulting in the accumulation of toxic DNA double-stand breaks in malignant cells, but not in normal counterparts. In addition, abrogation of RAD52-DNA interaction enhanced the antileukemia effect of already-approved drugs. BRCA-deficient status predisposing to RAD52-dependent synthetic lethality could be predicted by genetic abnormalities such as oncogenes BCR-ABL1 and PML-RAR, mutations in BRCA1 and/or BRCA2 genes, and gene expression profiles identifying leukemias displaying low levels of BRCA1 and/or BRCA2. We believe this work may initiate a personalized therapeutic approach in numerous patients with tumors displaying encoded and functional BRCA deficiency."	67	"HSC, AP-CML HSC, BC-CML HSC, CP-CML HSC, MPP, AP-CML MPP, BC-CML MPP, CMP, AP-CML CMP, BC-CML CMP, CP-CML CMP, GMP, AP-CML GMP, BC-CML GMP, CP-CML GMP, MEP, AP-CML MEP, BC-CML MEP, CP-CML MEP"	Microarray (Affymetrix HuGene-1_0-ST V1)	leukomics	Homo sapiens	4.71	HuGene	"rgb(0,109,219)"	diamond-open	CMP CD34+ 38+ lin- CD123+ CD45RA - G-CSF treated donor adult	myeloid progenitor	CMP	adult	common myeloid progenitor	Progenitor
GSM1162518;6326	6326	Cramer-Morales	GSM1162518	"GMP normal, replicate 2"	Homo sapiens	GMP	CL:0000557		granulocyte monocyte progenitor			Cramer-Morales	"Homologous recombination repair (HRR) protects cells from the lethal effect of spontaneous and therapy-induced DNA double-stand breaks. HRR usually depends on BRCA1/2-RAD51, and RAD52-RAD51 serves as back-up. To target HRR in tumor cells, a phenomenon called ""synthetic lethality"" was applied, which relies on the addiction of cancer cells to a single DNA repair pathway, whereas normal cells operate 2 or more mechanisms. Using mutagenesis and a peptide aptamer approach, we pinpointed phenylalanine 79 in RAD52 DNA binding domain I (RAD52-phenylalanine 79 [F79]) as a valid target to induce synthetic lethality in BRCA1- and/or BRCA2-deficient leukemias and carcinomas without affecting normal cells and tissues. Targeting RAD52-F79 disrupts the RAD52-DNA interaction, resulting in the accumulation of toxic DNA double-stand breaks in malignant cells, but not in normal counterparts. In addition, abrogation of RAD52-DNA interaction enhanced the antileukemia effect of already-approved drugs. BRCA-deficient status predisposing to RAD52-dependent synthetic lethality could be predicted by genetic abnormalities such as oncogenes BCR-ABL1 and PML-RAR, mutations in BRCA1 and/or BRCA2 genes, and gene expression profiles identifying leukemias displaying low levels of BRCA1 and/or BRCA2. We believe this work may initiate a personalized therapeutic approach in numerous patients with tumors displaying encoded and functional BRCA deficiency."	67	"HSC, AP-CML HSC, BC-CML HSC, CP-CML HSC, MPP, AP-CML MPP, BC-CML MPP, CMP, AP-CML CMP, BC-CML CMP, CP-CML CMP, GMP, AP-CML GMP, BC-CML GMP, CP-CML GMP, MEP, AP-CML MEP, BC-CML MEP, CP-CML MEP"	Microarray (Affymetrix HuGene-1_0-ST V1)	leukomics	Homo sapiens	4.71	HuGene	"rgb(0,109,219)"	diamond-open	GMP CD34+ 38+ lin- CD123+ CD45RA+ G-CSF treated donor adult	myeloid progenitor	GMP	adult	granulocyte monocyte progenitor	Progenitor
GSM1162520;6326	6326	Cramer-Morales	GSM1162520	"HSC normal, replicate 3"	Homo sapiens	HSC	CL:0000837		hematopoietic multipotent progenitor			Cramer-Morales	"Homologous recombination repair (HRR) protects cells from the lethal effect of spontaneous and therapy-induced DNA double-stand breaks. HRR usually depends on BRCA1/2-RAD51, and RAD52-RAD51 serves as back-up. To target HRR in tumor cells, a phenomenon called ""synthetic lethality"" was applied, which relies on the addiction of cancer cells to a single DNA repair pathway, whereas normal cells operate 2 or more mechanisms. Using mutagenesis and a peptide aptamer approach, we pinpointed phenylalanine 79 in RAD52 DNA binding domain I (RAD52-phenylalanine 79 [F79]) as a valid target to induce synthetic lethality in BRCA1- and/or BRCA2-deficient leukemias and carcinomas without affecting normal cells and tissues. Targeting RAD52-F79 disrupts the RAD52-DNA interaction, resulting in the accumulation of toxic DNA double-stand breaks in malignant cells, but not in normal counterparts. In addition, abrogation of RAD52-DNA interaction enhanced the antileukemia effect of already-approved drugs. BRCA-deficient status predisposing to RAD52-dependent synthetic lethality could be predicted by genetic abnormalities such as oncogenes BCR-ABL1 and PML-RAR, mutations in BRCA1 and/or BRCA2 genes, and gene expression profiles identifying leukemias displaying low levels of BRCA1 and/or BRCA2. We believe this work may initiate a personalized therapeutic approach in numerous patients with tumors displaying encoded and functional BRCA deficiency."	67	"HSC, AP-CML HSC, BC-CML HSC, CP-CML HSC, MPP, AP-CML MPP, BC-CML MPP, CMP, AP-CML CMP, BC-CML CMP, CP-CML CMP, GMP, AP-CML GMP, BC-CML GMP, CP-CML GMP, MEP, AP-CML MEP, BC-CML MEP, CP-CML MEP"	Microarray (Affymetrix HuGene-1_0-ST V1)	leukomics	Homo sapiens	4.71	HuGene	"rgb(0,109,219)"	diamond-open	MHP CD34+ 38- lin- CD45RA- CD90+ G-CSF treated donor adult	hematopoietic multipotent progenitor	MHP	adult	hematopoietic multipotent progenitor	Progenitor
GSM1162521;6326	6326	Cramer-Morales	GSM1162521	"MPP normal, replicate 3"	Homo sapiens	MPP	CL:0000837		hematopoietic multipotent progenitor			Cramer-Morales	"Homologous recombination repair (HRR) protects cells from the lethal effect of spontaneous and therapy-induced DNA double-stand breaks. HRR usually depends on BRCA1/2-RAD51, and RAD52-RAD51 serves as back-up. To target HRR in tumor cells, a phenomenon called ""synthetic lethality"" was applied, which relies on the addiction of cancer cells to a single DNA repair pathway, whereas normal cells operate 2 or more mechanisms. Using mutagenesis and a peptide aptamer approach, we pinpointed phenylalanine 79 in RAD52 DNA binding domain I (RAD52-phenylalanine 79 [F79]) as a valid target to induce synthetic lethality in BRCA1- and/or BRCA2-deficient leukemias and carcinomas without affecting normal cells and tissues. Targeting RAD52-F79 disrupts the RAD52-DNA interaction, resulting in the accumulation of toxic DNA double-stand breaks in malignant cells, but not in normal counterparts. In addition, abrogation of RAD52-DNA interaction enhanced the antileukemia effect of already-approved drugs. BRCA-deficient status predisposing to RAD52-dependent synthetic lethality could be predicted by genetic abnormalities such as oncogenes BCR-ABL1 and PML-RAR, mutations in BRCA1 and/or BRCA2 genes, and gene expression profiles identifying leukemias displaying low levels of BRCA1 and/or BRCA2. We believe this work may initiate a personalized therapeutic approach in numerous patients with tumors displaying encoded and functional BRCA deficiency."	67	"HSC, AP-CML HSC, BC-CML HSC, CP-CML HSC, MPP, AP-CML MPP, BC-CML MPP, CMP, AP-CML CMP, BC-CML CMP, CP-CML CMP, GMP, AP-CML GMP, BC-CML GMP, CP-CML GMP, MEP, AP-CML MEP, BC-CML MEP, CP-CML MEP"	Microarray (Affymetrix HuGene-1_0-ST V1)	leukomics	Homo sapiens	4.71	HuGene	"rgb(0,109,219)"	diamond-open	MPP Lin-CD34+CD38-CD90- G-CSF treated donor adult	hematopoietic multipotent progenitor	MPP	adult	hematopoietic multipotent progenitor	Progenitor
GSM1162522;6326	6326	Cramer-Morales	GSM1162522	"CMP normal, replicate 3"	Homo sapiens	CMP	CL:0000049		common myeloid progenitor			Cramer-Morales	"Homologous recombination repair (HRR) protects cells from the lethal effect of spontaneous and therapy-induced DNA double-stand breaks. HRR usually depends on BRCA1/2-RAD51, and RAD52-RAD51 serves as back-up. To target HRR in tumor cells, a phenomenon called ""synthetic lethality"" was applied, which relies on the addiction of cancer cells to a single DNA repair pathway, whereas normal cells operate 2 or more mechanisms. Using mutagenesis and a peptide aptamer approach, we pinpointed phenylalanine 79 in RAD52 DNA binding domain I (RAD52-phenylalanine 79 [F79]) as a valid target to induce synthetic lethality in BRCA1- and/or BRCA2-deficient leukemias and carcinomas without affecting normal cells and tissues. Targeting RAD52-F79 disrupts the RAD52-DNA interaction, resulting in the accumulation of toxic DNA double-stand breaks in malignant cells, but not in normal counterparts. In addition, abrogation of RAD52-DNA interaction enhanced the antileukemia effect of already-approved drugs. BRCA-deficient status predisposing to RAD52-dependent synthetic lethality could be predicted by genetic abnormalities such as oncogenes BCR-ABL1 and PML-RAR, mutations in BRCA1 and/or BRCA2 genes, and gene expression profiles identifying leukemias displaying low levels of BRCA1 and/or BRCA2. We believe this work may initiate a personalized therapeutic approach in numerous patients with tumors displaying encoded and functional BRCA deficiency."	67	"HSC, AP-CML HSC, BC-CML HSC, CP-CML HSC, MPP, AP-CML MPP, BC-CML MPP, CMP, AP-CML CMP, BC-CML CMP, CP-CML CMP, GMP, AP-CML GMP, BC-CML GMP, CP-CML GMP, MEP, AP-CML MEP, BC-CML MEP, CP-CML MEP"	Microarray (Affymetrix HuGene-1_0-ST V1)	leukomics	Homo sapiens	4.71	HuGene	"rgb(0,109,219)"	diamond-open	CMP CD34+ 38+ lin- CD123+ CD45RA - G-CSF treated donor adult	myeloid progenitor	CMP	adult	common myeloid progenitor	Progenitor
GSM1162523;6326	6326	Cramer-Morales	GSM1162523	"GMP normal, replicate 3"	Homo sapiens	GMP	CL:0000557		granulocyte monocyte progenitor			Cramer-Morales	"Homologous recombination repair (HRR) protects cells from the lethal effect of spontaneous and therapy-induced DNA double-stand breaks. HRR usually depends on BRCA1/2-RAD51, and RAD52-RAD51 serves as back-up. To target HRR in tumor cells, a phenomenon called ""synthetic lethality"" was applied, which relies on the addiction of cancer cells to a single DNA repair pathway, whereas normal cells operate 2 or more mechanisms. Using mutagenesis and a peptide aptamer approach, we pinpointed phenylalanine 79 in RAD52 DNA binding domain I (RAD52-phenylalanine 79 [F79]) as a valid target to induce synthetic lethality in BRCA1- and/or BRCA2-deficient leukemias and carcinomas without affecting normal cells and tissues. Targeting RAD52-F79 disrupts the RAD52-DNA interaction, resulting in the accumulation of toxic DNA double-stand breaks in malignant cells, but not in normal counterparts. In addition, abrogation of RAD52-DNA interaction enhanced the antileukemia effect of already-approved drugs. BRCA-deficient status predisposing to RAD52-dependent synthetic lethality could be predicted by genetic abnormalities such as oncogenes BCR-ABL1 and PML-RAR, mutations in BRCA1 and/or BRCA2 genes, and gene expression profiles identifying leukemias displaying low levels of BRCA1 and/or BRCA2. We believe this work may initiate a personalized therapeutic approach in numerous patients with tumors displaying encoded and functional BRCA deficiency."	67	"HSC, AP-CML HSC, BC-CML HSC, CP-CML HSC, MPP, AP-CML MPP, BC-CML MPP, CMP, AP-CML CMP, BC-CML CMP, CP-CML CMP, GMP, AP-CML GMP, BC-CML GMP, CP-CML GMP, MEP, AP-CML MEP, BC-CML MEP, CP-CML MEP"	Microarray (Affymetrix HuGene-1_0-ST V1)	leukomics	Homo sapiens	4.71	HuGene	"rgb(0,109,219)"	diamond-open	GMP CD34+ 38+ lin- CD123+ CD45RA+ G-CSF treated donor adult	myeloid progenitor	GMP	adult	granulocyte monocyte progenitor	Progenitor
GSM1210382;6339	6339	Doulatov	GSM1210382	Cord blood CD34+ CD38- CD90+ HSC biological rep1	Homo sapiens	CB-derived HMP	CL:0000837		hematopoietic multipotent progenitor			Doulatov	"Human pluripotent stem cells (hPSCs) represent a promising source of patient-specific cells for disease modeling, drug screens, and cellular therapies. How- ever, the inability to derive engraftable human he- matopoietic stem and progenitor cells (HSPCs) has limited their characterization to in vitro assays. We report a strategy to respecify lineage-restricted CD34+CD45+ myeloid precursors derived from hPSCs into multilineage progenitors that can be expanded in vitro and engrafted in vivo. HOXA9, ERG, and RORA conferred self-renewal and multilineage potential in vitro and maintained primitive CD34+CD38 cells. Screening cells via transplantation revealed that two additional factors, SOX4 and MYB, conferred engraftment. Progenitors specified with all five factors gave rise to reproducible short-term engraftment with myeloid and erythroid lineages. Erythroid precursors underwent hemoglobin switching in vivo, silencing embryonic and activating adult globin expression. Our combinatorial screening approach establishes a strategy for obtaining transcription-factor-mediated engraftment of blood progenitors from human pluripotent cells."	28	"ESC-derived CMP, iPSC-derived CMP, iPSC-derived CMP, CP-derived HP, fetal liver blood progenitor, ESC-derived HMP, ESC-derived HMP, fetal liver HMP, fetal liver-derived HMP, CB-derived HMP"	Microarray (Affymetrix HG-U133_Plus_2)		Homo sapiens	4.6	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	MHP CD34+ CD38- CD90+ cultured 24h neonatal	hematopoietic multipotent progenitor	MHP	neonatal	hematopoietic multipotent progenitor	Progenitor
GSM1210383;6339	6339	Doulatov	GSM1210383	Cord blood CD34+ CD38- CD90+ HSC biological rep2	Homo sapiens	CB-derived HMP	CL:0000837		hematopoietic multipotent progenitor			Doulatov	"Human pluripotent stem cells (hPSCs) represent a promising source of patient-specific cells for disease modeling, drug screens, and cellular therapies. How- ever, the inability to derive engraftable human he- matopoietic stem and progenitor cells (HSPCs) has limited their characterization to in vitro assays. We report a strategy to respecify lineage-restricted CD34+CD45+ myeloid precursors derived from hPSCs into multilineage progenitors that can be expanded in vitro and engrafted in vivo. HOXA9, ERG, and RORA conferred self-renewal and multilineage potential in vitro and maintained primitive CD34+CD38 cells. Screening cells via transplantation revealed that two additional factors, SOX4 and MYB, conferred engraftment. Progenitors specified with all five factors gave rise to reproducible short-term engraftment with myeloid and erythroid lineages. Erythroid precursors underwent hemoglobin switching in vivo, silencing embryonic and activating adult globin expression. Our combinatorial screening approach establishes a strategy for obtaining transcription-factor-mediated engraftment of blood progenitors from human pluripotent cells."	28	"ESC-derived CMP, iPSC-derived CMP, iPSC-derived CMP, CP-derived HP, fetal liver blood progenitor, ESC-derived HMP, ESC-derived HMP, fetal liver HMP, fetal liver-derived HMP, CB-derived HMP"	Microarray (Affymetrix HG-U133_Plus_2)		Homo sapiens	4.6	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	MHP CD34+ CD38- CD90+ cultured 24h neonatal	hematopoietic multipotent progenitor	MHP	neonatal	hematopoietic multipotent progenitor	Progenitor
GSM1210384;6339	6339	Doulatov	GSM1210384	Cord blood CD34+ CD38- CD90+ HSC biological rep3	Homo sapiens	CB-derived HMP	CL:0000837		hematopoietic multipotent progenitor			Doulatov	"Human pluripotent stem cells (hPSCs) represent a promising source of patient-specific cells for disease modeling, drug screens, and cellular therapies. How- ever, the inability to derive engraftable human he- matopoietic stem and progenitor cells (HSPCs) has limited their characterization to in vitro assays. We report a strategy to respecify lineage-restricted CD34+CD45+ myeloid precursors derived from hPSCs into multilineage progenitors that can be expanded in vitro and engrafted in vivo. HOXA9, ERG, and RORA conferred self-renewal and multilineage potential in vitro and maintained primitive CD34+CD38 cells. Screening cells via transplantation revealed that two additional factors, SOX4 and MYB, conferred engraftment. Progenitors specified with all five factors gave rise to reproducible short-term engraftment with myeloid and erythroid lineages. Erythroid precursors underwent hemoglobin switching in vivo, silencing embryonic and activating adult globin expression. Our combinatorial screening approach establishes a strategy for obtaining transcription-factor-mediated engraftment of blood progenitors from human pluripotent cells."	28	"ESC-derived CMP, iPSC-derived CMP, iPSC-derived CMP, CP-derived HP, fetal liver blood progenitor, ESC-derived HMP, ESC-derived HMP, fetal liver HMP, fetal liver-derived HMP, CB-derived HMP"	Microarray (Affymetrix HG-U133_Plus_2)		Homo sapiens	4.6	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	MHP CD34+ CD38- CD90+ cultured 24h neonatal	hematopoietic multipotent progenitor	MHP	neonatal	hematopoietic multipotent progenitor	Progenitor
GSM1210385;6339	6339	Doulatov	GSM1210385	Cord blood CD34+ CD38+ progenitors biological rep1	Homo sapiens	CP-derived HP	CL:0000837		hematopoietic multipotent progenitor			Doulatov	"Human pluripotent stem cells (hPSCs) represent a promising source of patient-specific cells for disease modeling, drug screens, and cellular therapies. How- ever, the inability to derive engraftable human he- matopoietic stem and progenitor cells (HSPCs) has limited their characterization to in vitro assays. We report a strategy to respecify lineage-restricted CD34+CD45+ myeloid precursors derived from hPSCs into multilineage progenitors that can be expanded in vitro and engrafted in vivo. HOXA9, ERG, and RORA conferred self-renewal and multilineage potential in vitro and maintained primitive CD34+CD38 cells. Screening cells via transplantation revealed that two additional factors, SOX4 and MYB, conferred engraftment. Progenitors specified with all five factors gave rise to reproducible short-term engraftment with myeloid and erythroid lineages. Erythroid precursors underwent hemoglobin switching in vivo, silencing embryonic and activating adult globin expression. Our combinatorial screening approach establishes a strategy for obtaining transcription-factor-mediated engraftment of blood progenitors from human pluripotent cells."	28	"ESC-derived CMP, iPSC-derived CMP, iPSC-derived CMP, CP-derived HP, fetal liver blood progenitor, ESC-derived HMP, ESC-derived HMP, fetal liver HMP, fetal liver-derived HMP, CB-derived HMP"	Microarray (Affymetrix HG-U133_Plus_2)		Homo sapiens	4.6	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	MHP CD34+ CD38+ cultured 24h neonatal	hematopoietic multipotent progenitor	MHP	neonatal	hematopoietic multipotent progenitor	Progenitor
GSM1210386;6339	6339	Doulatov	GSM1210386	Cord blood CD34+ CD38+ progenitors biological rep2	Homo sapiens	CP-derived HP	CL:0000837		hematopoietic multipotent progenitor			Doulatov	"Human pluripotent stem cells (hPSCs) represent a promising source of patient-specific cells for disease modeling, drug screens, and cellular therapies. How- ever, the inability to derive engraftable human he- matopoietic stem and progenitor cells (HSPCs) has limited their characterization to in vitro assays. We report a strategy to respecify lineage-restricted CD34+CD45+ myeloid precursors derived from hPSCs into multilineage progenitors that can be expanded in vitro and engrafted in vivo. HOXA9, ERG, and RORA conferred self-renewal and multilineage potential in vitro and maintained primitive CD34+CD38 cells. Screening cells via transplantation revealed that two additional factors, SOX4 and MYB, conferred engraftment. Progenitors specified with all five factors gave rise to reproducible short-term engraftment with myeloid and erythroid lineages. Erythroid precursors underwent hemoglobin switching in vivo, silencing embryonic and activating adult globin expression. Our combinatorial screening approach establishes a strategy for obtaining transcription-factor-mediated engraftment of blood progenitors from human pluripotent cells."	28	"ESC-derived CMP, iPSC-derived CMP, iPSC-derived CMP, CP-derived HP, fetal liver blood progenitor, ESC-derived HMP, ESC-derived HMP, fetal liver HMP, fetal liver-derived HMP, CB-derived HMP"	Microarray (Affymetrix HG-U133_Plus_2)		Homo sapiens	4.6	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	MHP CD34+ CD38+ cultured 24h neonatal	hematopoietic multipotent progenitor	MHP	neonatal	hematopoietic multipotent progenitor	Progenitor
GSM1210387;6339	6339	Doulatov	GSM1210387	Cord blood CD34+ CD38+ progenitors biological rep3	Homo sapiens	CP-derived HP	CL:0000837		hematopoietic multipotent progenitor			Doulatov	"Human pluripotent stem cells (hPSCs) represent a promising source of patient-specific cells for disease modeling, drug screens, and cellular therapies. How- ever, the inability to derive engraftable human he- matopoietic stem and progenitor cells (HSPCs) has limited their characterization to in vitro assays. We report a strategy to respecify lineage-restricted CD34+CD45+ myeloid precursors derived from hPSCs into multilineage progenitors that can be expanded in vitro and engrafted in vivo. HOXA9, ERG, and RORA conferred self-renewal and multilineage potential in vitro and maintained primitive CD34+CD38 cells. Screening cells via transplantation revealed that two additional factors, SOX4 and MYB, conferred engraftment. Progenitors specified with all five factors gave rise to reproducible short-term engraftment with myeloid and erythroid lineages. Erythroid precursors underwent hemoglobin switching in vivo, silencing embryonic and activating adult globin expression. Our combinatorial screening approach establishes a strategy for obtaining transcription-factor-mediated engraftment of blood progenitors from human pluripotent cells."	28	"ESC-derived CMP, iPSC-derived CMP, iPSC-derived CMP, CP-derived HP, fetal liver blood progenitor, ESC-derived HMP, ESC-derived HMP, fetal liver HMP, fetal liver-derived HMP, CB-derived HMP"	Microarray (Affymetrix HG-U133_Plus_2)		Homo sapiens	4.6	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	MHP CD34+ CD38+ cultured 24h neonatal	hematopoietic multipotent progenitor	MHP	neonatal	hematopoietic multipotent progenitor	Progenitor
GSM1210393;6339	6339	Doulatov	GSM1210393	Fetal liver CD34+ CD38- CD90+ HSC biological rep1	Homo sapiens	fetal liver HMP	CL:0000837		hematopoietic multipotent progenitor			Doulatov	"Human pluripotent stem cells (hPSCs) represent a promising source of patient-specific cells for disease modeling, drug screens, and cellular therapies. How- ever, the inability to derive engraftable human he- matopoietic stem and progenitor cells (HSPCs) has limited their characterization to in vitro assays. We report a strategy to respecify lineage-restricted CD34+CD45+ myeloid precursors derived from hPSCs into multilineage progenitors that can be expanded in vitro and engrafted in vivo. HOXA9, ERG, and RORA conferred self-renewal and multilineage potential in vitro and maintained primitive CD34+CD38 cells. Screening cells via transplantation revealed that two additional factors, SOX4 and MYB, conferred engraftment. Progenitors specified with all five factors gave rise to reproducible short-term engraftment with myeloid and erythroid lineages. Erythroid precursors underwent hemoglobin switching in vivo, silencing embryonic and activating adult globin expression. Our combinatorial screening approach establishes a strategy for obtaining transcription-factor-mediated engraftment of blood progenitors from human pluripotent cells."	28	"ESC-derived CMP, iPSC-derived CMP, iPSC-derived CMP, CP-derived HP, fetal liver blood progenitor, ESC-derived HMP, ESC-derived HMP, fetal liver HMP, fetal liver-derived HMP, CB-derived HMP"	Microarray (Affymetrix HG-U133_Plus_2)		Homo sapiens	4.6	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	MHP CD34+ CD38- CD90+ cultured 24h fetal	hematopoietic multipotent progenitor	MHP	fetal	hematopoietic multipotent progenitor	Progenitor
GSM1210394;6339	6339	Doulatov	GSM1210394	Fetal liver CD34+ CD38- CD90+ HSC biological rep2	Homo sapiens	fetal liver HMP	CL:0000837		hematopoietic multipotent progenitor			Doulatov	"Human pluripotent stem cells (hPSCs) represent a promising source of patient-specific cells for disease modeling, drug screens, and cellular therapies. How- ever, the inability to derive engraftable human he- matopoietic stem and progenitor cells (HSPCs) has limited their characterization to in vitro assays. We report a strategy to respecify lineage-restricted CD34+CD45+ myeloid precursors derived from hPSCs into multilineage progenitors that can be expanded in vitro and engrafted in vivo. HOXA9, ERG, and RORA conferred self-renewal and multilineage potential in vitro and maintained primitive CD34+CD38 cells. Screening cells via transplantation revealed that two additional factors, SOX4 and MYB, conferred engraftment. Progenitors specified with all five factors gave rise to reproducible short-term engraftment with myeloid and erythroid lineages. Erythroid precursors underwent hemoglobin switching in vivo, silencing embryonic and activating adult globin expression. Our combinatorial screening approach establishes a strategy for obtaining transcription-factor-mediated engraftment of blood progenitors from human pluripotent cells."	28	"ESC-derived CMP, iPSC-derived CMP, iPSC-derived CMP, CP-derived HP, fetal liver blood progenitor, ESC-derived HMP, ESC-derived HMP, fetal liver HMP, fetal liver-derived HMP, CB-derived HMP"	Microarray (Affymetrix HG-U133_Plus_2)		Homo sapiens	4.6	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	MHP CD34+ CD38- CD90+ cultured 24h fetal	hematopoietic multipotent progenitor	MHP	fetal	hematopoietic multipotent progenitor	Progenitor
GSM1210395;6339	6339	Doulatov	GSM1210395	Fetal liver CD34+ CD38- CD90+ HSC biological rep3	Homo sapiens	fetal liver HMP	CL:0000837		hematopoietic multipotent progenitor			Doulatov	"Human pluripotent stem cells (hPSCs) represent a promising source of patient-specific cells for disease modeling, drug screens, and cellular therapies. How- ever, the inability to derive engraftable human he- matopoietic stem and progenitor cells (HSPCs) has limited their characterization to in vitro assays. We report a strategy to respecify lineage-restricted CD34+CD45+ myeloid precursors derived from hPSCs into multilineage progenitors that can be expanded in vitro and engrafted in vivo. HOXA9, ERG, and RORA conferred self-renewal and multilineage potential in vitro and maintained primitive CD34+CD38 cells. Screening cells via transplantation revealed that two additional factors, SOX4 and MYB, conferred engraftment. Progenitors specified with all five factors gave rise to reproducible short-term engraftment with myeloid and erythroid lineages. Erythroid precursors underwent hemoglobin switching in vivo, silencing embryonic and activating adult globin expression. Our combinatorial screening approach establishes a strategy for obtaining transcription-factor-mediated engraftment of blood progenitors from human pluripotent cells."	28	"ESC-derived CMP, iPSC-derived CMP, iPSC-derived CMP, CP-derived HP, fetal liver blood progenitor, ESC-derived HMP, ESC-derived HMP, fetal liver HMP, fetal liver-derived HMP, CB-derived HMP"	Microarray (Affymetrix HG-U133_Plus_2)		Homo sapiens	4.6	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	MHP CD34+ CD38- CD90+ cultured 24h fetal	hematopoietic multipotent progenitor	MHP	fetal	hematopoietic multipotent progenitor	Progenitor
GSM1210396;6339	6339	Doulatov	GSM1210396	Fetal liver CD34+ CD38+ progenitors biological rep1	Homo sapiens	fetal liver blood progenitor	CL:0000837		hematopoietic multipotent progenitor			Doulatov	"Human pluripotent stem cells (hPSCs) represent a promising source of patient-specific cells for disease modeling, drug screens, and cellular therapies. How- ever, the inability to derive engraftable human he- matopoietic stem and progenitor cells (HSPCs) has limited their characterization to in vitro assays. We report a strategy to respecify lineage-restricted CD34+CD45+ myeloid precursors derived from hPSCs into multilineage progenitors that can be expanded in vitro and engrafted in vivo. HOXA9, ERG, and RORA conferred self-renewal and multilineage potential in vitro and maintained primitive CD34+CD38 cells. Screening cells via transplantation revealed that two additional factors, SOX4 and MYB, conferred engraftment. Progenitors specified with all five factors gave rise to reproducible short-term engraftment with myeloid and erythroid lineages. Erythroid precursors underwent hemoglobin switching in vivo, silencing embryonic and activating adult globin expression. Our combinatorial screening approach establishes a strategy for obtaining transcription-factor-mediated engraftment of blood progenitors from human pluripotent cells."	28	"ESC-derived CMP, iPSC-derived CMP, iPSC-derived CMP, CP-derived HP, fetal liver blood progenitor, ESC-derived HMP, ESC-derived HMP, fetal liver HMP, fetal liver-derived HMP, CB-derived HMP"	Microarray (Affymetrix HG-U133_Plus_2)		Homo sapiens	4.6	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	MHP CD34+ CD38+ cultured 24h fetal	hematopoietic multipotent progenitor	MHP	fetal	hematopoietic multipotent progenitor	Progenitor
GSM1210397;6339	6339	Doulatov	GSM1210397	Fetal liver CD34+ CD38+ progenitors biological rep2	Homo sapiens	fetal liver blood progenitor	CL:0000837		hematopoietic multipotent progenitor			Doulatov	"Human pluripotent stem cells (hPSCs) represent a promising source of patient-specific cells for disease modeling, drug screens, and cellular therapies. How- ever, the inability to derive engraftable human he- matopoietic stem and progenitor cells (HSPCs) has limited their characterization to in vitro assays. We report a strategy to respecify lineage-restricted CD34+CD45+ myeloid precursors derived from hPSCs into multilineage progenitors that can be expanded in vitro and engrafted in vivo. HOXA9, ERG, and RORA conferred self-renewal and multilineage potential in vitro and maintained primitive CD34+CD38 cells. Screening cells via transplantation revealed that two additional factors, SOX4 and MYB, conferred engraftment. Progenitors specified with all five factors gave rise to reproducible short-term engraftment with myeloid and erythroid lineages. Erythroid precursors underwent hemoglobin switching in vivo, silencing embryonic and activating adult globin expression. Our combinatorial screening approach establishes a strategy for obtaining transcription-factor-mediated engraftment of blood progenitors from human pluripotent cells."	28	"ESC-derived CMP, iPSC-derived CMP, iPSC-derived CMP, CP-derived HP, fetal liver blood progenitor, ESC-derived HMP, ESC-derived HMP, fetal liver HMP, fetal liver-derived HMP, CB-derived HMP"	Microarray (Affymetrix HG-U133_Plus_2)		Homo sapiens	4.6	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	MHP CD34+ CD38+ cultured 24h fetal	hematopoietic multipotent progenitor	MHP	fetal	hematopoietic multipotent progenitor	Progenitor
GSM1210398;6339	6339	Doulatov	GSM1210398	Fetal liver CD34+ CD38- CD90+ HSC 24h-culture biological rep1	Homo sapiens	fetal liver-derived HMP	CL:0000837		hematopoietic multipotent progenitor			Doulatov	"Human pluripotent stem cells (hPSCs) represent a promising source of patient-specific cells for disease modeling, drug screens, and cellular therapies. How- ever, the inability to derive engraftable human he- matopoietic stem and progenitor cells (HSPCs) has limited their characterization to in vitro assays. We report a strategy to respecify lineage-restricted CD34+CD45+ myeloid precursors derived from hPSCs into multilineage progenitors that can be expanded in vitro and engrafted in vivo. HOXA9, ERG, and RORA conferred self-renewal and multilineage potential in vitro and maintained primitive CD34+CD38 cells. Screening cells via transplantation revealed that two additional factors, SOX4 and MYB, conferred engraftment. Progenitors specified with all five factors gave rise to reproducible short-term engraftment with myeloid and erythroid lineages. Erythroid precursors underwent hemoglobin switching in vivo, silencing embryonic and activating adult globin expression. Our combinatorial screening approach establishes a strategy for obtaining transcription-factor-mediated engraftment of blood progenitors from human pluripotent cells."	28	"ESC-derived CMP, iPSC-derived CMP, iPSC-derived CMP, CP-derived HP, fetal liver blood progenitor, ESC-derived HMP, ESC-derived HMP, fetal liver HMP, fetal liver-derived HMP, CB-derived HMP"	Microarray (Affymetrix HG-U133_Plus_2)		Homo sapiens	4.6	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	MHP CD34+ C38- CD90+ cultured 24h fetal	hematopoietic multipotent progenitor	MHP	fetal	hematopoietic multipotent progenitor	Progenitor
GSM1210399;6339	6339	Doulatov	GSM1210399	Fetal liver CD34+ CD38- CD90+ HSC 24h-culture biological rep2	Homo sapiens	fetal liver-derived HMP	CL:0000837		hematopoietic multipotent progenitor			Doulatov	"Human pluripotent stem cells (hPSCs) represent a promising source of patient-specific cells for disease modeling, drug screens, and cellular therapies. How- ever, the inability to derive engraftable human he- matopoietic stem and progenitor cells (HSPCs) has limited their characterization to in vitro assays. We report a strategy to respecify lineage-restricted CD34+CD45+ myeloid precursors derived from hPSCs into multilineage progenitors that can be expanded in vitro and engrafted in vivo. HOXA9, ERG, and RORA conferred self-renewal and multilineage potential in vitro and maintained primitive CD34+CD38 cells. Screening cells via transplantation revealed that two additional factors, SOX4 and MYB, conferred engraftment. Progenitors specified with all five factors gave rise to reproducible short-term engraftment with myeloid and erythroid lineages. Erythroid precursors underwent hemoglobin switching in vivo, silencing embryonic and activating adult globin expression. Our combinatorial screening approach establishes a strategy for obtaining transcription-factor-mediated engraftment of blood progenitors from human pluripotent cells."	28	"ESC-derived CMP, iPSC-derived CMP, iPSC-derived CMP, CP-derived HP, fetal liver blood progenitor, ESC-derived HMP, ESC-derived HMP, fetal liver HMP, fetal liver-derived HMP, CB-derived HMP"	Microarray (Affymetrix HG-U133_Plus_2)		Homo sapiens	4.6	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	MHP CD34+ C38- CD90+ cultured 24h fetal	hematopoietic multipotent progenitor	MHP	fetal	hematopoietic multipotent progenitor	Progenitor
GSM1210400;6339	6339	Doulatov	GSM1210400	Fetal liver CD34+ CD38- CD90+ HSC 24h-culture biological rep3	Homo sapiens	fetal liver-derived HMP	CL:0000837		hematopoietic multipotent progenitor			Doulatov	"Human pluripotent stem cells (hPSCs) represent a promising source of patient-specific cells for disease modeling, drug screens, and cellular therapies. How- ever, the inability to derive engraftable human he- matopoietic stem and progenitor cells (HSPCs) has limited their characterization to in vitro assays. We report a strategy to respecify lineage-restricted CD34+CD45+ myeloid precursors derived from hPSCs into multilineage progenitors that can be expanded in vitro and engrafted in vivo. HOXA9, ERG, and RORA conferred self-renewal and multilineage potential in vitro and maintained primitive CD34+CD38 cells. Screening cells via transplantation revealed that two additional factors, SOX4 and MYB, conferred engraftment. Progenitors specified with all five factors gave rise to reproducible short-term engraftment with myeloid and erythroid lineages. Erythroid precursors underwent hemoglobin switching in vivo, silencing embryonic and activating adult globin expression. Our combinatorial screening approach establishes a strategy for obtaining transcription-factor-mediated engraftment of blood progenitors from human pluripotent cells."	28	"ESC-derived CMP, iPSC-derived CMP, iPSC-derived CMP, CP-derived HP, fetal liver blood progenitor, ESC-derived HMP, ESC-derived HMP, fetal liver HMP, fetal liver-derived HMP, CB-derived HMP"	Microarray (Affymetrix HG-U133_Plus_2)		Homo sapiens	4.6	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	MHP CD34+ C38- CD90+ cultured 24h fetal	hematopoietic multipotent progenitor	MHP	fetal	hematopoietic multipotent progenitor	Progenitor
GSM1210754;7392	7392	Zhao	GSM1210754	GSM1210754	Homo sapiens	HD CD8+ T Cell	Sample Type				biotin	Zhao	Zhao_2013_24130824	15	"HD CD8+ T Cell, HCV CD8+ T Cell"	Microarray (Affymetrix HG-U133_Plus_2 (GPL570 and A-AFFY-44))		Homo sapiens	3.8	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	HD A8-CD8+ T-cells	lymphoid	T Cell		CD8+ T cell	Lymphocyte
GSM1210755;7392	7392	Zhao	GSM1210755	GSM1210755	Homo sapiens	HD CD8+ T Cell	Sample Type				biotin	Zhao	Zhao_2013_24130824	15	"HD CD8+ T Cell, HCV CD8+ T Cell"	Microarray (Affymetrix HG-U133_Plus_2 (GPL570 and A-AFFY-44))		Homo sapiens	3.8	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	HD A9-CD8+ T-cells	lymphoid	T Cell		CD8+ T cell	Lymphocyte
GSM1210756;7392	7392	Zhao	GSM1210756	GSM1210756	Homo sapiens	HD CD8+ T Cell	Sample Type				biotin	Zhao	Zhao_2013_24130824	15	"HD CD8+ T Cell, HCV CD8+ T Cell"	Microarray (Affymetrix HG-U133_Plus_2 (GPL570 and A-AFFY-44))		Homo sapiens	3.8	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	HD A11-CD8+ T-cells	lymphoid	T Cell		CD8+ T cell	Lymphocyte
GSM1210757;7392	7392	Zhao	GSM1210757	GSM1210757	Homo sapiens	HD CD8+ T Cell	Sample Type				biotin	Zhao	Zhao_2013_24130824	15	"HD CD8+ T Cell, HCV CD8+ T Cell"	Microarray (Affymetrix HG-U133_Plus_2 (GPL570 and A-AFFY-44))		Homo sapiens	3.8	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	HD A13-CD8+ T-cells	lymphoid	T Cell		CD8+ T cell	Lymphocyte
GSM1210758;7392	7392	Zhao	GSM1210758	GSM1210758	Homo sapiens	HD CD8+ T Cell	Sample Type				biotin	Zhao	Zhao_2013_24130824	15	"HD CD8+ T Cell, HCV CD8+ T Cell"	Microarray (Affymetrix HG-U133_Plus_2 (GPL570 and A-AFFY-44))		Homo sapiens	3.8	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	HD A14-CD8+ T-cells	lymphoid	T Cell		CD8+ T cell	Lymphocyte
GSM1210759;7392	7392	Zhao	GSM1210759	GSM1210759	Homo sapiens	HCV CD8+ T Cell	Sample Type				biotin	Zhao	Zhao_2013_24130824	15	"HD CD8+ T Cell, HCV CD8+ T Cell"	Microarray (Affymetrix HG-U133_Plus_2 (GPL570 and A-AFFY-44))		Homo sapiens	3.8	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	HCV-h B4-CD8+ T-cells	lymphoid	T Cell		CD8+ T cell	Lymphocyte
GSM1210760;7392	7392	Zhao	GSM1210760	GSM1210760	Homo sapiens	HCV CD8+ T Cell	Sample Type				biotin	Zhao	Zhao_2013_24130824	15	"HD CD8+ T Cell, HCV CD8+ T Cell"	Microarray (Affymetrix HG-U133_Plus_2 (GPL570 and A-AFFY-44))		Homo sapiens	3.8	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	HCV-l B6-CD8+ T-cells	lymphoid	T Cell		CD8+ T cell	Lymphocyte
GSM1210761;7392	7392	Zhao	GSM1210761	GSM1210761	Homo sapiens	HCV CD8+ T Cell	Sample Type				biotin	Zhao	Zhao_2013_24130824	15	"HD CD8+ T Cell, HCV CD8+ T Cell"	Microarray (Affymetrix HG-U133_Plus_2 (GPL570 and A-AFFY-44))		Homo sapiens	3.8	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	HCV-h B9-CD8+ T-cells	lymphoid	T Cell		CD8+ T cell	Lymphocyte
GSM1210762;7392	7392	Zhao	GSM1210762	GSM1210762	Homo sapiens	HCV CD8+ T Cell	Sample Type				biotin	Zhao	Zhao_2013_24130824	15	"HD CD8+ T Cell, HCV CD8+ T Cell"	Microarray (Affymetrix HG-U133_Plus_2 (GPL570 and A-AFFY-44))		Homo sapiens	3.8	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	HCV-h B16-CD8+ T-cells	lymphoid	T Cell		CD8+ T cell	Lymphocyte
GSM1210763;7392	7392	Zhao	GSM1210763	GSM1210763	Homo sapiens	HCV CD8+ T Cell	Sample Type				biotin	Zhao	Zhao_2013_24130824	15	"HD CD8+ T Cell, HCV CD8+ T Cell"	Microarray (Affymetrix HG-U133_Plus_2 (GPL570 and A-AFFY-44))		Homo sapiens	3.8	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	HCV-h B18-CD8+ T-cells	lymphoid	T Cell		CD8+ T cell	Lymphocyte
GSM1210764;7392	7392	Zhao	GSM1210764	GSM1210764	Homo sapiens	HCV CD8+ T Cell	Sample Type				biotin	Zhao	Zhao_2013_24130824	15	"HD CD8+ T Cell, HCV CD8+ T Cell"	Microarray (Affymetrix HG-U133_Plus_2 (GPL570 and A-AFFY-44))		Homo sapiens	3.8	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	HCV-h B27-CD8+ T-cells	lymphoid	T Cell		CD8+ T cell	Lymphocyte
GSM1210765;7392	7392	Zhao	GSM1210765	GSM1210765	Homo sapiens	HCV CD8+ T Cell	Sample Type				biotin	Zhao	Zhao_2013_24130824	15	"HD CD8+ T Cell, HCV CD8+ T Cell"	Microarray (Affymetrix HG-U133_Plus_2 (GPL570 and A-AFFY-44))		Homo sapiens	3.8	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	HCV-l B31-CD8+ T-cells	lymphoid	T Cell		CD8+ T cell	Lymphocyte
GSM1210766;7392	7392	Zhao	GSM1210766	GSM1210766	Homo sapiens	HCV CD8+ T Cell	Sample Type				biotin	Zhao	Zhao_2013_24130824	15	"HD CD8+ T Cell, HCV CD8+ T Cell"	Microarray (Affymetrix HG-U133_Plus_2 (GPL570 and A-AFFY-44))		Homo sapiens	3.8	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	HCV-l B36-CD8+ T-cells	lymphoid	T Cell		CD8+ T cell	Lymphocyte
GSM1210767;7392	7392	Zhao	GSM1210767	GSM1210767	Homo sapiens	HCV CD8+ T Cell	Sample Type				biotin	Zhao	Zhao_2013_24130824	15	"HD CD8+ T Cell, HCV CD8+ T Cell"	Microarray (Affymetrix HG-U133_Plus_2 (GPL570 and A-AFFY-44))		Homo sapiens	3.8	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	HCV-l B39-CD8+ T-cells	lymphoid	T Cell		CD8+ T cell	Lymphocyte
GSM1210768;7392	7392	Zhao	GSM1210768	GSM1210768	Homo sapiens	HCV CD8+ T Cell	Sample Type				biotin	Zhao	Zhao_2013_24130824	15	"HD CD8+ T Cell, HCV CD8+ T Cell"	Microarray (Affymetrix HG-U133_Plus_2 (GPL570 and A-AFFY-44))		Homo sapiens	3.8	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	HCV-l B42-CD8+ T-cells	lymphoid	T Cell		CD8+ T cell	Lymphocyte
GSM1212208;6213	6213	Beliakova-Bethell	GSM1212208	Donor1_pos_CD4	Homo sapiens	CD4+ T-cell	CL:0000492		CD4+ T cell			Beliakova-Bethell	"Multiple scientific disciplines require the isolation of specific subsets of blood cells from patient samples for gene expression analysis by microarray or RNA-sequencing, preserving disease- or treatment-related signatures. However, little is known with respect to the impact of different cell isolation methods on gene expression and the effects of positive selection, negative selection, and fluorescence activated cell sorting (FACS) have not previously been assessed in parallel. To address this knowledge gap, CD4+ T cells, CD8+ T cells, B cells, and monocytes were isolated from blood samples from five independent donors using positive immunomagnetic selection, negative immunomagnetic selection, and FACS. We hypothesized that positive selection and FACS would yield higher purity but may have an impact on gene expression since both methods utilize antibodies that bind surface receptors of the cell type of interest. Moreover, FACS might upregulate stress response genes due to passage of the cells through the sorter. Microarray gene expression data were generated and subjected to unsupervised clustering and differential gene expression analysis. Surprisingly, these analyses revealed that gene expression signatures were more similar between cells isolated by negative selection and FACS compared to cells isolated by positive selection. Moreover, genes that are involved in the response to stress generally had the highest expression in cells isolated by negative or positive selection and not FACS. Thus, FACS is the recommended method for isolation of leukocyte subsets for gene expression studies since this method results in the purest subset populations and does not appear to induce a stress response."	50	"neg-select B-cell, CD19+ B-cell, FACS selected B-cell, neg-select CD4 T-cell, CD4+ T-cell, FACS selected CD4 T cell, neg-select CD8 T-cell, CD8+ T-cell, FACS selected CD8 T cell, neg-select Mo, CD33+ Mo, FACS selected Mo"	Microarray (Illumina HumanHT-12 V4)	leukomics	Homo sapiens	3.3	Illumina V4	"rgb(146,0,0)"	diamond	T Cell CD4+ bead-selected adult	lymphoid	T Cell	adult	CD4+ T cell	Lymphocyte
GSM1212210;6213	6213	Beliakova-Bethell	GSM1212210	Donor2_pos_B	Homo sapiens	CD19+ B-cell	CL:0000236		B cell			Beliakova-Bethell	"Multiple scientific disciplines require the isolation of specific subsets of blood cells from patient samples for gene expression analysis by microarray or RNA-sequencing, preserving disease- or treatment-related signatures. However, little is known with respect to the impact of different cell isolation methods on gene expression and the effects of positive selection, negative selection, and fluorescence activated cell sorting (FACS) have not previously been assessed in parallel. To address this knowledge gap, CD4+ T cells, CD8+ T cells, B cells, and monocytes were isolated from blood samples from five independent donors using positive immunomagnetic selection, negative immunomagnetic selection, and FACS. We hypothesized that positive selection and FACS would yield higher purity but may have an impact on gene expression since both methods utilize antibodies that bind surface receptors of the cell type of interest. Moreover, FACS might upregulate stress response genes due to passage of the cells through the sorter. Microarray gene expression data were generated and subjected to unsupervised clustering and differential gene expression analysis. Surprisingly, these analyses revealed that gene expression signatures were more similar between cells isolated by negative selection and FACS compared to cells isolated by positive selection. Moreover, genes that are involved in the response to stress generally had the highest expression in cells isolated by negative or positive selection and not FACS. Thus, FACS is the recommended method for isolation of leukocyte subsets for gene expression studies since this method results in the purest subset populations and does not appear to induce a stress response."	50	"neg-select B-cell, CD19+ B-cell, FACS selected B-cell, neg-select CD4 T-cell, CD4+ T-cell, FACS selected CD4 T cell, neg-select CD8 T-cell, CD8+ T-cell, FACS selected CD8 T cell, neg-select Mo, CD33+ Mo, FACS selected Mo"	Microarray (Illumina HumanHT-12 V4)	leukomics	Homo sapiens	3.3	Illumina V4	"rgb(146,0,0)"	diamond	B Cell CD19+ bead-selected adult	lymphoid	B Cell	adult	B cell	Lymphocyte
GSM1212212;6213	6213	Beliakova-Bethell	GSM1212212	Donor4_pos_mono	Homo sapiens	CD33+ Mo	CL:0000576		monocyte			Beliakova-Bethell	"Multiple scientific disciplines require the isolation of specific subsets of blood cells from patient samples for gene expression analysis by microarray or RNA-sequencing, preserving disease- or treatment-related signatures. However, little is known with respect to the impact of different cell isolation methods on gene expression and the effects of positive selection, negative selection, and fluorescence activated cell sorting (FACS) have not previously been assessed in parallel. To address this knowledge gap, CD4+ T cells, CD8+ T cells, B cells, and monocytes were isolated from blood samples from five independent donors using positive immunomagnetic selection, negative immunomagnetic selection, and FACS. We hypothesized that positive selection and FACS would yield higher purity but may have an impact on gene expression since both methods utilize antibodies that bind surface receptors of the cell type of interest. Moreover, FACS might upregulate stress response genes due to passage of the cells through the sorter. Microarray gene expression data were generated and subjected to unsupervised clustering and differential gene expression analysis. Surprisingly, these analyses revealed that gene expression signatures were more similar between cells isolated by negative selection and FACS compared to cells isolated by positive selection. Moreover, genes that are involved in the response to stress generally had the highest expression in cells isolated by negative or positive selection and not FACS. Thus, FACS is the recommended method for isolation of leukocyte subsets for gene expression studies since this method results in the purest subset populations and does not appear to induce a stress response."	50	"neg-select B-cell, CD19+ B-cell, FACS selected B-cell, neg-select CD4 T-cell, CD4+ T-cell, FACS selected CD4 T cell, neg-select CD8 T-cell, CD8+ T-cell, FACS selected CD8 T cell, neg-select Mo, CD33+ Mo, FACS selected Mo"	Microarray (Illumina HumanHT-12 V4)	leukomics	Homo sapiens	3.3	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD33+ bead-selected adult	myeloid	myeloid	adult	monocyte	Circulating Monocyte & Granulocyte
GSM1212213;6213	6213	Beliakova-Bethell	GSM1212213	Donor3_FACS_B	Homo sapiens	FACS selected B-cell	CL:0000236		B cell			Beliakova-Bethell	"Multiple scientific disciplines require the isolation of specific subsets of blood cells from patient samples for gene expression analysis by microarray or RNA-sequencing, preserving disease- or treatment-related signatures. However, little is known with respect to the impact of different cell isolation methods on gene expression and the effects of positive selection, negative selection, and fluorescence activated cell sorting (FACS) have not previously been assessed in parallel. To address this knowledge gap, CD4+ T cells, CD8+ T cells, B cells, and monocytes were isolated from blood samples from five independent donors using positive immunomagnetic selection, negative immunomagnetic selection, and FACS. We hypothesized that positive selection and FACS would yield higher purity but may have an impact on gene expression since both methods utilize antibodies that bind surface receptors of the cell type of interest. Moreover, FACS might upregulate stress response genes due to passage of the cells through the sorter. Microarray gene expression data were generated and subjected to unsupervised clustering and differential gene expression analysis. Surprisingly, these analyses revealed that gene expression signatures were more similar between cells isolated by negative selection and FACS compared to cells isolated by positive selection. Moreover, genes that are involved in the response to stress generally had the highest expression in cells isolated by negative or positive selection and not FACS. Thus, FACS is the recommended method for isolation of leukocyte subsets for gene expression studies since this method results in the purest subset populations and does not appear to induce a stress response."	50	"neg-select B-cell, CD19+ B-cell, FACS selected B-cell, neg-select CD4 T-cell, CD4+ T-cell, FACS selected CD4 T cell, neg-select CD8 T-cell, CD8+ T-cell, FACS selected CD8 T cell, neg-select Mo, CD33+ Mo, FACS selected Mo"	Microarray (Illumina HumanHT-12 V4)	leukomics	Homo sapiens	3.3	Illumina V4	"rgb(146,0,0)"	diamond	B Cell CD33-CD4-CD8-CD19+ FACS adult	lymphoid	B Cell	adult	B cell	Lymphocyte
GSM1212214;6213	6213	Beliakova-Bethell	GSM1212214	Donor2_pos_CD8	Homo sapiens	CD8+ T-cell	CL:0000625		CD8+ T cell			Beliakova-Bethell	"Multiple scientific disciplines require the isolation of specific subsets of blood cells from patient samples for gene expression analysis by microarray or RNA-sequencing, preserving disease- or treatment-related signatures. However, little is known with respect to the impact of different cell isolation methods on gene expression and the effects of positive selection, negative selection, and fluorescence activated cell sorting (FACS) have not previously been assessed in parallel. To address this knowledge gap, CD4+ T cells, CD8+ T cells, B cells, and monocytes were isolated from blood samples from five independent donors using positive immunomagnetic selection, negative immunomagnetic selection, and FACS. We hypothesized that positive selection and FACS would yield higher purity but may have an impact on gene expression since both methods utilize antibodies that bind surface receptors of the cell type of interest. Moreover, FACS might upregulate stress response genes due to passage of the cells through the sorter. Microarray gene expression data were generated and subjected to unsupervised clustering and differential gene expression analysis. Surprisingly, these analyses revealed that gene expression signatures were more similar between cells isolated by negative selection and FACS compared to cells isolated by positive selection. Moreover, genes that are involved in the response to stress generally had the highest expression in cells isolated by negative or positive selection and not FACS. Thus, FACS is the recommended method for isolation of leukocyte subsets for gene expression studies since this method results in the purest subset populations and does not appear to induce a stress response."	50	"neg-select B-cell, CD19+ B-cell, FACS selected B-cell, neg-select CD4 T-cell, CD4+ T-cell, FACS selected CD4 T cell, neg-select CD8 T-cell, CD8+ T-cell, FACS selected CD8 T cell, neg-select Mo, CD33+ Mo, FACS selected Mo"	Microarray (Illumina HumanHT-12 V4)	leukomics	Homo sapiens	3.3	Illumina V4	"rgb(146,0,0)"	diamond	T Cell CD8+ bead-selected adult	lymphoid	T Cell	adult	CD8+ T cell	Lymphocyte
GSM1212215;6213	6213	Beliakova-Bethell	GSM1212215	Donor4_FACS_CD4	Homo sapiens	FACS selected CD4 T cell	CL:0000492		CD4+ T cell			Beliakova-Bethell	"Multiple scientific disciplines require the isolation of specific subsets of blood cells from patient samples for gene expression analysis by microarray or RNA-sequencing, preserving disease- or treatment-related signatures. However, little is known with respect to the impact of different cell isolation methods on gene expression and the effects of positive selection, negative selection, and fluorescence activated cell sorting (FACS) have not previously been assessed in parallel. To address this knowledge gap, CD4+ T cells, CD8+ T cells, B cells, and monocytes were isolated from blood samples from five independent donors using positive immunomagnetic selection, negative immunomagnetic selection, and FACS. We hypothesized that positive selection and FACS would yield higher purity but may have an impact on gene expression since both methods utilize antibodies that bind surface receptors of the cell type of interest. Moreover, FACS might upregulate stress response genes due to passage of the cells through the sorter. Microarray gene expression data were generated and subjected to unsupervised clustering and differential gene expression analysis. Surprisingly, these analyses revealed that gene expression signatures were more similar between cells isolated by negative selection and FACS compared to cells isolated by positive selection. Moreover, genes that are involved in the response to stress generally had the highest expression in cells isolated by negative or positive selection and not FACS. Thus, FACS is the recommended method for isolation of leukocyte subsets for gene expression studies since this method results in the purest subset populations and does not appear to induce a stress response."	50	"neg-select B-cell, CD19+ B-cell, FACS selected B-cell, neg-select CD4 T-cell, CD4+ T-cell, FACS selected CD4 T cell, neg-select CD8 T-cell, CD8+ T-cell, FACS selected CD8 T cell, neg-select Mo, CD33+ Mo, FACS selected Mo"	Microarray (Illumina HumanHT-12 V4)	leukomics	Homo sapiens	3.3	Illumina V4	"rgb(146,0,0)"	diamond	T Cell CD33-CD8-CD4+ FACS adult	lymphoid	T Cell	adult	CD4+ T cell	Lymphocyte
GSM1212216;6213	6213	Beliakova-Bethell	GSM1212216	Donor4_pos_B	Homo sapiens	CD19+ B-cell	CL:0000236		B cell			Beliakova-Bethell	"Multiple scientific disciplines require the isolation of specific subsets of blood cells from patient samples for gene expression analysis by microarray or RNA-sequencing, preserving disease- or treatment-related signatures. However, little is known with respect to the impact of different cell isolation methods on gene expression and the effects of positive selection, negative selection, and fluorescence activated cell sorting (FACS) have not previously been assessed in parallel. To address this knowledge gap, CD4+ T cells, CD8+ T cells, B cells, and monocytes were isolated from blood samples from five independent donors using positive immunomagnetic selection, negative immunomagnetic selection, and FACS. We hypothesized that positive selection and FACS would yield higher purity but may have an impact on gene expression since both methods utilize antibodies that bind surface receptors of the cell type of interest. Moreover, FACS might upregulate stress response genes due to passage of the cells through the sorter. Microarray gene expression data were generated and subjected to unsupervised clustering and differential gene expression analysis. Surprisingly, these analyses revealed that gene expression signatures were more similar between cells isolated by negative selection and FACS compared to cells isolated by positive selection. Moreover, genes that are involved in the response to stress generally had the highest expression in cells isolated by negative or positive selection and not FACS. Thus, FACS is the recommended method for isolation of leukocyte subsets for gene expression studies since this method results in the purest subset populations and does not appear to induce a stress response."	50	"neg-select B-cell, CD19+ B-cell, FACS selected B-cell, neg-select CD4 T-cell, CD4+ T-cell, FACS selected CD4 T cell, neg-select CD8 T-cell, CD8+ T-cell, FACS selected CD8 T cell, neg-select Mo, CD33+ Mo, FACS selected Mo"	Microarray (Illumina HumanHT-12 V4)	leukomics	Homo sapiens	3.3	Illumina V4	"rgb(146,0,0)"	diamond	B Cell CD19+ bead-selected adult	lymphoid	B Cell	adult	B cell	Lymphocyte
GSM1212219;6213	6213	Beliakova-Bethell	GSM1212219	Donor2_pos_CD4	Homo sapiens	CD4+ T-cell	CL:0000492		CD4+ T cell			Beliakova-Bethell	"Multiple scientific disciplines require the isolation of specific subsets of blood cells from patient samples for gene expression analysis by microarray or RNA-sequencing, preserving disease- or treatment-related signatures. However, little is known with respect to the impact of different cell isolation methods on gene expression and the effects of positive selection, negative selection, and fluorescence activated cell sorting (FACS) have not previously been assessed in parallel. To address this knowledge gap, CD4+ T cells, CD8+ T cells, B cells, and monocytes were isolated from blood samples from five independent donors using positive immunomagnetic selection, negative immunomagnetic selection, and FACS. We hypothesized that positive selection and FACS would yield higher purity but may have an impact on gene expression since both methods utilize antibodies that bind surface receptors of the cell type of interest. Moreover, FACS might upregulate stress response genes due to passage of the cells through the sorter. Microarray gene expression data were generated and subjected to unsupervised clustering and differential gene expression analysis. Surprisingly, these analyses revealed that gene expression signatures were more similar between cells isolated by negative selection and FACS compared to cells isolated by positive selection. Moreover, genes that are involved in the response to stress generally had the highest expression in cells isolated by negative or positive selection and not FACS. Thus, FACS is the recommended method for isolation of leukocyte subsets for gene expression studies since this method results in the purest subset populations and does not appear to induce a stress response."	50	"neg-select B-cell, CD19+ B-cell, FACS selected B-cell, neg-select CD4 T-cell, CD4+ T-cell, FACS selected CD4 T cell, neg-select CD8 T-cell, CD8+ T-cell, FACS selected CD8 T cell, neg-select Mo, CD33+ Mo, FACS selected Mo"	Microarray (Illumina HumanHT-12 V4)	leukomics	Homo sapiens	3.3	Illumina V4	"rgb(146,0,0)"	diamond	T Cell CD4+ bead-selected adult	lymphoid	T Cell	adult	CD4+ T cell	Lymphocyte
GSM1212220;6213	6213	Beliakova-Bethell	GSM1212220	Donor2_FACS_CD8	Homo sapiens	FACS selected CD8 T cell	CL:0000625		CD8+ T cell			Beliakova-Bethell	"Multiple scientific disciplines require the isolation of specific subsets of blood cells from patient samples for gene expression analysis by microarray or RNA-sequencing, preserving disease- or treatment-related signatures. However, little is known with respect to the impact of different cell isolation methods on gene expression and the effects of positive selection, negative selection, and fluorescence activated cell sorting (FACS) have not previously been assessed in parallel. To address this knowledge gap, CD4+ T cells, CD8+ T cells, B cells, and monocytes were isolated from blood samples from five independent donors using positive immunomagnetic selection, negative immunomagnetic selection, and FACS. We hypothesized that positive selection and FACS would yield higher purity but may have an impact on gene expression since both methods utilize antibodies that bind surface receptors of the cell type of interest. Moreover, FACS might upregulate stress response genes due to passage of the cells through the sorter. Microarray gene expression data were generated and subjected to unsupervised clustering and differential gene expression analysis. Surprisingly, these analyses revealed that gene expression signatures were more similar between cells isolated by negative selection and FACS compared to cells isolated by positive selection. Moreover, genes that are involved in the response to stress generally had the highest expression in cells isolated by negative or positive selection and not FACS. Thus, FACS is the recommended method for isolation of leukocyte subsets for gene expression studies since this method results in the purest subset populations and does not appear to induce a stress response."	50	"neg-select B-cell, CD19+ B-cell, FACS selected B-cell, neg-select CD4 T-cell, CD4+ T-cell, FACS selected CD4 T cell, neg-select CD8 T-cell, CD8+ T-cell, FACS selected CD8 T cell, neg-select Mo, CD33+ Mo, FACS selected Mo"	Microarray (Illumina HumanHT-12 V4)	leukomics	Homo sapiens	3.3	Illumina V4	"rgb(146,0,0)"	diamond	T Cell CD33-CD4-CD8+ FACS adult	lymphoid	T Cell	adult	CD8+ T cell	Lymphocyte
GSM1212221;6213	6213	Beliakova-Bethell	GSM1212221	Donor5_pos_mono	Homo sapiens	CD33+ Mo	CL:0000576		monocyte			Beliakova-Bethell	"Multiple scientific disciplines require the isolation of specific subsets of blood cells from patient samples for gene expression analysis by microarray or RNA-sequencing, preserving disease- or treatment-related signatures. However, little is known with respect to the impact of different cell isolation methods on gene expression and the effects of positive selection, negative selection, and fluorescence activated cell sorting (FACS) have not previously been assessed in parallel. To address this knowledge gap, CD4+ T cells, CD8+ T cells, B cells, and monocytes were isolated from blood samples from five independent donors using positive immunomagnetic selection, negative immunomagnetic selection, and FACS. We hypothesized that positive selection and FACS would yield higher purity but may have an impact on gene expression since both methods utilize antibodies that bind surface receptors of the cell type of interest. Moreover, FACS might upregulate stress response genes due to passage of the cells through the sorter. Microarray gene expression data were generated and subjected to unsupervised clustering and differential gene expression analysis. Surprisingly, these analyses revealed that gene expression signatures were more similar between cells isolated by negative selection and FACS compared to cells isolated by positive selection. Moreover, genes that are involved in the response to stress generally had the highest expression in cells isolated by negative or positive selection and not FACS. Thus, FACS is the recommended method for isolation of leukocyte subsets for gene expression studies since this method results in the purest subset populations and does not appear to induce a stress response."	50	"neg-select B-cell, CD19+ B-cell, FACS selected B-cell, neg-select CD4 T-cell, CD4+ T-cell, FACS selected CD4 T cell, neg-select CD8 T-cell, CD8+ T-cell, FACS selected CD8 T cell, neg-select Mo, CD33+ Mo, FACS selected Mo"	Microarray (Illumina HumanHT-12 V4)	leukomics	Homo sapiens	3.3	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD33+ bead-selected adult	myeloid	myeloid	adult	monocyte	Circulating Monocyte & Granulocyte
GSM1212222;6213	6213	Beliakova-Bethell	GSM1212222	Donor1_FACS_CD4	Homo sapiens	FACS selected CD4 T cell	CL:0000492		CD4+ T cell			Beliakova-Bethell	"Multiple scientific disciplines require the isolation of specific subsets of blood cells from patient samples for gene expression analysis by microarray or RNA-sequencing, preserving disease- or treatment-related signatures. However, little is known with respect to the impact of different cell isolation methods on gene expression and the effects of positive selection, negative selection, and fluorescence activated cell sorting (FACS) have not previously been assessed in parallel. To address this knowledge gap, CD4+ T cells, CD8+ T cells, B cells, and monocytes were isolated from blood samples from five independent donors using positive immunomagnetic selection, negative immunomagnetic selection, and FACS. We hypothesized that positive selection and FACS would yield higher purity but may have an impact on gene expression since both methods utilize antibodies that bind surface receptors of the cell type of interest. Moreover, FACS might upregulate stress response genes due to passage of the cells through the sorter. Microarray gene expression data were generated and subjected to unsupervised clustering and differential gene expression analysis. Surprisingly, these analyses revealed that gene expression signatures were more similar between cells isolated by negative selection and FACS compared to cells isolated by positive selection. Moreover, genes that are involved in the response to stress generally had the highest expression in cells isolated by negative or positive selection and not FACS. Thus, FACS is the recommended method for isolation of leukocyte subsets for gene expression studies since this method results in the purest subset populations and does not appear to induce a stress response."	50	"neg-select B-cell, CD19+ B-cell, FACS selected B-cell, neg-select CD4 T-cell, CD4+ T-cell, FACS selected CD4 T cell, neg-select CD8 T-cell, CD8+ T-cell, FACS selected CD8 T cell, neg-select Mo, CD33+ Mo, FACS selected Mo"	Microarray (Illumina HumanHT-12 V4)	leukomics	Homo sapiens	3.3	Illumina V4	"rgb(146,0,0)"	diamond	T Cell CD33-CD8-CD4+ FACS adult	lymphoid	T Cell	adult	CD4+ T cell	Lymphocyte
GSM1212225;6213	6213	Beliakova-Bethell	GSM1212225	Donor3_pos_CD8	Homo sapiens	CD8+ T-cell	CL:0000625		CD8+ T cell			Beliakova-Bethell	"Multiple scientific disciplines require the isolation of specific subsets of blood cells from patient samples for gene expression analysis by microarray or RNA-sequencing, preserving disease- or treatment-related signatures. However, little is known with respect to the impact of different cell isolation methods on gene expression and the effects of positive selection, negative selection, and fluorescence activated cell sorting (FACS) have not previously been assessed in parallel. To address this knowledge gap, CD4+ T cells, CD8+ T cells, B cells, and monocytes were isolated from blood samples from five independent donors using positive immunomagnetic selection, negative immunomagnetic selection, and FACS. We hypothesized that positive selection and FACS would yield higher purity but may have an impact on gene expression since both methods utilize antibodies that bind surface receptors of the cell type of interest. Moreover, FACS might upregulate stress response genes due to passage of the cells through the sorter. Microarray gene expression data were generated and subjected to unsupervised clustering and differential gene expression analysis. Surprisingly, these analyses revealed that gene expression signatures were more similar between cells isolated by negative selection and FACS compared to cells isolated by positive selection. Moreover, genes that are involved in the response to stress generally had the highest expression in cells isolated by negative or positive selection and not FACS. Thus, FACS is the recommended method for isolation of leukocyte subsets for gene expression studies since this method results in the purest subset populations and does not appear to induce a stress response."	50	"neg-select B-cell, CD19+ B-cell, FACS selected B-cell, neg-select CD4 T-cell, CD4+ T-cell, FACS selected CD4 T cell, neg-select CD8 T-cell, CD8+ T-cell, FACS selected CD8 T cell, neg-select Mo, CD33+ Mo, FACS selected Mo"	Microarray (Illumina HumanHT-12 V4)	leukomics	Homo sapiens	3.3	Illumina V4	"rgb(146,0,0)"	diamond	T Cell CD8+ bead-selected adult	lymphoid	T Cell	adult	CD8+ T cell	Lymphocyte
GSM1212227;6213	6213	Beliakova-Bethell	GSM1212227	Donor3_pos_CD4	Homo sapiens	CD4+ T-cell	CL:0000492		CD4+ T cell			Beliakova-Bethell	"Multiple scientific disciplines require the isolation of specific subsets of blood cells from patient samples for gene expression analysis by microarray or RNA-sequencing, preserving disease- or treatment-related signatures. However, little is known with respect to the impact of different cell isolation methods on gene expression and the effects of positive selection, negative selection, and fluorescence activated cell sorting (FACS) have not previously been assessed in parallel. To address this knowledge gap, CD4+ T cells, CD8+ T cells, B cells, and monocytes were isolated from blood samples from five independent donors using positive immunomagnetic selection, negative immunomagnetic selection, and FACS. We hypothesized that positive selection and FACS would yield higher purity but may have an impact on gene expression since both methods utilize antibodies that bind surface receptors of the cell type of interest. Moreover, FACS might upregulate stress response genes due to passage of the cells through the sorter. Microarray gene expression data were generated and subjected to unsupervised clustering and differential gene expression analysis. Surprisingly, these analyses revealed that gene expression signatures were more similar between cells isolated by negative selection and FACS compared to cells isolated by positive selection. Moreover, genes that are involved in the response to stress generally had the highest expression in cells isolated by negative or positive selection and not FACS. Thus, FACS is the recommended method for isolation of leukocyte subsets for gene expression studies since this method results in the purest subset populations and does not appear to induce a stress response."	50	"neg-select B-cell, CD19+ B-cell, FACS selected B-cell, neg-select CD4 T-cell, CD4+ T-cell, FACS selected CD4 T cell, neg-select CD8 T-cell, CD8+ T-cell, FACS selected CD8 T cell, neg-select Mo, CD33+ Mo, FACS selected Mo"	Microarray (Illumina HumanHT-12 V4)	leukomics	Homo sapiens	3.3	Illumina V4	"rgb(146,0,0)"	diamond	T Cell CD4+ bead-selected adult	lymphoid	T Cell	adult	CD4+ T cell	Lymphocyte
GSM1212228;6213	6213	Beliakova-Bethell	GSM1212228	Donor4_FACS_CD8	Homo sapiens	FACS selected CD8 T cell	CL:0000625		CD8+ T cell			Beliakova-Bethell	"Multiple scientific disciplines require the isolation of specific subsets of blood cells from patient samples for gene expression analysis by microarray or RNA-sequencing, preserving disease- or treatment-related signatures. However, little is known with respect to the impact of different cell isolation methods on gene expression and the effects of positive selection, negative selection, and fluorescence activated cell sorting (FACS) have not previously been assessed in parallel. To address this knowledge gap, CD4+ T cells, CD8+ T cells, B cells, and monocytes were isolated from blood samples from five independent donors using positive immunomagnetic selection, negative immunomagnetic selection, and FACS. We hypothesized that positive selection and FACS would yield higher purity but may have an impact on gene expression since both methods utilize antibodies that bind surface receptors of the cell type of interest. Moreover, FACS might upregulate stress response genes due to passage of the cells through the sorter. Microarray gene expression data were generated and subjected to unsupervised clustering and differential gene expression analysis. Surprisingly, these analyses revealed that gene expression signatures were more similar between cells isolated by negative selection and FACS compared to cells isolated by positive selection. Moreover, genes that are involved in the response to stress generally had the highest expression in cells isolated by negative or positive selection and not FACS. Thus, FACS is the recommended method for isolation of leukocyte subsets for gene expression studies since this method results in the purest subset populations and does not appear to induce a stress response."	50	"neg-select B-cell, CD19+ B-cell, FACS selected B-cell, neg-select CD4 T-cell, CD4+ T-cell, FACS selected CD4 T cell, neg-select CD8 T-cell, CD8+ T-cell, FACS selected CD8 T cell, neg-select Mo, CD33+ Mo, FACS selected Mo"	Microarray (Illumina HumanHT-12 V4)	leukomics	Homo sapiens	3.3	Illumina V4	"rgb(146,0,0)"	diamond	T Cell CD33-CD4-CD8+ FACS adult	lymphoid	T Cell	adult	CD8+ T cell	Lymphocyte
GSM1212229;6213	6213	Beliakova-Bethell	GSM1212229	Donor1_pos_mono	Homo sapiens	CD33+ Mo	CL:0000576		monocyte			Beliakova-Bethell	"Multiple scientific disciplines require the isolation of specific subsets of blood cells from patient samples for gene expression analysis by microarray or RNA-sequencing, preserving disease- or treatment-related signatures. However, little is known with respect to the impact of different cell isolation methods on gene expression and the effects of positive selection, negative selection, and fluorescence activated cell sorting (FACS) have not previously been assessed in parallel. To address this knowledge gap, CD4+ T cells, CD8+ T cells, B cells, and monocytes were isolated from blood samples from five independent donors using positive immunomagnetic selection, negative immunomagnetic selection, and FACS. We hypothesized that positive selection and FACS would yield higher purity but may have an impact on gene expression since both methods utilize antibodies that bind surface receptors of the cell type of interest. Moreover, FACS might upregulate stress response genes due to passage of the cells through the sorter. Microarray gene expression data were generated and subjected to unsupervised clustering and differential gene expression analysis. Surprisingly, these analyses revealed that gene expression signatures were more similar between cells isolated by negative selection and FACS compared to cells isolated by positive selection. Moreover, genes that are involved in the response to stress generally had the highest expression in cells isolated by negative or positive selection and not FACS. Thus, FACS is the recommended method for isolation of leukocyte subsets for gene expression studies since this method results in the purest subset populations and does not appear to induce a stress response."	50	"neg-select B-cell, CD19+ B-cell, FACS selected B-cell, neg-select CD4 T-cell, CD4+ T-cell, FACS selected CD4 T cell, neg-select CD8 T-cell, CD8+ T-cell, FACS selected CD8 T cell, neg-select Mo, CD33+ Mo, FACS selected Mo"	Microarray (Illumina HumanHT-12 V4)	leukomics	Homo sapiens	3.3	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD33+ bead-selected adult	myeloid	myeloid	adult	monocyte	Circulating Monocyte & Granulocyte
GSM1212230;6213	6213	Beliakova-Bethell	GSM1212230	Donor3_FACS_CD8	Homo sapiens	FACS selected CD8 T cell	CL:0000625		CD8+ T cell			Beliakova-Bethell	"Multiple scientific disciplines require the isolation of specific subsets of blood cells from patient samples for gene expression analysis by microarray or RNA-sequencing, preserving disease- or treatment-related signatures. However, little is known with respect to the impact of different cell isolation methods on gene expression and the effects of positive selection, negative selection, and fluorescence activated cell sorting (FACS) have not previously been assessed in parallel. To address this knowledge gap, CD4+ T cells, CD8+ T cells, B cells, and monocytes were isolated from blood samples from five independent donors using positive immunomagnetic selection, negative immunomagnetic selection, and FACS. We hypothesized that positive selection and FACS would yield higher purity but may have an impact on gene expression since both methods utilize antibodies that bind surface receptors of the cell type of interest. Moreover, FACS might upregulate stress response genes due to passage of the cells through the sorter. Microarray gene expression data were generated and subjected to unsupervised clustering and differential gene expression analysis. Surprisingly, these analyses revealed that gene expression signatures were more similar between cells isolated by negative selection and FACS compared to cells isolated by positive selection. Moreover, genes that are involved in the response to stress generally had the highest expression in cells isolated by negative or positive selection and not FACS. Thus, FACS is the recommended method for isolation of leukocyte subsets for gene expression studies since this method results in the purest subset populations and does not appear to induce a stress response."	50	"neg-select B-cell, CD19+ B-cell, FACS selected B-cell, neg-select CD4 T-cell, CD4+ T-cell, FACS selected CD4 T cell, neg-select CD8 T-cell, CD8+ T-cell, FACS selected CD8 T cell, neg-select Mo, CD33+ Mo, FACS selected Mo"	Microarray (Illumina HumanHT-12 V4)	leukomics	Homo sapiens	3.3	Illumina V4	"rgb(146,0,0)"	diamond	T Cell CD33-CD4-CD8+ FACS adult	lymphoid	T Cell	adult	CD8+ T cell	Lymphocyte
GSM1212232;6213	6213	Beliakova-Bethell	GSM1212232	Donor2_FACS_mono	Homo sapiens	FACS selected Mo	CL:0000576		monocyte			Beliakova-Bethell	"Multiple scientific disciplines require the isolation of specific subsets of blood cells from patient samples for gene expression analysis by microarray or RNA-sequencing, preserving disease- or treatment-related signatures. However, little is known with respect to the impact of different cell isolation methods on gene expression and the effects of positive selection, negative selection, and fluorescence activated cell sorting (FACS) have not previously been assessed in parallel. To address this knowledge gap, CD4+ T cells, CD8+ T cells, B cells, and monocytes were isolated from blood samples from five independent donors using positive immunomagnetic selection, negative immunomagnetic selection, and FACS. We hypothesized that positive selection and FACS would yield higher purity but may have an impact on gene expression since both methods utilize antibodies that bind surface receptors of the cell type of interest. Moreover, FACS might upregulate stress response genes due to passage of the cells through the sorter. Microarray gene expression data were generated and subjected to unsupervised clustering and differential gene expression analysis. Surprisingly, these analyses revealed that gene expression signatures were more similar between cells isolated by negative selection and FACS compared to cells isolated by positive selection. Moreover, genes that are involved in the response to stress generally had the highest expression in cells isolated by negative or positive selection and not FACS. Thus, FACS is the recommended method for isolation of leukocyte subsets for gene expression studies since this method results in the purest subset populations and does not appear to induce a stress response."	50	"neg-select B-cell, CD19+ B-cell, FACS selected B-cell, neg-select CD4 T-cell, CD4+ T-cell, FACS selected CD4 T cell, neg-select CD8 T-cell, CD8+ T-cell, FACS selected CD8 T cell, neg-select Mo, CD33+ Mo, FACS selected Mo"	Microarray (Illumina HumanHT-12 V4)	leukomics	Homo sapiens	3.3	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD45+CD33+ FACS adult	myeloid	myeloid	adult	monocyte	Circulating Monocyte & Granulocyte
GSM1212233;6213	6213	Beliakova-Bethell	GSM1212233	Donor5_pos_CD8	Homo sapiens	CD8+ T-cell	CL:0000625		CD8+ T cell			Beliakova-Bethell	"Multiple scientific disciplines require the isolation of specific subsets of blood cells from patient samples for gene expression analysis by microarray or RNA-sequencing, preserving disease- or treatment-related signatures. However, little is known with respect to the impact of different cell isolation methods on gene expression and the effects of positive selection, negative selection, and fluorescence activated cell sorting (FACS) have not previously been assessed in parallel. To address this knowledge gap, CD4+ T cells, CD8+ T cells, B cells, and monocytes were isolated from blood samples from five independent donors using positive immunomagnetic selection, negative immunomagnetic selection, and FACS. We hypothesized that positive selection and FACS would yield higher purity but may have an impact on gene expression since both methods utilize antibodies that bind surface receptors of the cell type of interest. Moreover, FACS might upregulate stress response genes due to passage of the cells through the sorter. Microarray gene expression data were generated and subjected to unsupervised clustering and differential gene expression analysis. Surprisingly, these analyses revealed that gene expression signatures were more similar between cells isolated by negative selection and FACS compared to cells isolated by positive selection. Moreover, genes that are involved in the response to stress generally had the highest expression in cells isolated by negative or positive selection and not FACS. Thus, FACS is the recommended method for isolation of leukocyte subsets for gene expression studies since this method results in the purest subset populations and does not appear to induce a stress response."	50	"neg-select B-cell, CD19+ B-cell, FACS selected B-cell, neg-select CD4 T-cell, CD4+ T-cell, FACS selected CD4 T cell, neg-select CD8 T-cell, CD8+ T-cell, FACS selected CD8 T cell, neg-select Mo, CD33+ Mo, FACS selected Mo"	Microarray (Illumina HumanHT-12 V4)	leukomics	Homo sapiens	3.3	Illumina V4	"rgb(146,0,0)"	diamond	T Cell CD8+ bead-selected adult	lymphoid	T Cell	adult	CD8+ T cell	Lymphocyte
GSM1212234;6213	6213	Beliakova-Bethell	GSM1212234	Donor1_FACS_B	Homo sapiens	FACS selected B-cell	CL:0000236		B cell			Beliakova-Bethell	"Multiple scientific disciplines require the isolation of specific subsets of blood cells from patient samples for gene expression analysis by microarray or RNA-sequencing, preserving disease- or treatment-related signatures. However, little is known with respect to the impact of different cell isolation methods on gene expression and the effects of positive selection, negative selection, and fluorescence activated cell sorting (FACS) have not previously been assessed in parallel. To address this knowledge gap, CD4+ T cells, CD8+ T cells, B cells, and monocytes were isolated from blood samples from five independent donors using positive immunomagnetic selection, negative immunomagnetic selection, and FACS. We hypothesized that positive selection and FACS would yield higher purity but may have an impact on gene expression since both methods utilize antibodies that bind surface receptors of the cell type of interest. Moreover, FACS might upregulate stress response genes due to passage of the cells through the sorter. Microarray gene expression data were generated and subjected to unsupervised clustering and differential gene expression analysis. Surprisingly, these analyses revealed that gene expression signatures were more similar between cells isolated by negative selection and FACS compared to cells isolated by positive selection. Moreover, genes that are involved in the response to stress generally had the highest expression in cells isolated by negative or positive selection and not FACS. Thus, FACS is the recommended method for isolation of leukocyte subsets for gene expression studies since this method results in the purest subset populations and does not appear to induce a stress response."	50	"neg-select B-cell, CD19+ B-cell, FACS selected B-cell, neg-select CD4 T-cell, CD4+ T-cell, FACS selected CD4 T cell, neg-select CD8 T-cell, CD8+ T-cell, FACS selected CD8 T cell, neg-select Mo, CD33+ Mo, FACS selected Mo"	Microarray (Illumina HumanHT-12 V4)	leukomics	Homo sapiens	3.3	Illumina V4	"rgb(146,0,0)"	diamond	B Cell CD33-CD4-CD8-CD19+ FACS adult	lymphoid	B Cell	adult	B cell	Lymphocyte
GSM1212235;6213	6213	Beliakova-Bethell	GSM1212235	Donor4_pos_CD4	Homo sapiens	CD4+ T-cell	CL:0000492		CD4+ T cell			Beliakova-Bethell	"Multiple scientific disciplines require the isolation of specific subsets of blood cells from patient samples for gene expression analysis by microarray or RNA-sequencing, preserving disease- or treatment-related signatures. However, little is known with respect to the impact of different cell isolation methods on gene expression and the effects of positive selection, negative selection, and fluorescence activated cell sorting (FACS) have not previously been assessed in parallel. To address this knowledge gap, CD4+ T cells, CD8+ T cells, B cells, and monocytes were isolated from blood samples from five independent donors using positive immunomagnetic selection, negative immunomagnetic selection, and FACS. We hypothesized that positive selection and FACS would yield higher purity but may have an impact on gene expression since both methods utilize antibodies that bind surface receptors of the cell type of interest. Moreover, FACS might upregulate stress response genes due to passage of the cells through the sorter. Microarray gene expression data were generated and subjected to unsupervised clustering and differential gene expression analysis. Surprisingly, these analyses revealed that gene expression signatures were more similar between cells isolated by negative selection and FACS compared to cells isolated by positive selection. Moreover, genes that are involved in the response to stress generally had the highest expression in cells isolated by negative or positive selection and not FACS. Thus, FACS is the recommended method for isolation of leukocyte subsets for gene expression studies since this method results in the purest subset populations and does not appear to induce a stress response."	50	"neg-select B-cell, CD19+ B-cell, FACS selected B-cell, neg-select CD4 T-cell, CD4+ T-cell, FACS selected CD4 T cell, neg-select CD8 T-cell, CD8+ T-cell, FACS selected CD8 T cell, neg-select Mo, CD33+ Mo, FACS selected Mo"	Microarray (Illumina HumanHT-12 V4)	leukomics	Homo sapiens	3.3	Illumina V4	"rgb(146,0,0)"	diamond	T Cell CD4+ bead-selected adult	lymphoid	T Cell	adult	CD4+ T cell	Lymphocyte
GSM1212237;6213	6213	Beliakova-Bethell	GSM1212237	Donor5_FACS_CD4	Homo sapiens	FACS selected CD4 T cell	CL:0000492		CD4+ T cell			Beliakova-Bethell	"Multiple scientific disciplines require the isolation of specific subsets of blood cells from patient samples for gene expression analysis by microarray or RNA-sequencing, preserving disease- or treatment-related signatures. However, little is known with respect to the impact of different cell isolation methods on gene expression and the effects of positive selection, negative selection, and fluorescence activated cell sorting (FACS) have not previously been assessed in parallel. To address this knowledge gap, CD4+ T cells, CD8+ T cells, B cells, and monocytes were isolated from blood samples from five independent donors using positive immunomagnetic selection, negative immunomagnetic selection, and FACS. We hypothesized that positive selection and FACS would yield higher purity but may have an impact on gene expression since both methods utilize antibodies that bind surface receptors of the cell type of interest. Moreover, FACS might upregulate stress response genes due to passage of the cells through the sorter. Microarray gene expression data were generated and subjected to unsupervised clustering and differential gene expression analysis. Surprisingly, these analyses revealed that gene expression signatures were more similar between cells isolated by negative selection and FACS compared to cells isolated by positive selection. Moreover, genes that are involved in the response to stress generally had the highest expression in cells isolated by negative or positive selection and not FACS. Thus, FACS is the recommended method for isolation of leukocyte subsets for gene expression studies since this method results in the purest subset populations and does not appear to induce a stress response."	50	"neg-select B-cell, CD19+ B-cell, FACS selected B-cell, neg-select CD4 T-cell, CD4+ T-cell, FACS selected CD4 T cell, neg-select CD8 T-cell, CD8+ T-cell, FACS selected CD8 T cell, neg-select Mo, CD33+ Mo, FACS selected Mo"	Microarray (Illumina HumanHT-12 V4)	leukomics	Homo sapiens	3.3	Illumina V4	"rgb(146,0,0)"	diamond	T Cell CD33-CD8-CD4+ FACS adult	lymphoid	T Cell	adult	CD4+ T cell	Lymphocyte
GSM1212240;6213	6213	Beliakova-Bethell	GSM1212240	Donor3_FACS_CD4	Homo sapiens	FACS selected CD4 T cell	CL:0000492		CD4+ T cell			Beliakova-Bethell	"Multiple scientific disciplines require the isolation of specific subsets of blood cells from patient samples for gene expression analysis by microarray or RNA-sequencing, preserving disease- or treatment-related signatures. However, little is known with respect to the impact of different cell isolation methods on gene expression and the effects of positive selection, negative selection, and fluorescence activated cell sorting (FACS) have not previously been assessed in parallel. To address this knowledge gap, CD4+ T cells, CD8+ T cells, B cells, and monocytes were isolated from blood samples from five independent donors using positive immunomagnetic selection, negative immunomagnetic selection, and FACS. We hypothesized that positive selection and FACS would yield higher purity but may have an impact on gene expression since both methods utilize antibodies that bind surface receptors of the cell type of interest. Moreover, FACS might upregulate stress response genes due to passage of the cells through the sorter. Microarray gene expression data were generated and subjected to unsupervised clustering and differential gene expression analysis. Surprisingly, these analyses revealed that gene expression signatures were more similar between cells isolated by negative selection and FACS compared to cells isolated by positive selection. Moreover, genes that are involved in the response to stress generally had the highest expression in cells isolated by negative or positive selection and not FACS. Thus, FACS is the recommended method for isolation of leukocyte subsets for gene expression studies since this method results in the purest subset populations and does not appear to induce a stress response."	50	"neg-select B-cell, CD19+ B-cell, FACS selected B-cell, neg-select CD4 T-cell, CD4+ T-cell, FACS selected CD4 T cell, neg-select CD8 T-cell, CD8+ T-cell, FACS selected CD8 T cell, neg-select Mo, CD33+ Mo, FACS selected Mo"	Microarray (Illumina HumanHT-12 V4)	leukomics	Homo sapiens	3.3	Illumina V4	"rgb(146,0,0)"	diamond	T Cell CD33-CD8-CD4+ FACS adult	lymphoid	T Cell	adult	CD4+ T cell	Lymphocyte
GSM1212241;6213	6213	Beliakova-Bethell	GSM1212241	Donor1_pos_CD8	Homo sapiens	CD8+ T-cell	CL:0000625		CD8+ T cell			Beliakova-Bethell	"Multiple scientific disciplines require the isolation of specific subsets of blood cells from patient samples for gene expression analysis by microarray or RNA-sequencing, preserving disease- or treatment-related signatures. However, little is known with respect to the impact of different cell isolation methods on gene expression and the effects of positive selection, negative selection, and fluorescence activated cell sorting (FACS) have not previously been assessed in parallel. To address this knowledge gap, CD4+ T cells, CD8+ T cells, B cells, and monocytes were isolated from blood samples from five independent donors using positive immunomagnetic selection, negative immunomagnetic selection, and FACS. We hypothesized that positive selection and FACS would yield higher purity but may have an impact on gene expression since both methods utilize antibodies that bind surface receptors of the cell type of interest. Moreover, FACS might upregulate stress response genes due to passage of the cells through the sorter. Microarray gene expression data were generated and subjected to unsupervised clustering and differential gene expression analysis. Surprisingly, these analyses revealed that gene expression signatures were more similar between cells isolated by negative selection and FACS compared to cells isolated by positive selection. Moreover, genes that are involved in the response to stress generally had the highest expression in cells isolated by negative or positive selection and not FACS. Thus, FACS is the recommended method for isolation of leukocyte subsets for gene expression studies since this method results in the purest subset populations and does not appear to induce a stress response."	50	"neg-select B-cell, CD19+ B-cell, FACS selected B-cell, neg-select CD4 T-cell, CD4+ T-cell, FACS selected CD4 T cell, neg-select CD8 T-cell, CD8+ T-cell, FACS selected CD8 T cell, neg-select Mo, CD33+ Mo, FACS selected Mo"	Microarray (Illumina HumanHT-12 V4)	leukomics	Homo sapiens	3.3	Illumina V4	"rgb(146,0,0)"	diamond	T Cell CD8+ bead-selected adult	lymphoid	T Cell	adult	CD8+ T cell	Lymphocyte
GSM1212243;6213	6213	Beliakova-Bethell	GSM1212243	Donor2_pos_mono	Homo sapiens	CD33+ Mo	CL:0000576		monocyte			Beliakova-Bethell	"Multiple scientific disciplines require the isolation of specific subsets of blood cells from patient samples for gene expression analysis by microarray or RNA-sequencing, preserving disease- or treatment-related signatures. However, little is known with respect to the impact of different cell isolation methods on gene expression and the effects of positive selection, negative selection, and fluorescence activated cell sorting (FACS) have not previously been assessed in parallel. To address this knowledge gap, CD4+ T cells, CD8+ T cells, B cells, and monocytes were isolated from blood samples from five independent donors using positive immunomagnetic selection, negative immunomagnetic selection, and FACS. We hypothesized that positive selection and FACS would yield higher purity but may have an impact on gene expression since both methods utilize antibodies that bind surface receptors of the cell type of interest. Moreover, FACS might upregulate stress response genes due to passage of the cells through the sorter. Microarray gene expression data were generated and subjected to unsupervised clustering and differential gene expression analysis. Surprisingly, these analyses revealed that gene expression signatures were more similar between cells isolated by negative selection and FACS compared to cells isolated by positive selection. Moreover, genes that are involved in the response to stress generally had the highest expression in cells isolated by negative or positive selection and not FACS. Thus, FACS is the recommended method for isolation of leukocyte subsets for gene expression studies since this method results in the purest subset populations and does not appear to induce a stress response."	50	"neg-select B-cell, CD19+ B-cell, FACS selected B-cell, neg-select CD4 T-cell, CD4+ T-cell, FACS selected CD4 T cell, neg-select CD8 T-cell, CD8+ T-cell, FACS selected CD8 T cell, neg-select Mo, CD33+ Mo, FACS selected Mo"	Microarray (Illumina HumanHT-12 V4)	leukomics	Homo sapiens	3.3	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD33+ bead-selected adult	myeloid	myeloid	adult	monocyte	Circulating Monocyte & Granulocyte
GSM1212244;6213	6213	Beliakova-Bethell	GSM1212244	Donor2_FACS_B	Homo sapiens	FACS selected B-cell	CL:0000236		B cell			Beliakova-Bethell	"Multiple scientific disciplines require the isolation of specific subsets of blood cells from patient samples for gene expression analysis by microarray or RNA-sequencing, preserving disease- or treatment-related signatures. However, little is known with respect to the impact of different cell isolation methods on gene expression and the effects of positive selection, negative selection, and fluorescence activated cell sorting (FACS) have not previously been assessed in parallel. To address this knowledge gap, CD4+ T cells, CD8+ T cells, B cells, and monocytes were isolated from blood samples from five independent donors using positive immunomagnetic selection, negative immunomagnetic selection, and FACS. We hypothesized that positive selection and FACS would yield higher purity but may have an impact on gene expression since both methods utilize antibodies that bind surface receptors of the cell type of interest. Moreover, FACS might upregulate stress response genes due to passage of the cells through the sorter. Microarray gene expression data were generated and subjected to unsupervised clustering and differential gene expression analysis. Surprisingly, these analyses revealed that gene expression signatures were more similar between cells isolated by negative selection and FACS compared to cells isolated by positive selection. Moreover, genes that are involved in the response to stress generally had the highest expression in cells isolated by negative or positive selection and not FACS. Thus, FACS is the recommended method for isolation of leukocyte subsets for gene expression studies since this method results in the purest subset populations and does not appear to induce a stress response."	50	"neg-select B-cell, CD19+ B-cell, FACS selected B-cell, neg-select CD4 T-cell, CD4+ T-cell, FACS selected CD4 T cell, neg-select CD8 T-cell, CD8+ T-cell, FACS selected CD8 T cell, neg-select Mo, CD33+ Mo, FACS selected Mo"	Microarray (Illumina HumanHT-12 V4)	leukomics	Homo sapiens	3.3	Illumina V4	"rgb(146,0,0)"	diamond	B Cell CD33-CD4-CD8-CD19+ FACS adult	lymphoid	B Cell	adult	B cell	Lymphocyte
GSM1212245;6213	6213	Beliakova-Bethell	GSM1212245	Donor5_FACS_CD8	Homo sapiens	FACS selected CD8 T cell	CL:0000625		CD8+ T cell			Beliakova-Bethell	"Multiple scientific disciplines require the isolation of specific subsets of blood cells from patient samples for gene expression analysis by microarray or RNA-sequencing, preserving disease- or treatment-related signatures. However, little is known with respect to the impact of different cell isolation methods on gene expression and the effects of positive selection, negative selection, and fluorescence activated cell sorting (FACS) have not previously been assessed in parallel. To address this knowledge gap, CD4+ T cells, CD8+ T cells, B cells, and monocytes were isolated from blood samples from five independent donors using positive immunomagnetic selection, negative immunomagnetic selection, and FACS. We hypothesized that positive selection and FACS would yield higher purity but may have an impact on gene expression since both methods utilize antibodies that bind surface receptors of the cell type of interest. Moreover, FACS might upregulate stress response genes due to passage of the cells through the sorter. Microarray gene expression data were generated and subjected to unsupervised clustering and differential gene expression analysis. Surprisingly, these analyses revealed that gene expression signatures were more similar between cells isolated by negative selection and FACS compared to cells isolated by positive selection. Moreover, genes that are involved in the response to stress generally had the highest expression in cells isolated by negative or positive selection and not FACS. Thus, FACS is the recommended method for isolation of leukocyte subsets for gene expression studies since this method results in the purest subset populations and does not appear to induce a stress response."	50	"neg-select B-cell, CD19+ B-cell, FACS selected B-cell, neg-select CD4 T-cell, CD4+ T-cell, FACS selected CD4 T cell, neg-select CD8 T-cell, CD8+ T-cell, FACS selected CD8 T cell, neg-select Mo, CD33+ Mo, FACS selected Mo"	Microarray (Illumina HumanHT-12 V4)	leukomics	Homo sapiens	3.3	Illumina V4	"rgb(146,0,0)"	diamond	T Cell CD33-CD4-CD8+ FACS adult	lymphoid	T Cell	adult	CD8+ T cell	Lymphocyte
GSM1212246;6213	6213	Beliakova-Bethell	GSM1212246	Donor3_pos_B	Homo sapiens	CD19+ B-cell	CL:0000236		B cell			Beliakova-Bethell	"Multiple scientific disciplines require the isolation of specific subsets of blood cells from patient samples for gene expression analysis by microarray or RNA-sequencing, preserving disease- or treatment-related signatures. However, little is known with respect to the impact of different cell isolation methods on gene expression and the effects of positive selection, negative selection, and fluorescence activated cell sorting (FACS) have not previously been assessed in parallel. To address this knowledge gap, CD4+ T cells, CD8+ T cells, B cells, and monocytes were isolated from blood samples from five independent donors using positive immunomagnetic selection, negative immunomagnetic selection, and FACS. We hypothesized that positive selection and FACS would yield higher purity but may have an impact on gene expression since both methods utilize antibodies that bind surface receptors of the cell type of interest. Moreover, FACS might upregulate stress response genes due to passage of the cells through the sorter. Microarray gene expression data were generated and subjected to unsupervised clustering and differential gene expression analysis. Surprisingly, these analyses revealed that gene expression signatures were more similar between cells isolated by negative selection and FACS compared to cells isolated by positive selection. Moreover, genes that are involved in the response to stress generally had the highest expression in cells isolated by negative or positive selection and not FACS. Thus, FACS is the recommended method for isolation of leukocyte subsets for gene expression studies since this method results in the purest subset populations and does not appear to induce a stress response."	50	"neg-select B-cell, CD19+ B-cell, FACS selected B-cell, neg-select CD4 T-cell, CD4+ T-cell, FACS selected CD4 T cell, neg-select CD8 T-cell, CD8+ T-cell, FACS selected CD8 T cell, neg-select Mo, CD33+ Mo, FACS selected Mo"	Microarray (Illumina HumanHT-12 V4)	leukomics	Homo sapiens	3.3	Illumina V4	"rgb(146,0,0)"	diamond	B Cell CD19+ bead-selected adult	lymphoid	B Cell	adult	B cell	Lymphocyte
GSM1212248;6213	6213	Beliakova-Bethell	GSM1212248	Donor2_FACS_CD4	Homo sapiens	FACS selected CD4 T cell	CL:0000492		CD4+ T cell			Beliakova-Bethell	"Multiple scientific disciplines require the isolation of specific subsets of blood cells from patient samples for gene expression analysis by microarray or RNA-sequencing, preserving disease- or treatment-related signatures. However, little is known with respect to the impact of different cell isolation methods on gene expression and the effects of positive selection, negative selection, and fluorescence activated cell sorting (FACS) have not previously been assessed in parallel. To address this knowledge gap, CD4+ T cells, CD8+ T cells, B cells, and monocytes were isolated from blood samples from five independent donors using positive immunomagnetic selection, negative immunomagnetic selection, and FACS. We hypothesized that positive selection and FACS would yield higher purity but may have an impact on gene expression since both methods utilize antibodies that bind surface receptors of the cell type of interest. Moreover, FACS might upregulate stress response genes due to passage of the cells through the sorter. Microarray gene expression data were generated and subjected to unsupervised clustering and differential gene expression analysis. Surprisingly, these analyses revealed that gene expression signatures were more similar between cells isolated by negative selection and FACS compared to cells isolated by positive selection. Moreover, genes that are involved in the response to stress generally had the highest expression in cells isolated by negative or positive selection and not FACS. Thus, FACS is the recommended method for isolation of leukocyte subsets for gene expression studies since this method results in the purest subset populations and does not appear to induce a stress response."	50	"neg-select B-cell, CD19+ B-cell, FACS selected B-cell, neg-select CD4 T-cell, CD4+ T-cell, FACS selected CD4 T cell, neg-select CD8 T-cell, CD8+ T-cell, FACS selected CD8 T cell, neg-select Mo, CD33+ Mo, FACS selected Mo"	Microarray (Illumina HumanHT-12 V4)	leukomics	Homo sapiens	3.3	Illumina V4	"rgb(146,0,0)"	diamond	T Cell CD33-CD8-CD4+ FACS adult	lymphoid	T Cell	adult	CD4+ T cell	Lymphocyte
GSM1212249;6213	6213	Beliakova-Bethell	GSM1212249	Donor4_pos_CD8	Homo sapiens	CD8+ T-cell	CL:0000625		CD8+ T cell			Beliakova-Bethell	"Multiple scientific disciplines require the isolation of specific subsets of blood cells from patient samples for gene expression analysis by microarray or RNA-sequencing, preserving disease- or treatment-related signatures. However, little is known with respect to the impact of different cell isolation methods on gene expression and the effects of positive selection, negative selection, and fluorescence activated cell sorting (FACS) have not previously been assessed in parallel. To address this knowledge gap, CD4+ T cells, CD8+ T cells, B cells, and monocytes were isolated from blood samples from five independent donors using positive immunomagnetic selection, negative immunomagnetic selection, and FACS. We hypothesized that positive selection and FACS would yield higher purity but may have an impact on gene expression since both methods utilize antibodies that bind surface receptors of the cell type of interest. Moreover, FACS might upregulate stress response genes due to passage of the cells through the sorter. Microarray gene expression data were generated and subjected to unsupervised clustering and differential gene expression analysis. Surprisingly, these analyses revealed that gene expression signatures were more similar between cells isolated by negative selection and FACS compared to cells isolated by positive selection. Moreover, genes that are involved in the response to stress generally had the highest expression in cells isolated by negative or positive selection and not FACS. Thus, FACS is the recommended method for isolation of leukocyte subsets for gene expression studies since this method results in the purest subset populations and does not appear to induce a stress response."	50	"neg-select B-cell, CD19+ B-cell, FACS selected B-cell, neg-select CD4 T-cell, CD4+ T-cell, FACS selected CD4 T cell, neg-select CD8 T-cell, CD8+ T-cell, FACS selected CD8 T cell, neg-select Mo, CD33+ Mo, FACS selected Mo"	Microarray (Illumina HumanHT-12 V4)	leukomics	Homo sapiens	3.3	Illumina V4	"rgb(146,0,0)"	diamond	T Cell CD8+ bead-selected adult	lymphoid	T Cell	adult	CD8+ T cell	Lymphocyte
GSM1212251;6213	6213	Beliakova-Bethell	GSM1212251	Donor3_pos_mono	Homo sapiens	CD33+ Mo	CL:0000576		monocyte			Beliakova-Bethell	"Multiple scientific disciplines require the isolation of specific subsets of blood cells from patient samples for gene expression analysis by microarray or RNA-sequencing, preserving disease- or treatment-related signatures. However, little is known with respect to the impact of different cell isolation methods on gene expression and the effects of positive selection, negative selection, and fluorescence activated cell sorting (FACS) have not previously been assessed in parallel. To address this knowledge gap, CD4+ T cells, CD8+ T cells, B cells, and monocytes were isolated from blood samples from five independent donors using positive immunomagnetic selection, negative immunomagnetic selection, and FACS. We hypothesized that positive selection and FACS would yield higher purity but may have an impact on gene expression since both methods utilize antibodies that bind surface receptors of the cell type of interest. Moreover, FACS might upregulate stress response genes due to passage of the cells through the sorter. Microarray gene expression data were generated and subjected to unsupervised clustering and differential gene expression analysis. Surprisingly, these analyses revealed that gene expression signatures were more similar between cells isolated by negative selection and FACS compared to cells isolated by positive selection. Moreover, genes that are involved in the response to stress generally had the highest expression in cells isolated by negative or positive selection and not FACS. Thus, FACS is the recommended method for isolation of leukocyte subsets for gene expression studies since this method results in the purest subset populations and does not appear to induce a stress response."	50	"neg-select B-cell, CD19+ B-cell, FACS selected B-cell, neg-select CD4 T-cell, CD4+ T-cell, FACS selected CD4 T cell, neg-select CD8 T-cell, CD8+ T-cell, FACS selected CD8 T cell, neg-select Mo, CD33+ Mo, FACS selected Mo"	Microarray (Illumina HumanHT-12 V4)	leukomics	Homo sapiens	3.3	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD33+ bead-selected adult	myeloid	myeloid	adult	monocyte	Circulating Monocyte & Granulocyte
GSM1212253;6213	6213	Beliakova-Bethell	GSM1212253	Donor1_FACS_CD8	Homo sapiens	FACS selected CD8 T cell	CL:0000625		CD8+ T cell			Beliakova-Bethell	"Multiple scientific disciplines require the isolation of specific subsets of blood cells from patient samples for gene expression analysis by microarray or RNA-sequencing, preserving disease- or treatment-related signatures. However, little is known with respect to the impact of different cell isolation methods on gene expression and the effects of positive selection, negative selection, and fluorescence activated cell sorting (FACS) have not previously been assessed in parallel. To address this knowledge gap, CD4+ T cells, CD8+ T cells, B cells, and monocytes were isolated from blood samples from five independent donors using positive immunomagnetic selection, negative immunomagnetic selection, and FACS. We hypothesized that positive selection and FACS would yield higher purity but may have an impact on gene expression since both methods utilize antibodies that bind surface receptors of the cell type of interest. Moreover, FACS might upregulate stress response genes due to passage of the cells through the sorter. Microarray gene expression data were generated and subjected to unsupervised clustering and differential gene expression analysis. Surprisingly, these analyses revealed that gene expression signatures were more similar between cells isolated by negative selection and FACS compared to cells isolated by positive selection. Moreover, genes that are involved in the response to stress generally had the highest expression in cells isolated by negative or positive selection and not FACS. Thus, FACS is the recommended method for isolation of leukocyte subsets for gene expression studies since this method results in the purest subset populations and does not appear to induce a stress response."	50	"neg-select B-cell, CD19+ B-cell, FACS selected B-cell, neg-select CD4 T-cell, CD4+ T-cell, FACS selected CD4 T cell, neg-select CD8 T-cell, CD8+ T-cell, FACS selected CD8 T cell, neg-select Mo, CD33+ Mo, FACS selected Mo"	Microarray (Illumina HumanHT-12 V4)	leukomics	Homo sapiens	3.3	Illumina V4	"rgb(146,0,0)"	diamond	T Cell CD33-CD4-CD8+ FACS adult	lymphoid	T Cell	adult	CD8+ T cell	Lymphocyte
GSM1212254;6213	6213	Beliakova-Bethell	GSM1212254	Donor5_pos_CD4	Homo sapiens	CD4+ T-cell	CL:0000492		CD4+ T cell			Beliakova-Bethell	"Multiple scientific disciplines require the isolation of specific subsets of blood cells from patient samples for gene expression analysis by microarray or RNA-sequencing, preserving disease- or treatment-related signatures. However, little is known with respect to the impact of different cell isolation methods on gene expression and the effects of positive selection, negative selection, and fluorescence activated cell sorting (FACS) have not previously been assessed in parallel. To address this knowledge gap, CD4+ T cells, CD8+ T cells, B cells, and monocytes were isolated from blood samples from five independent donors using positive immunomagnetic selection, negative immunomagnetic selection, and FACS. We hypothesized that positive selection and FACS would yield higher purity but may have an impact on gene expression since both methods utilize antibodies that bind surface receptors of the cell type of interest. Moreover, FACS might upregulate stress response genes due to passage of the cells through the sorter. Microarray gene expression data were generated and subjected to unsupervised clustering and differential gene expression analysis. Surprisingly, these analyses revealed that gene expression signatures were more similar between cells isolated by negative selection and FACS compared to cells isolated by positive selection. Moreover, genes that are involved in the response to stress generally had the highest expression in cells isolated by negative or positive selection and not FACS. Thus, FACS is the recommended method for isolation of leukocyte subsets for gene expression studies since this method results in the purest subset populations and does not appear to induce a stress response."	50	"neg-select B-cell, CD19+ B-cell, FACS selected B-cell, neg-select CD4 T-cell, CD4+ T-cell, FACS selected CD4 T cell, neg-select CD8 T-cell, CD8+ T-cell, FACS selected CD8 T cell, neg-select Mo, CD33+ Mo, FACS selected Mo"	Microarray (Illumina HumanHT-12 V4)	leukomics	Homo sapiens	3.3	Illumina V4	"rgb(146,0,0)"	diamond	T Cell CD4+ bead-selected adult	lymphoid	T Cell	adult	CD4+ T cell	Lymphocyte
GSM1212256;6213	6213	Beliakova-Bethell	GSM1212256	Donor5_pos_B	Homo sapiens	CD19+ B-cell	CL:0000236		B cell			Beliakova-Bethell	"Multiple scientific disciplines require the isolation of specific subsets of blood cells from patient samples for gene expression analysis by microarray or RNA-sequencing, preserving disease- or treatment-related signatures. However, little is known with respect to the impact of different cell isolation methods on gene expression and the effects of positive selection, negative selection, and fluorescence activated cell sorting (FACS) have not previously been assessed in parallel. To address this knowledge gap, CD4+ T cells, CD8+ T cells, B cells, and monocytes were isolated from blood samples from five independent donors using positive immunomagnetic selection, negative immunomagnetic selection, and FACS. We hypothesized that positive selection and FACS would yield higher purity but may have an impact on gene expression since both methods utilize antibodies that bind surface receptors of the cell type of interest. Moreover, FACS might upregulate stress response genes due to passage of the cells through the sorter. Microarray gene expression data were generated and subjected to unsupervised clustering and differential gene expression analysis. Surprisingly, these analyses revealed that gene expression signatures were more similar between cells isolated by negative selection and FACS compared to cells isolated by positive selection. Moreover, genes that are involved in the response to stress generally had the highest expression in cells isolated by negative or positive selection and not FACS. Thus, FACS is the recommended method for isolation of leukocyte subsets for gene expression studies since this method results in the purest subset populations and does not appear to induce a stress response."	50	"neg-select B-cell, CD19+ B-cell, FACS selected B-cell, neg-select CD4 T-cell, CD4+ T-cell, FACS selected CD4 T cell, neg-select CD8 T-cell, CD8+ T-cell, FACS selected CD8 T cell, neg-select Mo, CD33+ Mo, FACS selected Mo"	Microarray (Illumina HumanHT-12 V4)	leukomics	Homo sapiens	3.3	Illumina V4	"rgb(146,0,0)"	diamond	B Cell CD19+ bead-selected adult	lymphoid	B Cell	adult	B cell	Lymphocyte
GSM1367902;6741	6741	Banchereau	GSM1367902	"Fluzone, replicate 1"	Homo sapiens	CD1c+ FZ	CL:0002399		CD1c+ dendritic cell			Banchereau	"The mechanisms by which microbial vaccines interact with human APCs remain elusive. Herein, we describe the transcriptional programs induced in human DCs by pathogens, innate receptor ligands and vaccines. Exposure of DCs to influenza, Salmonella enterica and Staphylococcus aureus allows us to build a modular framework containing 204 transcript clusters. We use this framework to characterize the responses of human monocytes, monocyte-derived DCs and blood DC subsets to 13 vaccines. Different vaccines induce distinct transcriptional programs based on pathogen type, adjuvant formulation and APC targeted. Fluzone, Pneumovax and Gardasil, respectively, activate monocyte-derived DCs, monocytes and CD1c+ blood DCs, highlighting APC specialization in response to vaccines. Finally, the blood signatures from individuals vaccinated with Fluzone or infected with influenza reveal a signature of adaptive immunity activation following vaccination and symptomatic infections, but not asymptomatic infections. These data, offered with a web interface, may guide the development of improved vaccines. Abstract from Nat Commun. 2014 Oct 22;5:5283."	88	"CD141+ DC, CD141+ FZ, CD141+ PVX, CD1c+ DC, CD1c+ FZ, CD1c+ Gardasil, CD1c+ Havrix, CD1c+ HEPB, CD1c+ Hib, CD1c+ Imovax, CD1c+ Ixiaro, CD1c+ PVX, CD1c+ Menomune, CD1c+ Polio, CD1c+ TDAP, CD1c+ Varicella, CD1c+ Zostavax"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.2	Illumina V4	"rgb(146,0,0)"	diamond	c-DC HLA-DR+CD11c+ CD1c+ influenza vaccine adult	myeloid	myeloid	adult	CD1c+ dendritic cell	Dendritic Cell
GSM1367903;6741	6741	Banchereau	GSM1367903	"Fluzone, replicate 2"	Homo sapiens	CD141+ FZ	CL:0002394		CD141+ dendritic cell			Banchereau	"The mechanisms by which microbial vaccines interact with human APCs remain elusive. Herein, we describe the transcriptional programs induced in human DCs by pathogens, innate receptor ligands and vaccines. Exposure of DCs to influenza, Salmonella enterica and Staphylococcus aureus allows us to build a modular framework containing 204 transcript clusters. We use this framework to characterize the responses of human monocytes, monocyte-derived DCs and blood DC subsets to 13 vaccines. Different vaccines induce distinct transcriptional programs based on pathogen type, adjuvant formulation and APC targeted. Fluzone, Pneumovax and Gardasil, respectively, activate monocyte-derived DCs, monocytes and CD1c+ blood DCs, highlighting APC specialization in response to vaccines. Finally, the blood signatures from individuals vaccinated with Fluzone or infected with influenza reveal a signature of adaptive immunity activation following vaccination and symptomatic infections, but not asymptomatic infections. These data, offered with a web interface, may guide the development of improved vaccines. Abstract from Nat Commun. 2014 Oct 22;5:5283."	88	"CD141+ DC, CD141+ FZ, CD141+ PVX, CD1c+ DC, CD1c+ FZ, CD1c+ Gardasil, CD1c+ Havrix, CD1c+ HEPB, CD1c+ Hib, CD1c+ Imovax, CD1c+ Ixiaro, CD1c+ PVX, CD1c+ Menomune, CD1c+ Polio, CD1c+ TDAP, CD1c+ Varicella, CD1c+ Zostavax"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.2	Illumina V4	"rgb(146,0,0)"	diamond	c-DC HLA-DR+CD11c+ CD141+ influenza vaccine adult	myeloid	myeloid	adult	CD141+ dendritic cell	Dendritic Cell
GSM1367904;6741	6741	Banchereau	GSM1367904	"Havrix, replicate 1"	Homo sapiens	CD1c+ Havrix	CL:0002399		CD1c+ dendritic cell			Banchereau	"The mechanisms by which microbial vaccines interact with human APCs remain elusive. Herein, we describe the transcriptional programs induced in human DCs by pathogens, innate receptor ligands and vaccines. Exposure of DCs to influenza, Salmonella enterica and Staphylococcus aureus allows us to build a modular framework containing 204 transcript clusters. We use this framework to characterize the responses of human monocytes, monocyte-derived DCs and blood DC subsets to 13 vaccines. Different vaccines induce distinct transcriptional programs based on pathogen type, adjuvant formulation and APC targeted. Fluzone, Pneumovax and Gardasil, respectively, activate monocyte-derived DCs, monocytes and CD1c+ blood DCs, highlighting APC specialization in response to vaccines. Finally, the blood signatures from individuals vaccinated with Fluzone or infected with influenza reveal a signature of adaptive immunity activation following vaccination and symptomatic infections, but not asymptomatic infections. These data, offered with a web interface, may guide the development of improved vaccines. Abstract from Nat Commun. 2014 Oct 22;5:5283."	88	"CD141+ DC, CD141+ FZ, CD141+ PVX, CD1c+ DC, CD1c+ FZ, CD1c+ Gardasil, CD1c+ Havrix, CD1c+ HEPB, CD1c+ Hib, CD1c+ Imovax, CD1c+ Ixiaro, CD1c+ PVX, CD1c+ Menomune, CD1c+ Polio, CD1c+ TDAP, CD1c+ Varicella, CD1c+ Zostavax"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.2	Illumina V4	"rgb(146,0,0)"	diamond	c-DC HLA-DR+CD11c+ CD1c+ Hepatitis A vaccine adult	myeloid	myeloid	adult	CD1c+ dendritic cell	Dendritic Cell
GSM1367905;6741	6741	Banchereau	GSM1367905	"Engerix-B, replicate 1"	Homo sapiens	CD1c+ HEPB	CL:0002399		CD1c+ dendritic cell			Banchereau	"The mechanisms by which microbial vaccines interact with human APCs remain elusive. Herein, we describe the transcriptional programs induced in human DCs by pathogens, innate receptor ligands and vaccines. Exposure of DCs to influenza, Salmonella enterica and Staphylococcus aureus allows us to build a modular framework containing 204 transcript clusters. We use this framework to characterize the responses of human monocytes, monocyte-derived DCs and blood DC subsets to 13 vaccines. Different vaccines induce distinct transcriptional programs based on pathogen type, adjuvant formulation and APC targeted. Fluzone, Pneumovax and Gardasil, respectively, activate monocyte-derived DCs, monocytes and CD1c+ blood DCs, highlighting APC specialization in response to vaccines. Finally, the blood signatures from individuals vaccinated with Fluzone or infected with influenza reveal a signature of adaptive immunity activation following vaccination and symptomatic infections, but not asymptomatic infections. These data, offered with a web interface, may guide the development of improved vaccines. Abstract from Nat Commun. 2014 Oct 22;5:5283."	88	"CD141+ DC, CD141+ FZ, CD141+ PVX, CD1c+ DC, CD1c+ FZ, CD1c+ Gardasil, CD1c+ Havrix, CD1c+ HEPB, CD1c+ Hib, CD1c+ Imovax, CD1c+ Ixiaro, CD1c+ PVX, CD1c+ Menomune, CD1c+ Polio, CD1c+ TDAP, CD1c+ Varicella, CD1c+ Zostavax"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.2	Illumina V4	"rgb(146,0,0)"	diamond	c-DC HLA-DR+CD11c+ CD1c+ Hepatitis B vaccine adult	myeloid	myeloid	adult	CD1c+ dendritic cell	Dendritic Cell
GSM1367906;6741	6741	Banchereau	GSM1367906	"Zostavax, replicate 1"	Homo sapiens	CD1c+ Zostavax	CL:0002399		CD1c+ dendritic cell			Banchereau	"The mechanisms by which microbial vaccines interact with human APCs remain elusive. Herein, we describe the transcriptional programs induced in human DCs by pathogens, innate receptor ligands and vaccines. Exposure of DCs to influenza, Salmonella enterica and Staphylococcus aureus allows us to build a modular framework containing 204 transcript clusters. We use this framework to characterize the responses of human monocytes, monocyte-derived DCs and blood DC subsets to 13 vaccines. Different vaccines induce distinct transcriptional programs based on pathogen type, adjuvant formulation and APC targeted. Fluzone, Pneumovax and Gardasil, respectively, activate monocyte-derived DCs, monocytes and CD1c+ blood DCs, highlighting APC specialization in response to vaccines. Finally, the blood signatures from individuals vaccinated with Fluzone or infected with influenza reveal a signature of adaptive immunity activation following vaccination and symptomatic infections, but not asymptomatic infections. These data, offered with a web interface, may guide the development of improved vaccines. Abstract from Nat Commun. 2014 Oct 22;5:5283."	88	"CD141+ DC, CD141+ FZ, CD141+ PVX, CD1c+ DC, CD1c+ FZ, CD1c+ Gardasil, CD1c+ Havrix, CD1c+ HEPB, CD1c+ Hib, CD1c+ Imovax, CD1c+ Ixiaro, CD1c+ PVX, CD1c+ Menomune, CD1c+ Polio, CD1c+ TDAP, CD1c+ Varicella, CD1c+ Zostavax"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.2	Illumina V4	"rgb(146,0,0)"	diamond	c-DC HLA-DR+CD11c+ CD1c+ Herpes Zoster vaccine adult	myeloid	myeloid	adult	CD1c+ dendritic cell	Dendritic Cell
GSM1367907;6741	6741	Banchereau	GSM1367907	"ActHib, replicate 1"	Homo sapiens	CD1c+ Hib	CL:0002399		CD1c+ dendritic cell			Banchereau	"The mechanisms by which microbial vaccines interact with human APCs remain elusive. Herein, we describe the transcriptional programs induced in human DCs by pathogens, innate receptor ligands and vaccines. Exposure of DCs to influenza, Salmonella enterica and Staphylococcus aureus allows us to build a modular framework containing 204 transcript clusters. We use this framework to characterize the responses of human monocytes, monocyte-derived DCs and blood DC subsets to 13 vaccines. Different vaccines induce distinct transcriptional programs based on pathogen type, adjuvant formulation and APC targeted. Fluzone, Pneumovax and Gardasil, respectively, activate monocyte-derived DCs, monocytes and CD1c+ blood DCs, highlighting APC specialization in response to vaccines. Finally, the blood signatures from individuals vaccinated with Fluzone or infected with influenza reveal a signature of adaptive immunity activation following vaccination and symptomatic infections, but not asymptomatic infections. These data, offered with a web interface, may guide the development of improved vaccines. Abstract from Nat Commun. 2014 Oct 22;5:5283."	88	"CD141+ DC, CD141+ FZ, CD141+ PVX, CD1c+ DC, CD1c+ FZ, CD1c+ Gardasil, CD1c+ Havrix, CD1c+ HEPB, CD1c+ Hib, CD1c+ Imovax, CD1c+ Ixiaro, CD1c+ PVX, CD1c+ Menomune, CD1c+ Polio, CD1c+ TDAP, CD1c+ Varicella, CD1c+ Zostavax"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.2	Illumina V4	"rgb(146,0,0)"	diamond	c-DC HLA-DR+CD11c+ CD1c+ Haemophilus influenza vaccine adult	myeloid	myeloid	adult	CD1c+ dendritic cell	Dendritic Cell
GSM1367908;6741	6741	Banchereau	GSM1367908	"Gardasil, replicate 1"	Homo sapiens	CD1c+ Gardasil	CL:0002399		CD1c+ dendritic cell			Banchereau	"The mechanisms by which microbial vaccines interact with human APCs remain elusive. Herein, we describe the transcriptional programs induced in human DCs by pathogens, innate receptor ligands and vaccines. Exposure of DCs to influenza, Salmonella enterica and Staphylococcus aureus allows us to build a modular framework containing 204 transcript clusters. We use this framework to characterize the responses of human monocytes, monocyte-derived DCs and blood DC subsets to 13 vaccines. Different vaccines induce distinct transcriptional programs based on pathogen type, adjuvant formulation and APC targeted. Fluzone, Pneumovax and Gardasil, respectively, activate monocyte-derived DCs, monocytes and CD1c+ blood DCs, highlighting APC specialization in response to vaccines. Finally, the blood signatures from individuals vaccinated with Fluzone or infected with influenza reveal a signature of adaptive immunity activation following vaccination and symptomatic infections, but not asymptomatic infections. These data, offered with a web interface, may guide the development of improved vaccines. Abstract from Nat Commun. 2014 Oct 22;5:5283."	88	"CD141+ DC, CD141+ FZ, CD141+ PVX, CD1c+ DC, CD1c+ FZ, CD1c+ Gardasil, CD1c+ Havrix, CD1c+ HEPB, CD1c+ Hib, CD1c+ Imovax, CD1c+ Ixiaro, CD1c+ PVX, CD1c+ Menomune, CD1c+ Polio, CD1c+ TDAP, CD1c+ Varicella, CD1c+ Zostavax"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.2	Illumina V4	"rgb(146,0,0)"	diamond	c-DC HLA-DR+CD11c+ CD1c+ Papilloma virus vaccine adult	myeloid	myeloid	adult	CD1c+ dendritic cell	Dendritic Cell
GSM1367909;6741	6741	Banchereau	GSM1367909	"Ixiaro, replicate 1"	Homo sapiens	CD1c+ Ixiaro	CL:0002399		CD1c+ dendritic cell			Banchereau	"The mechanisms by which microbial vaccines interact with human APCs remain elusive. Herein, we describe the transcriptional programs induced in human DCs by pathogens, innate receptor ligands and vaccines. Exposure of DCs to influenza, Salmonella enterica and Staphylococcus aureus allows us to build a modular framework containing 204 transcript clusters. We use this framework to characterize the responses of human monocytes, monocyte-derived DCs and blood DC subsets to 13 vaccines. Different vaccines induce distinct transcriptional programs based on pathogen type, adjuvant formulation and APC targeted. Fluzone, Pneumovax and Gardasil, respectively, activate monocyte-derived DCs, monocytes and CD1c+ blood DCs, highlighting APC specialization in response to vaccines. Finally, the blood signatures from individuals vaccinated with Fluzone or infected with influenza reveal a signature of adaptive immunity activation following vaccination and symptomatic infections, but not asymptomatic infections. These data, offered with a web interface, may guide the development of improved vaccines. Abstract from Nat Commun. 2014 Oct 22;5:5283."	88	"CD141+ DC, CD141+ FZ, CD141+ PVX, CD1c+ DC, CD1c+ FZ, CD1c+ Gardasil, CD1c+ Havrix, CD1c+ HEPB, CD1c+ Hib, CD1c+ Imovax, CD1c+ Ixiaro, CD1c+ PVX, CD1c+ Menomune, CD1c+ Polio, CD1c+ TDAP, CD1c+ Varicella, CD1c+ Zostavax"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.2	Illumina V4	"rgb(146,0,0)"	diamond	c-DC HLA-DR+CD11c+ CD1c+ Japanese encephalitis vaccine adult	myeloid	myeloid	adult	CD1c+ dendritic cell	Dendritic Cell
GSM1367910;6741	6741	Banchereau	GSM1367910	"Medium, replicate 1"	Homo sapiens	CD1c+ DC	CL:0002399		CD1c+ dendritic cell			Banchereau	"The mechanisms by which microbial vaccines interact with human APCs remain elusive. Herein, we describe the transcriptional programs induced in human DCs by pathogens, innate receptor ligands and vaccines. Exposure of DCs to influenza, Salmonella enterica and Staphylococcus aureus allows us to build a modular framework containing 204 transcript clusters. We use this framework to characterize the responses of human monocytes, monocyte-derived DCs and blood DC subsets to 13 vaccines. Different vaccines induce distinct transcriptional programs based on pathogen type, adjuvant formulation and APC targeted. Fluzone, Pneumovax and Gardasil, respectively, activate monocyte-derived DCs, monocytes and CD1c+ blood DCs, highlighting APC specialization in response to vaccines. Finally, the blood signatures from individuals vaccinated with Fluzone or infected with influenza reveal a signature of adaptive immunity activation following vaccination and symptomatic infections, but not asymptomatic infections. These data, offered with a web interface, may guide the development of improved vaccines. Abstract from Nat Commun. 2014 Oct 22;5:5283."	88	"CD141+ DC, CD141+ FZ, CD141+ PVX, CD1c+ DC, CD1c+ FZ, CD1c+ Gardasil, CD1c+ Havrix, CD1c+ HEPB, CD1c+ Hib, CD1c+ Imovax, CD1c+ Ixiaro, CD1c+ PVX, CD1c+ Menomune, CD1c+ Polio, CD1c+ TDAP, CD1c+ Varicella, CD1c+ Zostavax"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.2	Illumina V4	"rgb(146,0,0)"	diamond	c-DC HLA-DR+CD11c+ CD1c+  adult	myeloid	myeloid	adult	CD1c+ dendritic cell	Dendritic Cell
GSM1367911;6741	6741	Banchereau	GSM1367911	"Medium, replicate 2"	Homo sapiens	CD1c+ DC	CL:0002399		CD1c+ dendritic cell			Banchereau	"The mechanisms by which microbial vaccines interact with human APCs remain elusive. Herein, we describe the transcriptional programs induced in human DCs by pathogens, innate receptor ligands and vaccines. Exposure of DCs to influenza, Salmonella enterica and Staphylococcus aureus allows us to build a modular framework containing 204 transcript clusters. We use this framework to characterize the responses of human monocytes, monocyte-derived DCs and blood DC subsets to 13 vaccines. Different vaccines induce distinct transcriptional programs based on pathogen type, adjuvant formulation and APC targeted. Fluzone, Pneumovax and Gardasil, respectively, activate monocyte-derived DCs, monocytes and CD1c+ blood DCs, highlighting APC specialization in response to vaccines. Finally, the blood signatures from individuals vaccinated with Fluzone or infected with influenza reveal a signature of adaptive immunity activation following vaccination and symptomatic infections, but not asymptomatic infections. These data, offered with a web interface, may guide the development of improved vaccines. Abstract from Nat Commun. 2014 Oct 22;5:5283."	88	"CD141+ DC, CD141+ FZ, CD141+ PVX, CD1c+ DC, CD1c+ FZ, CD1c+ Gardasil, CD1c+ Havrix, CD1c+ HEPB, CD1c+ Hib, CD1c+ Imovax, CD1c+ Ixiaro, CD1c+ PVX, CD1c+ Menomune, CD1c+ Polio, CD1c+ TDAP, CD1c+ Varicella, CD1c+ Zostavax"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.2	Illumina V4	"rgb(146,0,0)"	diamond	c-DC HLA-DR+CD11c+ CD1c+  adult	myeloid	myeloid	adult	CD1c+ dendritic cell	Dendritic Cell
GSM1367912;6741	6741	Banchereau	GSM1367912	"Medium, replicate 3"	Homo sapiens	CD141+ DC	CL:0002394		CD141+ dendritic cell			Banchereau	"The mechanisms by which microbial vaccines interact with human APCs remain elusive. Herein, we describe the transcriptional programs induced in human DCs by pathogens, innate receptor ligands and vaccines. Exposure of DCs to influenza, Salmonella enterica and Staphylococcus aureus allows us to build a modular framework containing 204 transcript clusters. We use this framework to characterize the responses of human monocytes, monocyte-derived DCs and blood DC subsets to 13 vaccines. Different vaccines induce distinct transcriptional programs based on pathogen type, adjuvant formulation and APC targeted. Fluzone, Pneumovax and Gardasil, respectively, activate monocyte-derived DCs, monocytes and CD1c+ blood DCs, highlighting APC specialization in response to vaccines. Finally, the blood signatures from individuals vaccinated with Fluzone or infected with influenza reveal a signature of adaptive immunity activation following vaccination and symptomatic infections, but not asymptomatic infections. These data, offered with a web interface, may guide the development of improved vaccines. Abstract from Nat Commun. 2014 Oct 22;5:5283."	88	"CD141+ DC, CD141+ FZ, CD141+ PVX, CD1c+ DC, CD1c+ FZ, CD1c+ Gardasil, CD1c+ Havrix, CD1c+ HEPB, CD1c+ Hib, CD1c+ Imovax, CD1c+ Ixiaro, CD1c+ PVX, CD1c+ Menomune, CD1c+ Polio, CD1c+ TDAP, CD1c+ Varicella, CD1c+ Zostavax"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.2	Illumina V4	"rgb(146,0,0)"	diamond	c-DC HLA-DR+CD11c+ CD141+  adult	myeloid	myeloid	adult	CD141+ dendritic cell	Dendritic Cell
GSM1367913;6741	6741	Banchereau	GSM1367913	"Menomune, replicate 1"	Homo sapiens	CD1c+ Menomune	CL:0002399		CD1c+ dendritic cell			Banchereau	"The mechanisms by which microbial vaccines interact with human APCs remain elusive. Herein, we describe the transcriptional programs induced in human DCs by pathogens, innate receptor ligands and vaccines. Exposure of DCs to influenza, Salmonella enterica and Staphylococcus aureus allows us to build a modular framework containing 204 transcript clusters. We use this framework to characterize the responses of human monocytes, monocyte-derived DCs and blood DC subsets to 13 vaccines. Different vaccines induce distinct transcriptional programs based on pathogen type, adjuvant formulation and APC targeted. Fluzone, Pneumovax and Gardasil, respectively, activate monocyte-derived DCs, monocytes and CD1c+ blood DCs, highlighting APC specialization in response to vaccines. Finally, the blood signatures from individuals vaccinated with Fluzone or infected with influenza reveal a signature of adaptive immunity activation following vaccination and symptomatic infections, but not asymptomatic infections. These data, offered with a web interface, may guide the development of improved vaccines. Abstract from Nat Commun. 2014 Oct 22;5:5283."	88	"CD141+ DC, CD141+ FZ, CD141+ PVX, CD1c+ DC, CD1c+ FZ, CD1c+ Gardasil, CD1c+ Havrix, CD1c+ HEPB, CD1c+ Hib, CD1c+ Imovax, CD1c+ Ixiaro, CD1c+ PVX, CD1c+ Menomune, CD1c+ Polio, CD1c+ TDAP, CD1c+ Varicella, CD1c+ Zostavax"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.2	Illumina V4	"rgb(146,0,0)"	diamond	c-DC HLA-DR+CD11c+ CD1c+ Neisseiria meningitis vaccine adult	myeloid	myeloid	adult	CD1c+ dendritic cell	Dendritic Cell
GSM1367914;6741	6741	Banchereau	GSM1367914	"Ipol, replicate 1"	Homo sapiens	CD1c+ Polio	CL:0002399		CD1c+ dendritic cell			Banchereau	"The mechanisms by which microbial vaccines interact with human APCs remain elusive. Herein, we describe the transcriptional programs induced in human DCs by pathogens, innate receptor ligands and vaccines. Exposure of DCs to influenza, Salmonella enterica and Staphylococcus aureus allows us to build a modular framework containing 204 transcript clusters. We use this framework to characterize the responses of human monocytes, monocyte-derived DCs and blood DC subsets to 13 vaccines. Different vaccines induce distinct transcriptional programs based on pathogen type, adjuvant formulation and APC targeted. Fluzone, Pneumovax and Gardasil, respectively, activate monocyte-derived DCs, monocytes and CD1c+ blood DCs, highlighting APC specialization in response to vaccines. Finally, the blood signatures from individuals vaccinated with Fluzone or infected with influenza reveal a signature of adaptive immunity activation following vaccination and symptomatic infections, but not asymptomatic infections. These data, offered with a web interface, may guide the development of improved vaccines. Abstract from Nat Commun. 2014 Oct 22;5:5283."	88	"CD141+ DC, CD141+ FZ, CD141+ PVX, CD1c+ DC, CD1c+ FZ, CD1c+ Gardasil, CD1c+ Havrix, CD1c+ HEPB, CD1c+ Hib, CD1c+ Imovax, CD1c+ Ixiaro, CD1c+ PVX, CD1c+ Menomune, CD1c+ Polio, CD1c+ TDAP, CD1c+ Varicella, CD1c+ Zostavax"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.2	Illumina V4	"rgb(146,0,0)"	diamond	c-DC HLA-DR+CD11c+ CD1c+ polio vaccine adult	myeloid	myeloid	adult	CD1c+ dendritic cell	Dendritic Cell
GSM1367915;6741	6741	Banchereau	GSM1367915	"Pneumovax, replicate 1"	Homo sapiens	CD1c+ PVX	CL:0002399		CD1c+ dendritic cell			Banchereau	"The mechanisms by which microbial vaccines interact with human APCs remain elusive. Herein, we describe the transcriptional programs induced in human DCs by pathogens, innate receptor ligands and vaccines. Exposure of DCs to influenza, Salmonella enterica and Staphylococcus aureus allows us to build a modular framework containing 204 transcript clusters. We use this framework to characterize the responses of human monocytes, monocyte-derived DCs and blood DC subsets to 13 vaccines. Different vaccines induce distinct transcriptional programs based on pathogen type, adjuvant formulation and APC targeted. Fluzone, Pneumovax and Gardasil, respectively, activate monocyte-derived DCs, monocytes and CD1c+ blood DCs, highlighting APC specialization in response to vaccines. Finally, the blood signatures from individuals vaccinated with Fluzone or infected with influenza reveal a signature of adaptive immunity activation following vaccination and symptomatic infections, but not asymptomatic infections. These data, offered with a web interface, may guide the development of improved vaccines. Abstract from Nat Commun. 2014 Oct 22;5:5283."	88	"CD141+ DC, CD141+ FZ, CD141+ PVX, CD1c+ DC, CD1c+ FZ, CD1c+ Gardasil, CD1c+ Havrix, CD1c+ HEPB, CD1c+ Hib, CD1c+ Imovax, CD1c+ Ixiaro, CD1c+ PVX, CD1c+ Menomune, CD1c+ Polio, CD1c+ TDAP, CD1c+ Varicella, CD1c+ Zostavax"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.2	Illumina V4	"rgb(146,0,0)"	diamond	c-DC HLA-DR+CD11c+ CD1c+ Pneumococcus vaccine adult	myeloid	myeloid	adult	CD1c+ dendritic cell	Dendritic Cell
GSM1367916;6741	6741	Banchereau	GSM1367916	"Pneumovax, replicate 2"	Homo sapiens	CD141+ PVX	CL:0002394		CD141+ dendritic cell			Banchereau	"The mechanisms by which microbial vaccines interact with human APCs remain elusive. Herein, we describe the transcriptional programs induced in human DCs by pathogens, innate receptor ligands and vaccines. Exposure of DCs to influenza, Salmonella enterica and Staphylococcus aureus allows us to build a modular framework containing 204 transcript clusters. We use this framework to characterize the responses of human monocytes, monocyte-derived DCs and blood DC subsets to 13 vaccines. Different vaccines induce distinct transcriptional programs based on pathogen type, adjuvant formulation and APC targeted. Fluzone, Pneumovax and Gardasil, respectively, activate monocyte-derived DCs, monocytes and CD1c+ blood DCs, highlighting APC specialization in response to vaccines. Finally, the blood signatures from individuals vaccinated with Fluzone or infected with influenza reveal a signature of adaptive immunity activation following vaccination and symptomatic infections, but not asymptomatic infections. These data, offered with a web interface, may guide the development of improved vaccines. Abstract from Nat Commun. 2014 Oct 22;5:5283."	88	"CD141+ DC, CD141+ FZ, CD141+ PVX, CD1c+ DC, CD1c+ FZ, CD1c+ Gardasil, CD1c+ Havrix, CD1c+ HEPB, CD1c+ Hib, CD1c+ Imovax, CD1c+ Ixiaro, CD1c+ PVX, CD1c+ Menomune, CD1c+ Polio, CD1c+ TDAP, CD1c+ Varicella, CD1c+ Zostavax"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.2	Illumina V4	"rgb(146,0,0)"	diamond	c-DC HLA-DR+CD11c+ CD141+ Pneumococcus vaccine adult	myeloid	myeloid	adult	CD141+ dendritic cell	Dendritic Cell
GSM1367917;6741	6741	Banchereau	GSM1367917	"Imovax, replicate 1"	Homo sapiens	CD1c+ Imovax	CL:0002399		CD1c+ dendritic cell			Banchereau	"The mechanisms by which microbial vaccines interact with human APCs remain elusive. Herein, we describe the transcriptional programs induced in human DCs by pathogens, innate receptor ligands and vaccines. Exposure of DCs to influenza, Salmonella enterica and Staphylococcus aureus allows us to build a modular framework containing 204 transcript clusters. We use this framework to characterize the responses of human monocytes, monocyte-derived DCs and blood DC subsets to 13 vaccines. Different vaccines induce distinct transcriptional programs based on pathogen type, adjuvant formulation and APC targeted. Fluzone, Pneumovax and Gardasil, respectively, activate monocyte-derived DCs, monocytes and CD1c+ blood DCs, highlighting APC specialization in response to vaccines. Finally, the blood signatures from individuals vaccinated with Fluzone or infected with influenza reveal a signature of adaptive immunity activation following vaccination and symptomatic infections, but not asymptomatic infections. These data, offered with a web interface, may guide the development of improved vaccines. Abstract from Nat Commun. 2014 Oct 22;5:5283."	88	"CD141+ DC, CD141+ FZ, CD141+ PVX, CD1c+ DC, CD1c+ FZ, CD1c+ Gardasil, CD1c+ Havrix, CD1c+ HEPB, CD1c+ Hib, CD1c+ Imovax, CD1c+ Ixiaro, CD1c+ PVX, CD1c+ Menomune, CD1c+ Polio, CD1c+ TDAP, CD1c+ Varicella, CD1c+ Zostavax"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.2	Illumina V4	"rgb(146,0,0)"	diamond	c-DC HLA-DR+CD11c+ CD1c+ rabies vaccine adult	myeloid	myeloid	adult	CD1c+ dendritic cell	Dendritic Cell
GSM1367918;6741	6741	Banchereau	GSM1367918	"Adacel, replicate 1"	Homo sapiens	CD1c+ TDAP	CL:0002399		CD1c+ dendritic cell			Banchereau	"The mechanisms by which microbial vaccines interact with human APCs remain elusive. Herein, we describe the transcriptional programs induced in human DCs by pathogens, innate receptor ligands and vaccines. Exposure of DCs to influenza, Salmonella enterica and Staphylococcus aureus allows us to build a modular framework containing 204 transcript clusters. We use this framework to characterize the responses of human monocytes, monocyte-derived DCs and blood DC subsets to 13 vaccines. Different vaccines induce distinct transcriptional programs based on pathogen type, adjuvant formulation and APC targeted. Fluzone, Pneumovax and Gardasil, respectively, activate monocyte-derived DCs, monocytes and CD1c+ blood DCs, highlighting APC specialization in response to vaccines. Finally, the blood signatures from individuals vaccinated with Fluzone or infected with influenza reveal a signature of adaptive immunity activation following vaccination and symptomatic infections, but not asymptomatic infections. These data, offered with a web interface, may guide the development of improved vaccines. Abstract from Nat Commun. 2014 Oct 22;5:5283."	88	"CD141+ DC, CD141+ FZ, CD141+ PVX, CD1c+ DC, CD1c+ FZ, CD1c+ Gardasil, CD1c+ Havrix, CD1c+ HEPB, CD1c+ Hib, CD1c+ Imovax, CD1c+ Ixiaro, CD1c+ PVX, CD1c+ Menomune, CD1c+ Polio, CD1c+ TDAP, CD1c+ Varicella, CD1c+ Zostavax"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.2	Illumina V4	"rgb(146,0,0)"	diamond	c-DC HLA-DR+CD11c+ CD1c+ Tetanus Diphteria Pertussis vaccine adult	myeloid	myeloid	adult	CD1c+ dendritic cell	Dendritic Cell
GSM1367919;6741	6741	Banchereau	GSM1367919	"Varivax, replicate 1"	Homo sapiens	CD1c+ Varicella	CL:0002399		CD1c+ dendritic cell			Banchereau	"The mechanisms by which microbial vaccines interact with human APCs remain elusive. Herein, we describe the transcriptional programs induced in human DCs by pathogens, innate receptor ligands and vaccines. Exposure of DCs to influenza, Salmonella enterica and Staphylococcus aureus allows us to build a modular framework containing 204 transcript clusters. We use this framework to characterize the responses of human monocytes, monocyte-derived DCs and blood DC subsets to 13 vaccines. Different vaccines induce distinct transcriptional programs based on pathogen type, adjuvant formulation and APC targeted. Fluzone, Pneumovax and Gardasil, respectively, activate monocyte-derived DCs, monocytes and CD1c+ blood DCs, highlighting APC specialization in response to vaccines. Finally, the blood signatures from individuals vaccinated with Fluzone or infected with influenza reveal a signature of adaptive immunity activation following vaccination and symptomatic infections, but not asymptomatic infections. These data, offered with a web interface, may guide the development of improved vaccines. Abstract from Nat Commun. 2014 Oct 22;5:5283."	88	"CD141+ DC, CD141+ FZ, CD141+ PVX, CD1c+ DC, CD1c+ FZ, CD1c+ Gardasil, CD1c+ Havrix, CD1c+ HEPB, CD1c+ Hib, CD1c+ Imovax, CD1c+ Ixiaro, CD1c+ PVX, CD1c+ Menomune, CD1c+ Polio, CD1c+ TDAP, CD1c+ Varicella, CD1c+ Zostavax"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.2	Illumina V4	"rgb(146,0,0)"	diamond	c-DC HLA-DR+CD11c+ CD1c+ Varicella vaccine adult	myeloid	myeloid	adult	CD1c+ dendritic cell	Dendritic Cell
GSM1367920;6741	6741	Banchereau	GSM1367920	"Fluzone, replicate 3"	Homo sapiens	CD1c+ FZ	CL:0002399		CD1c+ dendritic cell			Banchereau	"The mechanisms by which microbial vaccines interact with human APCs remain elusive. Herein, we describe the transcriptional programs induced in human DCs by pathogens, innate receptor ligands and vaccines. Exposure of DCs to influenza, Salmonella enterica and Staphylococcus aureus allows us to build a modular framework containing 204 transcript clusters. We use this framework to characterize the responses of human monocytes, monocyte-derived DCs and blood DC subsets to 13 vaccines. Different vaccines induce distinct transcriptional programs based on pathogen type, adjuvant formulation and APC targeted. Fluzone, Pneumovax and Gardasil, respectively, activate monocyte-derived DCs, monocytes and CD1c+ blood DCs, highlighting APC specialization in response to vaccines. Finally, the blood signatures from individuals vaccinated with Fluzone or infected with influenza reveal a signature of adaptive immunity activation following vaccination and symptomatic infections, but not asymptomatic infections. These data, offered with a web interface, may guide the development of improved vaccines. Abstract from Nat Commun. 2014 Oct 22;5:5283."	88	"CD141+ DC, CD141+ FZ, CD141+ PVX, CD1c+ DC, CD1c+ FZ, CD1c+ Gardasil, CD1c+ Havrix, CD1c+ HEPB, CD1c+ Hib, CD1c+ Imovax, CD1c+ Ixiaro, CD1c+ PVX, CD1c+ Menomune, CD1c+ Polio, CD1c+ TDAP, CD1c+ Varicella, CD1c+ Zostavax"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.2	Illumina V4	"rgb(146,0,0)"	diamond	c-DC HLA-DR+CD11c+ CD1c+ influenza vaccine adult	myeloid	myeloid	adult	CD1c+ dendritic cell	Dendritic Cell
GSM1367921;6741	6741	Banchereau	GSM1367921	"Fluzone, replicate 4"	Homo sapiens	CD141+ FZ	CL:0002394		CD141+ dendritic cell			Banchereau	"The mechanisms by which microbial vaccines interact with human APCs remain elusive. Herein, we describe the transcriptional programs induced in human DCs by pathogens, innate receptor ligands and vaccines. Exposure of DCs to influenza, Salmonella enterica and Staphylococcus aureus allows us to build a modular framework containing 204 transcript clusters. We use this framework to characterize the responses of human monocytes, monocyte-derived DCs and blood DC subsets to 13 vaccines. Different vaccines induce distinct transcriptional programs based on pathogen type, adjuvant formulation and APC targeted. Fluzone, Pneumovax and Gardasil, respectively, activate monocyte-derived DCs, monocytes and CD1c+ blood DCs, highlighting APC specialization in response to vaccines. Finally, the blood signatures from individuals vaccinated with Fluzone or infected with influenza reveal a signature of adaptive immunity activation following vaccination and symptomatic infections, but not asymptomatic infections. These data, offered with a web interface, may guide the development of improved vaccines. Abstract from Nat Commun. 2014 Oct 22;5:5283."	88	"CD141+ DC, CD141+ FZ, CD141+ PVX, CD1c+ DC, CD1c+ FZ, CD1c+ Gardasil, CD1c+ Havrix, CD1c+ HEPB, CD1c+ Hib, CD1c+ Imovax, CD1c+ Ixiaro, CD1c+ PVX, CD1c+ Menomune, CD1c+ Polio, CD1c+ TDAP, CD1c+ Varicella, CD1c+ Zostavax"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.2	Illumina V4	"rgb(146,0,0)"	diamond	c-DC HLA-DR+CD11c+ CD141+ influenza vaccine adult	myeloid	myeloid	adult	CD141+ dendritic cell	Dendritic Cell
GSM1367922;6741	6741	Banchereau	GSM1367922	"Havrix, replicate 2"	Homo sapiens	CD1c+ Havrix	CL:0002399		CD1c+ dendritic cell			Banchereau	"The mechanisms by which microbial vaccines interact with human APCs remain elusive. Herein, we describe the transcriptional programs induced in human DCs by pathogens, innate receptor ligands and vaccines. Exposure of DCs to influenza, Salmonella enterica and Staphylococcus aureus allows us to build a modular framework containing 204 transcript clusters. We use this framework to characterize the responses of human monocytes, monocyte-derived DCs and blood DC subsets to 13 vaccines. Different vaccines induce distinct transcriptional programs based on pathogen type, adjuvant formulation and APC targeted. Fluzone, Pneumovax and Gardasil, respectively, activate monocyte-derived DCs, monocytes and CD1c+ blood DCs, highlighting APC specialization in response to vaccines. Finally, the blood signatures from individuals vaccinated with Fluzone or infected with influenza reveal a signature of adaptive immunity activation following vaccination and symptomatic infections, but not asymptomatic infections. These data, offered with a web interface, may guide the development of improved vaccines. Abstract from Nat Commun. 2014 Oct 22;5:5283."	88	"CD141+ DC, CD141+ FZ, CD141+ PVX, CD1c+ DC, CD1c+ FZ, CD1c+ Gardasil, CD1c+ Havrix, CD1c+ HEPB, CD1c+ Hib, CD1c+ Imovax, CD1c+ Ixiaro, CD1c+ PVX, CD1c+ Menomune, CD1c+ Polio, CD1c+ TDAP, CD1c+ Varicella, CD1c+ Zostavax"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.2	Illumina V4	"rgb(146,0,0)"	diamond	c-DC HLA-DR+CD11c+ CD1c+ Hepatitis A vaccine adult	myeloid	myeloid	adult	CD1c+ dendritic cell	Dendritic Cell
GSM1367923;6741	6741	Banchereau	GSM1367923	"Engerix-B, replicate 2"	Homo sapiens	CD1c+ HEPB	CL:0002399		CD1c+ dendritic cell			Banchereau	"The mechanisms by which microbial vaccines interact with human APCs remain elusive. Herein, we describe the transcriptional programs induced in human DCs by pathogens, innate receptor ligands and vaccines. Exposure of DCs to influenza, Salmonella enterica and Staphylococcus aureus allows us to build a modular framework containing 204 transcript clusters. We use this framework to characterize the responses of human monocytes, monocyte-derived DCs and blood DC subsets to 13 vaccines. Different vaccines induce distinct transcriptional programs based on pathogen type, adjuvant formulation and APC targeted. Fluzone, Pneumovax and Gardasil, respectively, activate monocyte-derived DCs, monocytes and CD1c+ blood DCs, highlighting APC specialization in response to vaccines. Finally, the blood signatures from individuals vaccinated with Fluzone or infected with influenza reveal a signature of adaptive immunity activation following vaccination and symptomatic infections, but not asymptomatic infections. These data, offered with a web interface, may guide the development of improved vaccines. Abstract from Nat Commun. 2014 Oct 22;5:5283."	88	"CD141+ DC, CD141+ FZ, CD141+ PVX, CD1c+ DC, CD1c+ FZ, CD1c+ Gardasil, CD1c+ Havrix, CD1c+ HEPB, CD1c+ Hib, CD1c+ Imovax, CD1c+ Ixiaro, CD1c+ PVX, CD1c+ Menomune, CD1c+ Polio, CD1c+ TDAP, CD1c+ Varicella, CD1c+ Zostavax"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.2	Illumina V4	"rgb(146,0,0)"	diamond	c-DC HLA-DR+CD11c+ CD1c+ Hepatitis B vaccine adult	myeloid	myeloid	adult	CD1c+ dendritic cell	Dendritic Cell
GSM1367924;6741	6741	Banchereau	GSM1367924	"Zostavax, replicate 2"	Homo sapiens	CD1c+ Zostavax	CL:0002399		CD1c+ dendritic cell			Banchereau	"The mechanisms by which microbial vaccines interact with human APCs remain elusive. Herein, we describe the transcriptional programs induced in human DCs by pathogens, innate receptor ligands and vaccines. Exposure of DCs to influenza, Salmonella enterica and Staphylococcus aureus allows us to build a modular framework containing 204 transcript clusters. We use this framework to characterize the responses of human monocytes, monocyte-derived DCs and blood DC subsets to 13 vaccines. Different vaccines induce distinct transcriptional programs based on pathogen type, adjuvant formulation and APC targeted. Fluzone, Pneumovax and Gardasil, respectively, activate monocyte-derived DCs, monocytes and CD1c+ blood DCs, highlighting APC specialization in response to vaccines. Finally, the blood signatures from individuals vaccinated with Fluzone or infected with influenza reveal a signature of adaptive immunity activation following vaccination and symptomatic infections, but not asymptomatic infections. These data, offered with a web interface, may guide the development of improved vaccines. Abstract from Nat Commun. 2014 Oct 22;5:5283."	88	"CD141+ DC, CD141+ FZ, CD141+ PVX, CD1c+ DC, CD1c+ FZ, CD1c+ Gardasil, CD1c+ Havrix, CD1c+ HEPB, CD1c+ Hib, CD1c+ Imovax, CD1c+ Ixiaro, CD1c+ PVX, CD1c+ Menomune, CD1c+ Polio, CD1c+ TDAP, CD1c+ Varicella, CD1c+ Zostavax"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.2	Illumina V4	"rgb(146,0,0)"	diamond	c-DC HLA-DR+CD11c+ CD1c+ Herpes Zoster vaccine adult	myeloid	myeloid	adult	CD1c+ dendritic cell	Dendritic Cell
GSM1367925;6741	6741	Banchereau	GSM1367925	"ActHib, replicate 2"	Homo sapiens	CD1c+ Hib	CL:0002399		CD1c+ dendritic cell			Banchereau	"The mechanisms by which microbial vaccines interact with human APCs remain elusive. Herein, we describe the transcriptional programs induced in human DCs by pathogens, innate receptor ligands and vaccines. Exposure of DCs to influenza, Salmonella enterica and Staphylococcus aureus allows us to build a modular framework containing 204 transcript clusters. We use this framework to characterize the responses of human monocytes, monocyte-derived DCs and blood DC subsets to 13 vaccines. Different vaccines induce distinct transcriptional programs based on pathogen type, adjuvant formulation and APC targeted. Fluzone, Pneumovax and Gardasil, respectively, activate monocyte-derived DCs, monocytes and CD1c+ blood DCs, highlighting APC specialization in response to vaccines. Finally, the blood signatures from individuals vaccinated with Fluzone or infected with influenza reveal a signature of adaptive immunity activation following vaccination and symptomatic infections, but not asymptomatic infections. These data, offered with a web interface, may guide the development of improved vaccines. Abstract from Nat Commun. 2014 Oct 22;5:5283."	88	"CD141+ DC, CD141+ FZ, CD141+ PVX, CD1c+ DC, CD1c+ FZ, CD1c+ Gardasil, CD1c+ Havrix, CD1c+ HEPB, CD1c+ Hib, CD1c+ Imovax, CD1c+ Ixiaro, CD1c+ PVX, CD1c+ Menomune, CD1c+ Polio, CD1c+ TDAP, CD1c+ Varicella, CD1c+ Zostavax"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.2	Illumina V4	"rgb(146,0,0)"	diamond	c-DC HLA-DR+CD11c+ CD1c+ Haemophilus influenza vaccine adult	myeloid	myeloid	adult	CD1c+ dendritic cell	Dendritic Cell
GSM1367926;6741	6741	Banchereau	GSM1367926	"Gardasil, replicate 2"	Homo sapiens	CD1c+ Gardasil	CL:0002399		CD1c+ dendritic cell			Banchereau	"The mechanisms by which microbial vaccines interact with human APCs remain elusive. Herein, we describe the transcriptional programs induced in human DCs by pathogens, innate receptor ligands and vaccines. Exposure of DCs to influenza, Salmonella enterica and Staphylococcus aureus allows us to build a modular framework containing 204 transcript clusters. We use this framework to characterize the responses of human monocytes, monocyte-derived DCs and blood DC subsets to 13 vaccines. Different vaccines induce distinct transcriptional programs based on pathogen type, adjuvant formulation and APC targeted. Fluzone, Pneumovax and Gardasil, respectively, activate monocyte-derived DCs, monocytes and CD1c+ blood DCs, highlighting APC specialization in response to vaccines. Finally, the blood signatures from individuals vaccinated with Fluzone or infected with influenza reveal a signature of adaptive immunity activation following vaccination and symptomatic infections, but not asymptomatic infections. These data, offered with a web interface, may guide the development of improved vaccines. Abstract from Nat Commun. 2014 Oct 22;5:5283."	88	"CD141+ DC, CD141+ FZ, CD141+ PVX, CD1c+ DC, CD1c+ FZ, CD1c+ Gardasil, CD1c+ Havrix, CD1c+ HEPB, CD1c+ Hib, CD1c+ Imovax, CD1c+ Ixiaro, CD1c+ PVX, CD1c+ Menomune, CD1c+ Polio, CD1c+ TDAP, CD1c+ Varicella, CD1c+ Zostavax"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.2	Illumina V4	"rgb(146,0,0)"	diamond	c-DC HLA-DR+CD11c+ CD1c+ Papilloma virus vaccine adult	myeloid	myeloid	adult	CD1c+ dendritic cell	Dendritic Cell
GSM1367927;6741	6741	Banchereau	GSM1367927	"Ixiaro, replicate 2"	Homo sapiens	CD1c+ Ixiaro	CL:0002399		CD1c+ dendritic cell			Banchereau	"The mechanisms by which microbial vaccines interact with human APCs remain elusive. Herein, we describe the transcriptional programs induced in human DCs by pathogens, innate receptor ligands and vaccines. Exposure of DCs to influenza, Salmonella enterica and Staphylococcus aureus allows us to build a modular framework containing 204 transcript clusters. We use this framework to characterize the responses of human monocytes, monocyte-derived DCs and blood DC subsets to 13 vaccines. Different vaccines induce distinct transcriptional programs based on pathogen type, adjuvant formulation and APC targeted. Fluzone, Pneumovax and Gardasil, respectively, activate monocyte-derived DCs, monocytes and CD1c+ blood DCs, highlighting APC specialization in response to vaccines. Finally, the blood signatures from individuals vaccinated with Fluzone or infected with influenza reveal a signature of adaptive immunity activation following vaccination and symptomatic infections, but not asymptomatic infections. These data, offered with a web interface, may guide the development of improved vaccines. Abstract from Nat Commun. 2014 Oct 22;5:5283."	88	"CD141+ DC, CD141+ FZ, CD141+ PVX, CD1c+ DC, CD1c+ FZ, CD1c+ Gardasil, CD1c+ Havrix, CD1c+ HEPB, CD1c+ Hib, CD1c+ Imovax, CD1c+ Ixiaro, CD1c+ PVX, CD1c+ Menomune, CD1c+ Polio, CD1c+ TDAP, CD1c+ Varicella, CD1c+ Zostavax"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.2	Illumina V4	"rgb(146,0,0)"	diamond	c-DC HLA-DR+CD11c+ CD1c+ Japanese encephalitis vaccine adult	myeloid	myeloid	adult	CD1c+ dendritic cell	Dendritic Cell
GSM1367928;6741	6741	Banchereau	GSM1367928	"Medium, replicate 4"	Homo sapiens	CD1c+ DC	CL:0002399		CD1c+ dendritic cell			Banchereau	"The mechanisms by which microbial vaccines interact with human APCs remain elusive. Herein, we describe the transcriptional programs induced in human DCs by pathogens, innate receptor ligands and vaccines. Exposure of DCs to influenza, Salmonella enterica and Staphylococcus aureus allows us to build a modular framework containing 204 transcript clusters. We use this framework to characterize the responses of human monocytes, monocyte-derived DCs and blood DC subsets to 13 vaccines. Different vaccines induce distinct transcriptional programs based on pathogen type, adjuvant formulation and APC targeted. Fluzone, Pneumovax and Gardasil, respectively, activate monocyte-derived DCs, monocytes and CD1c+ blood DCs, highlighting APC specialization in response to vaccines. Finally, the blood signatures from individuals vaccinated with Fluzone or infected with influenza reveal a signature of adaptive immunity activation following vaccination and symptomatic infections, but not asymptomatic infections. These data, offered with a web interface, may guide the development of improved vaccines. Abstract from Nat Commun. 2014 Oct 22;5:5283."	88	"CD141+ DC, CD141+ FZ, CD141+ PVX, CD1c+ DC, CD1c+ FZ, CD1c+ Gardasil, CD1c+ Havrix, CD1c+ HEPB, CD1c+ Hib, CD1c+ Imovax, CD1c+ Ixiaro, CD1c+ PVX, CD1c+ Menomune, CD1c+ Polio, CD1c+ TDAP, CD1c+ Varicella, CD1c+ Zostavax"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.2	Illumina V4	"rgb(146,0,0)"	diamond	c-DC HLA-DR+CD11c+ CD1c+  adult	myeloid	myeloid	adult	CD1c+ dendritic cell	Dendritic Cell
GSM1367929;6741	6741	Banchereau	GSM1367929	"Medium, replicate 5"	Homo sapiens	CD1c+ DC	CL:0002399		CD1c+ dendritic cell			Banchereau	"The mechanisms by which microbial vaccines interact with human APCs remain elusive. Herein, we describe the transcriptional programs induced in human DCs by pathogens, innate receptor ligands and vaccines. Exposure of DCs to influenza, Salmonella enterica and Staphylococcus aureus allows us to build a modular framework containing 204 transcript clusters. We use this framework to characterize the responses of human monocytes, monocyte-derived DCs and blood DC subsets to 13 vaccines. Different vaccines induce distinct transcriptional programs based on pathogen type, adjuvant formulation and APC targeted. Fluzone, Pneumovax and Gardasil, respectively, activate monocyte-derived DCs, monocytes and CD1c+ blood DCs, highlighting APC specialization in response to vaccines. Finally, the blood signatures from individuals vaccinated with Fluzone or infected with influenza reveal a signature of adaptive immunity activation following vaccination and symptomatic infections, but not asymptomatic infections. These data, offered with a web interface, may guide the development of improved vaccines. Abstract from Nat Commun. 2014 Oct 22;5:5283."	88	"CD141+ DC, CD141+ FZ, CD141+ PVX, CD1c+ DC, CD1c+ FZ, CD1c+ Gardasil, CD1c+ Havrix, CD1c+ HEPB, CD1c+ Hib, CD1c+ Imovax, CD1c+ Ixiaro, CD1c+ PVX, CD1c+ Menomune, CD1c+ Polio, CD1c+ TDAP, CD1c+ Varicella, CD1c+ Zostavax"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.2	Illumina V4	"rgb(146,0,0)"	diamond	c-DC HLA-DR+CD11c+ CD1c+  adult	myeloid	myeloid	adult	CD1c+ dendritic cell	Dendritic Cell
GSM1367930;6741	6741	Banchereau	GSM1367930	"Medium, replicate 6"	Homo sapiens	CD141+ DC	CL:0002399		CD141+ dendritic cell			Banchereau	"The mechanisms by which microbial vaccines interact with human APCs remain elusive. Herein, we describe the transcriptional programs induced in human DCs by pathogens, innate receptor ligands and vaccines. Exposure of DCs to influenza, Salmonella enterica and Staphylococcus aureus allows us to build a modular framework containing 204 transcript clusters. We use this framework to characterize the responses of human monocytes, monocyte-derived DCs and blood DC subsets to 13 vaccines. Different vaccines induce distinct transcriptional programs based on pathogen type, adjuvant formulation and APC targeted. Fluzone, Pneumovax and Gardasil, respectively, activate monocyte-derived DCs, monocytes and CD1c+ blood DCs, highlighting APC specialization in response to vaccines. Finally, the blood signatures from individuals vaccinated with Fluzone or infected with influenza reveal a signature of adaptive immunity activation following vaccination and symptomatic infections, but not asymptomatic infections. These data, offered with a web interface, may guide the development of improved vaccines. Abstract from Nat Commun. 2014 Oct 22;5:5283."	88	"CD141+ DC, CD141+ FZ, CD141+ PVX, CD1c+ DC, CD1c+ FZ, CD1c+ Gardasil, CD1c+ Havrix, CD1c+ HEPB, CD1c+ Hib, CD1c+ Imovax, CD1c+ Ixiaro, CD1c+ PVX, CD1c+ Menomune, CD1c+ Polio, CD1c+ TDAP, CD1c+ Varicella, CD1c+ Zostavax"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.2	Illumina V4	"rgb(146,0,0)"	diamond	c-DC HLA-DR+CD11c+ CD141+  adult	myeloid	myeloid	adult	CD141+ dendritic cell	Dendritic Cell
GSM1367931;6741	6741	Banchereau	GSM1367931	"Menomune, replicate 2"	Homo sapiens	CD1c+ Menomune	CL:0002399		CD1c+ dendritic cell			Banchereau	"The mechanisms by which microbial vaccines interact with human APCs remain elusive. Herein, we describe the transcriptional programs induced in human DCs by pathogens, innate receptor ligands and vaccines. Exposure of DCs to influenza, Salmonella enterica and Staphylococcus aureus allows us to build a modular framework containing 204 transcript clusters. We use this framework to characterize the responses of human monocytes, monocyte-derived DCs and blood DC subsets to 13 vaccines. Different vaccines induce distinct transcriptional programs based on pathogen type, adjuvant formulation and APC targeted. Fluzone, Pneumovax and Gardasil, respectively, activate monocyte-derived DCs, monocytes and CD1c+ blood DCs, highlighting APC specialization in response to vaccines. Finally, the blood signatures from individuals vaccinated with Fluzone or infected with influenza reveal a signature of adaptive immunity activation following vaccination and symptomatic infections, but not asymptomatic infections. These data, offered with a web interface, may guide the development of improved vaccines. Abstract from Nat Commun. 2014 Oct 22;5:5283."	88	"CD141+ DC, CD141+ FZ, CD141+ PVX, CD1c+ DC, CD1c+ FZ, CD1c+ Gardasil, CD1c+ Havrix, CD1c+ HEPB, CD1c+ Hib, CD1c+ Imovax, CD1c+ Ixiaro, CD1c+ PVX, CD1c+ Menomune, CD1c+ Polio, CD1c+ TDAP, CD1c+ Varicella, CD1c+ Zostavax"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.2	Illumina V4	"rgb(146,0,0)"	diamond	c-DC HLA-DR+CD11c+ CD1c+ Neisseiria meningitis vaccine adult	myeloid	myeloid	adult	CD1c+ dendritic cell	Dendritic Cell
GSM1367932;6741	6741	Banchereau	GSM1367932	"Ipol, replicate 2"	Homo sapiens	CD1c+ Polio	CL:0002399		CD1c+ dendritic cell			Banchereau	"The mechanisms by which microbial vaccines interact with human APCs remain elusive. Herein, we describe the transcriptional programs induced in human DCs by pathogens, innate receptor ligands and vaccines. Exposure of DCs to influenza, Salmonella enterica and Staphylococcus aureus allows us to build a modular framework containing 204 transcript clusters. We use this framework to characterize the responses of human monocytes, monocyte-derived DCs and blood DC subsets to 13 vaccines. Different vaccines induce distinct transcriptional programs based on pathogen type, adjuvant formulation and APC targeted. Fluzone, Pneumovax and Gardasil, respectively, activate monocyte-derived DCs, monocytes and CD1c+ blood DCs, highlighting APC specialization in response to vaccines. Finally, the blood signatures from individuals vaccinated with Fluzone or infected with influenza reveal a signature of adaptive immunity activation following vaccination and symptomatic infections, but not asymptomatic infections. These data, offered with a web interface, may guide the development of improved vaccines. Abstract from Nat Commun. 2014 Oct 22;5:5283."	88	"CD141+ DC, CD141+ FZ, CD141+ PVX, CD1c+ DC, CD1c+ FZ, CD1c+ Gardasil, CD1c+ Havrix, CD1c+ HEPB, CD1c+ Hib, CD1c+ Imovax, CD1c+ Ixiaro, CD1c+ PVX, CD1c+ Menomune, CD1c+ Polio, CD1c+ TDAP, CD1c+ Varicella, CD1c+ Zostavax"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.2	Illumina V4	"rgb(146,0,0)"	diamond	c-DC HLA-DR+CD11c+ CD1c+ polio vaccine adult	myeloid	myeloid	adult	CD1c+ dendritic cell	Dendritic Cell
GSM1367933;6741	6741	Banchereau	GSM1367933	"Pneumovax, replicate 3"	Homo sapiens	CD1c+ PVX	CL:0002399		CD1c+ dendritic cell			Banchereau	"The mechanisms by which microbial vaccines interact with human APCs remain elusive. Herein, we describe the transcriptional programs induced in human DCs by pathogens, innate receptor ligands and vaccines. Exposure of DCs to influenza, Salmonella enterica and Staphylococcus aureus allows us to build a modular framework containing 204 transcript clusters. We use this framework to characterize the responses of human monocytes, monocyte-derived DCs and blood DC subsets to 13 vaccines. Different vaccines induce distinct transcriptional programs based on pathogen type, adjuvant formulation and APC targeted. Fluzone, Pneumovax and Gardasil, respectively, activate monocyte-derived DCs, monocytes and CD1c+ blood DCs, highlighting APC specialization in response to vaccines. Finally, the blood signatures from individuals vaccinated with Fluzone or infected with influenza reveal a signature of adaptive immunity activation following vaccination and symptomatic infections, but not asymptomatic infections. These data, offered with a web interface, may guide the development of improved vaccines. Abstract from Nat Commun. 2014 Oct 22;5:5283."	88	"CD141+ DC, CD141+ FZ, CD141+ PVX, CD1c+ DC, CD1c+ FZ, CD1c+ Gardasil, CD1c+ Havrix, CD1c+ HEPB, CD1c+ Hib, CD1c+ Imovax, CD1c+ Ixiaro, CD1c+ PVX, CD1c+ Menomune, CD1c+ Polio, CD1c+ TDAP, CD1c+ Varicella, CD1c+ Zostavax"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.2	Illumina V4	"rgb(146,0,0)"	diamond	c-DC HLA-DR+CD11c+ CD1c+ Pneumococcus vaccine adult	myeloid	myeloid	adult	CD1c+ dendritic cell	Dendritic Cell
GSM1367934;6741	6741	Banchereau	GSM1367934	"Pneumovax, replicate 4"	Homo sapiens	CD141+ PVX	CL:0002394		CD141+ dendritic cell			Banchereau	"The mechanisms by which microbial vaccines interact with human APCs remain elusive. Herein, we describe the transcriptional programs induced in human DCs by pathogens, innate receptor ligands and vaccines. Exposure of DCs to influenza, Salmonella enterica and Staphylococcus aureus allows us to build a modular framework containing 204 transcript clusters. We use this framework to characterize the responses of human monocytes, monocyte-derived DCs and blood DC subsets to 13 vaccines. Different vaccines induce distinct transcriptional programs based on pathogen type, adjuvant formulation and APC targeted. Fluzone, Pneumovax and Gardasil, respectively, activate monocyte-derived DCs, monocytes and CD1c+ blood DCs, highlighting APC specialization in response to vaccines. Finally, the blood signatures from individuals vaccinated with Fluzone or infected with influenza reveal a signature of adaptive immunity activation following vaccination and symptomatic infections, but not asymptomatic infections. These data, offered with a web interface, may guide the development of improved vaccines. Abstract from Nat Commun. 2014 Oct 22;5:5283."	88	"CD141+ DC, CD141+ FZ, CD141+ PVX, CD1c+ DC, CD1c+ FZ, CD1c+ Gardasil, CD1c+ Havrix, CD1c+ HEPB, CD1c+ Hib, CD1c+ Imovax, CD1c+ Ixiaro, CD1c+ PVX, CD1c+ Menomune, CD1c+ Polio, CD1c+ TDAP, CD1c+ Varicella, CD1c+ Zostavax"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.2	Illumina V4	"rgb(146,0,0)"	diamond	c-DC HLA-DR+CD11c+ CD141+ Pneumococcus vaccine adult	myeloid	myeloid	adult	CD141+ dendritic cell	Dendritic Cell
GSM1367935;6741	6741	Banchereau	GSM1367935	"Imovax, replicate 2"	Homo sapiens	CD1c+ Imovax	CL:0002399		CD1c+ dendritic cell			Banchereau	"The mechanisms by which microbial vaccines interact with human APCs remain elusive. Herein, we describe the transcriptional programs induced in human DCs by pathogens, innate receptor ligands and vaccines. Exposure of DCs to influenza, Salmonella enterica and Staphylococcus aureus allows us to build a modular framework containing 204 transcript clusters. We use this framework to characterize the responses of human monocytes, monocyte-derived DCs and blood DC subsets to 13 vaccines. Different vaccines induce distinct transcriptional programs based on pathogen type, adjuvant formulation and APC targeted. Fluzone, Pneumovax and Gardasil, respectively, activate monocyte-derived DCs, monocytes and CD1c+ blood DCs, highlighting APC specialization in response to vaccines. Finally, the blood signatures from individuals vaccinated with Fluzone or infected with influenza reveal a signature of adaptive immunity activation following vaccination and symptomatic infections, but not asymptomatic infections. These data, offered with a web interface, may guide the development of improved vaccines. Abstract from Nat Commun. 2014 Oct 22;5:5283."	88	"CD141+ DC, CD141+ FZ, CD141+ PVX, CD1c+ DC, CD1c+ FZ, CD1c+ Gardasil, CD1c+ Havrix, CD1c+ HEPB, CD1c+ Hib, CD1c+ Imovax, CD1c+ Ixiaro, CD1c+ PVX, CD1c+ Menomune, CD1c+ Polio, CD1c+ TDAP, CD1c+ Varicella, CD1c+ Zostavax"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.2	Illumina V4	"rgb(146,0,0)"	diamond	c-DC HLA-DR+CD11c+ CD1c+ rabies vaccine adult	myeloid	myeloid	adult	CD1c+ dendritic cell	Dendritic Cell
GSM1367936;6741	6741	Banchereau	GSM1367936	"Adacel, replicate 2"	Homo sapiens	CD1c+ TDAP	CL:0002399		CD1c+ dendritic cell			Banchereau	"The mechanisms by which microbial vaccines interact with human APCs remain elusive. Herein, we describe the transcriptional programs induced in human DCs by pathogens, innate receptor ligands and vaccines. Exposure of DCs to influenza, Salmonella enterica and Staphylococcus aureus allows us to build a modular framework containing 204 transcript clusters. We use this framework to characterize the responses of human monocytes, monocyte-derived DCs and blood DC subsets to 13 vaccines. Different vaccines induce distinct transcriptional programs based on pathogen type, adjuvant formulation and APC targeted. Fluzone, Pneumovax and Gardasil, respectively, activate monocyte-derived DCs, monocytes and CD1c+ blood DCs, highlighting APC specialization in response to vaccines. Finally, the blood signatures from individuals vaccinated with Fluzone or infected with influenza reveal a signature of adaptive immunity activation following vaccination and symptomatic infections, but not asymptomatic infections. These data, offered with a web interface, may guide the development of improved vaccines. Abstract from Nat Commun. 2014 Oct 22;5:5283."	88	"CD141+ DC, CD141+ FZ, CD141+ PVX, CD1c+ DC, CD1c+ FZ, CD1c+ Gardasil, CD1c+ Havrix, CD1c+ HEPB, CD1c+ Hib, CD1c+ Imovax, CD1c+ Ixiaro, CD1c+ PVX, CD1c+ Menomune, CD1c+ Polio, CD1c+ TDAP, CD1c+ Varicella, CD1c+ Zostavax"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.2	Illumina V4	"rgb(146,0,0)"	diamond	c-DC HLA-DR+CD11c+ CD1c+ Tetanus Diphteria Pertussis vaccine adult	myeloid	myeloid	adult	CD1c+ dendritic cell	Dendritic Cell
GSM1367937;6741	6741	Banchereau	GSM1367937	"Varivax, replicate 2"	Homo sapiens	CD1c+ Varicella	CL:0002399		CD1c+ dendritic cell			Banchereau	"The mechanisms by which microbial vaccines interact with human APCs remain elusive. Herein, we describe the transcriptional programs induced in human DCs by pathogens, innate receptor ligands and vaccines. Exposure of DCs to influenza, Salmonella enterica and Staphylococcus aureus allows us to build a modular framework containing 204 transcript clusters. We use this framework to characterize the responses of human monocytes, monocyte-derived DCs and blood DC subsets to 13 vaccines. Different vaccines induce distinct transcriptional programs based on pathogen type, adjuvant formulation and APC targeted. Fluzone, Pneumovax and Gardasil, respectively, activate monocyte-derived DCs, monocytes and CD1c+ blood DCs, highlighting APC specialization in response to vaccines. Finally, the blood signatures from individuals vaccinated with Fluzone or infected with influenza reveal a signature of adaptive immunity activation following vaccination and symptomatic infections, but not asymptomatic infections. These data, offered with a web interface, may guide the development of improved vaccines. Abstract from Nat Commun. 2014 Oct 22;5:5283."	88	"CD141+ DC, CD141+ FZ, CD141+ PVX, CD1c+ DC, CD1c+ FZ, CD1c+ Gardasil, CD1c+ Havrix, CD1c+ HEPB, CD1c+ Hib, CD1c+ Imovax, CD1c+ Ixiaro, CD1c+ PVX, CD1c+ Menomune, CD1c+ Polio, CD1c+ TDAP, CD1c+ Varicella, CD1c+ Zostavax"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.2	Illumina V4	"rgb(146,0,0)"	diamond	c-DC HLA-DR+CD11c+ CD1c+ Varicella vaccine adult	myeloid	myeloid	adult	CD1c+ dendritic cell	Dendritic Cell
GSM1367938;6741	6741	Banchereau	GSM1367938	"Fluzone, replicate 5"	Homo sapiens	CD1c+ FZ	CL:0002399		CD1c+ dendritic cell			Banchereau	"The mechanisms by which microbial vaccines interact with human APCs remain elusive. Herein, we describe the transcriptional programs induced in human DCs by pathogens, innate receptor ligands and vaccines. Exposure of DCs to influenza, Salmonella enterica and Staphylococcus aureus allows us to build a modular framework containing 204 transcript clusters. We use this framework to characterize the responses of human monocytes, monocyte-derived DCs and blood DC subsets to 13 vaccines. Different vaccines induce distinct transcriptional programs based on pathogen type, adjuvant formulation and APC targeted. Fluzone, Pneumovax and Gardasil, respectively, activate monocyte-derived DCs, monocytes and CD1c+ blood DCs, highlighting APC specialization in response to vaccines. Finally, the blood signatures from individuals vaccinated with Fluzone or infected with influenza reveal a signature of adaptive immunity activation following vaccination and symptomatic infections, but not asymptomatic infections. These data, offered with a web interface, may guide the development of improved vaccines. Abstract from Nat Commun. 2014 Oct 22;5:5283."	88	"CD141+ DC, CD141+ FZ, CD141+ PVX, CD1c+ DC, CD1c+ FZ, CD1c+ Gardasil, CD1c+ Havrix, CD1c+ HEPB, CD1c+ Hib, CD1c+ Imovax, CD1c+ Ixiaro, CD1c+ PVX, CD1c+ Menomune, CD1c+ Polio, CD1c+ TDAP, CD1c+ Varicella, CD1c+ Zostavax"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.2	Illumina V4	"rgb(146,0,0)"	diamond	c-DC HLA-DR+CD11c+ CD1c+ influenza vaccine adult	myeloid	myeloid	adult	CD1c+ dendritic cell	Dendritic Cell
GSM1367939;6741	6741	Banchereau	GSM1367939	"Fluzone, replicate 6"	Homo sapiens	CD141+ FZ	CL:0002394		CD141+ dendritic cell			Banchereau	"The mechanisms by which microbial vaccines interact with human APCs remain elusive. Herein, we describe the transcriptional programs induced in human DCs by pathogens, innate receptor ligands and vaccines. Exposure of DCs to influenza, Salmonella enterica and Staphylococcus aureus allows us to build a modular framework containing 204 transcript clusters. We use this framework to characterize the responses of human monocytes, monocyte-derived DCs and blood DC subsets to 13 vaccines. Different vaccines induce distinct transcriptional programs based on pathogen type, adjuvant formulation and APC targeted. Fluzone, Pneumovax and Gardasil, respectively, activate monocyte-derived DCs, monocytes and CD1c+ blood DCs, highlighting APC specialization in response to vaccines. Finally, the blood signatures from individuals vaccinated with Fluzone or infected with influenza reveal a signature of adaptive immunity activation following vaccination and symptomatic infections, but not asymptomatic infections. These data, offered with a web interface, may guide the development of improved vaccines. Abstract from Nat Commun. 2014 Oct 22;5:5283."	88	"CD141+ DC, CD141+ FZ, CD141+ PVX, CD1c+ DC, CD1c+ FZ, CD1c+ Gardasil, CD1c+ Havrix, CD1c+ HEPB, CD1c+ Hib, CD1c+ Imovax, CD1c+ Ixiaro, CD1c+ PVX, CD1c+ Menomune, CD1c+ Polio, CD1c+ TDAP, CD1c+ Varicella, CD1c+ Zostavax"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.2	Illumina V4	"rgb(146,0,0)"	diamond	c-DC HLA-DR+CD11c+ CD141+ influenza vaccine adult	myeloid	myeloid	adult	CD141+ dendritic cell	Dendritic Cell
GSM1367940;6741	6741	Banchereau	GSM1367940	"Havrix, replicate 3"	Homo sapiens	CD1c+ Havrix	CL:0002399		CD1c+ dendritic cell			Banchereau	"The mechanisms by which microbial vaccines interact with human APCs remain elusive. Herein, we describe the transcriptional programs induced in human DCs by pathogens, innate receptor ligands and vaccines. Exposure of DCs to influenza, Salmonella enterica and Staphylococcus aureus allows us to build a modular framework containing 204 transcript clusters. We use this framework to characterize the responses of human monocytes, monocyte-derived DCs and blood DC subsets to 13 vaccines. Different vaccines induce distinct transcriptional programs based on pathogen type, adjuvant formulation and APC targeted. Fluzone, Pneumovax and Gardasil, respectively, activate monocyte-derived DCs, monocytes and CD1c+ blood DCs, highlighting APC specialization in response to vaccines. Finally, the blood signatures from individuals vaccinated with Fluzone or infected with influenza reveal a signature of adaptive immunity activation following vaccination and symptomatic infections, but not asymptomatic infections. These data, offered with a web interface, may guide the development of improved vaccines. Abstract from Nat Commun. 2014 Oct 22;5:5283."	88	"CD141+ DC, CD141+ FZ, CD141+ PVX, CD1c+ DC, CD1c+ FZ, CD1c+ Gardasil, CD1c+ Havrix, CD1c+ HEPB, CD1c+ Hib, CD1c+ Imovax, CD1c+ Ixiaro, CD1c+ PVX, CD1c+ Menomune, CD1c+ Polio, CD1c+ TDAP, CD1c+ Varicella, CD1c+ Zostavax"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.2	Illumina V4	"rgb(146,0,0)"	diamond	c-DC HLA-DR+CD11c+ CD1c+ Hepatitis A vaccine adult	myeloid	myeloid	adult	CD1c+ dendritic cell	Dendritic Cell
GSM1367941;6741	6741	Banchereau	GSM1367941	"Engerix-B, replicate 3"	Homo sapiens	CD1c+ HEPB	CL:0002399		CD1c+ dendritic cell			Banchereau	"The mechanisms by which microbial vaccines interact with human APCs remain elusive. Herein, we describe the transcriptional programs induced in human DCs by pathogens, innate receptor ligands and vaccines. Exposure of DCs to influenza, Salmonella enterica and Staphylococcus aureus allows us to build a modular framework containing 204 transcript clusters. We use this framework to characterize the responses of human monocytes, monocyte-derived DCs and blood DC subsets to 13 vaccines. Different vaccines induce distinct transcriptional programs based on pathogen type, adjuvant formulation and APC targeted. Fluzone, Pneumovax and Gardasil, respectively, activate monocyte-derived DCs, monocytes and CD1c+ blood DCs, highlighting APC specialization in response to vaccines. Finally, the blood signatures from individuals vaccinated with Fluzone or infected with influenza reveal a signature of adaptive immunity activation following vaccination and symptomatic infections, but not asymptomatic infections. These data, offered with a web interface, may guide the development of improved vaccines. Abstract from Nat Commun. 2014 Oct 22;5:5283."	88	"CD141+ DC, CD141+ FZ, CD141+ PVX, CD1c+ DC, CD1c+ FZ, CD1c+ Gardasil, CD1c+ Havrix, CD1c+ HEPB, CD1c+ Hib, CD1c+ Imovax, CD1c+ Ixiaro, CD1c+ PVX, CD1c+ Menomune, CD1c+ Polio, CD1c+ TDAP, CD1c+ Varicella, CD1c+ Zostavax"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.2	Illumina V4	"rgb(146,0,0)"	diamond	c-DC HLA-DR+CD11c+ CD1c+ Hepatitis B vaccine adult	myeloid	myeloid	adult	CD1c+ dendritic cell	Dendritic Cell
GSM1367942;6741	6741	Banchereau	GSM1367942	"Zostavax, replicate 3"	Homo sapiens	CD1c+ Zostavax	CL:0002399		CD1c+ dendritic cell			Banchereau	"The mechanisms by which microbial vaccines interact with human APCs remain elusive. Herein, we describe the transcriptional programs induced in human DCs by pathogens, innate receptor ligands and vaccines. Exposure of DCs to influenza, Salmonella enterica and Staphylococcus aureus allows us to build a modular framework containing 204 transcript clusters. We use this framework to characterize the responses of human monocytes, monocyte-derived DCs and blood DC subsets to 13 vaccines. Different vaccines induce distinct transcriptional programs based on pathogen type, adjuvant formulation and APC targeted. Fluzone, Pneumovax and Gardasil, respectively, activate monocyte-derived DCs, monocytes and CD1c+ blood DCs, highlighting APC specialization in response to vaccines. Finally, the blood signatures from individuals vaccinated with Fluzone or infected with influenza reveal a signature of adaptive immunity activation following vaccination and symptomatic infections, but not asymptomatic infections. These data, offered with a web interface, may guide the development of improved vaccines. Abstract from Nat Commun. 2014 Oct 22;5:5283."	88	"CD141+ DC, CD141+ FZ, CD141+ PVX, CD1c+ DC, CD1c+ FZ, CD1c+ Gardasil, CD1c+ Havrix, CD1c+ HEPB, CD1c+ Hib, CD1c+ Imovax, CD1c+ Ixiaro, CD1c+ PVX, CD1c+ Menomune, CD1c+ Polio, CD1c+ TDAP, CD1c+ Varicella, CD1c+ Zostavax"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.2	Illumina V4	"rgb(146,0,0)"	diamond	c-DC HLA-DR+CD11c+ CD1c+ Herpes Zoster vaccine adult	myeloid	myeloid	adult	CD1c+ dendritic cell	Dendritic Cell
GSM1367943;6741	6741	Banchereau	GSM1367943	"ActHib, replicate 3"	Homo sapiens	CD1c+ Hib	CL:0002399		CD1c+ dendritic cell			Banchereau	"The mechanisms by which microbial vaccines interact with human APCs remain elusive. Herein, we describe the transcriptional programs induced in human DCs by pathogens, innate receptor ligands and vaccines. Exposure of DCs to influenza, Salmonella enterica and Staphylococcus aureus allows us to build a modular framework containing 204 transcript clusters. We use this framework to characterize the responses of human monocytes, monocyte-derived DCs and blood DC subsets to 13 vaccines. Different vaccines induce distinct transcriptional programs based on pathogen type, adjuvant formulation and APC targeted. Fluzone, Pneumovax and Gardasil, respectively, activate monocyte-derived DCs, monocytes and CD1c+ blood DCs, highlighting APC specialization in response to vaccines. Finally, the blood signatures from individuals vaccinated with Fluzone or infected with influenza reveal a signature of adaptive immunity activation following vaccination and symptomatic infections, but not asymptomatic infections. These data, offered with a web interface, may guide the development of improved vaccines. Abstract from Nat Commun. 2014 Oct 22;5:5283."	88	"CD141+ DC, CD141+ FZ, CD141+ PVX, CD1c+ DC, CD1c+ FZ, CD1c+ Gardasil, CD1c+ Havrix, CD1c+ HEPB, CD1c+ Hib, CD1c+ Imovax, CD1c+ Ixiaro, CD1c+ PVX, CD1c+ Menomune, CD1c+ Polio, CD1c+ TDAP, CD1c+ Varicella, CD1c+ Zostavax"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.2	Illumina V4	"rgb(146,0,0)"	diamond	c-DC HLA-DR+CD11c+ CD1c+ Haemophilus influenza vaccine adult	myeloid	myeloid	adult	CD1c+ dendritic cell	Dendritic Cell
GSM1367944;6741	6741	Banchereau	GSM1367944	"Gardasil, replicate 3"	Homo sapiens	CD1c+ Gardasil	CL:0002399		CD1c+ dendritic cell			Banchereau	"The mechanisms by which microbial vaccines interact with human APCs remain elusive. Herein, we describe the transcriptional programs induced in human DCs by pathogens, innate receptor ligands and vaccines. Exposure of DCs to influenza, Salmonella enterica and Staphylococcus aureus allows us to build a modular framework containing 204 transcript clusters. We use this framework to characterize the responses of human monocytes, monocyte-derived DCs and blood DC subsets to 13 vaccines. Different vaccines induce distinct transcriptional programs based on pathogen type, adjuvant formulation and APC targeted. Fluzone, Pneumovax and Gardasil, respectively, activate monocyte-derived DCs, monocytes and CD1c+ blood DCs, highlighting APC specialization in response to vaccines. Finally, the blood signatures from individuals vaccinated with Fluzone or infected with influenza reveal a signature of adaptive immunity activation following vaccination and symptomatic infections, but not asymptomatic infections. These data, offered with a web interface, may guide the development of improved vaccines. Abstract from Nat Commun. 2014 Oct 22;5:5283."	88	"CD141+ DC, CD141+ FZ, CD141+ PVX, CD1c+ DC, CD1c+ FZ, CD1c+ Gardasil, CD1c+ Havrix, CD1c+ HEPB, CD1c+ Hib, CD1c+ Imovax, CD1c+ Ixiaro, CD1c+ PVX, CD1c+ Menomune, CD1c+ Polio, CD1c+ TDAP, CD1c+ Varicella, CD1c+ Zostavax"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.2	Illumina V4	"rgb(146,0,0)"	diamond	c-DC HLA-DR+CD11c+ CD1c+ Papilloma virus vaccine adult	myeloid	myeloid	adult	CD1c+ dendritic cell	Dendritic Cell
GSM1367945;6741	6741	Banchereau	GSM1367945	"Ixiaro, replicate 3"	Homo sapiens	CD1c+ Ixiaro	CL:0002399		CD1c+ dendritic cell			Banchereau	"The mechanisms by which microbial vaccines interact with human APCs remain elusive. Herein, we describe the transcriptional programs induced in human DCs by pathogens, innate receptor ligands and vaccines. Exposure of DCs to influenza, Salmonella enterica and Staphylococcus aureus allows us to build a modular framework containing 204 transcript clusters. We use this framework to characterize the responses of human monocytes, monocyte-derived DCs and blood DC subsets to 13 vaccines. Different vaccines induce distinct transcriptional programs based on pathogen type, adjuvant formulation and APC targeted. Fluzone, Pneumovax and Gardasil, respectively, activate monocyte-derived DCs, monocytes and CD1c+ blood DCs, highlighting APC specialization in response to vaccines. Finally, the blood signatures from individuals vaccinated with Fluzone or infected with influenza reveal a signature of adaptive immunity activation following vaccination and symptomatic infections, but not asymptomatic infections. These data, offered with a web interface, may guide the development of improved vaccines. Abstract from Nat Commun. 2014 Oct 22;5:5283."	88	"CD141+ DC, CD141+ FZ, CD141+ PVX, CD1c+ DC, CD1c+ FZ, CD1c+ Gardasil, CD1c+ Havrix, CD1c+ HEPB, CD1c+ Hib, CD1c+ Imovax, CD1c+ Ixiaro, CD1c+ PVX, CD1c+ Menomune, CD1c+ Polio, CD1c+ TDAP, CD1c+ Varicella, CD1c+ Zostavax"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.2	Illumina V4	"rgb(146,0,0)"	diamond	c-DC HLA-DR+CD11c+ CD1c+ Japanese encephalitis vaccine adult	myeloid	myeloid	adult	CD1c+ dendritic cell	Dendritic Cell
GSM1367946;6741	6741	Banchereau	GSM1367946	"Medium, replicate 7"	Homo sapiens	CD1c+ DC	CL:0002399		CD1c+ dendritic cell			Banchereau	"The mechanisms by which microbial vaccines interact with human APCs remain elusive. Herein, we describe the transcriptional programs induced in human DCs by pathogens, innate receptor ligands and vaccines. Exposure of DCs to influenza, Salmonella enterica and Staphylococcus aureus allows us to build a modular framework containing 204 transcript clusters. We use this framework to characterize the responses of human monocytes, monocyte-derived DCs and blood DC subsets to 13 vaccines. Different vaccines induce distinct transcriptional programs based on pathogen type, adjuvant formulation and APC targeted. Fluzone, Pneumovax and Gardasil, respectively, activate monocyte-derived DCs, monocytes and CD1c+ blood DCs, highlighting APC specialization in response to vaccines. Finally, the blood signatures from individuals vaccinated with Fluzone or infected with influenza reveal a signature of adaptive immunity activation following vaccination and symptomatic infections, but not asymptomatic infections. These data, offered with a web interface, may guide the development of improved vaccines. Abstract from Nat Commun. 2014 Oct 22;5:5283."	88	"CD141+ DC, CD141+ FZ, CD141+ PVX, CD1c+ DC, CD1c+ FZ, CD1c+ Gardasil, CD1c+ Havrix, CD1c+ HEPB, CD1c+ Hib, CD1c+ Imovax, CD1c+ Ixiaro, CD1c+ PVX, CD1c+ Menomune, CD1c+ Polio, CD1c+ TDAP, CD1c+ Varicella, CD1c+ Zostavax"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.2	Illumina V4	"rgb(146,0,0)"	diamond	c-DC HLA-DR+CD11c+ CD1c+  adult	myeloid	myeloid	adult	CD1c+ dendritic cell	Dendritic Cell
GSM1367947;6741	6741	Banchereau	GSM1367947	"Medium, replicate 8"	Homo sapiens	CD1c+ DC	CL:0002399		CD1c+ dendritic cell			Banchereau	"The mechanisms by which microbial vaccines interact with human APCs remain elusive. Herein, we describe the transcriptional programs induced in human DCs by pathogens, innate receptor ligands and vaccines. Exposure of DCs to influenza, Salmonella enterica and Staphylococcus aureus allows us to build a modular framework containing 204 transcript clusters. We use this framework to characterize the responses of human monocytes, monocyte-derived DCs and blood DC subsets to 13 vaccines. Different vaccines induce distinct transcriptional programs based on pathogen type, adjuvant formulation and APC targeted. Fluzone, Pneumovax and Gardasil, respectively, activate monocyte-derived DCs, monocytes and CD1c+ blood DCs, highlighting APC specialization in response to vaccines. Finally, the blood signatures from individuals vaccinated with Fluzone or infected with influenza reveal a signature of adaptive immunity activation following vaccination and symptomatic infections, but not asymptomatic infections. These data, offered with a web interface, may guide the development of improved vaccines. Abstract from Nat Commun. 2014 Oct 22;5:5283."	88	"CD141+ DC, CD141+ FZ, CD141+ PVX, CD1c+ DC, CD1c+ FZ, CD1c+ Gardasil, CD1c+ Havrix, CD1c+ HEPB, CD1c+ Hib, CD1c+ Imovax, CD1c+ Ixiaro, CD1c+ PVX, CD1c+ Menomune, CD1c+ Polio, CD1c+ TDAP, CD1c+ Varicella, CD1c+ Zostavax"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.2	Illumina V4	"rgb(146,0,0)"	diamond	c-DC HLA-DR+CD11c+ CD1c+  adult	myeloid	myeloid	adult	CD1c+ dendritic cell	Dendritic Cell
GSM1367948;6741	6741	Banchereau	GSM1367948	"Medium, replicate 9"	Homo sapiens	CD141+ DC	CL:0002394		CD141+ dendritic cell			Banchereau	"The mechanisms by which microbial vaccines interact with human APCs remain elusive. Herein, we describe the transcriptional programs induced in human DCs by pathogens, innate receptor ligands and vaccines. Exposure of DCs to influenza, Salmonella enterica and Staphylococcus aureus allows us to build a modular framework containing 204 transcript clusters. We use this framework to characterize the responses of human monocytes, monocyte-derived DCs and blood DC subsets to 13 vaccines. Different vaccines induce distinct transcriptional programs based on pathogen type, adjuvant formulation and APC targeted. Fluzone, Pneumovax and Gardasil, respectively, activate monocyte-derived DCs, monocytes and CD1c+ blood DCs, highlighting APC specialization in response to vaccines. Finally, the blood signatures from individuals vaccinated with Fluzone or infected with influenza reveal a signature of adaptive immunity activation following vaccination and symptomatic infections, but not asymptomatic infections. These data, offered with a web interface, may guide the development of improved vaccines. Abstract from Nat Commun. 2014 Oct 22;5:5283."	88	"CD141+ DC, CD141+ FZ, CD141+ PVX, CD1c+ DC, CD1c+ FZ, CD1c+ Gardasil, CD1c+ Havrix, CD1c+ HEPB, CD1c+ Hib, CD1c+ Imovax, CD1c+ Ixiaro, CD1c+ PVX, CD1c+ Menomune, CD1c+ Polio, CD1c+ TDAP, CD1c+ Varicella, CD1c+ Zostavax"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.2	Illumina V4	"rgb(146,0,0)"	diamond	c-DC HLA-DR+CD11c+ CD141+  adult	myeloid	myeloid	adult	CD141+ dendritic cell	Dendritic Cell
GSM1367949;6741	6741	Banchereau	GSM1367949	"Menomune, replicate 3"	Homo sapiens	CD1c+ Menomune	CL:0002399		CD1c+ dendritic cell			Banchereau	"The mechanisms by which microbial vaccines interact with human APCs remain elusive. Herein, we describe the transcriptional programs induced in human DCs by pathogens, innate receptor ligands and vaccines. Exposure of DCs to influenza, Salmonella enterica and Staphylococcus aureus allows us to build a modular framework containing 204 transcript clusters. We use this framework to characterize the responses of human monocytes, monocyte-derived DCs and blood DC subsets to 13 vaccines. Different vaccines induce distinct transcriptional programs based on pathogen type, adjuvant formulation and APC targeted. Fluzone, Pneumovax and Gardasil, respectively, activate monocyte-derived DCs, monocytes and CD1c+ blood DCs, highlighting APC specialization in response to vaccines. Finally, the blood signatures from individuals vaccinated with Fluzone or infected with influenza reveal a signature of adaptive immunity activation following vaccination and symptomatic infections, but not asymptomatic infections. These data, offered with a web interface, may guide the development of improved vaccines. Abstract from Nat Commun. 2014 Oct 22;5:5283."	88	"CD141+ DC, CD141+ FZ, CD141+ PVX, CD1c+ DC, CD1c+ FZ, CD1c+ Gardasil, CD1c+ Havrix, CD1c+ HEPB, CD1c+ Hib, CD1c+ Imovax, CD1c+ Ixiaro, CD1c+ PVX, CD1c+ Menomune, CD1c+ Polio, CD1c+ TDAP, CD1c+ Varicella, CD1c+ Zostavax"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.2	Illumina V4	"rgb(146,0,0)"	diamond	c-DC HLA-DR+CD11c+ CD1c+ Neisseiria meningitis vaccine adult	myeloid	myeloid	adult	CD1c+ dendritic cell	Dendritic Cell
GSM1367950;6741	6741	Banchereau	GSM1367950	"Ipol, replicate 3"	Homo sapiens	CD1c+ Polio	CL:0002399		CD1c+ dendritic cell			Banchereau	"The mechanisms by which microbial vaccines interact with human APCs remain elusive. Herein, we describe the transcriptional programs induced in human DCs by pathogens, innate receptor ligands and vaccines. Exposure of DCs to influenza, Salmonella enterica and Staphylococcus aureus allows us to build a modular framework containing 204 transcript clusters. We use this framework to characterize the responses of human monocytes, monocyte-derived DCs and blood DC subsets to 13 vaccines. Different vaccines induce distinct transcriptional programs based on pathogen type, adjuvant formulation and APC targeted. Fluzone, Pneumovax and Gardasil, respectively, activate monocyte-derived DCs, monocytes and CD1c+ blood DCs, highlighting APC specialization in response to vaccines. Finally, the blood signatures from individuals vaccinated with Fluzone or infected with influenza reveal a signature of adaptive immunity activation following vaccination and symptomatic infections, but not asymptomatic infections. These data, offered with a web interface, may guide the development of improved vaccines. Abstract from Nat Commun. 2014 Oct 22;5:5283."	88	"CD141+ DC, CD141+ FZ, CD141+ PVX, CD1c+ DC, CD1c+ FZ, CD1c+ Gardasil, CD1c+ Havrix, CD1c+ HEPB, CD1c+ Hib, CD1c+ Imovax, CD1c+ Ixiaro, CD1c+ PVX, CD1c+ Menomune, CD1c+ Polio, CD1c+ TDAP, CD1c+ Varicella, CD1c+ Zostavax"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.2	Illumina V4	"rgb(146,0,0)"	diamond	c-DC HLA-DR+CD11c+ CD1c+ polio vaccine adult	myeloid	myeloid	adult	CD1c+ dendritic cell	Dendritic Cell
GSM1367951;6741	6741	Banchereau	GSM1367951	"Pneumovax, replicate 5"	Homo sapiens	CD1c+ PVX	CL:0002399		CD1c+ dendritic cell			Banchereau	"The mechanisms by which microbial vaccines interact with human APCs remain elusive. Herein, we describe the transcriptional programs induced in human DCs by pathogens, innate receptor ligands and vaccines. Exposure of DCs to influenza, Salmonella enterica and Staphylococcus aureus allows us to build a modular framework containing 204 transcript clusters. We use this framework to characterize the responses of human monocytes, monocyte-derived DCs and blood DC subsets to 13 vaccines. Different vaccines induce distinct transcriptional programs based on pathogen type, adjuvant formulation and APC targeted. Fluzone, Pneumovax and Gardasil, respectively, activate monocyte-derived DCs, monocytes and CD1c+ blood DCs, highlighting APC specialization in response to vaccines. Finally, the blood signatures from individuals vaccinated with Fluzone or infected with influenza reveal a signature of adaptive immunity activation following vaccination and symptomatic infections, but not asymptomatic infections. These data, offered with a web interface, may guide the development of improved vaccines. Abstract from Nat Commun. 2014 Oct 22;5:5283."	88	"CD141+ DC, CD141+ FZ, CD141+ PVX, CD1c+ DC, CD1c+ FZ, CD1c+ Gardasil, CD1c+ Havrix, CD1c+ HEPB, CD1c+ Hib, CD1c+ Imovax, CD1c+ Ixiaro, CD1c+ PVX, CD1c+ Menomune, CD1c+ Polio, CD1c+ TDAP, CD1c+ Varicella, CD1c+ Zostavax"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.2	Illumina V4	"rgb(146,0,0)"	diamond	c-DC HLA-DR+CD11c+ CD1c+ Pneumococcus vaccine adult	myeloid	myeloid	adult	CD1c+ dendritic cell	Dendritic Cell
GSM1367952;6741	6741	Banchereau	GSM1367952	"Imovax, replicate 3"	Homo sapiens	CD1c+ Imovax	CL:0002399		CD1c+ dendritic cell			Banchereau	"The mechanisms by which microbial vaccines interact with human APCs remain elusive. Herein, we describe the transcriptional programs induced in human DCs by pathogens, innate receptor ligands and vaccines. Exposure of DCs to influenza, Salmonella enterica and Staphylococcus aureus allows us to build a modular framework containing 204 transcript clusters. We use this framework to characterize the responses of human monocytes, monocyte-derived DCs and blood DC subsets to 13 vaccines. Different vaccines induce distinct transcriptional programs based on pathogen type, adjuvant formulation and APC targeted. Fluzone, Pneumovax and Gardasil, respectively, activate monocyte-derived DCs, monocytes and CD1c+ blood DCs, highlighting APC specialization in response to vaccines. Finally, the blood signatures from individuals vaccinated with Fluzone or infected with influenza reveal a signature of adaptive immunity activation following vaccination and symptomatic infections, but not asymptomatic infections. These data, offered with a web interface, may guide the development of improved vaccines. Abstract from Nat Commun. 2014 Oct 22;5:5283."	88	"CD141+ DC, CD141+ FZ, CD141+ PVX, CD1c+ DC, CD1c+ FZ, CD1c+ Gardasil, CD1c+ Havrix, CD1c+ HEPB, CD1c+ Hib, CD1c+ Imovax, CD1c+ Ixiaro, CD1c+ PVX, CD1c+ Menomune, CD1c+ Polio, CD1c+ TDAP, CD1c+ Varicella, CD1c+ Zostavax"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.2	Illumina V4	"rgb(146,0,0)"	diamond	c-DC HLA-DR+CD11c+ CD1c+ rabies vaccine adult	myeloid	myeloid	adult	CD1c+ dendritic cell	Dendritic Cell
GSM1367953;6741	6741	Banchereau	GSM1367953	"Adacel, replicate 3"	Homo sapiens	CD1c+ TDAP	CL:0002399		CD1c+ dendritic cell			Banchereau	"The mechanisms by which microbial vaccines interact with human APCs remain elusive. Herein, we describe the transcriptional programs induced in human DCs by pathogens, innate receptor ligands and vaccines. Exposure of DCs to influenza, Salmonella enterica and Staphylococcus aureus allows us to build a modular framework containing 204 transcript clusters. We use this framework to characterize the responses of human monocytes, monocyte-derived DCs and blood DC subsets to 13 vaccines. Different vaccines induce distinct transcriptional programs based on pathogen type, adjuvant formulation and APC targeted. Fluzone, Pneumovax and Gardasil, respectively, activate monocyte-derived DCs, monocytes and CD1c+ blood DCs, highlighting APC specialization in response to vaccines. Finally, the blood signatures from individuals vaccinated with Fluzone or infected with influenza reveal a signature of adaptive immunity activation following vaccination and symptomatic infections, but not asymptomatic infections. These data, offered with a web interface, may guide the development of improved vaccines. Abstract from Nat Commun. 2014 Oct 22;5:5283."	88	"CD141+ DC, CD141+ FZ, CD141+ PVX, CD1c+ DC, CD1c+ FZ, CD1c+ Gardasil, CD1c+ Havrix, CD1c+ HEPB, CD1c+ Hib, CD1c+ Imovax, CD1c+ Ixiaro, CD1c+ PVX, CD1c+ Menomune, CD1c+ Polio, CD1c+ TDAP, CD1c+ Varicella, CD1c+ Zostavax"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.2	Illumina V4	"rgb(146,0,0)"	diamond	c-DC HLA-DR+CD11c+ CD1c+ Tetanus Diphteria Pertussis vaccine adult	myeloid	myeloid	adult	CD1c+ dendritic cell	Dendritic Cell
GSM1367954;6741	6741	Banchereau	GSM1367954	"Varivax, replicate 3"	Homo sapiens	CD1c+ Varicella	CL:0002399		CD1c+ dendritic cell			Banchereau	"The mechanisms by which microbial vaccines interact with human APCs remain elusive. Herein, we describe the transcriptional programs induced in human DCs by pathogens, innate receptor ligands and vaccines. Exposure of DCs to influenza, Salmonella enterica and Staphylococcus aureus allows us to build a modular framework containing 204 transcript clusters. We use this framework to characterize the responses of human monocytes, monocyte-derived DCs and blood DC subsets to 13 vaccines. Different vaccines induce distinct transcriptional programs based on pathogen type, adjuvant formulation and APC targeted. Fluzone, Pneumovax and Gardasil, respectively, activate monocyte-derived DCs, monocytes and CD1c+ blood DCs, highlighting APC specialization in response to vaccines. Finally, the blood signatures from individuals vaccinated with Fluzone or infected with influenza reveal a signature of adaptive immunity activation following vaccination and symptomatic infections, but not asymptomatic infections. These data, offered with a web interface, may guide the development of improved vaccines. Abstract from Nat Commun. 2014 Oct 22;5:5283."	88	"CD141+ DC, CD141+ FZ, CD141+ PVX, CD1c+ DC, CD1c+ FZ, CD1c+ Gardasil, CD1c+ Havrix, CD1c+ HEPB, CD1c+ Hib, CD1c+ Imovax, CD1c+ Ixiaro, CD1c+ PVX, CD1c+ Menomune, CD1c+ Polio, CD1c+ TDAP, CD1c+ Varicella, CD1c+ Zostavax"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.2	Illumina V4	"rgb(146,0,0)"	diamond	c-DC HLA-DR+CD11c+ CD1c+ Varicella vaccine adult	myeloid	myeloid	adult	CD1c+ dendritic cell	Dendritic Cell
GSM1367955;6741	6741	Banchereau	GSM1367955	"Fluzone, replicate 7"	Homo sapiens	CD1c+ FZ	CL:0002399		CD1c+ dendritic cell			Banchereau	"The mechanisms by which microbial vaccines interact with human APCs remain elusive. Herein, we describe the transcriptional programs induced in human DCs by pathogens, innate receptor ligands and vaccines. Exposure of DCs to influenza, Salmonella enterica and Staphylococcus aureus allows us to build a modular framework containing 204 transcript clusters. We use this framework to characterize the responses of human monocytes, monocyte-derived DCs and blood DC subsets to 13 vaccines. Different vaccines induce distinct transcriptional programs based on pathogen type, adjuvant formulation and APC targeted. Fluzone, Pneumovax and Gardasil, respectively, activate monocyte-derived DCs, monocytes and CD1c+ blood DCs, highlighting APC specialization in response to vaccines. Finally, the blood signatures from individuals vaccinated with Fluzone or infected with influenza reveal a signature of adaptive immunity activation following vaccination and symptomatic infections, but not asymptomatic infections. These data, offered with a web interface, may guide the development of improved vaccines. Abstract from Nat Commun. 2014 Oct 22;5:5283."	88	"CD141+ DC, CD141+ FZ, CD141+ PVX, CD1c+ DC, CD1c+ FZ, CD1c+ Gardasil, CD1c+ Havrix, CD1c+ HEPB, CD1c+ Hib, CD1c+ Imovax, CD1c+ Ixiaro, CD1c+ PVX, CD1c+ Menomune, CD1c+ Polio, CD1c+ TDAP, CD1c+ Varicella, CD1c+ Zostavax"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.2	Illumina V4	"rgb(146,0,0)"	diamond	c-DC HLA-DR+CD11c+ CD1c+ influenza vaccine adult	myeloid	myeloid	adult	CD1c+ dendritic cell	Dendritic Cell
GSM1367956;6741	6741	Banchereau	GSM1367956	"Fluzone, replicate 8"	Homo sapiens	CD141+ FZ	CL:0002394		CD141+ dendritic cell			Banchereau	"The mechanisms by which microbial vaccines interact with human APCs remain elusive. Herein, we describe the transcriptional programs induced in human DCs by pathogens, innate receptor ligands and vaccines. Exposure of DCs to influenza, Salmonella enterica and Staphylococcus aureus allows us to build a modular framework containing 204 transcript clusters. We use this framework to characterize the responses of human monocytes, monocyte-derived DCs and blood DC subsets to 13 vaccines. Different vaccines induce distinct transcriptional programs based on pathogen type, adjuvant formulation and APC targeted. Fluzone, Pneumovax and Gardasil, respectively, activate monocyte-derived DCs, monocytes and CD1c+ blood DCs, highlighting APC specialization in response to vaccines. Finally, the blood signatures from individuals vaccinated with Fluzone or infected with influenza reveal a signature of adaptive immunity activation following vaccination and symptomatic infections, but not asymptomatic infections. These data, offered with a web interface, may guide the development of improved vaccines. Abstract from Nat Commun. 2014 Oct 22;5:5283."	88	"CD141+ DC, CD141+ FZ, CD141+ PVX, CD1c+ DC, CD1c+ FZ, CD1c+ Gardasil, CD1c+ Havrix, CD1c+ HEPB, CD1c+ Hib, CD1c+ Imovax, CD1c+ Ixiaro, CD1c+ PVX, CD1c+ Menomune, CD1c+ Polio, CD1c+ TDAP, CD1c+ Varicella, CD1c+ Zostavax"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.2	Illumina V4	"rgb(146,0,0)"	diamond	c-DC HLA-DR+CD11c+ CD141+ influenza vaccine adult	myeloid	myeloid	adult	CD141+ dendritic cell	Dendritic Cell
GSM1367957;6741	6741	Banchereau	GSM1367957	"Havrix, replicate 4"	Homo sapiens	CD1c+ Havrix	CL:0002399		CD1c+ dendritic cell			Banchereau	"The mechanisms by which microbial vaccines interact with human APCs remain elusive. Herein, we describe the transcriptional programs induced in human DCs by pathogens, innate receptor ligands and vaccines. Exposure of DCs to influenza, Salmonella enterica and Staphylococcus aureus allows us to build a modular framework containing 204 transcript clusters. We use this framework to characterize the responses of human monocytes, monocyte-derived DCs and blood DC subsets to 13 vaccines. Different vaccines induce distinct transcriptional programs based on pathogen type, adjuvant formulation and APC targeted. Fluzone, Pneumovax and Gardasil, respectively, activate monocyte-derived DCs, monocytes and CD1c+ blood DCs, highlighting APC specialization in response to vaccines. Finally, the blood signatures from individuals vaccinated with Fluzone or infected with influenza reveal a signature of adaptive immunity activation following vaccination and symptomatic infections, but not asymptomatic infections. These data, offered with a web interface, may guide the development of improved vaccines. Abstract from Nat Commun. 2014 Oct 22;5:5283."	88	"CD141+ DC, CD141+ FZ, CD141+ PVX, CD1c+ DC, CD1c+ FZ, CD1c+ Gardasil, CD1c+ Havrix, CD1c+ HEPB, CD1c+ Hib, CD1c+ Imovax, CD1c+ Ixiaro, CD1c+ PVX, CD1c+ Menomune, CD1c+ Polio, CD1c+ TDAP, CD1c+ Varicella, CD1c+ Zostavax"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.2	Illumina V4	"rgb(146,0,0)"	diamond	c-DC HLA-DR+CD11c+ CD1c+ Hepatitis A vaccine adult	myeloid	myeloid	adult	CD1c+ dendritic cell	Dendritic Cell
GSM1367958;6741	6741	Banchereau	GSM1367958	"Engerix-B, replicate 4"	Homo sapiens	CD1c+ HEPB	CL:0002399		CD1c+ dendritic cell			Banchereau	"The mechanisms by which microbial vaccines interact with human APCs remain elusive. Herein, we describe the transcriptional programs induced in human DCs by pathogens, innate receptor ligands and vaccines. Exposure of DCs to influenza, Salmonella enterica and Staphylococcus aureus allows us to build a modular framework containing 204 transcript clusters. We use this framework to characterize the responses of human monocytes, monocyte-derived DCs and blood DC subsets to 13 vaccines. Different vaccines induce distinct transcriptional programs based on pathogen type, adjuvant formulation and APC targeted. Fluzone, Pneumovax and Gardasil, respectively, activate monocyte-derived DCs, monocytes and CD1c+ blood DCs, highlighting APC specialization in response to vaccines. Finally, the blood signatures from individuals vaccinated with Fluzone or infected with influenza reveal a signature of adaptive immunity activation following vaccination and symptomatic infections, but not asymptomatic infections. These data, offered with a web interface, may guide the development of improved vaccines. Abstract from Nat Commun. 2014 Oct 22;5:5283."	88	"CD141+ DC, CD141+ FZ, CD141+ PVX, CD1c+ DC, CD1c+ FZ, CD1c+ Gardasil, CD1c+ Havrix, CD1c+ HEPB, CD1c+ Hib, CD1c+ Imovax, CD1c+ Ixiaro, CD1c+ PVX, CD1c+ Menomune, CD1c+ Polio, CD1c+ TDAP, CD1c+ Varicella, CD1c+ Zostavax"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.2	Illumina V4	"rgb(146,0,0)"	diamond	c-DC HLA-DR+CD11c+ CD1c+ Hepatitis B vaccine adult	myeloid	myeloid	adult	CD1c+ dendritic cell	Dendritic Cell
GSM1367959;6741	6741	Banchereau	GSM1367959	"Zostavax, replicate 4"	Homo sapiens	CD1c+ Zostavax	CL:0002399		CD1c+ dendritic cell			Banchereau	"The mechanisms by which microbial vaccines interact with human APCs remain elusive. Herein, we describe the transcriptional programs induced in human DCs by pathogens, innate receptor ligands and vaccines. Exposure of DCs to influenza, Salmonella enterica and Staphylococcus aureus allows us to build a modular framework containing 204 transcript clusters. We use this framework to characterize the responses of human monocytes, monocyte-derived DCs and blood DC subsets to 13 vaccines. Different vaccines induce distinct transcriptional programs based on pathogen type, adjuvant formulation and APC targeted. Fluzone, Pneumovax and Gardasil, respectively, activate monocyte-derived DCs, monocytes and CD1c+ blood DCs, highlighting APC specialization in response to vaccines. Finally, the blood signatures from individuals vaccinated with Fluzone or infected with influenza reveal a signature of adaptive immunity activation following vaccination and symptomatic infections, but not asymptomatic infections. These data, offered with a web interface, may guide the development of improved vaccines. Abstract from Nat Commun. 2014 Oct 22;5:5283."	88	"CD141+ DC, CD141+ FZ, CD141+ PVX, CD1c+ DC, CD1c+ FZ, CD1c+ Gardasil, CD1c+ Havrix, CD1c+ HEPB, CD1c+ Hib, CD1c+ Imovax, CD1c+ Ixiaro, CD1c+ PVX, CD1c+ Menomune, CD1c+ Polio, CD1c+ TDAP, CD1c+ Varicella, CD1c+ Zostavax"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.2	Illumina V4	"rgb(146,0,0)"	diamond	c-DC HLA-DR+CD11c+ CD1c+ Herpes Zoster vaccine adult	myeloid	myeloid	adult	CD1c+ dendritic cell	Dendritic Cell
GSM1367960;6741	6741	Banchereau	GSM1367960	"ActHib, replicate 4"	Homo sapiens	CD1c+ Hib	CL:0002399		CD1c+ dendritic cell			Banchereau	"The mechanisms by which microbial vaccines interact with human APCs remain elusive. Herein, we describe the transcriptional programs induced in human DCs by pathogens, innate receptor ligands and vaccines. Exposure of DCs to influenza, Salmonella enterica and Staphylococcus aureus allows us to build a modular framework containing 204 transcript clusters. We use this framework to characterize the responses of human monocytes, monocyte-derived DCs and blood DC subsets to 13 vaccines. Different vaccines induce distinct transcriptional programs based on pathogen type, adjuvant formulation and APC targeted. Fluzone, Pneumovax and Gardasil, respectively, activate monocyte-derived DCs, monocytes and CD1c+ blood DCs, highlighting APC specialization in response to vaccines. Finally, the blood signatures from individuals vaccinated with Fluzone or infected with influenza reveal a signature of adaptive immunity activation following vaccination and symptomatic infections, but not asymptomatic infections. These data, offered with a web interface, may guide the development of improved vaccines. Abstract from Nat Commun. 2014 Oct 22;5:5283."	88	"CD141+ DC, CD141+ FZ, CD141+ PVX, CD1c+ DC, CD1c+ FZ, CD1c+ Gardasil, CD1c+ Havrix, CD1c+ HEPB, CD1c+ Hib, CD1c+ Imovax, CD1c+ Ixiaro, CD1c+ PVX, CD1c+ Menomune, CD1c+ Polio, CD1c+ TDAP, CD1c+ Varicella, CD1c+ Zostavax"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.2	Illumina V4	"rgb(146,0,0)"	diamond	c-DC HLA-DR+CD11c+ CD1c+ Haemophilus influenza vaccine adult	myeloid	myeloid	adult	CD1c+ dendritic cell	Dendritic Cell
GSM1367961;6741	6741	Banchereau	GSM1367961	"Gardasil, replicate 4"	Homo sapiens	CD1c+ Gardasil	CL:0002399		CD1c+ dendritic cell			Banchereau	"The mechanisms by which microbial vaccines interact with human APCs remain elusive. Herein, we describe the transcriptional programs induced in human DCs by pathogens, innate receptor ligands and vaccines. Exposure of DCs to influenza, Salmonella enterica and Staphylococcus aureus allows us to build a modular framework containing 204 transcript clusters. We use this framework to characterize the responses of human monocytes, monocyte-derived DCs and blood DC subsets to 13 vaccines. Different vaccines induce distinct transcriptional programs based on pathogen type, adjuvant formulation and APC targeted. Fluzone, Pneumovax and Gardasil, respectively, activate monocyte-derived DCs, monocytes and CD1c+ blood DCs, highlighting APC specialization in response to vaccines. Finally, the blood signatures from individuals vaccinated with Fluzone or infected with influenza reveal a signature of adaptive immunity activation following vaccination and symptomatic infections, but not asymptomatic infections. These data, offered with a web interface, may guide the development of improved vaccines. Abstract from Nat Commun. 2014 Oct 22;5:5283."	88	"CD141+ DC, CD141+ FZ, CD141+ PVX, CD1c+ DC, CD1c+ FZ, CD1c+ Gardasil, CD1c+ Havrix, CD1c+ HEPB, CD1c+ Hib, CD1c+ Imovax, CD1c+ Ixiaro, CD1c+ PVX, CD1c+ Menomune, CD1c+ Polio, CD1c+ TDAP, CD1c+ Varicella, CD1c+ Zostavax"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.2	Illumina V4	"rgb(146,0,0)"	diamond	c-DC HLA-DR+CD11c+ CD1c+ Papilloma virus vaccine adult	myeloid	myeloid	adult	CD1c+ dendritic cell	Dendritic Cell
GSM1367962;6741	6741	Banchereau	GSM1367962	"Ixiaro, replicate 4"	Homo sapiens	CD1c+ Ixiaro	CL:0002399		CD1c+ dendritic cell			Banchereau	"The mechanisms by which microbial vaccines interact with human APCs remain elusive. Herein, we describe the transcriptional programs induced in human DCs by pathogens, innate receptor ligands and vaccines. Exposure of DCs to influenza, Salmonella enterica and Staphylococcus aureus allows us to build a modular framework containing 204 transcript clusters. We use this framework to characterize the responses of human monocytes, monocyte-derived DCs and blood DC subsets to 13 vaccines. Different vaccines induce distinct transcriptional programs based on pathogen type, adjuvant formulation and APC targeted. Fluzone, Pneumovax and Gardasil, respectively, activate monocyte-derived DCs, monocytes and CD1c+ blood DCs, highlighting APC specialization in response to vaccines. Finally, the blood signatures from individuals vaccinated with Fluzone or infected with influenza reveal a signature of adaptive immunity activation following vaccination and symptomatic infections, but not asymptomatic infections. These data, offered with a web interface, may guide the development of improved vaccines. Abstract from Nat Commun. 2014 Oct 22;5:5283."	88	"CD141+ DC, CD141+ FZ, CD141+ PVX, CD1c+ DC, CD1c+ FZ, CD1c+ Gardasil, CD1c+ Havrix, CD1c+ HEPB, CD1c+ Hib, CD1c+ Imovax, CD1c+ Ixiaro, CD1c+ PVX, CD1c+ Menomune, CD1c+ Polio, CD1c+ TDAP, CD1c+ Varicella, CD1c+ Zostavax"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.2	Illumina V4	"rgb(146,0,0)"	diamond	c-DC HLA-DR+CD11c+ CD1c+ Japanese encephalitis vaccine adult	myeloid	myeloid	adult	CD1c+ dendritic cell	Dendritic Cell
GSM1367963;6741	6741	Banchereau	GSM1367963	"Medium, replicate 10"	Homo sapiens	CD1c+ DC	CL:0002399		CD1c+ dendritic cell			Banchereau	"The mechanisms by which microbial vaccines interact with human APCs remain elusive. Herein, we describe the transcriptional programs induced in human DCs by pathogens, innate receptor ligands and vaccines. Exposure of DCs to influenza, Salmonella enterica and Staphylococcus aureus allows us to build a modular framework containing 204 transcript clusters. We use this framework to characterize the responses of human monocytes, monocyte-derived DCs and blood DC subsets to 13 vaccines. Different vaccines induce distinct transcriptional programs based on pathogen type, adjuvant formulation and APC targeted. Fluzone, Pneumovax and Gardasil, respectively, activate monocyte-derived DCs, monocytes and CD1c+ blood DCs, highlighting APC specialization in response to vaccines. Finally, the blood signatures from individuals vaccinated with Fluzone or infected with influenza reveal a signature of adaptive immunity activation following vaccination and symptomatic infections, but not asymptomatic infections. These data, offered with a web interface, may guide the development of improved vaccines. Abstract from Nat Commun. 2014 Oct 22;5:5283."	88	"CD141+ DC, CD141+ FZ, CD141+ PVX, CD1c+ DC, CD1c+ FZ, CD1c+ Gardasil, CD1c+ Havrix, CD1c+ HEPB, CD1c+ Hib, CD1c+ Imovax, CD1c+ Ixiaro, CD1c+ PVX, CD1c+ Menomune, CD1c+ Polio, CD1c+ TDAP, CD1c+ Varicella, CD1c+ Zostavax"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.2	Illumina V4	"rgb(146,0,0)"	diamond	c-DC HLA-DR+CD11c+ CD1c+  adult	myeloid	myeloid	adult	CD1c+ dendritic cell	Dendritic Cell
GSM1367964;6741	6741	Banchereau	GSM1367964	"Medium, replicate 11"	Homo sapiens	CD1c+ DC	CL:0002399		CD1c+ dendritic cell			Banchereau	"The mechanisms by which microbial vaccines interact with human APCs remain elusive. Herein, we describe the transcriptional programs induced in human DCs by pathogens, innate receptor ligands and vaccines. Exposure of DCs to influenza, Salmonella enterica and Staphylococcus aureus allows us to build a modular framework containing 204 transcript clusters. We use this framework to characterize the responses of human monocytes, monocyte-derived DCs and blood DC subsets to 13 vaccines. Different vaccines induce distinct transcriptional programs based on pathogen type, adjuvant formulation and APC targeted. Fluzone, Pneumovax and Gardasil, respectively, activate monocyte-derived DCs, monocytes and CD1c+ blood DCs, highlighting APC specialization in response to vaccines. Finally, the blood signatures from individuals vaccinated with Fluzone or infected with influenza reveal a signature of adaptive immunity activation following vaccination and symptomatic infections, but not asymptomatic infections. These data, offered with a web interface, may guide the development of improved vaccines. Abstract from Nat Commun. 2014 Oct 22;5:5283."	88	"CD141+ DC, CD141+ FZ, CD141+ PVX, CD1c+ DC, CD1c+ FZ, CD1c+ Gardasil, CD1c+ Havrix, CD1c+ HEPB, CD1c+ Hib, CD1c+ Imovax, CD1c+ Ixiaro, CD1c+ PVX, CD1c+ Menomune, CD1c+ Polio, CD1c+ TDAP, CD1c+ Varicella, CD1c+ Zostavax"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.2	Illumina V4	"rgb(146,0,0)"	diamond	c-DC HLA-DR+CD11c+ CD1c+  adult	myeloid	myeloid	adult	CD1c+ dendritic cell	Dendritic Cell
GSM1367965;6741	6741	Banchereau	GSM1367965	"Medium, replicate 12"	Homo sapiens	CD141+ DC	CL:0002394		CD141+ dendritic cell			Banchereau	"The mechanisms by which microbial vaccines interact with human APCs remain elusive. Herein, we describe the transcriptional programs induced in human DCs by pathogens, innate receptor ligands and vaccines. Exposure of DCs to influenza, Salmonella enterica and Staphylococcus aureus allows us to build a modular framework containing 204 transcript clusters. We use this framework to characterize the responses of human monocytes, monocyte-derived DCs and blood DC subsets to 13 vaccines. Different vaccines induce distinct transcriptional programs based on pathogen type, adjuvant formulation and APC targeted. Fluzone, Pneumovax and Gardasil, respectively, activate monocyte-derived DCs, monocytes and CD1c+ blood DCs, highlighting APC specialization in response to vaccines. Finally, the blood signatures from individuals vaccinated with Fluzone or infected with influenza reveal a signature of adaptive immunity activation following vaccination and symptomatic infections, but not asymptomatic infections. These data, offered with a web interface, may guide the development of improved vaccines. Abstract from Nat Commun. 2014 Oct 22;5:5283."	88	"CD141+ DC, CD141+ FZ, CD141+ PVX, CD1c+ DC, CD1c+ FZ, CD1c+ Gardasil, CD1c+ Havrix, CD1c+ HEPB, CD1c+ Hib, CD1c+ Imovax, CD1c+ Ixiaro, CD1c+ PVX, CD1c+ Menomune, CD1c+ Polio, CD1c+ TDAP, CD1c+ Varicella, CD1c+ Zostavax"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.2	Illumina V4	"rgb(146,0,0)"	diamond	c-DC HLA-DR+CD11c+ CD141+  adult	myeloid	myeloid	adult	CD141+ dendritic cell	Dendritic Cell
GSM1367966;6741	6741	Banchereau	GSM1367966	"Menomune, replicate 4"	Homo sapiens	CD1c+ Menomune	CL:0002399		CD1c+ dendritic cell			Banchereau	"The mechanisms by which microbial vaccines interact with human APCs remain elusive. Herein, we describe the transcriptional programs induced in human DCs by pathogens, innate receptor ligands and vaccines. Exposure of DCs to influenza, Salmonella enterica and Staphylococcus aureus allows us to build a modular framework containing 204 transcript clusters. We use this framework to characterize the responses of human monocytes, monocyte-derived DCs and blood DC subsets to 13 vaccines. Different vaccines induce distinct transcriptional programs based on pathogen type, adjuvant formulation and APC targeted. Fluzone, Pneumovax and Gardasil, respectively, activate monocyte-derived DCs, monocytes and CD1c+ blood DCs, highlighting APC specialization in response to vaccines. Finally, the blood signatures from individuals vaccinated with Fluzone or infected with influenza reveal a signature of adaptive immunity activation following vaccination and symptomatic infections, but not asymptomatic infections. These data, offered with a web interface, may guide the development of improved vaccines. Abstract from Nat Commun. 2014 Oct 22;5:5283."	88	"CD141+ DC, CD141+ FZ, CD141+ PVX, CD1c+ DC, CD1c+ FZ, CD1c+ Gardasil, CD1c+ Havrix, CD1c+ HEPB, CD1c+ Hib, CD1c+ Imovax, CD1c+ Ixiaro, CD1c+ PVX, CD1c+ Menomune, CD1c+ Polio, CD1c+ TDAP, CD1c+ Varicella, CD1c+ Zostavax"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.2	Illumina V4	"rgb(146,0,0)"	diamond	c-DC HLA-DR+CD11c+ CD1c+ Neisseiria meningitis vaccine adult	myeloid	myeloid	adult	CD1c+ dendritic cell	Dendritic Cell
GSM1367967;6741	6741	Banchereau	GSM1367967	"Ipol, replicate 4"	Homo sapiens	CD1c+ Polio	CL:0002399		CD1c+ dendritic cell			Banchereau	"The mechanisms by which microbial vaccines interact with human APCs remain elusive. Herein, we describe the transcriptional programs induced in human DCs by pathogens, innate receptor ligands and vaccines. Exposure of DCs to influenza, Salmonella enterica and Staphylococcus aureus allows us to build a modular framework containing 204 transcript clusters. We use this framework to characterize the responses of human monocytes, monocyte-derived DCs and blood DC subsets to 13 vaccines. Different vaccines induce distinct transcriptional programs based on pathogen type, adjuvant formulation and APC targeted. Fluzone, Pneumovax and Gardasil, respectively, activate monocyte-derived DCs, monocytes and CD1c+ blood DCs, highlighting APC specialization in response to vaccines. Finally, the blood signatures from individuals vaccinated with Fluzone or infected with influenza reveal a signature of adaptive immunity activation following vaccination and symptomatic infections, but not asymptomatic infections. These data, offered with a web interface, may guide the development of improved vaccines. Abstract from Nat Commun. 2014 Oct 22;5:5283."	88	"CD141+ DC, CD141+ FZ, CD141+ PVX, CD1c+ DC, CD1c+ FZ, CD1c+ Gardasil, CD1c+ Havrix, CD1c+ HEPB, CD1c+ Hib, CD1c+ Imovax, CD1c+ Ixiaro, CD1c+ PVX, CD1c+ Menomune, CD1c+ Polio, CD1c+ TDAP, CD1c+ Varicella, CD1c+ Zostavax"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.2	Illumina V4	"rgb(146,0,0)"	diamond	c-DC HLA-DR+CD11c+ CD1c+ polio vaccine adult	myeloid	myeloid	adult	CD1c+ dendritic cell	Dendritic Cell
GSM1367968;6741	6741	Banchereau	GSM1367968	"Pneumovax, replicate 6"	Homo sapiens	CD1c+ PVX	CL:0002399		CD1c+ dendritic cell			Banchereau	"The mechanisms by which microbial vaccines interact with human APCs remain elusive. Herein, we describe the transcriptional programs induced in human DCs by pathogens, innate receptor ligands and vaccines. Exposure of DCs to influenza, Salmonella enterica and Staphylococcus aureus allows us to build a modular framework containing 204 transcript clusters. We use this framework to characterize the responses of human monocytes, monocyte-derived DCs and blood DC subsets to 13 vaccines. Different vaccines induce distinct transcriptional programs based on pathogen type, adjuvant formulation and APC targeted. Fluzone, Pneumovax and Gardasil, respectively, activate monocyte-derived DCs, monocytes and CD1c+ blood DCs, highlighting APC specialization in response to vaccines. Finally, the blood signatures from individuals vaccinated with Fluzone or infected with influenza reveal a signature of adaptive immunity activation following vaccination and symptomatic infections, but not asymptomatic infections. These data, offered with a web interface, may guide the development of improved vaccines. Abstract from Nat Commun. 2014 Oct 22;5:5283."	88	"CD141+ DC, CD141+ FZ, CD141+ PVX, CD1c+ DC, CD1c+ FZ, CD1c+ Gardasil, CD1c+ Havrix, CD1c+ HEPB, CD1c+ Hib, CD1c+ Imovax, CD1c+ Ixiaro, CD1c+ PVX, CD1c+ Menomune, CD1c+ Polio, CD1c+ TDAP, CD1c+ Varicella, CD1c+ Zostavax"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.2	Illumina V4	"rgb(146,0,0)"	diamond	c-DC HLA-DR+CD11c+ CD1c+ Pneumococcus vaccine adult	myeloid	myeloid	adult	CD1c+ dendritic cell	Dendritic Cell
GSM1367969;6741	6741	Banchereau	GSM1367969	"Imovax, replicate 4"	Homo sapiens	CD1c+ Imovax	CL:0002399		CD1c+ dendritic cell			Banchereau	"The mechanisms by which microbial vaccines interact with human APCs remain elusive. Herein, we describe the transcriptional programs induced in human DCs by pathogens, innate receptor ligands and vaccines. Exposure of DCs to influenza, Salmonella enterica and Staphylococcus aureus allows us to build a modular framework containing 204 transcript clusters. We use this framework to characterize the responses of human monocytes, monocyte-derived DCs and blood DC subsets to 13 vaccines. Different vaccines induce distinct transcriptional programs based on pathogen type, adjuvant formulation and APC targeted. Fluzone, Pneumovax and Gardasil, respectively, activate monocyte-derived DCs, monocytes and CD1c+ blood DCs, highlighting APC specialization in response to vaccines. Finally, the blood signatures from individuals vaccinated with Fluzone or infected with influenza reveal a signature of adaptive immunity activation following vaccination and symptomatic infections, but not asymptomatic infections. These data, offered with a web interface, may guide the development of improved vaccines. Abstract from Nat Commun. 2014 Oct 22;5:5283."	88	"CD141+ DC, CD141+ FZ, CD141+ PVX, CD1c+ DC, CD1c+ FZ, CD1c+ Gardasil, CD1c+ Havrix, CD1c+ HEPB, CD1c+ Hib, CD1c+ Imovax, CD1c+ Ixiaro, CD1c+ PVX, CD1c+ Menomune, CD1c+ Polio, CD1c+ TDAP, CD1c+ Varicella, CD1c+ Zostavax"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.2	Illumina V4	"rgb(146,0,0)"	diamond	c-DC HLA-DR+CD11c+ CD1c+ rabies vaccine adult	myeloid	myeloid	adult	CD1c+ dendritic cell	Dendritic Cell
GSM1367970;6741	6741	Banchereau	GSM1367970	"Adacel, replicate 4"	Homo sapiens	CD1c+ TDAP	CL:0002399		CD1c+ dendritic cell			Banchereau	"The mechanisms by which microbial vaccines interact with human APCs remain elusive. Herein, we describe the transcriptional programs induced in human DCs by pathogens, innate receptor ligands and vaccines. Exposure of DCs to influenza, Salmonella enterica and Staphylococcus aureus allows us to build a modular framework containing 204 transcript clusters. We use this framework to characterize the responses of human monocytes, monocyte-derived DCs and blood DC subsets to 13 vaccines. Different vaccines induce distinct transcriptional programs based on pathogen type, adjuvant formulation and APC targeted. Fluzone, Pneumovax and Gardasil, respectively, activate monocyte-derived DCs, monocytes and CD1c+ blood DCs, highlighting APC specialization in response to vaccines. Finally, the blood signatures from individuals vaccinated with Fluzone or infected with influenza reveal a signature of adaptive immunity activation following vaccination and symptomatic infections, but not asymptomatic infections. These data, offered with a web interface, may guide the development of improved vaccines. Abstract from Nat Commun. 2014 Oct 22;5:5283."	88	"CD141+ DC, CD141+ FZ, CD141+ PVX, CD1c+ DC, CD1c+ FZ, CD1c+ Gardasil, CD1c+ Havrix, CD1c+ HEPB, CD1c+ Hib, CD1c+ Imovax, CD1c+ Ixiaro, CD1c+ PVX, CD1c+ Menomune, CD1c+ Polio, CD1c+ TDAP, CD1c+ Varicella, CD1c+ Zostavax"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.2	Illumina V4	"rgb(146,0,0)"	diamond	c-DC HLA-DR+CD11c+ CD1c+ Varicella vaccine adult	myeloid	myeloid	adult	CD1c+ dendritic cell	Dendritic Cell
GSM1367971;6741	6741	Banchereau	GSM1367971	"Varivax, replicate 4"	Homo sapiens	CD1c+ Varicella	CL:0002399		CD1c+ dendritic cell			Banchereau	"The mechanisms by which microbial vaccines interact with human APCs remain elusive. Herein, we describe the transcriptional programs induced in human DCs by pathogens, innate receptor ligands and vaccines. Exposure of DCs to influenza, Salmonella enterica and Staphylococcus aureus allows us to build a modular framework containing 204 transcript clusters. We use this framework to characterize the responses of human monocytes, monocyte-derived DCs and blood DC subsets to 13 vaccines. Different vaccines induce distinct transcriptional programs based on pathogen type, adjuvant formulation and APC targeted. Fluzone, Pneumovax and Gardasil, respectively, activate monocyte-derived DCs, monocytes and CD1c+ blood DCs, highlighting APC specialization in response to vaccines. Finally, the blood signatures from individuals vaccinated with Fluzone or infected with influenza reveal a signature of adaptive immunity activation following vaccination and symptomatic infections, but not asymptomatic infections. These data, offered with a web interface, may guide the development of improved vaccines. Abstract from Nat Commun. 2014 Oct 22;5:5283."	88	"CD141+ DC, CD141+ FZ, CD141+ PVX, CD1c+ DC, CD1c+ FZ, CD1c+ Gardasil, CD1c+ Havrix, CD1c+ HEPB, CD1c+ Hib, CD1c+ Imovax, CD1c+ Ixiaro, CD1c+ PVX, CD1c+ Menomune, CD1c+ Polio, CD1c+ TDAP, CD1c+ Varicella, CD1c+ Zostavax"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.2	Illumina V4	"rgb(146,0,0)"	diamond	c-DC HLA-DR+CD11c+ CD1c+ Varicella vaccine adult	myeloid	myeloid	adult	CD1c+ dendritic cell	Dendritic Cell
GSM1367972;6741	6741	Banchereau	GSM1367972	"Fluzone, replicate 9"	Homo sapiens	CD1c+ FZ	CL:0002399		CD1c+ dendritic cell			Banchereau	"The mechanisms by which microbial vaccines interact with human APCs remain elusive. Herein, we describe the transcriptional programs induced in human DCs by pathogens, innate receptor ligands and vaccines. Exposure of DCs to influenza, Salmonella enterica and Staphylococcus aureus allows us to build a modular framework containing 204 transcript clusters. We use this framework to characterize the responses of human monocytes, monocyte-derived DCs and blood DC subsets to 13 vaccines. Different vaccines induce distinct transcriptional programs based on pathogen type, adjuvant formulation and APC targeted. Fluzone, Pneumovax and Gardasil, respectively, activate monocyte-derived DCs, monocytes and CD1c+ blood DCs, highlighting APC specialization in response to vaccines. Finally, the blood signatures from individuals vaccinated with Fluzone or infected with influenza reveal a signature of adaptive immunity activation following vaccination and symptomatic infections, but not asymptomatic infections. These data, offered with a web interface, may guide the development of improved vaccines. Abstract from Nat Commun. 2014 Oct 22;5:5283."	88	"CD141+ DC, CD141+ FZ, CD141+ PVX, CD1c+ DC, CD1c+ FZ, CD1c+ Gardasil, CD1c+ Havrix, CD1c+ HEPB, CD1c+ Hib, CD1c+ Imovax, CD1c+ Ixiaro, CD1c+ PVX, CD1c+ Menomune, CD1c+ Polio, CD1c+ TDAP, CD1c+ Varicella, CD1c+ Zostavax"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.2	Illumina V4	"rgb(146,0,0)"	diamond	c-DC HLA-DR+CD11c+ CD1c+ influenza vaccine adult	myeloid	myeloid	adult	CD1c+ dendritic cell	Dendritic Cell
GSM1367973;6741	6741	Banchereau	GSM1367973	"Fluzone, replicate 10"	Homo sapiens	CD141+ FZ	CL:0002394		CD141+ dendritic cell			Banchereau	"The mechanisms by which microbial vaccines interact with human APCs remain elusive. Herein, we describe the transcriptional programs induced in human DCs by pathogens, innate receptor ligands and vaccines. Exposure of DCs to influenza, Salmonella enterica and Staphylococcus aureus allows us to build a modular framework containing 204 transcript clusters. We use this framework to characterize the responses of human monocytes, monocyte-derived DCs and blood DC subsets to 13 vaccines. Different vaccines induce distinct transcriptional programs based on pathogen type, adjuvant formulation and APC targeted. Fluzone, Pneumovax and Gardasil, respectively, activate monocyte-derived DCs, monocytes and CD1c+ blood DCs, highlighting APC specialization in response to vaccines. Finally, the blood signatures from individuals vaccinated with Fluzone or infected with influenza reveal a signature of adaptive immunity activation following vaccination and symptomatic infections, but not asymptomatic infections. These data, offered with a web interface, may guide the development of improved vaccines. Abstract from Nat Commun. 2014 Oct 22;5:5283."	88	"CD141+ DC, CD141+ FZ, CD141+ PVX, CD1c+ DC, CD1c+ FZ, CD1c+ Gardasil, CD1c+ Havrix, CD1c+ HEPB, CD1c+ Hib, CD1c+ Imovax, CD1c+ Ixiaro, CD1c+ PVX, CD1c+ Menomune, CD1c+ Polio, CD1c+ TDAP, CD1c+ Varicella, CD1c+ Zostavax"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.2	Illumina V4	"rgb(146,0,0)"	diamond	c-DC HLA-DR+CD11c+ CD141+ influenza vaccine adult	myeloid	myeloid	adult	CD141+ dendritic cell	Dendritic Cell
GSM1367974;6741	6741	Banchereau	GSM1367974	"Havrix, replicate 5"	Homo sapiens	CD1c+ Havrix	CL:0002399		CD1c+ dendritic cell			Banchereau	"The mechanisms by which microbial vaccines interact with human APCs remain elusive. Herein, we describe the transcriptional programs induced in human DCs by pathogens, innate receptor ligands and vaccines. Exposure of DCs to influenza, Salmonella enterica and Staphylococcus aureus allows us to build a modular framework containing 204 transcript clusters. We use this framework to characterize the responses of human monocytes, monocyte-derived DCs and blood DC subsets to 13 vaccines. Different vaccines induce distinct transcriptional programs based on pathogen type, adjuvant formulation and APC targeted. Fluzone, Pneumovax and Gardasil, respectively, activate monocyte-derived DCs, monocytes and CD1c+ blood DCs, highlighting APC specialization in response to vaccines. Finally, the blood signatures from individuals vaccinated with Fluzone or infected with influenza reveal a signature of adaptive immunity activation following vaccination and symptomatic infections, but not asymptomatic infections. These data, offered with a web interface, may guide the development of improved vaccines. Abstract from Nat Commun. 2014 Oct 22;5:5283."	88	"CD141+ DC, CD141+ FZ, CD141+ PVX, CD1c+ DC, CD1c+ FZ, CD1c+ Gardasil, CD1c+ Havrix, CD1c+ HEPB, CD1c+ Hib, CD1c+ Imovax, CD1c+ Ixiaro, CD1c+ PVX, CD1c+ Menomune, CD1c+ Polio, CD1c+ TDAP, CD1c+ Varicella, CD1c+ Zostavax"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.2	Illumina V4	"rgb(146,0,0)"	diamond	c-DC HLA-DR+CD11c+ CD1c+ Hepatitis A vaccine adult	myeloid	myeloid	adult	CD1c+ dendritic cell	Dendritic Cell
GSM1367975;6741	6741	Banchereau	GSM1367975	"Engerix-B, replicate 5"	Homo sapiens	CD1c+ HEPB	CL:0002399		CD1c+ dendritic cell			Banchereau	"The mechanisms by which microbial vaccines interact with human APCs remain elusive. Herein, we describe the transcriptional programs induced in human DCs by pathogens, innate receptor ligands and vaccines. Exposure of DCs to influenza, Salmonella enterica and Staphylococcus aureus allows us to build a modular framework containing 204 transcript clusters. We use this framework to characterize the responses of human monocytes, monocyte-derived DCs and blood DC subsets to 13 vaccines. Different vaccines induce distinct transcriptional programs based on pathogen type, adjuvant formulation and APC targeted. Fluzone, Pneumovax and Gardasil, respectively, activate monocyte-derived DCs, monocytes and CD1c+ blood DCs, highlighting APC specialization in response to vaccines. Finally, the blood signatures from individuals vaccinated with Fluzone or infected with influenza reveal a signature of adaptive immunity activation following vaccination and symptomatic infections, but not asymptomatic infections. These data, offered with a web interface, may guide the development of improved vaccines. Abstract from Nat Commun. 2014 Oct 22;5:5283."	88	"CD141+ DC, CD141+ FZ, CD141+ PVX, CD1c+ DC, CD1c+ FZ, CD1c+ Gardasil, CD1c+ Havrix, CD1c+ HEPB, CD1c+ Hib, CD1c+ Imovax, CD1c+ Ixiaro, CD1c+ PVX, CD1c+ Menomune, CD1c+ Polio, CD1c+ TDAP, CD1c+ Varicella, CD1c+ Zostavax"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.2	Illumina V4	"rgb(146,0,0)"	diamond	c-DC HLA-DR+CD11c+ CD1c+ Hepatitis B vaccine adult	myeloid	myeloid	adult	CD1c+ dendritic cell	Dendritic Cell
GSM1367976;6741	6741	Banchereau	GSM1367976	"Zostavax, replicate 5"	Homo sapiens	CD1c+ Zostavax	CL:0002399		CD1c+ dendritic cell			Banchereau	"The mechanisms by which microbial vaccines interact with human APCs remain elusive. Herein, we describe the transcriptional programs induced in human DCs by pathogens, innate receptor ligands and vaccines. Exposure of DCs to influenza, Salmonella enterica and Staphylococcus aureus allows us to build a modular framework containing 204 transcript clusters. We use this framework to characterize the responses of human monocytes, monocyte-derived DCs and blood DC subsets to 13 vaccines. Different vaccines induce distinct transcriptional programs based on pathogen type, adjuvant formulation and APC targeted. Fluzone, Pneumovax and Gardasil, respectively, activate monocyte-derived DCs, monocytes and CD1c+ blood DCs, highlighting APC specialization in response to vaccines. Finally, the blood signatures from individuals vaccinated with Fluzone or infected with influenza reveal a signature of adaptive immunity activation following vaccination and symptomatic infections, but not asymptomatic infections. These data, offered with a web interface, may guide the development of improved vaccines. Abstract from Nat Commun. 2014 Oct 22;5:5283."	88	"CD141+ DC, CD141+ FZ, CD141+ PVX, CD1c+ DC, CD1c+ FZ, CD1c+ Gardasil, CD1c+ Havrix, CD1c+ HEPB, CD1c+ Hib, CD1c+ Imovax, CD1c+ Ixiaro, CD1c+ PVX, CD1c+ Menomune, CD1c+ Polio, CD1c+ TDAP, CD1c+ Varicella, CD1c+ Zostavax"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.2	Illumina V4	"rgb(146,0,0)"	diamond	c-DC HLA-DR+CD11c+ CD1c+ Herpes Zoster vaccine adult	myeloid	myeloid	adult	CD1c+ dendritic cell	Dendritic Cell
GSM1367977;6741	6741	Banchereau	GSM1367977	"ActHib, replicate 5"	Homo sapiens	CD1c+ Hib	CL:0002399		CD1c+ dendritic cell			Banchereau	"The mechanisms by which microbial vaccines interact with human APCs remain elusive. Herein, we describe the transcriptional programs induced in human DCs by pathogens, innate receptor ligands and vaccines. Exposure of DCs to influenza, Salmonella enterica and Staphylococcus aureus allows us to build a modular framework containing 204 transcript clusters. We use this framework to characterize the responses of human monocytes, monocyte-derived DCs and blood DC subsets to 13 vaccines. Different vaccines induce distinct transcriptional programs based on pathogen type, adjuvant formulation and APC targeted. Fluzone, Pneumovax and Gardasil, respectively, activate monocyte-derived DCs, monocytes and CD1c+ blood DCs, highlighting APC specialization in response to vaccines. Finally, the blood signatures from individuals vaccinated with Fluzone or infected with influenza reveal a signature of adaptive immunity activation following vaccination and symptomatic infections, but not asymptomatic infections. These data, offered with a web interface, may guide the development of improved vaccines. Abstract from Nat Commun. 2014 Oct 22;5:5283."	88	"CD141+ DC, CD141+ FZ, CD141+ PVX, CD1c+ DC, CD1c+ FZ, CD1c+ Gardasil, CD1c+ Havrix, CD1c+ HEPB, CD1c+ Hib, CD1c+ Imovax, CD1c+ Ixiaro, CD1c+ PVX, CD1c+ Menomune, CD1c+ Polio, CD1c+ TDAP, CD1c+ Varicella, CD1c+ Zostavax"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.2	Illumina V4	"rgb(146,0,0)"	diamond	c-DC HLA-DR+CD11c+ CD1c+ influenza vaccine adult	myeloid	myeloid	adult	CD1c+ dendritic cell	Dendritic Cell
GSM1367978;6741	6741	Banchereau	GSM1367978	"Gardasil, replicate 5"	Homo sapiens	CD1c+ Gardasil	CL:0002399		CD1c+ dendritic cell			Banchereau	"The mechanisms by which microbial vaccines interact with human APCs remain elusive. Herein, we describe the transcriptional programs induced in human DCs by pathogens, innate receptor ligands and vaccines. Exposure of DCs to influenza, Salmonella enterica and Staphylococcus aureus allows us to build a modular framework containing 204 transcript clusters. We use this framework to characterize the responses of human monocytes, monocyte-derived DCs and blood DC subsets to 13 vaccines. Different vaccines induce distinct transcriptional programs based on pathogen type, adjuvant formulation and APC targeted. Fluzone, Pneumovax and Gardasil, respectively, activate monocyte-derived DCs, monocytes and CD1c+ blood DCs, highlighting APC specialization in response to vaccines. Finally, the blood signatures from individuals vaccinated with Fluzone or infected with influenza reveal a signature of adaptive immunity activation following vaccination and symptomatic infections, but not asymptomatic infections. These data, offered with a web interface, may guide the development of improved vaccines. Abstract from Nat Commun. 2014 Oct 22;5:5283."	88	"CD141+ DC, CD141+ FZ, CD141+ PVX, CD1c+ DC, CD1c+ FZ, CD1c+ Gardasil, CD1c+ Havrix, CD1c+ HEPB, CD1c+ Hib, CD1c+ Imovax, CD1c+ Ixiaro, CD1c+ PVX, CD1c+ Menomune, CD1c+ Polio, CD1c+ TDAP, CD1c+ Varicella, CD1c+ Zostavax"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.2	Illumina V4	"rgb(146,0,0)"	diamond	c-DC HLA-DR+CD11c+ CD1c+ Papilloma virus vaccine adult	myeloid	myeloid	adult	CD1c+ dendritic cell	Dendritic Cell
GSM1367979;6741	6741	Banchereau	GSM1367979	"Ixiaro, replicate 5"	Homo sapiens	CD1c+ Ixiaro	CL:0002399		CD1c+ dendritic cell			Banchereau	"The mechanisms by which microbial vaccines interact with human APCs remain elusive. Herein, we describe the transcriptional programs induced in human DCs by pathogens, innate receptor ligands and vaccines. Exposure of DCs to influenza, Salmonella enterica and Staphylococcus aureus allows us to build a modular framework containing 204 transcript clusters. We use this framework to characterize the responses of human monocytes, monocyte-derived DCs and blood DC subsets to 13 vaccines. Different vaccines induce distinct transcriptional programs based on pathogen type, adjuvant formulation and APC targeted. Fluzone, Pneumovax and Gardasil, respectively, activate monocyte-derived DCs, monocytes and CD1c+ blood DCs, highlighting APC specialization in response to vaccines. Finally, the blood signatures from individuals vaccinated with Fluzone or infected with influenza reveal a signature of adaptive immunity activation following vaccination and symptomatic infections, but not asymptomatic infections. These data, offered with a web interface, may guide the development of improved vaccines. Abstract from Nat Commun. 2014 Oct 22;5:5283."	88	"CD141+ DC, CD141+ FZ, CD141+ PVX, CD1c+ DC, CD1c+ FZ, CD1c+ Gardasil, CD1c+ Havrix, CD1c+ HEPB, CD1c+ Hib, CD1c+ Imovax, CD1c+ Ixiaro, CD1c+ PVX, CD1c+ Menomune, CD1c+ Polio, CD1c+ TDAP, CD1c+ Varicella, CD1c+ Zostavax"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.2	Illumina V4	"rgb(146,0,0)"	diamond	c-DC HLA-DR+CD11c+ CD1c+ Japanese encephalitis vaccine adult	myeloid	myeloid	adult	CD1c+ dendritic cell	Dendritic Cell
GSM1367980;6741	6741	Banchereau	GSM1367980	"Medium, replicate 13"	Homo sapiens	CD1c+ DC	CL:0002399		CD1c+ dendritic cell			Banchereau	"The mechanisms by which microbial vaccines interact with human APCs remain elusive. Herein, we describe the transcriptional programs induced in human DCs by pathogens, innate receptor ligands and vaccines. Exposure of DCs to influenza, Salmonella enterica and Staphylococcus aureus allows us to build a modular framework containing 204 transcript clusters. We use this framework to characterize the responses of human monocytes, monocyte-derived DCs and blood DC subsets to 13 vaccines. Different vaccines induce distinct transcriptional programs based on pathogen type, adjuvant formulation and APC targeted. Fluzone, Pneumovax and Gardasil, respectively, activate monocyte-derived DCs, monocytes and CD1c+ blood DCs, highlighting APC specialization in response to vaccines. Finally, the blood signatures from individuals vaccinated with Fluzone or infected with influenza reveal a signature of adaptive immunity activation following vaccination and symptomatic infections, but not asymptomatic infections. These data, offered with a web interface, may guide the development of improved vaccines. Abstract from Nat Commun. 2014 Oct 22;5:5283."	88	"CD141+ DC, CD141+ FZ, CD141+ PVX, CD1c+ DC, CD1c+ FZ, CD1c+ Gardasil, CD1c+ Havrix, CD1c+ HEPB, CD1c+ Hib, CD1c+ Imovax, CD1c+ Ixiaro, CD1c+ PVX, CD1c+ Menomune, CD1c+ Polio, CD1c+ TDAP, CD1c+ Varicella, CD1c+ Zostavax"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.2	Illumina V4	"rgb(146,0,0)"	diamond	c-DC HLA-DR+CD11c+ CD1c+  adult	myeloid	myeloid	adult	CD1c+ dendritic cell	Dendritic Cell
GSM1367981;6741	6741	Banchereau	GSM1367981	"Medium, replicate 14"	Homo sapiens	CD1c+ DC	CL:0002399		CD1c+ dendritic cell			Banchereau	"The mechanisms by which microbial vaccines interact with human APCs remain elusive. Herein, we describe the transcriptional programs induced in human DCs by pathogens, innate receptor ligands and vaccines. Exposure of DCs to influenza, Salmonella enterica and Staphylococcus aureus allows us to build a modular framework containing 204 transcript clusters. We use this framework to characterize the responses of human monocytes, monocyte-derived DCs and blood DC subsets to 13 vaccines. Different vaccines induce distinct transcriptional programs based on pathogen type, adjuvant formulation and APC targeted. Fluzone, Pneumovax and Gardasil, respectively, activate monocyte-derived DCs, monocytes and CD1c+ blood DCs, highlighting APC specialization in response to vaccines. Finally, the blood signatures from individuals vaccinated with Fluzone or infected with influenza reveal a signature of adaptive immunity activation following vaccination and symptomatic infections, but not asymptomatic infections. These data, offered with a web interface, may guide the development of improved vaccines. Abstract from Nat Commun. 2014 Oct 22;5:5283."	88	"CD141+ DC, CD141+ FZ, CD141+ PVX, CD1c+ DC, CD1c+ FZ, CD1c+ Gardasil, CD1c+ Havrix, CD1c+ HEPB, CD1c+ Hib, CD1c+ Imovax, CD1c+ Ixiaro, CD1c+ PVX, CD1c+ Menomune, CD1c+ Polio, CD1c+ TDAP, CD1c+ Varicella, CD1c+ Zostavax"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.2	Illumina V4	"rgb(146,0,0)"	diamond	c-DC HLA-DR+CD11c+ CD1c+  adult	myeloid	myeloid	adult	CD1c+ dendritic cell	Dendritic Cell
GSM1367982;6741	6741	Banchereau	GSM1367982	"Medium, replicate 15"	Homo sapiens	CD141+ DC	CL:0002394		CD141+ dendritic cell			Banchereau	"The mechanisms by which microbial vaccines interact with human APCs remain elusive. Herein, we describe the transcriptional programs induced in human DCs by pathogens, innate receptor ligands and vaccines. Exposure of DCs to influenza, Salmonella enterica and Staphylococcus aureus allows us to build a modular framework containing 204 transcript clusters. We use this framework to characterize the responses of human monocytes, monocyte-derived DCs and blood DC subsets to 13 vaccines. Different vaccines induce distinct transcriptional programs based on pathogen type, adjuvant formulation and APC targeted. Fluzone, Pneumovax and Gardasil, respectively, activate monocyte-derived DCs, monocytes and CD1c+ blood DCs, highlighting APC specialization in response to vaccines. Finally, the blood signatures from individuals vaccinated with Fluzone or infected with influenza reveal a signature of adaptive immunity activation following vaccination and symptomatic infections, but not asymptomatic infections. These data, offered with a web interface, may guide the development of improved vaccines. Abstract from Nat Commun. 2014 Oct 22;5:5283."	88	"CD141+ DC, CD141+ FZ, CD141+ PVX, CD1c+ DC, CD1c+ FZ, CD1c+ Gardasil, CD1c+ Havrix, CD1c+ HEPB, CD1c+ Hib, CD1c+ Imovax, CD1c+ Ixiaro, CD1c+ PVX, CD1c+ Menomune, CD1c+ Polio, CD1c+ TDAP, CD1c+ Varicella, CD1c+ Zostavax"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.2	Illumina V4	"rgb(146,0,0)"	diamond	c-DC HLA-DR+CD11c+ CD141+  adult	myeloid	myeloid	adult	CD141+ dendritic cell	Dendritic Cell
GSM1367983;6741	6741	Banchereau	GSM1367983	"Menomune, replicate 5"	Homo sapiens	CD1c+ Menomune	CL:0002399		CD1c+ dendritic cell			Banchereau	"The mechanisms by which microbial vaccines interact with human APCs remain elusive. Herein, we describe the transcriptional programs induced in human DCs by pathogens, innate receptor ligands and vaccines. Exposure of DCs to influenza, Salmonella enterica and Staphylococcus aureus allows us to build a modular framework containing 204 transcript clusters. We use this framework to characterize the responses of human monocytes, monocyte-derived DCs and blood DC subsets to 13 vaccines. Different vaccines induce distinct transcriptional programs based on pathogen type, adjuvant formulation and APC targeted. Fluzone, Pneumovax and Gardasil, respectively, activate monocyte-derived DCs, monocytes and CD1c+ blood DCs, highlighting APC specialization in response to vaccines. Finally, the blood signatures from individuals vaccinated with Fluzone or infected with influenza reveal a signature of adaptive immunity activation following vaccination and symptomatic infections, but not asymptomatic infections. These data, offered with a web interface, may guide the development of improved vaccines. Abstract from Nat Commun. 2014 Oct 22;5:5283."	88	"CD141+ DC, CD141+ FZ, CD141+ PVX, CD1c+ DC, CD1c+ FZ, CD1c+ Gardasil, CD1c+ Havrix, CD1c+ HEPB, CD1c+ Hib, CD1c+ Imovax, CD1c+ Ixiaro, CD1c+ PVX, CD1c+ Menomune, CD1c+ Polio, CD1c+ TDAP, CD1c+ Varicella, CD1c+ Zostavax"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.2	Illumina V4	"rgb(146,0,0)"	diamond	c-DC HLA-DR+CD11c+ CD1c+ Neisseiria meningitis vaccine adult	myeloid	myeloid	adult	CD1c+ dendritic cell	Dendritic Cell
GSM1367984;6741	6741	Banchereau	GSM1367984	"Ipol, replicate 5"	Homo sapiens	CD1c+ Polio	CL:0002399		CD1c+ dendritic cell			Banchereau	"The mechanisms by which microbial vaccines interact with human APCs remain elusive. Herein, we describe the transcriptional programs induced in human DCs by pathogens, innate receptor ligands and vaccines. Exposure of DCs to influenza, Salmonella enterica and Staphylococcus aureus allows us to build a modular framework containing 204 transcript clusters. We use this framework to characterize the responses of human monocytes, monocyte-derived DCs and blood DC subsets to 13 vaccines. Different vaccines induce distinct transcriptional programs based on pathogen type, adjuvant formulation and APC targeted. Fluzone, Pneumovax and Gardasil, respectively, activate monocyte-derived DCs, monocytes and CD1c+ blood DCs, highlighting APC specialization in response to vaccines. Finally, the blood signatures from individuals vaccinated with Fluzone or infected with influenza reveal a signature of adaptive immunity activation following vaccination and symptomatic infections, but not asymptomatic infections. These data, offered with a web interface, may guide the development of improved vaccines. Abstract from Nat Commun. 2014 Oct 22;5:5283."	88	"CD141+ DC, CD141+ FZ, CD141+ PVX, CD1c+ DC, CD1c+ FZ, CD1c+ Gardasil, CD1c+ Havrix, CD1c+ HEPB, CD1c+ Hib, CD1c+ Imovax, CD1c+ Ixiaro, CD1c+ PVX, CD1c+ Menomune, CD1c+ Polio, CD1c+ TDAP, CD1c+ Varicella, CD1c+ Zostavax"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.2	Illumina V4	"rgb(146,0,0)"	diamond	c-DC HLA-DR+CD11c+ CD1c+ polio vaccine adult	myeloid	myeloid	adult	CD1c+ dendritic cell	Dendritic Cell
GSM1367985;6741	6741	Banchereau	GSM1367985	"Pneumovax, replicate 7"	Homo sapiens	CD1c+ PVX	CL:0002399		CD1c+ dendritic cell			Banchereau	"The mechanisms by which microbial vaccines interact with human APCs remain elusive. Herein, we describe the transcriptional programs induced in human DCs by pathogens, innate receptor ligands and vaccines. Exposure of DCs to influenza, Salmonella enterica and Staphylococcus aureus allows us to build a modular framework containing 204 transcript clusters. We use this framework to characterize the responses of human monocytes, monocyte-derived DCs and blood DC subsets to 13 vaccines. Different vaccines induce distinct transcriptional programs based on pathogen type, adjuvant formulation and APC targeted. Fluzone, Pneumovax and Gardasil, respectively, activate monocyte-derived DCs, monocytes and CD1c+ blood DCs, highlighting APC specialization in response to vaccines. Finally, the blood signatures from individuals vaccinated with Fluzone or infected with influenza reveal a signature of adaptive immunity activation following vaccination and symptomatic infections, but not asymptomatic infections. These data, offered with a web interface, may guide the development of improved vaccines. Abstract from Nat Commun. 2014 Oct 22;5:5283."	88	"CD141+ DC, CD141+ FZ, CD141+ PVX, CD1c+ DC, CD1c+ FZ, CD1c+ Gardasil, CD1c+ Havrix, CD1c+ HEPB, CD1c+ Hib, CD1c+ Imovax, CD1c+ Ixiaro, CD1c+ PVX, CD1c+ Menomune, CD1c+ Polio, CD1c+ TDAP, CD1c+ Varicella, CD1c+ Zostavax"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.2	Illumina V4	"rgb(146,0,0)"	diamond	c-DC HLA-DR+CD11c+ CD1c+ CD1c+ dendritic cell exposed to Pneumococcus vaccine adult	myeloid	myeloid	adult	CD1c+ dendritic cell	Dendritic Cell
GSM1367986;6741	6741	Banchereau	GSM1367986	"Pneumovax, replicate 8"	Homo sapiens	CD141+ PVX	CL:0002394		CD141+ dendritic cell			Banchereau	"The mechanisms by which microbial vaccines interact with human APCs remain elusive. Herein, we describe the transcriptional programs induced in human DCs by pathogens, innate receptor ligands and vaccines. Exposure of DCs to influenza, Salmonella enterica and Staphylococcus aureus allows us to build a modular framework containing 204 transcript clusters. We use this framework to characterize the responses of human monocytes, monocyte-derived DCs and blood DC subsets to 13 vaccines. Different vaccines induce distinct transcriptional programs based on pathogen type, adjuvant formulation and APC targeted. Fluzone, Pneumovax and Gardasil, respectively, activate monocyte-derived DCs, monocytes and CD1c+ blood DCs, highlighting APC specialization in response to vaccines. Finally, the blood signatures from individuals vaccinated with Fluzone or infected with influenza reveal a signature of adaptive immunity activation following vaccination and symptomatic infections, but not asymptomatic infections. These data, offered with a web interface, may guide the development of improved vaccines. Abstract from Nat Commun. 2014 Oct 22;5:5283."	88	"CD141+ DC, CD141+ FZ, CD141+ PVX, CD1c+ DC, CD1c+ FZ, CD1c+ Gardasil, CD1c+ Havrix, CD1c+ HEPB, CD1c+ Hib, CD1c+ Imovax, CD1c+ Ixiaro, CD1c+ PVX, CD1c+ Menomune, CD1c+ Polio, CD1c+ TDAP, CD1c+ Varicella, CD1c+ Zostavax"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.2	Illumina V4	"rgb(146,0,0)"	diamond	c-DC HLA-DR+CD11c+ CD141+ Pneumococcus vaccine adult	myeloid	myeloid	adult	CD141+ dendritic cell	Dendritic Cell
GSM1367987;6741	6741	Banchereau	GSM1367987	"Imovax, replicate 5"	Homo sapiens	CD1c+ Imovax	CL:0002399		CD1c+ dendritic cell			Banchereau	"The mechanisms by which microbial vaccines interact with human APCs remain elusive. Herein, we describe the transcriptional programs induced in human DCs by pathogens, innate receptor ligands and vaccines. Exposure of DCs to influenza, Salmonella enterica and Staphylococcus aureus allows us to build a modular framework containing 204 transcript clusters. We use this framework to characterize the responses of human monocytes, monocyte-derived DCs and blood DC subsets to 13 vaccines. Different vaccines induce distinct transcriptional programs based on pathogen type, adjuvant formulation and APC targeted. Fluzone, Pneumovax and Gardasil, respectively, activate monocyte-derived DCs, monocytes and CD1c+ blood DCs, highlighting APC specialization in response to vaccines. Finally, the blood signatures from individuals vaccinated with Fluzone or infected with influenza reveal a signature of adaptive immunity activation following vaccination and symptomatic infections, but not asymptomatic infections. These data, offered with a web interface, may guide the development of improved vaccines. Abstract from Nat Commun. 2014 Oct 22;5:5283."	88	"CD141+ DC, CD141+ FZ, CD141+ PVX, CD1c+ DC, CD1c+ FZ, CD1c+ Gardasil, CD1c+ Havrix, CD1c+ HEPB, CD1c+ Hib, CD1c+ Imovax, CD1c+ Ixiaro, CD1c+ PVX, CD1c+ Menomune, CD1c+ Polio, CD1c+ TDAP, CD1c+ Varicella, CD1c+ Zostavax"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.2	Illumina V4	"rgb(146,0,0)"	diamond	c-DC HLA-DR+CD11c+ CD1c+ rabies vaccine adult	myeloid	myeloid	adult	CD1c+ dendritic cell	Dendritic Cell
GSM1367988;6741	6741	Banchereau	GSM1367988	"Adacel, replicate 5"	Homo sapiens	CD1c+ TDAP	CL:0002399		CD1c+ dendritic cell			Banchereau	"The mechanisms by which microbial vaccines interact with human APCs remain elusive. Herein, we describe the transcriptional programs induced in human DCs by pathogens, innate receptor ligands and vaccines. Exposure of DCs to influenza, Salmonella enterica and Staphylococcus aureus allows us to build a modular framework containing 204 transcript clusters. We use this framework to characterize the responses of human monocytes, monocyte-derived DCs and blood DC subsets to 13 vaccines. Different vaccines induce distinct transcriptional programs based on pathogen type, adjuvant formulation and APC targeted. Fluzone, Pneumovax and Gardasil, respectively, activate monocyte-derived DCs, monocytes and CD1c+ blood DCs, highlighting APC specialization in response to vaccines. Finally, the blood signatures from individuals vaccinated with Fluzone or infected with influenza reveal a signature of adaptive immunity activation following vaccination and symptomatic infections, but not asymptomatic infections. These data, offered with a web interface, may guide the development of improved vaccines. Abstract from Nat Commun. 2014 Oct 22;5:5283."	88	"CD141+ DC, CD141+ FZ, CD141+ PVX, CD1c+ DC, CD1c+ FZ, CD1c+ Gardasil, CD1c+ Havrix, CD1c+ HEPB, CD1c+ Hib, CD1c+ Imovax, CD1c+ Ixiaro, CD1c+ PVX, CD1c+ Menomune, CD1c+ Polio, CD1c+ TDAP, CD1c+ Varicella, CD1c+ Zostavax"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.2	Illumina V4	"rgb(146,0,0)"	diamond	c-DC HLA-DR+CD11c+ CD1c+ Tetanus Diphteria Pertussis vaccine adult	myeloid	myeloid	adult	CD1c+ dendritic cell	Dendritic Cell
GSM1367989;6741	6741	Banchereau	GSM1367989	"Varivax, replicate 5"	Homo sapiens	CD1c+ Varicella	CL:0002399		CD1c+ dendritic cell			Banchereau	"The mechanisms by which microbial vaccines interact with human APCs remain elusive. Herein, we describe the transcriptional programs induced in human DCs by pathogens, innate receptor ligands and vaccines. Exposure of DCs to influenza, Salmonella enterica and Staphylococcus aureus allows us to build a modular framework containing 204 transcript clusters. We use this framework to characterize the responses of human monocytes, monocyte-derived DCs and blood DC subsets to 13 vaccines. Different vaccines induce distinct transcriptional programs based on pathogen type, adjuvant formulation and APC targeted. Fluzone, Pneumovax and Gardasil, respectively, activate monocyte-derived DCs, monocytes and CD1c+ blood DCs, highlighting APC specialization in response to vaccines. Finally, the blood signatures from individuals vaccinated with Fluzone or infected with influenza reveal a signature of adaptive immunity activation following vaccination and symptomatic infections, but not asymptomatic infections. These data, offered with a web interface, may guide the development of improved vaccines. Abstract from Nat Commun. 2014 Oct 22;5:5283."	88	"CD141+ DC, CD141+ FZ, CD141+ PVX, CD1c+ DC, CD1c+ FZ, CD1c+ Gardasil, CD1c+ Havrix, CD1c+ HEPB, CD1c+ Hib, CD1c+ Imovax, CD1c+ Ixiaro, CD1c+ PVX, CD1c+ Menomune, CD1c+ Polio, CD1c+ TDAP, CD1c+ Varicella, CD1c+ Zostavax"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.2	Illumina V4	"rgb(146,0,0)"	diamond	c-DC HLA-DR+CD11c+ CD1c+ Varicella vaccine adult	myeloid	myeloid	adult	CD1c+ dendritic cell	Dendritic Cell
GSM1386443;7003	7003	Balan	GSM1386443	CD141- XCR1- CD34- DC in FS36 media replicate 1	Homo sapiens	CD141- XCR1- DC	CL:0000451	dendritic cell	hematopoietic multipotent progenitor			Balan	"Human monocyte-derived dendritic cell (MoDC) have been used in the clinic with moderately encouraging results. Mouse XCR1(+) DC excel at cross-presentation, can be targeted in vivo to induce protective immunity, and share characteristics with XCR1(+) human DC. Assessment of the immunoactivation potential of XCR1(+) human DC is hindered by their paucity in vivo and by their lack of a well-defined in vitro counterpart. We report in this study a protocol generating both XCR1(+) and XCR1(-) human DC in CD34(+) progenitor cultures (CD34-DC). Gene expression profiling, phenotypic characterization, and functional studies demonstrated that XCR1(-) CD34-DC are similar to canonical MoDC, whereas XCR1(+) CD34-DC resemble XCR1(+) blood DC (bDC). XCR1(+) DC were strongly activated by polyinosinic-polycytidylic acid but not LPS, and conversely for MoDC. XCR1(+) DC and MoDC expressed strikingly different patterns of molecules involved in inflammation and in cross-talk with NK or T cells. XCR1(+) CD34-DC but not MoDC efficiently cross-presented a cell-associated Ag upon stimulation by polyinosinic-polycytidylic acid or R848, likewise to what was reported for XCR1(+) bDC. Hence, it is feasible to generate high numbers of bona fide XCR1(+) human DC in vitro as a model to decipher the functions of XCR1(+) bDC and as a potential source of XCR1(+) DC for clinical use. Abstract from Journal of Immunology. 2014 Aug 15;193(4):1622-35. doi: 10.4049/jimmunol.1401243."	74	"pDC, CD141- XCR1- DC, CD141+ XCR1- DC, CD1c+, CD1c+ LPS 16h, CD1c+ R848 16h, CD1c+ pIC16hr, MoDC, MoDC +LPS 16h, MoDC +R848 16h, MoDC +pIC 16h, XCR1+, XCR1+ LPS 16h, XCR1+ R848 16h, XCR1+ pIC 16h, XCR1-, XCR1- LPS 16h, XCR1- R848 16h, XCR1- pIC 16h"	Microarray (Affymetrix HuGene-1_0-ST V1 (GPL 6244 and A-AFFY-141))		Homo sapiens	2.66	HuGene	"rgb(0,109,219)"	diamond-open	SC-DC p-DC expanded from CD34+ progenitors in FLT3-L SCF GM-CSF IL4 neonatal	myeloid	myeloid	neonatal	dendritic cell	Macrophage
GSM1386444;7003	7003	Balan	GSM1386444	CD141- XCR1- CD34- DC in FS36 media replicate 2	Homo sapiens	CD141- XCR1- DC	CL:0000451	dendritic cell	hematopoietic multipotent progenitor			Balan	"Human monocyte-derived dendritic cell (MoDC) have been used in the clinic with moderately encouraging results. Mouse XCR1(+) DC excel at cross-presentation, can be targeted in vivo to induce protective immunity, and share characteristics with XCR1(+) human DC. Assessment of the immunoactivation potential of XCR1(+) human DC is hindered by their paucity in vivo and by their lack of a well-defined in vitro counterpart. We report in this study a protocol generating both XCR1(+) and XCR1(-) human DC in CD34(+) progenitor cultures (CD34-DC). Gene expression profiling, phenotypic characterization, and functional studies demonstrated that XCR1(-) CD34-DC are similar to canonical MoDC, whereas XCR1(+) CD34-DC resemble XCR1(+) blood DC (bDC). XCR1(+) DC were strongly activated by polyinosinic-polycytidylic acid but not LPS, and conversely for MoDC. XCR1(+) DC and MoDC expressed strikingly different patterns of molecules involved in inflammation and in cross-talk with NK or T cells. XCR1(+) CD34-DC but not MoDC efficiently cross-presented a cell-associated Ag upon stimulation by polyinosinic-polycytidylic acid or R848, likewise to what was reported for XCR1(+) bDC. Hence, it is feasible to generate high numbers of bona fide XCR1(+) human DC in vitro as a model to decipher the functions of XCR1(+) bDC and as a potential source of XCR1(+) DC for clinical use. Abstract from Journal of Immunology. 2014 Aug 15;193(4):1622-35. doi: 10.4049/jimmunol.1401243."	74	"pDC, CD141- XCR1- DC, CD141+ XCR1- DC, CD1c+, CD1c+ LPS 16h, CD1c+ R848 16h, CD1c+ pIC16hr, MoDC, MoDC +LPS 16h, MoDC +R848 16h, MoDC +pIC 16h, XCR1+, XCR1+ LPS 16h, XCR1+ R848 16h, XCR1+ pIC 16h, XCR1-, XCR1- LPS 16h, XCR1- R848 16h, XCR1- pIC 16h"	Microarray (Affymetrix HuGene-1_0-ST V1 (GPL 6244 and A-AFFY-141))		Homo sapiens	2.66	HuGene	"rgb(0,109,219)"	diamond-open	SC-DC p-DC expanded from CD34+ progenitors in FLT3-L SCF GM-CSF IL4 neonatal	myeloid	myeloid	neonatal	dendritic cell	Macrophage
GSM1386445;7003	7003	Balan	GSM1386445	CD141- XCR1- CD34- DC in FS36 media replicate 3	Homo sapiens	CD141- XCR1- DC	CL:0000451	dendritic cell	hematopoietic multipotent progenitor			Balan	"Human monocyte-derived dendritic cell (MoDC) have been used in the clinic with moderately encouraging results. Mouse XCR1(+) DC excel at cross-presentation, can be targeted in vivo to induce protective immunity, and share characteristics with XCR1(+) human DC. Assessment of the immunoactivation potential of XCR1(+) human DC is hindered by their paucity in vivo and by their lack of a well-defined in vitro counterpart. We report in this study a protocol generating both XCR1(+) and XCR1(-) human DC in CD34(+) progenitor cultures (CD34-DC). Gene expression profiling, phenotypic characterization, and functional studies demonstrated that XCR1(-) CD34-DC are similar to canonical MoDC, whereas XCR1(+) CD34-DC resemble XCR1(+) blood DC (bDC). XCR1(+) DC were strongly activated by polyinosinic-polycytidylic acid but not LPS, and conversely for MoDC. XCR1(+) DC and MoDC expressed strikingly different patterns of molecules involved in inflammation and in cross-talk with NK or T cells. XCR1(+) CD34-DC but not MoDC efficiently cross-presented a cell-associated Ag upon stimulation by polyinosinic-polycytidylic acid or R848, likewise to what was reported for XCR1(+) bDC. Hence, it is feasible to generate high numbers of bona fide XCR1(+) human DC in vitro as a model to decipher the functions of XCR1(+) bDC and as a potential source of XCR1(+) DC for clinical use. Abstract from Journal of Immunology. 2014 Aug 15;193(4):1622-35. doi: 10.4049/jimmunol.1401243."	74	"pDC, CD141- XCR1- DC, CD141+ XCR1- DC, CD1c+, CD1c+ LPS 16h, CD1c+ R848 16h, CD1c+ pIC16hr, MoDC, MoDC +LPS 16h, MoDC +R848 16h, MoDC +pIC 16h, XCR1+, XCR1+ LPS 16h, XCR1+ R848 16h, XCR1+ pIC 16h, XCR1-, XCR1- LPS 16h, XCR1- R848 16h, XCR1- pIC 16h"	Microarray (Affymetrix HuGene-1_0-ST V1 (GPL 6244 and A-AFFY-141))		Homo sapiens	2.66	HuGene	"rgb(0,109,219)"	diamond-open	SC-DC p-DC expanded from CD34+ progenitors in FLT3-L SCF GM-CSF IL4 neonatal	myeloid	myeloid	neonatal	dendritic cell	Macrophage
GSM1386446;7003	7003	Balan	GSM1386446	CD141+ XCR1- CD34- DC in FS36 media replicate 1	Homo sapiens	CD141+ XCR1- DC	CL:0002394	CD141+ dendritic cell	hematopoietic multipotent progenitor			Balan	"Human monocyte-derived dendritic cell (MoDC) have been used in the clinic with moderately encouraging results. Mouse XCR1(+) DC excel at cross-presentation, can be targeted in vivo to induce protective immunity, and share characteristics with XCR1(+) human DC. Assessment of the immunoactivation potential of XCR1(+) human DC is hindered by their paucity in vivo and by their lack of a well-defined in vitro counterpart. We report in this study a protocol generating both XCR1(+) and XCR1(-) human DC in CD34(+) progenitor cultures (CD34-DC). Gene expression profiling, phenotypic characterization, and functional studies demonstrated that XCR1(-) CD34-DC are similar to canonical MoDC, whereas XCR1(+) CD34-DC resemble XCR1(+) blood DC (bDC). XCR1(+) DC were strongly activated by polyinosinic-polycytidylic acid but not LPS, and conversely for MoDC. XCR1(+) DC and MoDC expressed strikingly different patterns of molecules involved in inflammation and in cross-talk with NK or T cells. XCR1(+) CD34-DC but not MoDC efficiently cross-presented a cell-associated Ag upon stimulation by polyinosinic-polycytidylic acid or R848, likewise to what was reported for XCR1(+) bDC. Hence, it is feasible to generate high numbers of bona fide XCR1(+) human DC in vitro as a model to decipher the functions of XCR1(+) bDC and as a potential source of XCR1(+) DC for clinical use. Abstract from Journal of Immunology. 2014 Aug 15;193(4):1622-35. doi: 10.4049/jimmunol.1401243."	74	"pDC, CD141- XCR1- DC, CD141+ XCR1- DC, CD1c+, CD1c+ LPS 16h, CD1c+ R848 16h, CD1c+ pIC16hr, MoDC, MoDC +LPS 16h, MoDC +R848 16h, MoDC +pIC 16h, XCR1+, XCR1+ LPS 16h, XCR1+ R848 16h, XCR1+ pIC 16h, XCR1-, XCR1- LPS 16h, XCR1- R848 16h, XCR1- pIC 16h"	Microarray (Affymetrix HuGene-1_0-ST V1 (GPL 6244 and A-AFFY-141))		Homo sapiens	2.66	HuGene	"rgb(0,109,219)"	diamond-open	SC-DC CD141+ Flt-3L SCF TPO then GM-CSF IL-4 neonatal	myeloid	myeloid	neonatal	CD141+ dendritic cell	Macrophage
GSM1386447;7003	7003	Balan	GSM1386447	CD141+ XCR1- CD34- DC in FS36 media replicate 2	Homo sapiens	CD141+ XCR1- DC	CL:0002394	CD141+ dendritic cell	hematopoietic multipotent progenitor			Balan	"Human monocyte-derived dendritic cell (MoDC) have been used in the clinic with moderately encouraging results. Mouse XCR1(+) DC excel at cross-presentation, can be targeted in vivo to induce protective immunity, and share characteristics with XCR1(+) human DC. Assessment of the immunoactivation potential of XCR1(+) human DC is hindered by their paucity in vivo and by their lack of a well-defined in vitro counterpart. We report in this study a protocol generating both XCR1(+) and XCR1(-) human DC in CD34(+) progenitor cultures (CD34-DC). Gene expression profiling, phenotypic characterization, and functional studies demonstrated that XCR1(-) CD34-DC are similar to canonical MoDC, whereas XCR1(+) CD34-DC resemble XCR1(+) blood DC (bDC). XCR1(+) DC were strongly activated by polyinosinic-polycytidylic acid but not LPS, and conversely for MoDC. XCR1(+) DC and MoDC expressed strikingly different patterns of molecules involved in inflammation and in cross-talk with NK or T cells. XCR1(+) CD34-DC but not MoDC efficiently cross-presented a cell-associated Ag upon stimulation by polyinosinic-polycytidylic acid or R848, likewise to what was reported for XCR1(+) bDC. Hence, it is feasible to generate high numbers of bona fide XCR1(+) human DC in vitro as a model to decipher the functions of XCR1(+) bDC and as a potential source of XCR1(+) DC for clinical use. Abstract from Journal of Immunology. 2014 Aug 15;193(4):1622-35. doi: 10.4049/jimmunol.1401243."	74	"pDC, CD141- XCR1- DC, CD141+ XCR1- DC, CD1c+, CD1c+ LPS 16h, CD1c+ R848 16h, CD1c+ pIC16hr, MoDC, MoDC +LPS 16h, MoDC +R848 16h, MoDC +pIC 16h, XCR1+, XCR1+ LPS 16h, XCR1+ R848 16h, XCR1+ pIC 16h, XCR1-, XCR1- LPS 16h, XCR1- R848 16h, XCR1- pIC 16h"	Microarray (Affymetrix HuGene-1_0-ST V1 (GPL 6244 and A-AFFY-141))		Homo sapiens	2.66	HuGene	"rgb(0,109,219)"	diamond-open	SC-DC CD141+ Flt-3L SCF TPO then GM-CSF IL-4 neonatal	myeloid	myeloid	neonatal	CD141+ dendritic cell	Macrophage
GSM1386448;7003	7003	Balan	GSM1386448	CD141+ XCR1- CD34- DC in FS36 media replicate 3	Homo sapiens	CD141+ XCR1- DC	CL:0002394	CD141+ dendritic cell	hematopoietic multipotent progenitor			Balan	"Human monocyte-derived dendritic cell (MoDC) have been used in the clinic with moderately encouraging results. Mouse XCR1(+) DC excel at cross-presentation, can be targeted in vivo to induce protective immunity, and share characteristics with XCR1(+) human DC. Assessment of the immunoactivation potential of XCR1(+) human DC is hindered by their paucity in vivo and by their lack of a well-defined in vitro counterpart. We report in this study a protocol generating both XCR1(+) and XCR1(-) human DC in CD34(+) progenitor cultures (CD34-DC). Gene expression profiling, phenotypic characterization, and functional studies demonstrated that XCR1(-) CD34-DC are similar to canonical MoDC, whereas XCR1(+) CD34-DC resemble XCR1(+) blood DC (bDC). XCR1(+) DC were strongly activated by polyinosinic-polycytidylic acid but not LPS, and conversely for MoDC. XCR1(+) DC and MoDC expressed strikingly different patterns of molecules involved in inflammation and in cross-talk with NK or T cells. XCR1(+) CD34-DC but not MoDC efficiently cross-presented a cell-associated Ag upon stimulation by polyinosinic-polycytidylic acid or R848, likewise to what was reported for XCR1(+) bDC. Hence, it is feasible to generate high numbers of bona fide XCR1(+) human DC in vitro as a model to decipher the functions of XCR1(+) bDC and as a potential source of XCR1(+) DC for clinical use. Abstract from Journal of Immunology. 2014 Aug 15;193(4):1622-35. doi: 10.4049/jimmunol.1401243."	74	"pDC, CD141- XCR1- DC, CD141+ XCR1- DC, CD1c+, CD1c+ LPS 16h, CD1c+ R848 16h, CD1c+ pIC16hr, MoDC, MoDC +LPS 16h, MoDC +R848 16h, MoDC +pIC 16h, XCR1+, XCR1+ LPS 16h, XCR1+ R848 16h, XCR1+ pIC 16h, XCR1-, XCR1- LPS 16h, XCR1- R848 16h, XCR1- pIC 16h"	Microarray (Affymetrix HuGene-1_0-ST V1 (GPL 6244 and A-AFFY-141))		Homo sapiens	2.66	HuGene	"rgb(0,109,219)"	diamond-open	SC-DC CD141+ Flt-3L SCF TPO then GM-CSF IL-4 neonatal	myeloid	myeloid	neonatal	CD141+ dendritic cell	Macrophage
GSM1386487;7003	7003	Balan	GSM1386487	"UN CD1c+ bDC, replicate 1"	Homo sapiens	CD1c+	CL:0002399		CD1c+ dendritic cell			Balan	"Human monocyte-derived dendritic cell (MoDC) have been used in the clinic with moderately encouraging results. Mouse XCR1(+) DC excel at cross-presentation, can be targeted in vivo to induce protective immunity, and share characteristics with XCR1(+) human DC. Assessment of the immunoactivation potential of XCR1(+) human DC is hindered by their paucity in vivo and by their lack of a well-defined in vitro counterpart. We report in this study a protocol generating both XCR1(+) and XCR1(-) human DC in CD34(+) progenitor cultures (CD34-DC). Gene expression profiling, phenotypic characterization, and functional studies demonstrated that XCR1(-) CD34-DC are similar to canonical MoDC, whereas XCR1(+) CD34-DC resemble XCR1(+) blood DC (bDC). XCR1(+) DC were strongly activated by polyinosinic-polycytidylic acid but not LPS, and conversely for MoDC. XCR1(+) DC and MoDC expressed strikingly different patterns of molecules involved in inflammation and in cross-talk with NK or T cells. XCR1(+) CD34-DC but not MoDC efficiently cross-presented a cell-associated Ag upon stimulation by polyinosinic-polycytidylic acid or R848, likewise to what was reported for XCR1(+) bDC. Hence, it is feasible to generate high numbers of bona fide XCR1(+) human DC in vitro as a model to decipher the functions of XCR1(+) bDC and as a potential source of XCR1(+) DC for clinical use. Abstract from Journal of Immunology. 2014 Aug 15;193(4):1622-35. doi: 10.4049/jimmunol.1401243."	74	"pDC, CD141- XCR1- DC, CD141+ XCR1- DC, CD1c+, CD1c+ LPS 16h, CD1c+ R848 16h, CD1c+ pIC16hr, MoDC, MoDC +LPS 16h, MoDC +R848 16h, MoDC +pIC 16h, XCR1+, XCR1+ LPS 16h, XCR1+ R848 16h, XCR1+ pIC 16h, XCR1-, XCR1- LPS 16h, XCR1- R848 16h, XCR1- pIC 16h"	Microarray (Affymetrix HuGene-1_0-ST V1 (GPL 6244 and A-AFFY-141))		Homo sapiens	2.66	HuGene	"rgb(0,109,219)"	diamond-open	SC-DC CD1c+ FLT3-L SCF GM-CSF IL4 adult	myeloid	myeloid	adult	CD1c+ dendritic cell	Dendritic Cell
GSM1386488;7003	7003	Balan	GSM1386488	"PIC CD1c+ bDC, replicate 1"	Homo sapiens	CD1c+ pIC16hr	CL:0002399		CD1c+ dendritic cell			Balan	"Human monocyte-derived dendritic cell (MoDC) have been used in the clinic with moderately encouraging results. Mouse XCR1(+) DC excel at cross-presentation, can be targeted in vivo to induce protective immunity, and share characteristics with XCR1(+) human DC. Assessment of the immunoactivation potential of XCR1(+) human DC is hindered by their paucity in vivo and by their lack of a well-defined in vitro counterpart. We report in this study a protocol generating both XCR1(+) and XCR1(-) human DC in CD34(+) progenitor cultures (CD34-DC). Gene expression profiling, phenotypic characterization, and functional studies demonstrated that XCR1(-) CD34-DC are similar to canonical MoDC, whereas XCR1(+) CD34-DC resemble XCR1(+) blood DC (bDC). XCR1(+) DC were strongly activated by polyinosinic-polycytidylic acid but not LPS, and conversely for MoDC. XCR1(+) DC and MoDC expressed strikingly different patterns of molecules involved in inflammation and in cross-talk with NK or T cells. XCR1(+) CD34-DC but not MoDC efficiently cross-presented a cell-associated Ag upon stimulation by polyinosinic-polycytidylic acid or R848, likewise to what was reported for XCR1(+) bDC. Hence, it is feasible to generate high numbers of bona fide XCR1(+) human DC in vitro as a model to decipher the functions of XCR1(+) bDC and as a potential source of XCR1(+) DC for clinical use. Abstract from Journal of Immunology. 2014 Aug 15;193(4):1622-35. doi: 10.4049/jimmunol.1401243."	74	"pDC, CD141- XCR1- DC, CD141+ XCR1- DC, CD1c+, CD1c+ LPS 16h, CD1c+ R848 16h, CD1c+ pIC16hr, MoDC, MoDC +LPS 16h, MoDC +R848 16h, MoDC +pIC 16h, XCR1+, XCR1+ LPS 16h, XCR1+ R848 16h, XCR1+ pIC 16h, XCR1-, XCR1- LPS 16h, XCR1- R848 16h, XCR1- pIC 16h"	Microarray (Affymetrix HuGene-1_0-ST V1 (GPL 6244 and A-AFFY-141))		Homo sapiens	2.66	HuGene	"rgb(0,109,219)"	diamond-open	CD1c+  FLT3-L SCF GM-CSF IL4 PolyIC 16hours adult	myeloid	myeloid	adult	CD1c+ dendritic cell	Dendritic Cell
GSM1386489;7003	7003	Balan	GSM1386489	"R848 CD1c+ bDC, replicate 1"	Homo sapiens	CD1c+ R848 16h	CL:0002399		CD1c+ dendritic cell			Balan	"Human monocyte-derived dendritic cell (MoDC) have been used in the clinic with moderately encouraging results. Mouse XCR1(+) DC excel at cross-presentation, can be targeted in vivo to induce protective immunity, and share characteristics with XCR1(+) human DC. Assessment of the immunoactivation potential of XCR1(+) human DC is hindered by their paucity in vivo and by their lack of a well-defined in vitro counterpart. We report in this study a protocol generating both XCR1(+) and XCR1(-) human DC in CD34(+) progenitor cultures (CD34-DC). Gene expression profiling, phenotypic characterization, and functional studies demonstrated that XCR1(-) CD34-DC are similar to canonical MoDC, whereas XCR1(+) CD34-DC resemble XCR1(+) blood DC (bDC). XCR1(+) DC were strongly activated by polyinosinic-polycytidylic acid but not LPS, and conversely for MoDC. XCR1(+) DC and MoDC expressed strikingly different patterns of molecules involved in inflammation and in cross-talk with NK or T cells. XCR1(+) CD34-DC but not MoDC efficiently cross-presented a cell-associated Ag upon stimulation by polyinosinic-polycytidylic acid or R848, likewise to what was reported for XCR1(+) bDC. Hence, it is feasible to generate high numbers of bona fide XCR1(+) human DC in vitro as a model to decipher the functions of XCR1(+) bDC and as a potential source of XCR1(+) DC for clinical use. Abstract from Journal of Immunology. 2014 Aug 15;193(4):1622-35. doi: 10.4049/jimmunol.1401243."	74	"pDC, CD141- XCR1- DC, CD141+ XCR1- DC, CD1c+, CD1c+ LPS 16h, CD1c+ R848 16h, CD1c+ pIC16hr, MoDC, MoDC +LPS 16h, MoDC +R848 16h, MoDC +pIC 16h, XCR1+, XCR1+ LPS 16h, XCR1+ R848 16h, XCR1+ pIC 16h, XCR1-, XCR1- LPS 16h, XCR1- R848 16h, XCR1- pIC 16h"	Microarray (Affymetrix HuGene-1_0-ST V1 (GPL 6244 and A-AFFY-141))		Homo sapiens	2.66	HuGene	"rgb(0,109,219)"	diamond-open	CD1c+  FLT3-L SCF GM-CSF IL4 R848 16hours adult	myeloid	myeloid	adult	CD1c+ dendritic cell	Dendritic Cell
GSM1386490;7003	7003	Balan	GSM1386490	CD1c+ bDC + LPS 1g/mL 16hrs replicate 1	Homo sapiens	CD1c+ LPS 16h	CL:0002399		CD1c+ dendritic cell			Balan	"Human monocyte-derived dendritic cell (MoDC) have been used in the clinic with moderately encouraging results. Mouse XCR1(+) DC excel at cross-presentation, can be targeted in vivo to induce protective immunity, and share characteristics with XCR1(+) human DC. Assessment of the immunoactivation potential of XCR1(+) human DC is hindered by their paucity in vivo and by their lack of a well-defined in vitro counterpart. We report in this study a protocol generating both XCR1(+) and XCR1(-) human DC in CD34(+) progenitor cultures (CD34-DC). Gene expression profiling, phenotypic characterization, and functional studies demonstrated that XCR1(-) CD34-DC are similar to canonical MoDC, whereas XCR1(+) CD34-DC resemble XCR1(+) blood DC (bDC). XCR1(+) DC were strongly activated by polyinosinic-polycytidylic acid but not LPS, and conversely for MoDC. XCR1(+) DC and MoDC expressed strikingly different patterns of molecules involved in inflammation and in cross-talk with NK or T cells. XCR1(+) CD34-DC but not MoDC efficiently cross-presented a cell-associated Ag upon stimulation by polyinosinic-polycytidylic acid or R848, likewise to what was reported for XCR1(+) bDC. Hence, it is feasible to generate high numbers of bona fide XCR1(+) human DC in vitro as a model to decipher the functions of XCR1(+) bDC and as a potential source of XCR1(+) DC for clinical use. Abstract from Journal of Immunology. 2014 Aug 15;193(4):1622-35. doi: 10.4049/jimmunol.1401243."	74	"pDC, CD141- XCR1- DC, CD141+ XCR1- DC, CD1c+, CD1c+ LPS 16h, CD1c+ R848 16h, CD1c+ pIC16hr, MoDC, MoDC +LPS 16h, MoDC +R848 16h, MoDC +pIC 16h, XCR1+, XCR1+ LPS 16h, XCR1+ R848 16h, XCR1+ pIC 16h, XCR1-, XCR1- LPS 16h, XCR1- R848 16h, XCR1- pIC 16h"	Microarray (Affymetrix HuGene-1_0-ST V1 (GPL 6244 and A-AFFY-141))		Homo sapiens	2.66	HuGene	"rgb(0,109,219)"	diamond-open	SC-DC CD1c+ expanded from CD1c+ in FLT3-L SCF GM-CSF IL4 LPS adult	myeloid	myeloid	adult	CD1c+ dendritic cell	Dendritic Cell
GSM1386491;7003	7003	Balan	GSM1386491	"UN XCR1+ bDC, replicate 1"	Homo sapiens	XCR1+	CL:0000451		dendritic cell			Balan	"Human monocyte-derived dendritic cell (MoDC) have been used in the clinic with moderately encouraging results. Mouse XCR1(+) DC excel at cross-presentation, can be targeted in vivo to induce protective immunity, and share characteristics with XCR1(+) human DC. Assessment of the immunoactivation potential of XCR1(+) human DC is hindered by their paucity in vivo and by their lack of a well-defined in vitro counterpart. We report in this study a protocol generating both XCR1(+) and XCR1(-) human DC in CD34(+) progenitor cultures (CD34-DC). Gene expression profiling, phenotypic characterization, and functional studies demonstrated that XCR1(-) CD34-DC are similar to canonical MoDC, whereas XCR1(+) CD34-DC resemble XCR1(+) blood DC (bDC). XCR1(+) DC were strongly activated by polyinosinic-polycytidylic acid but not LPS, and conversely for MoDC. XCR1(+) DC and MoDC expressed strikingly different patterns of molecules involved in inflammation and in cross-talk with NK or T cells. XCR1(+) CD34-DC but not MoDC efficiently cross-presented a cell-associated Ag upon stimulation by polyinosinic-polycytidylic acid or R848, likewise to what was reported for XCR1(+) bDC. Hence, it is feasible to generate high numbers of bona fide XCR1(+) human DC in vitro as a model to decipher the functions of XCR1(+) bDC and as a potential source of XCR1(+) DC for clinical use. Abstract from Journal of Immunology. 2014 Aug 15;193(4):1622-35. doi: 10.4049/jimmunol.1401243."	74	"pDC, CD141- XCR1- DC, CD141+ XCR1- DC, CD1c+, CD1c+ LPS 16h, CD1c+ R848 16h, CD1c+ pIC16hr, MoDC, MoDC +LPS 16h, MoDC +R848 16h, MoDC +pIC 16h, XCR1+, XCR1+ LPS 16h, XCR1+ R848 16h, XCR1+ pIC 16h, XCR1-, XCR1- LPS 16h, XCR1- R848 16h, XCR1- pIC 16h"	Microarray (Affymetrix HuGene-1_0-ST V1 (GPL 6244 and A-AFFY-141))		Homo sapiens	2.66	HuGene	"rgb(0,109,219)"	diamond-open	CD141+ FLT3-L SCF GM-CSF IL5 adult	myeloid	myeloid	adult	dendritic cell	Dendritic Cell
GSM1386492;7003	7003	Balan	GSM1386492	"PIC XCR1+ bDC, replicate 1"	Homo sapiens	XCR1+ pIC 16h	CL:0000451		dendritic cell			Balan	"Human monocyte-derived dendritic cell (MoDC) have been used in the clinic with moderately encouraging results. Mouse XCR1(+) DC excel at cross-presentation, can be targeted in vivo to induce protective immunity, and share characteristics with XCR1(+) human DC. Assessment of the immunoactivation potential of XCR1(+) human DC is hindered by their paucity in vivo and by their lack of a well-defined in vitro counterpart. We report in this study a protocol generating both XCR1(+) and XCR1(-) human DC in CD34(+) progenitor cultures (CD34-DC). Gene expression profiling, phenotypic characterization, and functional studies demonstrated that XCR1(-) CD34-DC are similar to canonical MoDC, whereas XCR1(+) CD34-DC resemble XCR1(+) blood DC (bDC). XCR1(+) DC were strongly activated by polyinosinic-polycytidylic acid but not LPS, and conversely for MoDC. XCR1(+) DC and MoDC expressed strikingly different patterns of molecules involved in inflammation and in cross-talk with NK or T cells. XCR1(+) CD34-DC but not MoDC efficiently cross-presented a cell-associated Ag upon stimulation by polyinosinic-polycytidylic acid or R848, likewise to what was reported for XCR1(+) bDC. Hence, it is feasible to generate high numbers of bona fide XCR1(+) human DC in vitro as a model to decipher the functions of XCR1(+) bDC and as a potential source of XCR1(+) DC for clinical use. Abstract from Journal of Immunology. 2014 Aug 15;193(4):1622-35. doi: 10.4049/jimmunol.1401243."	74	"pDC, CD141- XCR1- DC, CD141+ XCR1- DC, CD1c+, CD1c+ LPS 16h, CD1c+ R848 16h, CD1c+ pIC16hr, MoDC, MoDC +LPS 16h, MoDC +R848 16h, MoDC +pIC 16h, XCR1+, XCR1+ LPS 16h, XCR1+ R848 16h, XCR1+ pIC 16h, XCR1-, XCR1- LPS 16h, XCR1- R848 16h, XCR1- pIC 16h"	Microarray (Affymetrix HuGene-1_0-ST V1 (GPL 6244 and A-AFFY-141))		Homo sapiens	2.66	HuGene	"rgb(0,109,219)"	diamond-open	CD141+ FLT3-L SCF GM-CSF IL4 PolyIC 16hours adult	myeloid	myeloid	adult	dendritic cell	Dendritic Cell
GSM1386493;7003	7003	Balan	GSM1386493	"R848 XCR1+ bDC, replicate 1"	Homo sapiens	XCR1+ R848 16h	CL:0000451		dendritic cell			Balan	"Human monocyte-derived dendritic cell (MoDC) have been used in the clinic with moderately encouraging results. Mouse XCR1(+) DC excel at cross-presentation, can be targeted in vivo to induce protective immunity, and share characteristics with XCR1(+) human DC. Assessment of the immunoactivation potential of XCR1(+) human DC is hindered by their paucity in vivo and by their lack of a well-defined in vitro counterpart. We report in this study a protocol generating both XCR1(+) and XCR1(-) human DC in CD34(+) progenitor cultures (CD34-DC). Gene expression profiling, phenotypic characterization, and functional studies demonstrated that XCR1(-) CD34-DC are similar to canonical MoDC, whereas XCR1(+) CD34-DC resemble XCR1(+) blood DC (bDC). XCR1(+) DC were strongly activated by polyinosinic-polycytidylic acid but not LPS, and conversely for MoDC. XCR1(+) DC and MoDC expressed strikingly different patterns of molecules involved in inflammation and in cross-talk with NK or T cells. XCR1(+) CD34-DC but not MoDC efficiently cross-presented a cell-associated Ag upon stimulation by polyinosinic-polycytidylic acid or R848, likewise to what was reported for XCR1(+) bDC. Hence, it is feasible to generate high numbers of bona fide XCR1(+) human DC in vitro as a model to decipher the functions of XCR1(+) bDC and as a potential source of XCR1(+) DC for clinical use. Abstract from Journal of Immunology. 2014 Aug 15;193(4):1622-35. doi: 10.4049/jimmunol.1401243."	74	"pDC, CD141- XCR1- DC, CD141+ XCR1- DC, CD1c+, CD1c+ LPS 16h, CD1c+ R848 16h, CD1c+ pIC16hr, MoDC, MoDC +LPS 16h, MoDC +R848 16h, MoDC +pIC 16h, XCR1+, XCR1+ LPS 16h, XCR1+ R848 16h, XCR1+ pIC 16h, XCR1-, XCR1- LPS 16h, XCR1- R848 16h, XCR1- pIC 16h"	Microarray (Affymetrix HuGene-1_0-ST V1 (GPL 6244 and A-AFFY-141))		Homo sapiens	2.66	HuGene	"rgb(0,109,219)"	diamond-open	CD141+ FLT3-L SCF GM-CSF IL4 R848 16hours adult	myeloid	myeloid	adult	dendritic cell	Dendritic Cell
GSM1386494;7003	7003	Balan	GSM1386494	"LPS XCR1+ bDC, replicate 1"	Homo sapiens	XCR1+ LPS 16h	CL:0000451		dendritic cell			Balan	"Human monocyte-derived dendritic cell (MoDC) have been used in the clinic with moderately encouraging results. Mouse XCR1(+) DC excel at cross-presentation, can be targeted in vivo to induce protective immunity, and share characteristics with XCR1(+) human DC. Assessment of the immunoactivation potential of XCR1(+) human DC is hindered by their paucity in vivo and by their lack of a well-defined in vitro counterpart. We report in this study a protocol generating both XCR1(+) and XCR1(-) human DC in CD34(+) progenitor cultures (CD34-DC). Gene expression profiling, phenotypic characterization, and functional studies demonstrated that XCR1(-) CD34-DC are similar to canonical MoDC, whereas XCR1(+) CD34-DC resemble XCR1(+) blood DC (bDC). XCR1(+) DC were strongly activated by polyinosinic-polycytidylic acid but not LPS, and conversely for MoDC. XCR1(+) DC and MoDC expressed strikingly different patterns of molecules involved in inflammation and in cross-talk with NK or T cells. XCR1(+) CD34-DC but not MoDC efficiently cross-presented a cell-associated Ag upon stimulation by polyinosinic-polycytidylic acid or R848, likewise to what was reported for XCR1(+) bDC. Hence, it is feasible to generate high numbers of bona fide XCR1(+) human DC in vitro as a model to decipher the functions of XCR1(+) bDC and as a potential source of XCR1(+) DC for clinical use. Abstract from Journal of Immunology. 2014 Aug 15;193(4):1622-35. doi: 10.4049/jimmunol.1401243."	74	"pDC, CD141- XCR1- DC, CD141+ XCR1- DC, CD1c+, CD1c+ LPS 16h, CD1c+ R848 16h, CD1c+ pIC16hr, MoDC, MoDC +LPS 16h, MoDC +R848 16h, MoDC +pIC 16h, XCR1+, XCR1+ LPS 16h, XCR1+ R848 16h, XCR1+ pIC 16h, XCR1-, XCR1- LPS 16h, XCR1- R848 16h, XCR1- pIC 16h"	Microarray (Affymetrix HuGene-1_0-ST V1 (GPL 6244 and A-AFFY-141))		Homo sapiens	2.66	HuGene	"rgb(0,109,219)"	diamond-open	CD141+ FLT3-L SCF GM-CSF IL4 LPS 16hours adult	myeloid	myeloid	adult	dendritic cell	Dendritic Cell
GSM1386495;7003	7003	Balan	GSM1386495	"UN CD1c+ bDC, replicate 2"	Homo sapiens	CD1c+	CL:0002399		CD1c+ dendritic cell			Balan	"Human monocyte-derived dendritic cell (MoDC) have been used in the clinic with moderately encouraging results. Mouse XCR1(+) DC excel at cross-presentation, can be targeted in vivo to induce protective immunity, and share characteristics with XCR1(+) human DC. Assessment of the immunoactivation potential of XCR1(+) human DC is hindered by their paucity in vivo and by their lack of a well-defined in vitro counterpart. We report in this study a protocol generating both XCR1(+) and XCR1(-) human DC in CD34(+) progenitor cultures (CD34-DC). Gene expression profiling, phenotypic characterization, and functional studies demonstrated that XCR1(-) CD34-DC are similar to canonical MoDC, whereas XCR1(+) CD34-DC resemble XCR1(+) blood DC (bDC). XCR1(+) DC were strongly activated by polyinosinic-polycytidylic acid but not LPS, and conversely for MoDC. XCR1(+) DC and MoDC expressed strikingly different patterns of molecules involved in inflammation and in cross-talk with NK or T cells. XCR1(+) CD34-DC but not MoDC efficiently cross-presented a cell-associated Ag upon stimulation by polyinosinic-polycytidylic acid or R848, likewise to what was reported for XCR1(+) bDC. Hence, it is feasible to generate high numbers of bona fide XCR1(+) human DC in vitro as a model to decipher the functions of XCR1(+) bDC and as a potential source of XCR1(+) DC for clinical use. Abstract from Journal of Immunology. 2014 Aug 15;193(4):1622-35. doi: 10.4049/jimmunol.1401243."	74	"pDC, CD141- XCR1- DC, CD141+ XCR1- DC, CD1c+, CD1c+ LPS 16h, CD1c+ R848 16h, CD1c+ pIC16hr, MoDC, MoDC +LPS 16h, MoDC +R848 16h, MoDC +pIC 16h, XCR1+, XCR1+ LPS 16h, XCR1+ R848 16h, XCR1+ pIC 16h, XCR1-, XCR1- LPS 16h, XCR1- R848 16h, XCR1- pIC 16h"	Microarray (Affymetrix HuGene-1_0-ST V1 (GPL 6244 and A-AFFY-141))		Homo sapiens	2.66	HuGene	"rgb(0,109,219)"	diamond-open	SC-DC CD1c+ FLT3-L SCF GM-CSF IL4 adult	myeloid	myeloid	adult	CD1c+ dendritic cell	Dendritic Cell
GSM1386496;7003	7003	Balan	GSM1386496	"PIC CD1c+ bDC, replicate 2"	Homo sapiens	CD1c+ pIC16hr	CL:0002399		CD1c+ dendritic cell			Balan	"Human monocyte-derived dendritic cell (MoDC) have been used in the clinic with moderately encouraging results. Mouse XCR1(+) DC excel at cross-presentation, can be targeted in vivo to induce protective immunity, and share characteristics with XCR1(+) human DC. Assessment of the immunoactivation potential of XCR1(+) human DC is hindered by their paucity in vivo and by their lack of a well-defined in vitro counterpart. We report in this study a protocol generating both XCR1(+) and XCR1(-) human DC in CD34(+) progenitor cultures (CD34-DC). Gene expression profiling, phenotypic characterization, and functional studies demonstrated that XCR1(-) CD34-DC are similar to canonical MoDC, whereas XCR1(+) CD34-DC resemble XCR1(+) blood DC (bDC). XCR1(+) DC were strongly activated by polyinosinic-polycytidylic acid but not LPS, and conversely for MoDC. XCR1(+) DC and MoDC expressed strikingly different patterns of molecules involved in inflammation and in cross-talk with NK or T cells. XCR1(+) CD34-DC but not MoDC efficiently cross-presented a cell-associated Ag upon stimulation by polyinosinic-polycytidylic acid or R848, likewise to what was reported for XCR1(+) bDC. Hence, it is feasible to generate high numbers of bona fide XCR1(+) human DC in vitro as a model to decipher the functions of XCR1(+) bDC and as a potential source of XCR1(+) DC for clinical use. Abstract from Journal of Immunology. 2014 Aug 15;193(4):1622-35. doi: 10.4049/jimmunol.1401243."	74	"pDC, CD141- XCR1- DC, CD141+ XCR1- DC, CD1c+, CD1c+ LPS 16h, CD1c+ R848 16h, CD1c+ pIC16hr, MoDC, MoDC +LPS 16h, MoDC +R848 16h, MoDC +pIC 16h, XCR1+, XCR1+ LPS 16h, XCR1+ R848 16h, XCR1+ pIC 16h, XCR1-, XCR1- LPS 16h, XCR1- R848 16h, XCR1- pIC 16h"	Microarray (Affymetrix HuGene-1_0-ST V1 (GPL 6244 and A-AFFY-141))		Homo sapiens	2.66	HuGene	"rgb(0,109,219)"	diamond-open	CD1c+  FLT3-L SCF GM-CSF IL4 PolyIC 16hours adult	myeloid	myeloid	adult	CD1c+ dendritic cell	Dendritic Cell
GSM1386497;7003	7003	Balan	GSM1386497	"R848 CD1c+ bDC, replicate 2"	Homo sapiens	CD1c+ R848 16h	CL:0002399		CD1c+ dendritic cell			Balan	"Human monocyte-derived dendritic cell (MoDC) have been used in the clinic with moderately encouraging results. Mouse XCR1(+) DC excel at cross-presentation, can be targeted in vivo to induce protective immunity, and share characteristics with XCR1(+) human DC. Assessment of the immunoactivation potential of XCR1(+) human DC is hindered by their paucity in vivo and by their lack of a well-defined in vitro counterpart. We report in this study a protocol generating both XCR1(+) and XCR1(-) human DC in CD34(+) progenitor cultures (CD34-DC). Gene expression profiling, phenotypic characterization, and functional studies demonstrated that XCR1(-) CD34-DC are similar to canonical MoDC, whereas XCR1(+) CD34-DC resemble XCR1(+) blood DC (bDC). XCR1(+) DC were strongly activated by polyinosinic-polycytidylic acid but not LPS, and conversely for MoDC. XCR1(+) DC and MoDC expressed strikingly different patterns of molecules involved in inflammation and in cross-talk with NK or T cells. XCR1(+) CD34-DC but not MoDC efficiently cross-presented a cell-associated Ag upon stimulation by polyinosinic-polycytidylic acid or R848, likewise to what was reported for XCR1(+) bDC. Hence, it is feasible to generate high numbers of bona fide XCR1(+) human DC in vitro as a model to decipher the functions of XCR1(+) bDC and as a potential source of XCR1(+) DC for clinical use. Abstract from Journal of Immunology. 2014 Aug 15;193(4):1622-35. doi: 10.4049/jimmunol.1401243."	74	"pDC, CD141- XCR1- DC, CD141+ XCR1- DC, CD1c+, CD1c+ LPS 16h, CD1c+ R848 16h, CD1c+ pIC16hr, MoDC, MoDC +LPS 16h, MoDC +R848 16h, MoDC +pIC 16h, XCR1+, XCR1+ LPS 16h, XCR1+ R848 16h, XCR1+ pIC 16h, XCR1-, XCR1- LPS 16h, XCR1- R848 16h, XCR1- pIC 16h"	Microarray (Affymetrix HuGene-1_0-ST V1 (GPL 6244 and A-AFFY-141))		Homo sapiens	2.66	HuGene	"rgb(0,109,219)"	diamond-open	CD1c+  FLT3-L SCF GM-CSF IL4 R848 16hours adult	myeloid	myeloid	adult	CD1c+ dendritic cell	Dendritic Cell
GSM1386498;7003	7003	Balan	GSM1386498	CD1c+ bDC + LPS 1g/mL 16hrs replicate 2	Homo sapiens	CD1c+ LPS 16h	CL:0002399		CD1c+ dendritic cell			Balan	"Human monocyte-derived dendritic cell (MoDC) have been used in the clinic with moderately encouraging results. Mouse XCR1(+) DC excel at cross-presentation, can be targeted in vivo to induce protective immunity, and share characteristics with XCR1(+) human DC. Assessment of the immunoactivation potential of XCR1(+) human DC is hindered by their paucity in vivo and by their lack of a well-defined in vitro counterpart. We report in this study a protocol generating both XCR1(+) and XCR1(-) human DC in CD34(+) progenitor cultures (CD34-DC). Gene expression profiling, phenotypic characterization, and functional studies demonstrated that XCR1(-) CD34-DC are similar to canonical MoDC, whereas XCR1(+) CD34-DC resemble XCR1(+) blood DC (bDC). XCR1(+) DC were strongly activated by polyinosinic-polycytidylic acid but not LPS, and conversely for MoDC. XCR1(+) DC and MoDC expressed strikingly different patterns of molecules involved in inflammation and in cross-talk with NK or T cells. XCR1(+) CD34-DC but not MoDC efficiently cross-presented a cell-associated Ag upon stimulation by polyinosinic-polycytidylic acid or R848, likewise to what was reported for XCR1(+) bDC. Hence, it is feasible to generate high numbers of bona fide XCR1(+) human DC in vitro as a model to decipher the functions of XCR1(+) bDC and as a potential source of XCR1(+) DC for clinical use. Abstract from Journal of Immunology. 2014 Aug 15;193(4):1622-35. doi: 10.4049/jimmunol.1401243."	74	"pDC, CD141- XCR1- DC, CD141+ XCR1- DC, CD1c+, CD1c+ LPS 16h, CD1c+ R848 16h, CD1c+ pIC16hr, MoDC, MoDC +LPS 16h, MoDC +R848 16h, MoDC +pIC 16h, XCR1+, XCR1+ LPS 16h, XCR1+ R848 16h, XCR1+ pIC 16h, XCR1-, XCR1- LPS 16h, XCR1- R848 16h, XCR1- pIC 16h"	Microarray (Affymetrix HuGene-1_0-ST V1 (GPL 6244 and A-AFFY-141))		Homo sapiens	2.66	HuGene	"rgb(0,109,219)"	diamond-open	SC-DC CD1c+ FLT3-L SCF GM-CSF IL4 LPS adult	myeloid	myeloid	adult	CD1c+ dendritic cell	Dendritic Cell
GSM1386499;7003	7003	Balan	GSM1386499	"UN XCR1+ bDC, replicate 2"	Homo sapiens	XCR1+	CL:0000451		dendritic cell			Balan	"Human monocyte-derived dendritic cell (MoDC) have been used in the clinic with moderately encouraging results. Mouse XCR1(+) DC excel at cross-presentation, can be targeted in vivo to induce protective immunity, and share characteristics with XCR1(+) human DC. Assessment of the immunoactivation potential of XCR1(+) human DC is hindered by their paucity in vivo and by their lack of a well-defined in vitro counterpart. We report in this study a protocol generating both XCR1(+) and XCR1(-) human DC in CD34(+) progenitor cultures (CD34-DC). Gene expression profiling, phenotypic characterization, and functional studies demonstrated that XCR1(-) CD34-DC are similar to canonical MoDC, whereas XCR1(+) CD34-DC resemble XCR1(+) blood DC (bDC). XCR1(+) DC were strongly activated by polyinosinic-polycytidylic acid but not LPS, and conversely for MoDC. XCR1(+) DC and MoDC expressed strikingly different patterns of molecules involved in inflammation and in cross-talk with NK or T cells. XCR1(+) CD34-DC but not MoDC efficiently cross-presented a cell-associated Ag upon stimulation by polyinosinic-polycytidylic acid or R848, likewise to what was reported for XCR1(+) bDC. Hence, it is feasible to generate high numbers of bona fide XCR1(+) human DC in vitro as a model to decipher the functions of XCR1(+) bDC and as a potential source of XCR1(+) DC for clinical use. Abstract from Journal of Immunology. 2014 Aug 15;193(4):1622-35. doi: 10.4049/jimmunol.1401243."	74	"pDC, CD141- XCR1- DC, CD141+ XCR1- DC, CD1c+, CD1c+ LPS 16h, CD1c+ R848 16h, CD1c+ pIC16hr, MoDC, MoDC +LPS 16h, MoDC +R848 16h, MoDC +pIC 16h, XCR1+, XCR1+ LPS 16h, XCR1+ R848 16h, XCR1+ pIC 16h, XCR1-, XCR1- LPS 16h, XCR1- R848 16h, XCR1- pIC 16h"	Microarray (Affymetrix HuGene-1_0-ST V1 (GPL 6244 and A-AFFY-141))		Homo sapiens	2.66	HuGene	"rgb(0,109,219)"	diamond-open	CD141+ FLT3-L SCF GM-CSF IL5 adult	myeloid	myeloid	adult	dendritic cell	Dendritic Cell
GSM1386500;7003	7003	Balan	GSM1386500	"PIC XCR1+ bDC, replicate 2"	Homo sapiens	XCR1+ pIC 16h	CL:0000451		dendritic cell			Balan	"Human monocyte-derived dendritic cell (MoDC) have been used in the clinic with moderately encouraging results. Mouse XCR1(+) DC excel at cross-presentation, can be targeted in vivo to induce protective immunity, and share characteristics with XCR1(+) human DC. Assessment of the immunoactivation potential of XCR1(+) human DC is hindered by their paucity in vivo and by their lack of a well-defined in vitro counterpart. We report in this study a protocol generating both XCR1(+) and XCR1(-) human DC in CD34(+) progenitor cultures (CD34-DC). Gene expression profiling, phenotypic characterization, and functional studies demonstrated that XCR1(-) CD34-DC are similar to canonical MoDC, whereas XCR1(+) CD34-DC resemble XCR1(+) blood DC (bDC). XCR1(+) DC were strongly activated by polyinosinic-polycytidylic acid but not LPS, and conversely for MoDC. XCR1(+) DC and MoDC expressed strikingly different patterns of molecules involved in inflammation and in cross-talk with NK or T cells. XCR1(+) CD34-DC but not MoDC efficiently cross-presented a cell-associated Ag upon stimulation by polyinosinic-polycytidylic acid or R848, likewise to what was reported for XCR1(+) bDC. Hence, it is feasible to generate high numbers of bona fide XCR1(+) human DC in vitro as a model to decipher the functions of XCR1(+) bDC and as a potential source of XCR1(+) DC for clinical use. Abstract from Journal of Immunology. 2014 Aug 15;193(4):1622-35. doi: 10.4049/jimmunol.1401243."	74	"pDC, CD141- XCR1- DC, CD141+ XCR1- DC, CD1c+, CD1c+ LPS 16h, CD1c+ R848 16h, CD1c+ pIC16hr, MoDC, MoDC +LPS 16h, MoDC +R848 16h, MoDC +pIC 16h, XCR1+, XCR1+ LPS 16h, XCR1+ R848 16h, XCR1+ pIC 16h, XCR1-, XCR1- LPS 16h, XCR1- R848 16h, XCR1- pIC 16h"	Microarray (Affymetrix HuGene-1_0-ST V1 (GPL 6244 and A-AFFY-141))		Homo sapiens	2.66	HuGene	"rgb(0,109,219)"	diamond-open	CD141+ FLT3-L SCF GM-CSF IL4 PolyIC 16hours adult	myeloid	myeloid	adult	dendritic cell	Dendritic Cell
GSM1386501;7003	7003	Balan	GSM1386501	"R848 XCR1+ bDC, replicate 2"	Homo sapiens	XCR1+ R848 16h	CL:0000451		dendritic cell			Balan	"Human monocyte-derived dendritic cell (MoDC) have been used in the clinic with moderately encouraging results. Mouse XCR1(+) DC excel at cross-presentation, can be targeted in vivo to induce protective immunity, and share characteristics with XCR1(+) human DC. Assessment of the immunoactivation potential of XCR1(+) human DC is hindered by their paucity in vivo and by their lack of a well-defined in vitro counterpart. We report in this study a protocol generating both XCR1(+) and XCR1(-) human DC in CD34(+) progenitor cultures (CD34-DC). Gene expression profiling, phenotypic characterization, and functional studies demonstrated that XCR1(-) CD34-DC are similar to canonical MoDC, whereas XCR1(+) CD34-DC resemble XCR1(+) blood DC (bDC). XCR1(+) DC were strongly activated by polyinosinic-polycytidylic acid but not LPS, and conversely for MoDC. XCR1(+) DC and MoDC expressed strikingly different patterns of molecules involved in inflammation and in cross-talk with NK or T cells. XCR1(+) CD34-DC but not MoDC efficiently cross-presented a cell-associated Ag upon stimulation by polyinosinic-polycytidylic acid or R848, likewise to what was reported for XCR1(+) bDC. Hence, it is feasible to generate high numbers of bona fide XCR1(+) human DC in vitro as a model to decipher the functions of XCR1(+) bDC and as a potential source of XCR1(+) DC for clinical use. Abstract from Journal of Immunology. 2014 Aug 15;193(4):1622-35. doi: 10.4049/jimmunol.1401243."	74	"pDC, CD141- XCR1- DC, CD141+ XCR1- DC, CD1c+, CD1c+ LPS 16h, CD1c+ R848 16h, CD1c+ pIC16hr, MoDC, MoDC +LPS 16h, MoDC +R848 16h, MoDC +pIC 16h, XCR1+, XCR1+ LPS 16h, XCR1+ R848 16h, XCR1+ pIC 16h, XCR1-, XCR1- LPS 16h, XCR1- R848 16h, XCR1- pIC 16h"	Microarray (Affymetrix HuGene-1_0-ST V1 (GPL 6244 and A-AFFY-141))		Homo sapiens	2.66	HuGene	"rgb(0,109,219)"	diamond-open	CD141+ FLT3-L SCF GM-CSF IL4 R848 16hours adult	myeloid	myeloid	adult	dendritic cell	Dendritic Cell
GSM1386502;7003	7003	Balan	GSM1386502	"LPS XCR1+ bDC, replicate 2"	Homo sapiens	XCR1+ LPS 16h	CL:0000451		dendritic cell			Balan	"Human monocyte-derived dendritic cell (MoDC) have been used in the clinic with moderately encouraging results. Mouse XCR1(+) DC excel at cross-presentation, can be targeted in vivo to induce protective immunity, and share characteristics with XCR1(+) human DC. Assessment of the immunoactivation potential of XCR1(+) human DC is hindered by their paucity in vivo and by their lack of a well-defined in vitro counterpart. We report in this study a protocol generating both XCR1(+) and XCR1(-) human DC in CD34(+) progenitor cultures (CD34-DC). Gene expression profiling, phenotypic characterization, and functional studies demonstrated that XCR1(-) CD34-DC are similar to canonical MoDC, whereas XCR1(+) CD34-DC resemble XCR1(+) blood DC (bDC). XCR1(+) DC were strongly activated by polyinosinic-polycytidylic acid but not LPS, and conversely for MoDC. XCR1(+) DC and MoDC expressed strikingly different patterns of molecules involved in inflammation and in cross-talk with NK or T cells. XCR1(+) CD34-DC but not MoDC efficiently cross-presented a cell-associated Ag upon stimulation by polyinosinic-polycytidylic acid or R848, likewise to what was reported for XCR1(+) bDC. Hence, it is feasible to generate high numbers of bona fide XCR1(+) human DC in vitro as a model to decipher the functions of XCR1(+) bDC and as a potential source of XCR1(+) DC for clinical use. Abstract from Journal of Immunology. 2014 Aug 15;193(4):1622-35. doi: 10.4049/jimmunol.1401243."	74	"pDC, CD141- XCR1- DC, CD141+ XCR1- DC, CD1c+, CD1c+ LPS 16h, CD1c+ R848 16h, CD1c+ pIC16hr, MoDC, MoDC +LPS 16h, MoDC +R848 16h, MoDC +pIC 16h, XCR1+, XCR1+ LPS 16h, XCR1+ R848 16h, XCR1+ pIC 16h, XCR1-, XCR1- LPS 16h, XCR1- R848 16h, XCR1- pIC 16h"	Microarray (Affymetrix HuGene-1_0-ST V1 (GPL 6244 and A-AFFY-141))		Homo sapiens	2.66	HuGene	"rgb(0,109,219)"	diamond-open	c-DC CD141+  adult	myeloid	myeloid	adult	dendritic cell	Dendritic Cell
GSM1386503;7003	7003	Balan	GSM1386503	"UN bpDC, replicate 1"	Homo sapiens	pDC	myeloid		plasmacytoid dendritic cell			Balan	"Human monocyte-derived dendritic cell (MoDC) have been used in the clinic with moderately encouraging results. Mouse XCR1(+) DC excel at cross-presentation, can be targeted in vivo to induce protective immunity, and share characteristics with XCR1(+) human DC. Assessment of the immunoactivation potential of XCR1(+) human DC is hindered by their paucity in vivo and by their lack of a well-defined in vitro counterpart. We report in this study a protocol generating both XCR1(+) and XCR1(-) human DC in CD34(+) progenitor cultures (CD34-DC). Gene expression profiling, phenotypic characterization, and functional studies demonstrated that XCR1(-) CD34-DC are similar to canonical MoDC, whereas XCR1(+) CD34-DC resemble XCR1(+) blood DC (bDC). XCR1(+) DC were strongly activated by polyinosinic-polycytidylic acid but not LPS, and conversely for MoDC. XCR1(+) DC and MoDC expressed strikingly different patterns of molecules involved in inflammation and in cross-talk with NK or T cells. XCR1(+) CD34-DC but not MoDC efficiently cross-presented a cell-associated Ag upon stimulation by polyinosinic-polycytidylic acid or R848, likewise to what was reported for XCR1(+) bDC. Hence, it is feasible to generate high numbers of bona fide XCR1(+) human DC in vitro as a model to decipher the functions of XCR1(+) bDC and as a potential source of XCR1(+) DC for clinical use. Abstract from Journal of Immunology. 2014 Aug 15;193(4):1622-35. doi: 10.4049/jimmunol.1401243."	74	"pDC, CD141- XCR1- DC, CD141+ XCR1- DC, CD1c+, CD1c+ LPS 16h, CD1c+ R848 16h, CD1c+ pIC16hr, MoDC, MoDC +LPS 16h, MoDC +R848 16h, MoDC +pIC 16h, XCR1+, XCR1+ LPS 16h, XCR1+ R848 16h, XCR1+ pIC 16h, XCR1-, XCR1- LPS 16h, XCR1- R848 16h, XCR1- pIC 16h"	Microarray (Affymetrix HuGene-1_0-ST V1 (GPL 6244 and A-AFFY-141))		Homo sapiens	2.66	HuGene	"rgb(0,109,219)"	diamond-open	CD141+ FLT3-L SCF GM-CSF IL4 adult	myeloid	myeloid	adult	plasmacytoid dendritic cell	Dendritic Cell
GSM1480261;6787	6787	Renoux	GSM1480261	Lin-CD34+CD38-CD90-CD45RA+ LMPP from Cord blood batch1	Homo sapiens	LMPP	CL:0000837		hematopoietic multipotent progenitor			Renoux	"Natural killer (NK) cells are cytotoxic lymphocytes and play a vital role in controlling viral infections and cancer. In contrast to B and T lymphopoiesis where cellular and regulatory pathways have been extensively characterized, the cellular stages of early human NK cell commitment remain poorly understood. Here we demonstrate that a Lin(-)CD34(+)CD38(+)CD123(-)CD45RA(+)CD7(+)CD10(+)CD127(-) population represents a NK lineage-restricted progenitor (NKP) in fetal development, umbilical cord blood, and adult tissues. The newly identified NKP has robust NK cell potential both in vitro and in vivo, generates functionally cytotoxic NK cells, and lacks the ability to produce T cells, B cells, myeloid cells, and innate lymphoid-like cells (ILCs). Our findings identify an early step to human NK cell commitment and provide new insights into the human hematopoietic hierarchy. Abstract from Immunity. 2015 Aug 18;43(2):394-407."	15	"LMPP, CLP, NKP, NK"	Microarray (Affymetrix HuGene-1_0-ST V1 (GPL 6244 and A-AFFY-141))		Homo sapiens	2.28	HuGene	"rgb(0,109,219)"	diamond-open	LP Lin-CD34+CD38-CD90-CD45RA+  neonatal	lymphoid progenitor	LP	neonatal	early T lineage precursor	Progenitor
GSM1480262;6787	6787	Renoux	GSM1480262	Lin-CD34+CD38-CD90-CD45RA+ LMPP from Cord blood batch2	Homo sapiens	LMPP	CL:0000837		hematopoietic multipotent progenitor			Renoux	"Natural killer (NK) cells are cytotoxic lymphocytes and play a vital role in controlling viral infections and cancer. In contrast to B and T lymphopoiesis where cellular and regulatory pathways have been extensively characterized, the cellular stages of early human NK cell commitment remain poorly understood. Here we demonstrate that a Lin(-)CD34(+)CD38(+)CD123(-)CD45RA(+)CD7(+)CD10(+)CD127(-) population represents a NK lineage-restricted progenitor (NKP) in fetal development, umbilical cord blood, and adult tissues. The newly identified NKP has robust NK cell potential both in vitro and in vivo, generates functionally cytotoxic NK cells, and lacks the ability to produce T cells, B cells, myeloid cells, and innate lymphoid-like cells (ILCs). Our findings identify an early step to human NK cell commitment and provide new insights into the human hematopoietic hierarchy. Abstract from Immunity. 2015 Aug 18;43(2):394-407."	15	"LMPP, CLP, NKP, NK"	Microarray (Affymetrix HuGene-1_0-ST V1 (GPL 6244 and A-AFFY-141))		Homo sapiens	2.28	HuGene	"rgb(0,109,219)"	diamond-open	LP Lin-CD34+CD38-CD90-CD45RA+  neonatal	lymphoid progenitor	LP	neonatal	early T lineage precursor	Progenitor
GSM1480263;6787	6787	Renoux	GSM1480263	Lin-CD34+CD38-CD90-CD45RA+ LMPP from Cord blood batch3	Homo sapiens	LMPP	CL:0000837		hematopoietic multipotent progenitor			Renoux	"Natural killer (NK) cells are cytotoxic lymphocytes and play a vital role in controlling viral infections and cancer. In contrast to B and T lymphopoiesis where cellular and regulatory pathways have been extensively characterized, the cellular stages of early human NK cell commitment remain poorly understood. Here we demonstrate that a Lin(-)CD34(+)CD38(+)CD123(-)CD45RA(+)CD7(+)CD10(+)CD127(-) population represents a NK lineage-restricted progenitor (NKP) in fetal development, umbilical cord blood, and adult tissues. The newly identified NKP has robust NK cell potential both in vitro and in vivo, generates functionally cytotoxic NK cells, and lacks the ability to produce T cells, B cells, myeloid cells, and innate lymphoid-like cells (ILCs). Our findings identify an early step to human NK cell commitment and provide new insights into the human hematopoietic hierarchy. Abstract from Immunity. 2015 Aug 18;43(2):394-407."	15	"LMPP, CLP, NKP, NK"	Microarray (Affymetrix HuGene-1_0-ST V1 (GPL 6244 and A-AFFY-141))		Homo sapiens	2.28	HuGene	"rgb(0,109,219)"	diamond-open	LP Lin-CD34+CD38-CD90-CD45RA+  neonatal	lymphoid progenitor	LP	neonatal	early T lineage precursor	Progenitor
GSM1480264;6787	6787	Renoux	GSM1480264	Lin-CD34+CD38-CD90-CD45RA+ LMPP from Cord blood batch4	Homo sapiens	LMPP	CL:0000837		hematopoietic multipotent progenitor			Renoux	"Natural killer (NK) cells are cytotoxic lymphocytes and play a vital role in controlling viral infections and cancer. In contrast to B and T lymphopoiesis where cellular and regulatory pathways have been extensively characterized, the cellular stages of early human NK cell commitment remain poorly understood. Here we demonstrate that a Lin(-)CD34(+)CD38(+)CD123(-)CD45RA(+)CD7(+)CD10(+)CD127(-) population represents a NK lineage-restricted progenitor (NKP) in fetal development, umbilical cord blood, and adult tissues. The newly identified NKP has robust NK cell potential both in vitro and in vivo, generates functionally cytotoxic NK cells, and lacks the ability to produce T cells, B cells, myeloid cells, and innate lymphoid-like cells (ILCs). Our findings identify an early step to human NK cell commitment and provide new insights into the human hematopoietic hierarchy. Abstract from Immunity. 2015 Aug 18;43(2):394-407."	15	"LMPP, CLP, NKP, NK"	Microarray (Affymetrix HuGene-1_0-ST V1 (GPL 6244 and A-AFFY-141))		Homo sapiens	2.28	HuGene	"rgb(0,109,219)"	diamond-open	LP Lin-CD34+CD38-CD90-CD45RA+  neonatal	lymphoid progenitor	LP	neonatal	early T lineage precursor	Progenitor
GSM1480265;6787	6787	Renoux	GSM1480265	Lin-CD34+CD38+CD123-CD45RA+CD7+CD10+CD127- NKP from Cord blood batch1	Homo sapiens	NKP	stem progenitor cell		natural killer progenitor			Renoux	"Natural killer (NK) cells are cytotoxic lymphocytes and play a vital role in controlling viral infections and cancer. In contrast to B and T lymphopoiesis where cellular and regulatory pathways have been extensively characterized, the cellular stages of early human NK cell commitment remain poorly understood. Here we demonstrate that a Lin(-)CD34(+)CD38(+)CD123(-)CD45RA(+)CD7(+)CD10(+)CD127(-) population represents a NK lineage-restricted progenitor (NKP) in fetal development, umbilical cord blood, and adult tissues. The newly identified NKP has robust NK cell potential both in vitro and in vivo, generates functionally cytotoxic NK cells, and lacks the ability to produce T cells, B cells, myeloid cells, and innate lymphoid-like cells (ILCs). Our findings identify an early step to human NK cell commitment and provide new insights into the human hematopoietic hierarchy. Abstract from Immunity. 2015 Aug 18;43(2):394-407."	15	"LMPP, CLP, NKP, NK"	Microarray (Affymetrix HuGene-1_0-ST V1 (GPL 6244 and A-AFFY-141))		Homo sapiens	2.28	HuGene	"rgb(0,109,219)"	diamond-open	NKP Lin-CD34+CD38+CD123-CD45RA+CD7+CD10+CD127-  neonatal	lymphoid progenitor	NKP	neonatal	natural killer progenitor	Lymphocyte
GSM1480266;6787	6787	Renoux	GSM1480266	Lin-CD34+CD38+CD123-CD45RA+CD7+CD10+CD127- NKP from Cord blood batch2	Homo sapiens	NKP	stem progenitor cell		natural killer progenitor			Renoux	"Natural killer (NK) cells are cytotoxic lymphocytes and play a vital role in controlling viral infections and cancer. In contrast to B and T lymphopoiesis where cellular and regulatory pathways have been extensively characterized, the cellular stages of early human NK cell commitment remain poorly understood. Here we demonstrate that a Lin(-)CD34(+)CD38(+)CD123(-)CD45RA(+)CD7(+)CD10(+)CD127(-) population represents a NK lineage-restricted progenitor (NKP) in fetal development, umbilical cord blood, and adult tissues. The newly identified NKP has robust NK cell potential both in vitro and in vivo, generates functionally cytotoxic NK cells, and lacks the ability to produce T cells, B cells, myeloid cells, and innate lymphoid-like cells (ILCs). Our findings identify an early step to human NK cell commitment and provide new insights into the human hematopoietic hierarchy. Abstract from Immunity. 2015 Aug 18;43(2):394-407."	15	"LMPP, CLP, NKP, NK"	Microarray (Affymetrix HuGene-1_0-ST V1 (GPL 6244 and A-AFFY-141))		Homo sapiens	2.28	HuGene	"rgb(0,109,219)"	diamond-open	NKP Lin-CD34+CD38+CD123-CD45RA+CD7+CD10+CD127-  neonatal	lymphoid progenitor	NKP	neonatal	natural killer progenitor	Lymphocyte
GSM1480267;6787	6787	Renoux	GSM1480267	Lin-CD34+CD38+CD123-CD45RA+CD7+CD10+CD127- NKP from Cord blood batch3	Homo sapiens	NKP	stem progenitor cell		natural killer progenitor			Renoux	"Natural killer (NK) cells are cytotoxic lymphocytes and play a vital role in controlling viral infections and cancer. In contrast to B and T lymphopoiesis where cellular and regulatory pathways have been extensively characterized, the cellular stages of early human NK cell commitment remain poorly understood. Here we demonstrate that a Lin(-)CD34(+)CD38(+)CD123(-)CD45RA(+)CD7(+)CD10(+)CD127(-) population represents a NK lineage-restricted progenitor (NKP) in fetal development, umbilical cord blood, and adult tissues. The newly identified NKP has robust NK cell potential both in vitro and in vivo, generates functionally cytotoxic NK cells, and lacks the ability to produce T cells, B cells, myeloid cells, and innate lymphoid-like cells (ILCs). Our findings identify an early step to human NK cell commitment and provide new insights into the human hematopoietic hierarchy. Abstract from Immunity. 2015 Aug 18;43(2):394-407."	15	"LMPP, CLP, NKP, NK"	Microarray (Affymetrix HuGene-1_0-ST V1 (GPL 6244 and A-AFFY-141))		Homo sapiens	2.28	HuGene	"rgb(0,109,219)"	diamond-open	NKP Lin-CD34+CD38+CD123-CD45RA+CD7+CD10+CD127-  neonatal	lymphoid progenitor	NKP	neonatal	natural killer progenitor	Lymphocyte
GSM1480268;6787	6787	Renoux	GSM1480268	Lin-CD34+CD38+CD123-CD45RA+CD7+CD10+CD127- NKP from Cord blood batch4	Homo sapiens	NKP	stem progenitor cell		natural killer progenitor			Renoux	"Natural killer (NK) cells are cytotoxic lymphocytes and play a vital role in controlling viral infections and cancer. In contrast to B and T lymphopoiesis where cellular and regulatory pathways have been extensively characterized, the cellular stages of early human NK cell commitment remain poorly understood. Here we demonstrate that a Lin(-)CD34(+)CD38(+)CD123(-)CD45RA(+)CD7(+)CD10(+)CD127(-) population represents a NK lineage-restricted progenitor (NKP) in fetal development, umbilical cord blood, and adult tissues. The newly identified NKP has robust NK cell potential both in vitro and in vivo, generates functionally cytotoxic NK cells, and lacks the ability to produce T cells, B cells, myeloid cells, and innate lymphoid-like cells (ILCs). Our findings identify an early step to human NK cell commitment and provide new insights into the human hematopoietic hierarchy. Abstract from Immunity. 2015 Aug 18;43(2):394-407."	15	"LMPP, CLP, NKP, NK"	Microarray (Affymetrix HuGene-1_0-ST V1 (GPL 6244 and A-AFFY-141))		Homo sapiens	2.28	HuGene	"rgb(0,109,219)"	diamond-open	NKP Lin-CD34+CD38+CD123-CD45RA+CD7+CD10+CD127-  neonatal	lymphoid	NKP	neonatal	natural killer progenitor	Progenitor
GSM1480269;6787	6787	Renoux	GSM1480269	CD3-CD56+NKp46+ NK from Cord blood batch1	Homo sapiens	NK	CL:0000623		natural killer cell			Renoux	"Natural killer (NK) cells are cytotoxic lymphocytes and play a vital role in controlling viral infections and cancer. In contrast to B and T lymphopoiesis where cellular and regulatory pathways have been extensively characterized, the cellular stages of early human NK cell commitment remain poorly understood. Here we demonstrate that a Lin(-)CD34(+)CD38(+)CD123(-)CD45RA(+)CD7(+)CD10(+)CD127(-) population represents a NK lineage-restricted progenitor (NKP) in fetal development, umbilical cord blood, and adult tissues. The newly identified NKP has robust NK cell potential both in vitro and in vivo, generates functionally cytotoxic NK cells, and lacks the ability to produce T cells, B cells, myeloid cells, and innate lymphoid-like cells (ILCs). Our findings identify an early step to human NK cell commitment and provide new insights into the human hematopoietic hierarchy. Abstract from Immunity. 2015 Aug 18;43(2):394-407."	15	"LMPP, CLP, NKP, NK"	Microarray (Affymetrix HuGene-1_0-ST V1 (GPL 6244 and A-AFFY-141))		Homo sapiens	2.28	HuGene	"rgb(0,109,219)"	diamond-open	NK CD3-CD56+NKp46+  neonatal	lymphoid	NK	neonatal	natural killer cell	Lymphocyte
GSM1480270;6787	6787	Renoux	GSM1480270	CD3-CD56+NKp46+ NK from Cord blood batch2	Homo sapiens	NK	CL:0000623		natural killer cell			Renoux	"Natural killer (NK) cells are cytotoxic lymphocytes and play a vital role in controlling viral infections and cancer. In contrast to B and T lymphopoiesis where cellular and regulatory pathways have been extensively characterized, the cellular stages of early human NK cell commitment remain poorly understood. Here we demonstrate that a Lin(-)CD34(+)CD38(+)CD123(-)CD45RA(+)CD7(+)CD10(+)CD127(-) population represents a NK lineage-restricted progenitor (NKP) in fetal development, umbilical cord blood, and adult tissues. The newly identified NKP has robust NK cell potential both in vitro and in vivo, generates functionally cytotoxic NK cells, and lacks the ability to produce T cells, B cells, myeloid cells, and innate lymphoid-like cells (ILCs). Our findings identify an early step to human NK cell commitment and provide new insights into the human hematopoietic hierarchy. Abstract from Immunity. 2015 Aug 18;43(2):394-407."	15	"LMPP, CLP, NKP, NK"	Microarray (Affymetrix HuGene-1_0-ST V1 (GPL 6244 and A-AFFY-141))		Homo sapiens	2.28	HuGene	"rgb(0,109,219)"	diamond-open	NK CD3-CD56+NKp46+  neonatal	lymphoid	NK	neonatal	natural killer cell	Lymphocyte
GSM1480271;6787	6787	Renoux	GSM1480271	CD3-CD56+NKp46+ NK from Cord blood batch3	Homo sapiens	NK	CL:0000623		natural killer cell			Renoux	"Natural killer (NK) cells are cytotoxic lymphocytes and play a vital role in controlling viral infections and cancer. In contrast to B and T lymphopoiesis where cellular and regulatory pathways have been extensively characterized, the cellular stages of early human NK cell commitment remain poorly understood. Here we demonstrate that a Lin(-)CD34(+)CD38(+)CD123(-)CD45RA(+)CD7(+)CD10(+)CD127(-) population represents a NK lineage-restricted progenitor (NKP) in fetal development, umbilical cord blood, and adult tissues. The newly identified NKP has robust NK cell potential both in vitro and in vivo, generates functionally cytotoxic NK cells, and lacks the ability to produce T cells, B cells, myeloid cells, and innate lymphoid-like cells (ILCs). Our findings identify an early step to human NK cell commitment and provide new insights into the human hematopoietic hierarchy. Abstract from Immunity. 2015 Aug 18;43(2):394-407."	15	"LMPP, CLP, NKP, NK"	Microarray (Affymetrix HuGene-1_0-ST V1 (GPL 6244 and A-AFFY-141))		Homo sapiens	2.28	HuGene	"rgb(0,109,219)"	diamond-open	NK CD3-CD56+NKp46+  neonatal	lymphoid	NK	neonatal	natural killer cell	Lymphocyte
GSM1480272;6787	6787	Renoux	GSM1480272	CD3-CD56+NKp46+ NK from Cord blood batch4	Homo sapiens	NK	CL:0000623		natural killer cell			Renoux	"Natural killer (NK) cells are cytotoxic lymphocytes and play a vital role in controlling viral infections and cancer. In contrast to B and T lymphopoiesis where cellular and regulatory pathways have been extensively characterized, the cellular stages of early human NK cell commitment remain poorly understood. Here we demonstrate that a Lin(-)CD34(+)CD38(+)CD123(-)CD45RA(+)CD7(+)CD10(+)CD127(-) population represents a NK lineage-restricted progenitor (NKP) in fetal development, umbilical cord blood, and adult tissues. The newly identified NKP has robust NK cell potential both in vitro and in vivo, generates functionally cytotoxic NK cells, and lacks the ability to produce T cells, B cells, myeloid cells, and innate lymphoid-like cells (ILCs). Our findings identify an early step to human NK cell commitment and provide new insights into the human hematopoietic hierarchy. Abstract from Immunity. 2015 Aug 18;43(2):394-407."	15	"LMPP, CLP, NKP, NK"	Microarray (Affymetrix HuGene-1_0-ST V1 (GPL 6244 and A-AFFY-141))		Homo sapiens	2.28	HuGene	"rgb(0,109,219)"	diamond-open	NK CD3-CD56+NKp46+  neonatal	lymphoid	NK	neonatal	natural killer cell	Lymphocyte
GSM1480273;6787	6787	Renoux	GSM1480273	CD45RA+CD7+CD10+CD127+ CLP from cord blood batch1	Homo sapiens	CLP	CL:0000049		common lymphoid progenitor			Renoux	"Natural killer (NK) cells are cytotoxic lymphocytes and play a vital role in controlling viral infections and cancer. In contrast to B and T lymphopoiesis where cellular and regulatory pathways have been extensively characterized, the cellular stages of early human NK cell commitment remain poorly understood. Here we demonstrate that a Lin(-)CD34(+)CD38(+)CD123(-)CD45RA(+)CD7(+)CD10(+)CD127(-) population represents a NK lineage-restricted progenitor (NKP) in fetal development, umbilical cord blood, and adult tissues. The newly identified NKP has robust NK cell potential both in vitro and in vivo, generates functionally cytotoxic NK cells, and lacks the ability to produce T cells, B cells, myeloid cells, and innate lymphoid-like cells (ILCs). Our findings identify an early step to human NK cell commitment and provide new insights into the human hematopoietic hierarchy. Abstract from Immunity. 2015 Aug 18;43(2):394-407."	15	"LMPP, CLP, NKP, NK"	Microarray (Affymetrix HuGene-1_0-ST V1 (GPL 6244 and A-AFFY-141))		Homo sapiens	2.28	HuGene	"rgb(0,109,219)"	diamond-open	LP CD45RA+ CD7+ CD10+ CD127+  neonatal	lymphoid progenitor	LP	neonatal	common lymphoid progenitor	Progenitor
GSM1480274;6787	6787	Renoux	GSM1480274	CD45RA+CD7+CD10+CD127+ CLP from cord blood batch2	Homo sapiens	CLP	CL:0000049		common lymphoid progenitor			Renoux	"Natural killer (NK) cells are cytotoxic lymphocytes and play a vital role in controlling viral infections and cancer. In contrast to B and T lymphopoiesis where cellular and regulatory pathways have been extensively characterized, the cellular stages of early human NK cell commitment remain poorly understood. Here we demonstrate that a Lin(-)CD34(+)CD38(+)CD123(-)CD45RA(+)CD7(+)CD10(+)CD127(-) population represents a NK lineage-restricted progenitor (NKP) in fetal development, umbilical cord blood, and adult tissues. The newly identified NKP has robust NK cell potential both in vitro and in vivo, generates functionally cytotoxic NK cells, and lacks the ability to produce T cells, B cells, myeloid cells, and innate lymphoid-like cells (ILCs). Our findings identify an early step to human NK cell commitment and provide new insights into the human hematopoietic hierarchy. Abstract from Immunity. 2015 Aug 18;43(2):394-407."	15	"LMPP, CLP, NKP, NK"	Microarray (Affymetrix HuGene-1_0-ST V1 (GPL 6244 and A-AFFY-141))		Homo sapiens	2.28	HuGene	"rgb(0,109,219)"	diamond-open	LP CD45RA+ CD7+ CD10+ CD127+  neonatal	lymphoid progenitor	LP	neonatal	common lymphoid progenitor	Progenitor
GSM1480275;6787	6787	Renoux	GSM1480275	CD45RA+CD7+CD10+CD127+ CLP from cord blood batch3	Homo sapiens	CLP	CL:0000049		common lymphoid progenitor			Renoux	"Natural killer (NK) cells are cytotoxic lymphocytes and play a vital role in controlling viral infections and cancer. In contrast to B and T lymphopoiesis where cellular and regulatory pathways have been extensively characterized, the cellular stages of early human NK cell commitment remain poorly understood. Here we demonstrate that a Lin(-)CD34(+)CD38(+)CD123(-)CD45RA(+)CD7(+)CD10(+)CD127(-) population represents a NK lineage-restricted progenitor (NKP) in fetal development, umbilical cord blood, and adult tissues. The newly identified NKP has robust NK cell potential both in vitro and in vivo, generates functionally cytotoxic NK cells, and lacks the ability to produce T cells, B cells, myeloid cells, and innate lymphoid-like cells (ILCs). Our findings identify an early step to human NK cell commitment and provide new insights into the human hematopoietic hierarchy. Abstract from Immunity. 2015 Aug 18;43(2):394-407."	15	"LMPP, CLP, NKP, NK"	Microarray (Affymetrix HuGene-1_0-ST V1 (GPL 6244 and A-AFFY-141))		Homo sapiens	2.28	HuGene	"rgb(0,109,219)"	diamond-open	LP CD45RA+ CD7+ CD10+ CD127+  neonatal	lymphoid progenitor	LP	neonatal	common lymphoid progenitor	Progenitor
GSM1600118;6272	6272	Wise	GSM1600118	untreated control1	Homo sapiens	monocyte	CL:0000576		monocyte			Wise	"Aim: Macrophage infiltration contributes to the pathogenesis of Type 2 diabetes. Mesenchymal stem cells (MSCs) possess immunomodulatory properties, making them an ideal candidate for therapeutic intervention. This study investigated whether MSCs can modulate the phenotype of monocytes isolated from Type 2 diabetic patients with end-stage renal disease. Materials & methods: Monocytes from control (n = 4) and Type 2 diabetic patients with end-stage renal disease (n = 5) were assessed using flow cytometry and microarray profiling, following 48 h of co-culture with MSCs. Results: Control subjects had a greater proportion of CD14++CD16- monocytes while diabetic patients had a higher proportion of CD14++CD16+ and CD14+CD16++ monocytes. MSCs promoted the proliferation of monocytes isolated from diabetic patients, reduced HLA-DR expression in both groups and promoted the expression of anti-inflammatory genes. Conclusion: MSC-derived factors alter the polarization of monocytes isolated from healthy and diabetic subjects toward an M2 phenotype. Abstract from Regen Med. 2015 Nov 6."	18	"monocyte, diabetic monocyte, monocyte + MSC, diabetic monocyte + MSC"	Microarray (Affymetrix HuGene-2_0-ST V1)		Homo sapiens	0.92	HuGene	"rgb(0,109,219)"	diamond-open	Monocyte CD14+  adult	myeloid	myeloid	adult	monocyte	Macrophage
GSM1600119;6272	6272	Wise	GSM1600119	msc control1	Homo sapiens	monocyte + MSC	CL:0000576		monocyte			Wise	"Aim: Macrophage infiltration contributes to the pathogenesis of Type 2 diabetes. Mesenchymal stem cells (MSCs) possess immunomodulatory properties, making them an ideal candidate for therapeutic intervention. This study investigated whether MSCs can modulate the phenotype of monocytes isolated from Type 2 diabetic patients with end-stage renal disease. Materials & methods: Monocytes from control (n = 4) and Type 2 diabetic patients with end-stage renal disease (n = 5) were assessed using flow cytometry and microarray profiling, following 48 h of co-culture with MSCs. Results: Control subjects had a greater proportion of CD14++CD16- monocytes while diabetic patients had a higher proportion of CD14++CD16+ and CD14+CD16++ monocytes. MSCs promoted the proliferation of monocytes isolated from diabetic patients, reduced HLA-DR expression in both groups and promoted the expression of anti-inflammatory genes. Conclusion: MSC-derived factors alter the polarization of monocytes isolated from healthy and diabetic subjects toward an M2 phenotype. Abstract from Regen Med. 2015 Nov 6."	18	"monocyte, diabetic monocyte, monocyte + MSC, diabetic monocyte + MSC"	Microarray (Affymetrix HuGene-2_0-ST V1)		Homo sapiens	0.92	HuGene	"rgb(0,109,219)"	diamond-open	Monocyte CD14+ cocultured with MSC adult	myeloid	myeloid	adult	monocyte	Macrophage
GSM1600120;6272	6272	Wise	GSM1600120	untreated control2	Homo sapiens	monocyte	CL:0000576		monocyte			Wise	"Aim: Macrophage infiltration contributes to the pathogenesis of Type 2 diabetes. Mesenchymal stem cells (MSCs) possess immunomodulatory properties, making them an ideal candidate for therapeutic intervention. This study investigated whether MSCs can modulate the phenotype of monocytes isolated from Type 2 diabetic patients with end-stage renal disease. Materials & methods: Monocytes from control (n = 4) and Type 2 diabetic patients with end-stage renal disease (n = 5) were assessed using flow cytometry and microarray profiling, following 48 h of co-culture with MSCs. Results: Control subjects had a greater proportion of CD14++CD16- monocytes while diabetic patients had a higher proportion of CD14++CD16+ and CD14+CD16++ monocytes. MSCs promoted the proliferation of monocytes isolated from diabetic patients, reduced HLA-DR expression in both groups and promoted the expression of anti-inflammatory genes. Conclusion: MSC-derived factors alter the polarization of monocytes isolated from healthy and diabetic subjects toward an M2 phenotype. Abstract from Regen Med. 2015 Nov 6."	18	"monocyte, diabetic monocyte, monocyte + MSC, diabetic monocyte + MSC"	Microarray (Affymetrix HuGene-2_0-ST V1)		Homo sapiens	0.92	HuGene	"rgb(0,109,219)"	diamond-open	Monocyte CD14+  adult	myeloid	myeloid	adult	monocyte	Macrophage
GSM1600121;6272	6272	Wise	GSM1600121	msc control2	Homo sapiens	monocyte + MSC	CL:0000576		monocyte			Wise	"Aim: Macrophage infiltration contributes to the pathogenesis of Type 2 diabetes. Mesenchymal stem cells (MSCs) possess immunomodulatory properties, making them an ideal candidate for therapeutic intervention. This study investigated whether MSCs can modulate the phenotype of monocytes isolated from Type 2 diabetic patients with end-stage renal disease. Materials & methods: Monocytes from control (n = 4) and Type 2 diabetic patients with end-stage renal disease (n = 5) were assessed using flow cytometry and microarray profiling, following 48 h of co-culture with MSCs. Results: Control subjects had a greater proportion of CD14++CD16- monocytes while diabetic patients had a higher proportion of CD14++CD16+ and CD14+CD16++ monocytes. MSCs promoted the proliferation of monocytes isolated from diabetic patients, reduced HLA-DR expression in both groups and promoted the expression of anti-inflammatory genes. Conclusion: MSC-derived factors alter the polarization of monocytes isolated from healthy and diabetic subjects toward an M2 phenotype. Abstract from Regen Med. 2015 Nov 6."	18	"monocyte, diabetic monocyte, monocyte + MSC, diabetic monocyte + MSC"	Microarray (Affymetrix HuGene-2_0-ST V1)		Homo sapiens	0.92	HuGene	"rgb(0,109,219)"	diamond-open	Monocyte CD14+ cocultured with MSC adult	myeloid	myeloid	adult	monocyte	Macrophage
GSM1600122;6272	6272	Wise	GSM1600122	untreated control3	Homo sapiens	monocyte	CL:0000576		monocyte			Wise	"Aim: Macrophage infiltration contributes to the pathogenesis of Type 2 diabetes. Mesenchymal stem cells (MSCs) possess immunomodulatory properties, making them an ideal candidate for therapeutic intervention. This study investigated whether MSCs can modulate the phenotype of monocytes isolated from Type 2 diabetic patients with end-stage renal disease. Materials & methods: Monocytes from control (n = 4) and Type 2 diabetic patients with end-stage renal disease (n = 5) were assessed using flow cytometry and microarray profiling, following 48 h of co-culture with MSCs. Results: Control subjects had a greater proportion of CD14++CD16- monocytes while diabetic patients had a higher proportion of CD14++CD16+ and CD14+CD16++ monocytes. MSCs promoted the proliferation of monocytes isolated from diabetic patients, reduced HLA-DR expression in both groups and promoted the expression of anti-inflammatory genes. Conclusion: MSC-derived factors alter the polarization of monocytes isolated from healthy and diabetic subjects toward an M2 phenotype. Abstract from Regen Med. 2015 Nov 6."	18	"monocyte, diabetic monocyte, monocyte + MSC, diabetic monocyte + MSC"	Microarray (Affymetrix HuGene-2_0-ST V1)		Homo sapiens	0.92	HuGene	"rgb(0,109,219)"	diamond-open	Monocyte CD14+  adult	myeloid	myeloid	adult	monocyte	Macrophage
GSM1600123;6272	6272	Wise	GSM1600123	msc control3	Homo sapiens	monocyte + MSC	CL:0000576		monocyte			Wise	"Aim: Macrophage infiltration contributes to the pathogenesis of Type 2 diabetes. Mesenchymal stem cells (MSCs) possess immunomodulatory properties, making them an ideal candidate for therapeutic intervention. This study investigated whether MSCs can modulate the phenotype of monocytes isolated from Type 2 diabetic patients with end-stage renal disease. Materials & methods: Monocytes from control (n = 4) and Type 2 diabetic patients with end-stage renal disease (n = 5) were assessed using flow cytometry and microarray profiling, following 48 h of co-culture with MSCs. Results: Control subjects had a greater proportion of CD14++CD16- monocytes while diabetic patients had a higher proportion of CD14++CD16+ and CD14+CD16++ monocytes. MSCs promoted the proliferation of monocytes isolated from diabetic patients, reduced HLA-DR expression in both groups and promoted the expression of anti-inflammatory genes. Conclusion: MSC-derived factors alter the polarization of monocytes isolated from healthy and diabetic subjects toward an M2 phenotype. Abstract from Regen Med. 2015 Nov 6."	18	"monocyte, diabetic monocyte, monocyte + MSC, diabetic monocyte + MSC"	Microarray (Affymetrix HuGene-2_0-ST V1)		Homo sapiens	0.92	HuGene	"rgb(0,109,219)"	diamond-open	Monocyte CD14+ cocultured with MSC adult	myeloid	myeloid	adult	monocyte	Macrophage
GSM1600124;6272	6272	Wise	GSM1600124	untreated control4	Homo sapiens	monocyte	CL:0000576		monocyte			Wise	"Aim: Macrophage infiltration contributes to the pathogenesis of Type 2 diabetes. Mesenchymal stem cells (MSCs) possess immunomodulatory properties, making them an ideal candidate for therapeutic intervention. This study investigated whether MSCs can modulate the phenotype of monocytes isolated from Type 2 diabetic patients with end-stage renal disease. Materials & methods: Monocytes from control (n = 4) and Type 2 diabetic patients with end-stage renal disease (n = 5) were assessed using flow cytometry and microarray profiling, following 48 h of co-culture with MSCs. Results: Control subjects had a greater proportion of CD14++CD16- monocytes while diabetic patients had a higher proportion of CD14++CD16+ and CD14+CD16++ monocytes. MSCs promoted the proliferation of monocytes isolated from diabetic patients, reduced HLA-DR expression in both groups and promoted the expression of anti-inflammatory genes. Conclusion: MSC-derived factors alter the polarization of monocytes isolated from healthy and diabetic subjects toward an M2 phenotype. Abstract from Regen Med. 2015 Nov 6."	18	"monocyte, diabetic monocyte, monocyte + MSC, diabetic monocyte + MSC"	Microarray (Affymetrix HuGene-2_0-ST V1)		Homo sapiens	0.92	HuGene	"rgb(0,109,219)"	diamond-open	Monocyte CD14+  adult	myeloid	myeloid	adult	monocyte	Macrophage
GSM1600125;6272	6272	Wise	GSM1600125	msc control4	Homo sapiens	monocyte + MSC	CL:0000576		monocyte			Wise	"Aim: Macrophage infiltration contributes to the pathogenesis of Type 2 diabetes. Mesenchymal stem cells (MSCs) possess immunomodulatory properties, making them an ideal candidate for therapeutic intervention. This study investigated whether MSCs can modulate the phenotype of monocytes isolated from Type 2 diabetic patients with end-stage renal disease. Materials & methods: Monocytes from control (n = 4) and Type 2 diabetic patients with end-stage renal disease (n = 5) were assessed using flow cytometry and microarray profiling, following 48 h of co-culture with MSCs. Results: Control subjects had a greater proportion of CD14++CD16- monocytes while diabetic patients had a higher proportion of CD14++CD16+ and CD14+CD16++ monocytes. MSCs promoted the proliferation of monocytes isolated from diabetic patients, reduced HLA-DR expression in both groups and promoted the expression of anti-inflammatory genes. Conclusion: MSC-derived factors alter the polarization of monocytes isolated from healthy and diabetic subjects toward an M2 phenotype. Abstract from Regen Med. 2015 Nov 6."	18	"monocyte, diabetic monocyte, monocyte + MSC, diabetic monocyte + MSC"	Microarray (Affymetrix HuGene-2_0-ST V1)		Homo sapiens	0.92	HuGene	"rgb(0,109,219)"	diamond-open	Monocyte CD14+ cocultured with MSC adult	myeloid	myeloid	adult	monocyte	Macrophage
GSM1600126;6272	6272	Wise	GSM1600126	untreated diabetic UR4413277	Homo sapiens	diabetic monocyte	CL:0000576		monocyte			Wise	"Aim: Macrophage infiltration contributes to the pathogenesis of Type 2 diabetes. Mesenchymal stem cells (MSCs) possess immunomodulatory properties, making them an ideal candidate for therapeutic intervention. This study investigated whether MSCs can modulate the phenotype of monocytes isolated from Type 2 diabetic patients with end-stage renal disease. Materials & methods: Monocytes from control (n = 4) and Type 2 diabetic patients with end-stage renal disease (n = 5) were assessed using flow cytometry and microarray profiling, following 48 h of co-culture with MSCs. Results: Control subjects had a greater proportion of CD14++CD16- monocytes while diabetic patients had a higher proportion of CD14++CD16+ and CD14+CD16++ monocytes. MSCs promoted the proliferation of monocytes isolated from diabetic patients, reduced HLA-DR expression in both groups and promoted the expression of anti-inflammatory genes. Conclusion: MSC-derived factors alter the polarization of monocytes isolated from healthy and diabetic subjects toward an M2 phenotype. Abstract from Regen Med. 2015 Nov 6."	18	"monocyte, diabetic monocyte, monocyte + MSC, diabetic monocyte + MSC"	Microarray (Affymetrix HuGene-2_0-ST V1)		Homo sapiens	0.92	HuGene	"rgb(0,109,219)"	diamond-open	Monocyte CD14+ diabetic adult	myeloid	myeloid	adult	monocyte	Macrophage
GSM1600127;6272	6272	Wise	GSM1600127	msc diabetic UR4413277	Homo sapiens	diabetic monocyte + MSC	CL:0000576		monocyte			Wise	"Aim: Macrophage infiltration contributes to the pathogenesis of Type 2 diabetes. Mesenchymal stem cells (MSCs) possess immunomodulatory properties, making them an ideal candidate for therapeutic intervention. This study investigated whether MSCs can modulate the phenotype of monocytes isolated from Type 2 diabetic patients with end-stage renal disease. Materials & methods: Monocytes from control (n = 4) and Type 2 diabetic patients with end-stage renal disease (n = 5) were assessed using flow cytometry and microarray profiling, following 48 h of co-culture with MSCs. Results: Control subjects had a greater proportion of CD14++CD16- monocytes while diabetic patients had a higher proportion of CD14++CD16+ and CD14+CD16++ monocytes. MSCs promoted the proliferation of monocytes isolated from diabetic patients, reduced HLA-DR expression in both groups and promoted the expression of anti-inflammatory genes. Conclusion: MSC-derived factors alter the polarization of monocytes isolated from healthy and diabetic subjects toward an M2 phenotype. Abstract from Regen Med. 2015 Nov 6."	18	"monocyte, diabetic monocyte, monocyte + MSC, diabetic monocyte + MSC"	Microarray (Affymetrix HuGene-2_0-ST V1)		Homo sapiens	0.92	HuGene	"rgb(0,109,219)"	diamond-open	Monocyte CD14+ diabetic cocultured with MSC adult	myeloid	myeloid	adult	monocyte	Macrophage
GSM1600128;6272	6272	Wise	GSM1600128	untreated diabetic UR706566	Homo sapiens	diabetic monocyte	CL:0000576		monocyte			Wise	"Aim: Macrophage infiltration contributes to the pathogenesis of Type 2 diabetes. Mesenchymal stem cells (MSCs) possess immunomodulatory properties, making them an ideal candidate for therapeutic intervention. This study investigated whether MSCs can modulate the phenotype of monocytes isolated from Type 2 diabetic patients with end-stage renal disease. Materials & methods: Monocytes from control (n = 4) and Type 2 diabetic patients with end-stage renal disease (n = 5) were assessed using flow cytometry and microarray profiling, following 48 h of co-culture with MSCs. Results: Control subjects had a greater proportion of CD14++CD16- monocytes while diabetic patients had a higher proportion of CD14++CD16+ and CD14+CD16++ monocytes. MSCs promoted the proliferation of monocytes isolated from diabetic patients, reduced HLA-DR expression in both groups and promoted the expression of anti-inflammatory genes. Conclusion: MSC-derived factors alter the polarization of monocytes isolated from healthy and diabetic subjects toward an M2 phenotype. Abstract from Regen Med. 2015 Nov 6."	18	"monocyte, diabetic monocyte, monocyte + MSC, diabetic monocyte + MSC"	Microarray (Affymetrix HuGene-2_0-ST V1)		Homo sapiens	0.92	HuGene	"rgb(0,109,219)"	diamond-open	Monocyte CD14+ diabetic adult	myeloid	myeloid	adult	monocyte	Macrophage
GSM1600129;6272	6272	Wise	GSM1600129	msc diabetic UR706566	Homo sapiens	diabetic monocyte + MSC	CL:0000576		monocyte			Wise	"Aim: Macrophage infiltration contributes to the pathogenesis of Type 2 diabetes. Mesenchymal stem cells (MSCs) possess immunomodulatory properties, making them an ideal candidate for therapeutic intervention. This study investigated whether MSCs can modulate the phenotype of monocytes isolated from Type 2 diabetic patients with end-stage renal disease. Materials & methods: Monocytes from control (n = 4) and Type 2 diabetic patients with end-stage renal disease (n = 5) were assessed using flow cytometry and microarray profiling, following 48 h of co-culture with MSCs. Results: Control subjects had a greater proportion of CD14++CD16- monocytes while diabetic patients had a higher proportion of CD14++CD16+ and CD14+CD16++ monocytes. MSCs promoted the proliferation of monocytes isolated from diabetic patients, reduced HLA-DR expression in both groups and promoted the expression of anti-inflammatory genes. Conclusion: MSC-derived factors alter the polarization of monocytes isolated from healthy and diabetic subjects toward an M2 phenotype. Abstract from Regen Med. 2015 Nov 6."	18	"monocyte, diabetic monocyte, monocyte + MSC, diabetic monocyte + MSC"	Microarray (Affymetrix HuGene-2_0-ST V1)		Homo sapiens	0.92	HuGene	"rgb(0,109,219)"	diamond-open	Monocyte CD14+ diabetic cocultured with MSC adult	myeloid	myeloid	adult	monocyte	Macrophage
GSM1600130;6272	6272	Wise	GSM1600130	untreated diabetic UR4093157	Homo sapiens	diabetic monocyte	CL:0000576		monocyte			Wise	"Aim: Macrophage infiltration contributes to the pathogenesis of Type 2 diabetes. Mesenchymal stem cells (MSCs) possess immunomodulatory properties, making them an ideal candidate for therapeutic intervention. This study investigated whether MSCs can modulate the phenotype of monocytes isolated from Type 2 diabetic patients with end-stage renal disease. Materials & methods: Monocytes from control (n = 4) and Type 2 diabetic patients with end-stage renal disease (n = 5) were assessed using flow cytometry and microarray profiling, following 48 h of co-culture with MSCs. Results: Control subjects had a greater proportion of CD14++CD16- monocytes while diabetic patients had a higher proportion of CD14++CD16+ and CD14+CD16++ monocytes. MSCs promoted the proliferation of monocytes isolated from diabetic patients, reduced HLA-DR expression in both groups and promoted the expression of anti-inflammatory genes. Conclusion: MSC-derived factors alter the polarization of monocytes isolated from healthy and diabetic subjects toward an M2 phenotype. Abstract from Regen Med. 2015 Nov 6."	18	"monocyte, diabetic monocyte, monocyte + MSC, diabetic monocyte + MSC"	Microarray (Affymetrix HuGene-2_0-ST V1)		Homo sapiens	0.92	HuGene	"rgb(0,109,219)"	diamond-open	Monocyte CD14+ diabetic adult	myeloid	myeloid	adult	monocyte	Macrophage
GSM1600131;6272	6272	Wise	GSM1600131	msc diabetic UR4093157	Homo sapiens	diabetic monocyte + MSC	CL:0000576		monocyte			Wise	"Aim: Macrophage infiltration contributes to the pathogenesis of Type 2 diabetes. Mesenchymal stem cells (MSCs) possess immunomodulatory properties, making them an ideal candidate for therapeutic intervention. This study investigated whether MSCs can modulate the phenotype of monocytes isolated from Type 2 diabetic patients with end-stage renal disease. Materials & methods: Monocytes from control (n = 4) and Type 2 diabetic patients with end-stage renal disease (n = 5) were assessed using flow cytometry and microarray profiling, following 48 h of co-culture with MSCs. Results: Control subjects had a greater proportion of CD14++CD16- monocytes while diabetic patients had a higher proportion of CD14++CD16+ and CD14+CD16++ monocytes. MSCs promoted the proliferation of monocytes isolated from diabetic patients, reduced HLA-DR expression in both groups and promoted the expression of anti-inflammatory genes. Conclusion: MSC-derived factors alter the polarization of monocytes isolated from healthy and diabetic subjects toward an M2 phenotype. Abstract from Regen Med. 2015 Nov 6."	18	"monocyte, diabetic monocyte, monocyte + MSC, diabetic monocyte + MSC"	Microarray (Affymetrix HuGene-2_0-ST V1)		Homo sapiens	0.92	HuGene	"rgb(0,109,219)"	diamond-open	Monocyte CD14+ diabetic cocultured with MSC adult	myeloid	myeloid	adult	monocyte	Macrophage
GSM1600132;6272	6272	Wise	GSM1600132	untreated diabetic UR337042	Homo sapiens	diabetic monocyte	CL:0000576		monocyte			Wise	"Aim: Macrophage infiltration contributes to the pathogenesis of Type 2 diabetes. Mesenchymal stem cells (MSCs) possess immunomodulatory properties, making them an ideal candidate for therapeutic intervention. This study investigated whether MSCs can modulate the phenotype of monocytes isolated from Type 2 diabetic patients with end-stage renal disease. Materials & methods: Monocytes from control (n = 4) and Type 2 diabetic patients with end-stage renal disease (n = 5) were assessed using flow cytometry and microarray profiling, following 48 h of co-culture with MSCs. Results: Control subjects had a greater proportion of CD14++CD16- monocytes while diabetic patients had a higher proportion of CD14++CD16+ and CD14+CD16++ monocytes. MSCs promoted the proliferation of monocytes isolated from diabetic patients, reduced HLA-DR expression in both groups and promoted the expression of anti-inflammatory genes. Conclusion: MSC-derived factors alter the polarization of monocytes isolated from healthy and diabetic subjects toward an M2 phenotype. Abstract from Regen Med. 2015 Nov 6."	18	"monocyte, diabetic monocyte, monocyte + MSC, diabetic monocyte + MSC"	Microarray (Affymetrix HuGene-2_0-ST V1)		Homo sapiens	0.92	HuGene	"rgb(0,109,219)"	diamond-open	Monocyte CD14+ diabetic adult	myeloid	myeloid	adult	monocyte	Macrophage
GSM1600133;6272	6272	Wise	GSM1600133	msc diabetic UR337042	Homo sapiens	monocyte + MSC	CL:0000576		monocyte			Wise	"Aim: Macrophage infiltration contributes to the pathogenesis of Type 2 diabetes. Mesenchymal stem cells (MSCs) possess immunomodulatory properties, making them an ideal candidate for therapeutic intervention. This study investigated whether MSCs can modulate the phenotype of monocytes isolated from Type 2 diabetic patients with end-stage renal disease. Materials & methods: Monocytes from control (n = 4) and Type 2 diabetic patients with end-stage renal disease (n = 5) were assessed using flow cytometry and microarray profiling, following 48 h of co-culture with MSCs. Results: Control subjects had a greater proportion of CD14++CD16- monocytes while diabetic patients had a higher proportion of CD14++CD16+ and CD14+CD16++ monocytes. MSCs promoted the proliferation of monocytes isolated from diabetic patients, reduced HLA-DR expression in both groups and promoted the expression of anti-inflammatory genes. Conclusion: MSC-derived factors alter the polarization of monocytes isolated from healthy and diabetic subjects toward an M2 phenotype. Abstract from Regen Med. 2015 Nov 6."	18	"monocyte, diabetic monocyte, monocyte + MSC, diabetic monocyte + MSC"	Microarray (Affymetrix HuGene-2_0-ST V1)		Homo sapiens	0.92	HuGene	"rgb(0,109,219)"	diamond-open	Monocyte CD14+ cocultured with MSC adult	myeloid	myeloid	adult	monocyte	Macrophage
GSM1600134;6272	6272	Wise	GSM1600134	untreated diabetic UR4294238	Homo sapiens	diabetic monocyte	CL:0000576		monocyte			Wise	"Aim: Macrophage infiltration contributes to the pathogenesis of Type 2 diabetes. Mesenchymal stem cells (MSCs) possess immunomodulatory properties, making them an ideal candidate for therapeutic intervention. This study investigated whether MSCs can modulate the phenotype of monocytes isolated from Type 2 diabetic patients with end-stage renal disease. Materials & methods: Monocytes from control (n = 4) and Type 2 diabetic patients with end-stage renal disease (n = 5) were assessed using flow cytometry and microarray profiling, following 48 h of co-culture with MSCs. Results: Control subjects had a greater proportion of CD14++CD16- monocytes while diabetic patients had a higher proportion of CD14++CD16+ and CD14+CD16++ monocytes. MSCs promoted the proliferation of monocytes isolated from diabetic patients, reduced HLA-DR expression in both groups and promoted the expression of anti-inflammatory genes. Conclusion: MSC-derived factors alter the polarization of monocytes isolated from healthy and diabetic subjects toward an M2 phenotype. Abstract from Regen Med. 2015 Nov 6."	18	"monocyte, diabetic monocyte, monocyte + MSC, diabetic monocyte + MSC"	Microarray (Affymetrix HuGene-2_0-ST V1)		Homo sapiens	0.92	HuGene	"rgb(0,109,219)"	diamond-open	Monocyte CD14+ diabetic adult	myeloid	myeloid	adult	monocyte	Macrophage
GSM1600135;6272	6272	Wise	GSM1600135	msc diabetic UR4294238	Homo sapiens	diabetic monocyte + MSC	CL:0000576		monocyte			Wise	"Aim: Macrophage infiltration contributes to the pathogenesis of Type 2 diabetes. Mesenchymal stem cells (MSCs) possess immunomodulatory properties, making them an ideal candidate for therapeutic intervention. This study investigated whether MSCs can modulate the phenotype of monocytes isolated from Type 2 diabetic patients with end-stage renal disease. Materials & methods: Monocytes from control (n = 4) and Type 2 diabetic patients with end-stage renal disease (n = 5) were assessed using flow cytometry and microarray profiling, following 48 h of co-culture with MSCs. Results: Control subjects had a greater proportion of CD14++CD16- monocytes while diabetic patients had a higher proportion of CD14++CD16+ and CD14+CD16++ monocytes. MSCs promoted the proliferation of monocytes isolated from diabetic patients, reduced HLA-DR expression in both groups and promoted the expression of anti-inflammatory genes. Conclusion: MSC-derived factors alter the polarization of monocytes isolated from healthy and diabetic subjects toward an M2 phenotype. Abstract from Regen Med. 2015 Nov 6."	18	"monocyte, diabetic monocyte, monocyte + MSC, diabetic monocyte + MSC"	Microarray (Affymetrix HuGene-2_0-ST V1)		Homo sapiens	0.92	HuGene	"rgb(0,109,219)"	diamond-open	Monocyte CD14+ diabetic cocultured with MSC adult	myeloid	myeloid	adult	monocyte	Macrophage
GSM1612360;7319	7319	Xiao	GSM1612360	"IL3Ra high progenitor cells, replicate 1"	Homo sapiens	IL3Ra high progenitor cells	CL:0000837		hematopoietic multipotent progenitor			Xiao	"Osteoclasts (OCs) originate from the myeloid cell lineage, but the successive steps in their lineage commitment are ill-defined, especially in humans. To clarify OC origin, we sorted cell populations from pediatric bone marrow (BM) by flow cytometry and assessed their differentiation potential in vitro. Within the CD11b(-)CD34(+)c-KIT(+) BM cell population, OC-differentiation potential was restricted to FLT3(+) cells and enriched in an IL3 receptor (R)(high) subset that constituted less than 0.5% of total BM. These IL3R(high) cells also generated macrophages (Ms) and dendritic cells (DCs) but lacked granulocyte (GR)-differentiation potential, as demonstrated at the clonal level. The IL3R(low) subset was re-defined as common progenitor of GR, M, OC, and DC (GMODP) and gave rise to the IL3R(high) subset that was identified as common progenitor of M, OC, and DC (MODP). Unbiased transcriptome analysis of CD11b(-)CD34(+)c-KIT(+)FLT3(+) IL3R(low) and IL3R(high) subsets corroborated our definitions of the GMODP and MODP and their developmental relationship. Abstract from Stem Cell Reports. 2015 Jun 9;4(6):984-94. doi: 10.1016/j.stemcr.2015.04.012."	6	"IL3Ra high progenitor cells, IL3Ra low progenitor cells"	RNASeq (Illumina HiSeq 2000)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross		myeloid progenitor	MHP	adult	common myeloid progenitor	Progenitor
GSM1612361;7319	7319	Xiao	GSM1612361	"IL3Ra high progenitor cells, replicate 2"	Homo sapiens	IL3Ra high progenitor cells	CL:0000837		hematopoietic multipotent progenitor			Xiao	"Osteoclasts (OCs) originate from the myeloid cell lineage, but the successive steps in their lineage commitment are ill-defined, especially in humans. To clarify OC origin, we sorted cell populations from pediatric bone marrow (BM) by flow cytometry and assessed their differentiation potential in vitro. Within the CD11b(-)CD34(+)c-KIT(+) BM cell population, OC-differentiation potential was restricted to FLT3(+) cells and enriched in an IL3 receptor (R)(high) subset that constituted less than 0.5% of total BM. These IL3R(high) cells also generated macrophages (Ms) and dendritic cells (DCs) but lacked granulocyte (GR)-differentiation potential, as demonstrated at the clonal level. The IL3R(low) subset was re-defined as common progenitor of GR, M, OC, and DC (GMODP) and gave rise to the IL3R(high) subset that was identified as common progenitor of M, OC, and DC (MODP). Unbiased transcriptome analysis of CD11b(-)CD34(+)c-KIT(+)FLT3(+) IL3R(low) and IL3R(high) subsets corroborated our definitions of the GMODP and MODP and their developmental relationship. Abstract from Stem Cell Reports. 2015 Jun 9;4(6):984-94. doi: 10.1016/j.stemcr.2015.04.012."	6	"IL3Ra high progenitor cells, IL3Ra low progenitor cells"	RNASeq (Illumina HiSeq 2000)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross		myeloid progenitor	MHP	adult	common myeloid progenitor	Progenitor
GSM1612362;7319	7319	Xiao	GSM1612362	"IL3Ra high progenitor cells, replicate 3"	Homo sapiens	IL3Ra high progenitor cells	CL:0000837		hematopoietic multipotent progenitor			Xiao	"Osteoclasts (OCs) originate from the myeloid cell lineage, but the successive steps in their lineage commitment are ill-defined, especially in humans. To clarify OC origin, we sorted cell populations from pediatric bone marrow (BM) by flow cytometry and assessed their differentiation potential in vitro. Within the CD11b(-)CD34(+)c-KIT(+) BM cell population, OC-differentiation potential was restricted to FLT3(+) cells and enriched in an IL3 receptor (R)(high) subset that constituted less than 0.5% of total BM. These IL3R(high) cells also generated macrophages (Ms) and dendritic cells (DCs) but lacked granulocyte (GR)-differentiation potential, as demonstrated at the clonal level. The IL3R(low) subset was re-defined as common progenitor of GR, M, OC, and DC (GMODP) and gave rise to the IL3R(high) subset that was identified as common progenitor of M, OC, and DC (MODP). Unbiased transcriptome analysis of CD11b(-)CD34(+)c-KIT(+)FLT3(+) IL3R(low) and IL3R(high) subsets corroborated our definitions of the GMODP and MODP and their developmental relationship. Abstract from Stem Cell Reports. 2015 Jun 9;4(6):984-94. doi: 10.1016/j.stemcr.2015.04.012."	6	"IL3Ra high progenitor cells, IL3Ra low progenitor cells"	RNASeq (Illumina HiSeq 2000)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross		myeloid progenitor	MHP	adult	common myeloid progenitor	Progenitor
GSM1612363;7319	7319	Xiao	GSM1612363	"IL3Ra low progenitor cells, replicate 1"	Homo sapiens	IL3Ra low progenitor cells	CL:0000837		hematopoietic multipotent progenitor			Xiao	"Osteoclasts (OCs) originate from the myeloid cell lineage, but the successive steps in their lineage commitment are ill-defined, especially in humans. To clarify OC origin, we sorted cell populations from pediatric bone marrow (BM) by flow cytometry and assessed their differentiation potential in vitro. Within the CD11b(-)CD34(+)c-KIT(+) BM cell population, OC-differentiation potential was restricted to FLT3(+) cells and enriched in an IL3 receptor (R)(high) subset that constituted less than 0.5% of total BM. These IL3R(high) cells also generated macrophages (Ms) and dendritic cells (DCs) but lacked granulocyte (GR)-differentiation potential, as demonstrated at the clonal level. The IL3R(low) subset was re-defined as common progenitor of GR, M, OC, and DC (GMODP) and gave rise to the IL3R(high) subset that was identified as common progenitor of M, OC, and DC (MODP). Unbiased transcriptome analysis of CD11b(-)CD34(+)c-KIT(+)FLT3(+) IL3R(low) and IL3R(high) subsets corroborated our definitions of the GMODP and MODP and their developmental relationship. Abstract from Stem Cell Reports. 2015 Jun 9;4(6):984-94. doi: 10.1016/j.stemcr.2015.04.012."	6	"IL3Ra high progenitor cells, IL3Ra low progenitor cells"	RNASeq (Illumina HiSeq 2000)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross		myeloid progenitor	MHP	adult	common myeloid progenitor	Progenitor
GSM1612364;7319	7319	Xiao	GSM1612364	"IL3Ra low progenitor cells, replicate 2"	Homo sapiens	IL3Ra low progenitor cells	CL:0000837		hematopoietic multipotent progenitor			Xiao	"Osteoclasts (OCs) originate from the myeloid cell lineage, but the successive steps in their lineage commitment are ill-defined, especially in humans. To clarify OC origin, we sorted cell populations from pediatric bone marrow (BM) by flow cytometry and assessed their differentiation potential in vitro. Within the CD11b(-)CD34(+)c-KIT(+) BM cell population, OC-differentiation potential was restricted to FLT3(+) cells and enriched in an IL3 receptor (R)(high) subset that constituted less than 0.5% of total BM. These IL3R(high) cells also generated macrophages (Ms) and dendritic cells (DCs) but lacked granulocyte (GR)-differentiation potential, as demonstrated at the clonal level. The IL3R(low) subset was re-defined as common progenitor of GR, M, OC, and DC (GMODP) and gave rise to the IL3R(high) subset that was identified as common progenitor of M, OC, and DC (MODP). Unbiased transcriptome analysis of CD11b(-)CD34(+)c-KIT(+)FLT3(+) IL3R(low) and IL3R(high) subsets corroborated our definitions of the GMODP and MODP and their developmental relationship. Abstract from Stem Cell Reports. 2015 Jun 9;4(6):984-94. doi: 10.1016/j.stemcr.2015.04.012."	6	"IL3Ra high progenitor cells, IL3Ra low progenitor cells"	RNASeq (Illumina HiSeq 2000)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross		myeloid progenitor	MHP	adult	common myeloid progenitor	Progenitor
GSM1612365;7319	7319	Xiao	GSM1612365	"IL3Ra low progenitor cells, replicate 3"	Homo sapiens	IL3Ra low progenitor cells	CL:0000837		hematopoietic multipotent progenitor			Xiao	"Osteoclasts (OCs) originate from the myeloid cell lineage, but the successive steps in their lineage commitment are ill-defined, especially in humans. To clarify OC origin, we sorted cell populations from pediatric bone marrow (BM) by flow cytometry and assessed their differentiation potential in vitro. Within the CD11b(-)CD34(+)c-KIT(+) BM cell population, OC-differentiation potential was restricted to FLT3(+) cells and enriched in an IL3 receptor (R)(high) subset that constituted less than 0.5% of total BM. These IL3R(high) cells also generated macrophages (Ms) and dendritic cells (DCs) but lacked granulocyte (GR)-differentiation potential, as demonstrated at the clonal level. The IL3R(low) subset was re-defined as common progenitor of GR, M, OC, and DC (GMODP) and gave rise to the IL3R(high) subset that was identified as common progenitor of M, OC, and DC (MODP). Unbiased transcriptome analysis of CD11b(-)CD34(+)c-KIT(+)FLT3(+) IL3R(low) and IL3R(high) subsets corroborated our definitions of the GMODP and MODP and their developmental relationship. Abstract from Stem Cell Reports. 2015 Jun 9;4(6):984-94. doi: 10.1016/j.stemcr.2015.04.012."	6	"IL3Ra high progenitor cells, IL3Ra low progenitor cells"	RNASeq (Illumina HiSeq 2000)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross		myeloid progenitor	MHP	adult	common myeloid progenitor	Progenitor
GSM1695850;7284	7284	Casero	GSM1695850	HSC sample 1	Homo sapiens	HSC	CL:0000037		hematopoietic multipotent progenitor			Casero	"To elucidate the transcriptional 'landscape' that regulates human lymphoid commitment during postnatal life, we used RNA sequencing to assemble the long non-coding transcriptome across human bone marrow and thymic progenitor cells spanning the earliest stages of B lymphoid and T lymphoid specification. Over 3,000 genes encoding previously unknown long non-coding RNAs (lncRNAs) were revealed through the analysis of these rare populations. Lymphoid commitment was characterized by lncRNA expression patterns that were highly stage specific and were more lineage specific than those of protein-coding genes. Protein-coding genes co-expressed with neighboring lncRNA genes showed enrichment for ontologies related to lymphoid differentiation. The exquisite cell-type specificity of global lncRNA expression patterns independently revealed new developmental relationships among the earliest progenitor cells in the human bone marrow and thymus. Abstract from Nat Immunol. 2015 Dec;16(12):1282-91. doi: 10.1038/ni.3299."	20	"HSC, LMPP, CLP, BCP, thymic MLP, thymic MLP 2, thymic T-cell progenitor, Thymic CD4+CD8+ T-cell, Thymic CD4+ T-cell, Thymic CD8+ T-cell"	RNASeq (Illumina HiSeq 2000)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross	MHP CD34+CD38-  adult	hematopoietic multipotent progenitor	MHP	adult	hematopoietic stem cell	Progenitor
GSM1695851;7284	7284	Casero	GSM1695851	HSC sample 2	Homo sapiens	HSC	CL:0000037		hematopoietic multipotent progenitor			Casero	"To elucidate the transcriptional 'landscape' that regulates human lymphoid commitment during postnatal life, we used RNA sequencing to assemble the long non-coding transcriptome across human bone marrow and thymic progenitor cells spanning the earliest stages of B lymphoid and T lymphoid specification. Over 3,000 genes encoding previously unknown long non-coding RNAs (lncRNAs) were revealed through the analysis of these rare populations. Lymphoid commitment was characterized by lncRNA expression patterns that were highly stage specific and were more lineage specific than those of protein-coding genes. Protein-coding genes co-expressed with neighboring lncRNA genes showed enrichment for ontologies related to lymphoid differentiation. The exquisite cell-type specificity of global lncRNA expression patterns independently revealed new developmental relationships among the earliest progenitor cells in the human bone marrow and thymus. Abstract from Nat Immunol. 2015 Dec;16(12):1282-91. doi: 10.1038/ni.3299."	20	"HSC, LMPP, CLP, BCP, thymic MLP, thymic MLP 2, thymic T-cell progenitor, Thymic CD4+CD8+ T-cell, Thymic CD4+ T-cell, Thymic CD8+ T-cell"	RNASeq (Illumina HiSeq 2000)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross	MHP CD34+CD38-  adult	hematopoietic multipotent progenitor	MHP	adult	hematopoietic stem cell	Progenitor
GSM1695852;7284	7284	Casero	GSM1695852	LMPP sample 1	Homo sapiens	LMPP	CL:0000936		early lymphoid progenitor			Casero	"To elucidate the transcriptional 'landscape' that regulates human lymphoid commitment during postnatal life, we used RNA sequencing to assemble the long non-coding transcriptome across human bone marrow and thymic progenitor cells spanning the earliest stages of B lymphoid and T lymphoid specification. Over 3,000 genes encoding previously unknown long non-coding RNAs (lncRNAs) were revealed through the analysis of these rare populations. Lymphoid commitment was characterized by lncRNA expression patterns that were highly stage specific and were more lineage specific than those of protein-coding genes. Protein-coding genes co-expressed with neighboring lncRNA genes showed enrichment for ontologies related to lymphoid differentiation. The exquisite cell-type specificity of global lncRNA expression patterns independently revealed new developmental relationships among the earliest progenitor cells in the human bone marrow and thymus. Abstract from Nat Immunol. 2015 Dec;16(12):1282-91. doi: 10.1038/ni.3299."	20	"HSC, LMPP, CLP, BCP, thymic MLP, thymic MLP 2, thymic T-cell progenitor, Thymic CD4+CD8+ T-cell, Thymic CD4+ T-cell, Thymic CD8+ T-cell"	RNASeq (Illumina HiSeq 2000)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross	LP adult bone marrow CD34+CD45RA+CD38+CD10- CD62Lhi 	lymphoid progenitor	LP	adult	early lymphoid progenitor	Progenitor
GSM1695853;7284	7284	Casero	GSM1695853	LMPP sample 2	Homo sapiens	LMPP	CL:0000936		early lymphoid progenitor			Casero	"To elucidate the transcriptional 'landscape' that regulates human lymphoid commitment during postnatal life, we used RNA sequencing to assemble the long non-coding transcriptome across human bone marrow and thymic progenitor cells spanning the earliest stages of B lymphoid and T lymphoid specification. Over 3,000 genes encoding previously unknown long non-coding RNAs (lncRNAs) were revealed through the analysis of these rare populations. Lymphoid commitment was characterized by lncRNA expression patterns that were highly stage specific and were more lineage specific than those of protein-coding genes. Protein-coding genes co-expressed with neighboring lncRNA genes showed enrichment for ontologies related to lymphoid differentiation. The exquisite cell-type specificity of global lncRNA expression patterns independently revealed new developmental relationships among the earliest progenitor cells in the human bone marrow and thymus. Abstract from Nat Immunol. 2015 Dec;16(12):1282-91. doi: 10.1038/ni.3299."	20	"HSC, LMPP, CLP, BCP, thymic MLP, thymic MLP 2, thymic T-cell progenitor, Thymic CD4+CD8+ T-cell, Thymic CD4+ T-cell, Thymic CD8+ T-cell"	RNASeq (Illumina HiSeq 2000)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross	LP adult bone marrow CD34+CD45RA+CD38+CD10- CD62Lhi 	lymphoid progenitor	LP	adult	early lymphoid progenitor	Progenitor
GSM1695854;7284	7284	Casero	GSM1695854	CLP sample 1	Homo sapiens	CLP	CL:0000051		common lymphoid progenitor			Casero	"To elucidate the transcriptional 'landscape' that regulates human lymphoid commitment during postnatal life, we used RNA sequencing to assemble the long non-coding transcriptome across human bone marrow and thymic progenitor cells spanning the earliest stages of B lymphoid and T lymphoid specification. Over 3,000 genes encoding previously unknown long non-coding RNAs (lncRNAs) were revealed through the analysis of these rare populations. Lymphoid commitment was characterized by lncRNA expression patterns that were highly stage specific and were more lineage specific than those of protein-coding genes. Protein-coding genes co-expressed with neighboring lncRNA genes showed enrichment for ontologies related to lymphoid differentiation. The exquisite cell-type specificity of global lncRNA expression patterns independently revealed new developmental relationships among the earliest progenitor cells in the human bone marrow and thymus. Abstract from Nat Immunol. 2015 Dec;16(12):1282-91. doi: 10.1038/ni.3299."	20	"HSC, LMPP, CLP, BCP, thymic MLP, thymic MLP 2, thymic T-cell progenitor, Thymic CD4+CD8+ T-cell, Thymic CD4+ T-cell, Thymic CD8+ T-cell"	RNASeq (Illumina HiSeq 2000)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross	CLP adult bone marrow CD34+CD38+CD10+CD45RA+ 	lymphoid progenitor	CLP	adult	common lymphoid progenitor	Progenitor
GSM1695855;7284	7284	Casero	GSM1695855	CLP sample 2	Homo sapiens	CLP	CL:0000051		common lymphoid progenitor			Casero	"To elucidate the transcriptional 'landscape' that regulates human lymphoid commitment during postnatal life, we used RNA sequencing to assemble the long non-coding transcriptome across human bone marrow and thymic progenitor cells spanning the earliest stages of B lymphoid and T lymphoid specification. Over 3,000 genes encoding previously unknown long non-coding RNAs (lncRNAs) were revealed through the analysis of these rare populations. Lymphoid commitment was characterized by lncRNA expression patterns that were highly stage specific and were more lineage specific than those of protein-coding genes. Protein-coding genes co-expressed with neighboring lncRNA genes showed enrichment for ontologies related to lymphoid differentiation. The exquisite cell-type specificity of global lncRNA expression patterns independently revealed new developmental relationships among the earliest progenitor cells in the human bone marrow and thymus. Abstract from Nat Immunol. 2015 Dec;16(12):1282-91. doi: 10.1038/ni.3299."	20	"HSC, LMPP, CLP, BCP, thymic MLP, thymic MLP 2, thymic T-cell progenitor, Thymic CD4+CD8+ T-cell, Thymic CD4+ T-cell, Thymic CD8+ T-cell"	RNASeq (Illumina HiSeq 2000)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross	CLP adult bone marrow CD34+CD38+CD10+CD45RA+ 	lymphoid progenitor	CLP	adult	common lymphoid progenitor	Progenitor
GSM1695856;7284	7284	Casero	GSM1695856	BCP sample 1	Homo sapiens	BCP	CL:0000236		B cell			Casero	"To elucidate the transcriptional 'landscape' that regulates human lymphoid commitment during postnatal life, we used RNA sequencing to assemble the long non-coding transcriptome across human bone marrow and thymic progenitor cells spanning the earliest stages of B lymphoid and T lymphoid specification. Over 3,000 genes encoding previously unknown long non-coding RNAs (lncRNAs) were revealed through the analysis of these rare populations. Lymphoid commitment was characterized by lncRNA expression patterns that were highly stage specific and were more lineage specific than those of protein-coding genes. Protein-coding genes co-expressed with neighboring lncRNA genes showed enrichment for ontologies related to lymphoid differentiation. The exquisite cell-type specificity of global lncRNA expression patterns independently revealed new developmental relationships among the earliest progenitor cells in the human bone marrow and thymus. Abstract from Nat Immunol. 2015 Dec;16(12):1282-91. doi: 10.1038/ni.3299."	20	"HSC, LMPP, CLP, BCP, thymic MLP, thymic MLP 2, thymic T-cell progenitor, Thymic CD4+CD8+ T-cell, Thymic CD4+ T-cell, Thymic CD8+ T-cell"	RNASeq (Illumina HiSeq 2000)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross	CD34+CD38+CD19+	lymphoid progenitor	LP	adult	pro-B cell	Progenitor
GSM1695857;7284	7284	Casero	GSM1695857	BCP sample 2	Homo sapiens	BCP	CL:0000236		B cell			Casero	"To elucidate the transcriptional 'landscape' that regulates human lymphoid commitment during postnatal life, we used RNA sequencing to assemble the long non-coding transcriptome across human bone marrow and thymic progenitor cells spanning the earliest stages of B lymphoid and T lymphoid specification. Over 3,000 genes encoding previously unknown long non-coding RNAs (lncRNAs) were revealed through the analysis of these rare populations. Lymphoid commitment was characterized by lncRNA expression patterns that were highly stage specific and were more lineage specific than those of protein-coding genes. Protein-coding genes co-expressed with neighboring lncRNA genes showed enrichment for ontologies related to lymphoid differentiation. The exquisite cell-type specificity of global lncRNA expression patterns independently revealed new developmental relationships among the earliest progenitor cells in the human bone marrow and thymus. Abstract from Nat Immunol. 2015 Dec;16(12):1282-91. doi: 10.1038/ni.3299."	20	"HSC, LMPP, CLP, BCP, thymic MLP, thymic MLP 2, thymic T-cell progenitor, Thymic CD4+CD8+ T-cell, Thymic CD4+ T-cell, Thymic CD8+ T-cell"	RNASeq (Illumina HiSeq 2000)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross	CD34+CD38+CD19+	lymphoid progenitor	LP	adult	pro-B cell	Progenitor
GSM1695858;7284	7284	Casero	GSM1695858	Thy1 sample 1	Homo sapiens	thymic MLP	CL:0002043		hematopoietic multipotent progenitor			Casero	"To elucidate the transcriptional 'landscape' that regulates human lymphoid commitment during postnatal life, we used RNA sequencing to assemble the long non-coding transcriptome across human bone marrow and thymic progenitor cells spanning the earliest stages of B lymphoid and T lymphoid specification. Over 3,000 genes encoding previously unknown long non-coding RNAs (lncRNAs) were revealed through the analysis of these rare populations. Lymphoid commitment was characterized by lncRNA expression patterns that were highly stage specific and were more lineage specific than those of protein-coding genes. Protein-coding genes co-expressed with neighboring lncRNA genes showed enrichment for ontologies related to lymphoid differentiation. The exquisite cell-type specificity of global lncRNA expression patterns independently revealed new developmental relationships among the earliest progenitor cells in the human bone marrow and thymus. Abstract from Nat Immunol. 2015 Dec;16(12):1282-91. doi: 10.1038/ni.3299."	20	"HSC, LMPP, CLP, BCP, thymic MLP, thymic MLP 2, thymic T-cell progenitor, Thymic CD4+CD8+ T-cell, Thymic CD4+ T-cell, Thymic CD8+ T-cell"	RNASeq (Illumina HiSeq 2000)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross		hematopoietic multipotent progenitor	LP	adult	hematopoietic multipotent progenitor	Mixed
GSM1695859;7284	7284	Casero	GSM1695859	Thy1 sample 2	Homo sapiens	thymic MLP	CL:0002043		hematopoietic multipotent progenitor			Casero	"To elucidate the transcriptional 'landscape' that regulates human lymphoid commitment during postnatal life, we used RNA sequencing to assemble the long non-coding transcriptome across human bone marrow and thymic progenitor cells spanning the earliest stages of B lymphoid and T lymphoid specification. Over 3,000 genes encoding previously unknown long non-coding RNAs (lncRNAs) were revealed through the analysis of these rare populations. Lymphoid commitment was characterized by lncRNA expression patterns that were highly stage specific and were more lineage specific than those of protein-coding genes. Protein-coding genes co-expressed with neighboring lncRNA genes showed enrichment for ontologies related to lymphoid differentiation. The exquisite cell-type specificity of global lncRNA expression patterns independently revealed new developmental relationships among the earliest progenitor cells in the human bone marrow and thymus. Abstract from Nat Immunol. 2015 Dec;16(12):1282-91. doi: 10.1038/ni.3299."	20	"HSC, LMPP, CLP, BCP, thymic MLP, thymic MLP 2, thymic T-cell progenitor, Thymic CD4+CD8+ T-cell, Thymic CD4+ T-cell, Thymic CD8+ T-cell"	RNASeq (Illumina HiSeq 2000)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross		hematopoietic multipotent progenitor	LP	adult	hematopoietic multipotent progenitor	Progenitor
GSM1695860;7284	7284	Casero	GSM1695860	Thy2 sample 1	Homo sapiens	thymic MLP 2	CL:0002425		early T lineage precursor			Casero	"To elucidate the transcriptional 'landscape' that regulates human lymphoid commitment during postnatal life, we used RNA sequencing to assemble the long non-coding transcriptome across human bone marrow and thymic progenitor cells spanning the earliest stages of B lymphoid and T lymphoid specification. Over 3,000 genes encoding previously unknown long non-coding RNAs (lncRNAs) were revealed through the analysis of these rare populations. Lymphoid commitment was characterized by lncRNA expression patterns that were highly stage specific and were more lineage specific than those of protein-coding genes. Protein-coding genes co-expressed with neighboring lncRNA genes showed enrichment for ontologies related to lymphoid differentiation. The exquisite cell-type specificity of global lncRNA expression patterns independently revealed new developmental relationships among the earliest progenitor cells in the human bone marrow and thymus. Abstract from Nat Immunol. 2015 Dec;16(12):1282-91. doi: 10.1038/ni.3299."	20	"HSC, LMPP, CLP, BCP, thymic MLP, thymic MLP 2, thymic T-cell progenitor, Thymic CD4+CD8+ T-cell, Thymic CD4+ T-cell, Thymic CD8+ T-cell"	RNASeq (Illumina HiSeq 2000)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross		lymphoid progenitor	LP	adult	early T lineage precursor	Progenitor
GSM1695861;7284	7284	Casero	GSM1695861	Thy2 sample 2	Homo sapiens	thymic MLP 2	CL:0002425		early T lineage precursor			Casero	"To elucidate the transcriptional 'landscape' that regulates human lymphoid commitment during postnatal life, we used RNA sequencing to assemble the long non-coding transcriptome across human bone marrow and thymic progenitor cells spanning the earliest stages of B lymphoid and T lymphoid specification. Over 3,000 genes encoding previously unknown long non-coding RNAs (lncRNAs) were revealed through the analysis of these rare populations. Lymphoid commitment was characterized by lncRNA expression patterns that were highly stage specific and were more lineage specific than those of protein-coding genes. Protein-coding genes co-expressed with neighboring lncRNA genes showed enrichment for ontologies related to lymphoid differentiation. The exquisite cell-type specificity of global lncRNA expression patterns independently revealed new developmental relationships among the earliest progenitor cells in the human bone marrow and thymus. Abstract from Nat Immunol. 2015 Dec;16(12):1282-91. doi: 10.1038/ni.3299."	20	"HSC, LMPP, CLP, BCP, thymic MLP, thymic MLP 2, thymic T-cell progenitor, Thymic CD4+CD8+ T-cell, Thymic CD4+ T-cell, Thymic CD8+ T-cell"	RNASeq (Illumina HiSeq 2000)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross		lymphoid progenitor	LP	adult	early T lineage precursor	Progenitor
GSM1695862;7284	7284	Casero	GSM1695862	Thy3 sample 1	Homo sapiens	thymic T-cell progenitor	CL:0001028		CD7+ lymphoid progenitor			Casero	"To elucidate the transcriptional 'landscape' that regulates human lymphoid commitment during postnatal life, we used RNA sequencing to assemble the long non-coding transcriptome across human bone marrow and thymic progenitor cells spanning the earliest stages of B lymphoid and T lymphoid specification. Over 3,000 genes encoding previously unknown long non-coding RNAs (lncRNAs) were revealed through the analysis of these rare populations. Lymphoid commitment was characterized by lncRNA expression patterns that were highly stage specific and were more lineage specific than those of protein-coding genes. Protein-coding genes co-expressed with neighboring lncRNA genes showed enrichment for ontologies related to lymphoid differentiation. The exquisite cell-type specificity of global lncRNA expression patterns independently revealed new developmental relationships among the earliest progenitor cells in the human bone marrow and thymus. Abstract from Nat Immunol. 2015 Dec;16(12):1282-91. doi: 10.1038/ni.3299."	20	"HSC, LMPP, CLP, BCP, thymic MLP, thymic MLP 2, thymic T-cell progenitor, Thymic CD4+CD8+ T-cell, Thymic CD4+ T-cell, Thymic CD8+ T-cell"	RNASeq (Illumina HiSeq 2000)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross		lymphoid progenitor	LP	adult	CD7+ lymphoid progenitor	Progenitor
GSM1695863;7284	7284	Casero	GSM1695863	Thy3 sample 2	Homo sapiens	thymic T-cell progenitor	CL:0001028		CD7+ lymphoid progenitor			Casero	"To elucidate the transcriptional 'landscape' that regulates human lymphoid commitment during postnatal life, we used RNA sequencing to assemble the long non-coding transcriptome across human bone marrow and thymic progenitor cells spanning the earliest stages of B lymphoid and T lymphoid specification. Over 3,000 genes encoding previously unknown long non-coding RNAs (lncRNAs) were revealed through the analysis of these rare populations. Lymphoid commitment was characterized by lncRNA expression patterns that were highly stage specific and were more lineage specific than those of protein-coding genes. Protein-coding genes co-expressed with neighboring lncRNA genes showed enrichment for ontologies related to lymphoid differentiation. The exquisite cell-type specificity of global lncRNA expression patterns independently revealed new developmental relationships among the earliest progenitor cells in the human bone marrow and thymus. Abstract from Nat Immunol. 2015 Dec;16(12):1282-91. doi: 10.1038/ni.3299."	20	"HSC, LMPP, CLP, BCP, thymic MLP, thymic MLP 2, thymic T-cell progenitor, Thymic CD4+CD8+ T-cell, Thymic CD4+ T-cell, Thymic CD8+ T-cell"	RNASeq (Illumina HiSeq 2000)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross		lymphoid progenitor	LP	adult	CD7+ lymphoid progenitor	Progenitor
GSM1695864;7284	7284	Casero	GSM1695864	Thy4 sample 1	Homo sapiens	Thymic CD4+CD8+ T-cell	CL:0000809		T cell			Casero	"To elucidate the transcriptional 'landscape' that regulates human lymphoid commitment during postnatal life, we used RNA sequencing to assemble the long non-coding transcriptome across human bone marrow and thymic progenitor cells spanning the earliest stages of B lymphoid and T lymphoid specification. Over 3,000 genes encoding previously unknown long non-coding RNAs (lncRNAs) were revealed through the analysis of these rare populations. Lymphoid commitment was characterized by lncRNA expression patterns that were highly stage specific and were more lineage specific than those of protein-coding genes. Protein-coding genes co-expressed with neighboring lncRNA genes showed enrichment for ontologies related to lymphoid differentiation. The exquisite cell-type specificity of global lncRNA expression patterns independently revealed new developmental relationships among the earliest progenitor cells in the human bone marrow and thymus. Abstract from Nat Immunol. 2015 Dec;16(12):1282-91. doi: 10.1038/ni.3299."	20	"HSC, LMPP, CLP, BCP, thymic MLP, thymic MLP 2, thymic T-cell progenitor, Thymic CD4+CD8+ T-cell, Thymic CD4+ T-cell, Thymic CD8+ T-cell"	RNASeq (Illumina HiSeq 2000)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross		lymphoid progenitor	T Cell	adult	double-positive thymocyte	Lymphocyte
GSM1695865;7284	7284	Casero	GSM1695865	Thy4 sample 2	Homo sapiens	Thymic CD4+CD8+ T-cell	CL:0000809		T cell			Casero	"To elucidate the transcriptional 'landscape' that regulates human lymphoid commitment during postnatal life, we used RNA sequencing to assemble the long non-coding transcriptome across human bone marrow and thymic progenitor cells spanning the earliest stages of B lymphoid and T lymphoid specification. Over 3,000 genes encoding previously unknown long non-coding RNAs (lncRNAs) were revealed through the analysis of these rare populations. Lymphoid commitment was characterized by lncRNA expression patterns that were highly stage specific and were more lineage specific than those of protein-coding genes. Protein-coding genes co-expressed with neighboring lncRNA genes showed enrichment for ontologies related to lymphoid differentiation. The exquisite cell-type specificity of global lncRNA expression patterns independently revealed new developmental relationships among the earliest progenitor cells in the human bone marrow and thymus. Abstract from Nat Immunol. 2015 Dec;16(12):1282-91. doi: 10.1038/ni.3299."	20	"HSC, LMPP, CLP, BCP, thymic MLP, thymic MLP 2, thymic T-cell progenitor, Thymic CD4+CD8+ T-cell, Thymic CD4+ T-cell, Thymic CD8+ T-cell"	RNASeq (Illumina HiSeq 2000)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross		lymphoid progenitor	T Cell	adult	double-positive thymocyte	Lymphocyte
GSM1695866;7284	7284	Casero	GSM1695866	Thy5 sample 1	Homo sapiens	Thymic CD4+ T-cell	CL:0000624		CD4+ T cell			Casero	"To elucidate the transcriptional 'landscape' that regulates human lymphoid commitment during postnatal life, we used RNA sequencing to assemble the long non-coding transcriptome across human bone marrow and thymic progenitor cells spanning the earliest stages of B lymphoid and T lymphoid specification. Over 3,000 genes encoding previously unknown long non-coding RNAs (lncRNAs) were revealed through the analysis of these rare populations. Lymphoid commitment was characterized by lncRNA expression patterns that were highly stage specific and were more lineage specific than those of protein-coding genes. Protein-coding genes co-expressed with neighboring lncRNA genes showed enrichment for ontologies related to lymphoid differentiation. The exquisite cell-type specificity of global lncRNA expression patterns independently revealed new developmental relationships among the earliest progenitor cells in the human bone marrow and thymus. Abstract from Nat Immunol. 2015 Dec;16(12):1282-91. doi: 10.1038/ni.3299."	20	"HSC, LMPP, CLP, BCP, thymic MLP, thymic MLP 2, thymic T-cell progenitor, Thymic CD4+CD8+ T-cell, Thymic CD4+ T-cell, Thymic CD8+ T-cell"	RNASeq (Illumina HiSeq 2000)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross		lymphoid	T Cell	adult	CD4+ T cell	Lymphocyte
GSM1695867;7284	7284	Casero	GSM1695867	Thy5 sample 2	Homo sapiens	Thymic CD4+ T-cell	CL:0000624		CD4+ T cell			Casero	"To elucidate the transcriptional 'landscape' that regulates human lymphoid commitment during postnatal life, we used RNA sequencing to assemble the long non-coding transcriptome across human bone marrow and thymic progenitor cells spanning the earliest stages of B lymphoid and T lymphoid specification. Over 3,000 genes encoding previously unknown long non-coding RNAs (lncRNAs) were revealed through the analysis of these rare populations. Lymphoid commitment was characterized by lncRNA expression patterns that were highly stage specific and were more lineage specific than those of protein-coding genes. Protein-coding genes co-expressed with neighboring lncRNA genes showed enrichment for ontologies related to lymphoid differentiation. The exquisite cell-type specificity of global lncRNA expression patterns independently revealed new developmental relationships among the earliest progenitor cells in the human bone marrow and thymus. Abstract from Nat Immunol. 2015 Dec;16(12):1282-91. doi: 10.1038/ni.3299."	20	"HSC, LMPP, CLP, BCP, thymic MLP, thymic MLP 2, thymic T-cell progenitor, Thymic CD4+CD8+ T-cell, Thymic CD4+ T-cell, Thymic CD8+ T-cell"	RNASeq (Illumina HiSeq 2000)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross		lymphoid	T Cell	adult	CD4+ T cell	Lymphocyte
GSM1695868;7284	7284	Casero	GSM1695868	Thy6 sample 1	Homo sapiens	Thymic CD8+ T-cell	CL:0000625		CD8+ T cell			Casero	"To elucidate the transcriptional 'landscape' that regulates human lymphoid commitment during postnatal life, we used RNA sequencing to assemble the long non-coding transcriptome across human bone marrow and thymic progenitor cells spanning the earliest stages of B lymphoid and T lymphoid specification. Over 3,000 genes encoding previously unknown long non-coding RNAs (lncRNAs) were revealed through the analysis of these rare populations. Lymphoid commitment was characterized by lncRNA expression patterns that were highly stage specific and were more lineage specific than those of protein-coding genes. Protein-coding genes co-expressed with neighboring lncRNA genes showed enrichment for ontologies related to lymphoid differentiation. The exquisite cell-type specificity of global lncRNA expression patterns independently revealed new developmental relationships among the earliest progenitor cells in the human bone marrow and thymus. Abstract from Nat Immunol. 2015 Dec;16(12):1282-91. doi: 10.1038/ni.3299."	20	"HSC, LMPP, CLP, BCP, thymic MLP, thymic MLP 2, thymic T-cell progenitor, Thymic CD4+CD8+ T-cell, Thymic CD4+ T-cell, Thymic CD8+ T-cell"	RNASeq (Illumina HiSeq 2000)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross		lymphoid	T Cell	adult	CD8+ T cell	Lymphocyte
GSM1695869;7284	7284	Casero	GSM1695869	Thy6 sample 2	Homo sapiens	Thymic CD8+ T-cell	CL:0000625		CD8+ T cell			Casero	"To elucidate the transcriptional 'landscape' that regulates human lymphoid commitment during postnatal life, we used RNA sequencing to assemble the long non-coding transcriptome across human bone marrow and thymic progenitor cells spanning the earliest stages of B lymphoid and T lymphoid specification. Over 3,000 genes encoding previously unknown long non-coding RNAs (lncRNAs) were revealed through the analysis of these rare populations. Lymphoid commitment was characterized by lncRNA expression patterns that were highly stage specific and were more lineage specific than those of protein-coding genes. Protein-coding genes co-expressed with neighboring lncRNA genes showed enrichment for ontologies related to lymphoid differentiation. The exquisite cell-type specificity of global lncRNA expression patterns independently revealed new developmental relationships among the earliest progenitor cells in the human bone marrow and thymus. Abstract from Nat Immunol. 2015 Dec;16(12):1282-91. doi: 10.1038/ni.3299."	20	"HSC, LMPP, CLP, BCP, thymic MLP, thymic MLP 2, thymic T-cell progenitor, Thymic CD4+CD8+ T-cell, Thymic CD4+ T-cell, Thymic CD8+ T-cell"	RNASeq (Illumina HiSeq 2000)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross		lymphoid	T Cell	adult	CD8+ T cell	Lymphocyte
GSM1977401;7283	7283	Notta	GSM1977401	CB1_HSC	Homo sapiens	HSC	CL:0000837		hematopoietic multipotent progenitor			Notta	"In a classical view of hematopoiesis, the various blood cell lineages arise via a hierarchical scheme starting with multipotent stem cells that become increasingly restricted in their differentiation potential through oligopotent and then unipotent progenitors. We developed a cell-sorting scheme to resolve myeloid (My), erythroid (Er), and megakaryocytic (Mk) fates from single CD34(+) cells and then mapped the progenitor hierarchy across human development. Fetal liver contained large numbers of distinct oligopotent progenitors with intermingled My, Er, and Mk fates. However, few oligopotent progenitor intermediates were present in the adult bone marrow. Instead, only two progenitor classes predominate, multipotent and unipotent, with Er-Mk lineages emerging from multipotent cells. The developmental shift to an adult ""two-tier"" hierarchy challenges current dogma and provides a revised framework to understand normal and disease states of human hematopoiesis. Abstract from Science. 2016 Jan 8;351(6269):aab2116. doi: 10.1126/science.aab2116."	24	"HSC, MPP_71-BAH-, MPP_71+, MPP_71+BAH+, CMP_71-BAH-, CMP_71+, CMP_71+_BAH+, MEP_71-BAH-, MEP_71+, MEP_71+BAH+, MLP, GMP"	RNASeq (Illumina HiSeq 2000)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross	MHP CD34  neonatal	hematopoietic multipotent progenitor	MHP	neonatal	hematopoietic multipotent progenitor	Progenitor
GSM1977407;7283	7283	Notta	GSM1977407	CB2_HSC	Homo sapiens	HSC	CL:0000837		hematopoietic multipotent progenitor			Notta	"In a classical view of hematopoiesis, the various blood cell lineages arise via a hierarchical scheme starting with multipotent stem cells that become increasingly restricted in their differentiation potential through oligopotent and then unipotent progenitors. We developed a cell-sorting scheme to resolve myeloid (My), erythroid (Er), and megakaryocytic (Mk) fates from single CD34(+) cells and then mapped the progenitor hierarchy across human development. Fetal liver contained large numbers of distinct oligopotent progenitors with intermingled My, Er, and Mk fates. However, few oligopotent progenitor intermediates were present in the adult bone marrow. Instead, only two progenitor classes predominate, multipotent and unipotent, with Er-Mk lineages emerging from multipotent cells. The developmental shift to an adult ""two-tier"" hierarchy challenges current dogma and provides a revised framework to understand normal and disease states of human hematopoiesis. Abstract from Science. 2016 Jan 8;351(6269):aab2116. doi: 10.1126/science.aab2116."	24	"HSC, MPP_71-BAH-, MPP_71+, MPP_71+BAH+, CMP_71-BAH-, CMP_71+, CMP_71+_BAH+, MEP_71-BAH-, MEP_71+, MEP_71+BAH+, MLP, GMP"	RNASeq (Illumina HiSeq 2000)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross	MHP CD34  neonatal	hematopoietic multipotent progenitor	MHP	neonatal	hematopoietic multipotent progenitor	Progenitor
GSM2036944;7288	7288	Healy	GSM2036944	microglia_M0_1	Homo sapiens	microglia	CL:0000129		microglia			Healy	"Multifocal inflammatory lesions featuring destruction of lipid-rich myelin are pathologic hallmarks of multiple sclerosis. Lesion activity is assessed by the extent and composition of myelin uptake by myeloid cells present in such lesions. In the inflamed CNS, myeloid cells are comprised of brain-resident microglia, an endogenous cell population, and monocyte-derived macrophages, which infiltrate from the systemic compartment. Using microglia isolated from the adult human brain, we demonstrate that myelin phagocytosis is dependent on the polarization state of the cells. Myelin ingestion is significantly enhanced in cells exposed to TGF- compared with resting basal conditions and markedly reduced in classically activated polarized cells. Transcriptional analysis indicated that TGF--treated microglia closely resembled M0 cells. The tyrosine kinase phagocytic receptor MerTK was one of the most upregulated among a select number of differentially expressed genes in TGF--treated microglia. In contrast, MerTK and its known ligands, growth arrest-specific 6 and Protein S, were downregulated in classically activated cells. MerTK expression and myelin phagocytosis were higher in CNS-derived microglia than observed in monocyte-derived macrophages, both basally and under all tested polarization conditions. Specific MerTK inhibitors reduced myelin phagocytosis and the resultant anti-inflammatory biased cytokine responses for both cell types. Defining and modulating the mechanisms that regulate myelin phagocytosis has the potential to impact lesion and disease evolution in multiple sclerosis. Relevant effects would include enhancing myelin clearance, increasing anti-inflammatory molecule production by myeloid cells, and thereby permitting subsequent tissue repair. Abstract from J Immunol. 2016 Apr 15;196(8):3375-84. doi: 10.4049/jimmunol.1502562."	30	"MDM-CSF1, MDM +IFNg +LPS 2d, MDM + IL4 + IL13 2d, MDM + IL4 + IL13 +IL10 2d, MDM + TGFB, microglia, microglia + IFNg + LPS 2d, microglia + IL4 + IL13, microglia + IL4 + IL10 + IL13, microglia + TGFB"	Microarray (Affymetrix HuGene-2_0-ST V1)		Homo sapiens	3.56	HuGene	"rgb(0,109,219)"	diamond-open		myeloid	myeloid	adult	microglia	Macrophage
GSM2036945;7288	7288	Healy	GSM2036945	microglia_M0_2	Homo sapiens	microglia	CL:0000129		microglia			Healy	"Multifocal inflammatory lesions featuring destruction of lipid-rich myelin are pathologic hallmarks of multiple sclerosis. Lesion activity is assessed by the extent and composition of myelin uptake by myeloid cells present in such lesions. In the inflamed CNS, myeloid cells are comprised of brain-resident microglia, an endogenous cell population, and monocyte-derived macrophages, which infiltrate from the systemic compartment. Using microglia isolated from the adult human brain, we demonstrate that myelin phagocytosis is dependent on the polarization state of the cells. Myelin ingestion is significantly enhanced in cells exposed to TGF- compared with resting basal conditions and markedly reduced in classically activated polarized cells. Transcriptional analysis indicated that TGF--treated microglia closely resembled M0 cells. The tyrosine kinase phagocytic receptor MerTK was one of the most upregulated among a select number of differentially expressed genes in TGF--treated microglia. In contrast, MerTK and its known ligands, growth arrest-specific 6 and Protein S, were downregulated in classically activated cells. MerTK expression and myelin phagocytosis were higher in CNS-derived microglia than observed in monocyte-derived macrophages, both basally and under all tested polarization conditions. Specific MerTK inhibitors reduced myelin phagocytosis and the resultant anti-inflammatory biased cytokine responses for both cell types. Defining and modulating the mechanisms that regulate myelin phagocytosis has the potential to impact lesion and disease evolution in multiple sclerosis. Relevant effects would include enhancing myelin clearance, increasing anti-inflammatory molecule production by myeloid cells, and thereby permitting subsequent tissue repair. Abstract from J Immunol. 2016 Apr 15;196(8):3375-84. doi: 10.4049/jimmunol.1502562."	30	"MDM-CSF1, MDM +IFNg +LPS 2d, MDM + IL4 + IL13 2d, MDM + IL4 + IL13 +IL10 2d, MDM + TGFB, microglia, microglia + IFNg + LPS 2d, microglia + IL4 + IL13, microglia + IL4 + IL10 + IL13, microglia + TGFB"	Microarray (Affymetrix HuGene-2_0-ST V1)		Homo sapiens	3.56	HuGene	"rgb(0,109,219)"	diamond-open		myeloid	myeloid	adult	microglia	Macrophage
GSM2036946;7288	7288	Healy	GSM2036946	microglia_M0_3	Homo sapiens	microglia	CL:0000129		microglia			Healy	"Multifocal inflammatory lesions featuring destruction of lipid-rich myelin are pathologic hallmarks of multiple sclerosis. Lesion activity is assessed by the extent and composition of myelin uptake by myeloid cells present in such lesions. In the inflamed CNS, myeloid cells are comprised of brain-resident microglia, an endogenous cell population, and monocyte-derived macrophages, which infiltrate from the systemic compartment. Using microglia isolated from the adult human brain, we demonstrate that myelin phagocytosis is dependent on the polarization state of the cells. Myelin ingestion is significantly enhanced in cells exposed to TGF- compared with resting basal conditions and markedly reduced in classically activated polarized cells. Transcriptional analysis indicated that TGF--treated microglia closely resembled M0 cells. The tyrosine kinase phagocytic receptor MerTK was one of the most upregulated among a select number of differentially expressed genes in TGF--treated microglia. In contrast, MerTK and its known ligands, growth arrest-specific 6 and Protein S, were downregulated in classically activated cells. MerTK expression and myelin phagocytosis were higher in CNS-derived microglia than observed in monocyte-derived macrophages, both basally and under all tested polarization conditions. Specific MerTK inhibitors reduced myelin phagocytosis and the resultant anti-inflammatory biased cytokine responses for both cell types. Defining and modulating the mechanisms that regulate myelin phagocytosis has the potential to impact lesion and disease evolution in multiple sclerosis. Relevant effects would include enhancing myelin clearance, increasing anti-inflammatory molecule production by myeloid cells, and thereby permitting subsequent tissue repair. Abstract from J Immunol. 2016 Apr 15;196(8):3375-84. doi: 10.4049/jimmunol.1502562."	30	"MDM-CSF1, MDM +IFNg +LPS 2d, MDM + IL4 + IL13 2d, MDM + IL4 + IL13 +IL10 2d, MDM + TGFB, microglia, microglia + IFNg + LPS 2d, microglia + IL4 + IL13, microglia + IL4 + IL10 + IL13, microglia + TGFB"	Microarray (Affymetrix HuGene-2_0-ST V1)		Homo sapiens	3.56	HuGene	"rgb(0,109,219)"	diamond-open		myeloid	myeloid	adult	microglia	Macrophage
GSM2036947;7288	7288	Healy	GSM2036947	microglia_Mtgf_1	Homo sapiens	microglia + TGFB	CL:0000129		microglia			Healy	"Multifocal inflammatory lesions featuring destruction of lipid-rich myelin are pathologic hallmarks of multiple sclerosis. Lesion activity is assessed by the extent and composition of myelin uptake by myeloid cells present in such lesions. In the inflamed CNS, myeloid cells are comprised of brain-resident microglia, an endogenous cell population, and monocyte-derived macrophages, which infiltrate from the systemic compartment. Using microglia isolated from the adult human brain, we demonstrate that myelin phagocytosis is dependent on the polarization state of the cells. Myelin ingestion is significantly enhanced in cells exposed to TGF- compared with resting basal conditions and markedly reduced in classically activated polarized cells. Transcriptional analysis indicated that TGF--treated microglia closely resembled M0 cells. The tyrosine kinase phagocytic receptor MerTK was one of the most upregulated among a select number of differentially expressed genes in TGF--treated microglia. In contrast, MerTK and its known ligands, growth arrest-specific 6 and Protein S, were downregulated in classically activated cells. MerTK expression and myelin phagocytosis were higher in CNS-derived microglia than observed in monocyte-derived macrophages, both basally and under all tested polarization conditions. Specific MerTK inhibitors reduced myelin phagocytosis and the resultant anti-inflammatory biased cytokine responses for both cell types. Defining and modulating the mechanisms that regulate myelin phagocytosis has the potential to impact lesion and disease evolution in multiple sclerosis. Relevant effects would include enhancing myelin clearance, increasing anti-inflammatory molecule production by myeloid cells, and thereby permitting subsequent tissue repair. Abstract from J Immunol. 2016 Apr 15;196(8):3375-84. doi: 10.4049/jimmunol.1502562."	30	"MDM-CSF1, MDM +IFNg +LPS 2d, MDM + IL4 + IL13 2d, MDM + IL4 + IL13 +IL10 2d, MDM + TGFB, microglia, microglia + IFNg + LPS 2d, microglia + IL4 + IL13, microglia + IL4 + IL10 + IL13, microglia + TGFB"	Microarray (Affymetrix HuGene-2_0-ST V1)		Homo sapiens	3.56	HuGene	"rgb(0,109,219)"	diamond-open		myeloid	myeloid	adult	microglia	Macrophage
GSM2036948;7288	7288	Healy	GSM2036948	microglia_Mtgf_2	Homo sapiens	microglia + TGFB	CL:0000129		microglia			Healy	"Multifocal inflammatory lesions featuring destruction of lipid-rich myelin are pathologic hallmarks of multiple sclerosis. Lesion activity is assessed by the extent and composition of myelin uptake by myeloid cells present in such lesions. In the inflamed CNS, myeloid cells are comprised of brain-resident microglia, an endogenous cell population, and monocyte-derived macrophages, which infiltrate from the systemic compartment. Using microglia isolated from the adult human brain, we demonstrate that myelin phagocytosis is dependent on the polarization state of the cells. Myelin ingestion is significantly enhanced in cells exposed to TGF- compared with resting basal conditions and markedly reduced in classically activated polarized cells. Transcriptional analysis indicated that TGF--treated microglia closely resembled M0 cells. The tyrosine kinase phagocytic receptor MerTK was one of the most upregulated among a select number of differentially expressed genes in TGF--treated microglia. In contrast, MerTK and its known ligands, growth arrest-specific 6 and Protein S, were downregulated in classically activated cells. MerTK expression and myelin phagocytosis were higher in CNS-derived microglia than observed in monocyte-derived macrophages, both basally and under all tested polarization conditions. Specific MerTK inhibitors reduced myelin phagocytosis and the resultant anti-inflammatory biased cytokine responses for both cell types. Defining and modulating the mechanisms that regulate myelin phagocytosis has the potential to impact lesion and disease evolution in multiple sclerosis. Relevant effects would include enhancing myelin clearance, increasing anti-inflammatory molecule production by myeloid cells, and thereby permitting subsequent tissue repair. Abstract from J Immunol. 2016 Apr 15;196(8):3375-84. doi: 10.4049/jimmunol.1502562."	30	"MDM-CSF1, MDM +IFNg +LPS 2d, MDM + IL4 + IL13 2d, MDM + IL4 + IL13 +IL10 2d, MDM + TGFB, microglia, microglia + IFNg + LPS 2d, microglia + IL4 + IL13, microglia + IL4 + IL10 + IL13, microglia + TGFB"	Microarray (Affymetrix HuGene-2_0-ST V1)		Homo sapiens	3.56	HuGene	"rgb(0,109,219)"	diamond-open		myeloid	myeloid	adult	microglia	Macrophage
GSM2036949;7288	7288	Healy	GSM2036949	microglia_Mtgf_3	Homo sapiens	microglia + TGFB	CL:0000129		microglia			Healy	"Multifocal inflammatory lesions featuring destruction of lipid-rich myelin are pathologic hallmarks of multiple sclerosis. Lesion activity is assessed by the extent and composition of myelin uptake by myeloid cells present in such lesions. In the inflamed CNS, myeloid cells are comprised of brain-resident microglia, an endogenous cell population, and monocyte-derived macrophages, which infiltrate from the systemic compartment. Using microglia isolated from the adult human brain, we demonstrate that myelin phagocytosis is dependent on the polarization state of the cells. Myelin ingestion is significantly enhanced in cells exposed to TGF- compared with resting basal conditions and markedly reduced in classically activated polarized cells. Transcriptional analysis indicated that TGF--treated microglia closely resembled M0 cells. The tyrosine kinase phagocytic receptor MerTK was one of the most upregulated among a select number of differentially expressed genes in TGF--treated microglia. In contrast, MerTK and its known ligands, growth arrest-specific 6 and Protein S, were downregulated in classically activated cells. MerTK expression and myelin phagocytosis were higher in CNS-derived microglia than observed in monocyte-derived macrophages, both basally and under all tested polarization conditions. Specific MerTK inhibitors reduced myelin phagocytosis and the resultant anti-inflammatory biased cytokine responses for both cell types. Defining and modulating the mechanisms that regulate myelin phagocytosis has the potential to impact lesion and disease evolution in multiple sclerosis. Relevant effects would include enhancing myelin clearance, increasing anti-inflammatory molecule production by myeloid cells, and thereby permitting subsequent tissue repair. Abstract from J Immunol. 2016 Apr 15;196(8):3375-84. doi: 10.4049/jimmunol.1502562."	30	"MDM-CSF1, MDM +IFNg +LPS 2d, MDM + IL4 + IL13 2d, MDM + IL4 + IL13 +IL10 2d, MDM + TGFB, microglia, microglia + IFNg + LPS 2d, microglia + IL4 + IL13, microglia + IL4 + IL10 + IL13, microglia + TGFB"	Microarray (Affymetrix HuGene-2_0-ST V1)		Homo sapiens	3.56	HuGene	"rgb(0,109,219)"	diamond-open		myeloid	myeloid	adult	microglia	Macrophage
GSM2036950;7288	7288	Healy	GSM2036950	microglia_M1_1	Homo sapiens	microglia + IFNg + LPS 2d	CL:0000129		microglia			Healy	"Multifocal inflammatory lesions featuring destruction of lipid-rich myelin are pathologic hallmarks of multiple sclerosis. Lesion activity is assessed by the extent and composition of myelin uptake by myeloid cells present in such lesions. In the inflamed CNS, myeloid cells are comprised of brain-resident microglia, an endogenous cell population, and monocyte-derived macrophages, which infiltrate from the systemic compartment. Using microglia isolated from the adult human brain, we demonstrate that myelin phagocytosis is dependent on the polarization state of the cells. Myelin ingestion is significantly enhanced in cells exposed to TGF- compared with resting basal conditions and markedly reduced in classically activated polarized cells. Transcriptional analysis indicated that TGF--treated microglia closely resembled M0 cells. The tyrosine kinase phagocytic receptor MerTK was one of the most upregulated among a select number of differentially expressed genes in TGF--treated microglia. In contrast, MerTK and its known ligands, growth arrest-specific 6 and Protein S, were downregulated in classically activated cells. MerTK expression and myelin phagocytosis were higher in CNS-derived microglia than observed in monocyte-derived macrophages, both basally and under all tested polarization conditions. Specific MerTK inhibitors reduced myelin phagocytosis and the resultant anti-inflammatory biased cytokine responses for both cell types. Defining and modulating the mechanisms that regulate myelin phagocytosis has the potential to impact lesion and disease evolution in multiple sclerosis. Relevant effects would include enhancing myelin clearance, increasing anti-inflammatory molecule production by myeloid cells, and thereby permitting subsequent tissue repair. Abstract from J Immunol. 2016 Apr 15;196(8):3375-84. doi: 10.4049/jimmunol.1502562."	30	"MDM-CSF1, MDM +IFNg +LPS 2d, MDM + IL4 + IL13 2d, MDM + IL4 + IL13 +IL10 2d, MDM + TGFB, microglia, microglia + IFNg + LPS 2d, microglia + IL4 + IL13, microglia + IL4 + IL10 + IL13, microglia + TGFB"	Microarray (Affymetrix HuGene-2_0-ST V1)		Homo sapiens	3.56	HuGene	"rgb(0,109,219)"	diamond-open		myeloid	myeloid	adult	microglia	Macrophage
GSM2036951;7288	7288	Healy	GSM2036951	microglia_M1_2	Homo sapiens	microglia + IFNg + LPS 2d	CL:0000129		microglia			Healy	"Multifocal inflammatory lesions featuring destruction of lipid-rich myelin are pathologic hallmarks of multiple sclerosis. Lesion activity is assessed by the extent and composition of myelin uptake by myeloid cells present in such lesions. In the inflamed CNS, myeloid cells are comprised of brain-resident microglia, an endogenous cell population, and monocyte-derived macrophages, which infiltrate from the systemic compartment. Using microglia isolated from the adult human brain, we demonstrate that myelin phagocytosis is dependent on the polarization state of the cells. Myelin ingestion is significantly enhanced in cells exposed to TGF- compared with resting basal conditions and markedly reduced in classically activated polarized cells. Transcriptional analysis indicated that TGF--treated microglia closely resembled M0 cells. The tyrosine kinase phagocytic receptor MerTK was one of the most upregulated among a select number of differentially expressed genes in TGF--treated microglia. In contrast, MerTK and its known ligands, growth arrest-specific 6 and Protein S, were downregulated in classically activated cells. MerTK expression and myelin phagocytosis were higher in CNS-derived microglia than observed in monocyte-derived macrophages, both basally and under all tested polarization conditions. Specific MerTK inhibitors reduced myelin phagocytosis and the resultant anti-inflammatory biased cytokine responses for both cell types. Defining and modulating the mechanisms that regulate myelin phagocytosis has the potential to impact lesion and disease evolution in multiple sclerosis. Relevant effects would include enhancing myelin clearance, increasing anti-inflammatory molecule production by myeloid cells, and thereby permitting subsequent tissue repair. Abstract from J Immunol. 2016 Apr 15;196(8):3375-84. doi: 10.4049/jimmunol.1502562."	30	"MDM-CSF1, MDM +IFNg +LPS 2d, MDM + IL4 + IL13 2d, MDM + IL4 + IL13 +IL10 2d, MDM + TGFB, microglia, microglia + IFNg + LPS 2d, microglia + IL4 + IL13, microglia + IL4 + IL10 + IL13, microglia + TGFB"	Microarray (Affymetrix HuGene-2_0-ST V1)		Homo sapiens	3.56	HuGene	"rgb(0,109,219)"	diamond-open		myeloid	myeloid	adult	microglia	Macrophage
GSM2036952;7288	7288	Healy	GSM2036952	microglia_M1_3	Homo sapiens	microglia + IFNg + LPS 2d	CL:0000129		microglia			Healy	"Multifocal inflammatory lesions featuring destruction of lipid-rich myelin are pathologic hallmarks of multiple sclerosis. Lesion activity is assessed by the extent and composition of myelin uptake by myeloid cells present in such lesions. In the inflamed CNS, myeloid cells are comprised of brain-resident microglia, an endogenous cell population, and monocyte-derived macrophages, which infiltrate from the systemic compartment. Using microglia isolated from the adult human brain, we demonstrate that myelin phagocytosis is dependent on the polarization state of the cells. Myelin ingestion is significantly enhanced in cells exposed to TGF- compared with resting basal conditions and markedly reduced in classically activated polarized cells. Transcriptional analysis indicated that TGF--treated microglia closely resembled M0 cells. The tyrosine kinase phagocytic receptor MerTK was one of the most upregulated among a select number of differentially expressed genes in TGF--treated microglia. In contrast, MerTK and its known ligands, growth arrest-specific 6 and Protein S, were downregulated in classically activated cells. MerTK expression and myelin phagocytosis were higher in CNS-derived microglia than observed in monocyte-derived macrophages, both basally and under all tested polarization conditions. Specific MerTK inhibitors reduced myelin phagocytosis and the resultant anti-inflammatory biased cytokine responses for both cell types. Defining and modulating the mechanisms that regulate myelin phagocytosis has the potential to impact lesion and disease evolution in multiple sclerosis. Relevant effects would include enhancing myelin clearance, increasing anti-inflammatory molecule production by myeloid cells, and thereby permitting subsequent tissue repair. Abstract from J Immunol. 2016 Apr 15;196(8):3375-84. doi: 10.4049/jimmunol.1502562."	30	"MDM-CSF1, MDM +IFNg +LPS 2d, MDM + IL4 + IL13 2d, MDM + IL4 + IL13 +IL10 2d, MDM + TGFB, microglia, microglia + IFNg + LPS 2d, microglia + IL4 + IL13, microglia + IL4 + IL10 + IL13, microglia + TGFB"	Microarray (Affymetrix HuGene-2_0-ST V1)		Homo sapiens	3.56	HuGene	"rgb(0,109,219)"	diamond-open		myeloid	myeloid	adult	microglia	Macrophage
GSM2036953;7288	7288	Healy	GSM2036953	microglia_M2a_1	Homo sapiens	microglia + IL4 + IL13	CL:0000129		microglia			Healy	"Multifocal inflammatory lesions featuring destruction of lipid-rich myelin are pathologic hallmarks of multiple sclerosis. Lesion activity is assessed by the extent and composition of myelin uptake by myeloid cells present in such lesions. In the inflamed CNS, myeloid cells are comprised of brain-resident microglia, an endogenous cell population, and monocyte-derived macrophages, which infiltrate from the systemic compartment. Using microglia isolated from the adult human brain, we demonstrate that myelin phagocytosis is dependent on the polarization state of the cells. Myelin ingestion is significantly enhanced in cells exposed to TGF- compared with resting basal conditions and markedly reduced in classically activated polarized cells. Transcriptional analysis indicated that TGF--treated microglia closely resembled M0 cells. The tyrosine kinase phagocytic receptor MerTK was one of the most upregulated among a select number of differentially expressed genes in TGF--treated microglia. In contrast, MerTK and its known ligands, growth arrest-specific 6 and Protein S, were downregulated in classically activated cells. MerTK expression and myelin phagocytosis were higher in CNS-derived microglia than observed in monocyte-derived macrophages, both basally and under all tested polarization conditions. Specific MerTK inhibitors reduced myelin phagocytosis and the resultant anti-inflammatory biased cytokine responses for both cell types. Defining and modulating the mechanisms that regulate myelin phagocytosis has the potential to impact lesion and disease evolution in multiple sclerosis. Relevant effects would include enhancing myelin clearance, increasing anti-inflammatory molecule production by myeloid cells, and thereby permitting subsequent tissue repair. Abstract from J Immunol. 2016 Apr 15;196(8):3375-84. doi: 10.4049/jimmunol.1502562."	30	"MDM-CSF1, MDM +IFNg +LPS 2d, MDM + IL4 + IL13 2d, MDM + IL4 + IL13 +IL10 2d, MDM + TGFB, microglia, microglia + IFNg + LPS 2d, microglia + IL4 + IL13, microglia + IL4 + IL10 + IL13, microglia + TGFB"	Microarray (Affymetrix HuGene-2_0-ST V1)		Homo sapiens	3.56	HuGene	"rgb(0,109,219)"	diamond-open		myeloid	myeloid	adult	microglia	Macrophage
GSM2036954;7288	7288	Healy	GSM2036954	microglia_M2a_2	Homo sapiens	microglia + IL4 + IL13	CL:0000129		microglia			Healy	"Multifocal inflammatory lesions featuring destruction of lipid-rich myelin are pathologic hallmarks of multiple sclerosis. Lesion activity is assessed by the extent and composition of myelin uptake by myeloid cells present in such lesions. In the inflamed CNS, myeloid cells are comprised of brain-resident microglia, an endogenous cell population, and monocyte-derived macrophages, which infiltrate from the systemic compartment. Using microglia isolated from the adult human brain, we demonstrate that myelin phagocytosis is dependent on the polarization state of the cells. Myelin ingestion is significantly enhanced in cells exposed to TGF- compared with resting basal conditions and markedly reduced in classically activated polarized cells. Transcriptional analysis indicated that TGF--treated microglia closely resembled M0 cells. The tyrosine kinase phagocytic receptor MerTK was one of the most upregulated among a select number of differentially expressed genes in TGF--treated microglia. In contrast, MerTK and its known ligands, growth arrest-specific 6 and Protein S, were downregulated in classically activated cells. MerTK expression and myelin phagocytosis were higher in CNS-derived microglia than observed in monocyte-derived macrophages, both basally and under all tested polarization conditions. Specific MerTK inhibitors reduced myelin phagocytosis and the resultant anti-inflammatory biased cytokine responses for both cell types. Defining and modulating the mechanisms that regulate myelin phagocytosis has the potential to impact lesion and disease evolution in multiple sclerosis. Relevant effects would include enhancing myelin clearance, increasing anti-inflammatory molecule production by myeloid cells, and thereby permitting subsequent tissue repair. Abstract from J Immunol. 2016 Apr 15;196(8):3375-84. doi: 10.4049/jimmunol.1502562."	30	"MDM-CSF1, MDM +IFNg +LPS 2d, MDM + IL4 + IL13 2d, MDM + IL4 + IL13 +IL10 2d, MDM + TGFB, microglia, microglia + IFNg + LPS 2d, microglia + IL4 + IL13, microglia + IL4 + IL10 + IL13, microglia + TGFB"	Microarray (Affymetrix HuGene-2_0-ST V1)		Homo sapiens	3.56	HuGene	"rgb(0,109,219)"	diamond-open		myeloid	myeloid	adult	microglia	Macrophage
GSM2036955;7288	7288	Healy	GSM2036955	microglia_M2a_3	Homo sapiens	microglia + IL4 + IL13	CL:0000129		microglia			Healy	"Multifocal inflammatory lesions featuring destruction of lipid-rich myelin are pathologic hallmarks of multiple sclerosis. Lesion activity is assessed by the extent and composition of myelin uptake by myeloid cells present in such lesions. In the inflamed CNS, myeloid cells are comprised of brain-resident microglia, an endogenous cell population, and monocyte-derived macrophages, which infiltrate from the systemic compartment. Using microglia isolated from the adult human brain, we demonstrate that myelin phagocytosis is dependent on the polarization state of the cells. Myelin ingestion is significantly enhanced in cells exposed to TGF- compared with resting basal conditions and markedly reduced in classically activated polarized cells. Transcriptional analysis indicated that TGF--treated microglia closely resembled M0 cells. The tyrosine kinase phagocytic receptor MerTK was one of the most upregulated among a select number of differentially expressed genes in TGF--treated microglia. In contrast, MerTK and its known ligands, growth arrest-specific 6 and Protein S, were downregulated in classically activated cells. MerTK expression and myelin phagocytosis were higher in CNS-derived microglia than observed in monocyte-derived macrophages, both basally and under all tested polarization conditions. Specific MerTK inhibitors reduced myelin phagocytosis and the resultant anti-inflammatory biased cytokine responses for both cell types. Defining and modulating the mechanisms that regulate myelin phagocytosis has the potential to impact lesion and disease evolution in multiple sclerosis. Relevant effects would include enhancing myelin clearance, increasing anti-inflammatory molecule production by myeloid cells, and thereby permitting subsequent tissue repair. Abstract from J Immunol. 2016 Apr 15;196(8):3375-84. doi: 10.4049/jimmunol.1502562."	30	"MDM-CSF1, MDM +IFNg +LPS 2d, MDM + IL4 + IL13 2d, MDM + IL4 + IL13 +IL10 2d, MDM + TGFB, microglia, microglia + IFNg + LPS 2d, microglia + IL4 + IL13, microglia + IL4 + IL10 + IL13, microglia + TGFB"	Microarray (Affymetrix HuGene-2_0-ST V1)		Homo sapiens	3.56	HuGene	"rgb(0,109,219)"	diamond-open		myeloid	myeloid	adult	microglia	Macrophage
GSM2036956;7288	7288	Healy	GSM2036956	microglia_M2c_1	Homo sapiens	microglia + IL4 + IL10 + IL13	CL:0000129		microglia			Healy	"Multifocal inflammatory lesions featuring destruction of lipid-rich myelin are pathologic hallmarks of multiple sclerosis. Lesion activity is assessed by the extent and composition of myelin uptake by myeloid cells present in such lesions. In the inflamed CNS, myeloid cells are comprised of brain-resident microglia, an endogenous cell population, and monocyte-derived macrophages, which infiltrate from the systemic compartment. Using microglia isolated from the adult human brain, we demonstrate that myelin phagocytosis is dependent on the polarization state of the cells. Myelin ingestion is significantly enhanced in cells exposed to TGF- compared with resting basal conditions and markedly reduced in classically activated polarized cells. Transcriptional analysis indicated that TGF--treated microglia closely resembled M0 cells. The tyrosine kinase phagocytic receptor MerTK was one of the most upregulated among a select number of differentially expressed genes in TGF--treated microglia. In contrast, MerTK and its known ligands, growth arrest-specific 6 and Protein S, were downregulated in classically activated cells. MerTK expression and myelin phagocytosis were higher in CNS-derived microglia than observed in monocyte-derived macrophages, both basally and under all tested polarization conditions. Specific MerTK inhibitors reduced myelin phagocytosis and the resultant anti-inflammatory biased cytokine responses for both cell types. Defining and modulating the mechanisms that regulate myelin phagocytosis has the potential to impact lesion and disease evolution in multiple sclerosis. Relevant effects would include enhancing myelin clearance, increasing anti-inflammatory molecule production by myeloid cells, and thereby permitting subsequent tissue repair. Abstract from J Immunol. 2016 Apr 15;196(8):3375-84. doi: 10.4049/jimmunol.1502562."	30	"MDM-CSF1, MDM +IFNg +LPS 2d, MDM + IL4 + IL13 2d, MDM + IL4 + IL13 +IL10 2d, MDM + TGFB, microglia, microglia + IFNg + LPS 2d, microglia + IL4 + IL13, microglia + IL4 + IL10 + IL13, microglia + TGFB"	Microarray (Affymetrix HuGene-2_0-ST V1)		Homo sapiens	3.56	HuGene	"rgb(0,109,219)"	diamond-open		myeloid	myeloid	adult	microglia	Macrophage
GSM2036957;7288	7288	Healy	GSM2036957	microglia_M2c_2	Homo sapiens	microglia + IL4 + IL10 + IL13	CL:0000129		microglia			Healy	"Multifocal inflammatory lesions featuring destruction of lipid-rich myelin are pathologic hallmarks of multiple sclerosis. Lesion activity is assessed by the extent and composition of myelin uptake by myeloid cells present in such lesions. In the inflamed CNS, myeloid cells are comprised of brain-resident microglia, an endogenous cell population, and monocyte-derived macrophages, which infiltrate from the systemic compartment. Using microglia isolated from the adult human brain, we demonstrate that myelin phagocytosis is dependent on the polarization state of the cells. Myelin ingestion is significantly enhanced in cells exposed to TGF- compared with resting basal conditions and markedly reduced in classically activated polarized cells. Transcriptional analysis indicated that TGF--treated microglia closely resembled M0 cells. The tyrosine kinase phagocytic receptor MerTK was one of the most upregulated among a select number of differentially expressed genes in TGF--treated microglia. In contrast, MerTK and its known ligands, growth arrest-specific 6 and Protein S, were downregulated in classically activated cells. MerTK expression and myelin phagocytosis were higher in CNS-derived microglia than observed in monocyte-derived macrophages, both basally and under all tested polarization conditions. Specific MerTK inhibitors reduced myelin phagocytosis and the resultant anti-inflammatory biased cytokine responses for both cell types. Defining and modulating the mechanisms that regulate myelin phagocytosis has the potential to impact lesion and disease evolution in multiple sclerosis. Relevant effects would include enhancing myelin clearance, increasing anti-inflammatory molecule production by myeloid cells, and thereby permitting subsequent tissue repair. Abstract from J Immunol. 2016 Apr 15;196(8):3375-84. doi: 10.4049/jimmunol.1502562."	30	"MDM-CSF1, MDM +IFNg +LPS 2d, MDM + IL4 + IL13 2d, MDM + IL4 + IL13 +IL10 2d, MDM + TGFB, microglia, microglia + IFNg + LPS 2d, microglia + IL4 + IL13, microglia + IL4 + IL10 + IL13, microglia + TGFB"	Microarray (Affymetrix HuGene-2_0-ST V1)		Homo sapiens	3.56	HuGene	"rgb(0,109,219)"	diamond-open		myeloid	TRM	adult	microglia	Macrophage
GSM2036958;7288	7288	Healy	GSM2036958	microglia_M2c_3	Homo sapiens	microglia + IL4 + IL10 + IL13	CL:0000129		microglia			Healy	"Multifocal inflammatory lesions featuring destruction of lipid-rich myelin are pathologic hallmarks of multiple sclerosis. Lesion activity is assessed by the extent and composition of myelin uptake by myeloid cells present in such lesions. In the inflamed CNS, myeloid cells are comprised of brain-resident microglia, an endogenous cell population, and monocyte-derived macrophages, which infiltrate from the systemic compartment. Using microglia isolated from the adult human brain, we demonstrate that myelin phagocytosis is dependent on the polarization state of the cells. Myelin ingestion is significantly enhanced in cells exposed to TGF- compared with resting basal conditions and markedly reduced in classically activated polarized cells. Transcriptional analysis indicated that TGF--treated microglia closely resembled M0 cells. The tyrosine kinase phagocytic receptor MerTK was one of the most upregulated among a select number of differentially expressed genes in TGF--treated microglia. In contrast, MerTK and its known ligands, growth arrest-specific 6 and Protein S, were downregulated in classically activated cells. MerTK expression and myelin phagocytosis were higher in CNS-derived microglia than observed in monocyte-derived macrophages, both basally and under all tested polarization conditions. Specific MerTK inhibitors reduced myelin phagocytosis and the resultant anti-inflammatory biased cytokine responses for both cell types. Defining and modulating the mechanisms that regulate myelin phagocytosis has the potential to impact lesion and disease evolution in multiple sclerosis. Relevant effects would include enhancing myelin clearance, increasing anti-inflammatory molecule production by myeloid cells, and thereby permitting subsequent tissue repair. Abstract from J Immunol. 2016 Apr 15;196(8):3375-84. doi: 10.4049/jimmunol.1502562."	30	"MDM-CSF1, MDM +IFNg +LPS 2d, MDM + IL4 + IL13 2d, MDM + IL4 + IL13 +IL10 2d, MDM + TGFB, microglia, microglia + IFNg + LPS 2d, microglia + IL4 + IL13, microglia + IL4 + IL10 + IL13, microglia + TGFB"	Microarray (Affymetrix HuGene-2_0-ST V1)		Homo sapiens	3.56	HuGene	"rgb(0,109,219)"	diamond-open		myeloid	TRM	adult	microglia	Macrophage
GSM2036961;7288	7288	Healy	GSM2036961	macrophages_M0_1	Homo sapiens	MDM-CSF1	CL:0000235	macrophage	monocyte			Healy	"Multifocal inflammatory lesions featuring destruction of lipid-rich myelin are pathologic hallmarks of multiple sclerosis. Lesion activity is assessed by the extent and composition of myelin uptake by myeloid cells present in such lesions. In the inflamed CNS, myeloid cells are comprised of brain-resident microglia, an endogenous cell population, and monocyte-derived macrophages, which infiltrate from the systemic compartment. Using microglia isolated from the adult human brain, we demonstrate that myelin phagocytosis is dependent on the polarization state of the cells. Myelin ingestion is significantly enhanced in cells exposed to TGF- compared with resting basal conditions and markedly reduced in classically activated polarized cells. Transcriptional analysis indicated that TGF--treated microglia closely resembled M0 cells. The tyrosine kinase phagocytic receptor MerTK was one of the most upregulated among a select number of differentially expressed genes in TGF--treated microglia. In contrast, MerTK and its known ligands, growth arrest-specific 6 and Protein S, were downregulated in classically activated cells. MerTK expression and myelin phagocytosis were higher in CNS-derived microglia than observed in monocyte-derived macrophages, both basally and under all tested polarization conditions. Specific MerTK inhibitors reduced myelin phagocytosis and the resultant anti-inflammatory biased cytokine responses for both cell types. Defining and modulating the mechanisms that regulate myelin phagocytosis has the potential to impact lesion and disease evolution in multiple sclerosis. Relevant effects would include enhancing myelin clearance, increasing anti-inflammatory molecule production by myeloid cells, and thereby permitting subsequent tissue repair. Abstract from J Immunol. 2016 Apr 15;196(8):3375-84. doi: 10.4049/jimmunol.1502562."	30	"MDM-CSF1, MDM +IFNg +LPS 2d, MDM + IL4 + IL13 2d, MDM + IL4 + IL13 +IL10 2d, MDM + TGFB, microglia, microglia + IFNg + LPS 2d, microglia + IL4 + IL13, microglia + IL4 + IL10 + IL13, microglia + TGFB"	Microarray (Affymetrix HuGene-2_0-ST V1)		Homo sapiens	3.56	HuGene	"rgb(0,109,219)"	diamond-open	Mo-Mac adult peripheral blood  CSF1 5d	myeloid	Mo-Mac	adult	macrophage	Macrophage
GSM2036962;7288	7288	Healy	GSM2036962	macrophages_M0_2	Homo sapiens	MDM-CSF1	CL:0000235	macrophage	monocyte			Healy	"Multifocal inflammatory lesions featuring destruction of lipid-rich myelin are pathologic hallmarks of multiple sclerosis. Lesion activity is assessed by the extent and composition of myelin uptake by myeloid cells present in such lesions. In the inflamed CNS, myeloid cells are comprised of brain-resident microglia, an endogenous cell population, and monocyte-derived macrophages, which infiltrate from the systemic compartment. Using microglia isolated from the adult human brain, we demonstrate that myelin phagocytosis is dependent on the polarization state of the cells. Myelin ingestion is significantly enhanced in cells exposed to TGF- compared with resting basal conditions and markedly reduced in classically activated polarized cells. Transcriptional analysis indicated that TGF--treated microglia closely resembled M0 cells. The tyrosine kinase phagocytic receptor MerTK was one of the most upregulated among a select number of differentially expressed genes in TGF--treated microglia. In contrast, MerTK and its known ligands, growth arrest-specific 6 and Protein S, were downregulated in classically activated cells. MerTK expression and myelin phagocytosis were higher in CNS-derived microglia than observed in monocyte-derived macrophages, both basally and under all tested polarization conditions. Specific MerTK inhibitors reduced myelin phagocytosis and the resultant anti-inflammatory biased cytokine responses for both cell types. Defining and modulating the mechanisms that regulate myelin phagocytosis has the potential to impact lesion and disease evolution in multiple sclerosis. Relevant effects would include enhancing myelin clearance, increasing anti-inflammatory molecule production by myeloid cells, and thereby permitting subsequent tissue repair. Abstract from J Immunol. 2016 Apr 15;196(8):3375-84. doi: 10.4049/jimmunol.1502562."	30	"MDM-CSF1, MDM +IFNg +LPS 2d, MDM + IL4 + IL13 2d, MDM + IL4 + IL13 +IL10 2d, MDM + TGFB, microglia, microglia + IFNg + LPS 2d, microglia + IL4 + IL13, microglia + IL4 + IL10 + IL13, microglia + TGFB"	Microarray (Affymetrix HuGene-2_0-ST V1)		Homo sapiens	3.56	HuGene	"rgb(0,109,219)"	diamond-open	Mo-Mac adult peripheral blood  CSF1 5d	myeloid	Mo-Mac	adult	macrophage	Macrophage
GSM2036963;7288	7288	Healy	GSM2036963	macrophages_M0_3	Homo sapiens	MDM-CSF1	CL:0000235	macrophage	monocyte			Healy	"Multifocal inflammatory lesions featuring destruction of lipid-rich myelin are pathologic hallmarks of multiple sclerosis. Lesion activity is assessed by the extent and composition of myelin uptake by myeloid cells present in such lesions. In the inflamed CNS, myeloid cells are comprised of brain-resident microglia, an endogenous cell population, and monocyte-derived macrophages, which infiltrate from the systemic compartment. Using microglia isolated from the adult human brain, we demonstrate that myelin phagocytosis is dependent on the polarization state of the cells. Myelin ingestion is significantly enhanced in cells exposed to TGF- compared with resting basal conditions and markedly reduced in classically activated polarized cells. Transcriptional analysis indicated that TGF--treated microglia closely resembled M0 cells. The tyrosine kinase phagocytic receptor MerTK was one of the most upregulated among a select number of differentially expressed genes in TGF--treated microglia. In contrast, MerTK and its known ligands, growth arrest-specific 6 and Protein S, were downregulated in classically activated cells. MerTK expression and myelin phagocytosis were higher in CNS-derived microglia than observed in monocyte-derived macrophages, both basally and under all tested polarization conditions. Specific MerTK inhibitors reduced myelin phagocytosis and the resultant anti-inflammatory biased cytokine responses for both cell types. Defining and modulating the mechanisms that regulate myelin phagocytosis has the potential to impact lesion and disease evolution in multiple sclerosis. Relevant effects would include enhancing myelin clearance, increasing anti-inflammatory molecule production by myeloid cells, and thereby permitting subsequent tissue repair. Abstract from J Immunol. 2016 Apr 15;196(8):3375-84. doi: 10.4049/jimmunol.1502562."	30	"MDM-CSF1, MDM +IFNg +LPS 2d, MDM + IL4 + IL13 2d, MDM + IL4 + IL13 +IL10 2d, MDM + TGFB, microglia, microglia + IFNg + LPS 2d, microglia + IL4 + IL13, microglia + IL4 + IL10 + IL13, microglia + TGFB"	Microarray (Affymetrix HuGene-2_0-ST V1)		Homo sapiens	3.56	HuGene	"rgb(0,109,219)"	diamond-open	Mo-Mac adult peripheral blood  CSF1 5d	myeloid	Mo-Mac	adult	macrophage	Macrophage
GSM2036964;7288	7288	Healy	GSM2036964	macrophages_Mtgf_1	Homo sapiens	MDM + IL4 + IL13 +IL10 2d	CL:0000235	macrophage	monocyte			Healy	"Multifocal inflammatory lesions featuring destruction of lipid-rich myelin are pathologic hallmarks of multiple sclerosis. Lesion activity is assessed by the extent and composition of myelin uptake by myeloid cells present in such lesions. In the inflamed CNS, myeloid cells are comprised of brain-resident microglia, an endogenous cell population, and monocyte-derived macrophages, which infiltrate from the systemic compartment. Using microglia isolated from the adult human brain, we demonstrate that myelin phagocytosis is dependent on the polarization state of the cells. Myelin ingestion is significantly enhanced in cells exposed to TGF- compared with resting basal conditions and markedly reduced in classically activated polarized cells. Transcriptional analysis indicated that TGF--treated microglia closely resembled M0 cells. The tyrosine kinase phagocytic receptor MerTK was one of the most upregulated among a select number of differentially expressed genes in TGF--treated microglia. In contrast, MerTK and its known ligands, growth arrest-specific 6 and Protein S, were downregulated in classically activated cells. MerTK expression and myelin phagocytosis were higher in CNS-derived microglia than observed in monocyte-derived macrophages, both basally and under all tested polarization conditions. Specific MerTK inhibitors reduced myelin phagocytosis and the resultant anti-inflammatory biased cytokine responses for both cell types. Defining and modulating the mechanisms that regulate myelin phagocytosis has the potential to impact lesion and disease evolution in multiple sclerosis. Relevant effects would include enhancing myelin clearance, increasing anti-inflammatory molecule production by myeloid cells, and thereby permitting subsequent tissue repair. Abstract from J Immunol. 2016 Apr 15;196(8):3375-84. doi: 10.4049/jimmunol.1502562."	30	"MDM-CSF1, MDM +IFNg +LPS 2d, MDM + IL4 + IL13 2d, MDM + IL4 + IL13 +IL10 2d, MDM + TGFB, microglia, microglia + IFNg + LPS 2d, microglia + IL4 + IL13, microglia + IL4 + IL10 + IL13, microglia + TGFB"	Microarray (Affymetrix HuGene-2_0-ST V1)		Homo sapiens	3.56	HuGene	"rgb(0,109,219)"	diamond-open	Mo-Mac adult peripheral blood  CSF1 5d then TFGB 2d	myeloid	Mo-Mac	adult	macrophage	Macrophage
GSM2036965;7288	7288	Healy	GSM2036965	macrophages_Mtgf_2	Homo sapiens	MDM + TGFB	CL:0000235	macrophage	monocyte			Healy	"Multifocal inflammatory lesions featuring destruction of lipid-rich myelin are pathologic hallmarks of multiple sclerosis. Lesion activity is assessed by the extent and composition of myelin uptake by myeloid cells present in such lesions. In the inflamed CNS, myeloid cells are comprised of brain-resident microglia, an endogenous cell population, and monocyte-derived macrophages, which infiltrate from the systemic compartment. Using microglia isolated from the adult human brain, we demonstrate that myelin phagocytosis is dependent on the polarization state of the cells. Myelin ingestion is significantly enhanced in cells exposed to TGF- compared with resting basal conditions and markedly reduced in classically activated polarized cells. Transcriptional analysis indicated that TGF--treated microglia closely resembled M0 cells. The tyrosine kinase phagocytic receptor MerTK was one of the most upregulated among a select number of differentially expressed genes in TGF--treated microglia. In contrast, MerTK and its known ligands, growth arrest-specific 6 and Protein S, were downregulated in classically activated cells. MerTK expression and myelin phagocytosis were higher in CNS-derived microglia than observed in monocyte-derived macrophages, both basally and under all tested polarization conditions. Specific MerTK inhibitors reduced myelin phagocytosis and the resultant anti-inflammatory biased cytokine responses for both cell types. Defining and modulating the mechanisms that regulate myelin phagocytosis has the potential to impact lesion and disease evolution in multiple sclerosis. Relevant effects would include enhancing myelin clearance, increasing anti-inflammatory molecule production by myeloid cells, and thereby permitting subsequent tissue repair. Abstract from J Immunol. 2016 Apr 15;196(8):3375-84. doi: 10.4049/jimmunol.1502562."	30	"MDM-CSF1, MDM +IFNg +LPS 2d, MDM + IL4 + IL13 2d, MDM + IL4 + IL13 +IL10 2d, MDM + TGFB, microglia, microglia + IFNg + LPS 2d, microglia + IL4 + IL13, microglia + IL4 + IL10 + IL13, microglia + TGFB"	Microarray (Affymetrix HuGene-2_0-ST V1)		Homo sapiens	3.56	HuGene	"rgb(0,109,219)"	diamond-open	Mo-Mac adult peripheral blood  CSF1 5d then TFGB 2d	myeloid	Mo-Mac	adult	macrophage	Macrophage
GSM2036966;7288	7288	Healy	GSM2036966	macrophages_Mtgf_3	Homo sapiens	MDM + TGFB	CL:0000235	macrophage	monocyte			Healy	"Multifocal inflammatory lesions featuring destruction of lipid-rich myelin are pathologic hallmarks of multiple sclerosis. Lesion activity is assessed by the extent and composition of myelin uptake by myeloid cells present in such lesions. In the inflamed CNS, myeloid cells are comprised of brain-resident microglia, an endogenous cell population, and monocyte-derived macrophages, which infiltrate from the systemic compartment. Using microglia isolated from the adult human brain, we demonstrate that myelin phagocytosis is dependent on the polarization state of the cells. Myelin ingestion is significantly enhanced in cells exposed to TGF- compared with resting basal conditions and markedly reduced in classically activated polarized cells. Transcriptional analysis indicated that TGF--treated microglia closely resembled M0 cells. The tyrosine kinase phagocytic receptor MerTK was one of the most upregulated among a select number of differentially expressed genes in TGF--treated microglia. In contrast, MerTK and its known ligands, growth arrest-specific 6 and Protein S, were downregulated in classically activated cells. MerTK expression and myelin phagocytosis were higher in CNS-derived microglia than observed in monocyte-derived macrophages, both basally and under all tested polarization conditions. Specific MerTK inhibitors reduced myelin phagocytosis and the resultant anti-inflammatory biased cytokine responses for both cell types. Defining and modulating the mechanisms that regulate myelin phagocytosis has the potential to impact lesion and disease evolution in multiple sclerosis. Relevant effects would include enhancing myelin clearance, increasing anti-inflammatory molecule production by myeloid cells, and thereby permitting subsequent tissue repair. Abstract from J Immunol. 2016 Apr 15;196(8):3375-84. doi: 10.4049/jimmunol.1502562."	30	"MDM-CSF1, MDM +IFNg +LPS 2d, MDM + IL4 + IL13 2d, MDM + IL4 + IL13 +IL10 2d, MDM + TGFB, microglia, microglia + IFNg + LPS 2d, microglia + IL4 + IL13, microglia + IL4 + IL10 + IL13, microglia + TGFB"	Microarray (Affymetrix HuGene-2_0-ST V1)		Homo sapiens	3.56	HuGene	"rgb(0,109,219)"	diamond-open	Mo-Mac adult peripheral blood  CSF1 5d then TFGB 2d	myeloid	Mo-Mac	adult	macrophage	Macrophage
GSM2036967;7288	7288	Healy	GSM2036967	macrophages_M1_1	Homo sapiens	MDM +IFNg +LPS 2d	CL:0000235	macrophage	monocyte			Healy	"Multifocal inflammatory lesions featuring destruction of lipid-rich myelin are pathologic hallmarks of multiple sclerosis. Lesion activity is assessed by the extent and composition of myelin uptake by myeloid cells present in such lesions. In the inflamed CNS, myeloid cells are comprised of brain-resident microglia, an endogenous cell population, and monocyte-derived macrophages, which infiltrate from the systemic compartment. Using microglia isolated from the adult human brain, we demonstrate that myelin phagocytosis is dependent on the polarization state of the cells. Myelin ingestion is significantly enhanced in cells exposed to TGF- compared with resting basal conditions and markedly reduced in classically activated polarized cells. Transcriptional analysis indicated that TGF--treated microglia closely resembled M0 cells. The tyrosine kinase phagocytic receptor MerTK was one of the most upregulated among a select number of differentially expressed genes in TGF--treated microglia. In contrast, MerTK and its known ligands, growth arrest-specific 6 and Protein S, were downregulated in classically activated cells. MerTK expression and myelin phagocytosis were higher in CNS-derived microglia than observed in monocyte-derived macrophages, both basally and under all tested polarization conditions. Specific MerTK inhibitors reduced myelin phagocytosis and the resultant anti-inflammatory biased cytokine responses for both cell types. Defining and modulating the mechanisms that regulate myelin phagocytosis has the potential to impact lesion and disease evolution in multiple sclerosis. Relevant effects would include enhancing myelin clearance, increasing anti-inflammatory molecule production by myeloid cells, and thereby permitting subsequent tissue repair. Abstract from J Immunol. 2016 Apr 15;196(8):3375-84. doi: 10.4049/jimmunol.1502562."	30	"MDM-CSF1, MDM +IFNg +LPS 2d, MDM + IL4 + IL13 2d, MDM + IL4 + IL13 +IL10 2d, MDM + TGFB, microglia, microglia + IFNg + LPS 2d, microglia + IL4 + IL13, microglia + IL4 + IL10 + IL13, microglia + TGFB"	Microarray (Affymetrix HuGene-2_0-ST V1)		Homo sapiens	3.56	HuGene	"rgb(0,109,219)"	diamond-open	Mo-Mac adult peripheral blood  GM-CSF 5d then LPS IFNgamma 2d	myeloid	Mo-Mac	adult	macrophage	Macrophage
GSM2036968;7288	7288	Healy	GSM2036968	macrophages_M1_2	Homo sapiens	MDM +IFNg +LPS 2d	CL:0000235	macrophage	monocyte			Healy	"Multifocal inflammatory lesions featuring destruction of lipid-rich myelin are pathologic hallmarks of multiple sclerosis. Lesion activity is assessed by the extent and composition of myelin uptake by myeloid cells present in such lesions. In the inflamed CNS, myeloid cells are comprised of brain-resident microglia, an endogenous cell population, and monocyte-derived macrophages, which infiltrate from the systemic compartment. Using microglia isolated from the adult human brain, we demonstrate that myelin phagocytosis is dependent on the polarization state of the cells. Myelin ingestion is significantly enhanced in cells exposed to TGF- compared with resting basal conditions and markedly reduced in classically activated polarized cells. Transcriptional analysis indicated that TGF--treated microglia closely resembled M0 cells. The tyrosine kinase phagocytic receptor MerTK was one of the most upregulated among a select number of differentially expressed genes in TGF--treated microglia. In contrast, MerTK and its known ligands, growth arrest-specific 6 and Protein S, were downregulated in classically activated cells. MerTK expression and myelin phagocytosis were higher in CNS-derived microglia than observed in monocyte-derived macrophages, both basally and under all tested polarization conditions. Specific MerTK inhibitors reduced myelin phagocytosis and the resultant anti-inflammatory biased cytokine responses for both cell types. Defining and modulating the mechanisms that regulate myelin phagocytosis has the potential to impact lesion and disease evolution in multiple sclerosis. Relevant effects would include enhancing myelin clearance, increasing anti-inflammatory molecule production by myeloid cells, and thereby permitting subsequent tissue repair. Abstract from J Immunol. 2016 Apr 15;196(8):3375-84. doi: 10.4049/jimmunol.1502562."	30	"MDM-CSF1, MDM +IFNg +LPS 2d, MDM + IL4 + IL13 2d, MDM + IL4 + IL13 +IL10 2d, MDM + TGFB, microglia, microglia + IFNg + LPS 2d, microglia + IL4 + IL13, microglia + IL4 + IL10 + IL13, microglia + TGFB"	Microarray (Affymetrix HuGene-2_0-ST V1)		Homo sapiens	3.56	HuGene	"rgb(0,109,219)"	diamond-open	Mo-Mac adult peripheral blood  GM-CSF 5d then LPS IFNgamma 2d	myeloid	Mo-Mac	adult	macrophage	Macrophage
GSM2036969;7288	7288	Healy	GSM2036969	macrophages_M1_3	Homo sapiens	MDM +IFNg +LPS 2d	CL:0000235	macrophage	monocyte			Healy	"Multifocal inflammatory lesions featuring destruction of lipid-rich myelin are pathologic hallmarks of multiple sclerosis. Lesion activity is assessed by the extent and composition of myelin uptake by myeloid cells present in such lesions. In the inflamed CNS, myeloid cells are comprised of brain-resident microglia, an endogenous cell population, and monocyte-derived macrophages, which infiltrate from the systemic compartment. Using microglia isolated from the adult human brain, we demonstrate that myelin phagocytosis is dependent on the polarization state of the cells. Myelin ingestion is significantly enhanced in cells exposed to TGF- compared with resting basal conditions and markedly reduced in classically activated polarized cells. Transcriptional analysis indicated that TGF--treated microglia closely resembled M0 cells. The tyrosine kinase phagocytic receptor MerTK was one of the most upregulated among a select number of differentially expressed genes in TGF--treated microglia. In contrast, MerTK and its known ligands, growth arrest-specific 6 and Protein S, were downregulated in classically activated cells. MerTK expression and myelin phagocytosis were higher in CNS-derived microglia than observed in monocyte-derived macrophages, both basally and under all tested polarization conditions. Specific MerTK inhibitors reduced myelin phagocytosis and the resultant anti-inflammatory biased cytokine responses for both cell types. Defining and modulating the mechanisms that regulate myelin phagocytosis has the potential to impact lesion and disease evolution in multiple sclerosis. Relevant effects would include enhancing myelin clearance, increasing anti-inflammatory molecule production by myeloid cells, and thereby permitting subsequent tissue repair. Abstract from J Immunol. 2016 Apr 15;196(8):3375-84. doi: 10.4049/jimmunol.1502562."	30	"MDM-CSF1, MDM +IFNg +LPS 2d, MDM + IL4 + IL13 2d, MDM + IL4 + IL13 +IL10 2d, MDM + TGFB, microglia, microglia + IFNg + LPS 2d, microglia + IL4 + IL13, microglia + IL4 + IL10 + IL13, microglia + TGFB"	Microarray (Affymetrix HuGene-2_0-ST V1)		Homo sapiens	3.56	HuGene	"rgb(0,109,219)"	diamond-open	Mo-Mac adult peripheral blood  GM-CSF 5d then LPS IFNgamma 2d	myeloid	Mo-Mac	adult	macrophage	Macrophage
GSM2036970;7288	7288	Healy	GSM2036970	macrophages_M2a_1	Homo sapiens	MDM + IL4 + IL13 2d	CL:0000235	macrophage	monocyte			Healy	"Multifocal inflammatory lesions featuring destruction of lipid-rich myelin are pathologic hallmarks of multiple sclerosis. Lesion activity is assessed by the extent and composition of myelin uptake by myeloid cells present in such lesions. In the inflamed CNS, myeloid cells are comprised of brain-resident microglia, an endogenous cell population, and monocyte-derived macrophages, which infiltrate from the systemic compartment. Using microglia isolated from the adult human brain, we demonstrate that myelin phagocytosis is dependent on the polarization state of the cells. Myelin ingestion is significantly enhanced in cells exposed to TGF- compared with resting basal conditions and markedly reduced in classically activated polarized cells. Transcriptional analysis indicated that TGF--treated microglia closely resembled M0 cells. The tyrosine kinase phagocytic receptor MerTK was one of the most upregulated among a select number of differentially expressed genes in TGF--treated microglia. In contrast, MerTK and its known ligands, growth arrest-specific 6 and Protein S, were downregulated in classically activated cells. MerTK expression and myelin phagocytosis were higher in CNS-derived microglia than observed in monocyte-derived macrophages, both basally and under all tested polarization conditions. Specific MerTK inhibitors reduced myelin phagocytosis and the resultant anti-inflammatory biased cytokine responses for both cell types. Defining and modulating the mechanisms that regulate myelin phagocytosis has the potential to impact lesion and disease evolution in multiple sclerosis. Relevant effects would include enhancing myelin clearance, increasing anti-inflammatory molecule production by myeloid cells, and thereby permitting subsequent tissue repair. Abstract from J Immunol. 2016 Apr 15;196(8):3375-84. doi: 10.4049/jimmunol.1502562."	30	"MDM-CSF1, MDM +IFNg +LPS 2d, MDM + IL4 + IL13 2d, MDM + IL4 + IL13 +IL10 2d, MDM + TGFB, microglia, microglia + IFNg + LPS 2d, microglia + IL4 + IL13, microglia + IL4 + IL10 + IL13, microglia + TGFB"	Microarray (Affymetrix HuGene-2_0-ST V1)		Homo sapiens	3.56	HuGene	"rgb(0,109,219)"	diamond-open	Mo-Mac adult peripheral blood  CSF1 5d then IL4 IL13 2d	myeloid	Mo-Mac	adult	macrophage	Macrophage
GSM2036971;7288	7288	Healy	GSM2036971	macrophages_M2a_2	Homo sapiens	MDM + IL4 + IL13 2d	CL:0000235	macrophage	monocyte			Healy	"Multifocal inflammatory lesions featuring destruction of lipid-rich myelin are pathologic hallmarks of multiple sclerosis. Lesion activity is assessed by the extent and composition of myelin uptake by myeloid cells present in such lesions. In the inflamed CNS, myeloid cells are comprised of brain-resident microglia, an endogenous cell population, and monocyte-derived macrophages, which infiltrate from the systemic compartment. Using microglia isolated from the adult human brain, we demonstrate that myelin phagocytosis is dependent on the polarization state of the cells. Myelin ingestion is significantly enhanced in cells exposed to TGF- compared with resting basal conditions and markedly reduced in classically activated polarized cells. Transcriptional analysis indicated that TGF--treated microglia closely resembled M0 cells. The tyrosine kinase phagocytic receptor MerTK was one of the most upregulated among a select number of differentially expressed genes in TGF--treated microglia. In contrast, MerTK and its known ligands, growth arrest-specific 6 and Protein S, were downregulated in classically activated cells. MerTK expression and myelin phagocytosis were higher in CNS-derived microglia than observed in monocyte-derived macrophages, both basally and under all tested polarization conditions. Specific MerTK inhibitors reduced myelin phagocytosis and the resultant anti-inflammatory biased cytokine responses for both cell types. Defining and modulating the mechanisms that regulate myelin phagocytosis has the potential to impact lesion and disease evolution in multiple sclerosis. Relevant effects would include enhancing myelin clearance, increasing anti-inflammatory molecule production by myeloid cells, and thereby permitting subsequent tissue repair. Abstract from J Immunol. 2016 Apr 15;196(8):3375-84. doi: 10.4049/jimmunol.1502562."	30	"MDM-CSF1, MDM +IFNg +LPS 2d, MDM + IL4 + IL13 2d, MDM + IL4 + IL13 +IL10 2d, MDM + TGFB, microglia, microglia + IFNg + LPS 2d, microglia + IL4 + IL13, microglia + IL4 + IL10 + IL13, microglia + TGFB"	Microarray (Affymetrix HuGene-2_0-ST V1)		Homo sapiens	3.56	HuGene	"rgb(0,109,219)"	diamond-open	Mo-Mac adult peripheral blood  CSF1 5d then IL4 IL13 2d	myeloid	Mo-Mac	adult	macrophage	Macrophage
GSM2036972;7288	7288	Healy	GSM2036972	macrophages_M2a_3	Homo sapiens	MDM + IL4 + IL13 2d	CL:0000235	macrophage	monocyte			Healy	"Multifocal inflammatory lesions featuring destruction of lipid-rich myelin are pathologic hallmarks of multiple sclerosis. Lesion activity is assessed by the extent and composition of myelin uptake by myeloid cells present in such lesions. In the inflamed CNS, myeloid cells are comprised of brain-resident microglia, an endogenous cell population, and monocyte-derived macrophages, which infiltrate from the systemic compartment. Using microglia isolated from the adult human brain, we demonstrate that myelin phagocytosis is dependent on the polarization state of the cells. Myelin ingestion is significantly enhanced in cells exposed to TGF- compared with resting basal conditions and markedly reduced in classically activated polarized cells. Transcriptional analysis indicated that TGF--treated microglia closely resembled M0 cells. The tyrosine kinase phagocytic receptor MerTK was one of the most upregulated among a select number of differentially expressed genes in TGF--treated microglia. In contrast, MerTK and its known ligands, growth arrest-specific 6 and Protein S, were downregulated in classically activated cells. MerTK expression and myelin phagocytosis were higher in CNS-derived microglia than observed in monocyte-derived macrophages, both basally and under all tested polarization conditions. Specific MerTK inhibitors reduced myelin phagocytosis and the resultant anti-inflammatory biased cytokine responses for both cell types. Defining and modulating the mechanisms that regulate myelin phagocytosis has the potential to impact lesion and disease evolution in multiple sclerosis. Relevant effects would include enhancing myelin clearance, increasing anti-inflammatory molecule production by myeloid cells, and thereby permitting subsequent tissue repair. Abstract from J Immunol. 2016 Apr 15;196(8):3375-84. doi: 10.4049/jimmunol.1502562."	30	"MDM-CSF1, MDM +IFNg +LPS 2d, MDM + IL4 + IL13 2d, MDM + IL4 + IL13 +IL10 2d, MDM + TGFB, microglia, microglia + IFNg + LPS 2d, microglia + IL4 + IL13, microglia + IL4 + IL10 + IL13, microglia + TGFB"	Microarray (Affymetrix HuGene-2_0-ST V1)		Homo sapiens	3.56	HuGene	"rgb(0,109,219)"	diamond-open	Mo-Mac adult peripheral blood  CSF1 5d then IL4 IL13 2d	myeloid	Mo-Mac	adult	macrophage	Macrophage
GSM2036973;7288	7288	Healy	GSM2036973	macrophages_M2c_1	Homo sapiens	MDM + IL4 + IL13 +IL10 2d	CL:0000235	macrophage	monocyte			Healy	"Multifocal inflammatory lesions featuring destruction of lipid-rich myelin are pathologic hallmarks of multiple sclerosis. Lesion activity is assessed by the extent and composition of myelin uptake by myeloid cells present in such lesions. In the inflamed CNS, myeloid cells are comprised of brain-resident microglia, an endogenous cell population, and monocyte-derived macrophages, which infiltrate from the systemic compartment. Using microglia isolated from the adult human brain, we demonstrate that myelin phagocytosis is dependent on the polarization state of the cells. Myelin ingestion is significantly enhanced in cells exposed to TGF- compared with resting basal conditions and markedly reduced in classically activated polarized cells. Transcriptional analysis indicated that TGF--treated microglia closely resembled M0 cells. The tyrosine kinase phagocytic receptor MerTK was one of the most upregulated among a select number of differentially expressed genes in TGF--treated microglia. In contrast, MerTK and its known ligands, growth arrest-specific 6 and Protein S, were downregulated in classically activated cells. MerTK expression and myelin phagocytosis were higher in CNS-derived microglia than observed in monocyte-derived macrophages, both basally and under all tested polarization conditions. Specific MerTK inhibitors reduced myelin phagocytosis and the resultant anti-inflammatory biased cytokine responses for both cell types. Defining and modulating the mechanisms that regulate myelin phagocytosis has the potential to impact lesion and disease evolution in multiple sclerosis. Relevant effects would include enhancing myelin clearance, increasing anti-inflammatory molecule production by myeloid cells, and thereby permitting subsequent tissue repair. Abstract from J Immunol. 2016 Apr 15;196(8):3375-84. doi: 10.4049/jimmunol.1502562."	30	"MDM-CSF1, MDM +IFNg +LPS 2d, MDM + IL4 + IL13 2d, MDM + IL4 + IL13 +IL10 2d, MDM + TGFB, microglia, microglia + IFNg + LPS 2d, microglia + IL4 + IL13, microglia + IL4 + IL10 + IL13, microglia + TGFB"	Microarray (Affymetrix HuGene-2_0-ST V1)		Homo sapiens	3.56	HuGene	"rgb(0,109,219)"	diamond-open	Mo-Mac adult peripheral blood  CSF1 5d then IL4 IL10 IL13 2d	myeloid	Mo-Mac	adult	macrophage	Macrophage
GSM2036974;7288	7288	Healy	GSM2036974	macrophages_M2c_2	Homo sapiens	MDM + IL4 + IL13 +IL10 2d	CL:0000235	macrophage	monocyte			Healy	"Multifocal inflammatory lesions featuring destruction of lipid-rich myelin are pathologic hallmarks of multiple sclerosis. Lesion activity is assessed by the extent and composition of myelin uptake by myeloid cells present in such lesions. In the inflamed CNS, myeloid cells are comprised of brain-resident microglia, an endogenous cell population, and monocyte-derived macrophages, which infiltrate from the systemic compartment. Using microglia isolated from the adult human brain, we demonstrate that myelin phagocytosis is dependent on the polarization state of the cells. Myelin ingestion is significantly enhanced in cells exposed to TGF- compared with resting basal conditions and markedly reduced in classically activated polarized cells. Transcriptional analysis indicated that TGF--treated microglia closely resembled M0 cells. The tyrosine kinase phagocytic receptor MerTK was one of the most upregulated among a select number of differentially expressed genes in TGF--treated microglia. In contrast, MerTK and its known ligands, growth arrest-specific 6 and Protein S, were downregulated in classically activated cells. MerTK expression and myelin phagocytosis were higher in CNS-derived microglia than observed in monocyte-derived macrophages, both basally and under all tested polarization conditions. Specific MerTK inhibitors reduced myelin phagocytosis and the resultant anti-inflammatory biased cytokine responses for both cell types. Defining and modulating the mechanisms that regulate myelin phagocytosis has the potential to impact lesion and disease evolution in multiple sclerosis. Relevant effects would include enhancing myelin clearance, increasing anti-inflammatory molecule production by myeloid cells, and thereby permitting subsequent tissue repair. Abstract from J Immunol. 2016 Apr 15;196(8):3375-84. doi: 10.4049/jimmunol.1502562."	30	"MDM-CSF1, MDM +IFNg +LPS 2d, MDM + IL4 + IL13 2d, MDM + IL4 + IL13 +IL10 2d, MDM + TGFB, microglia, microglia + IFNg + LPS 2d, microglia + IL4 + IL13, microglia + IL4 + IL10 + IL13, microglia + TGFB"	Microarray (Affymetrix HuGene-2_0-ST V1)		Homo sapiens	3.56	HuGene	"rgb(0,109,219)"	diamond-open	Mo-Mac adult peripheral blood  CSF1 5d then IL4 IL10 IL13 2d	myeloid	Mo-Mac	adult	macrophage	Macrophage
GSM2036975;7288	7288	Healy	GSM2036975	macrophages_M2c_3	Homo sapiens	MDM + IL4 + IL13 +IL10 2d	CL:0000235	macrophage	monocyte			Healy	"Multifocal inflammatory lesions featuring destruction of lipid-rich myelin are pathologic hallmarks of multiple sclerosis. Lesion activity is assessed by the extent and composition of myelin uptake by myeloid cells present in such lesions. In the inflamed CNS, myeloid cells are comprised of brain-resident microglia, an endogenous cell population, and monocyte-derived macrophages, which infiltrate from the systemic compartment. Using microglia isolated from the adult human brain, we demonstrate that myelin phagocytosis is dependent on the polarization state of the cells. Myelin ingestion is significantly enhanced in cells exposed to TGF- compared with resting basal conditions and markedly reduced in classically activated polarized cells. Transcriptional analysis indicated that TGF--treated microglia closely resembled M0 cells. The tyrosine kinase phagocytic receptor MerTK was one of the most upregulated among a select number of differentially expressed genes in TGF--treated microglia. In contrast, MerTK and its known ligands, growth arrest-specific 6 and Protein S, were downregulated in classically activated cells. MerTK expression and myelin phagocytosis were higher in CNS-derived microglia than observed in monocyte-derived macrophages, both basally and under all tested polarization conditions. Specific MerTK inhibitors reduced myelin phagocytosis and the resultant anti-inflammatory biased cytokine responses for both cell types. Defining and modulating the mechanisms that regulate myelin phagocytosis has the potential to impact lesion and disease evolution in multiple sclerosis. Relevant effects would include enhancing myelin clearance, increasing anti-inflammatory molecule production by myeloid cells, and thereby permitting subsequent tissue repair. Abstract from J Immunol. 2016 Apr 15;196(8):3375-84. doi: 10.4049/jimmunol.1502562."	30	"MDM-CSF1, MDM +IFNg +LPS 2d, MDM + IL4 + IL13 2d, MDM + IL4 + IL13 +IL10 2d, MDM + TGFB, microglia, microglia + IFNg + LPS 2d, microglia + IL4 + IL13, microglia + IL4 + IL10 + IL13, microglia + TGFB"	Microarray (Affymetrix HuGene-2_0-ST V1)		Homo sapiens	3.56	HuGene	"rgb(0,109,219)"	diamond-open	Mo-Mac adult peripheral blood  CSF1 5d then IL4 IL10 IL13 2d	myeloid	Mo-Mac	adult	macrophage	Macrophage
GSM2360265;7268	7268	Abud	GSM2360265	M-1	Homo sapiens	CD14+ CD16- monocyte	CL:0000576		monocyte			Abud	"Microglia play critical roles in brain development, homeostasis, and neurological disorders. Here, we report that human microglial-like cells (iMGLs) can be differentiated from iPSCs to study their function in neurological diseases, like Alzheimer's disease (AD). We find that iMGLs develop in vitro similarly to microglia in vivo, and whole-transcriptome analysis demonstrates that they are highly similar to cultured adult and fetal human microglia. Functional assessment of iMGLs reveals that they secrete cytokines in response to inflammatory stimuli, migrate and undergo calcium transients, and robustly phagocytose CNS substrates. iMGLs were used to examine the effects of A fibrils and brain-derived tau oligomers on AD-related gene expression and to interrogate mechanisms involved in synaptic pruning. Furthermore, iMGLs transplanted into transgenic mice and human brain organoids resemble microglia in vivo. Together, these findings demonstrate that iMGLs can be used to study microglial function, providing important new insight into human neurological disease. Abstract from Neuron. 2017 Apr 19;94(2):278-293.e9. doi: 10.1016/j.neuron.2017.03.042."	43	"iPSC, iPSC-derived HPC, iPSC-derived MGL, iPSC-derived MGL + neuron, iPSC-derived MGL + no CD200, iPSC-derived MGL + TGFb withdrawal, fetal microglia, adult microglia, DC, CD14+ CD16- monocyte, CD14+ CD16+ monocyte"	RNASeq (Illumina HiSeq 2500 (GPL16791))		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross	CD14+ CD16- Monocyte  adult	myeloid	Monocyte	adult	monocyte	Circulating Monocyte & Granulocyte
GSM2360266;7268	7268	Abud	GSM2360266	M-2	Homo sapiens	CD14+ CD16- monocyte	CL:0000576		monocyte			Abud	"Microglia play critical roles in brain development, homeostasis, and neurological disorders. Here, we report that human microglial-like cells (iMGLs) can be differentiated from iPSCs to study their function in neurological diseases, like Alzheimer's disease (AD). We find that iMGLs develop in vitro similarly to microglia in vivo, and whole-transcriptome analysis demonstrates that they are highly similar to cultured adult and fetal human microglia. Functional assessment of iMGLs reveals that they secrete cytokines in response to inflammatory stimuli, migrate and undergo calcium transients, and robustly phagocytose CNS substrates. iMGLs were used to examine the effects of A fibrils and brain-derived tau oligomers on AD-related gene expression and to interrogate mechanisms involved in synaptic pruning. Furthermore, iMGLs transplanted into transgenic mice and human brain organoids resemble microglia in vivo. Together, these findings demonstrate that iMGLs can be used to study microglial function, providing important new insight into human neurological disease. Abstract from Neuron. 2017 Apr 19;94(2):278-293.e9. doi: 10.1016/j.neuron.2017.03.042."	43	"iPSC, iPSC-derived HPC, iPSC-derived MGL, iPSC-derived MGL + neuron, iPSC-derived MGL + no CD200, iPSC-derived MGL + TGFb withdrawal, fetal microglia, adult microglia, DC, CD14+ CD16- monocyte, CD14+ CD16+ monocyte"	RNASeq (Illumina HiSeq 2500 (GPL16791))		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross	CD14+ CD16- Monocyte  adult	myeloid	Monocyte	adult	monocyte	Circulating Monocyte & Granulocyte
GSM2360267;7268	7268	Abud	GSM2360267	M-3	Homo sapiens	CD14+ CD16- monocyte	CL:0000576		monocyte			Abud	"Microglia play critical roles in brain development, homeostasis, and neurological disorders. Here, we report that human microglial-like cells (iMGLs) can be differentiated from iPSCs to study their function in neurological diseases, like Alzheimer's disease (AD). We find that iMGLs develop in vitro similarly to microglia in vivo, and whole-transcriptome analysis demonstrates that they are highly similar to cultured adult and fetal human microglia. Functional assessment of iMGLs reveals that they secrete cytokines in response to inflammatory stimuli, migrate and undergo calcium transients, and robustly phagocytose CNS substrates. iMGLs were used to examine the effects of A fibrils and brain-derived tau oligomers on AD-related gene expression and to interrogate mechanisms involved in synaptic pruning. Furthermore, iMGLs transplanted into transgenic mice and human brain organoids resemble microglia in vivo. Together, these findings demonstrate that iMGLs can be used to study microglial function, providing important new insight into human neurological disease. Abstract from Neuron. 2017 Apr 19;94(2):278-293.e9. doi: 10.1016/j.neuron.2017.03.042."	43	"iPSC, iPSC-derived HPC, iPSC-derived MGL, iPSC-derived MGL + neuron, iPSC-derived MGL + no CD200, iPSC-derived MGL + TGFb withdrawal, fetal microglia, adult microglia, DC, CD14+ CD16- monocyte, CD14+ CD16+ monocyte"	RNASeq (Illumina HiSeq 2500 (GPL16791))		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross	CD14+ CD16- Monocyte  adult	myeloid	Monocyte	adult	monocyte	Circulating Monocyte & Granulocyte
GSM2360268;7268	7268	Abud	GSM2360268	M-4	Homo sapiens	CD14+ CD16- monocyte	CL:0000576		monocyte			Abud	"Microglia play critical roles in brain development, homeostasis, and neurological disorders. Here, we report that human microglial-like cells (iMGLs) can be differentiated from iPSCs to study their function in neurological diseases, like Alzheimer's disease (AD). We find that iMGLs develop in vitro similarly to microglia in vivo, and whole-transcriptome analysis demonstrates that they are highly similar to cultured adult and fetal human microglia. Functional assessment of iMGLs reveals that they secrete cytokines in response to inflammatory stimuli, migrate and undergo calcium transients, and robustly phagocytose CNS substrates. iMGLs were used to examine the effects of A fibrils and brain-derived tau oligomers on AD-related gene expression and to interrogate mechanisms involved in synaptic pruning. Furthermore, iMGLs transplanted into transgenic mice and human brain organoids resemble microglia in vivo. Together, these findings demonstrate that iMGLs can be used to study microglial function, providing important new insight into human neurological disease. Abstract from Neuron. 2017 Apr 19;94(2):278-293.e9. doi: 10.1016/j.neuron.2017.03.042."	43	"iPSC, iPSC-derived HPC, iPSC-derived MGL, iPSC-derived MGL + neuron, iPSC-derived MGL + no CD200, iPSC-derived MGL + TGFb withdrawal, fetal microglia, adult microglia, DC, CD14+ CD16- monocyte, CD14+ CD16+ monocyte"	RNASeq (Illumina HiSeq 2500 (GPL16791))		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross	CD14+ CD16- Monocyte  adult	myeloid	Monocyte	adult	monocyte	Circulating Monocyte & Granulocyte
GSM2360269;7268	7268	Abud	GSM2360269	M-5	Homo sapiens	CD14+ CD16- monocyte	CL:0000576		monocyte			Abud	"Microglia play critical roles in brain development, homeostasis, and neurological disorders. Here, we report that human microglial-like cells (iMGLs) can be differentiated from iPSCs to study their function in neurological diseases, like Alzheimer's disease (AD). We find that iMGLs develop in vitro similarly to microglia in vivo, and whole-transcriptome analysis demonstrates that they are highly similar to cultured adult and fetal human microglia. Functional assessment of iMGLs reveals that they secrete cytokines in response to inflammatory stimuli, migrate and undergo calcium transients, and robustly phagocytose CNS substrates. iMGLs were used to examine the effects of A fibrils and brain-derived tau oligomers on AD-related gene expression and to interrogate mechanisms involved in synaptic pruning. Furthermore, iMGLs transplanted into transgenic mice and human brain organoids resemble microglia in vivo. Together, these findings demonstrate that iMGLs can be used to study microglial function, providing important new insight into human neurological disease. Abstract from Neuron. 2017 Apr 19;94(2):278-293.e9. doi: 10.1016/j.neuron.2017.03.042."	43	"iPSC, iPSC-derived HPC, iPSC-derived MGL, iPSC-derived MGL + neuron, iPSC-derived MGL + no CD200, iPSC-derived MGL + TGFb withdrawal, fetal microglia, adult microglia, DC, CD14+ CD16- monocyte, CD14+ CD16+ monocyte"	RNASeq (Illumina HiSeq 2500 (GPL16791))		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross	CD14+ CD16- Monocyte  adult	myeloid	Monocyte	adult	monocyte	Circulating Monocyte & Granulocyte
GSM2360270;7268	7268	Abud	GSM2360270	IM-1	Homo sapiens	CD14+ CD16+ monocyte	CL:0000576		monocyte			Abud	"Microglia play critical roles in brain development, homeostasis, and neurological disorders. Here, we report that human microglial-like cells (iMGLs) can be differentiated from iPSCs to study their function in neurological diseases, like Alzheimer's disease (AD). We find that iMGLs develop in vitro similarly to microglia in vivo, and whole-transcriptome analysis demonstrates that they are highly similar to cultured adult and fetal human microglia. Functional assessment of iMGLs reveals that they secrete cytokines in response to inflammatory stimuli, migrate and undergo calcium transients, and robustly phagocytose CNS substrates. iMGLs were used to examine the effects of A fibrils and brain-derived tau oligomers on AD-related gene expression and to interrogate mechanisms involved in synaptic pruning. Furthermore, iMGLs transplanted into transgenic mice and human brain organoids resemble microglia in vivo. Together, these findings demonstrate that iMGLs can be used to study microglial function, providing important new insight into human neurological disease. Abstract from Neuron. 2017 Apr 19;94(2):278-293.e9. doi: 10.1016/j.neuron.2017.03.042."	43	"iPSC, iPSC-derived HPC, iPSC-derived MGL, iPSC-derived MGL + neuron, iPSC-derived MGL + no CD200, iPSC-derived MGL + TGFb withdrawal, fetal microglia, adult microglia, DC, CD14+ CD16- monocyte, CD14+ CD16+ monocyte"	RNASeq (Illumina HiSeq 2500 (GPL16791))		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross	CD14+ CD16+ Monocyte  adult	myeloid	Monocyte	adult	monocyte	Circulating Monocyte & Granulocyte
GSM2360271;7268	7268	Abud	GSM2360271	IM-2	Homo sapiens	CD14+ CD16+ monocyte	CL:0000576		monocyte			Abud	"Microglia play critical roles in brain development, homeostasis, and neurological disorders. Here, we report that human microglial-like cells (iMGLs) can be differentiated from iPSCs to study their function in neurological diseases, like Alzheimer's disease (AD). We find that iMGLs develop in vitro similarly to microglia in vivo, and whole-transcriptome analysis demonstrates that they are highly similar to cultured adult and fetal human microglia. Functional assessment of iMGLs reveals that they secrete cytokines in response to inflammatory stimuli, migrate and undergo calcium transients, and robustly phagocytose CNS substrates. iMGLs were used to examine the effects of A fibrils and brain-derived tau oligomers on AD-related gene expression and to interrogate mechanisms involved in synaptic pruning. Furthermore, iMGLs transplanted into transgenic mice and human brain organoids resemble microglia in vivo. Together, these findings demonstrate that iMGLs can be used to study microglial function, providing important new insight into human neurological disease. Abstract from Neuron. 2017 Apr 19;94(2):278-293.e9. doi: 10.1016/j.neuron.2017.03.042."	43	"iPSC, iPSC-derived HPC, iPSC-derived MGL, iPSC-derived MGL + neuron, iPSC-derived MGL + no CD200, iPSC-derived MGL + TGFb withdrawal, fetal microglia, adult microglia, DC, CD14+ CD16- monocyte, CD14+ CD16+ monocyte"	RNASeq (Illumina HiSeq 2500 (GPL16791))		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross	CD14+ CD16+ Monocyte  adult	myeloid	Monocyte	adult	monocyte	Circulating Monocyte & Granulocyte
GSM2360272;7268	7268	Abud	GSM2360272	IM-3	Homo sapiens	CD14+ CD16+ monocyte	CL:0000576		monocyte			Abud	"Microglia play critical roles in brain development, homeostasis, and neurological disorders. Here, we report that human microglial-like cells (iMGLs) can be differentiated from iPSCs to study their function in neurological diseases, like Alzheimer's disease (AD). We find that iMGLs develop in vitro similarly to microglia in vivo, and whole-transcriptome analysis demonstrates that they are highly similar to cultured adult and fetal human microglia. Functional assessment of iMGLs reveals that they secrete cytokines in response to inflammatory stimuli, migrate and undergo calcium transients, and robustly phagocytose CNS substrates. iMGLs were used to examine the effects of A fibrils and brain-derived tau oligomers on AD-related gene expression and to interrogate mechanisms involved in synaptic pruning. Furthermore, iMGLs transplanted into transgenic mice and human brain organoids resemble microglia in vivo. Together, these findings demonstrate that iMGLs can be used to study microglial function, providing important new insight into human neurological disease. Abstract from Neuron. 2017 Apr 19;94(2):278-293.e9. doi: 10.1016/j.neuron.2017.03.042."	43	"iPSC, iPSC-derived HPC, iPSC-derived MGL, iPSC-derived MGL + neuron, iPSC-derived MGL + no CD200, iPSC-derived MGL + TGFb withdrawal, fetal microglia, adult microglia, DC, CD14+ CD16- monocyte, CD14+ CD16+ monocyte"	RNASeq (Illumina HiSeq 2500 (GPL16791))		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross	CD14+ CD16+ Monocyte  adult	myeloid	Monocyte	adult	monocyte	Circulating Monocyte & Granulocyte
GSM2360273;7268	7268	Abud	GSM2360273	IM-4	Homo sapiens	CD14+ CD16+ monocyte	CL:0000576		monocyte			Abud	"Microglia play critical roles in brain development, homeostasis, and neurological disorders. Here, we report that human microglial-like cells (iMGLs) can be differentiated from iPSCs to study their function in neurological diseases, like Alzheimer's disease (AD). We find that iMGLs develop in vitro similarly to microglia in vivo, and whole-transcriptome analysis demonstrates that they are highly similar to cultured adult and fetal human microglia. Functional assessment of iMGLs reveals that they secrete cytokines in response to inflammatory stimuli, migrate and undergo calcium transients, and robustly phagocytose CNS substrates. iMGLs were used to examine the effects of A fibrils and brain-derived tau oligomers on AD-related gene expression and to interrogate mechanisms involved in synaptic pruning. Furthermore, iMGLs transplanted into transgenic mice and human brain organoids resemble microglia in vivo. Together, these findings demonstrate that iMGLs can be used to study microglial function, providing important new insight into human neurological disease. Abstract from Neuron. 2017 Apr 19;94(2):278-293.e9. doi: 10.1016/j.neuron.2017.03.042."	43	"iPSC, iPSC-derived HPC, iPSC-derived MGL, iPSC-derived MGL + neuron, iPSC-derived MGL + no CD200, iPSC-derived MGL + TGFb withdrawal, fetal microglia, adult microglia, DC, CD14+ CD16- monocyte, CD14+ CD16+ monocyte"	RNASeq (Illumina HiSeq 2500 (GPL16791))		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross	CD14+ CD16+ Monocyte  adult	myeloid	Monocyte	adult	monocyte	Circulating Monocyte & Granulocyte
GSM2360280;7268	7268	Abud	GSM2360280	S8	Homo sapiens	DC	CL:0000451		dendritic cell	female		Abud	"Microglia play critical roles in brain development, homeostasis, and neurological disorders. Here, we report that human microglial-like cells (iMGLs) can be differentiated from iPSCs to study their function in neurological diseases, like Alzheimer's disease (AD). We find that iMGLs develop in vitro similarly to microglia in vivo, and whole-transcriptome analysis demonstrates that they are highly similar to cultured adult and fetal human microglia. Functional assessment of iMGLs reveals that they secrete cytokines in response to inflammatory stimuli, migrate and undergo calcium transients, and robustly phagocytose CNS substrates. iMGLs were used to examine the effects of A fibrils and brain-derived tau oligomers on AD-related gene expression and to interrogate mechanisms involved in synaptic pruning. Furthermore, iMGLs transplanted into transgenic mice and human brain organoids resemble microglia in vivo. Together, these findings demonstrate that iMGLs can be used to study microglial function, providing important new insight into human neurological disease. Abstract from Neuron. 2017 Apr 19;94(2):278-293.e9. doi: 10.1016/j.neuron.2017.03.042."	43	"iPSC, iPSC-derived HPC, iPSC-derived MGL, iPSC-derived MGL + neuron, iPSC-derived MGL + no CD200, iPSC-derived MGL + TGFb withdrawal, fetal microglia, adult microglia, DC, CD14+ CD16- monocyte, CD14+ CD16+ monocyte"	RNASeq (Illumina HiSeq 2500 (GPL16791))		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross	"pan-DC isolation, no phenotype c-DC  adult"	myeloid	c-DC	adult	dendritic cell	Mixed
GSM2360281;7268	7268	Abud	GSM2360281	S22	Homo sapiens	DC	CL:0000451		dendritic cell	female		Abud	"Microglia play critical roles in brain development, homeostasis, and neurological disorders. Here, we report that human microglial-like cells (iMGLs) can be differentiated from iPSCs to study their function in neurological diseases, like Alzheimer's disease (AD). We find that iMGLs develop in vitro similarly to microglia in vivo, and whole-transcriptome analysis demonstrates that they are highly similar to cultured adult and fetal human microglia. Functional assessment of iMGLs reveals that they secrete cytokines in response to inflammatory stimuli, migrate and undergo calcium transients, and robustly phagocytose CNS substrates. iMGLs were used to examine the effects of A fibrils and brain-derived tau oligomers on AD-related gene expression and to interrogate mechanisms involved in synaptic pruning. Furthermore, iMGLs transplanted into transgenic mice and human brain organoids resemble microglia in vivo. Together, these findings demonstrate that iMGLs can be used to study microglial function, providing important new insight into human neurological disease. Abstract from Neuron. 2017 Apr 19;94(2):278-293.e9. doi: 10.1016/j.neuron.2017.03.042."	43	"iPSC, iPSC-derived HPC, iPSC-derived MGL, iPSC-derived MGL + neuron, iPSC-derived MGL + no CD200, iPSC-derived MGL + TGFb withdrawal, fetal microglia, adult microglia, DC, CD14+ CD16- monocyte, CD14+ CD16+ monocyte"	RNASeq (Illumina HiSeq 2500 (GPL16791))		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross	"pan-DC isolation, no phenotype c-DC  adult"	myeloid	c-DC	adult	dendritic cell	Mixed
GSM2360282;7268	7268	Abud	GSM2360282	S25	Homo sapiens	DC	CL:0000451		dendritic cell	female		Abud	"Microglia play critical roles in brain development, homeostasis, and neurological disorders. Here, we report that human microglial-like cells (iMGLs) can be differentiated from iPSCs to study their function in neurological diseases, like Alzheimer's disease (AD). We find that iMGLs develop in vitro similarly to microglia in vivo, and whole-transcriptome analysis demonstrates that they are highly similar to cultured adult and fetal human microglia. Functional assessment of iMGLs reveals that they secrete cytokines in response to inflammatory stimuli, migrate and undergo calcium transients, and robustly phagocytose CNS substrates. iMGLs were used to examine the effects of A fibrils and brain-derived tau oligomers on AD-related gene expression and to interrogate mechanisms involved in synaptic pruning. Furthermore, iMGLs transplanted into transgenic mice and human brain organoids resemble microglia in vivo. Together, these findings demonstrate that iMGLs can be used to study microglial function, providing important new insight into human neurological disease. Abstract from Neuron. 2017 Apr 19;94(2):278-293.e9. doi: 10.1016/j.neuron.2017.03.042."	43	"iPSC, iPSC-derived HPC, iPSC-derived MGL, iPSC-derived MGL + neuron, iPSC-derived MGL + no CD200, iPSC-derived MGL + TGFb withdrawal, fetal microglia, adult microglia, DC, CD14+ CD16- monocyte, CD14+ CD16+ monocyte"	RNASeq (Illumina HiSeq 2500 (GPL16791))		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross	"pan-DC isolation, no phenotype c-DC  adult"	myeloid	c-DC	adult	dendritic cell	Mixed
GSM250022;6037	6037	Delorme	GSM250022	CD235a+ sorted rep 1	Homo sapiens	erythrocyte	CL:0000232		erythrocyte			Delorme	"We previously identified multipotent stem cells within the lamina propria of the human olfactory mucosa, located in the nasal cavity. We also demonstrated that this cell type differentiates into neural cells and improves locomotor behavior after transplantation in a rat model of Parkinson's disease. Yet, next to nothing is known about their specific stemness characteristics. We therefore devised a study aiming to compare olfactory lamina propria stem cells from 4 individuals to bone marrow mesenchymal stem cells from 4 age- and gender-matched individuals. Using pangenomic microarrays and immunostaining with 34 cell surface marker antibodies, we show here that olfactory stem cells are closely related to bone marrow stem cells. However, olfactory stem cells also exhibit singular traits. By means of techniques such as proliferation assay, cDNA microarrays, RT-PCR, in vitro and in vivo differentiation, we report that when compared to bone marrow stem cells, olfactory stem cells display (1) a high proliferation rate; (2) a propensity to differentiate into osseous cells; and (3) a disinclination to give rise to chondrocytes and adipocytes. Since peripheral olfactory stem cells originate from a neural crest-derived tissue and, as shown here, exhibit an increased expression of neural cell-related genes, we propose to name them olfactory ectomesenchymal stem cells (OE-MSC). Further studies are now required to corroborate the therapeutic potential of OE-MSCs in animal models of bone and brain diseases."	25	"olfactory lamina propria, NPC, MSC, erythrocyte, granulocyte, leukocyte"	Microarray (Affymetrix HG-U133_Plus_2 (GPL570 and A-AFFY-44))		Homo sapiens	4.4	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	MP CD235A+ erythrocyte  adult	myeloid progenitor	MP	adult	erythrocyte	Mixed
GSM250023;6037	6037	Delorme	GSM250023	CD235a+ sorted rep 2	Homo sapiens	erythrocyte	CL:0000232		erythrocyte			Delorme	"We previously identified multipotent stem cells within the lamina propria of the human olfactory mucosa, located in the nasal cavity. We also demonstrated that this cell type differentiates into neural cells and improves locomotor behavior after transplantation in a rat model of Parkinson's disease. Yet, next to nothing is known about their specific stemness characteristics. We therefore devised a study aiming to compare olfactory lamina propria stem cells from 4 individuals to bone marrow mesenchymal stem cells from 4 age- and gender-matched individuals. Using pangenomic microarrays and immunostaining with 34 cell surface marker antibodies, we show here that olfactory stem cells are closely related to bone marrow stem cells. However, olfactory stem cells also exhibit singular traits. By means of techniques such as proliferation assay, cDNA microarrays, RT-PCR, in vitro and in vivo differentiation, we report that when compared to bone marrow stem cells, olfactory stem cells display (1) a high proliferation rate; (2) a propensity to differentiate into osseous cells; and (3) a disinclination to give rise to chondrocytes and adipocytes. Since peripheral olfactory stem cells originate from a neural crest-derived tissue and, as shown here, exhibit an increased expression of neural cell-related genes, we propose to name them olfactory ectomesenchymal stem cells (OE-MSC). Further studies are now required to corroborate the therapeutic potential of OE-MSCs in animal models of bone and brain diseases."	25	"olfactory lamina propria, NPC, MSC, erythrocyte, granulocyte, leukocyte"	Microarray (Affymetrix HG-U133_Plus_2 (GPL570 and A-AFFY-44))		Homo sapiens	4.4	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	MP CD235A+ erythrocyte  adult	myeloid progenitor	MP	adult	erythrocyte	Mixed
GSM250024;6037	6037	Delorme	GSM250024	CD235a+ sorted rep 3	Homo sapiens	erythrocyte	CL:0000232		erythrocyte			Delorme	"We previously identified multipotent stem cells within the lamina propria of the human olfactory mucosa, located in the nasal cavity. We also demonstrated that this cell type differentiates into neural cells and improves locomotor behavior after transplantation in a rat model of Parkinson's disease. Yet, next to nothing is known about their specific stemness characteristics. We therefore devised a study aiming to compare olfactory lamina propria stem cells from 4 individuals to bone marrow mesenchymal stem cells from 4 age- and gender-matched individuals. Using pangenomic microarrays and immunostaining with 34 cell surface marker antibodies, we show here that olfactory stem cells are closely related to bone marrow stem cells. However, olfactory stem cells also exhibit singular traits. By means of techniques such as proliferation assay, cDNA microarrays, RT-PCR, in vitro and in vivo differentiation, we report that when compared to bone marrow stem cells, olfactory stem cells display (1) a high proliferation rate; (2) a propensity to differentiate into osseous cells; and (3) a disinclination to give rise to chondrocytes and adipocytes. Since peripheral olfactory stem cells originate from a neural crest-derived tissue and, as shown here, exhibit an increased expression of neural cell-related genes, we propose to name them olfactory ectomesenchymal stem cells (OE-MSC). Further studies are now required to corroborate the therapeutic potential of OE-MSCs in animal models of bone and brain diseases."	25	"olfactory lamina propria, NPC, MSC, erythrocyte, granulocyte, leukocyte"	Microarray (Affymetrix HG-U133_Plus_2 (GPL570 and A-AFFY-44))		Homo sapiens	4.4	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	MP CD235A+ erythrocyte  adult	myeloid progenitor	MP	adult	erythrocyte	Mixed
GSM250025;6037	6037	Delorme	GSM250025	CD11b+ sorted rep 1	Homo sapiens	granulocyte	CL:0000094		granulocyte			Delorme	"We previously identified multipotent stem cells within the lamina propria of the human olfactory mucosa, located in the nasal cavity. We also demonstrated that this cell type differentiates into neural cells and improves locomotor behavior after transplantation in a rat model of Parkinson's disease. Yet, next to nothing is known about their specific stemness characteristics. We therefore devised a study aiming to compare olfactory lamina propria stem cells from 4 individuals to bone marrow mesenchymal stem cells from 4 age- and gender-matched individuals. Using pangenomic microarrays and immunostaining with 34 cell surface marker antibodies, we show here that olfactory stem cells are closely related to bone marrow stem cells. However, olfactory stem cells also exhibit singular traits. By means of techniques such as proliferation assay, cDNA microarrays, RT-PCR, in vitro and in vivo differentiation, we report that when compared to bone marrow stem cells, olfactory stem cells display (1) a high proliferation rate; (2) a propensity to differentiate into osseous cells; and (3) a disinclination to give rise to chondrocytes and adipocytes. Since peripheral olfactory stem cells originate from a neural crest-derived tissue and, as shown here, exhibit an increased expression of neural cell-related genes, we propose to name them olfactory ectomesenchymal stem cells (OE-MSC). Further studies are now required to corroborate the therapeutic potential of OE-MSCs in animal models of bone and brain diseases."	25	"olfactory lamina propria, NPC, MSC, erythrocyte, granulocyte, leukocyte"	Microarray (Affymetrix HG-U133_Plus_2 (GPL570 and A-AFFY-44))		Homo sapiens	4.4	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	Granulocyte CD11b+  adult	myeloid	Granulocyte	adult	granulocyte	Circulating Monocyte & Granulocyte
GSM250026;6037	6037	Delorme	GSM250026	CD11b+ sorted rep 2	Homo sapiens	granulocyte	CL:0000094		granulocyte			Delorme	"We previously identified multipotent stem cells within the lamina propria of the human olfactory mucosa, located in the nasal cavity. We also demonstrated that this cell type differentiates into neural cells and improves locomotor behavior after transplantation in a rat model of Parkinson's disease. Yet, next to nothing is known about their specific stemness characteristics. We therefore devised a study aiming to compare olfactory lamina propria stem cells from 4 individuals to bone marrow mesenchymal stem cells from 4 age- and gender-matched individuals. Using pangenomic microarrays and immunostaining with 34 cell surface marker antibodies, we show here that olfactory stem cells are closely related to bone marrow stem cells. However, olfactory stem cells also exhibit singular traits. By means of techniques such as proliferation assay, cDNA microarrays, RT-PCR, in vitro and in vivo differentiation, we report that when compared to bone marrow stem cells, olfactory stem cells display (1) a high proliferation rate; (2) a propensity to differentiate into osseous cells; and (3) a disinclination to give rise to chondrocytes and adipocytes. Since peripheral olfactory stem cells originate from a neural crest-derived tissue and, as shown here, exhibit an increased expression of neural cell-related genes, we propose to name them olfactory ectomesenchymal stem cells (OE-MSC). Further studies are now required to corroborate the therapeutic potential of OE-MSCs in animal models of bone and brain diseases."	25	"olfactory lamina propria, NPC, MSC, erythrocyte, granulocyte, leukocyte"	Microarray (Affymetrix HG-U133_Plus_2 (GPL570 and A-AFFY-44))		Homo sapiens	4.4	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	Granulocyte CD11b+  adult	myeloid	Granulocyte	adult	granulocyte	Circulating Monocyte & Granulocyte
GSM250027;6037	6037	Delorme	GSM250027	CD11b+ sorted rep 3	Homo sapiens	granulocyte	CL:0000094		granulocyte			Delorme	"We previously identified multipotent stem cells within the lamina propria of the human olfactory mucosa, located in the nasal cavity. We also demonstrated that this cell type differentiates into neural cells and improves locomotor behavior after transplantation in a rat model of Parkinson's disease. Yet, next to nothing is known about their specific stemness characteristics. We therefore devised a study aiming to compare olfactory lamina propria stem cells from 4 individuals to bone marrow mesenchymal stem cells from 4 age- and gender-matched individuals. Using pangenomic microarrays and immunostaining with 34 cell surface marker antibodies, we show here that olfactory stem cells are closely related to bone marrow stem cells. However, olfactory stem cells also exhibit singular traits. By means of techniques such as proliferation assay, cDNA microarrays, RT-PCR, in vitro and in vivo differentiation, we report that when compared to bone marrow stem cells, olfactory stem cells display (1) a high proliferation rate; (2) a propensity to differentiate into osseous cells; and (3) a disinclination to give rise to chondrocytes and adipocytes. Since peripheral olfactory stem cells originate from a neural crest-derived tissue and, as shown here, exhibit an increased expression of neural cell-related genes, we propose to name them olfactory ectomesenchymal stem cells (OE-MSC). Further studies are now required to corroborate the therapeutic potential of OE-MSCs in animal models of bone and brain diseases."	25	"olfactory lamina propria, NPC, MSC, erythrocyte, granulocyte, leukocyte"	Microarray (Affymetrix HG-U133_Plus_2 (GPL570 and A-AFFY-44))		Homo sapiens	4.4	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	Granulocyte CD11b+  adult	myeloid	Granulocyte	adult	granulocyte	Circulating Monocyte & Granulocyte
GSM2576749;7193	7193	Douvaras	GSM2576749	Non-polarized macrophages rep.1	Homo sapiens	PBMC-derived macrophage	CL:0000235	macrophage	peripheral blood mononuclear cell			Douvaras	"Microglia, the immune cells of the brain, are crucial to proper development and maintenance of the CNS, and their involvement in numerous neurological disorders is increasingly being recognized. To improve our understanding of human microglial biology, we devised a chemically defined protocol to generate human microglia from pluripotent stem cells. Myeloid progenitors expressing CD14/CX3CR1 were generated within 30 days of differentiation from both embryonic and induced pluripotent stem cells (iPSCs). Further differentiation of the progenitors resulted in ramified microglia with highly motile processes, expressing typical microglial markers. Analyses of gene expression and cytokine release showed close similarities between iPSC-derived (iPSC-MG) and human primary microglia as well as clear distinctions from macrophages. iPSC-MG were able to phagocytose and responded to ADP by producing intracellular Ca2+ transients, whereas macrophages lacked such response. The differentiation protocol was highly reproducible across several pluripotent stem cell lines. Abstract from Stem Cell Reports. 2017 Jun 6;8(6):1516-1524. doi: 10.1016/j.stemcr.2017.04.023."	24	"microglia, microglia + serum free, iPSC-derived microglia, hepatic macrophage, PBMC-derived macrophage, PBMC-derived macrophage + IFNg + LPS, PBMC-derived macrophage + IL4 + IL13, PBMC-derived macrophage + IL10"	RNASeq (Illumina HiSeq 2500 (GPL16791))		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross	CD14+  CSF-1 5d adult	myeloid	Mo-Mac	adult	macrophage	Macrophage
GSM2576750;7193	7193	Douvaras	GSM2576750	Macrophages polarized with IFN- and LPS rep.1	Homo sapiens	PBMC-derived macrophage + IFNg + LPS	CL:0000235	macrophage	peripheral blood mononuclear cell			Douvaras	"Microglia, the immune cells of the brain, are crucial to proper development and maintenance of the CNS, and their involvement in numerous neurological disorders is increasingly being recognized. To improve our understanding of human microglial biology, we devised a chemically defined protocol to generate human microglia from pluripotent stem cells. Myeloid progenitors expressing CD14/CX3CR1 were generated within 30 days of differentiation from both embryonic and induced pluripotent stem cells (iPSCs). Further differentiation of the progenitors resulted in ramified microglia with highly motile processes, expressing typical microglial markers. Analyses of gene expression and cytokine release showed close similarities between iPSC-derived (iPSC-MG) and human primary microglia as well as clear distinctions from macrophages. iPSC-MG were able to phagocytose and responded to ADP by producing intracellular Ca2+ transients, whereas macrophages lacked such response. The differentiation protocol was highly reproducible across several pluripotent stem cell lines. Abstract from Stem Cell Reports. 2017 Jun 6;8(6):1516-1524. doi: 10.1016/j.stemcr.2017.04.023."	24	"microglia, microglia + serum free, iPSC-derived microglia, hepatic macrophage, PBMC-derived macrophage, PBMC-derived macrophage + IFNg + LPS, PBMC-derived macrophage + IL4 + IL13, PBMC-derived macrophage + IL10"	RNASeq (Illumina HiSeq 2500 (GPL16791))		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross	CD14+  CSF-1 5d +IFNg LPS 2d adult	myeloid	Mo-Mac	adult	macrophage	Macrophage
GSM2576751;7193	7193	Douvaras	GSM2576751	Macrophages polarized with IL-4 and IL-13 rep.1	Homo sapiens	PBMC-derived macrophage + IL4 + IL13	CL:0000235	macrophage	peripheral blood mononuclear cell			Douvaras	"Microglia, the immune cells of the brain, are crucial to proper development and maintenance of the CNS, and their involvement in numerous neurological disorders is increasingly being recognized. To improve our understanding of human microglial biology, we devised a chemically defined protocol to generate human microglia from pluripotent stem cells. Myeloid progenitors expressing CD14/CX3CR1 were generated within 30 days of differentiation from both embryonic and induced pluripotent stem cells (iPSCs). Further differentiation of the progenitors resulted in ramified microglia with highly motile processes, expressing typical microglial markers. Analyses of gene expression and cytokine release showed close similarities between iPSC-derived (iPSC-MG) and human primary microglia as well as clear distinctions from macrophages. iPSC-MG were able to phagocytose and responded to ADP by producing intracellular Ca2+ transients, whereas macrophages lacked such response. The differentiation protocol was highly reproducible across several pluripotent stem cell lines. Abstract from Stem Cell Reports. 2017 Jun 6;8(6):1516-1524. doi: 10.1016/j.stemcr.2017.04.023."	24	"microglia, microglia + serum free, iPSC-derived microglia, hepatic macrophage, PBMC-derived macrophage, PBMC-derived macrophage + IFNg + LPS, PBMC-derived macrophage + IL4 + IL13, PBMC-derived macrophage + IL10"	RNASeq (Illumina HiSeq 2500 (GPL16791))		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross	CD14+  CSF-1 5d + IL-4 IL-13 2d adult	myeloid	Mo-Mac	adult	macrophage	Macrophage
GSM2576752;7193	7193	Douvaras	GSM2576752	Macrophages polarized with IL-10 rep.1	Homo sapiens	PBMC-derived macrophage + IL10	CL:0000235	macrophage	peripheral blood mononuclear cell			Douvaras	"Microglia, the immune cells of the brain, are crucial to proper development and maintenance of the CNS, and their involvement in numerous neurological disorders is increasingly being recognized. To improve our understanding of human microglial biology, we devised a chemically defined protocol to generate human microglia from pluripotent stem cells. Myeloid progenitors expressing CD14/CX3CR1 were generated within 30 days of differentiation from both embryonic and induced pluripotent stem cells (iPSCs). Further differentiation of the progenitors resulted in ramified microglia with highly motile processes, expressing typical microglial markers. Analyses of gene expression and cytokine release showed close similarities between iPSC-derived (iPSC-MG) and human primary microglia as well as clear distinctions from macrophages. iPSC-MG were able to phagocytose and responded to ADP by producing intracellular Ca2+ transients, whereas macrophages lacked such response. The differentiation protocol was highly reproducible across several pluripotent stem cell lines. Abstract from Stem Cell Reports. 2017 Jun 6;8(6):1516-1524. doi: 10.1016/j.stemcr.2017.04.023."	24	"microglia, microglia + serum free, iPSC-derived microglia, hepatic macrophage, PBMC-derived macrophage, PBMC-derived macrophage + IFNg + LPS, PBMC-derived macrophage + IL4 + IL13, PBMC-derived macrophage + IL10"	RNASeq (Illumina HiSeq 2500 (GPL16791))		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross	CD14+  CSF-1 5d +IL10 2d adult	myeloid	Mo-Mac	adult	macrophage	Macrophage
GSM2576753;7193	7193	Douvaras	GSM2576753	Non-polarized macrophages rep.2	Homo sapiens	PBMC-derived macrophage	CL:0000235	macrophage	peripheral blood mononuclear cell			Douvaras	"Microglia, the immune cells of the brain, are crucial to proper development and maintenance of the CNS, and their involvement in numerous neurological disorders is increasingly being recognized. To improve our understanding of human microglial biology, we devised a chemically defined protocol to generate human microglia from pluripotent stem cells. Myeloid progenitors expressing CD14/CX3CR1 were generated within 30 days of differentiation from both embryonic and induced pluripotent stem cells (iPSCs). Further differentiation of the progenitors resulted in ramified microglia with highly motile processes, expressing typical microglial markers. Analyses of gene expression and cytokine release showed close similarities between iPSC-derived (iPSC-MG) and human primary microglia as well as clear distinctions from macrophages. iPSC-MG were able to phagocytose and responded to ADP by producing intracellular Ca2+ transients, whereas macrophages lacked such response. The differentiation protocol was highly reproducible across several pluripotent stem cell lines. Abstract from Stem Cell Reports. 2017 Jun 6;8(6):1516-1524. doi: 10.1016/j.stemcr.2017.04.023."	24	"microglia, microglia + serum free, iPSC-derived microglia, hepatic macrophage, PBMC-derived macrophage, PBMC-derived macrophage + IFNg + LPS, PBMC-derived macrophage + IL4 + IL13, PBMC-derived macrophage + IL10"	RNASeq (Illumina HiSeq 2500 (GPL16791))		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross	CD14+  CSF-1 5d adult	myeloid	Mo-Mac	adult	macrophage	Macrophage
GSM2576754;7193	7193	Douvaras	GSM2576754	Macrophages polarized with IFN- and LPS rep.2	Homo sapiens	PBMC-derived macrophage + IFNg + LPS	CL:0000235	macrophage	peripheral blood mononuclear cell			Douvaras	"Microglia, the immune cells of the brain, are crucial to proper development and maintenance of the CNS, and their involvement in numerous neurological disorders is increasingly being recognized. To improve our understanding of human microglial biology, we devised a chemically defined protocol to generate human microglia from pluripotent stem cells. Myeloid progenitors expressing CD14/CX3CR1 were generated within 30 days of differentiation from both embryonic and induced pluripotent stem cells (iPSCs). Further differentiation of the progenitors resulted in ramified microglia with highly motile processes, expressing typical microglial markers. Analyses of gene expression and cytokine release showed close similarities between iPSC-derived (iPSC-MG) and human primary microglia as well as clear distinctions from macrophages. iPSC-MG were able to phagocytose and responded to ADP by producing intracellular Ca2+ transients, whereas macrophages lacked such response. The differentiation protocol was highly reproducible across several pluripotent stem cell lines. Abstract from Stem Cell Reports. 2017 Jun 6;8(6):1516-1524. doi: 10.1016/j.stemcr.2017.04.023."	24	"microglia, microglia + serum free, iPSC-derived microglia, hepatic macrophage, PBMC-derived macrophage, PBMC-derived macrophage + IFNg + LPS, PBMC-derived macrophage + IL4 + IL13, PBMC-derived macrophage + IL10"	RNASeq (Illumina HiSeq 2500 (GPL16791))		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross	CD14+  CSF-1 5d +IFNg LPS 2d adult	myeloid	Mo-Mac	adult	macrophage	Macrophage
GSM2576755;7193	7193	Douvaras	GSM2576755	Macrophages polarized with IL-4 and IL-13 rep.2	Homo sapiens	PBMC-derived macrophage + IL4 + IL13	CL:0000235	macrophage	peripheral blood mononuclear cell			Douvaras	"Microglia, the immune cells of the brain, are crucial to proper development and maintenance of the CNS, and their involvement in numerous neurological disorders is increasingly being recognized. To improve our understanding of human microglial biology, we devised a chemically defined protocol to generate human microglia from pluripotent stem cells. Myeloid progenitors expressing CD14/CX3CR1 were generated within 30 days of differentiation from both embryonic and induced pluripotent stem cells (iPSCs). Further differentiation of the progenitors resulted in ramified microglia with highly motile processes, expressing typical microglial markers. Analyses of gene expression and cytokine release showed close similarities between iPSC-derived (iPSC-MG) and human primary microglia as well as clear distinctions from macrophages. iPSC-MG were able to phagocytose and responded to ADP by producing intracellular Ca2+ transients, whereas macrophages lacked such response. The differentiation protocol was highly reproducible across several pluripotent stem cell lines. Abstract from Stem Cell Reports. 2017 Jun 6;8(6):1516-1524. doi: 10.1016/j.stemcr.2017.04.023."	24	"microglia, microglia + serum free, iPSC-derived microglia, hepatic macrophage, PBMC-derived macrophage, PBMC-derived macrophage + IFNg + LPS, PBMC-derived macrophage + IL4 + IL13, PBMC-derived macrophage + IL10"	RNASeq (Illumina HiSeq 2500 (GPL16791))		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross	CD14+  CSF-1 5d + IL-4 IL-13 2d adult	myeloid	Mo-Mac	adult	macrophage	Macrophage
GSM2576756;7193	7193	Douvaras	GSM2576756	Macrophages polarized with IL-10 rep.2	Homo sapiens	PBMC-derived macrophage + IL10	CL:0000235	macrophage	peripheral blood mononuclear cell			Douvaras	"Microglia, the immune cells of the brain, are crucial to proper development and maintenance of the CNS, and their involvement in numerous neurological disorders is increasingly being recognized. To improve our understanding of human microglial biology, we devised a chemically defined protocol to generate human microglia from pluripotent stem cells. Myeloid progenitors expressing CD14/CX3CR1 were generated within 30 days of differentiation from both embryonic and induced pluripotent stem cells (iPSCs). Further differentiation of the progenitors resulted in ramified microglia with highly motile processes, expressing typical microglial markers. Analyses of gene expression and cytokine release showed close similarities between iPSC-derived (iPSC-MG) and human primary microglia as well as clear distinctions from macrophages. iPSC-MG were able to phagocytose and responded to ADP by producing intracellular Ca2+ transients, whereas macrophages lacked such response. The differentiation protocol was highly reproducible across several pluripotent stem cell lines. Abstract from Stem Cell Reports. 2017 Jun 6;8(6):1516-1524. doi: 10.1016/j.stemcr.2017.04.023."	24	"microglia, microglia + serum free, iPSC-derived microglia, hepatic macrophage, PBMC-derived macrophage, PBMC-derived macrophage + IFNg + LPS, PBMC-derived macrophage + IL4 + IL13, PBMC-derived macrophage + IL10"	RNASeq (Illumina HiSeq 2500 (GPL16791))		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross	CD14+  CSF-1 5d +IL10 2d adult	myeloid	Mo-Mac	adult	macrophage	Macrophage
GSM2576773;7193	7193	Douvaras	GSM2576773	Human hepatic macrophages rep.1	Homo sapiens	hepatic macrophage	CL:0000235		macrophage			Douvaras	"Microglia, the immune cells of the brain, are crucial to proper development and maintenance of the CNS, and their involvement in numerous neurological disorders is increasingly being recognized. To improve our understanding of human microglial biology, we devised a chemically defined protocol to generate human microglia from pluripotent stem cells. Myeloid progenitors expressing CD14/CX3CR1 were generated within 30 days of differentiation from both embryonic and induced pluripotent stem cells (iPSCs). Further differentiation of the progenitors resulted in ramified microglia with highly motile processes, expressing typical microglial markers. Analyses of gene expression and cytokine release showed close similarities between iPSC-derived (iPSC-MG) and human primary microglia as well as clear distinctions from macrophages. iPSC-MG were able to phagocytose and responded to ADP by producing intracellular Ca2+ transients, whereas macrophages lacked such response. The differentiation protocol was highly reproducible across several pluripotent stem cell lines. Abstract from Stem Cell Reports. 2017 Jun 6;8(6):1516-1524. doi: 10.1016/j.stemcr.2017.04.023."	24	"microglia, microglia + serum free, iPSC-derived microglia, hepatic macrophage, PBMC-derived macrophage, PBMC-derived macrophage + IFNg + LPS, PBMC-derived macrophage + IL4 + IL13, PBMC-derived macrophage + IL10"	RNASeq (Illumina HiSeq 2500 (GPL16791))		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross		myeloid	TRM	fetal	kupffer cell	Macrophage
GSM2576774;7193	7193	Douvaras	GSM2576774	Human hepatic macrophages rep.2	Homo sapiens	hepatic macrophage	CL:0000235		macrophage			Douvaras	"Microglia, the immune cells of the brain, are crucial to proper development and maintenance of the CNS, and their involvement in numerous neurological disorders is increasingly being recognized. To improve our understanding of human microglial biology, we devised a chemically defined protocol to generate human microglia from pluripotent stem cells. Myeloid progenitors expressing CD14/CX3CR1 were generated within 30 days of differentiation from both embryonic and induced pluripotent stem cells (iPSCs). Further differentiation of the progenitors resulted in ramified microglia with highly motile processes, expressing typical microglial markers. Analyses of gene expression and cytokine release showed close similarities between iPSC-derived (iPSC-MG) and human primary microglia as well as clear distinctions from macrophages. iPSC-MG were able to phagocytose and responded to ADP by producing intracellular Ca2+ transients, whereas macrophages lacked such response. The differentiation protocol was highly reproducible across several pluripotent stem cell lines. Abstract from Stem Cell Reports. 2017 Jun 6;8(6):1516-1524. doi: 10.1016/j.stemcr.2017.04.023."	24	"microglia, microglia + serum free, iPSC-derived microglia, hepatic macrophage, PBMC-derived macrophage, PBMC-derived macrophage + IFNg + LPS, PBMC-derived macrophage + IL4 + IL13, PBMC-derived macrophage + IL10"	RNASeq (Illumina HiSeq 2500 (GPL16791))		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross		myeloid	TRM	fetal	kupffer cell	Macrophage
GSM2651067;7371	7371	Tasnim	GSM2651067	PHKCs_1	Homo sapiens	KC	CL:0000091		kupffer cell		biotin	Tasnim	"Liver macrophages, Kupffer cells (KCs), play a critical role in drug-induced liver injury (DILI) and liver diseases including cholestasis, liver fibrosis and viral hepatitis. Application of KCs in in vitro models of DILI and liver diseases is hindered due to limited source of human KCs. In vivo, KCs originate from MYB-independent macrophage progenitors, which differentiate into liver-specific macrophages in response to hepatic cues in the liver. Here, we recapitulated KCs ontogeny by differentiation of MYB-independent iPSCs to macrophage-precursors and exposing them to hepatic cues to generate iPSC-derived KCs (iKCs). iKCs expressed macrophage markers (CD11/CD14/CD68/CD163/CD32) at 0.3-5 folds of primary adult human KCs (pKCs) and KC-specific CLEC-4F, ID1 and ID3. iKCs phagocytosed and secreted IL-6 and TNF upon stimulation at levels similar to pKCs but different from non-liver macrophages. Hepatocyte-iKCs co-culture model was more sensitive in detecting hepatotoxicity induced by inflammation-associated drugs, Acetaminophen and Trovafloxacin, and Chlorpromazine-induced cholestasis when compared to hepatocytes alone. Overall, iKCs were mature, liver-specific and functional. Furthermore, donor-matched iKCs and iPSC-hepatocyte co-culture exhibited minimal non-specific background response compared to donor-mismatched counterpart. iKCs offer a mature renewable human cell source for liver-specific macrophages, useful in developing in vitro model to study DILI and liver diseases such as cholestasis. Abstract from Biomaterials. 2018 Nov 16;192:377-391. doi: 10.1016/j.biomaterials.2018.11.016."	9	"iMAC, iKC, KC"	Microarray (Affymetrix HuGene-2_0-ST V1)		Homo sapiens	3.03	HuGene	"rgb(0,109,219)"	diamond-open	Kupffer cell	myeloid	TRM	adult	kupffer cell	Macrophage
GSM2651068;7371	7371	Tasnim	GSM2651068	PHKCs_2	Homo sapiens	KC	CL:0000091		kupffer cell		biotin	Tasnim	"Liver macrophages, Kupffer cells (KCs), play a critical role in drug-induced liver injury (DILI) and liver diseases including cholestasis, liver fibrosis and viral hepatitis. Application of KCs in in vitro models of DILI and liver diseases is hindered due to limited source of human KCs. In vivo, KCs originate from MYB-independent macrophage progenitors, which differentiate into liver-specific macrophages in response to hepatic cues in the liver. Here, we recapitulated KCs ontogeny by differentiation of MYB-independent iPSCs to macrophage-precursors and exposing them to hepatic cues to generate iPSC-derived KCs (iKCs). iKCs expressed macrophage markers (CD11/CD14/CD68/CD163/CD32) at 0.3-5 folds of primary adult human KCs (pKCs) and KC-specific CLEC-4F, ID1 and ID3. iKCs phagocytosed and secreted IL-6 and TNF upon stimulation at levels similar to pKCs but different from non-liver macrophages. Hepatocyte-iKCs co-culture model was more sensitive in detecting hepatotoxicity induced by inflammation-associated drugs, Acetaminophen and Trovafloxacin, and Chlorpromazine-induced cholestasis when compared to hepatocytes alone. Overall, iKCs were mature, liver-specific and functional. Furthermore, donor-matched iKCs and iPSC-hepatocyte co-culture exhibited minimal non-specific background response compared to donor-mismatched counterpart. iKCs offer a mature renewable human cell source for liver-specific macrophages, useful in developing in vitro model to study DILI and liver diseases such as cholestasis. Abstract from Biomaterials. 2018 Nov 16;192:377-391. doi: 10.1016/j.biomaterials.2018.11.016."	9	"iMAC, iKC, KC"	Microarray (Affymetrix HuGene-2_0-ST V1)		Homo sapiens	3.03	HuGene	"rgb(0,109,219)"	diamond-open	Kupffer cell	myeloid	TRM	adult	kupffer cell	Macrophage
GSM2651069;7371	7371	Tasnim	GSM2651069	PHKCs_3	Homo sapiens	KC	CL:0000091		kupffer cell		biotin	Tasnim	"Liver macrophages, Kupffer cells (KCs), play a critical role in drug-induced liver injury (DILI) and liver diseases including cholestasis, liver fibrosis and viral hepatitis. Application of KCs in in vitro models of DILI and liver diseases is hindered due to limited source of human KCs. In vivo, KCs originate from MYB-independent macrophage progenitors, which differentiate into liver-specific macrophages in response to hepatic cues in the liver. Here, we recapitulated KCs ontogeny by differentiation of MYB-independent iPSCs to macrophage-precursors and exposing them to hepatic cues to generate iPSC-derived KCs (iKCs). iKCs expressed macrophage markers (CD11/CD14/CD68/CD163/CD32) at 0.3-5 folds of primary adult human KCs (pKCs) and KC-specific CLEC-4F, ID1 and ID3. iKCs phagocytosed and secreted IL-6 and TNF upon stimulation at levels similar to pKCs but different from non-liver macrophages. Hepatocyte-iKCs co-culture model was more sensitive in detecting hepatotoxicity induced by inflammation-associated drugs, Acetaminophen and Trovafloxacin, and Chlorpromazine-induced cholestasis when compared to hepatocytes alone. Overall, iKCs were mature, liver-specific and functional. Furthermore, donor-matched iKCs and iPSC-hepatocyte co-culture exhibited minimal non-specific background response compared to donor-mismatched counterpart. iKCs offer a mature renewable human cell source for liver-specific macrophages, useful in developing in vitro model to study DILI and liver diseases such as cholestasis. Abstract from Biomaterials. 2018 Nov 16;192:377-391. doi: 10.1016/j.biomaterials.2018.11.016."	9	"iMAC, iKC, KC"	Microarray (Affymetrix HuGene-2_0-ST V1)		Homo sapiens	3.03	HuGene	"rgb(0,109,219)"	diamond-open	Kupffer cell	myeloid	TRM	adult	kupffer cell	Macrophage
GSM2717641;6530	6530	DeJong	GSM2717641	Preterm chorio_E. coli_Monocytes male 1485g	Homo sapiens	preterm +Ecoli	CL:0000576		monocyte	male		DeJong	"Escherichia coli and Staphylococcus epidermidis are predominant causes of neonatal sepsis, particularly affecting preterm infants. Susceptibility to infection has been attributed to immature innate monocyte defences, but no studies have assessed global transcriptional responses of neonatal monocytes to these pathogens. Here, we aimed to identify and characterise the neonatal monocyte transcriptional responses to E. coli and S. epidermidis and the role of common modifiers such as gestational age (GA) and exposure to chorioamnionitis (a common complication of preterm birth) to better understand early life innate immune responses. RNA-sequencing was performed on purified cord blood monocytes from very preterm (< 32 weeks GA) and term infants (3740 weeks GA) following standardised challenge with live S. epidermidis or E. coli. The major transcriptional changes induced by either pathogen were highly conserved between infant groups and stimuli, highlighting a common extant neonatal monocyte response to infection, largely mediated by TLR/NF-B/TREM-1 signalling. In addition, we observed an activated interferon-centred immune response specific to stimulation with E. coli in both preterm and term infants. These data provide novel insights into the functionality of neonatal monocytes at birth and highlight potential pathways that could be targeted to reduce the harmful effects of bacterial-induced inflammation in sepsis. E. coli and S. epidermidis elicit common transcriptional changes in cord monocytes. The common transcriptional response is mediated by TLR/NF-B/TREM-1 signalling. IFN genes are differentially regulated by E. coli and S. epidermidis in monocytes. These responses are largely unaffected by GA or exposure to chorioamnionitis. Abstract from J Mol Med (Berl). 2018 Feb;96(2):147-157. doi: 10.1007/s00109-017-1609-2. [Curator's note: Please note that two separate Stemformatics datasets (6412, 6530) are associated with the relevant publication.]"	43	"preterm, term, preterm +Ecoli, term +Ecoli, preterm +Sepidermidis, term +Sepidermidis"	RNASeq (Illumina HiSeq 2000 RNASeq hg19 Gene)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross	Monocyte CD14+ E. coli 2h neonatal	myeloid	Monocyte	neonatal	monocyte	Macrophage
GSM2717642;6530	6530	DeJong	GSM2717642	Preterm chorio_S. epidermidis_Monocytes male 1485g	Homo sapiens	preterm +Sepidermidis	CL:0000576		monocyte	male		DeJong	"Escherichia coli and Staphylococcus epidermidis are predominant causes of neonatal sepsis, particularly affecting preterm infants. Susceptibility to infection has been attributed to immature innate monocyte defences, but no studies have assessed global transcriptional responses of neonatal monocytes to these pathogens. Here, we aimed to identify and characterise the neonatal monocyte transcriptional responses to E. coli and S. epidermidis and the role of common modifiers such as gestational age (GA) and exposure to chorioamnionitis (a common complication of preterm birth) to better understand early life innate immune responses. RNA-sequencing was performed on purified cord blood monocytes from very preterm (< 32 weeks GA) and term infants (3740 weeks GA) following standardised challenge with live S. epidermidis or E. coli. The major transcriptional changes induced by either pathogen were highly conserved between infant groups and stimuli, highlighting a common extant neonatal monocyte response to infection, largely mediated by TLR/NF-B/TREM-1 signalling. In addition, we observed an activated interferon-centred immune response specific to stimulation with E. coli in both preterm and term infants. These data provide novel insights into the functionality of neonatal monocytes at birth and highlight potential pathways that could be targeted to reduce the harmful effects of bacterial-induced inflammation in sepsis. E. coli and S. epidermidis elicit common transcriptional changes in cord monocytes. The common transcriptional response is mediated by TLR/NF-B/TREM-1 signalling. IFN genes are differentially regulated by E. coli and S. epidermidis in monocytes. These responses are largely unaffected by GA or exposure to chorioamnionitis. Abstract from J Mol Med (Berl). 2018 Feb;96(2):147-157. doi: 10.1007/s00109-017-1609-2. [Curator's note: Please note that two separate Stemformatics datasets (6412, 6530) are associated with the relevant publication.]"	43	"preterm, term, preterm +Ecoli, term +Ecoli, preterm +Sepidermidis, term +Sepidermidis"	RNASeq (Illumina HiSeq 2000 RNASeq hg19 Gene)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross	Monocyte CD14+ S. epidermidis 2h neonatal	myeloid	Monocyte	neonatal	monocyte	Macrophage
GSM2717643;6530	6530	DeJong	GSM2717643	Preterm chorio_Unstimulated_Monocytes male 1485g	Homo sapiens	preterm	CL:0000576		monocyte	male		DeJong	"Escherichia coli and Staphylococcus epidermidis are predominant causes of neonatal sepsis, particularly affecting preterm infants. Susceptibility to infection has been attributed to immature innate monocyte defences, but no studies have assessed global transcriptional responses of neonatal monocytes to these pathogens. Here, we aimed to identify and characterise the neonatal monocyte transcriptional responses to E. coli and S. epidermidis and the role of common modifiers such as gestational age (GA) and exposure to chorioamnionitis (a common complication of preterm birth) to better understand early life innate immune responses. RNA-sequencing was performed on purified cord blood monocytes from very preterm (< 32 weeks GA) and term infants (3740 weeks GA) following standardised challenge with live S. epidermidis or E. coli. The major transcriptional changes induced by either pathogen were highly conserved between infant groups and stimuli, highlighting a common extant neonatal monocyte response to infection, largely mediated by TLR/NF-B/TREM-1 signalling. In addition, we observed an activated interferon-centred immune response specific to stimulation with E. coli in both preterm and term infants. These data provide novel insights into the functionality of neonatal monocytes at birth and highlight potential pathways that could be targeted to reduce the harmful effects of bacterial-induced inflammation in sepsis. E. coli and S. epidermidis elicit common transcriptional changes in cord monocytes. The common transcriptional response is mediated by TLR/NF-B/TREM-1 signalling. IFN genes are differentially regulated by E. coli and S. epidermidis in monocytes. These responses are largely unaffected by GA or exposure to chorioamnionitis. Abstract from J Mol Med (Berl). 2018 Feb;96(2):147-157. doi: 10.1007/s00109-017-1609-2. [Curator's note: Please note that two separate Stemformatics datasets (6412, 6530) are associated with the relevant publication.]"	43	"preterm, term, preterm +Ecoli, term +Ecoli, preterm +Sepidermidis, term +Sepidermidis"	RNASeq (Illumina HiSeq 2000 RNASeq hg19 Gene)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross	Monocyte CD14+  neonatal	myeloid	Monocyte	neonatal	monocyte	Macrophage
GSM2717644;6530	6530	DeJong	GSM2717644	Preterm chorio_E. coli_Monocytes female 1585g	Homo sapiens	preterm +Ecoli	CL:0000576		monocyte	female		DeJong	"Escherichia coli and Staphylococcus epidermidis are predominant causes of neonatal sepsis, particularly affecting preterm infants. Susceptibility to infection has been attributed to immature innate monocyte defences, but no studies have assessed global transcriptional responses of neonatal monocytes to these pathogens. Here, we aimed to identify and characterise the neonatal monocyte transcriptional responses to E. coli and S. epidermidis and the role of common modifiers such as gestational age (GA) and exposure to chorioamnionitis (a common complication of preterm birth) to better understand early life innate immune responses. RNA-sequencing was performed on purified cord blood monocytes from very preterm (< 32 weeks GA) and term infants (3740 weeks GA) following standardised challenge with live S. epidermidis or E. coli. The major transcriptional changes induced by either pathogen were highly conserved between infant groups and stimuli, highlighting a common extant neonatal monocyte response to infection, largely mediated by TLR/NF-B/TREM-1 signalling. In addition, we observed an activated interferon-centred immune response specific to stimulation with E. coli in both preterm and term infants. These data provide novel insights into the functionality of neonatal monocytes at birth and highlight potential pathways that could be targeted to reduce the harmful effects of bacterial-induced inflammation in sepsis. E. coli and S. epidermidis elicit common transcriptional changes in cord monocytes. The common transcriptional response is mediated by TLR/NF-B/TREM-1 signalling. IFN genes are differentially regulated by E. coli and S. epidermidis in monocytes. These responses are largely unaffected by GA or exposure to chorioamnionitis. Abstract from J Mol Med (Berl). 2018 Feb;96(2):147-157. doi: 10.1007/s00109-017-1609-2. [Curator's note: Please note that two separate Stemformatics datasets (6412, 6530) are associated with the relevant publication.]"	43	"preterm, term, preterm +Ecoli, term +Ecoli, preterm +Sepidermidis, term +Sepidermidis"	RNASeq (Illumina HiSeq 2000 RNASeq hg19 Gene)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross	Monocyte CD14+ E. coli 2h neonatal	myeloid	Monocyte	neonatal	monocyte	Macrophage
GSM2717645;6530	6530	DeJong	GSM2717645	Preterm chorio_S. epidermidis_Monocytes female 1585g	Homo sapiens	preterm +Sepidermidis	CL:0000576		monocyte	female		DeJong	"Escherichia coli and Staphylococcus epidermidis are predominant causes of neonatal sepsis, particularly affecting preterm infants. Susceptibility to infection has been attributed to immature innate monocyte defences, but no studies have assessed global transcriptional responses of neonatal monocytes to these pathogens. Here, we aimed to identify and characterise the neonatal monocyte transcriptional responses to E. coli and S. epidermidis and the role of common modifiers such as gestational age (GA) and exposure to chorioamnionitis (a common complication of preterm birth) to better understand early life innate immune responses. RNA-sequencing was performed on purified cord blood monocytes from very preterm (< 32 weeks GA) and term infants (3740 weeks GA) following standardised challenge with live S. epidermidis or E. coli. The major transcriptional changes induced by either pathogen were highly conserved between infant groups and stimuli, highlighting a common extant neonatal monocyte response to infection, largely mediated by TLR/NF-B/TREM-1 signalling. In addition, we observed an activated interferon-centred immune response specific to stimulation with E. coli in both preterm and term infants. These data provide novel insights into the functionality of neonatal monocytes at birth and highlight potential pathways that could be targeted to reduce the harmful effects of bacterial-induced inflammation in sepsis. E. coli and S. epidermidis elicit common transcriptional changes in cord monocytes. The common transcriptional response is mediated by TLR/NF-B/TREM-1 signalling. IFN genes are differentially regulated by E. coli and S. epidermidis in monocytes. These responses are largely unaffected by GA or exposure to chorioamnionitis. Abstract from J Mol Med (Berl). 2018 Feb;96(2):147-157. doi: 10.1007/s00109-017-1609-2. [Curator's note: Please note that two separate Stemformatics datasets (6412, 6530) are associated with the relevant publication.]"	43	"preterm, term, preterm +Ecoli, term +Ecoli, preterm +Sepidermidis, term +Sepidermidis"	RNASeq (Illumina HiSeq 2000 RNASeq hg19 Gene)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross	Monocyte CD14+ S. epidermidis 2h neonatal	myeloid	Monocyte	neonatal	monocyte	Macrophage
GSM2717646;6530	6530	DeJong	GSM2717646	Preterm chorio_Unstimulated_Monocytes female 1585g	Homo sapiens	preterm	CL:0000576		monocyte	female		DeJong	"Escherichia coli and Staphylococcus epidermidis are predominant causes of neonatal sepsis, particularly affecting preterm infants. Susceptibility to infection has been attributed to immature innate monocyte defences, but no studies have assessed global transcriptional responses of neonatal monocytes to these pathogens. Here, we aimed to identify and characterise the neonatal monocyte transcriptional responses to E. coli and S. epidermidis and the role of common modifiers such as gestational age (GA) and exposure to chorioamnionitis (a common complication of preterm birth) to better understand early life innate immune responses. RNA-sequencing was performed on purified cord blood monocytes from very preterm (< 32 weeks GA) and term infants (3740 weeks GA) following standardised challenge with live S. epidermidis or E. coli. The major transcriptional changes induced by either pathogen were highly conserved between infant groups and stimuli, highlighting a common extant neonatal monocyte response to infection, largely mediated by TLR/NF-B/TREM-1 signalling. In addition, we observed an activated interferon-centred immune response specific to stimulation with E. coli in both preterm and term infants. These data provide novel insights into the functionality of neonatal monocytes at birth and highlight potential pathways that could be targeted to reduce the harmful effects of bacterial-induced inflammation in sepsis. E. coli and S. epidermidis elicit common transcriptional changes in cord monocytes. The common transcriptional response is mediated by TLR/NF-B/TREM-1 signalling. IFN genes are differentially regulated by E. coli and S. epidermidis in monocytes. These responses are largely unaffected by GA or exposure to chorioamnionitis. Abstract from J Mol Med (Berl). 2018 Feb;96(2):147-157. doi: 10.1007/s00109-017-1609-2. [Curator's note: Please note that two separate Stemformatics datasets (6412, 6530) are associated with the relevant publication.]"	43	"preterm, term, preterm +Ecoli, term +Ecoli, preterm +Sepidermidis, term +Sepidermidis"	RNASeq (Illumina HiSeq 2000 RNASeq hg19 Gene)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross	Monocyte CD14+  neonatal	myeloid	Monocyte	neonatal	monocyte	Macrophage
GSM2717647;6530	6530	DeJong	GSM2717647	Preterm chorio_E. coli_Monocytes female 1740g	Homo sapiens	preterm +Ecoli	CL:0000576		monocyte	female		DeJong	"Escherichia coli and Staphylococcus epidermidis are predominant causes of neonatal sepsis, particularly affecting preterm infants. Susceptibility to infection has been attributed to immature innate monocyte defences, but no studies have assessed global transcriptional responses of neonatal monocytes to these pathogens. Here, we aimed to identify and characterise the neonatal monocyte transcriptional responses to E. coli and S. epidermidis and the role of common modifiers such as gestational age (GA) and exposure to chorioamnionitis (a common complication of preterm birth) to better understand early life innate immune responses. RNA-sequencing was performed on purified cord blood monocytes from very preterm (< 32 weeks GA) and term infants (3740 weeks GA) following standardised challenge with live S. epidermidis or E. coli. The major transcriptional changes induced by either pathogen were highly conserved between infant groups and stimuli, highlighting a common extant neonatal monocyte response to infection, largely mediated by TLR/NF-B/TREM-1 signalling. In addition, we observed an activated interferon-centred immune response specific to stimulation with E. coli in both preterm and term infants. These data provide novel insights into the functionality of neonatal monocytes at birth and highlight potential pathways that could be targeted to reduce the harmful effects of bacterial-induced inflammation in sepsis. E. coli and S. epidermidis elicit common transcriptional changes in cord monocytes. The common transcriptional response is mediated by TLR/NF-B/TREM-1 signalling. IFN genes are differentially regulated by E. coli and S. epidermidis in monocytes. These responses are largely unaffected by GA or exposure to chorioamnionitis. Abstract from J Mol Med (Berl). 2018 Feb;96(2):147-157. doi: 10.1007/s00109-017-1609-2. [Curator's note: Please note that two separate Stemformatics datasets (6412, 6530) are associated with the relevant publication.]"	43	"preterm, term, preterm +Ecoli, term +Ecoli, preterm +Sepidermidis, term +Sepidermidis"	RNASeq (Illumina HiSeq 2000 RNASeq hg19 Gene)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross	Monocyte CD14+ E. coli 2h neonatal	myeloid	Monocyte	neonatal	monocyte	Macrophage
GSM2717648;6530	6530	DeJong	GSM2717648	Preterm chorio_S. epidermidis_Monocytes female 1740g	Homo sapiens	preterm +Sepidermidis	CL:0000576		monocyte	female		DeJong	"Escherichia coli and Staphylococcus epidermidis are predominant causes of neonatal sepsis, particularly affecting preterm infants. Susceptibility to infection has been attributed to immature innate monocyte defences, but no studies have assessed global transcriptional responses of neonatal monocytes to these pathogens. Here, we aimed to identify and characterise the neonatal monocyte transcriptional responses to E. coli and S. epidermidis and the role of common modifiers such as gestational age (GA) and exposure to chorioamnionitis (a common complication of preterm birth) to better understand early life innate immune responses. RNA-sequencing was performed on purified cord blood monocytes from very preterm (< 32 weeks GA) and term infants (3740 weeks GA) following standardised challenge with live S. epidermidis or E. coli. The major transcriptional changes induced by either pathogen were highly conserved between infant groups and stimuli, highlighting a common extant neonatal monocyte response to infection, largely mediated by TLR/NF-B/TREM-1 signalling. In addition, we observed an activated interferon-centred immune response specific to stimulation with E. coli in both preterm and term infants. These data provide novel insights into the functionality of neonatal monocytes at birth and highlight potential pathways that could be targeted to reduce the harmful effects of bacterial-induced inflammation in sepsis. E. coli and S. epidermidis elicit common transcriptional changes in cord monocytes. The common transcriptional response is mediated by TLR/NF-B/TREM-1 signalling. IFN genes are differentially regulated by E. coli and S. epidermidis in monocytes. These responses are largely unaffected by GA or exposure to chorioamnionitis. Abstract from J Mol Med (Berl). 2018 Feb;96(2):147-157. doi: 10.1007/s00109-017-1609-2. [Curator's note: Please note that two separate Stemformatics datasets (6412, 6530) are associated with the relevant publication.]"	43	"preterm, term, preterm +Ecoli, term +Ecoli, preterm +Sepidermidis, term +Sepidermidis"	RNASeq (Illumina HiSeq 2000 RNASeq hg19 Gene)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross	Monocyte CD14+ S. epidermidis 2h neonatal	myeloid	Monocyte	neonatal	monocyte	Macrophage
GSM2717649;6530	6530	DeJong	GSM2717649	Preterm chorio_Unstimulated_Monocytes female 1740g	Homo sapiens	preterm	CL:0000576		monocyte	female		DeJong	"Escherichia coli and Staphylococcus epidermidis are predominant causes of neonatal sepsis, particularly affecting preterm infants. Susceptibility to infection has been attributed to immature innate monocyte defences, but no studies have assessed global transcriptional responses of neonatal monocytes to these pathogens. Here, we aimed to identify and characterise the neonatal monocyte transcriptional responses to E. coli and S. epidermidis and the role of common modifiers such as gestational age (GA) and exposure to chorioamnionitis (a common complication of preterm birth) to better understand early life innate immune responses. RNA-sequencing was performed on purified cord blood monocytes from very preterm (< 32 weeks GA) and term infants (3740 weeks GA) following standardised challenge with live S. epidermidis or E. coli. The major transcriptional changes induced by either pathogen were highly conserved between infant groups and stimuli, highlighting a common extant neonatal monocyte response to infection, largely mediated by TLR/NF-B/TREM-1 signalling. In addition, we observed an activated interferon-centred immune response specific to stimulation with E. coli in both preterm and term infants. These data provide novel insights into the functionality of neonatal monocytes at birth and highlight potential pathways that could be targeted to reduce the harmful effects of bacterial-induced inflammation in sepsis. E. coli and S. epidermidis elicit common transcriptional changes in cord monocytes. The common transcriptional response is mediated by TLR/NF-B/TREM-1 signalling. IFN genes are differentially regulated by E. coli and S. epidermidis in monocytes. These responses are largely unaffected by GA or exposure to chorioamnionitis. Abstract from J Mol Med (Berl). 2018 Feb;96(2):147-157. doi: 10.1007/s00109-017-1609-2. [Curator's note: Please note that two separate Stemformatics datasets (6412, 6530) are associated with the relevant publication.]"	43	"preterm, term, preterm +Ecoli, term +Ecoli, preterm +Sepidermidis, term +Sepidermidis"	RNASeq (Illumina HiSeq 2000 RNASeq hg19 Gene)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross	Monocyte CD14+  neonatal	myeloid	Monocyte	neonatal	monocyte	Macrophage
GSM2717650;6530	6530	DeJong	GSM2717650	Preterm chorio_E. coli_Monocytes male 1645g	Homo sapiens	preterm +Ecoli	CL:0000576		monocyte	male		DeJong	"Escherichia coli and Staphylococcus epidermidis are predominant causes of neonatal sepsis, particularly affecting preterm infants. Susceptibility to infection has been attributed to immature innate monocyte defences, but no studies have assessed global transcriptional responses of neonatal monocytes to these pathogens. Here, we aimed to identify and characterise the neonatal monocyte transcriptional responses to E. coli and S. epidermidis and the role of common modifiers such as gestational age (GA) and exposure to chorioamnionitis (a common complication of preterm birth) to better understand early life innate immune responses. RNA-sequencing was performed on purified cord blood monocytes from very preterm (< 32 weeks GA) and term infants (3740 weeks GA) following standardised challenge with live S. epidermidis or E. coli. The major transcriptional changes induced by either pathogen were highly conserved between infant groups and stimuli, highlighting a common extant neonatal monocyte response to infection, largely mediated by TLR/NF-B/TREM-1 signalling. In addition, we observed an activated interferon-centred immune response specific to stimulation with E. coli in both preterm and term infants. These data provide novel insights into the functionality of neonatal monocytes at birth and highlight potential pathways that could be targeted to reduce the harmful effects of bacterial-induced inflammation in sepsis. E. coli and S. epidermidis elicit common transcriptional changes in cord monocytes. The common transcriptional response is mediated by TLR/NF-B/TREM-1 signalling. IFN genes are differentially regulated by E. coli and S. epidermidis in monocytes. These responses are largely unaffected by GA or exposure to chorioamnionitis. Abstract from J Mol Med (Berl). 2018 Feb;96(2):147-157. doi: 10.1007/s00109-017-1609-2. [Curator's note: Please note that two separate Stemformatics datasets (6412, 6530) are associated with the relevant publication.]"	43	"preterm, term, preterm +Ecoli, term +Ecoli, preterm +Sepidermidis, term +Sepidermidis"	RNASeq (Illumina HiSeq 2000 RNASeq hg19 Gene)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross	Monocyte CD14+ E. coli 2h neonatal	myeloid	Monocyte	neonatal	monocyte	Macrophage
GSM2717651;6530	6530	DeJong	GSM2717651	Preterm chorio_S. epidermidis_Monocytes male 1645g	Homo sapiens	preterm +Sepidermidis	CL:0000576		monocyte	male		DeJong	"Escherichia coli and Staphylococcus epidermidis are predominant causes of neonatal sepsis, particularly affecting preterm infants. Susceptibility to infection has been attributed to immature innate monocyte defences, but no studies have assessed global transcriptional responses of neonatal monocytes to these pathogens. Here, we aimed to identify and characterise the neonatal monocyte transcriptional responses to E. coli and S. epidermidis and the role of common modifiers such as gestational age (GA) and exposure to chorioamnionitis (a common complication of preterm birth) to better understand early life innate immune responses. RNA-sequencing was performed on purified cord blood monocytes from very preterm (< 32 weeks GA) and term infants (3740 weeks GA) following standardised challenge with live S. epidermidis or E. coli. The major transcriptional changes induced by either pathogen were highly conserved between infant groups and stimuli, highlighting a common extant neonatal monocyte response to infection, largely mediated by TLR/NF-B/TREM-1 signalling. In addition, we observed an activated interferon-centred immune response specific to stimulation with E. coli in both preterm and term infants. These data provide novel insights into the functionality of neonatal monocytes at birth and highlight potential pathways that could be targeted to reduce the harmful effects of bacterial-induced inflammation in sepsis. E. coli and S. epidermidis elicit common transcriptional changes in cord monocytes. The common transcriptional response is mediated by TLR/NF-B/TREM-1 signalling. IFN genes are differentially regulated by E. coli and S. epidermidis in monocytes. These responses are largely unaffected by GA or exposure to chorioamnionitis. Abstract from J Mol Med (Berl). 2018 Feb;96(2):147-157. doi: 10.1007/s00109-017-1609-2. [Curator's note: Please note that two separate Stemformatics datasets (6412, 6530) are associated with the relevant publication.]"	43	"preterm, term, preterm +Ecoli, term +Ecoli, preterm +Sepidermidis, term +Sepidermidis"	RNASeq (Illumina HiSeq 2000 RNASeq hg19 Gene)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross	Monocyte CD14+ S. epidermidis 2h neonatal	myeloid	Monocyte	neonatal	monocyte	Macrophage
GSM2717652;6530	6530	DeJong	GSM2717652	Preterm chorio_Unstimulated_Monocytes male 1645g	Homo sapiens	preterm	CL:0000576		monocyte	male		DeJong	"Escherichia coli and Staphylococcus epidermidis are predominant causes of neonatal sepsis, particularly affecting preterm infants. Susceptibility to infection has been attributed to immature innate monocyte defences, but no studies have assessed global transcriptional responses of neonatal monocytes to these pathogens. Here, we aimed to identify and characterise the neonatal monocyte transcriptional responses to E. coli and S. epidermidis and the role of common modifiers such as gestational age (GA) and exposure to chorioamnionitis (a common complication of preterm birth) to better understand early life innate immune responses. RNA-sequencing was performed on purified cord blood monocytes from very preterm (< 32 weeks GA) and term infants (3740 weeks GA) following standardised challenge with live S. epidermidis or E. coli. The major transcriptional changes induced by either pathogen were highly conserved between infant groups and stimuli, highlighting a common extant neonatal monocyte response to infection, largely mediated by TLR/NF-B/TREM-1 signalling. In addition, we observed an activated interferon-centred immune response specific to stimulation with E. coli in both preterm and term infants. These data provide novel insights into the functionality of neonatal monocytes at birth and highlight potential pathways that could be targeted to reduce the harmful effects of bacterial-induced inflammation in sepsis. E. coli and S. epidermidis elicit common transcriptional changes in cord monocytes. The common transcriptional response is mediated by TLR/NF-B/TREM-1 signalling. IFN genes are differentially regulated by E. coli and S. epidermidis in monocytes. These responses are largely unaffected by GA or exposure to chorioamnionitis. Abstract from J Mol Med (Berl). 2018 Feb;96(2):147-157. doi: 10.1007/s00109-017-1609-2. [Curator's note: Please note that two separate Stemformatics datasets (6412, 6530) are associated with the relevant publication.]"	43	"preterm, term, preterm +Ecoli, term +Ecoli, preterm +Sepidermidis, term +Sepidermidis"	RNASeq (Illumina HiSeq 2000 RNASeq hg19 Gene)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross	Monocyte CD14+  neonatal	myeloid	Monocyte	neonatal	monocyte	Macrophage
GSM2717653;6530	6530	DeJong	GSM2717653	Preterm chorio_E. coli_Monocytes female 1520g	Homo sapiens	preterm +Ecoli	CL:0000576		monocyte	female		DeJong	"Escherichia coli and Staphylococcus epidermidis are predominant causes of neonatal sepsis, particularly affecting preterm infants. Susceptibility to infection has been attributed to immature innate monocyte defences, but no studies have assessed global transcriptional responses of neonatal monocytes to these pathogens. Here, we aimed to identify and characterise the neonatal monocyte transcriptional responses to E. coli and S. epidermidis and the role of common modifiers such as gestational age (GA) and exposure to chorioamnionitis (a common complication of preterm birth) to better understand early life innate immune responses. RNA-sequencing was performed on purified cord blood monocytes from very preterm (< 32 weeks GA) and term infants (3740 weeks GA) following standardised challenge with live S. epidermidis or E. coli. The major transcriptional changes induced by either pathogen were highly conserved between infant groups and stimuli, highlighting a common extant neonatal monocyte response to infection, largely mediated by TLR/NF-B/TREM-1 signalling. In addition, we observed an activated interferon-centred immune response specific to stimulation with E. coli in both preterm and term infants. These data provide novel insights into the functionality of neonatal monocytes at birth and highlight potential pathways that could be targeted to reduce the harmful effects of bacterial-induced inflammation in sepsis. E. coli and S. epidermidis elicit common transcriptional changes in cord monocytes. The common transcriptional response is mediated by TLR/NF-B/TREM-1 signalling. IFN genes are differentially regulated by E. coli and S. epidermidis in monocytes. These responses are largely unaffected by GA or exposure to chorioamnionitis. Abstract from J Mol Med (Berl). 2018 Feb;96(2):147-157. doi: 10.1007/s00109-017-1609-2. [Curator's note: Please note that two separate Stemformatics datasets (6412, 6530) are associated with the relevant publication.]"	43	"preterm, term, preterm +Ecoli, term +Ecoli, preterm +Sepidermidis, term +Sepidermidis"	RNASeq (Illumina HiSeq 2000 RNASeq hg19 Gene)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross	Monocyte CD14+ E. coli 2h neonatal	myeloid	Monocyte	neonatal	monocyte	Macrophage
GSM2717654;6530	6530	DeJong	GSM2717654	Preterm chorio_S. epidermidis_Monocytes female 1520g	Homo sapiens	preterm +Sepidermidis	CL:0000576		monocyte	female		DeJong	"Escherichia coli and Staphylococcus epidermidis are predominant causes of neonatal sepsis, particularly affecting preterm infants. Susceptibility to infection has been attributed to immature innate monocyte defences, but no studies have assessed global transcriptional responses of neonatal monocytes to these pathogens. Here, we aimed to identify and characterise the neonatal monocyte transcriptional responses to E. coli and S. epidermidis and the role of common modifiers such as gestational age (GA) and exposure to chorioamnionitis (a common complication of preterm birth) to better understand early life innate immune responses. RNA-sequencing was performed on purified cord blood monocytes from very preterm (< 32 weeks GA) and term infants (3740 weeks GA) following standardised challenge with live S. epidermidis or E. coli. The major transcriptional changes induced by either pathogen were highly conserved between infant groups and stimuli, highlighting a common extant neonatal monocyte response to infection, largely mediated by TLR/NF-B/TREM-1 signalling. In addition, we observed an activated interferon-centred immune response specific to stimulation with E. coli in both preterm and term infants. These data provide novel insights into the functionality of neonatal monocytes at birth and highlight potential pathways that could be targeted to reduce the harmful effects of bacterial-induced inflammation in sepsis. E. coli and S. epidermidis elicit common transcriptional changes in cord monocytes. The common transcriptional response is mediated by TLR/NF-B/TREM-1 signalling. IFN genes are differentially regulated by E. coli and S. epidermidis in monocytes. These responses are largely unaffected by GA or exposure to chorioamnionitis. Abstract from J Mol Med (Berl). 2018 Feb;96(2):147-157. doi: 10.1007/s00109-017-1609-2. [Curator's note: Please note that two separate Stemformatics datasets (6412, 6530) are associated with the relevant publication.]"	43	"preterm, term, preterm +Ecoli, term +Ecoli, preterm +Sepidermidis, term +Sepidermidis"	RNASeq (Illumina HiSeq 2000 RNASeq hg19 Gene)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross	Monocyte CD14+ S. epidermidis 2h neonatal	myeloid	Monocyte	neonatal	monocyte	Macrophage
GSM2717655;6530	6530	DeJong	GSM2717655	Preterm chorio_Unstimulated_Monocytes female 1520g	Homo sapiens	preterm	CL:0000576		monocyte	female		DeJong	"Escherichia coli and Staphylococcus epidermidis are predominant causes of neonatal sepsis, particularly affecting preterm infants. Susceptibility to infection has been attributed to immature innate monocyte defences, but no studies have assessed global transcriptional responses of neonatal monocytes to these pathogens. Here, we aimed to identify and characterise the neonatal monocyte transcriptional responses to E. coli and S. epidermidis and the role of common modifiers such as gestational age (GA) and exposure to chorioamnionitis (a common complication of preterm birth) to better understand early life innate immune responses. RNA-sequencing was performed on purified cord blood monocytes from very preterm (< 32 weeks GA) and term infants (3740 weeks GA) following standardised challenge with live S. epidermidis or E. coli. The major transcriptional changes induced by either pathogen were highly conserved between infant groups and stimuli, highlighting a common extant neonatal monocyte response to infection, largely mediated by TLR/NF-B/TREM-1 signalling. In addition, we observed an activated interferon-centred immune response specific to stimulation with E. coli in both preterm and term infants. These data provide novel insights into the functionality of neonatal monocytes at birth and highlight potential pathways that could be targeted to reduce the harmful effects of bacterial-induced inflammation in sepsis. E. coli and S. epidermidis elicit common transcriptional changes in cord monocytes. The common transcriptional response is mediated by TLR/NF-B/TREM-1 signalling. IFN genes are differentially regulated by E. coli and S. epidermidis in monocytes. These responses are largely unaffected by GA or exposure to chorioamnionitis. Abstract from J Mol Med (Berl). 2018 Feb;96(2):147-157. doi: 10.1007/s00109-017-1609-2. [Curator's note: Please note that two separate Stemformatics datasets (6412, 6530) are associated with the relevant publication.]"	43	"preterm, term, preterm +Ecoli, term +Ecoli, preterm +Sepidermidis, term +Sepidermidis"	RNASeq (Illumina HiSeq 2000 RNASeq hg19 Gene)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross	Monocyte CD14+  neonatal	myeloid	Monocyte	neonatal	monocyte	Macrophage
GSM2717656;6530	6530	DeJong	GSM2717656	Preterm_S. epidermidis_Monocytes male 1585g	Homo sapiens	preterm +Sepidermidis	CL:0000576		monocyte	male		DeJong	"Escherichia coli and Staphylococcus epidermidis are predominant causes of neonatal sepsis, particularly affecting preterm infants. Susceptibility to infection has been attributed to immature innate monocyte defences, but no studies have assessed global transcriptional responses of neonatal monocytes to these pathogens. Here, we aimed to identify and characterise the neonatal monocyte transcriptional responses to E. coli and S. epidermidis and the role of common modifiers such as gestational age (GA) and exposure to chorioamnionitis (a common complication of preterm birth) to better understand early life innate immune responses. RNA-sequencing was performed on purified cord blood monocytes from very preterm (< 32 weeks GA) and term infants (3740 weeks GA) following standardised challenge with live S. epidermidis or E. coli. The major transcriptional changes induced by either pathogen were highly conserved between infant groups and stimuli, highlighting a common extant neonatal monocyte response to infection, largely mediated by TLR/NF-B/TREM-1 signalling. In addition, we observed an activated interferon-centred immune response specific to stimulation with E. coli in both preterm and term infants. These data provide novel insights into the functionality of neonatal monocytes at birth and highlight potential pathways that could be targeted to reduce the harmful effects of bacterial-induced inflammation in sepsis. E. coli and S. epidermidis elicit common transcriptional changes in cord monocytes. The common transcriptional response is mediated by TLR/NF-B/TREM-1 signalling. IFN genes are differentially regulated by E. coli and S. epidermidis in monocytes. These responses are largely unaffected by GA or exposure to chorioamnionitis. Abstract from J Mol Med (Berl). 2018 Feb;96(2):147-157. doi: 10.1007/s00109-017-1609-2. [Curator's note: Please note that two separate Stemformatics datasets (6412, 6530) are associated with the relevant publication.]"	43	"preterm, term, preterm +Ecoli, term +Ecoli, preterm +Sepidermidis, term +Sepidermidis"	RNASeq (Illumina HiSeq 2000 RNASeq hg19 Gene)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross	Monocyte CD14+ S. epidermidis 2h neonatal	myeloid	Monocyte	neonatal	monocyte	Macrophage
GSM2717657;6530	6530	DeJong	GSM2717657	Preterm_Unstimulated_Monocytes male 1585g	Homo sapiens	preterm	CL:0000576		monocyte	male		DeJong	"Escherichia coli and Staphylococcus epidermidis are predominant causes of neonatal sepsis, particularly affecting preterm infants. Susceptibility to infection has been attributed to immature innate monocyte defences, but no studies have assessed global transcriptional responses of neonatal monocytes to these pathogens. Here, we aimed to identify and characterise the neonatal monocyte transcriptional responses to E. coli and S. epidermidis and the role of common modifiers such as gestational age (GA) and exposure to chorioamnionitis (a common complication of preterm birth) to better understand early life innate immune responses. RNA-sequencing was performed on purified cord blood monocytes from very preterm (< 32 weeks GA) and term infants (3740 weeks GA) following standardised challenge with live S. epidermidis or E. coli. The major transcriptional changes induced by either pathogen were highly conserved between infant groups and stimuli, highlighting a common extant neonatal monocyte response to infection, largely mediated by TLR/NF-B/TREM-1 signalling. In addition, we observed an activated interferon-centred immune response specific to stimulation with E. coli in both preterm and term infants. These data provide novel insights into the functionality of neonatal monocytes at birth and highlight potential pathways that could be targeted to reduce the harmful effects of bacterial-induced inflammation in sepsis. E. coli and S. epidermidis elicit common transcriptional changes in cord monocytes. The common transcriptional response is mediated by TLR/NF-B/TREM-1 signalling. IFN genes are differentially regulated by E. coli and S. epidermidis in monocytes. These responses are largely unaffected by GA or exposure to chorioamnionitis. Abstract from J Mol Med (Berl). 2018 Feb;96(2):147-157. doi: 10.1007/s00109-017-1609-2. [Curator's note: Please note that two separate Stemformatics datasets (6412, 6530) are associated with the relevant publication.]"	43	"preterm, term, preterm +Ecoli, term +Ecoli, preterm +Sepidermidis, term +Sepidermidis"	RNASeq (Illumina HiSeq 2000 RNASeq hg19 Gene)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross	Monocyte CD14+ E. coli 2h neonatal	myeloid	Monocyte	neonatal	monocyte	Macrophage
GSM2717658;6530	6530	DeJong	GSM2717658	Preterm_E. coli_Monocytes male 1440g	Homo sapiens	preterm +Ecoli	CL:0000576		monocyte	male		DeJong	"Escherichia coli and Staphylococcus epidermidis are predominant causes of neonatal sepsis, particularly affecting preterm infants. Susceptibility to infection has been attributed to immature innate monocyte defences, but no studies have assessed global transcriptional responses of neonatal monocytes to these pathogens. Here, we aimed to identify and characterise the neonatal monocyte transcriptional responses to E. coli and S. epidermidis and the role of common modifiers such as gestational age (GA) and exposure to chorioamnionitis (a common complication of preterm birth) to better understand early life innate immune responses. RNA-sequencing was performed on purified cord blood monocytes from very preterm (< 32 weeks GA) and term infants (3740 weeks GA) following standardised challenge with live S. epidermidis or E. coli. The major transcriptional changes induced by either pathogen were highly conserved between infant groups and stimuli, highlighting a common extant neonatal monocyte response to infection, largely mediated by TLR/NF-B/TREM-1 signalling. In addition, we observed an activated interferon-centred immune response specific to stimulation with E. coli in both preterm and term infants. These data provide novel insights into the functionality of neonatal monocytes at birth and highlight potential pathways that could be targeted to reduce the harmful effects of bacterial-induced inflammation in sepsis. E. coli and S. epidermidis elicit common transcriptional changes in cord monocytes. The common transcriptional response is mediated by TLR/NF-B/TREM-1 signalling. IFN genes are differentially regulated by E. coli and S. epidermidis in monocytes. These responses are largely unaffected by GA or exposure to chorioamnionitis. Abstract from J Mol Med (Berl). 2018 Feb;96(2):147-157. doi: 10.1007/s00109-017-1609-2. [Curator's note: Please note that two separate Stemformatics datasets (6412, 6530) are associated with the relevant publication.]"	43	"preterm, term, preterm +Ecoli, term +Ecoli, preterm +Sepidermidis, term +Sepidermidis"	RNASeq (Illumina HiSeq 2000 RNASeq hg19 Gene)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross	Monocyte CD14+ S. epidermidis 2h neonatal	myeloid	Monocyte	neonatal	monocyte	Macrophage
GSM2717659;6530	6530	DeJong	GSM2717659	Preterm_S. epidermidis_Monocytes male 1440g	Homo sapiens	preterm +Sepidermidis	CL:0000576		monocyte	male		DeJong	"Escherichia coli and Staphylococcus epidermidis are predominant causes of neonatal sepsis, particularly affecting preterm infants. Susceptibility to infection has been attributed to immature innate monocyte defences, but no studies have assessed global transcriptional responses of neonatal monocytes to these pathogens. Here, we aimed to identify and characterise the neonatal monocyte transcriptional responses to E. coli and S. epidermidis and the role of common modifiers such as gestational age (GA) and exposure to chorioamnionitis (a common complication of preterm birth) to better understand early life innate immune responses. RNA-sequencing was performed on purified cord blood monocytes from very preterm (< 32 weeks GA) and term infants (3740 weeks GA) following standardised challenge with live S. epidermidis or E. coli. The major transcriptional changes induced by either pathogen were highly conserved between infant groups and stimuli, highlighting a common extant neonatal monocyte response to infection, largely mediated by TLR/NF-B/TREM-1 signalling. In addition, we observed an activated interferon-centred immune response specific to stimulation with E. coli in both preterm and term infants. These data provide novel insights into the functionality of neonatal monocytes at birth and highlight potential pathways that could be targeted to reduce the harmful effects of bacterial-induced inflammation in sepsis. E. coli and S. epidermidis elicit common transcriptional changes in cord monocytes. The common transcriptional response is mediated by TLR/NF-B/TREM-1 signalling. IFN genes are differentially regulated by E. coli and S. epidermidis in monocytes. These responses are largely unaffected by GA or exposure to chorioamnionitis. Abstract from J Mol Med (Berl). 2018 Feb;96(2):147-157. doi: 10.1007/s00109-017-1609-2. [Curator's note: Please note that two separate Stemformatics datasets (6412, 6530) are associated with the relevant publication.]"	43	"preterm, term, preterm +Ecoli, term +Ecoli, preterm +Sepidermidis, term +Sepidermidis"	RNASeq (Illumina HiSeq 2000 RNASeq hg19 Gene)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross	Monocyte CD14+  neonatal	myeloid	Monocyte	neonatal	monocyte	Macrophage
GSM2717660;6530	6530	DeJong	GSM2717660	Preterm_Unstimulated_Monocytes male 1440g	Homo sapiens	preterm	CL:0000576		monocyte	male		DeJong	"Escherichia coli and Staphylococcus epidermidis are predominant causes of neonatal sepsis, particularly affecting preterm infants. Susceptibility to infection has been attributed to immature innate monocyte defences, but no studies have assessed global transcriptional responses of neonatal monocytes to these pathogens. Here, we aimed to identify and characterise the neonatal monocyte transcriptional responses to E. coli and S. epidermidis and the role of common modifiers such as gestational age (GA) and exposure to chorioamnionitis (a common complication of preterm birth) to better understand early life innate immune responses. RNA-sequencing was performed on purified cord blood monocytes from very preterm (< 32 weeks GA) and term infants (3740 weeks GA) following standardised challenge with live S. epidermidis or E. coli. The major transcriptional changes induced by either pathogen were highly conserved between infant groups and stimuli, highlighting a common extant neonatal monocyte response to infection, largely mediated by TLR/NF-B/TREM-1 signalling. In addition, we observed an activated interferon-centred immune response specific to stimulation with E. coli in both preterm and term infants. These data provide novel insights into the functionality of neonatal monocytes at birth and highlight potential pathways that could be targeted to reduce the harmful effects of bacterial-induced inflammation in sepsis. E. coli and S. epidermidis elicit common transcriptional changes in cord monocytes. The common transcriptional response is mediated by TLR/NF-B/TREM-1 signalling. IFN genes are differentially regulated by E. coli and S. epidermidis in monocytes. These responses are largely unaffected by GA or exposure to chorioamnionitis. Abstract from J Mol Med (Berl). 2018 Feb;96(2):147-157. doi: 10.1007/s00109-017-1609-2. [Curator's note: Please note that two separate Stemformatics datasets (6412, 6530) are associated with the relevant publication.]"	43	"preterm, term, preterm +Ecoli, term +Ecoli, preterm +Sepidermidis, term +Sepidermidis"	RNASeq (Illumina HiSeq 2000 RNASeq hg19 Gene)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross	Monocyte CD14+ E. coli 2h neonatal	myeloid	Monocyte	neonatal	monocyte	Macrophage
GSM2717661;6530	6530	DeJong	GSM2717661	Preterm_E. coli_Monocytes male 1515g	Homo sapiens	preterm +Ecoli	CL:0000576		monocyte	male		DeJong	"Escherichia coli and Staphylococcus epidermidis are predominant causes of neonatal sepsis, particularly affecting preterm infants. Susceptibility to infection has been attributed to immature innate monocyte defences, but no studies have assessed global transcriptional responses of neonatal monocytes to these pathogens. Here, we aimed to identify and characterise the neonatal monocyte transcriptional responses to E. coli and S. epidermidis and the role of common modifiers such as gestational age (GA) and exposure to chorioamnionitis (a common complication of preterm birth) to better understand early life innate immune responses. RNA-sequencing was performed on purified cord blood monocytes from very preterm (< 32 weeks GA) and term infants (3740 weeks GA) following standardised challenge with live S. epidermidis or E. coli. The major transcriptional changes induced by either pathogen were highly conserved between infant groups and stimuli, highlighting a common extant neonatal monocyte response to infection, largely mediated by TLR/NF-B/TREM-1 signalling. In addition, we observed an activated interferon-centred immune response specific to stimulation with E. coli in both preterm and term infants. These data provide novel insights into the functionality of neonatal monocytes at birth and highlight potential pathways that could be targeted to reduce the harmful effects of bacterial-induced inflammation in sepsis. E. coli and S. epidermidis elicit common transcriptional changes in cord monocytes. The common transcriptional response is mediated by TLR/NF-B/TREM-1 signalling. IFN genes are differentially regulated by E. coli and S. epidermidis in monocytes. These responses are largely unaffected by GA or exposure to chorioamnionitis. Abstract from J Mol Med (Berl). 2018 Feb;96(2):147-157. doi: 10.1007/s00109-017-1609-2. [Curator's note: Please note that two separate Stemformatics datasets (6412, 6530) are associated with the relevant publication.]"	43	"preterm, term, preterm +Ecoli, term +Ecoli, preterm +Sepidermidis, term +Sepidermidis"	RNASeq (Illumina HiSeq 2000 RNASeq hg19 Gene)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross	Monocyte CD14+ S. epidermidis 2h neonatal	myeloid	Monocyte	neonatal	monocyte	Macrophage
GSM2717662;6530	6530	DeJong	GSM2717662	Preterm_Unstimulated_Monocytes male 1515g	Homo sapiens	preterm	CL:0000576		monocyte	male		DeJong	"Escherichia coli and Staphylococcus epidermidis are predominant causes of neonatal sepsis, particularly affecting preterm infants. Susceptibility to infection has been attributed to immature innate monocyte defences, but no studies have assessed global transcriptional responses of neonatal monocytes to these pathogens. Here, we aimed to identify and characterise the neonatal monocyte transcriptional responses to E. coli and S. epidermidis and the role of common modifiers such as gestational age (GA) and exposure to chorioamnionitis (a common complication of preterm birth) to better understand early life innate immune responses. RNA-sequencing was performed on purified cord blood monocytes from very preterm (< 32 weeks GA) and term infants (3740 weeks GA) following standardised challenge with live S. epidermidis or E. coli. The major transcriptional changes induced by either pathogen were highly conserved between infant groups and stimuli, highlighting a common extant neonatal monocyte response to infection, largely mediated by TLR/NF-B/TREM-1 signalling. In addition, we observed an activated interferon-centred immune response specific to stimulation with E. coli in both preterm and term infants. These data provide novel insights into the functionality of neonatal monocytes at birth and highlight potential pathways that could be targeted to reduce the harmful effects of bacterial-induced inflammation in sepsis. E. coli and S. epidermidis elicit common transcriptional changes in cord monocytes. The common transcriptional response is mediated by TLR/NF-B/TREM-1 signalling. IFN genes are differentially regulated by E. coli and S. epidermidis in monocytes. These responses are largely unaffected by GA or exposure to chorioamnionitis. Abstract from J Mol Med (Berl). 2018 Feb;96(2):147-157. doi: 10.1007/s00109-017-1609-2. [Curator's note: Please note that two separate Stemformatics datasets (6412, 6530) are associated with the relevant publication.]"	43	"preterm, term, preterm +Ecoli, term +Ecoli, preterm +Sepidermidis, term +Sepidermidis"	RNASeq (Illumina HiSeq 2000 RNASeq hg19 Gene)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross	Monocyte CD14+  neonatal	myeloid	Monocyte	neonatal	monocyte	Macrophage
GSM2717663;6530	6530	DeJong	GSM2717663	Preterm_E. coli_Monocytes male 1545g	Homo sapiens	preterm +Ecoli	CL:0000576		monocyte	male		DeJong	"Escherichia coli and Staphylococcus epidermidis are predominant causes of neonatal sepsis, particularly affecting preterm infants. Susceptibility to infection has been attributed to immature innate monocyte defences, but no studies have assessed global transcriptional responses of neonatal monocytes to these pathogens. Here, we aimed to identify and characterise the neonatal monocyte transcriptional responses to E. coli and S. epidermidis and the role of common modifiers such as gestational age (GA) and exposure to chorioamnionitis (a common complication of preterm birth) to better understand early life innate immune responses. RNA-sequencing was performed on purified cord blood monocytes from very preterm (< 32 weeks GA) and term infants (3740 weeks GA) following standardised challenge with live S. epidermidis or E. coli. The major transcriptional changes induced by either pathogen were highly conserved between infant groups and stimuli, highlighting a common extant neonatal monocyte response to infection, largely mediated by TLR/NF-B/TREM-1 signalling. In addition, we observed an activated interferon-centred immune response specific to stimulation with E. coli in both preterm and term infants. These data provide novel insights into the functionality of neonatal monocytes at birth and highlight potential pathways that could be targeted to reduce the harmful effects of bacterial-induced inflammation in sepsis. E. coli and S. epidermidis elicit common transcriptional changes in cord monocytes. The common transcriptional response is mediated by TLR/NF-B/TREM-1 signalling. IFN genes are differentially regulated by E. coli and S. epidermidis in monocytes. These responses are largely unaffected by GA or exposure to chorioamnionitis. Abstract from J Mol Med (Berl). 2018 Feb;96(2):147-157. doi: 10.1007/s00109-017-1609-2. [Curator's note: Please note that two separate Stemformatics datasets (6412, 6530) are associated with the relevant publication.]"	43	"preterm, term, preterm +Ecoli, term +Ecoli, preterm +Sepidermidis, term +Sepidermidis"	RNASeq (Illumina HiSeq 2000 RNASeq hg19 Gene)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross	Monocyte CD14+ E. coli 2h neonatal	myeloid	Monocyte	neonatal	monocyte	Macrophage
GSM2717664;6530	6530	DeJong	GSM2717664	Preterm_S. epidermidis_Monocytes male 1545g	Homo sapiens	preterm +Sepidermidis	CL:0000576		monocyte	male		DeJong	"Escherichia coli and Staphylococcus epidermidis are predominant causes of neonatal sepsis, particularly affecting preterm infants. Susceptibility to infection has been attributed to immature innate monocyte defences, but no studies have assessed global transcriptional responses of neonatal monocytes to these pathogens. Here, we aimed to identify and characterise the neonatal monocyte transcriptional responses to E. coli and S. epidermidis and the role of common modifiers such as gestational age (GA) and exposure to chorioamnionitis (a common complication of preterm birth) to better understand early life innate immune responses. RNA-sequencing was performed on purified cord blood monocytes from very preterm (< 32 weeks GA) and term infants (3740 weeks GA) following standardised challenge with live S. epidermidis or E. coli. The major transcriptional changes induced by either pathogen were highly conserved between infant groups and stimuli, highlighting a common extant neonatal monocyte response to infection, largely mediated by TLR/NF-B/TREM-1 signalling. In addition, we observed an activated interferon-centred immune response specific to stimulation with E. coli in both preterm and term infants. These data provide novel insights into the functionality of neonatal monocytes at birth and highlight potential pathways that could be targeted to reduce the harmful effects of bacterial-induced inflammation in sepsis. E. coli and S. epidermidis elicit common transcriptional changes in cord monocytes. The common transcriptional response is mediated by TLR/NF-B/TREM-1 signalling. IFN genes are differentially regulated by E. coli and S. epidermidis in monocytes. These responses are largely unaffected by GA or exposure to chorioamnionitis. Abstract from J Mol Med (Berl). 2018 Feb;96(2):147-157. doi: 10.1007/s00109-017-1609-2. [Curator's note: Please note that two separate Stemformatics datasets (6412, 6530) are associated with the relevant publication.]"	43	"preterm, term, preterm +Ecoli, term +Ecoli, preterm +Sepidermidis, term +Sepidermidis"	RNASeq (Illumina HiSeq 2000 RNASeq hg19 Gene)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross	Monocyte CD14+ S. epidermidis 2h neonatal	myeloid	Monocyte	neonatal	monocyte	Macrophage
GSM2717665;6530	6530	DeJong	GSM2717665	Preterm_Unstimulated_Monocytes male 1545g	Homo sapiens	preterm	CL:0000576		monocyte	male		DeJong	"Escherichia coli and Staphylococcus epidermidis are predominant causes of neonatal sepsis, particularly affecting preterm infants. Susceptibility to infection has been attributed to immature innate monocyte defences, but no studies have assessed global transcriptional responses of neonatal monocytes to these pathogens. Here, we aimed to identify and characterise the neonatal monocyte transcriptional responses to E. coli and S. epidermidis and the role of common modifiers such as gestational age (GA) and exposure to chorioamnionitis (a common complication of preterm birth) to better understand early life innate immune responses. RNA-sequencing was performed on purified cord blood monocytes from very preterm (< 32 weeks GA) and term infants (3740 weeks GA) following standardised challenge with live S. epidermidis or E. coli. The major transcriptional changes induced by either pathogen were highly conserved between infant groups and stimuli, highlighting a common extant neonatal monocyte response to infection, largely mediated by TLR/NF-B/TREM-1 signalling. In addition, we observed an activated interferon-centred immune response specific to stimulation with E. coli in both preterm and term infants. These data provide novel insights into the functionality of neonatal monocytes at birth and highlight potential pathways that could be targeted to reduce the harmful effects of bacterial-induced inflammation in sepsis. E. coli and S. epidermidis elicit common transcriptional changes in cord monocytes. The common transcriptional response is mediated by TLR/NF-B/TREM-1 signalling. IFN genes are differentially regulated by E. coli and S. epidermidis in monocytes. These responses are largely unaffected by GA or exposure to chorioamnionitis. Abstract from J Mol Med (Berl). 2018 Feb;96(2):147-157. doi: 10.1007/s00109-017-1609-2. [Curator's note: Please note that two separate Stemformatics datasets (6412, 6530) are associated with the relevant publication.]"	43	"preterm, term, preterm +Ecoli, term +Ecoli, preterm +Sepidermidis, term +Sepidermidis"	RNASeq (Illumina HiSeq 2000 RNASeq hg19 Gene)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross	Monocyte CD14+  neonatal	myeloid	Monocyte	neonatal	monocyte	Macrophage
GSM2717666;6530	6530	DeJong	GSM2717666	Preterm_E. coli_Monocytes female 1600g	Homo sapiens	preterm +Ecoli	CL:0000576		monocyte	female		DeJong	"Escherichia coli and Staphylococcus epidermidis are predominant causes of neonatal sepsis, particularly affecting preterm infants. Susceptibility to infection has been attributed to immature innate monocyte defences, but no studies have assessed global transcriptional responses of neonatal monocytes to these pathogens. Here, we aimed to identify and characterise the neonatal monocyte transcriptional responses to E. coli and S. epidermidis and the role of common modifiers such as gestational age (GA) and exposure to chorioamnionitis (a common complication of preterm birth) to better understand early life innate immune responses. RNA-sequencing was performed on purified cord blood monocytes from very preterm (< 32 weeks GA) and term infants (3740 weeks GA) following standardised challenge with live S. epidermidis or E. coli. The major transcriptional changes induced by either pathogen were highly conserved between infant groups and stimuli, highlighting a common extant neonatal monocyte response to infection, largely mediated by TLR/NF-B/TREM-1 signalling. In addition, we observed an activated interferon-centred immune response specific to stimulation with E. coli in both preterm and term infants. These data provide novel insights into the functionality of neonatal monocytes at birth and highlight potential pathways that could be targeted to reduce the harmful effects of bacterial-induced inflammation in sepsis. E. coli and S. epidermidis elicit common transcriptional changes in cord monocytes. The common transcriptional response is mediated by TLR/NF-B/TREM-1 signalling. IFN genes are differentially regulated by E. coli and S. epidermidis in monocytes. These responses are largely unaffected by GA or exposure to chorioamnionitis. Abstract from J Mol Med (Berl). 2018 Feb;96(2):147-157. doi: 10.1007/s00109-017-1609-2. [Curator's note: Please note that two separate Stemformatics datasets (6412, 6530) are associated with the relevant publication.]"	43	"preterm, term, preterm +Ecoli, term +Ecoli, preterm +Sepidermidis, term +Sepidermidis"	RNASeq (Illumina HiSeq 2000 RNASeq hg19 Gene)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross	Monocyte CD14+ E. coli 2h neonatal	myeloid	Monocyte	neonatal	monocyte	Macrophage
GSM2717667;6530	6530	DeJong	GSM2717667	Preterm_S. epidermidis_Monocytes female 1600g	Homo sapiens	preterm +Sepidermidis	CL:0000576		monocyte	female		DeJong	"Escherichia coli and Staphylococcus epidermidis are predominant causes of neonatal sepsis, particularly affecting preterm infants. Susceptibility to infection has been attributed to immature innate monocyte defences, but no studies have assessed global transcriptional responses of neonatal monocytes to these pathogens. Here, we aimed to identify and characterise the neonatal monocyte transcriptional responses to E. coli and S. epidermidis and the role of common modifiers such as gestational age (GA) and exposure to chorioamnionitis (a common complication of preterm birth) to better understand early life innate immune responses. RNA-sequencing was performed on purified cord blood monocytes from very preterm (< 32 weeks GA) and term infants (3740 weeks GA) following standardised challenge with live S. epidermidis or E. coli. The major transcriptional changes induced by either pathogen were highly conserved between infant groups and stimuli, highlighting a common extant neonatal monocyte response to infection, largely mediated by TLR/NF-B/TREM-1 signalling. In addition, we observed an activated interferon-centred immune response specific to stimulation with E. coli in both preterm and term infants. These data provide novel insights into the functionality of neonatal monocytes at birth and highlight potential pathways that could be targeted to reduce the harmful effects of bacterial-induced inflammation in sepsis. E. coli and S. epidermidis elicit common transcriptional changes in cord monocytes. The common transcriptional response is mediated by TLR/NF-B/TREM-1 signalling. IFN genes are differentially regulated by E. coli and S. epidermidis in monocytes. These responses are largely unaffected by GA or exposure to chorioamnionitis. Abstract from J Mol Med (Berl). 2018 Feb;96(2):147-157. doi: 10.1007/s00109-017-1609-2. [Curator's note: Please note that two separate Stemformatics datasets (6412, 6530) are associated with the relevant publication.]"	43	"preterm, term, preterm +Ecoli, term +Ecoli, preterm +Sepidermidis, term +Sepidermidis"	RNASeq (Illumina HiSeq 2000 RNASeq hg19 Gene)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross	Monocyte CD14+ S. epidermidis 2h neonatal	myeloid	Monocyte	neonatal	monocyte	Macrophage
GSM2717668;6530	6530	DeJong	GSM2717668	Preterm _Unstimulated_Monocytes female 1600g	Homo sapiens	preterm	CL:0000576		monocyte	female		DeJong	"Escherichia coli and Staphylococcus epidermidis are predominant causes of neonatal sepsis, particularly affecting preterm infants. Susceptibility to infection has been attributed to immature innate monocyte defences, but no studies have assessed global transcriptional responses of neonatal monocytes to these pathogens. Here, we aimed to identify and characterise the neonatal monocyte transcriptional responses to E. coli and S. epidermidis and the role of common modifiers such as gestational age (GA) and exposure to chorioamnionitis (a common complication of preterm birth) to better understand early life innate immune responses. RNA-sequencing was performed on purified cord blood monocytes from very preterm (< 32 weeks GA) and term infants (3740 weeks GA) following standardised challenge with live S. epidermidis or E. coli. The major transcriptional changes induced by either pathogen were highly conserved between infant groups and stimuli, highlighting a common extant neonatal monocyte response to infection, largely mediated by TLR/NF-B/TREM-1 signalling. In addition, we observed an activated interferon-centred immune response specific to stimulation with E. coli in both preterm and term infants. These data provide novel insights into the functionality of neonatal monocytes at birth and highlight potential pathways that could be targeted to reduce the harmful effects of bacterial-induced inflammation in sepsis. E. coli and S. epidermidis elicit common transcriptional changes in cord monocytes. The common transcriptional response is mediated by TLR/NF-B/TREM-1 signalling. IFN genes are differentially regulated by E. coli and S. epidermidis in monocytes. These responses are largely unaffected by GA or exposure to chorioamnionitis. Abstract from J Mol Med (Berl). 2018 Feb;96(2):147-157. doi: 10.1007/s00109-017-1609-2. [Curator's note: Please note that two separate Stemformatics datasets (6412, 6530) are associated with the relevant publication.]"	43	"preterm, term, preterm +Ecoli, term +Ecoli, preterm +Sepidermidis, term +Sepidermidis"	RNASeq (Illumina HiSeq 2000 RNASeq hg19 Gene)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross	Monocyte CD14+  neonatal	myeloid	Monocyte	neonatal	monocyte	Macrophage
GSM2717669;6530	6530	DeJong	GSM2717669	Preterm_E. coli_Monocytes male 1780g	Homo sapiens	preterm +Ecoli	CL:0000576		monocyte	male		DeJong	"Escherichia coli and Staphylococcus epidermidis are predominant causes of neonatal sepsis, particularly affecting preterm infants. Susceptibility to infection has been attributed to immature innate monocyte defences, but no studies have assessed global transcriptional responses of neonatal monocytes to these pathogens. Here, we aimed to identify and characterise the neonatal monocyte transcriptional responses to E. coli and S. epidermidis and the role of common modifiers such as gestational age (GA) and exposure to chorioamnionitis (a common complication of preterm birth) to better understand early life innate immune responses. RNA-sequencing was performed on purified cord blood monocytes from very preterm (< 32 weeks GA) and term infants (3740 weeks GA) following standardised challenge with live S. epidermidis or E. coli. The major transcriptional changes induced by either pathogen were highly conserved between infant groups and stimuli, highlighting a common extant neonatal monocyte response to infection, largely mediated by TLR/NF-B/TREM-1 signalling. In addition, we observed an activated interferon-centred immune response specific to stimulation with E. coli in both preterm and term infants. These data provide novel insights into the functionality of neonatal monocytes at birth and highlight potential pathways that could be targeted to reduce the harmful effects of bacterial-induced inflammation in sepsis. E. coli and S. epidermidis elicit common transcriptional changes in cord monocytes. The common transcriptional response is mediated by TLR/NF-B/TREM-1 signalling. IFN genes are differentially regulated by E. coli and S. epidermidis in monocytes. These responses are largely unaffected by GA or exposure to chorioamnionitis. Abstract from J Mol Med (Berl). 2018 Feb;96(2):147-157. doi: 10.1007/s00109-017-1609-2. [Curator's note: Please note that two separate Stemformatics datasets (6412, 6530) are associated with the relevant publication.]"	43	"preterm, term, preterm +Ecoli, term +Ecoli, preterm +Sepidermidis, term +Sepidermidis"	RNASeq (Illumina HiSeq 2000 RNASeq hg19 Gene)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross	Monocyte CD14+ E. coli 2h neonatal	myeloid	Monocyte	neonatal	monocyte	Macrophage
GSM2717670;6530	6530	DeJong	GSM2717670	Preterm_S. epidermidis_Monocytes male 1780g	Homo sapiens	preterm +Sepidermidis	CL:0000576		monocyte	male		DeJong	"Escherichia coli and Staphylococcus epidermidis are predominant causes of neonatal sepsis, particularly affecting preterm infants. Susceptibility to infection has been attributed to immature innate monocyte defences, but no studies have assessed global transcriptional responses of neonatal monocytes to these pathogens. Here, we aimed to identify and characterise the neonatal monocyte transcriptional responses to E. coli and S. epidermidis and the role of common modifiers such as gestational age (GA) and exposure to chorioamnionitis (a common complication of preterm birth) to better understand early life innate immune responses. RNA-sequencing was performed on purified cord blood monocytes from very preterm (< 32 weeks GA) and term infants (3740 weeks GA) following standardised challenge with live S. epidermidis or E. coli. The major transcriptional changes induced by either pathogen were highly conserved between infant groups and stimuli, highlighting a common extant neonatal monocyte response to infection, largely mediated by TLR/NF-B/TREM-1 signalling. In addition, we observed an activated interferon-centred immune response specific to stimulation with E. coli in both preterm and term infants. These data provide novel insights into the functionality of neonatal monocytes at birth and highlight potential pathways that could be targeted to reduce the harmful effects of bacterial-induced inflammation in sepsis. E. coli and S. epidermidis elicit common transcriptional changes in cord monocytes. The common transcriptional response is mediated by TLR/NF-B/TREM-1 signalling. IFN genes are differentially regulated by E. coli and S. epidermidis in monocytes. These responses are largely unaffected by GA or exposure to chorioamnionitis. Abstract from J Mol Med (Berl). 2018 Feb;96(2):147-157. doi: 10.1007/s00109-017-1609-2. [Curator's note: Please note that two separate Stemformatics datasets (6412, 6530) are associated with the relevant publication.]"	43	"preterm, term, preterm +Ecoli, term +Ecoli, preterm +Sepidermidis, term +Sepidermidis"	RNASeq (Illumina HiSeq 2000 RNASeq hg19 Gene)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross	Monocyte CD14+ S. epidermidis 2h neonatal	myeloid	Monocyte	neonatal	monocyte	Macrophage
GSM2717671;6530	6530	DeJong	GSM2717671	Preterm_Unstimulated_Monocytes male 1780g	Homo sapiens	preterm	CL:0000576		monocyte	male		DeJong	"Escherichia coli and Staphylococcus epidermidis are predominant causes of neonatal sepsis, particularly affecting preterm infants. Susceptibility to infection has been attributed to immature innate monocyte defences, but no studies have assessed global transcriptional responses of neonatal monocytes to these pathogens. Here, we aimed to identify and characterise the neonatal monocyte transcriptional responses to E. coli and S. epidermidis and the role of common modifiers such as gestational age (GA) and exposure to chorioamnionitis (a common complication of preterm birth) to better understand early life innate immune responses. RNA-sequencing was performed on purified cord blood monocytes from very preterm (< 32 weeks GA) and term infants (3740 weeks GA) following standardised challenge with live S. epidermidis or E. coli. The major transcriptional changes induced by either pathogen were highly conserved between infant groups and stimuli, highlighting a common extant neonatal monocyte response to infection, largely mediated by TLR/NF-B/TREM-1 signalling. In addition, we observed an activated interferon-centred immune response specific to stimulation with E. coli in both preterm and term infants. These data provide novel insights into the functionality of neonatal monocytes at birth and highlight potential pathways that could be targeted to reduce the harmful effects of bacterial-induced inflammation in sepsis. E. coli and S. epidermidis elicit common transcriptional changes in cord monocytes. The common transcriptional response is mediated by TLR/NF-B/TREM-1 signalling. IFN genes are differentially regulated by E. coli and S. epidermidis in monocytes. These responses are largely unaffected by GA or exposure to chorioamnionitis. Abstract from J Mol Med (Berl). 2018 Feb;96(2):147-157. doi: 10.1007/s00109-017-1609-2. [Curator's note: Please note that two separate Stemformatics datasets (6412, 6530) are associated with the relevant publication.]"	43	"preterm, term, preterm +Ecoli, term +Ecoli, preterm +Sepidermidis, term +Sepidermidis"	RNASeq (Illumina HiSeq 2000 RNASeq hg19 Gene)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross	Monocyte CD14+  neonatal	myeloid	Monocyte	neonatal	monocyte	Macrophage
GSM2717672;6530	6530	DeJong	GSM2717672	Term_E. coli_Monocytes female 2700g	Homo sapiens	term +Ecoli	CL:0000576		monocyte	female		DeJong	"Escherichia coli and Staphylococcus epidermidis are predominant causes of neonatal sepsis, particularly affecting preterm infants. Susceptibility to infection has been attributed to immature innate monocyte defences, but no studies have assessed global transcriptional responses of neonatal monocytes to these pathogens. Here, we aimed to identify and characterise the neonatal monocyte transcriptional responses to E. coli and S. epidermidis and the role of common modifiers such as gestational age (GA) and exposure to chorioamnionitis (a common complication of preterm birth) to better understand early life innate immune responses. RNA-sequencing was performed on purified cord blood monocytes from very preterm (< 32 weeks GA) and term infants (3740 weeks GA) following standardised challenge with live S. epidermidis or E. coli. The major transcriptional changes induced by either pathogen were highly conserved between infant groups and stimuli, highlighting a common extant neonatal monocyte response to infection, largely mediated by TLR/NF-B/TREM-1 signalling. In addition, we observed an activated interferon-centred immune response specific to stimulation with E. coli in both preterm and term infants. These data provide novel insights into the functionality of neonatal monocytes at birth and highlight potential pathways that could be targeted to reduce the harmful effects of bacterial-induced inflammation in sepsis. E. coli and S. epidermidis elicit common transcriptional changes in cord monocytes. The common transcriptional response is mediated by TLR/NF-B/TREM-1 signalling. IFN genes are differentially regulated by E. coli and S. epidermidis in monocytes. These responses are largely unaffected by GA or exposure to chorioamnionitis. Abstract from J Mol Med (Berl). 2018 Feb;96(2):147-157. doi: 10.1007/s00109-017-1609-2. [Curator's note: Please note that two separate Stemformatics datasets (6412, 6530) are associated with the relevant publication.]"	43	"preterm, term, preterm +Ecoli, term +Ecoli, preterm +Sepidermidis, term +Sepidermidis"	RNASeq (Illumina HiSeq 2000 RNASeq hg19 Gene)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross	Monocyte CD14+ E. coli 2h neonatal	myeloid	Monocyte	neonatal	monocyte	Macrophage
GSM2717673;6530	6530	DeJong	GSM2717673	Term_S. epidermidis_Monocytes female 2700g	Homo sapiens	term +Sepidermidis	CL:0000576		monocyte	female		DeJong	"Escherichia coli and Staphylococcus epidermidis are predominant causes of neonatal sepsis, particularly affecting preterm infants. Susceptibility to infection has been attributed to immature innate monocyte defences, but no studies have assessed global transcriptional responses of neonatal monocytes to these pathogens. Here, we aimed to identify and characterise the neonatal monocyte transcriptional responses to E. coli and S. epidermidis and the role of common modifiers such as gestational age (GA) and exposure to chorioamnionitis (a common complication of preterm birth) to better understand early life innate immune responses. RNA-sequencing was performed on purified cord blood monocytes from very preterm (< 32 weeks GA) and term infants (3740 weeks GA) following standardised challenge with live S. epidermidis or E. coli. The major transcriptional changes induced by either pathogen were highly conserved between infant groups and stimuli, highlighting a common extant neonatal monocyte response to infection, largely mediated by TLR/NF-B/TREM-1 signalling. In addition, we observed an activated interferon-centred immune response specific to stimulation with E. coli in both preterm and term infants. These data provide novel insights into the functionality of neonatal monocytes at birth and highlight potential pathways that could be targeted to reduce the harmful effects of bacterial-induced inflammation in sepsis. E. coli and S. epidermidis elicit common transcriptional changes in cord monocytes. The common transcriptional response is mediated by TLR/NF-B/TREM-1 signalling. IFN genes are differentially regulated by E. coli and S. epidermidis in monocytes. These responses are largely unaffected by GA or exposure to chorioamnionitis. Abstract from J Mol Med (Berl). 2018 Feb;96(2):147-157. doi: 10.1007/s00109-017-1609-2. [Curator's note: Please note that two separate Stemformatics datasets (6412, 6530) are associated with the relevant publication.]"	43	"preterm, term, preterm +Ecoli, term +Ecoli, preterm +Sepidermidis, term +Sepidermidis"	RNASeq (Illumina HiSeq 2000 RNASeq hg19 Gene)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross	Monocyte CD14+ S. epidermidis 2h neonatal	myeloid	Monocyte	neonatal	monocyte	Macrophage
GSM2717674;6530	6530	DeJong	GSM2717674	Term_Unstimulated_Monocytes female 2700g	Homo sapiens	term	CL:0000576		monocyte	female		DeJong	"Escherichia coli and Staphylococcus epidermidis are predominant causes of neonatal sepsis, particularly affecting preterm infants. Susceptibility to infection has been attributed to immature innate monocyte defences, but no studies have assessed global transcriptional responses of neonatal monocytes to these pathogens. Here, we aimed to identify and characterise the neonatal monocyte transcriptional responses to E. coli and S. epidermidis and the role of common modifiers such as gestational age (GA) and exposure to chorioamnionitis (a common complication of preterm birth) to better understand early life innate immune responses. RNA-sequencing was performed on purified cord blood monocytes from very preterm (< 32 weeks GA) and term infants (3740 weeks GA) following standardised challenge with live S. epidermidis or E. coli. The major transcriptional changes induced by either pathogen were highly conserved between infant groups and stimuli, highlighting a common extant neonatal monocyte response to infection, largely mediated by TLR/NF-B/TREM-1 signalling. In addition, we observed an activated interferon-centred immune response specific to stimulation with E. coli in both preterm and term infants. These data provide novel insights into the functionality of neonatal monocytes at birth and highlight potential pathways that could be targeted to reduce the harmful effects of bacterial-induced inflammation in sepsis. E. coli and S. epidermidis elicit common transcriptional changes in cord monocytes. The common transcriptional response is mediated by TLR/NF-B/TREM-1 signalling. IFN genes are differentially regulated by E. coli and S. epidermidis in monocytes. These responses are largely unaffected by GA or exposure to chorioamnionitis. Abstract from J Mol Med (Berl). 2018 Feb;96(2):147-157. doi: 10.1007/s00109-017-1609-2. [Curator's note: Please note that two separate Stemformatics datasets (6412, 6530) are associated with the relevant publication.]"	43	"preterm, term, preterm +Ecoli, term +Ecoli, preterm +Sepidermidis, term +Sepidermidis"	RNASeq (Illumina HiSeq 2000 RNASeq hg19 Gene)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross	Monocyte CD14+  neonatal	myeloid	Monocyte	neonatal	monocyte	Macrophage
GSM2717675;6530	6530	DeJong	GSM2717675	Term_E. coli_Monocytes male 2915g	Homo sapiens	term +Ecoli	CL:0000576		monocyte	male		DeJong	"Escherichia coli and Staphylococcus epidermidis are predominant causes of neonatal sepsis, particularly affecting preterm infants. Susceptibility to infection has been attributed to immature innate monocyte defences, but no studies have assessed global transcriptional responses of neonatal monocytes to these pathogens. Here, we aimed to identify and characterise the neonatal monocyte transcriptional responses to E. coli and S. epidermidis and the role of common modifiers such as gestational age (GA) and exposure to chorioamnionitis (a common complication of preterm birth) to better understand early life innate immune responses. RNA-sequencing was performed on purified cord blood monocytes from very preterm (< 32 weeks GA) and term infants (3740 weeks GA) following standardised challenge with live S. epidermidis or E. coli. The major transcriptional changes induced by either pathogen were highly conserved between infant groups and stimuli, highlighting a common extant neonatal monocyte response to infection, largely mediated by TLR/NF-B/TREM-1 signalling. In addition, we observed an activated interferon-centred immune response specific to stimulation with E. coli in both preterm and term infants. These data provide novel insights into the functionality of neonatal monocytes at birth and highlight potential pathways that could be targeted to reduce the harmful effects of bacterial-induced inflammation in sepsis. E. coli and S. epidermidis elicit common transcriptional changes in cord monocytes. The common transcriptional response is mediated by TLR/NF-B/TREM-1 signalling. IFN genes are differentially regulated by E. coli and S. epidermidis in monocytes. These responses are largely unaffected by GA or exposure to chorioamnionitis. Abstract from J Mol Med (Berl). 2018 Feb;96(2):147-157. doi: 10.1007/s00109-017-1609-2. [Curator's note: Please note that two separate Stemformatics datasets (6412, 6530) are associated with the relevant publication.]"	43	"preterm, term, preterm +Ecoli, term +Ecoli, preterm +Sepidermidis, term +Sepidermidis"	RNASeq (Illumina HiSeq 2000 RNASeq hg19 Gene)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross	Monocyte CD14+ E. coli 2h neonatal	myeloid	Monocyte	neonatal	monocyte	Macrophage
GSM2717676;6530	6530	DeJong	GSM2717676	Term_S. epidermidis_Monocytes male 2915g	Homo sapiens	term +Sepidermidis	CL:0000576		monocyte	male		DeJong	"Escherichia coli and Staphylococcus epidermidis are predominant causes of neonatal sepsis, particularly affecting preterm infants. Susceptibility to infection has been attributed to immature innate monocyte defences, but no studies have assessed global transcriptional responses of neonatal monocytes to these pathogens. Here, we aimed to identify and characterise the neonatal monocyte transcriptional responses to E. coli and S. epidermidis and the role of common modifiers such as gestational age (GA) and exposure to chorioamnionitis (a common complication of preterm birth) to better understand early life innate immune responses. RNA-sequencing was performed on purified cord blood monocytes from very preterm (< 32 weeks GA) and term infants (3740 weeks GA) following standardised challenge with live S. epidermidis or E. coli. The major transcriptional changes induced by either pathogen were highly conserved between infant groups and stimuli, highlighting a common extant neonatal monocyte response to infection, largely mediated by TLR/NF-B/TREM-1 signalling. In addition, we observed an activated interferon-centred immune response specific to stimulation with E. coli in both preterm and term infants. These data provide novel insights into the functionality of neonatal monocytes at birth and highlight potential pathways that could be targeted to reduce the harmful effects of bacterial-induced inflammation in sepsis. E. coli and S. epidermidis elicit common transcriptional changes in cord monocytes. The common transcriptional response is mediated by TLR/NF-B/TREM-1 signalling. IFN genes are differentially regulated by E. coli and S. epidermidis in monocytes. These responses are largely unaffected by GA or exposure to chorioamnionitis. Abstract from J Mol Med (Berl). 2018 Feb;96(2):147-157. doi: 10.1007/s00109-017-1609-2. [Curator's note: Please note that two separate Stemformatics datasets (6412, 6530) are associated with the relevant publication.]"	43	"preterm, term, preterm +Ecoli, term +Ecoli, preterm +Sepidermidis, term +Sepidermidis"	RNASeq (Illumina HiSeq 2000 RNASeq hg19 Gene)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross	Monocyte CD14+ S. epidermidis 2h neonatal	myeloid	Monocyte	neonatal	monocyte	Macrophage
GSM2717677;6530	6530	DeJong	GSM2717677	Term_Unstimulated_Monocytes male 2915g	Homo sapiens	term	CL:0000576		monocyte	male		DeJong	"Escherichia coli and Staphylococcus epidermidis are predominant causes of neonatal sepsis, particularly affecting preterm infants. Susceptibility to infection has been attributed to immature innate monocyte defences, but no studies have assessed global transcriptional responses of neonatal monocytes to these pathogens. Here, we aimed to identify and characterise the neonatal monocyte transcriptional responses to E. coli and S. epidermidis and the role of common modifiers such as gestational age (GA) and exposure to chorioamnionitis (a common complication of preterm birth) to better understand early life innate immune responses. RNA-sequencing was performed on purified cord blood monocytes from very preterm (< 32 weeks GA) and term infants (3740 weeks GA) following standardised challenge with live S. epidermidis or E. coli. The major transcriptional changes induced by either pathogen were highly conserved between infant groups and stimuli, highlighting a common extant neonatal monocyte response to infection, largely mediated by TLR/NF-B/TREM-1 signalling. In addition, we observed an activated interferon-centred immune response specific to stimulation with E. coli in both preterm and term infants. These data provide novel insights into the functionality of neonatal monocytes at birth and highlight potential pathways that could be targeted to reduce the harmful effects of bacterial-induced inflammation in sepsis. E. coli and S. epidermidis elicit common transcriptional changes in cord monocytes. The common transcriptional response is mediated by TLR/NF-B/TREM-1 signalling. IFN genes are differentially regulated by E. coli and S. epidermidis in monocytes. These responses are largely unaffected by GA or exposure to chorioamnionitis. Abstract from J Mol Med (Berl). 2018 Feb;96(2):147-157. doi: 10.1007/s00109-017-1609-2. [Curator's note: Please note that two separate Stemformatics datasets (6412, 6530) are associated with the relevant publication.]"	43	"preterm, term, preterm +Ecoli, term +Ecoli, preterm +Sepidermidis, term +Sepidermidis"	RNASeq (Illumina HiSeq 2000 RNASeq hg19 Gene)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross	Monocyte CD14+  neonatal	myeloid	Monocyte	neonatal	monocyte	Macrophage
GSM2717678;6530	6530	DeJong	GSM2717678	Term_E. coli_Monocytes male 3630g	Homo sapiens	term +Ecoli	CL:0000576		monocyte	male		DeJong	"Escherichia coli and Staphylococcus epidermidis are predominant causes of neonatal sepsis, particularly affecting preterm infants. Susceptibility to infection has been attributed to immature innate monocyte defences, but no studies have assessed global transcriptional responses of neonatal monocytes to these pathogens. Here, we aimed to identify and characterise the neonatal monocyte transcriptional responses to E. coli and S. epidermidis and the role of common modifiers such as gestational age (GA) and exposure to chorioamnionitis (a common complication of preterm birth) to better understand early life innate immune responses. RNA-sequencing was performed on purified cord blood monocytes from very preterm (< 32 weeks GA) and term infants (3740 weeks GA) following standardised challenge with live S. epidermidis or E. coli. The major transcriptional changes induced by either pathogen were highly conserved between infant groups and stimuli, highlighting a common extant neonatal monocyte response to infection, largely mediated by TLR/NF-B/TREM-1 signalling. In addition, we observed an activated interferon-centred immune response specific to stimulation with E. coli in both preterm and term infants. These data provide novel insights into the functionality of neonatal monocytes at birth and highlight potential pathways that could be targeted to reduce the harmful effects of bacterial-induced inflammation in sepsis. E. coli and S. epidermidis elicit common transcriptional changes in cord monocytes. The common transcriptional response is mediated by TLR/NF-B/TREM-1 signalling. IFN genes are differentially regulated by E. coli and S. epidermidis in monocytes. These responses are largely unaffected by GA or exposure to chorioamnionitis. Abstract from J Mol Med (Berl). 2018 Feb;96(2):147-157. doi: 10.1007/s00109-017-1609-2. [Curator's note: Please note that two separate Stemformatics datasets (6412, 6530) are associated with the relevant publication.]"	43	"preterm, term, preterm +Ecoli, term +Ecoli, preterm +Sepidermidis, term +Sepidermidis"	RNASeq (Illumina HiSeq 2000 RNASeq hg19 Gene)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross	Monocyte CD14+ E. coli 2h neonatal	myeloid	Monocyte	neonatal	monocyte	Macrophage
GSM2717679;6530	6530	DeJong	GSM2717679	Term_S. epidermidis_Monocytes male 3630g	Homo sapiens	term +Sepidermidis	CL:0000576		monocyte	male		DeJong	"Escherichia coli and Staphylococcus epidermidis are predominant causes of neonatal sepsis, particularly affecting preterm infants. Susceptibility to infection has been attributed to immature innate monocyte defences, but no studies have assessed global transcriptional responses of neonatal monocytes to these pathogens. Here, we aimed to identify and characterise the neonatal monocyte transcriptional responses to E. coli and S. epidermidis and the role of common modifiers such as gestational age (GA) and exposure to chorioamnionitis (a common complication of preterm birth) to better understand early life innate immune responses. RNA-sequencing was performed on purified cord blood monocytes from very preterm (< 32 weeks GA) and term infants (3740 weeks GA) following standardised challenge with live S. epidermidis or E. coli. The major transcriptional changes induced by either pathogen were highly conserved between infant groups and stimuli, highlighting a common extant neonatal monocyte response to infection, largely mediated by TLR/NF-B/TREM-1 signalling. In addition, we observed an activated interferon-centred immune response specific to stimulation with E. coli in both preterm and term infants. These data provide novel insights into the functionality of neonatal monocytes at birth and highlight potential pathways that could be targeted to reduce the harmful effects of bacterial-induced inflammation in sepsis. E. coli and S. epidermidis elicit common transcriptional changes in cord monocytes. The common transcriptional response is mediated by TLR/NF-B/TREM-1 signalling. IFN genes are differentially regulated by E. coli and S. epidermidis in monocytes. These responses are largely unaffected by GA or exposure to chorioamnionitis. Abstract from J Mol Med (Berl). 2018 Feb;96(2):147-157. doi: 10.1007/s00109-017-1609-2. [Curator's note: Please note that two separate Stemformatics datasets (6412, 6530) are associated with the relevant publication.]"	43	"preterm, term, preterm +Ecoli, term +Ecoli, preterm +Sepidermidis, term +Sepidermidis"	RNASeq (Illumina HiSeq 2000 RNASeq hg19 Gene)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross	Monocyte CD14+ S. epidermidis 2h neonatal	myeloid	Monocyte	neonatal	monocyte	Macrophage
GSM2717680;6530	6530	DeJong	GSM2717680	Term_Unstimulated_Monocytes male 3630g	Homo sapiens	term	CL:0000576		monocyte	male		DeJong	"Escherichia coli and Staphylococcus epidermidis are predominant causes of neonatal sepsis, particularly affecting preterm infants. Susceptibility to infection has been attributed to immature innate monocyte defences, but no studies have assessed global transcriptional responses of neonatal monocytes to these pathogens. Here, we aimed to identify and characterise the neonatal monocyte transcriptional responses to E. coli and S. epidermidis and the role of common modifiers such as gestational age (GA) and exposure to chorioamnionitis (a common complication of preterm birth) to better understand early life innate immune responses. RNA-sequencing was performed on purified cord blood monocytes from very preterm (< 32 weeks GA) and term infants (3740 weeks GA) following standardised challenge with live S. epidermidis or E. coli. The major transcriptional changes induced by either pathogen were highly conserved between infant groups and stimuli, highlighting a common extant neonatal monocyte response to infection, largely mediated by TLR/NF-B/TREM-1 signalling. In addition, we observed an activated interferon-centred immune response specific to stimulation with E. coli in both preterm and term infants. These data provide novel insights into the functionality of neonatal monocytes at birth and highlight potential pathways that could be targeted to reduce the harmful effects of bacterial-induced inflammation in sepsis. E. coli and S. epidermidis elicit common transcriptional changes in cord monocytes. The common transcriptional response is mediated by TLR/NF-B/TREM-1 signalling. IFN genes are differentially regulated by E. coli and S. epidermidis in monocytes. These responses are largely unaffected by GA or exposure to chorioamnionitis. Abstract from J Mol Med (Berl). 2018 Feb;96(2):147-157. doi: 10.1007/s00109-017-1609-2. [Curator's note: Please note that two separate Stemformatics datasets (6412, 6530) are associated with the relevant publication.]"	43	"preterm, term, preterm +Ecoli, term +Ecoli, preterm +Sepidermidis, term +Sepidermidis"	RNASeq (Illumina HiSeq 2000 RNASeq hg19 Gene)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross	Monocyte CD14+  neonatal	myeloid	Monocyte	neonatal	monocyte	Macrophage
GSM2717681;6530	6530	DeJong	GSM2717681	Term_E. coli_Monocytes female 3170g	Homo sapiens	term +Ecoli	CL:0000576		monocyte	female		DeJong	"Escherichia coli and Staphylococcus epidermidis are predominant causes of neonatal sepsis, particularly affecting preterm infants. Susceptibility to infection has been attributed to immature innate monocyte defences, but no studies have assessed global transcriptional responses of neonatal monocytes to these pathogens. Here, we aimed to identify and characterise the neonatal monocyte transcriptional responses to E. coli and S. epidermidis and the role of common modifiers such as gestational age (GA) and exposure to chorioamnionitis (a common complication of preterm birth) to better understand early life innate immune responses. RNA-sequencing was performed on purified cord blood monocytes from very preterm (< 32 weeks GA) and term infants (3740 weeks GA) following standardised challenge with live S. epidermidis or E. coli. The major transcriptional changes induced by either pathogen were highly conserved between infant groups and stimuli, highlighting a common extant neonatal monocyte response to infection, largely mediated by TLR/NF-B/TREM-1 signalling. In addition, we observed an activated interferon-centred immune response specific to stimulation with E. coli in both preterm and term infants. These data provide novel insights into the functionality of neonatal monocytes at birth and highlight potential pathways that could be targeted to reduce the harmful effects of bacterial-induced inflammation in sepsis. E. coli and S. epidermidis elicit common transcriptional changes in cord monocytes. The common transcriptional response is mediated by TLR/NF-B/TREM-1 signalling. IFN genes are differentially regulated by E. coli and S. epidermidis in monocytes. These responses are largely unaffected by GA or exposure to chorioamnionitis. Abstract from J Mol Med (Berl). 2018 Feb;96(2):147-157. doi: 10.1007/s00109-017-1609-2. [Curator's note: Please note that two separate Stemformatics datasets (6412, 6530) are associated with the relevant publication.]"	43	"preterm, term, preterm +Ecoli, term +Ecoli, preterm +Sepidermidis, term +Sepidermidis"	RNASeq (Illumina HiSeq 2000 RNASeq hg19 Gene)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross	Monocyte CD14+ E. coli 2h neonatal	myeloid	Monocyte	neonatal	monocyte	Macrophage
GSM2717682;6530	6530	DeJong	GSM2717682	Term_S. epidermidis_Monocytes female 3170g	Homo sapiens	term +Sepidermidis	CL:0000576		monocyte	female		DeJong	"Escherichia coli and Staphylococcus epidermidis are predominant causes of neonatal sepsis, particularly affecting preterm infants. Susceptibility to infection has been attributed to immature innate monocyte defences, but no studies have assessed global transcriptional responses of neonatal monocytes to these pathogens. Here, we aimed to identify and characterise the neonatal monocyte transcriptional responses to E. coli and S. epidermidis and the role of common modifiers such as gestational age (GA) and exposure to chorioamnionitis (a common complication of preterm birth) to better understand early life innate immune responses. RNA-sequencing was performed on purified cord blood monocytes from very preterm (< 32 weeks GA) and term infants (3740 weeks GA) following standardised challenge with live S. epidermidis or E. coli. The major transcriptional changes induced by either pathogen were highly conserved between infant groups and stimuli, highlighting a common extant neonatal monocyte response to infection, largely mediated by TLR/NF-B/TREM-1 signalling. In addition, we observed an activated interferon-centred immune response specific to stimulation with E. coli in both preterm and term infants. These data provide novel insights into the functionality of neonatal monocytes at birth and highlight potential pathways that could be targeted to reduce the harmful effects of bacterial-induced inflammation in sepsis. E. coli and S. epidermidis elicit common transcriptional changes in cord monocytes. The common transcriptional response is mediated by TLR/NF-B/TREM-1 signalling. IFN genes are differentially regulated by E. coli and S. epidermidis in monocytes. These responses are largely unaffected by GA or exposure to chorioamnionitis. Abstract from J Mol Med (Berl). 2018 Feb;96(2):147-157. doi: 10.1007/s00109-017-1609-2. [Curator's note: Please note that two separate Stemformatics datasets (6412, 6530) are associated with the relevant publication.]"	43	"preterm, term, preterm +Ecoli, term +Ecoli, preterm +Sepidermidis, term +Sepidermidis"	RNASeq (Illumina HiSeq 2000 RNASeq hg19 Gene)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross	Monocyte CD14+ S. epidermidis 2h neonatal	myeloid	Monocyte	neonatal	monocyte	Macrophage
GSM2717683;6530	6530	DeJong	GSM2717683	Term_Unstimulated_Monocytes female 3170g	Homo sapiens	term	CL:0000576		monocyte	female		DeJong	"Escherichia coli and Staphylococcus epidermidis are predominant causes of neonatal sepsis, particularly affecting preterm infants. Susceptibility to infection has been attributed to immature innate monocyte defences, but no studies have assessed global transcriptional responses of neonatal monocytes to these pathogens. Here, we aimed to identify and characterise the neonatal monocyte transcriptional responses to E. coli and S. epidermidis and the role of common modifiers such as gestational age (GA) and exposure to chorioamnionitis (a common complication of preterm birth) to better understand early life innate immune responses. RNA-sequencing was performed on purified cord blood monocytes from very preterm (< 32 weeks GA) and term infants (3740 weeks GA) following standardised challenge with live S. epidermidis or E. coli. The major transcriptional changes induced by either pathogen were highly conserved between infant groups and stimuli, highlighting a common extant neonatal monocyte response to infection, largely mediated by TLR/NF-B/TREM-1 signalling. In addition, we observed an activated interferon-centred immune response specific to stimulation with E. coli in both preterm and term infants. These data provide novel insights into the functionality of neonatal monocytes at birth and highlight potential pathways that could be targeted to reduce the harmful effects of bacterial-induced inflammation in sepsis. E. coli and S. epidermidis elicit common transcriptional changes in cord monocytes. The common transcriptional response is mediated by TLR/NF-B/TREM-1 signalling. IFN genes are differentially regulated by E. coli and S. epidermidis in monocytes. These responses are largely unaffected by GA or exposure to chorioamnionitis. Abstract from J Mol Med (Berl). 2018 Feb;96(2):147-157. doi: 10.1007/s00109-017-1609-2. [Curator's note: Please note that two separate Stemformatics datasets (6412, 6530) are associated with the relevant publication.]"	43	"preterm, term, preterm +Ecoli, term +Ecoli, preterm +Sepidermidis, term +Sepidermidis"	RNASeq (Illumina HiSeq 2000 RNASeq hg19 Gene)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross	Monocyte CD14+  neonatal	myeloid	Monocyte	neonatal	monocyte	Macrophage
GSM2717684;6412	6412	DeJong	GSM2717684	Term E.coli	Homo sapiens	Term E.coli	CL:0000576		monocyte			DeJong	"Escherichia coli and Staphylococcus epidermidis are predominant causes of neonatal sepsis, particularly affecting preterm infants. Susceptibility to infection has been attributed to immature innate monocyte defences, but no studies have assessed global transcriptional responses of neonatal monocytes to these pathogens. Here, we aimed to identify and characterise the neonatal monocyte transcriptional responses to E. coli and S. epidermidis and the role of common modifiers such as gestational age (GA) and exposure to chorioamnionitis (a common complication of preterm birth) to better understand early life innate immune responses. RNA-sequencing was performed on purified cord blood monocytes from very preterm (< 32 weeks GA) and term infants (3740 weeks GA) following standardised challenge with live S. epidermidis or E. coli. The major transcriptional changes induced by either pathogen were highly conserved between infant groups and stimuli, highlighting a common extant neonatal monocyte response to infection, largely mediated by TLR/NF-B/TREM-1 signalling. In addition, we observed an activated interferon-centred immune response specific to stimulation with E. coli in both preterm and term infants. These data provide novel insights into the functionality of neonatal monocytes at birth and highlight potential pathways that could be targeted to reduce the harmful effects of bacterial-induced inflammation in sepsis. E. coli and S. epidermidis elicit common transcriptional changes in cord monocytes. The common transcriptional response is mediated by TLR/NF-B/TREM-1 signalling. IFN genes are differentially regulated by E. coli and S. epidermidis in monocytes. These responses are largely unaffected by GA or exposure to chorioamnionitis. Abstract from J Mol Med (Berl). 2018 Feb;96(2):147-157. doi: 10.1007/s00109-017-1609-2. [Curator's note: Please note that two separate Stemformatics datasets (6412, 6530) are associated with the relevant publication.]"	9	"Preterm E.coli, Preterm S.epi, Preterm unstimulated, Preterm Chorioamnionitis E.coli, Preterm Chorioamnionitis S.epi, Preterm Chorioamnionitis unstimulated, Term E.coli, Term S.epi, Term unstimulated"	RNASeq (Illumina HiSeq 2000 RNASeq hg19 Transcript)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross	Monocyte CD14+ E. coli 2h neonatal	myeloid	Monocyte	neonatal	monocyte	Macrophage
GSM2717685;6412	6412	DeJong	GSM2717685	Term S.epi	Homo sapiens	Term S.epi	CL:0000576		monocyte			DeJong	"Escherichia coli and Staphylococcus epidermidis are predominant causes of neonatal sepsis, particularly affecting preterm infants. Susceptibility to infection has been attributed to immature innate monocyte defences, but no studies have assessed global transcriptional responses of neonatal monocytes to these pathogens. Here, we aimed to identify and characterise the neonatal monocyte transcriptional responses to E. coli and S. epidermidis and the role of common modifiers such as gestational age (GA) and exposure to chorioamnionitis (a common complication of preterm birth) to better understand early life innate immune responses. RNA-sequencing was performed on purified cord blood monocytes from very preterm (< 32 weeks GA) and term infants (3740 weeks GA) following standardised challenge with live S. epidermidis or E. coli. The major transcriptional changes induced by either pathogen were highly conserved between infant groups and stimuli, highlighting a common extant neonatal monocyte response to infection, largely mediated by TLR/NF-B/TREM-1 signalling. In addition, we observed an activated interferon-centred immune response specific to stimulation with E. coli in both preterm and term infants. These data provide novel insights into the functionality of neonatal monocytes at birth and highlight potential pathways that could be targeted to reduce the harmful effects of bacterial-induced inflammation in sepsis. E. coli and S. epidermidis elicit common transcriptional changes in cord monocytes. The common transcriptional response is mediated by TLR/NF-B/TREM-1 signalling. IFN genes are differentially regulated by E. coli and S. epidermidis in monocytes. These responses are largely unaffected by GA or exposure to chorioamnionitis. Abstract from J Mol Med (Berl). 2018 Feb;96(2):147-157. doi: 10.1007/s00109-017-1609-2. [Curator's note: Please note that two separate Stemformatics datasets (6412, 6530) are associated with the relevant publication.]"	9	"Preterm E.coli, Preterm S.epi, Preterm unstimulated, Preterm Chorioamnionitis E.coli, Preterm Chorioamnionitis S.epi, Preterm Chorioamnionitis unstimulated, Term E.coli, Term S.epi, Term unstimulated"	RNASeq (Illumina HiSeq 2000 RNASeq hg19 Transcript)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross	Monocyte CD14+ S. epidermidis 2h neonatal	myeloid	Monocyte	neonatal	monocyte	Macrophage
GSM2717686;6412	6412	DeJong	GSM2717686	Term unstimulated	Homo sapiens	Term unstimulated	CL:0000576		monocyte			DeJong	"Escherichia coli and Staphylococcus epidermidis are predominant causes of neonatal sepsis, particularly affecting preterm infants. Susceptibility to infection has been attributed to immature innate monocyte defences, but no studies have assessed global transcriptional responses of neonatal monocytes to these pathogens. Here, we aimed to identify and characterise the neonatal monocyte transcriptional responses to E. coli and S. epidermidis and the role of common modifiers such as gestational age (GA) and exposure to chorioamnionitis (a common complication of preterm birth) to better understand early life innate immune responses. RNA-sequencing was performed on purified cord blood monocytes from very preterm (< 32 weeks GA) and term infants (3740 weeks GA) following standardised challenge with live S. epidermidis or E. coli. The major transcriptional changes induced by either pathogen were highly conserved between infant groups and stimuli, highlighting a common extant neonatal monocyte response to infection, largely mediated by TLR/NF-B/TREM-1 signalling. In addition, we observed an activated interferon-centred immune response specific to stimulation with E. coli in both preterm and term infants. These data provide novel insights into the functionality of neonatal monocytes at birth and highlight potential pathways that could be targeted to reduce the harmful effects of bacterial-induced inflammation in sepsis. E. coli and S. epidermidis elicit common transcriptional changes in cord monocytes. The common transcriptional response is mediated by TLR/NF-B/TREM-1 signalling. IFN genes are differentially regulated by E. coli and S. epidermidis in monocytes. These responses are largely unaffected by GA or exposure to chorioamnionitis. Abstract from J Mol Med (Berl). 2018 Feb;96(2):147-157. doi: 10.1007/s00109-017-1609-2. [Curator's note: Please note that two separate Stemformatics datasets (6412, 6530) are associated with the relevant publication.]"	9	"Preterm E.coli, Preterm S.epi, Preterm unstimulated, Preterm Chorioamnionitis E.coli, Preterm Chorioamnionitis S.epi, Preterm Chorioamnionitis unstimulated, Term E.coli, Term S.epi, Term unstimulated"	RNASeq (Illumina HiSeq 2000 RNASeq hg19 Transcript)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross	Monocyte CD14+  neonatal	myeloid	Monocyte	neonatal	monocyte	Macrophage
GSM2717687;6412	6412	DeJong	GSM2717687	Preterm E.coli	Homo sapiens	Preterm E.coli	CL:0000576		monocyte			DeJong	"Escherichia coli and Staphylococcus epidermidis are predominant causes of neonatal sepsis, particularly affecting preterm infants. Susceptibility to infection has been attributed to immature innate monocyte defences, but no studies have assessed global transcriptional responses of neonatal monocytes to these pathogens. Here, we aimed to identify and characterise the neonatal monocyte transcriptional responses to E. coli and S. epidermidis and the role of common modifiers such as gestational age (GA) and exposure to chorioamnionitis (a common complication of preterm birth) to better understand early life innate immune responses. RNA-sequencing was performed on purified cord blood monocytes from very preterm (< 32 weeks GA) and term infants (3740 weeks GA) following standardised challenge with live S. epidermidis or E. coli. The major transcriptional changes induced by either pathogen were highly conserved between infant groups and stimuli, highlighting a common extant neonatal monocyte response to infection, largely mediated by TLR/NF-B/TREM-1 signalling. In addition, we observed an activated interferon-centred immune response specific to stimulation with E. coli in both preterm and term infants. These data provide novel insights into the functionality of neonatal monocytes at birth and highlight potential pathways that could be targeted to reduce the harmful effects of bacterial-induced inflammation in sepsis. E. coli and S. epidermidis elicit common transcriptional changes in cord monocytes. The common transcriptional response is mediated by TLR/NF-B/TREM-1 signalling. IFN genes are differentially regulated by E. coli and S. epidermidis in monocytes. These responses are largely unaffected by GA or exposure to chorioamnionitis. Abstract from J Mol Med (Berl). 2018 Feb;96(2):147-157. doi: 10.1007/s00109-017-1609-2. [Curator's note: Please note that two separate Stemformatics datasets (6412, 6530) are associated with the relevant publication.]"	9	"Preterm E.coli, Preterm S.epi, Preterm unstimulated, Preterm Chorioamnionitis E.coli, Preterm Chorioamnionitis S.epi, Preterm Chorioamnionitis unstimulated, Term E.coli, Term S.epi, Term unstimulated"	RNASeq (Illumina HiSeq 2000 RNASeq hg19 Transcript)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross	Monocyte CD14+ E. coli 2h neonatal	myeloid	Monocyte	neonatal	monocyte	Macrophage
GSM2717688;6412	6412	DeJong	GSM2717688	Preterm S.epi	Homo sapiens	Preterm S.epi	CL:0000576		monocyte			DeJong	"Escherichia coli and Staphylococcus epidermidis are predominant causes of neonatal sepsis, particularly affecting preterm infants. Susceptibility to infection has been attributed to immature innate monocyte defences, but no studies have assessed global transcriptional responses of neonatal monocytes to these pathogens. Here, we aimed to identify and characterise the neonatal monocyte transcriptional responses to E. coli and S. epidermidis and the role of common modifiers such as gestational age (GA) and exposure to chorioamnionitis (a common complication of preterm birth) to better understand early life innate immune responses. RNA-sequencing was performed on purified cord blood monocytes from very preterm (< 32 weeks GA) and term infants (3740 weeks GA) following standardised challenge with live S. epidermidis or E. coli. The major transcriptional changes induced by either pathogen were highly conserved between infant groups and stimuli, highlighting a common extant neonatal monocyte response to infection, largely mediated by TLR/NF-B/TREM-1 signalling. In addition, we observed an activated interferon-centred immune response specific to stimulation with E. coli in both preterm and term infants. These data provide novel insights into the functionality of neonatal monocytes at birth and highlight potential pathways that could be targeted to reduce the harmful effects of bacterial-induced inflammation in sepsis. E. coli and S. epidermidis elicit common transcriptional changes in cord monocytes. The common transcriptional response is mediated by TLR/NF-B/TREM-1 signalling. IFN genes are differentially regulated by E. coli and S. epidermidis in monocytes. These responses are largely unaffected by GA or exposure to chorioamnionitis. Abstract from J Mol Med (Berl). 2018 Feb;96(2):147-157. doi: 10.1007/s00109-017-1609-2. [Curator's note: Please note that two separate Stemformatics datasets (6412, 6530) are associated with the relevant publication.]"	9	"Preterm E.coli, Preterm S.epi, Preterm unstimulated, Preterm Chorioamnionitis E.coli, Preterm Chorioamnionitis S.epi, Preterm Chorioamnionitis unstimulated, Term E.coli, Term S.epi, Term unstimulated"	RNASeq (Illumina HiSeq 2000 RNASeq hg19 Transcript)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross	Monocyte CD14+ S. epidermidis 2h neonatal	myeloid	Monocyte	neonatal	monocyte	Macrophage
GSM2717689;6412	6412	DeJong	GSM2717689	Preterm unstimulated	Homo sapiens	Preterm unstimulated	CL:0000576		monocyte			DeJong	"Escherichia coli and Staphylococcus epidermidis are predominant causes of neonatal sepsis, particularly affecting preterm infants. Susceptibility to infection has been attributed to immature innate monocyte defences, but no studies have assessed global transcriptional responses of neonatal monocytes to these pathogens. Here, we aimed to identify and characterise the neonatal monocyte transcriptional responses to E. coli and S. epidermidis and the role of common modifiers such as gestational age (GA) and exposure to chorioamnionitis (a common complication of preterm birth) to better understand early life innate immune responses. RNA-sequencing was performed on purified cord blood monocytes from very preterm (< 32 weeks GA) and term infants (3740 weeks GA) following standardised challenge with live S. epidermidis or E. coli. The major transcriptional changes induced by either pathogen were highly conserved between infant groups and stimuli, highlighting a common extant neonatal monocyte response to infection, largely mediated by TLR/NF-B/TREM-1 signalling. In addition, we observed an activated interferon-centred immune response specific to stimulation with E. coli in both preterm and term infants. These data provide novel insights into the functionality of neonatal monocytes at birth and highlight potential pathways that could be targeted to reduce the harmful effects of bacterial-induced inflammation in sepsis. E. coli and S. epidermidis elicit common transcriptional changes in cord monocytes. The common transcriptional response is mediated by TLR/NF-B/TREM-1 signalling. IFN genes are differentially regulated by E. coli and S. epidermidis in monocytes. These responses are largely unaffected by GA or exposure to chorioamnionitis. Abstract from J Mol Med (Berl). 2018 Feb;96(2):147-157. doi: 10.1007/s00109-017-1609-2. [Curator's note: Please note that two separate Stemformatics datasets (6412, 6530) are associated with the relevant publication.]"	9	"Preterm E.coli, Preterm S.epi, Preterm unstimulated, Preterm Chorioamnionitis E.coli, Preterm Chorioamnionitis S.epi, Preterm Chorioamnionitis unstimulated, Term E.coli, Term S.epi, Term unstimulated"	RNASeq (Illumina HiSeq 2000 RNASeq hg19 Transcript)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross	Monocyte CD14+  neonatal	myeloid	Monocyte	neonatal	monocyte	Macrophage
GSM2717690;6412	6412	DeJong	GSM2717690	Preterm Chorioamnionitis E.coli	Homo sapiens	Preterm Chorioamnionitis E.coli	CL:0000576		monocyte			DeJong	"Escherichia coli and Staphylococcus epidermidis are predominant causes of neonatal sepsis, particularly affecting preterm infants. Susceptibility to infection has been attributed to immature innate monocyte defences, but no studies have assessed global transcriptional responses of neonatal monocytes to these pathogens. Here, we aimed to identify and characterise the neonatal monocyte transcriptional responses to E. coli and S. epidermidis and the role of common modifiers such as gestational age (GA) and exposure to chorioamnionitis (a common complication of preterm birth) to better understand early life innate immune responses. RNA-sequencing was performed on purified cord blood monocytes from very preterm (< 32 weeks GA) and term infants (3740 weeks GA) following standardised challenge with live S. epidermidis or E. coli. The major transcriptional changes induced by either pathogen were highly conserved between infant groups and stimuli, highlighting a common extant neonatal monocyte response to infection, largely mediated by TLR/NF-B/TREM-1 signalling. In addition, we observed an activated interferon-centred immune response specific to stimulation with E. coli in both preterm and term infants. These data provide novel insights into the functionality of neonatal monocytes at birth and highlight potential pathways that could be targeted to reduce the harmful effects of bacterial-induced inflammation in sepsis. E. coli and S. epidermidis elicit common transcriptional changes in cord monocytes. The common transcriptional response is mediated by TLR/NF-B/TREM-1 signalling. IFN genes are differentially regulated by E. coli and S. epidermidis in monocytes. These responses are largely unaffected by GA or exposure to chorioamnionitis. Abstract from J Mol Med (Berl). 2018 Feb;96(2):147-157. doi: 10.1007/s00109-017-1609-2. [Curator's note: Please note that two separate Stemformatics datasets (6412, 6530) are associated with the relevant publication.]"	9	"Preterm E.coli, Preterm S.epi, Preterm unstimulated, Preterm Chorioamnionitis E.coli, Preterm Chorioamnionitis S.epi, Preterm Chorioamnionitis unstimulated, Term E.coli, Term S.epi, Term unstimulated"	RNASeq (Illumina HiSeq 2000 RNASeq hg19 Transcript)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross	Monocyte CD14+ E. coli 2h neonatal	myeloid	Monocyte	neonatal	monocyte	Macrophage
GSM2717691;6412	6412	DeJong	GSM2717691	Preterm Chorioamnionitis S.epi	Homo sapiens	Preterm Chorioamnionitis S.epi	CL:0000576		monocyte			DeJong	"Escherichia coli and Staphylococcus epidermidis are predominant causes of neonatal sepsis, particularly affecting preterm infants. Susceptibility to infection has been attributed to immature innate monocyte defences, but no studies have assessed global transcriptional responses of neonatal monocytes to these pathogens. Here, we aimed to identify and characterise the neonatal monocyte transcriptional responses to E. coli and S. epidermidis and the role of common modifiers such as gestational age (GA) and exposure to chorioamnionitis (a common complication of preterm birth) to better understand early life innate immune responses. RNA-sequencing was performed on purified cord blood monocytes from very preterm (< 32 weeks GA) and term infants (3740 weeks GA) following standardised challenge with live S. epidermidis or E. coli. The major transcriptional changes induced by either pathogen were highly conserved between infant groups and stimuli, highlighting a common extant neonatal monocyte response to infection, largely mediated by TLR/NF-B/TREM-1 signalling. In addition, we observed an activated interferon-centred immune response specific to stimulation with E. coli in both preterm and term infants. These data provide novel insights into the functionality of neonatal monocytes at birth and highlight potential pathways that could be targeted to reduce the harmful effects of bacterial-induced inflammation in sepsis. E. coli and S. epidermidis elicit common transcriptional changes in cord monocytes. The common transcriptional response is mediated by TLR/NF-B/TREM-1 signalling. IFN genes are differentially regulated by E. coli and S. epidermidis in monocytes. These responses are largely unaffected by GA or exposure to chorioamnionitis. Abstract from J Mol Med (Berl). 2018 Feb;96(2):147-157. doi: 10.1007/s00109-017-1609-2. [Curator's note: Please note that two separate Stemformatics datasets (6412, 6530) are associated with the relevant publication.]"	9	"Preterm E.coli, Preterm S.epi, Preterm unstimulated, Preterm Chorioamnionitis E.coli, Preterm Chorioamnionitis S.epi, Preterm Chorioamnionitis unstimulated, Term E.coli, Term S.epi, Term unstimulated"	RNASeq (Illumina HiSeq 2000 RNASeq hg19 Transcript)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross	Monocyte CD14+ S. epidermidis 2h neonatal	myeloid	Monocyte	neonatal	monocyte	Macrophage
GSM2717692;6412	6412	DeJong	GSM2717692	Preterm Chorioamnionitis unstimulated	Homo sapiens	Preterm Chorioamnionitis unstimulated	CL:0000576		monocyte			DeJong	"Escherichia coli and Staphylococcus epidermidis are predominant causes of neonatal sepsis, particularly affecting preterm infants. Susceptibility to infection has been attributed to immature innate monocyte defences, but no studies have assessed global transcriptional responses of neonatal monocytes to these pathogens. Here, we aimed to identify and characterise the neonatal monocyte transcriptional responses to E. coli and S. epidermidis and the role of common modifiers such as gestational age (GA) and exposure to chorioamnionitis (a common complication of preterm birth) to better understand early life innate immune responses. RNA-sequencing was performed on purified cord blood monocytes from very preterm (< 32 weeks GA) and term infants (3740 weeks GA) following standardised challenge with live S. epidermidis or E. coli. The major transcriptional changes induced by either pathogen were highly conserved between infant groups and stimuli, highlighting a common extant neonatal monocyte response to infection, largely mediated by TLR/NF-B/TREM-1 signalling. In addition, we observed an activated interferon-centred immune response specific to stimulation with E. coli in both preterm and term infants. These data provide novel insights into the functionality of neonatal monocytes at birth and highlight potential pathways that could be targeted to reduce the harmful effects of bacterial-induced inflammation in sepsis. E. coli and S. epidermidis elicit common transcriptional changes in cord monocytes. The common transcriptional response is mediated by TLR/NF-B/TREM-1 signalling. IFN genes are differentially regulated by E. coli and S. epidermidis in monocytes. These responses are largely unaffected by GA or exposure to chorioamnionitis. Abstract from J Mol Med (Berl). 2018 Feb;96(2):147-157. doi: 10.1007/s00109-017-1609-2. [Curator's note: Please note that two separate Stemformatics datasets (6412, 6530) are associated with the relevant publication.]"	9	"Preterm E.coli, Preterm S.epi, Preterm unstimulated, Preterm Chorioamnionitis E.coli, Preterm Chorioamnionitis S.epi, Preterm Chorioamnionitis unstimulated, Term E.coli, Term S.epi, Term unstimulated"	RNASeq (Illumina HiSeq 2000 RNASeq hg19 Transcript)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross	Monocyte CD14+  neonatal	myeloid	Monocyte	neonatal	monocyte	Macrophage
GSM2849362;7323	7323	Reid	GSM2849362	"Human bone marrow, CD34 positive CD45 positive sorted population, biological rep1"	Homo sapiens	HPC	CL:0000837		hematopoietic multipotent progenitor		biotin	Reid	"Human pluripotent stem cells (hPSCs) generate hematopoietic progenitor cells (HPCs) but fail to engraft xenograft models used to detect adult/somatic hematopoietic stem cells (HSCs) from donors. Recent progress to derive hPSC-derived HSCs has relied on cell-autonomous forced expression of transcription factors; however, the relationship of bone marrow to transplanted cells remains unknown. Here, we quantified a failure of hPSC-HPCs to survive even 24 hr post transplantation. Across several hPSC-HPC differentiation methodologies, we identified the lack of CXCR4 expression and function. Ectopic CXCR4 conferred CXCL12 ligand-dependent signaling of hPSC-HPCs in biochemical assays and increased migration/chemotaxis, hematopoietic progenitor capacity, and survival and proliferation following in vivo transplantation. This was accompanied by a transcriptional shift of hPSC-HPCs toward somatic/adult sources, but this approach failed to produce long-term HSC xenograft reconstitution. Our results reveal that networks involving CXCR4 should be targeted to generate putative HSCs with in vivo function from hPSCs. Abstract from Stem Cell Reports. 2018 May 8;10(5):1625-1641. doi: 10.1016/j.stemcr.2018.04.003. [Curator's note: This is a subset of data from the original publication corresponding to samples run on the Affymetrix Human Gene 2.0 ST Array. The other part of the data is available from Dataset #7324 Reid_2018_29742393_b]"	10	"HPC, ESC-hemogenic endothelium, ESC-derived HPC CXCR4.GFP-, ESC-derived HPC CXCR4.GFP+"	Microarray (Affymetrix HuGene-2_0-ST V1)		Homo sapiens	2.68	HuGene	"rgb(0,109,219)"	diamond-open		hematopoietic multipotent progenitor	MHP	adult	hematopoietic multipotent progenitor	Progenitor
GSM2849363;7323	7323	Reid	GSM2849363	"Human umbilical cord blood, CD34 positive CD45 positive CD38 negative sorted population, biological rep1"	Homo sapiens	HPC	CL:0000837		hematopoietic multipotent progenitor		biotin	Reid	"Human pluripotent stem cells (hPSCs) generate hematopoietic progenitor cells (HPCs) but fail to engraft xenograft models used to detect adult/somatic hematopoietic stem cells (HSCs) from donors. Recent progress to derive hPSC-derived HSCs has relied on cell-autonomous forced expression of transcription factors; however, the relationship of bone marrow to transplanted cells remains unknown. Here, we quantified a failure of hPSC-HPCs to survive even 24 hr post transplantation. Across several hPSC-HPC differentiation methodologies, we identified the lack of CXCR4 expression and function. Ectopic CXCR4 conferred CXCL12 ligand-dependent signaling of hPSC-HPCs in biochemical assays and increased migration/chemotaxis, hematopoietic progenitor capacity, and survival and proliferation following in vivo transplantation. This was accompanied by a transcriptional shift of hPSC-HPCs toward somatic/adult sources, but this approach failed to produce long-term HSC xenograft reconstitution. Our results reveal that networks involving CXCR4 should be targeted to generate putative HSCs with in vivo function from hPSCs. Abstract from Stem Cell Reports. 2018 May 8;10(5):1625-1641. doi: 10.1016/j.stemcr.2018.04.003. [Curator's note: This is a subset of data from the original publication corresponding to samples run on the Affymetrix Human Gene 2.0 ST Array. The other part of the data is available from Dataset #7324 Reid_2018_29742393_b]"	10	"HPC, ESC-hemogenic endothelium, ESC-derived HPC CXCR4.GFP-, ESC-derived HPC CXCR4.GFP+"	Microarray (Affymetrix HuGene-2_0-ST V1)		Homo sapiens	2.68	HuGene	"rgb(0,109,219)"	diamond-open		hematopoietic multipotent progenitor	MHP	neonatal	hematopoietic multipotent progenitor	Progenitor
GSM2849364;7323	7323	Reid	GSM2849364	"Human umbilical cord blood, CD34 positive CD45 positive CD38 negative sorted population, biological rep2"	Homo sapiens	HPC	CL:0000837		hematopoietic multipotent progenitor		biotin	Reid	"Human pluripotent stem cells (hPSCs) generate hematopoietic progenitor cells (HPCs) but fail to engraft xenograft models used to detect adult/somatic hematopoietic stem cells (HSCs) from donors. Recent progress to derive hPSC-derived HSCs has relied on cell-autonomous forced expression of transcription factors; however, the relationship of bone marrow to transplanted cells remains unknown. Here, we quantified a failure of hPSC-HPCs to survive even 24 hr post transplantation. Across several hPSC-HPC differentiation methodologies, we identified the lack of CXCR4 expression and function. Ectopic CXCR4 conferred CXCL12 ligand-dependent signaling of hPSC-HPCs in biochemical assays and increased migration/chemotaxis, hematopoietic progenitor capacity, and survival and proliferation following in vivo transplantation. This was accompanied by a transcriptional shift of hPSC-HPCs toward somatic/adult sources, but this approach failed to produce long-term HSC xenograft reconstitution. Our results reveal that networks involving CXCR4 should be targeted to generate putative HSCs with in vivo function from hPSCs. Abstract from Stem Cell Reports. 2018 May 8;10(5):1625-1641. doi: 10.1016/j.stemcr.2018.04.003. [Curator's note: This is a subset of data from the original publication corresponding to samples run on the Affymetrix Human Gene 2.0 ST Array. The other part of the data is available from Dataset #7324 Reid_2018_29742393_b]"	10	"HPC, ESC-hemogenic endothelium, ESC-derived HPC CXCR4.GFP-, ESC-derived HPC CXCR4.GFP+"	Microarray (Affymetrix HuGene-2_0-ST V1)		Homo sapiens	2.68	HuGene	"rgb(0,109,219)"	diamond-open		hematopoietic multipotent progenitor	MHP	neonatal	hematopoietic multipotent progenitor	Progenitor
GSM2859412;7379	7379	Monaco	GSM2859412	DZQV_CD8_CM_rep4	Homo sapiens	central memory CD8 T cell	CL:0000907		central memory CD8 T cell	male		Monaco	"The molecular characterization of immune subsets is important for designing effective strategies to understand and treat diseases. We characterized 29 immune cell types within the peripheral blood mononuclear cell (PBMC) fraction of healthy donors using RNA-seq (RNA sequencing) and flow cytometry. Our dataset was used, first, to identify sets of genes that are specific, are co-expressed, and have housekeeping roles across the 29 cell types. Then, we examined differences in mRNA heterogeneity and mRNA abundance revealing cell type specificity. Last, we performed absolute deconvolution on a suitable set of immune cell types using transcriptomics signatures normalized by mRNA abundance. Absolute deconvolution is ready to use for PBMC transcriptomic data using our Shiny app (https://github.com/giannimonaco/ABIS). We benchmarked different deconvolution and normalization methods and validated the resources in independent cohorts. Our work has research, clinical, and diagnostic value by making it possible to effectively associate observations in bulk transcriptomics data to specific immune subsets. Abstract from Cell Rep. 2019 Feb 5;26(6):1627-1640.e7. doi: 10.1016/j.celrep.2019.01.041."	127	"PBMC, basophil, neutrophil, monocyte CD14+, CD14+ CD16+ monocyte, CD16+ monocyte, DC, pDC, NK, VD2- T-cell, VD2+ T-cell, MAIT, naive CD4 T cell, naive CD8 T cell, central memory CD8 T cell, effector memory CD8 T cell, Treg, CD4+ TE, terminal effector CD8 T cell, Th1, Th1/Th17, Th17, Th2, follicular helper T cell, Progenitor cells, SM-B cell, NS B-cell, naive B cell, plasmablast, exhausted B cell"	RNASeq (Illumina HiSeq 2000)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross		lymphoid	T Cell	adult	CD8+ T cell	Lymphocyte
GSM2859413;7379	7379	Monaco	GSM2859413	DZQV_CD8_EM_rep4	Homo sapiens	effector memory CD8 T cell	CL:0000913		effector memory CD8 T cell	female		Monaco	"The molecular characterization of immune subsets is important for designing effective strategies to understand and treat diseases. We characterized 29 immune cell types within the peripheral blood mononuclear cell (PBMC) fraction of healthy donors using RNA-seq (RNA sequencing) and flow cytometry. Our dataset was used, first, to identify sets of genes that are specific, are co-expressed, and have housekeeping roles across the 29 cell types. Then, we examined differences in mRNA heterogeneity and mRNA abundance revealing cell type specificity. Last, we performed absolute deconvolution on a suitable set of immune cell types using transcriptomics signatures normalized by mRNA abundance. Absolute deconvolution is ready to use for PBMC transcriptomic data using our Shiny app (https://github.com/giannimonaco/ABIS). We benchmarked different deconvolution and normalization methods and validated the resources in independent cohorts. Our work has research, clinical, and diagnostic value by making it possible to effectively associate observations in bulk transcriptomics data to specific immune subsets. Abstract from Cell Rep. 2019 Feb 5;26(6):1627-1640.e7. doi: 10.1016/j.celrep.2019.01.041."	127	"PBMC, basophil, neutrophil, monocyte CD14+, CD14+ CD16+ monocyte, CD16+ monocyte, DC, pDC, NK, VD2- T-cell, VD2+ T-cell, MAIT, naive CD4 T cell, naive CD8 T cell, central memory CD8 T cell, effector memory CD8 T cell, Treg, CD4+ TE, terminal effector CD8 T cell, Th1, Th1/Th17, Th17, Th2, follicular helper T cell, Progenitor cells, SM-B cell, NS B-cell, naive B cell, plasmablast, exhausted B cell"	RNASeq (Illumina HiSeq 2000)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross		lymphoid	T Cell	adult	CD8+ T cell	Lymphocyte
GSM2859414;7379	7379	Monaco	GSM2859414	DZQV_CD8_TE_rep4	Homo sapiens	terminal effector CD8 T cell	CL:0001062		terminal effector CD8 T cell	male		Monaco	"The molecular characterization of immune subsets is important for designing effective strategies to understand and treat diseases. We characterized 29 immune cell types within the peripheral blood mononuclear cell (PBMC) fraction of healthy donors using RNA-seq (RNA sequencing) and flow cytometry. Our dataset was used, first, to identify sets of genes that are specific, are co-expressed, and have housekeeping roles across the 29 cell types. Then, we examined differences in mRNA heterogeneity and mRNA abundance revealing cell type specificity. Last, we performed absolute deconvolution on a suitable set of immune cell types using transcriptomics signatures normalized by mRNA abundance. Absolute deconvolution is ready to use for PBMC transcriptomic data using our Shiny app (https://github.com/giannimonaco/ABIS). We benchmarked different deconvolution and normalization methods and validated the resources in independent cohorts. Our work has research, clinical, and diagnostic value by making it possible to effectively associate observations in bulk transcriptomics data to specific immune subsets. Abstract from Cell Rep. 2019 Feb 5;26(6):1627-1640.e7. doi: 10.1016/j.celrep.2019.01.041."	127	"PBMC, basophil, neutrophil, monocyte CD14+, CD14+ CD16+ monocyte, CD16+ monocyte, DC, pDC, NK, VD2- T-cell, VD2+ T-cell, MAIT, naive CD4 T cell, naive CD8 T cell, central memory CD8 T cell, effector memory CD8 T cell, Treg, CD4+ TE, terminal effector CD8 T cell, Th1, Th1/Th17, Th17, Th2, follicular helper T cell, Progenitor cells, SM-B cell, NS B-cell, naive B cell, plasmablast, exhausted B cell"	RNASeq (Illumina HiSeq 2000)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross		lymphoid	T Cell	adult	CD8+ T cell	Lymphocyte
GSM2859424;7379	7379	Monaco	GSM2859424	DZQV_CD4_naive_rep4	Homo sapiens	naive CD4 T cell	T cell		T cell	female		Monaco	"The molecular characterization of immune subsets is important for designing effective strategies to understand and treat diseases. We characterized 29 immune cell types within the peripheral blood mononuclear cell (PBMC) fraction of healthy donors using RNA-seq (RNA sequencing) and flow cytometry. Our dataset was used, first, to identify sets of genes that are specific, are co-expressed, and have housekeeping roles across the 29 cell types. Then, we examined differences in mRNA heterogeneity and mRNA abundance revealing cell type specificity. Last, we performed absolute deconvolution on a suitable set of immune cell types using transcriptomics signatures normalized by mRNA abundance. Absolute deconvolution is ready to use for PBMC transcriptomic data using our Shiny app (https://github.com/giannimonaco/ABIS). We benchmarked different deconvolution and normalization methods and validated the resources in independent cohorts. Our work has research, clinical, and diagnostic value by making it possible to effectively associate observations in bulk transcriptomics data to specific immune subsets. Abstract from Cell Rep. 2019 Feb 5;26(6):1627-1640.e7. doi: 10.1016/j.celrep.2019.01.041."	127	"PBMC, basophil, neutrophil, monocyte CD14+, CD14+ CD16+ monocyte, CD16+ monocyte, DC, pDC, NK, VD2- T-cell, VD2+ T-cell, MAIT, naive CD4 T cell, naive CD8 T cell, central memory CD8 T cell, effector memory CD8 T cell, Treg, CD4+ TE, terminal effector CD8 T cell, Th1, Th1/Th17, Th17, Th2, follicular helper T cell, Progenitor cells, SM-B cell, NS B-cell, naive B cell, plasmablast, exhausted B cell"	RNASeq (Illumina HiSeq 2000)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross		lymphoid	T Cell	adult	CD4+ T cell	Lymphocyte
GSM2859425;7379	7379	Monaco	GSM2859425	DZQV_Progenitor_rep4	Homo sapiens	Progenitor cells	B cell		B cell	female		Monaco	"The molecular characterization of immune subsets is important for designing effective strategies to understand and treat diseases. We characterized 29 immune cell types within the peripheral blood mononuclear cell (PBMC) fraction of healthy donors using RNA-seq (RNA sequencing) and flow cytometry. Our dataset was used, first, to identify sets of genes that are specific, are co-expressed, and have housekeeping roles across the 29 cell types. Then, we examined differences in mRNA heterogeneity and mRNA abundance revealing cell type specificity. Last, we performed absolute deconvolution on a suitable set of immune cell types using transcriptomics signatures normalized by mRNA abundance. Absolute deconvolution is ready to use for PBMC transcriptomic data using our Shiny app (https://github.com/giannimonaco/ABIS). We benchmarked different deconvolution and normalization methods and validated the resources in independent cohorts. Our work has research, clinical, and diagnostic value by making it possible to effectively associate observations in bulk transcriptomics data to specific immune subsets. Abstract from Cell Rep. 2019 Feb 5;26(6):1627-1640.e7. doi: 10.1016/j.celrep.2019.01.041."	127	"PBMC, basophil, neutrophil, monocyte CD14+, CD14+ CD16+ monocyte, CD16+ monocyte, DC, pDC, NK, VD2- T-cell, VD2+ T-cell, MAIT, naive CD4 T cell, naive CD8 T cell, central memory CD8 T cell, effector memory CD8 T cell, Treg, CD4+ TE, terminal effector CD8 T cell, Th1, Th1/Th17, Th17, Th2, follicular helper T cell, Progenitor cells, SM-B cell, NS B-cell, naive B cell, plasmablast, exhausted B cell"	RNASeq (Illumina HiSeq 2000)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross		lymphoid progenitor	B Cell	adult	pro-B cell	Progenitor
GSM2859426;7379	7379	Monaco	GSM2859426	DZQV_B_naive_rep4	Homo sapiens	naive B cell	B cell		naive B cell	male		Monaco	"The molecular characterization of immune subsets is important for designing effective strategies to understand and treat diseases. We characterized 29 immune cell types within the peripheral blood mononuclear cell (PBMC) fraction of healthy donors using RNA-seq (RNA sequencing) and flow cytometry. Our dataset was used, first, to identify sets of genes that are specific, are co-expressed, and have housekeeping roles across the 29 cell types. Then, we examined differences in mRNA heterogeneity and mRNA abundance revealing cell type specificity. Last, we performed absolute deconvolution on a suitable set of immune cell types using transcriptomics signatures normalized by mRNA abundance. Absolute deconvolution is ready to use for PBMC transcriptomic data using our Shiny app (https://github.com/giannimonaco/ABIS). We benchmarked different deconvolution and normalization methods and validated the resources in independent cohorts. Our work has research, clinical, and diagnostic value by making it possible to effectively associate observations in bulk transcriptomics data to specific immune subsets. Abstract from Cell Rep. 2019 Feb 5;26(6):1627-1640.e7. doi: 10.1016/j.celrep.2019.01.041."	127	"PBMC, basophil, neutrophil, monocyte CD14+, CD14+ CD16+ monocyte, CD16+ monocyte, DC, pDC, NK, VD2- T-cell, VD2+ T-cell, MAIT, naive CD4 T cell, naive CD8 T cell, central memory CD8 T cell, effector memory CD8 T cell, Treg, CD4+ TE, terminal effector CD8 T cell, Th1, Th1/Th17, Th17, Th2, follicular helper T cell, Progenitor cells, SM-B cell, NS B-cell, naive B cell, plasmablast, exhausted B cell"	RNASeq (Illumina HiSeq 2000)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross		lymphoid	B Cell	adult	B cell	Lymphocyte
GSM2859427;7379	7379	Monaco	GSM2859427	DZQV_B_NSM_rep4	Homo sapiens	NS B-cell	B cell		B cell	male		Monaco	"The molecular characterization of immune subsets is important for designing effective strategies to understand and treat diseases. We characterized 29 immune cell types within the peripheral blood mononuclear cell (PBMC) fraction of healthy donors using RNA-seq (RNA sequencing) and flow cytometry. Our dataset was used, first, to identify sets of genes that are specific, are co-expressed, and have housekeeping roles across the 29 cell types. Then, we examined differences in mRNA heterogeneity and mRNA abundance revealing cell type specificity. Last, we performed absolute deconvolution on a suitable set of immune cell types using transcriptomics signatures normalized by mRNA abundance. Absolute deconvolution is ready to use for PBMC transcriptomic data using our Shiny app (https://github.com/giannimonaco/ABIS). We benchmarked different deconvolution and normalization methods and validated the resources in independent cohorts. Our work has research, clinical, and diagnostic value by making it possible to effectively associate observations in bulk transcriptomics data to specific immune subsets. Abstract from Cell Rep. 2019 Feb 5;26(6):1627-1640.e7. doi: 10.1016/j.celrep.2019.01.041."	127	"PBMC, basophil, neutrophil, monocyte CD14+, CD14+ CD16+ monocyte, CD16+ monocyte, DC, pDC, NK, VD2- T-cell, VD2+ T-cell, MAIT, naive CD4 T cell, naive CD8 T cell, central memory CD8 T cell, effector memory CD8 T cell, Treg, CD4+ TE, terminal effector CD8 T cell, Th1, Th1/Th17, Th17, Th2, follicular helper T cell, Progenitor cells, SM-B cell, NS B-cell, naive B cell, plasmablast, exhausted B cell"	RNASeq (Illumina HiSeq 2000)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross		lymphoid	T Cell	adult	B cell	Lymphocyte
GSM2859428;7379	7379	Monaco	GSM2859428	DZQV_B_Ex_rep4	Homo sapiens	exhausted B cell	B cell		B cell	male		Monaco	"The molecular characterization of immune subsets is important for designing effective strategies to understand and treat diseases. We characterized 29 immune cell types within the peripheral blood mononuclear cell (PBMC) fraction of healthy donors using RNA-seq (RNA sequencing) and flow cytometry. Our dataset was used, first, to identify sets of genes that are specific, are co-expressed, and have housekeeping roles across the 29 cell types. Then, we examined differences in mRNA heterogeneity and mRNA abundance revealing cell type specificity. Last, we performed absolute deconvolution on a suitable set of immune cell types using transcriptomics signatures normalized by mRNA abundance. Absolute deconvolution is ready to use for PBMC transcriptomic data using our Shiny app (https://github.com/giannimonaco/ABIS). We benchmarked different deconvolution and normalization methods and validated the resources in independent cohorts. Our work has research, clinical, and diagnostic value by making it possible to effectively associate observations in bulk transcriptomics data to specific immune subsets. Abstract from Cell Rep. 2019 Feb 5;26(6):1627-1640.e7. doi: 10.1016/j.celrep.2019.01.041."	127	"PBMC, basophil, neutrophil, monocyte CD14+, CD14+ CD16+ monocyte, CD16+ monocyte, DC, pDC, NK, VD2- T-cell, VD2+ T-cell, MAIT, naive CD4 T cell, naive CD8 T cell, central memory CD8 T cell, effector memory CD8 T cell, Treg, CD4+ TE, terminal effector CD8 T cell, Th1, Th1/Th17, Th17, Th2, follicular helper T cell, Progenitor cells, SM-B cell, NS B-cell, naive B cell, plasmablast, exhausted B cell"	RNASeq (Illumina HiSeq 2000)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross		lymphoid	T Cell	adult	B cell	Lymphocyte
GSM2859429;7379	7379	Monaco	GSM2859429	DZQV_B_SM_rep4	Homo sapiens	SM-B cell	B cell		B cell	female		Monaco	"The molecular characterization of immune subsets is important for designing effective strategies to understand and treat diseases. We characterized 29 immune cell types within the peripheral blood mononuclear cell (PBMC) fraction of healthy donors using RNA-seq (RNA sequencing) and flow cytometry. Our dataset was used, first, to identify sets of genes that are specific, are co-expressed, and have housekeeping roles across the 29 cell types. Then, we examined differences in mRNA heterogeneity and mRNA abundance revealing cell type specificity. Last, we performed absolute deconvolution on a suitable set of immune cell types using transcriptomics signatures normalized by mRNA abundance. Absolute deconvolution is ready to use for PBMC transcriptomic data using our Shiny app (https://github.com/giannimonaco/ABIS). We benchmarked different deconvolution and normalization methods and validated the resources in independent cohorts. Our work has research, clinical, and diagnostic value by making it possible to effectively associate observations in bulk transcriptomics data to specific immune subsets. Abstract from Cell Rep. 2019 Feb 5;26(6):1627-1640.e7. doi: 10.1016/j.celrep.2019.01.041."	127	"PBMC, basophil, neutrophil, monocyte CD14+, CD14+ CD16+ monocyte, CD16+ monocyte, DC, pDC, NK, VD2- T-cell, VD2+ T-cell, MAIT, naive CD4 T cell, naive CD8 T cell, central memory CD8 T cell, effector memory CD8 T cell, Treg, CD4+ TE, terminal effector CD8 T cell, Th1, Th1/Th17, Th17, Th2, follicular helper T cell, Progenitor cells, SM-B cell, NS B-cell, naive B cell, plasmablast, exhausted B cell"	RNASeq (Illumina HiSeq 2000)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross		lymphoid	T Cell	adult	B cell	Lymphocyte
GSM2859434;7379	7379	Monaco	GSM2859434	DZQV_NK_rep4	Homo sapiens	NK	NK		natural killer cell	male		Monaco	"The molecular characterization of immune subsets is important for designing effective strategies to understand and treat diseases. We characterized 29 immune cell types within the peripheral blood mononuclear cell (PBMC) fraction of healthy donors using RNA-seq (RNA sequencing) and flow cytometry. Our dataset was used, first, to identify sets of genes that are specific, are co-expressed, and have housekeeping roles across the 29 cell types. Then, we examined differences in mRNA heterogeneity and mRNA abundance revealing cell type specificity. Last, we performed absolute deconvolution on a suitable set of immune cell types using transcriptomics signatures normalized by mRNA abundance. Absolute deconvolution is ready to use for PBMC transcriptomic data using our Shiny app (https://github.com/giannimonaco/ABIS). We benchmarked different deconvolution and normalization methods and validated the resources in independent cohorts. Our work has research, clinical, and diagnostic value by making it possible to effectively associate observations in bulk transcriptomics data to specific immune subsets. Abstract from Cell Rep. 2019 Feb 5;26(6):1627-1640.e7. doi: 10.1016/j.celrep.2019.01.041."	127	"PBMC, basophil, neutrophil, monocyte CD14+, CD14+ CD16+ monocyte, CD16+ monocyte, DC, pDC, NK, VD2- T-cell, VD2+ T-cell, MAIT, naive CD4 T cell, naive CD8 T cell, central memory CD8 T cell, effector memory CD8 T cell, Treg, CD4+ TE, terminal effector CD8 T cell, Th1, Th1/Th17, Th17, Th2, follicular helper T cell, Progenitor cells, SM-B cell, NS B-cell, naive B cell, plasmablast, exhausted B cell"	RNASeq (Illumina HiSeq 2000)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross		lymphoid	NK	adult	natural killer cell	Lymphocyte
GSM2859435;7379	7379	Monaco	GSM2859435	DZQV_pDC_rep4	Homo sapiens	pDC	pDC		plasmacytoid dendritic cell	female		Monaco	"The molecular characterization of immune subsets is important for designing effective strategies to understand and treat diseases. We characterized 29 immune cell types within the peripheral blood mononuclear cell (PBMC) fraction of healthy donors using RNA-seq (RNA sequencing) and flow cytometry. Our dataset was used, first, to identify sets of genes that are specific, are co-expressed, and have housekeeping roles across the 29 cell types. Then, we examined differences in mRNA heterogeneity and mRNA abundance revealing cell type specificity. Last, we performed absolute deconvolution on a suitable set of immune cell types using transcriptomics signatures normalized by mRNA abundance. Absolute deconvolution is ready to use for PBMC transcriptomic data using our Shiny app (https://github.com/giannimonaco/ABIS). We benchmarked different deconvolution and normalization methods and validated the resources in independent cohorts. Our work has research, clinical, and diagnostic value by making it possible to effectively associate observations in bulk transcriptomics data to specific immune subsets. Abstract from Cell Rep. 2019 Feb 5;26(6):1627-1640.e7. doi: 10.1016/j.celrep.2019.01.041."	127	"PBMC, basophil, neutrophil, monocyte CD14+, CD14+ CD16+ monocyte, CD16+ monocyte, DC, pDC, NK, VD2- T-cell, VD2+ T-cell, MAIT, naive CD4 T cell, naive CD8 T cell, central memory CD8 T cell, effector memory CD8 T cell, Treg, CD4+ TE, terminal effector CD8 T cell, Th1, Th1/Th17, Th17, Th2, follicular helper T cell, Progenitor cells, SM-B cell, NS B-cell, naive B cell, plasmablast, exhausted B cell"	RNASeq (Illumina HiSeq 2000)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross		myeloid	p-DC	adult	plasmacytoid dendritic cell	Mixed
GSM2859439;7379	7379	Monaco	GSM2859439	925L_CD8_naive_rep2	Homo sapiens	naive CD8 T cell	T cell		naive CD8 T cell	male		Monaco	"The molecular characterization of immune subsets is important for designing effective strategies to understand and treat diseases. We characterized 29 immune cell types within the peripheral blood mononuclear cell (PBMC) fraction of healthy donors using RNA-seq (RNA sequencing) and flow cytometry. Our dataset was used, first, to identify sets of genes that are specific, are co-expressed, and have housekeeping roles across the 29 cell types. Then, we examined differences in mRNA heterogeneity and mRNA abundance revealing cell type specificity. Last, we performed absolute deconvolution on a suitable set of immune cell types using transcriptomics signatures normalized by mRNA abundance. Absolute deconvolution is ready to use for PBMC transcriptomic data using our Shiny app (https://github.com/giannimonaco/ABIS). We benchmarked different deconvolution and normalization methods and validated the resources in independent cohorts. Our work has research, clinical, and diagnostic value by making it possible to effectively associate observations in bulk transcriptomics data to specific immune subsets. Abstract from Cell Rep. 2019 Feb 5;26(6):1627-1640.e7. doi: 10.1016/j.celrep.2019.01.041."	127	"PBMC, basophil, neutrophil, monocyte CD14+, CD14+ CD16+ monocyte, CD16+ monocyte, DC, pDC, NK, VD2- T-cell, VD2+ T-cell, MAIT, naive CD4 T cell, naive CD8 T cell, central memory CD8 T cell, effector memory CD8 T cell, Treg, CD4+ TE, terminal effector CD8 T cell, Th1, Th1/Th17, Th17, Th2, follicular helper T cell, Progenitor cells, SM-B cell, NS B-cell, naive B cell, plasmablast, exhausted B cell"	RNASeq (Illumina HiSeq 2000)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross		lymphoid	T Cell	adult	CD8+ T cell	Lymphocyte
GSM2859440;7379	7379	Monaco	GSM2859440	925L_CD8_CM_rep2	Homo sapiens	CM T cell	T cell		central memory T cell	female		Monaco	"The molecular characterization of immune subsets is important for designing effective strategies to understand and treat diseases. We characterized 29 immune cell types within the peripheral blood mononuclear cell (PBMC) fraction of healthy donors using RNA-seq (RNA sequencing) and flow cytometry. Our dataset was used, first, to identify sets of genes that are specific, are co-expressed, and have housekeeping roles across the 29 cell types. Then, we examined differences in mRNA heterogeneity and mRNA abundance revealing cell type specificity. Last, we performed absolute deconvolution on a suitable set of immune cell types using transcriptomics signatures normalized by mRNA abundance. Absolute deconvolution is ready to use for PBMC transcriptomic data using our Shiny app (https://github.com/giannimonaco/ABIS). We benchmarked different deconvolution and normalization methods and validated the resources in independent cohorts. Our work has research, clinical, and diagnostic value by making it possible to effectively associate observations in bulk transcriptomics data to specific immune subsets. Abstract from Cell Rep. 2019 Feb 5;26(6):1627-1640.e7. doi: 10.1016/j.celrep.2019.01.041."	127	"PBMC, basophil, neutrophil, monocyte CD14+, CD14+ CD16+ monocyte, CD16+ monocyte, DC, pDC, NK, VD2- T-cell, VD2+ T-cell, MAIT, naive CD4 T cell, naive CD8 T cell, central memory CD8 T cell, effector memory CD8 T cell, Treg, CD4+ TE, terminal effector CD8 T cell, Th1, Th1/Th17, Th17, Th2, follicular helper T cell, Progenitor cells, SM-B cell, NS B-cell, naive B cell, plasmablast, exhausted B cell"	RNASeq (Illumina HiSeq 2000)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross		lymphoid	T Cell	adult	CD8+ T cell	Lymphocyte
GSM2859441;7379	7379	Monaco	GSM2859441	925L_CD8_EM_rep2	Homo sapiens	EMT cell	T cell		effector memory T cell	female		Monaco	"The molecular characterization of immune subsets is important for designing effective strategies to understand and treat diseases. We characterized 29 immune cell types within the peripheral blood mononuclear cell (PBMC) fraction of healthy donors using RNA-seq (RNA sequencing) and flow cytometry. Our dataset was used, first, to identify sets of genes that are specific, are co-expressed, and have housekeeping roles across the 29 cell types. Then, we examined differences in mRNA heterogeneity and mRNA abundance revealing cell type specificity. Last, we performed absolute deconvolution on a suitable set of immune cell types using transcriptomics signatures normalized by mRNA abundance. Absolute deconvolution is ready to use for PBMC transcriptomic data using our Shiny app (https://github.com/giannimonaco/ABIS). We benchmarked different deconvolution and normalization methods and validated the resources in independent cohorts. Our work has research, clinical, and diagnostic value by making it possible to effectively associate observations in bulk transcriptomics data to specific immune subsets. Abstract from Cell Rep. 2019 Feb 5;26(6):1627-1640.e7. doi: 10.1016/j.celrep.2019.01.041."	127	"PBMC, basophil, neutrophil, monocyte CD14+, CD14+ CD16+ monocyte, CD16+ monocyte, DC, pDC, NK, VD2- T-cell, VD2+ T-cell, MAIT, naive CD4 T cell, naive CD8 T cell, central memory CD8 T cell, effector memory CD8 T cell, Treg, CD4+ TE, terminal effector CD8 T cell, Th1, Th1/Th17, Th17, Th2, follicular helper T cell, Progenitor cells, SM-B cell, NS B-cell, naive B cell, plasmablast, exhausted B cell"	RNASeq (Illumina HiSeq 2000)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross		lymphoid	T Cell	adult	CD8+ T cell	Lymphocyte
GSM2859442;7379	7379	Monaco	GSM2859442	925L_CD8_TE_rep2	Homo sapiens	CD8+ TE	T cell		T cell	female		Monaco	"The molecular characterization of immune subsets is important for designing effective strategies to understand and treat diseases. We characterized 29 immune cell types within the peripheral blood mononuclear cell (PBMC) fraction of healthy donors using RNA-seq (RNA sequencing) and flow cytometry. Our dataset was used, first, to identify sets of genes that are specific, are co-expressed, and have housekeeping roles across the 29 cell types. Then, we examined differences in mRNA heterogeneity and mRNA abundance revealing cell type specificity. Last, we performed absolute deconvolution on a suitable set of immune cell types using transcriptomics signatures normalized by mRNA abundance. Absolute deconvolution is ready to use for PBMC transcriptomic data using our Shiny app (https://github.com/giannimonaco/ABIS). We benchmarked different deconvolution and normalization methods and validated the resources in independent cohorts. Our work has research, clinical, and diagnostic value by making it possible to effectively associate observations in bulk transcriptomics data to specific immune subsets. Abstract from Cell Rep. 2019 Feb 5;26(6):1627-1640.e7. doi: 10.1016/j.celrep.2019.01.041."	127	"PBMC, basophil, neutrophil, monocyte CD14+, CD14+ CD16+ monocyte, CD16+ monocyte, DC, pDC, NK, VD2- T-cell, VD2+ T-cell, MAIT, naive CD4 T cell, naive CD8 T cell, central memory CD8 T cell, effector memory CD8 T cell, Treg, CD4+ TE, terminal effector CD8 T cell, Th1, Th1/Th17, Th17, Th2, follicular helper T cell, Progenitor cells, SM-B cell, NS B-cell, naive B cell, plasmablast, exhausted B cell"	RNASeq (Illumina HiSeq 2000)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross		lymphoid	T Cell	adult	CD8+ T cell	Lymphocyte
GSM2859452;7379	7379	Monaco	GSM2859452	925L_CD4_naive_rep2	Homo sapiens	naive CD4 T cell	T cell		T cell	female		Monaco	"The molecular characterization of immune subsets is important for designing effective strategies to understand and treat diseases. We characterized 29 immune cell types within the peripheral blood mononuclear cell (PBMC) fraction of healthy donors using RNA-seq (RNA sequencing) and flow cytometry. Our dataset was used, first, to identify sets of genes that are specific, are co-expressed, and have housekeeping roles across the 29 cell types. Then, we examined differences in mRNA heterogeneity and mRNA abundance revealing cell type specificity. Last, we performed absolute deconvolution on a suitable set of immune cell types using transcriptomics signatures normalized by mRNA abundance. Absolute deconvolution is ready to use for PBMC transcriptomic data using our Shiny app (https://github.com/giannimonaco/ABIS). We benchmarked different deconvolution and normalization methods and validated the resources in independent cohorts. Our work has research, clinical, and diagnostic value by making it possible to effectively associate observations in bulk transcriptomics data to specific immune subsets. Abstract from Cell Rep. 2019 Feb 5;26(6):1627-1640.e7. doi: 10.1016/j.celrep.2019.01.041."	127	"PBMC, basophil, neutrophil, monocyte CD14+, CD14+ CD16+ monocyte, CD16+ monocyte, DC, pDC, NK, VD2- T-cell, VD2+ T-cell, MAIT, naive CD4 T cell, naive CD8 T cell, central memory CD8 T cell, effector memory CD8 T cell, Treg, CD4+ TE, terminal effector CD8 T cell, Th1, Th1/Th17, Th17, Th2, follicular helper T cell, Progenitor cells, SM-B cell, NS B-cell, naive B cell, plasmablast, exhausted B cell"	RNASeq (Illumina HiSeq 2000)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross		lymphoid	T Cell	adult	CD4+ T cell	Lymphocyte
GSM2859453;7379	7379	Monaco	GSM2859453	925L_CD4_TE_rep2	Homo sapiens	CD4+ TE	T cell		T cell	male		Monaco	"The molecular characterization of immune subsets is important for designing effective strategies to understand and treat diseases. We characterized 29 immune cell types within the peripheral blood mononuclear cell (PBMC) fraction of healthy donors using RNA-seq (RNA sequencing) and flow cytometry. Our dataset was used, first, to identify sets of genes that are specific, are co-expressed, and have housekeeping roles across the 29 cell types. Then, we examined differences in mRNA heterogeneity and mRNA abundance revealing cell type specificity. Last, we performed absolute deconvolution on a suitable set of immune cell types using transcriptomics signatures normalized by mRNA abundance. Absolute deconvolution is ready to use for PBMC transcriptomic data using our Shiny app (https://github.com/giannimonaco/ABIS). We benchmarked different deconvolution and normalization methods and validated the resources in independent cohorts. Our work has research, clinical, and diagnostic value by making it possible to effectively associate observations in bulk transcriptomics data to specific immune subsets. Abstract from Cell Rep. 2019 Feb 5;26(6):1627-1640.e7. doi: 10.1016/j.celrep.2019.01.041."	127	"PBMC, basophil, neutrophil, monocyte CD14+, CD14+ CD16+ monocyte, CD16+ monocyte, DC, pDC, NK, VD2- T-cell, VD2+ T-cell, MAIT, naive CD4 T cell, naive CD8 T cell, central memory CD8 T cell, effector memory CD8 T cell, Treg, CD4+ TE, terminal effector CD8 T cell, Th1, Th1/Th17, Th17, Th2, follicular helper T cell, Progenitor cells, SM-B cell, NS B-cell, naive B cell, plasmablast, exhausted B cell"	RNASeq (Illumina HiSeq 2000)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross		lymphoid	T Cell	adult	CD4+ T cell	Lymphocyte
GSM2859454;7379	7379	Monaco	GSM2859454	925L_Progenitor_rep2	Homo sapiens	Progenitor cells	B cell		B cell	male		Monaco	"The molecular characterization of immune subsets is important for designing effective strategies to understand and treat diseases. We characterized 29 immune cell types within the peripheral blood mononuclear cell (PBMC) fraction of healthy donors using RNA-seq (RNA sequencing) and flow cytometry. Our dataset was used, first, to identify sets of genes that are specific, are co-expressed, and have housekeeping roles across the 29 cell types. Then, we examined differences in mRNA heterogeneity and mRNA abundance revealing cell type specificity. Last, we performed absolute deconvolution on a suitable set of immune cell types using transcriptomics signatures normalized by mRNA abundance. Absolute deconvolution is ready to use for PBMC transcriptomic data using our Shiny app (https://github.com/giannimonaco/ABIS). We benchmarked different deconvolution and normalization methods and validated the resources in independent cohorts. Our work has research, clinical, and diagnostic value by making it possible to effectively associate observations in bulk transcriptomics data to specific immune subsets. Abstract from Cell Rep. 2019 Feb 5;26(6):1627-1640.e7. doi: 10.1016/j.celrep.2019.01.041."	127	"PBMC, basophil, neutrophil, monocyte CD14+, CD14+ CD16+ monocyte, CD16+ monocyte, DC, pDC, NK, VD2- T-cell, VD2+ T-cell, MAIT, naive CD4 T cell, naive CD8 T cell, central memory CD8 T cell, effector memory CD8 T cell, Treg, CD4+ TE, terminal effector CD8 T cell, Th1, Th1/Th17, Th17, Th2, follicular helper T cell, Progenitor cells, SM-B cell, NS B-cell, naive B cell, plasmablast, exhausted B cell"	RNASeq (Illumina HiSeq 2000)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross		lymphoid progenitor	B Cell	adult	pro-B cell	Progenitor
GSM2859455;7379	7379	Monaco	GSM2859455	925L_B_naive_rep2	Homo sapiens	naive B cell	B cell		naive B cell	male		Monaco	"The molecular characterization of immune subsets is important for designing effective strategies to understand and treat diseases. We characterized 29 immune cell types within the peripheral blood mononuclear cell (PBMC) fraction of healthy donors using RNA-seq (RNA sequencing) and flow cytometry. Our dataset was used, first, to identify sets of genes that are specific, are co-expressed, and have housekeeping roles across the 29 cell types. Then, we examined differences in mRNA heterogeneity and mRNA abundance revealing cell type specificity. Last, we performed absolute deconvolution on a suitable set of immune cell types using transcriptomics signatures normalized by mRNA abundance. Absolute deconvolution is ready to use for PBMC transcriptomic data using our Shiny app (https://github.com/giannimonaco/ABIS). We benchmarked different deconvolution and normalization methods and validated the resources in independent cohorts. Our work has research, clinical, and diagnostic value by making it possible to effectively associate observations in bulk transcriptomics data to specific immune subsets. Abstract from Cell Rep. 2019 Feb 5;26(6):1627-1640.e7. doi: 10.1016/j.celrep.2019.01.041."	127	"PBMC, basophil, neutrophil, monocyte CD14+, CD14+ CD16+ monocyte, CD16+ monocyte, DC, pDC, NK, VD2- T-cell, VD2+ T-cell, MAIT, naive CD4 T cell, naive CD8 T cell, central memory CD8 T cell, effector memory CD8 T cell, Treg, CD4+ TE, terminal effector CD8 T cell, Th1, Th1/Th17, Th17, Th2, follicular helper T cell, Progenitor cells, SM-B cell, NS B-cell, naive B cell, plasmablast, exhausted B cell"	RNASeq (Illumina HiSeq 2000)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross		lymphoid	B Cell	adult	B cell	Lymphocyte
GSM2859456;7379	7379	Monaco	GSM2859456	925L_B_NSM_rep2	Homo sapiens	NS B-cell	B cell		B cell	male		Monaco	"The molecular characterization of immune subsets is important for designing effective strategies to understand and treat diseases. We characterized 29 immune cell types within the peripheral blood mononuclear cell (PBMC) fraction of healthy donors using RNA-seq (RNA sequencing) and flow cytometry. Our dataset was used, first, to identify sets of genes that are specific, are co-expressed, and have housekeeping roles across the 29 cell types. Then, we examined differences in mRNA heterogeneity and mRNA abundance revealing cell type specificity. Last, we performed absolute deconvolution on a suitable set of immune cell types using transcriptomics signatures normalized by mRNA abundance. Absolute deconvolution is ready to use for PBMC transcriptomic data using our Shiny app (https://github.com/giannimonaco/ABIS). We benchmarked different deconvolution and normalization methods and validated the resources in independent cohorts. Our work has research, clinical, and diagnostic value by making it possible to effectively associate observations in bulk transcriptomics data to specific immune subsets. Abstract from Cell Rep. 2019 Feb 5;26(6):1627-1640.e7. doi: 10.1016/j.celrep.2019.01.041."	127	"PBMC, basophil, neutrophil, monocyte CD14+, CD14+ CD16+ monocyte, CD16+ monocyte, DC, pDC, NK, VD2- T-cell, VD2+ T-cell, MAIT, naive CD4 T cell, naive CD8 T cell, central memory CD8 T cell, effector memory CD8 T cell, Treg, CD4+ TE, terminal effector CD8 T cell, Th1, Th1/Th17, Th17, Th2, follicular helper T cell, Progenitor cells, SM-B cell, NS B-cell, naive B cell, plasmablast, exhausted B cell"	RNASeq (Illumina HiSeq 2000)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross		lymphoid	B Cell	adult	B cell	Lymphocyte
GSM2859457;7379	7379	Monaco	GSM2859457	925L_B_Ex_rep2	Homo sapiens	exhausted B cell	B cell		B cell	female		Monaco	"The molecular characterization of immune subsets is important for designing effective strategies to understand and treat diseases. We characterized 29 immune cell types within the peripheral blood mononuclear cell (PBMC) fraction of healthy donors using RNA-seq (RNA sequencing) and flow cytometry. Our dataset was used, first, to identify sets of genes that are specific, are co-expressed, and have housekeeping roles across the 29 cell types. Then, we examined differences in mRNA heterogeneity and mRNA abundance revealing cell type specificity. Last, we performed absolute deconvolution on a suitable set of immune cell types using transcriptomics signatures normalized by mRNA abundance. Absolute deconvolution is ready to use for PBMC transcriptomic data using our Shiny app (https://github.com/giannimonaco/ABIS). We benchmarked different deconvolution and normalization methods and validated the resources in independent cohorts. Our work has research, clinical, and diagnostic value by making it possible to effectively associate observations in bulk transcriptomics data to specific immune subsets. Abstract from Cell Rep. 2019 Feb 5;26(6):1627-1640.e7. doi: 10.1016/j.celrep.2019.01.041."	127	"PBMC, basophil, neutrophil, monocyte CD14+, CD14+ CD16+ monocyte, CD16+ monocyte, DC, pDC, NK, VD2- T-cell, VD2+ T-cell, MAIT, naive CD4 T cell, naive CD8 T cell, central memory CD8 T cell, effector memory CD8 T cell, Treg, CD4+ TE, terminal effector CD8 T cell, Th1, Th1/Th17, Th17, Th2, follicular helper T cell, Progenitor cells, SM-B cell, NS B-cell, naive B cell, plasmablast, exhausted B cell"	RNASeq (Illumina HiSeq 2000)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross		lymphoid	B Cell	adult	B cell	Lymphocyte
GSM2859458;7379	7379	Monaco	GSM2859458	925L_B_SM_rep2	Homo sapiens	SM-B cell	B cell		B cell	female		Monaco	"The molecular characterization of immune subsets is important for designing effective strategies to understand and treat diseases. We characterized 29 immune cell types within the peripheral blood mononuclear cell (PBMC) fraction of healthy donors using RNA-seq (RNA sequencing) and flow cytometry. Our dataset was used, first, to identify sets of genes that are specific, are co-expressed, and have housekeeping roles across the 29 cell types. Then, we examined differences in mRNA heterogeneity and mRNA abundance revealing cell type specificity. Last, we performed absolute deconvolution on a suitable set of immune cell types using transcriptomics signatures normalized by mRNA abundance. Absolute deconvolution is ready to use for PBMC transcriptomic data using our Shiny app (https://github.com/giannimonaco/ABIS). We benchmarked different deconvolution and normalization methods and validated the resources in independent cohorts. Our work has research, clinical, and diagnostic value by making it possible to effectively associate observations in bulk transcriptomics data to specific immune subsets. Abstract from Cell Rep. 2019 Feb 5;26(6):1627-1640.e7. doi: 10.1016/j.celrep.2019.01.041."	127	"PBMC, basophil, neutrophil, monocyte CD14+, CD14+ CD16+ monocyte, CD16+ monocyte, DC, pDC, NK, VD2- T-cell, VD2+ T-cell, MAIT, naive CD4 T cell, naive CD8 T cell, central memory CD8 T cell, effector memory CD8 T cell, Treg, CD4+ TE, terminal effector CD8 T cell, Th1, Th1/Th17, Th17, Th2, follicular helper T cell, Progenitor cells, SM-B cell, NS B-cell, naive B cell, plasmablast, exhausted B cell"	RNASeq (Illumina HiSeq 2000)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross		lymphoid	B Cell	adult	B cell	Lymphocyte
GSM2859463;7379	7379	Monaco	GSM2859463	925L_NK_rep2	Homo sapiens	NK	NK		natural killer cell	female		Monaco	"The molecular characterization of immune subsets is important for designing effective strategies to understand and treat diseases. We characterized 29 immune cell types within the peripheral blood mononuclear cell (PBMC) fraction of healthy donors using RNA-seq (RNA sequencing) and flow cytometry. Our dataset was used, first, to identify sets of genes that are specific, are co-expressed, and have housekeeping roles across the 29 cell types. Then, we examined differences in mRNA heterogeneity and mRNA abundance revealing cell type specificity. Last, we performed absolute deconvolution on a suitable set of immune cell types using transcriptomics signatures normalized by mRNA abundance. Absolute deconvolution is ready to use for PBMC transcriptomic data using our Shiny app (https://github.com/giannimonaco/ABIS). We benchmarked different deconvolution and normalization methods and validated the resources in independent cohorts. Our work has research, clinical, and diagnostic value by making it possible to effectively associate observations in bulk transcriptomics data to specific immune subsets. Abstract from Cell Rep. 2019 Feb 5;26(6):1627-1640.e7. doi: 10.1016/j.celrep.2019.01.041."	127	"PBMC, basophil, neutrophil, monocyte CD14+, CD14+ CD16+ monocyte, CD16+ monocyte, DC, pDC, NK, VD2- T-cell, VD2+ T-cell, MAIT, naive CD4 T cell, naive CD8 T cell, central memory CD8 T cell, effector memory CD8 T cell, Treg, CD4+ TE, terminal effector CD8 T cell, Th1, Th1/Th17, Th17, Th2, follicular helper T cell, Progenitor cells, SM-B cell, NS B-cell, naive B cell, plasmablast, exhausted B cell"	RNASeq (Illumina HiSeq 2000)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross		lymphoid	NK	adult	natural killer cell	Lymphocyte
GSM2859464;7379	7379	Monaco	GSM2859464	925L_pDC_rep2	Homo sapiens	pDC	pDC		plasmacytoid dendritic cell	female		Monaco	"The molecular characterization of immune subsets is important for designing effective strategies to understand and treat diseases. We characterized 29 immune cell types within the peripheral blood mononuclear cell (PBMC) fraction of healthy donors using RNA-seq (RNA sequencing) and flow cytometry. Our dataset was used, first, to identify sets of genes that are specific, are co-expressed, and have housekeeping roles across the 29 cell types. Then, we examined differences in mRNA heterogeneity and mRNA abundance revealing cell type specificity. Last, we performed absolute deconvolution on a suitable set of immune cell types using transcriptomics signatures normalized by mRNA abundance. Absolute deconvolution is ready to use for PBMC transcriptomic data using our Shiny app (https://github.com/giannimonaco/ABIS). We benchmarked different deconvolution and normalization methods and validated the resources in independent cohorts. Our work has research, clinical, and diagnostic value by making it possible to effectively associate observations in bulk transcriptomics data to specific immune subsets. Abstract from Cell Rep. 2019 Feb 5;26(6):1627-1640.e7. doi: 10.1016/j.celrep.2019.01.041."	127	"PBMC, basophil, neutrophil, monocyte CD14+, CD14+ CD16+ monocyte, CD16+ monocyte, DC, pDC, NK, VD2- T-cell, VD2+ T-cell, MAIT, naive CD4 T cell, naive CD8 T cell, central memory CD8 T cell, effector memory CD8 T cell, Treg, CD4+ TE, terminal effector CD8 T cell, Th1, Th1/Th17, Th17, Th2, follicular helper T cell, Progenitor cells, SM-B cell, NS B-cell, naive B cell, plasmablast, exhausted B cell"	RNASeq (Illumina HiSeq 2000)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross		myeloid	p-DC	adult	plasmacytoid dendritic cell	Mixed
GSM2859468;7379	7379	Monaco	GSM2859468	9JD4_CD8_naive_rep1	Homo sapiens	naive CD8 T cell	T cell		naive CD8 T cell	female		Monaco	"The molecular characterization of immune subsets is important for designing effective strategies to understand and treat diseases. We characterized 29 immune cell types within the peripheral blood mononuclear cell (PBMC) fraction of healthy donors using RNA-seq (RNA sequencing) and flow cytometry. Our dataset was used, first, to identify sets of genes that are specific, are co-expressed, and have housekeeping roles across the 29 cell types. Then, we examined differences in mRNA heterogeneity and mRNA abundance revealing cell type specificity. Last, we performed absolute deconvolution on a suitable set of immune cell types using transcriptomics signatures normalized by mRNA abundance. Absolute deconvolution is ready to use for PBMC transcriptomic data using our Shiny app (https://github.com/giannimonaco/ABIS). We benchmarked different deconvolution and normalization methods and validated the resources in independent cohorts. Our work has research, clinical, and diagnostic value by making it possible to effectively associate observations in bulk transcriptomics data to specific immune subsets. Abstract from Cell Rep. 2019 Feb 5;26(6):1627-1640.e7. doi: 10.1016/j.celrep.2019.01.041."	127	"PBMC, basophil, neutrophil, monocyte CD14+, CD14+ CD16+ monocyte, CD16+ monocyte, DC, pDC, NK, VD2- T-cell, VD2+ T-cell, MAIT, naive CD4 T cell, naive CD8 T cell, central memory CD8 T cell, effector memory CD8 T cell, Treg, CD4+ TE, terminal effector CD8 T cell, Th1, Th1/Th17, Th17, Th2, follicular helper T cell, Progenitor cells, SM-B cell, NS B-cell, naive B cell, plasmablast, exhausted B cell"	RNASeq (Illumina HiSeq 2000)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross		lymphoid	T Cell	adult	CD8+ T cell	Lymphocyte
GSM2859469;7379	7379	Monaco	GSM2859469	9JD4_CD8_CM_rep1	Homo sapiens	CM T cell	T cell		central memory T cell	female		Monaco	"The molecular characterization of immune subsets is important for designing effective strategies to understand and treat diseases. We characterized 29 immune cell types within the peripheral blood mononuclear cell (PBMC) fraction of healthy donors using RNA-seq (RNA sequencing) and flow cytometry. Our dataset was used, first, to identify sets of genes that are specific, are co-expressed, and have housekeeping roles across the 29 cell types. Then, we examined differences in mRNA heterogeneity and mRNA abundance revealing cell type specificity. Last, we performed absolute deconvolution on a suitable set of immune cell types using transcriptomics signatures normalized by mRNA abundance. Absolute deconvolution is ready to use for PBMC transcriptomic data using our Shiny app (https://github.com/giannimonaco/ABIS). We benchmarked different deconvolution and normalization methods and validated the resources in independent cohorts. Our work has research, clinical, and diagnostic value by making it possible to effectively associate observations in bulk transcriptomics data to specific immune subsets. Abstract from Cell Rep. 2019 Feb 5;26(6):1627-1640.e7. doi: 10.1016/j.celrep.2019.01.041."	127	"PBMC, basophil, neutrophil, monocyte CD14+, CD14+ CD16+ monocyte, CD16+ monocyte, DC, pDC, NK, VD2- T-cell, VD2+ T-cell, MAIT, naive CD4 T cell, naive CD8 T cell, central memory CD8 T cell, effector memory CD8 T cell, Treg, CD4+ TE, terminal effector CD8 T cell, Th1, Th1/Th17, Th17, Th2, follicular helper T cell, Progenitor cells, SM-B cell, NS B-cell, naive B cell, plasmablast, exhausted B cell"	RNASeq (Illumina HiSeq 2000)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross		lymphoid	T Cell	adult	CD8+ T cell	Lymphocyte
GSM2859470;7379	7379	Monaco	GSM2859470	9JD4_CD8_EM_rep1	Homo sapiens	EMT cell	T cell		effector memory T cell	female		Monaco	"The molecular characterization of immune subsets is important for designing effective strategies to understand and treat diseases. We characterized 29 immune cell types within the peripheral blood mononuclear cell (PBMC) fraction of healthy donors using RNA-seq (RNA sequencing) and flow cytometry. Our dataset was used, first, to identify sets of genes that are specific, are co-expressed, and have housekeeping roles across the 29 cell types. Then, we examined differences in mRNA heterogeneity and mRNA abundance revealing cell type specificity. Last, we performed absolute deconvolution on a suitable set of immune cell types using transcriptomics signatures normalized by mRNA abundance. Absolute deconvolution is ready to use for PBMC transcriptomic data using our Shiny app (https://github.com/giannimonaco/ABIS). We benchmarked different deconvolution and normalization methods and validated the resources in independent cohorts. Our work has research, clinical, and diagnostic value by making it possible to effectively associate observations in bulk transcriptomics data to specific immune subsets. Abstract from Cell Rep. 2019 Feb 5;26(6):1627-1640.e7. doi: 10.1016/j.celrep.2019.01.041."	127	"PBMC, basophil, neutrophil, monocyte CD14+, CD14+ CD16+ monocyte, CD16+ monocyte, DC, pDC, NK, VD2- T-cell, VD2+ T-cell, MAIT, naive CD4 T cell, naive CD8 T cell, central memory CD8 T cell, effector memory CD8 T cell, Treg, CD4+ TE, terminal effector CD8 T cell, Th1, Th1/Th17, Th17, Th2, follicular helper T cell, Progenitor cells, SM-B cell, NS B-cell, naive B cell, plasmablast, exhausted B cell"	RNASeq (Illumina HiSeq 2000)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross		lymphoid	T Cell	adult	CD8+ T cell	Lymphocyte
GSM2859471;7379	7379	Monaco	GSM2859471	9JD4_CD8_TE_rep1	Homo sapiens	CD8+ TE	T cell		T cell	male		Monaco	"The molecular characterization of immune subsets is important for designing effective strategies to understand and treat diseases. We characterized 29 immune cell types within the peripheral blood mononuclear cell (PBMC) fraction of healthy donors using RNA-seq (RNA sequencing) and flow cytometry. Our dataset was used, first, to identify sets of genes that are specific, are co-expressed, and have housekeeping roles across the 29 cell types. Then, we examined differences in mRNA heterogeneity and mRNA abundance revealing cell type specificity. Last, we performed absolute deconvolution on a suitable set of immune cell types using transcriptomics signatures normalized by mRNA abundance. Absolute deconvolution is ready to use for PBMC transcriptomic data using our Shiny app (https://github.com/giannimonaco/ABIS). We benchmarked different deconvolution and normalization methods and validated the resources in independent cohorts. Our work has research, clinical, and diagnostic value by making it possible to effectively associate observations in bulk transcriptomics data to specific immune subsets. Abstract from Cell Rep. 2019 Feb 5;26(6):1627-1640.e7. doi: 10.1016/j.celrep.2019.01.041."	127	"PBMC, basophil, neutrophil, monocyte CD14+, CD14+ CD16+ monocyte, CD16+ monocyte, DC, pDC, NK, VD2- T-cell, VD2+ T-cell, MAIT, naive CD4 T cell, naive CD8 T cell, central memory CD8 T cell, effector memory CD8 T cell, Treg, CD4+ TE, terminal effector CD8 T cell, Th1, Th1/Th17, Th17, Th2, follicular helper T cell, Progenitor cells, SM-B cell, NS B-cell, naive B cell, plasmablast, exhausted B cell"	RNASeq (Illumina HiSeq 2000)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross		lymphoid	T Cell	adult	CD8+ T cell	Lymphocyte
GSM2859481;7379	7379	Monaco	GSM2859481	9JD4_CD4_naive_rep1	Homo sapiens	naive CD4 T cell	T cell		naive CD4 T cell	female		Monaco	"The molecular characterization of immune subsets is important for designing effective strategies to understand and treat diseases. We characterized 29 immune cell types within the peripheral blood mononuclear cell (PBMC) fraction of healthy donors using RNA-seq (RNA sequencing) and flow cytometry. Our dataset was used, first, to identify sets of genes that are specific, are co-expressed, and have housekeeping roles across the 29 cell types. Then, we examined differences in mRNA heterogeneity and mRNA abundance revealing cell type specificity. Last, we performed absolute deconvolution on a suitable set of immune cell types using transcriptomics signatures normalized by mRNA abundance. Absolute deconvolution is ready to use for PBMC transcriptomic data using our Shiny app (https://github.com/giannimonaco/ABIS). We benchmarked different deconvolution and normalization methods and validated the resources in independent cohorts. Our work has research, clinical, and diagnostic value by making it possible to effectively associate observations in bulk transcriptomics data to specific immune subsets. Abstract from Cell Rep. 2019 Feb 5;26(6):1627-1640.e7. doi: 10.1016/j.celrep.2019.01.041."	127	"PBMC, basophil, neutrophil, monocyte CD14+, CD14+ CD16+ monocyte, CD16+ monocyte, DC, pDC, NK, VD2- T-cell, VD2+ T-cell, MAIT, naive CD4 T cell, naive CD8 T cell, central memory CD8 T cell, effector memory CD8 T cell, Treg, CD4+ TE, terminal effector CD8 T cell, Th1, Th1/Th17, Th17, Th2, follicular helper T cell, Progenitor cells, SM-B cell, NS B-cell, naive B cell, plasmablast, exhausted B cell"	RNASeq (Illumina HiSeq 2000)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross		lymphoid	T Cell	adult	CD4+ T cell	Lymphocyte
GSM2859482;7379	7379	Monaco	GSM2859482	9JD4_CD4_TE_rep1	Homo sapiens	CD4+ TE	T cell		T cell	male		Monaco	"The molecular characterization of immune subsets is important for designing effective strategies to understand and treat diseases. We characterized 29 immune cell types within the peripheral blood mononuclear cell (PBMC) fraction of healthy donors using RNA-seq (RNA sequencing) and flow cytometry. Our dataset was used, first, to identify sets of genes that are specific, are co-expressed, and have housekeeping roles across the 29 cell types. Then, we examined differences in mRNA heterogeneity and mRNA abundance revealing cell type specificity. Last, we performed absolute deconvolution on a suitable set of immune cell types using transcriptomics signatures normalized by mRNA abundance. Absolute deconvolution is ready to use for PBMC transcriptomic data using our Shiny app (https://github.com/giannimonaco/ABIS). We benchmarked different deconvolution and normalization methods and validated the resources in independent cohorts. Our work has research, clinical, and diagnostic value by making it possible to effectively associate observations in bulk transcriptomics data to specific immune subsets. Abstract from Cell Rep. 2019 Feb 5;26(6):1627-1640.e7. doi: 10.1016/j.celrep.2019.01.041."	127	"PBMC, basophil, neutrophil, monocyte CD14+, CD14+ CD16+ monocyte, CD16+ monocyte, DC, pDC, NK, VD2- T-cell, VD2+ T-cell, MAIT, naive CD4 T cell, naive CD8 T cell, central memory CD8 T cell, effector memory CD8 T cell, Treg, CD4+ TE, terminal effector CD8 T cell, Th1, Th1/Th17, Th17, Th2, follicular helper T cell, Progenitor cells, SM-B cell, NS B-cell, naive B cell, plasmablast, exhausted B cell"	RNASeq (Illumina HiSeq 2000)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross		lymphoid	T Cell	adult	CD4+ T cell	Lymphocyte
GSM2859483;7379	7379	Monaco	GSM2859483	9JD4_Progenitor_rep1	Homo sapiens	Progenitor cells	B cell		B cell	male		Monaco	"The molecular characterization of immune subsets is important for designing effective strategies to understand and treat diseases. We characterized 29 immune cell types within the peripheral blood mononuclear cell (PBMC) fraction of healthy donors using RNA-seq (RNA sequencing) and flow cytometry. Our dataset was used, first, to identify sets of genes that are specific, are co-expressed, and have housekeeping roles across the 29 cell types. Then, we examined differences in mRNA heterogeneity and mRNA abundance revealing cell type specificity. Last, we performed absolute deconvolution on a suitable set of immune cell types using transcriptomics signatures normalized by mRNA abundance. Absolute deconvolution is ready to use for PBMC transcriptomic data using our Shiny app (https://github.com/giannimonaco/ABIS). We benchmarked different deconvolution and normalization methods and validated the resources in independent cohorts. Our work has research, clinical, and diagnostic value by making it possible to effectively associate observations in bulk transcriptomics data to specific immune subsets. Abstract from Cell Rep. 2019 Feb 5;26(6):1627-1640.e7. doi: 10.1016/j.celrep.2019.01.041."	127	"PBMC, basophil, neutrophil, monocyte CD14+, CD14+ CD16+ monocyte, CD16+ monocyte, DC, pDC, NK, VD2- T-cell, VD2+ T-cell, MAIT, naive CD4 T cell, naive CD8 T cell, central memory CD8 T cell, effector memory CD8 T cell, Treg, CD4+ TE, terminal effector CD8 T cell, Th1, Th1/Th17, Th17, Th2, follicular helper T cell, Progenitor cells, SM-B cell, NS B-cell, naive B cell, plasmablast, exhausted B cell"	RNASeq (Illumina HiSeq 2000)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross		lymphoid progenitor	B Cell	adult	pro-B cell	Progenitor
GSM2859484;7379	7379	Monaco	GSM2859484	9JD4_B_naive_rep1	Homo sapiens	naive B cell	B cell		naive B cell	female		Monaco	"The molecular characterization of immune subsets is important for designing effective strategies to understand and treat diseases. We characterized 29 immune cell types within the peripheral blood mononuclear cell (PBMC) fraction of healthy donors using RNA-seq (RNA sequencing) and flow cytometry. Our dataset was used, first, to identify sets of genes that are specific, are co-expressed, and have housekeeping roles across the 29 cell types. Then, we examined differences in mRNA heterogeneity and mRNA abundance revealing cell type specificity. Last, we performed absolute deconvolution on a suitable set of immune cell types using transcriptomics signatures normalized by mRNA abundance. Absolute deconvolution is ready to use for PBMC transcriptomic data using our Shiny app (https://github.com/giannimonaco/ABIS). We benchmarked different deconvolution and normalization methods and validated the resources in independent cohorts. Our work has research, clinical, and diagnostic value by making it possible to effectively associate observations in bulk transcriptomics data to specific immune subsets. Abstract from Cell Rep. 2019 Feb 5;26(6):1627-1640.e7. doi: 10.1016/j.celrep.2019.01.041."	127	"PBMC, basophil, neutrophil, monocyte CD14+, CD14+ CD16+ monocyte, CD16+ monocyte, DC, pDC, NK, VD2- T-cell, VD2+ T-cell, MAIT, naive CD4 T cell, naive CD8 T cell, central memory CD8 T cell, effector memory CD8 T cell, Treg, CD4+ TE, terminal effector CD8 T cell, Th1, Th1/Th17, Th17, Th2, follicular helper T cell, Progenitor cells, SM-B cell, NS B-cell, naive B cell, plasmablast, exhausted B cell"	RNASeq (Illumina HiSeq 2000)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross		lymphoid	B Cell	adult	B cell	Lymphocyte
GSM2859485;7379	7379	Monaco	GSM2859485	9JD4_B_NSM_rep1	Homo sapiens	NS B-cell	B cell		B cell	female		Monaco	"The molecular characterization of immune subsets is important for designing effective strategies to understand and treat diseases. We characterized 29 immune cell types within the peripheral blood mononuclear cell (PBMC) fraction of healthy donors using RNA-seq (RNA sequencing) and flow cytometry. Our dataset was used, first, to identify sets of genes that are specific, are co-expressed, and have housekeeping roles across the 29 cell types. Then, we examined differences in mRNA heterogeneity and mRNA abundance revealing cell type specificity. Last, we performed absolute deconvolution on a suitable set of immune cell types using transcriptomics signatures normalized by mRNA abundance. Absolute deconvolution is ready to use for PBMC transcriptomic data using our Shiny app (https://github.com/giannimonaco/ABIS). We benchmarked different deconvolution and normalization methods and validated the resources in independent cohorts. Our work has research, clinical, and diagnostic value by making it possible to effectively associate observations in bulk transcriptomics data to specific immune subsets. Abstract from Cell Rep. 2019 Feb 5;26(6):1627-1640.e7. doi: 10.1016/j.celrep.2019.01.041."	127	"PBMC, basophil, neutrophil, monocyte CD14+, CD14+ CD16+ monocyte, CD16+ monocyte, DC, pDC, NK, VD2- T-cell, VD2+ T-cell, MAIT, naive CD4 T cell, naive CD8 T cell, central memory CD8 T cell, effector memory CD8 T cell, Treg, CD4+ TE, terminal effector CD8 T cell, Th1, Th1/Th17, Th17, Th2, follicular helper T cell, Progenitor cells, SM-B cell, NS B-cell, naive B cell, plasmablast, exhausted B cell"	RNASeq (Illumina HiSeq 2000)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross		lymphoid	B Cell	adult	B cell	Lymphocyte
GSM2859486;7379	7379	Monaco	GSM2859486	9JD4_B_Ex_rep1	Homo sapiens	exhausted B cell	B cell		B cell	male		Monaco	"The molecular characterization of immune subsets is important for designing effective strategies to understand and treat diseases. We characterized 29 immune cell types within the peripheral blood mononuclear cell (PBMC) fraction of healthy donors using RNA-seq (RNA sequencing) and flow cytometry. Our dataset was used, first, to identify sets of genes that are specific, are co-expressed, and have housekeeping roles across the 29 cell types. Then, we examined differences in mRNA heterogeneity and mRNA abundance revealing cell type specificity. Last, we performed absolute deconvolution on a suitable set of immune cell types using transcriptomics signatures normalized by mRNA abundance. Absolute deconvolution is ready to use for PBMC transcriptomic data using our Shiny app (https://github.com/giannimonaco/ABIS). We benchmarked different deconvolution and normalization methods and validated the resources in independent cohorts. Our work has research, clinical, and diagnostic value by making it possible to effectively associate observations in bulk transcriptomics data to specific immune subsets. Abstract from Cell Rep. 2019 Feb 5;26(6):1627-1640.e7. doi: 10.1016/j.celrep.2019.01.041."	127	"PBMC, basophil, neutrophil, monocyte CD14+, CD14+ CD16+ monocyte, CD16+ monocyte, DC, pDC, NK, VD2- T-cell, VD2+ T-cell, MAIT, naive CD4 T cell, naive CD8 T cell, central memory CD8 T cell, effector memory CD8 T cell, Treg, CD4+ TE, terminal effector CD8 T cell, Th1, Th1/Th17, Th17, Th2, follicular helper T cell, Progenitor cells, SM-B cell, NS B-cell, naive B cell, plasmablast, exhausted B cell"	RNASeq (Illumina HiSeq 2000)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross		lymphoid	B Cell	adult	B cell	Lymphocyte
GSM2859487;7379	7379	Monaco	GSM2859487	9JD4_B_SM_rep1	Homo sapiens	SM-B cell	B cell		B cell	male		Monaco	"The molecular characterization of immune subsets is important for designing effective strategies to understand and treat diseases. We characterized 29 immune cell types within the peripheral blood mononuclear cell (PBMC) fraction of healthy donors using RNA-seq (RNA sequencing) and flow cytometry. Our dataset was used, first, to identify sets of genes that are specific, are co-expressed, and have housekeeping roles across the 29 cell types. Then, we examined differences in mRNA heterogeneity and mRNA abundance revealing cell type specificity. Last, we performed absolute deconvolution on a suitable set of immune cell types using transcriptomics signatures normalized by mRNA abundance. Absolute deconvolution is ready to use for PBMC transcriptomic data using our Shiny app (https://github.com/giannimonaco/ABIS). We benchmarked different deconvolution and normalization methods and validated the resources in independent cohorts. Our work has research, clinical, and diagnostic value by making it possible to effectively associate observations in bulk transcriptomics data to specific immune subsets. Abstract from Cell Rep. 2019 Feb 5;26(6):1627-1640.e7. doi: 10.1016/j.celrep.2019.01.041."	127	"PBMC, basophil, neutrophil, monocyte CD14+, CD14+ CD16+ monocyte, CD16+ monocyte, DC, pDC, NK, VD2- T-cell, VD2+ T-cell, MAIT, naive CD4 T cell, naive CD8 T cell, central memory CD8 T cell, effector memory CD8 T cell, Treg, CD4+ TE, terminal effector CD8 T cell, Th1, Th1/Th17, Th17, Th2, follicular helper T cell, Progenitor cells, SM-B cell, NS B-cell, naive B cell, plasmablast, exhausted B cell"	RNASeq (Illumina HiSeq 2000)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross		lymphoid	B Cell	adult	B cell	Lymphocyte
GSM2859492;7379	7379	Monaco	GSM2859492	9JD4_NK_rep1	Homo sapiens	NK	NK		natural killer cell	male		Monaco	"The molecular characterization of immune subsets is important for designing effective strategies to understand and treat diseases. We characterized 29 immune cell types within the peripheral blood mononuclear cell (PBMC) fraction of healthy donors using RNA-seq (RNA sequencing) and flow cytometry. Our dataset was used, first, to identify sets of genes that are specific, are co-expressed, and have housekeeping roles across the 29 cell types. Then, we examined differences in mRNA heterogeneity and mRNA abundance revealing cell type specificity. Last, we performed absolute deconvolution on a suitable set of immune cell types using transcriptomics signatures normalized by mRNA abundance. Absolute deconvolution is ready to use for PBMC transcriptomic data using our Shiny app (https://github.com/giannimonaco/ABIS). We benchmarked different deconvolution and normalization methods and validated the resources in independent cohorts. Our work has research, clinical, and diagnostic value by making it possible to effectively associate observations in bulk transcriptomics data to specific immune subsets. Abstract from Cell Rep. 2019 Feb 5;26(6):1627-1640.e7. doi: 10.1016/j.celrep.2019.01.041."	127	"PBMC, basophil, neutrophil, monocyte CD14+, CD14+ CD16+ monocyte, CD16+ monocyte, DC, pDC, NK, VD2- T-cell, VD2+ T-cell, MAIT, naive CD4 T cell, naive CD8 T cell, central memory CD8 T cell, effector memory CD8 T cell, Treg, CD4+ TE, terminal effector CD8 T cell, Th1, Th1/Th17, Th17, Th2, follicular helper T cell, Progenitor cells, SM-B cell, NS B-cell, naive B cell, plasmablast, exhausted B cell"	RNASeq (Illumina HiSeq 2000)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross		lymphoid	B Cell	adult	natural killer cell	Lymphocyte
GSM2859493;7379	7379	Monaco	GSM2859493	9JD4_pDC_rep1	Homo sapiens	pDC	pDC		plasmacytoid dendritic cell	male		Monaco	"The molecular characterization of immune subsets is important for designing effective strategies to understand and treat diseases. We characterized 29 immune cell types within the peripheral blood mononuclear cell (PBMC) fraction of healthy donors using RNA-seq (RNA sequencing) and flow cytometry. Our dataset was used, first, to identify sets of genes that are specific, are co-expressed, and have housekeeping roles across the 29 cell types. Then, we examined differences in mRNA heterogeneity and mRNA abundance revealing cell type specificity. Last, we performed absolute deconvolution on a suitable set of immune cell types using transcriptomics signatures normalized by mRNA abundance. Absolute deconvolution is ready to use for PBMC transcriptomic data using our Shiny app (https://github.com/giannimonaco/ABIS). We benchmarked different deconvolution and normalization methods and validated the resources in independent cohorts. Our work has research, clinical, and diagnostic value by making it possible to effectively associate observations in bulk transcriptomics data to specific immune subsets. Abstract from Cell Rep. 2019 Feb 5;26(6):1627-1640.e7. doi: 10.1016/j.celrep.2019.01.041."	127	"PBMC, basophil, neutrophil, monocyte CD14+, CD14+ CD16+ monocyte, CD16+ monocyte, DC, pDC, NK, VD2- T-cell, VD2+ T-cell, MAIT, naive CD4 T cell, naive CD8 T cell, central memory CD8 T cell, effector memory CD8 T cell, Treg, CD4+ TE, terminal effector CD8 T cell, Th1, Th1/Th17, Th17, Th2, follicular helper T cell, Progenitor cells, SM-B cell, NS B-cell, naive B cell, plasmablast, exhausted B cell"	RNASeq (Illumina HiSeq 2000)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross		myeloid	p-DC	adult	plasmacytoid dendritic cell	Mixed
GSM2859516;7379	7379	Monaco	GSM2859516	G4YW_CD4_naive_rep3	Homo sapiens	naive CD4 T cell	T cell		T cell	female		Monaco	"The molecular characterization of immune subsets is important for designing effective strategies to understand and treat diseases. We characterized 29 immune cell types within the peripheral blood mononuclear cell (PBMC) fraction of healthy donors using RNA-seq (RNA sequencing) and flow cytometry. Our dataset was used, first, to identify sets of genes that are specific, are co-expressed, and have housekeeping roles across the 29 cell types. Then, we examined differences in mRNA heterogeneity and mRNA abundance revealing cell type specificity. Last, we performed absolute deconvolution on a suitable set of immune cell types using transcriptomics signatures normalized by mRNA abundance. Absolute deconvolution is ready to use for PBMC transcriptomic data using our Shiny app (https://github.com/giannimonaco/ABIS). We benchmarked different deconvolution and normalization methods and validated the resources in independent cohorts. Our work has research, clinical, and diagnostic value by making it possible to effectively associate observations in bulk transcriptomics data to specific immune subsets. Abstract from Cell Rep. 2019 Feb 5;26(6):1627-1640.e7. doi: 10.1016/j.celrep.2019.01.041."	127	"PBMC, basophil, neutrophil, monocyte CD14+, CD14+ CD16+ monocyte, CD16+ monocyte, DC, pDC, NK, VD2- T-cell, VD2+ T-cell, MAIT, naive CD4 T cell, naive CD8 T cell, central memory CD8 T cell, effector memory CD8 T cell, Treg, CD4+ TE, terminal effector CD8 T cell, Th1, Th1/Th17, Th17, Th2, follicular helper T cell, Progenitor cells, SM-B cell, NS B-cell, naive B cell, plasmablast, exhausted B cell"	RNASeq (Illumina HiSeq 2000)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross		lymphoid	T Cell	adult	CD4+ T cell	Lymphocyte
GSM2859517;7379	7379	Monaco	GSM2859517	G4YW_Progenitor_rep3	Homo sapiens	Progenitor cells	B cell		B cell	female		Monaco	"The molecular characterization of immune subsets is important for designing effective strategies to understand and treat diseases. We characterized 29 immune cell types within the peripheral blood mononuclear cell (PBMC) fraction of healthy donors using RNA-seq (RNA sequencing) and flow cytometry. Our dataset was used, first, to identify sets of genes that are specific, are co-expressed, and have housekeeping roles across the 29 cell types. Then, we examined differences in mRNA heterogeneity and mRNA abundance revealing cell type specificity. Last, we performed absolute deconvolution on a suitable set of immune cell types using transcriptomics signatures normalized by mRNA abundance. Absolute deconvolution is ready to use for PBMC transcriptomic data using our Shiny app (https://github.com/giannimonaco/ABIS). We benchmarked different deconvolution and normalization methods and validated the resources in independent cohorts. Our work has research, clinical, and diagnostic value by making it possible to effectively associate observations in bulk transcriptomics data to specific immune subsets. Abstract from Cell Rep. 2019 Feb 5;26(6):1627-1640.e7. doi: 10.1016/j.celrep.2019.01.041."	127	"PBMC, basophil, neutrophil, monocyte CD14+, CD14+ CD16+ monocyte, CD16+ monocyte, DC, pDC, NK, VD2- T-cell, VD2+ T-cell, MAIT, naive CD4 T cell, naive CD8 T cell, central memory CD8 T cell, effector memory CD8 T cell, Treg, CD4+ TE, terminal effector CD8 T cell, Th1, Th1/Th17, Th17, Th2, follicular helper T cell, Progenitor cells, SM-B cell, NS B-cell, naive B cell, plasmablast, exhausted B cell"	RNASeq (Illumina HiSeq 2000)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross		lymphoid progenitor	B Cell	adult	pro-B cell	Progenitor
GSM2859518;7379	7379	Monaco	GSM2859518	G4YW_B_naive_rep3	Homo sapiens	naive B cell	B cell		naive B cell	male		Monaco	"The molecular characterization of immune subsets is important for designing effective strategies to understand and treat diseases. We characterized 29 immune cell types within the peripheral blood mononuclear cell (PBMC) fraction of healthy donors using RNA-seq (RNA sequencing) and flow cytometry. Our dataset was used, first, to identify sets of genes that are specific, are co-expressed, and have housekeeping roles across the 29 cell types. Then, we examined differences in mRNA heterogeneity and mRNA abundance revealing cell type specificity. Last, we performed absolute deconvolution on a suitable set of immune cell types using transcriptomics signatures normalized by mRNA abundance. Absolute deconvolution is ready to use for PBMC transcriptomic data using our Shiny app (https://github.com/giannimonaco/ABIS). We benchmarked different deconvolution and normalization methods and validated the resources in independent cohorts. Our work has research, clinical, and diagnostic value by making it possible to effectively associate observations in bulk transcriptomics data to specific immune subsets. Abstract from Cell Rep. 2019 Feb 5;26(6):1627-1640.e7. doi: 10.1016/j.celrep.2019.01.041."	127	"PBMC, basophil, neutrophil, monocyte CD14+, CD14+ CD16+ monocyte, CD16+ monocyte, DC, pDC, NK, VD2- T-cell, VD2+ T-cell, MAIT, naive CD4 T cell, naive CD8 T cell, central memory CD8 T cell, effector memory CD8 T cell, Treg, CD4+ TE, terminal effector CD8 T cell, Th1, Th1/Th17, Th17, Th2, follicular helper T cell, Progenitor cells, SM-B cell, NS B-cell, naive B cell, plasmablast, exhausted B cell"	RNASeq (Illumina HiSeq 2000)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross		lymphoid	B Cell	adult	B cell	Lymphocyte
GSM2859519;7379	7379	Monaco	GSM2859519	G4YW_B_NSM_rep3	Homo sapiens	NS B-cell	B cell		B cell	female		Monaco	"The molecular characterization of immune subsets is important for designing effective strategies to understand and treat diseases. We characterized 29 immune cell types within the peripheral blood mononuclear cell (PBMC) fraction of healthy donors using RNA-seq (RNA sequencing) and flow cytometry. Our dataset was used, first, to identify sets of genes that are specific, are co-expressed, and have housekeeping roles across the 29 cell types. Then, we examined differences in mRNA heterogeneity and mRNA abundance revealing cell type specificity. Last, we performed absolute deconvolution on a suitable set of immune cell types using transcriptomics signatures normalized by mRNA abundance. Absolute deconvolution is ready to use for PBMC transcriptomic data using our Shiny app (https://github.com/giannimonaco/ABIS). We benchmarked different deconvolution and normalization methods and validated the resources in independent cohorts. Our work has research, clinical, and diagnostic value by making it possible to effectively associate observations in bulk transcriptomics data to specific immune subsets. Abstract from Cell Rep. 2019 Feb 5;26(6):1627-1640.e7. doi: 10.1016/j.celrep.2019.01.041."	127	"PBMC, basophil, neutrophil, monocyte CD14+, CD14+ CD16+ monocyte, CD16+ monocyte, DC, pDC, NK, VD2- T-cell, VD2+ T-cell, MAIT, naive CD4 T cell, naive CD8 T cell, central memory CD8 T cell, effector memory CD8 T cell, Treg, CD4+ TE, terminal effector CD8 T cell, Th1, Th1/Th17, Th17, Th2, follicular helper T cell, Progenitor cells, SM-B cell, NS B-cell, naive B cell, plasmablast, exhausted B cell"	RNASeq (Illumina HiSeq 2000)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross		lymphoid	B Cell	adult	B cell	Lymphocyte
GSM2859520;7379	7379	Monaco	GSM2859520	G4YW_B_Ex_rep3	Homo sapiens	exhausted B cell	B cell		B cell	male		Monaco	"The molecular characterization of immune subsets is important for designing effective strategies to understand and treat diseases. We characterized 29 immune cell types within the peripheral blood mononuclear cell (PBMC) fraction of healthy donors using RNA-seq (RNA sequencing) and flow cytometry. Our dataset was used, first, to identify sets of genes that are specific, are co-expressed, and have housekeeping roles across the 29 cell types. Then, we examined differences in mRNA heterogeneity and mRNA abundance revealing cell type specificity. Last, we performed absolute deconvolution on a suitable set of immune cell types using transcriptomics signatures normalized by mRNA abundance. Absolute deconvolution is ready to use for PBMC transcriptomic data using our Shiny app (https://github.com/giannimonaco/ABIS). We benchmarked different deconvolution and normalization methods and validated the resources in independent cohorts. Our work has research, clinical, and diagnostic value by making it possible to effectively associate observations in bulk transcriptomics data to specific immune subsets. Abstract from Cell Rep. 2019 Feb 5;26(6):1627-1640.e7. doi: 10.1016/j.celrep.2019.01.041."	127	"PBMC, basophil, neutrophil, monocyte CD14+, CD14+ CD16+ monocyte, CD16+ monocyte, DC, pDC, NK, VD2- T-cell, VD2+ T-cell, MAIT, naive CD4 T cell, naive CD8 T cell, central memory CD8 T cell, effector memory CD8 T cell, Treg, CD4+ TE, terminal effector CD8 T cell, Th1, Th1/Th17, Th17, Th2, follicular helper T cell, Progenitor cells, SM-B cell, NS B-cell, naive B cell, plasmablast, exhausted B cell"	RNASeq (Illumina HiSeq 2000)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross		lymphoid	B Cell	adult	B cell	Lymphocyte
GSM2859521;7379	7379	Monaco	GSM2859521	G4YW_B_SM_rep3	Homo sapiens	SM-B cell	B cell		B cell	male		Monaco	"The molecular characterization of immune subsets is important for designing effective strategies to understand and treat diseases. We characterized 29 immune cell types within the peripheral blood mononuclear cell (PBMC) fraction of healthy donors using RNA-seq (RNA sequencing) and flow cytometry. Our dataset was used, first, to identify sets of genes that are specific, are co-expressed, and have housekeeping roles across the 29 cell types. Then, we examined differences in mRNA heterogeneity and mRNA abundance revealing cell type specificity. Last, we performed absolute deconvolution on a suitable set of immune cell types using transcriptomics signatures normalized by mRNA abundance. Absolute deconvolution is ready to use for PBMC transcriptomic data using our Shiny app (https://github.com/giannimonaco/ABIS). We benchmarked different deconvolution and normalization methods and validated the resources in independent cohorts. Our work has research, clinical, and diagnostic value by making it possible to effectively associate observations in bulk transcriptomics data to specific immune subsets. Abstract from Cell Rep. 2019 Feb 5;26(6):1627-1640.e7. doi: 10.1016/j.celrep.2019.01.041."	127	"PBMC, basophil, neutrophil, monocyte CD14+, CD14+ CD16+ monocyte, CD16+ monocyte, DC, pDC, NK, VD2- T-cell, VD2+ T-cell, MAIT, naive CD4 T cell, naive CD8 T cell, central memory CD8 T cell, effector memory CD8 T cell, Treg, CD4+ TE, terminal effector CD8 T cell, Th1, Th1/Th17, Th17, Th2, follicular helper T cell, Progenitor cells, SM-B cell, NS B-cell, naive B cell, plasmablast, exhausted B cell"	RNASeq (Illumina HiSeq 2000)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross		lymphoid	B Cell	adult	B cell	Lymphocyte
GSM2859526;7379	7379	Monaco	GSM2859526	G4YW_NK_rep3	Homo sapiens	NK	NK		natural killer cell	male		Monaco	"The molecular characterization of immune subsets is important for designing effective strategies to understand and treat diseases. We characterized 29 immune cell types within the peripheral blood mononuclear cell (PBMC) fraction of healthy donors using RNA-seq (RNA sequencing) and flow cytometry. Our dataset was used, first, to identify sets of genes that are specific, are co-expressed, and have housekeeping roles across the 29 cell types. Then, we examined differences in mRNA heterogeneity and mRNA abundance revealing cell type specificity. Last, we performed absolute deconvolution on a suitable set of immune cell types using transcriptomics signatures normalized by mRNA abundance. Absolute deconvolution is ready to use for PBMC transcriptomic data using our Shiny app (https://github.com/giannimonaco/ABIS). We benchmarked different deconvolution and normalization methods and validated the resources in independent cohorts. Our work has research, clinical, and diagnostic value by making it possible to effectively associate observations in bulk transcriptomics data to specific immune subsets. Abstract from Cell Rep. 2019 Feb 5;26(6):1627-1640.e7. doi: 10.1016/j.celrep.2019.01.041."	127	"PBMC, basophil, neutrophil, monocyte CD14+, CD14+ CD16+ monocyte, CD16+ monocyte, DC, pDC, NK, VD2- T-cell, VD2+ T-cell, MAIT, naive CD4 T cell, naive CD8 T cell, central memory CD8 T cell, effector memory CD8 T cell, Treg, CD4+ TE, terminal effector CD8 T cell, Th1, Th1/Th17, Th17, Th2, follicular helper T cell, Progenitor cells, SM-B cell, NS B-cell, naive B cell, plasmablast, exhausted B cell"	RNASeq (Illumina HiSeq 2000)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross		lymphoid	NK	adult	natural killer cell	Lymphocyte
GSM2859527;7379	7379	Monaco	GSM2859527	G4YW_pDC_rep3	Homo sapiens	pDC	pDC		plasmacytoid dendritic cell	female		Monaco	"The molecular characterization of immune subsets is important for designing effective strategies to understand and treat diseases. We characterized 29 immune cell types within the peripheral blood mononuclear cell (PBMC) fraction of healthy donors using RNA-seq (RNA sequencing) and flow cytometry. Our dataset was used, first, to identify sets of genes that are specific, are co-expressed, and have housekeeping roles across the 29 cell types. Then, we examined differences in mRNA heterogeneity and mRNA abundance revealing cell type specificity. Last, we performed absolute deconvolution on a suitable set of immune cell types using transcriptomics signatures normalized by mRNA abundance. Absolute deconvolution is ready to use for PBMC transcriptomic data using our Shiny app (https://github.com/giannimonaco/ABIS). We benchmarked different deconvolution and normalization methods and validated the resources in independent cohorts. Our work has research, clinical, and diagnostic value by making it possible to effectively associate observations in bulk transcriptomics data to specific immune subsets. Abstract from Cell Rep. 2019 Feb 5;26(6):1627-1640.e7. doi: 10.1016/j.celrep.2019.01.041."	127	"PBMC, basophil, neutrophil, monocyte CD14+, CD14+ CD16+ monocyte, CD16+ monocyte, DC, pDC, NK, VD2- T-cell, VD2+ T-cell, MAIT, naive CD4 T cell, naive CD8 T cell, central memory CD8 T cell, effector memory CD8 T cell, Treg, CD4+ TE, terminal effector CD8 T cell, Th1, Th1/Th17, Th17, Th2, follicular helper T cell, Progenitor cells, SM-B cell, NS B-cell, naive B cell, plasmablast, exhausted B cell"	RNASeq (Illumina HiSeq 2000)		Homo sapiens	0.2	RNASeq	"rgb(0,146,146)"	cross		myeloid	p-DC	adult	plasmacytoid dendritic cell	Mixed
GSM2861551;7358	7358	Thion	GSM2861551	Human Fetal Microglia 14+2	Homo sapiens	microglia week 14	CL:0000129		microglia		biotin	Thion	"Microglia are embryonically seeded macrophages that contribute to brain development, homeostasis, and pathologies. It is thus essential to decipher how microglial properties are temporally regulated by intrinsic and extrinsic factors, such as sexual identity and the microbiome. Here, we found that microglia undergo differentiation phases, discernable by transcriptomic signatures and chromatin accessibility landscapes, which can diverge in adult males and females. Remarkably, the absence of microbiome in germ-free mice had a time and sexually dimorphic impact both prenatally and postnatally: microglia were more profoundly perturbed in male embryos and female adults. Antibiotic treatment of adult mice triggered sexually biased microglial responses revealing both acute and long-term effects of microbiota depletion. Finally, human fetal microglia exhibited significant overlap with the murine transcriptomic signature. Our study shows that microglia respond to environmental challenges in a sex- and time-dependent manner from prenatal stages, with major implications for our understanding of microglial contributions to health and disease. Abstract from Cell. 2018 Jan 25;172(3):500-516.e16. doi: 10.1016/j.cell.2017.11.042."	10	"microglia week 14, microglia week 15, microglia week 16, microglia week 20+"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.2	Illumina V4	"rgb(146,0,0)"	diamond	Fetal Microglia	myeloid	TRM	fetal	microglia	Mixed
GSM2861552;7358	7358	Thion	GSM2861552	"Human Fetal Microglia 14, replicate 1"	Homo sapiens	microglia week 14	CL:0000129		microglia		biotin	Thion	"Microglia are embryonically seeded macrophages that contribute to brain development, homeostasis, and pathologies. It is thus essential to decipher how microglial properties are temporally regulated by intrinsic and extrinsic factors, such as sexual identity and the microbiome. Here, we found that microglia undergo differentiation phases, discernable by transcriptomic signatures and chromatin accessibility landscapes, which can diverge in adult males and females. Remarkably, the absence of microbiome in germ-free mice had a time and sexually dimorphic impact both prenatally and postnatally: microglia were more profoundly perturbed in male embryos and female adults. Antibiotic treatment of adult mice triggered sexually biased microglial responses revealing both acute and long-term effects of microbiota depletion. Finally, human fetal microglia exhibited significant overlap with the murine transcriptomic signature. Our study shows that microglia respond to environmental challenges in a sex- and time-dependent manner from prenatal stages, with major implications for our understanding of microglial contributions to health and disease. Abstract from Cell. 2018 Jan 25;172(3):500-516.e16. doi: 10.1016/j.cell.2017.11.042."	10	"microglia week 14, microglia week 15, microglia week 16, microglia week 20+"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.2	Illumina V4	"rgb(146,0,0)"	diamond	Fetal Microglia	myeloid	TRM	fetal	microglia	Mixed
GSM2861553;7358	7358	Thion	GSM2861553	"Human Fetal Microglia 14, replicate 2"	Homo sapiens	microglia week 14	CL:0000129		microglia		biotin	Thion	"Microglia are embryonically seeded macrophages that contribute to brain development, homeostasis, and pathologies. It is thus essential to decipher how microglial properties are temporally regulated by intrinsic and extrinsic factors, such as sexual identity and the microbiome. Here, we found that microglia undergo differentiation phases, discernable by transcriptomic signatures and chromatin accessibility landscapes, which can diverge in adult males and females. Remarkably, the absence of microbiome in germ-free mice had a time and sexually dimorphic impact both prenatally and postnatally: microglia were more profoundly perturbed in male embryos and female adults. Antibiotic treatment of adult mice triggered sexually biased microglial responses revealing both acute and long-term effects of microbiota depletion. Finally, human fetal microglia exhibited significant overlap with the murine transcriptomic signature. Our study shows that microglia respond to environmental challenges in a sex- and time-dependent manner from prenatal stages, with major implications for our understanding of microglial contributions to health and disease. Abstract from Cell. 2018 Jan 25;172(3):500-516.e16. doi: 10.1016/j.cell.2017.11.042."	10	"microglia week 14, microglia week 15, microglia week 16, microglia week 20+"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.2	Illumina V4	"rgb(146,0,0)"	diamond	Fetal Microglia	myeloid	TRM	fetal	microglia	Mixed
GSM2861554;7358	7358	Thion	GSM2861554	Human Fetal Microglia 15+1	Homo sapiens	microglia week 15	CL:0000129		microglia		biotin	Thion	"Microglia are embryonically seeded macrophages that contribute to brain development, homeostasis, and pathologies. It is thus essential to decipher how microglial properties are temporally regulated by intrinsic and extrinsic factors, such as sexual identity and the microbiome. Here, we found that microglia undergo differentiation phases, discernable by transcriptomic signatures and chromatin accessibility landscapes, which can diverge in adult males and females. Remarkably, the absence of microbiome in germ-free mice had a time and sexually dimorphic impact both prenatally and postnatally: microglia were more profoundly perturbed in male embryos and female adults. Antibiotic treatment of adult mice triggered sexually biased microglial responses revealing both acute and long-term effects of microbiota depletion. Finally, human fetal microglia exhibited significant overlap with the murine transcriptomic signature. Our study shows that microglia respond to environmental challenges in a sex- and time-dependent manner from prenatal stages, with major implications for our understanding of microglial contributions to health and disease. Abstract from Cell. 2018 Jan 25;172(3):500-516.e16. doi: 10.1016/j.cell.2017.11.042."	10	"microglia week 14, microglia week 15, microglia week 16, microglia week 20+"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.2	Illumina V4	"rgb(146,0,0)"	diamond	Fetal Microglia	myeloid	TRM	fetal	microglia	Mixed
GSM2861555;7358	7358	Thion	GSM2861555	Human Fetal Microglia 16+2	Homo sapiens	microglia week 16	CL:0000129		microglia		biotin	Thion	"Microglia are embryonically seeded macrophages that contribute to brain development, homeostasis, and pathologies. It is thus essential to decipher how microglial properties are temporally regulated by intrinsic and extrinsic factors, such as sexual identity and the microbiome. Here, we found that microglia undergo differentiation phases, discernable by transcriptomic signatures and chromatin accessibility landscapes, which can diverge in adult males and females. Remarkably, the absence of microbiome in germ-free mice had a time and sexually dimorphic impact both prenatally and postnatally: microglia were more profoundly perturbed in male embryos and female adults. Antibiotic treatment of adult mice triggered sexually biased microglial responses revealing both acute and long-term effects of microbiota depletion. Finally, human fetal microglia exhibited significant overlap with the murine transcriptomic signature. Our study shows that microglia respond to environmental challenges in a sex- and time-dependent manner from prenatal stages, with major implications for our understanding of microglial contributions to health and disease. Abstract from Cell. 2018 Jan 25;172(3):500-516.e16. doi: 10.1016/j.cell.2017.11.042."	10	"microglia week 14, microglia week 15, microglia week 16, microglia week 20+"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.2	Illumina V4	"rgb(146,0,0)"	diamond	Fetal Microglia	myeloid	TRM	fetal	microglia	Mixed
GSM2861556;7358	7358	Thion	GSM2861556	Human Fetal Microglia 16+5	Homo sapiens	microglia week 16	CL:0000129		microglia		biotin	Thion	"Microglia are embryonically seeded macrophages that contribute to brain development, homeostasis, and pathologies. It is thus essential to decipher how microglial properties are temporally regulated by intrinsic and extrinsic factors, such as sexual identity and the microbiome. Here, we found that microglia undergo differentiation phases, discernable by transcriptomic signatures and chromatin accessibility landscapes, which can diverge in adult males and females. Remarkably, the absence of microbiome in germ-free mice had a time and sexually dimorphic impact both prenatally and postnatally: microglia were more profoundly perturbed in male embryos and female adults. Antibiotic treatment of adult mice triggered sexually biased microglial responses revealing both acute and long-term effects of microbiota depletion. Finally, human fetal microglia exhibited significant overlap with the murine transcriptomic signature. Our study shows that microglia respond to environmental challenges in a sex- and time-dependent manner from prenatal stages, with major implications for our understanding of microglial contributions to health and disease. Abstract from Cell. 2018 Jan 25;172(3):500-516.e16. doi: 10.1016/j.cell.2017.11.042."	10	"microglia week 14, microglia week 15, microglia week 16, microglia week 20+"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.2	Illumina V4	"rgb(146,0,0)"	diamond	Fetal Microglia	myeloid	TRM	fetal	microglia	Mixed
GSM2861557;7358	7358	Thion	GSM2861557	Human Fetal Microglia 16	Homo sapiens	microglia week 16	CL:0000129		microglia		biotin	Thion	"Microglia are embryonically seeded macrophages that contribute to brain development, homeostasis, and pathologies. It is thus essential to decipher how microglial properties are temporally regulated by intrinsic and extrinsic factors, such as sexual identity and the microbiome. Here, we found that microglia undergo differentiation phases, discernable by transcriptomic signatures and chromatin accessibility landscapes, which can diverge in adult males and females. Remarkably, the absence of microbiome in germ-free mice had a time and sexually dimorphic impact both prenatally and postnatally: microglia were more profoundly perturbed in male embryos and female adults. Antibiotic treatment of adult mice triggered sexually biased microglial responses revealing both acute and long-term effects of microbiota depletion. Finally, human fetal microglia exhibited significant overlap with the murine transcriptomic signature. Our study shows that microglia respond to environmental challenges in a sex- and time-dependent manner from prenatal stages, with major implications for our understanding of microglial contributions to health and disease. Abstract from Cell. 2018 Jan 25;172(3):500-516.e16. doi: 10.1016/j.cell.2017.11.042."	10	"microglia week 14, microglia week 15, microglia week 16, microglia week 20+"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.2	Illumina V4	"rgb(146,0,0)"	diamond	Fetal Microglia	myeloid	TRM	fetal	microglia	Mixed
GSM2861558;7358	7358	Thion	GSM2861558	Human Fetal Microglia 19+5	Homo sapiens	microglia week 20+	CL:0000129		microglia		biotin	Thion	"Microglia are embryonically seeded macrophages that contribute to brain development, homeostasis, and pathologies. It is thus essential to decipher how microglial properties are temporally regulated by intrinsic and extrinsic factors, such as sexual identity and the microbiome. Here, we found that microglia undergo differentiation phases, discernable by transcriptomic signatures and chromatin accessibility landscapes, which can diverge in adult males and females. Remarkably, the absence of microbiome in germ-free mice had a time and sexually dimorphic impact both prenatally and postnatally: microglia were more profoundly perturbed in male embryos and female adults. Antibiotic treatment of adult mice triggered sexually biased microglial responses revealing both acute and long-term effects of microbiota depletion. Finally, human fetal microglia exhibited significant overlap with the murine transcriptomic signature. Our study shows that microglia respond to environmental challenges in a sex- and time-dependent manner from prenatal stages, with major implications for our understanding of microglial contributions to health and disease. Abstract from Cell. 2018 Jan 25;172(3):500-516.e16. doi: 10.1016/j.cell.2017.11.042."	10	"microglia week 14, microglia week 15, microglia week 16, microglia week 20+"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.2	Illumina V4	"rgb(146,0,0)"	diamond	Fetal Microglia	myeloid	TRM	fetal	microglia	Mixed
GSM2861559;7358	7358	Thion	GSM2861559	Human Fetal Microglia 20	Homo sapiens	microglia week 20+	CL:0000129		microglia		biotin	Thion	"Microglia are embryonically seeded macrophages that contribute to brain development, homeostasis, and pathologies. It is thus essential to decipher how microglial properties are temporally regulated by intrinsic and extrinsic factors, such as sexual identity and the microbiome. Here, we found that microglia undergo differentiation phases, discernable by transcriptomic signatures and chromatin accessibility landscapes, which can diverge in adult males and females. Remarkably, the absence of microbiome in germ-free mice had a time and sexually dimorphic impact both prenatally and postnatally: microglia were more profoundly perturbed in male embryos and female adults. Antibiotic treatment of adult mice triggered sexually biased microglial responses revealing both acute and long-term effects of microbiota depletion. Finally, human fetal microglia exhibited significant overlap with the murine transcriptomic signature. Our study shows that microglia respond to environmental challenges in a sex- and time-dependent manner from prenatal stages, with major implications for our understanding of microglial contributions to health and disease. Abstract from Cell. 2018 Jan 25;172(3):500-516.e16. doi: 10.1016/j.cell.2017.11.042."	10	"microglia week 14, microglia week 15, microglia week 16, microglia week 20+"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.2	Illumina V4	"rgb(146,0,0)"	diamond	Fetal Microglia	myeloid	TRM	fetal	microglia	Mixed
GSM2861560;7358	7358	Thion	GSM2861560	Human Fetal Microglia 23+3	Homo sapiens	microglia week 20+	CL:0000129		microglia		biotin	Thion	"Microglia are embryonically seeded macrophages that contribute to brain development, homeostasis, and pathologies. It is thus essential to decipher how microglial properties are temporally regulated by intrinsic and extrinsic factors, such as sexual identity and the microbiome. Here, we found that microglia undergo differentiation phases, discernable by transcriptomic signatures and chromatin accessibility landscapes, which can diverge in adult males and females. Remarkably, the absence of microbiome in germ-free mice had a time and sexually dimorphic impact both prenatally and postnatally: microglia were more profoundly perturbed in male embryos and female adults. Antibiotic treatment of adult mice triggered sexually biased microglial responses revealing both acute and long-term effects of microbiota depletion. Finally, human fetal microglia exhibited significant overlap with the murine transcriptomic signature. Our study shows that microglia respond to environmental challenges in a sex- and time-dependent manner from prenatal stages, with major implications for our understanding of microglial contributions to health and disease. Abstract from Cell. 2018 Jan 25;172(3):500-516.e16. doi: 10.1016/j.cell.2017.11.042."	10	"microglia week 14, microglia week 15, microglia week 16, microglia week 20+"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	3.2	Illumina V4	"rgb(146,0,0)"	diamond	Fetal Microglia	myeloid	TRM	fetal	microglia	Mixed
GSM396486;6003	6003	Karlsson	GSM396486	human blood monocytes rep1	Homo sapiens	monocyte	CL:0000576		monocyte			Karlsson	"To develop a simple and efficient method for producing homogeneous populations of monocytes and macrophages from human embryonic stem cells (hES). Human embryonic stem cell lines KCL001, KCL002, and HUES-2 were differentiated into monocytes by coculture-free differentiation with two growth factors using a three-step method. The method involved embryoid body (EB) formation in hES media, directed differentiation with macrophage colony-stimulating factor and interleukin (IL)-3, and harvest of nonadherent monocytes from the culture supernatants. hES monocytes (esMCs) were analyzed by microscopy, flow cytometry, transcriptome analysis, and tested for the ability to differentiate into macrophages. hES monocyte-derived macrophages (esMDM) were analyzed for phagocytosis and endocytosis by microscopy and flow cytometry, cytokine secretion by multiplex cytokine assay, and for interferon (IFN)-gamma and IL-4 activation by flow cytometry. Homogeneous esMCs (>90% CD14-positive) that did not require any additional purification steps were produced after 18.7 +/- 7.7 days (mean +/- SD, n equals 19). Production continued for several months when growth factors were replaced, with a total yield of 3.4 x 10(5) +/- 2.0 esMCs (mean +/- SD, n equals 9) per EB. Transcriptome analysis of the esMC and the esMDM revealed a distinct myeloid signature that correlated with primary adult blood-derived monocytes and spleen tissue samples but not with other tissue samples tested. We found that esMCs and esMDMs expressed well-defined markers of the mononuclear phagocyte system including PU-1, C/EBPalpha, EMR1, and EMR2, MPEG1, CD1c, CD4, CD18, CD32, CD33, CD68, cathepsins and serine carboxypeptidase. Finally, esMCs differentiated into functional macrophages that could endocytose acetylated low-density lipoprotein, phagocytose opsonized yeast particles, secrete specific cytokines in response to lipopolysaccharide, and be activated differentially with IFN-gamma and IL-4. We have developed a simple and efficient method for producing homogeneous populations of monocytes and macrophages from hES cells. esMCs have a myeloid signature and can differentiate into functional macrophages. The method should prove useful in answering experimental questions regarding monocyte and macrophage development and biology."	9	"monocyte, ESC-derived monocyte, ESC-derived macrophage"	Microarray (Affymetrix HuGene-1_0-ST V1)		Homo sapiens	4.63	HuGene	"rgb(0,109,219)"	diamond-open	Monocyte CD14+  adult	myeloid	Monocyte	adult	monocyte	Circulating Monocyte & Granulocyte
GSM396487;6003	6003	Karlsson	GSM396487	human blood monocytes rep2	Homo sapiens	monocyte	CL:0000576		monocyte			Karlsson	"To develop a simple and efficient method for producing homogeneous populations of monocytes and macrophages from human embryonic stem cells (hES). Human embryonic stem cell lines KCL001, KCL002, and HUES-2 were differentiated into monocytes by coculture-free differentiation with two growth factors using a three-step method. The method involved embryoid body (EB) formation in hES media, directed differentiation with macrophage colony-stimulating factor and interleukin (IL)-3, and harvest of nonadherent monocytes from the culture supernatants. hES monocytes (esMCs) were analyzed by microscopy, flow cytometry, transcriptome analysis, and tested for the ability to differentiate into macrophages. hES monocyte-derived macrophages (esMDM) were analyzed for phagocytosis and endocytosis by microscopy and flow cytometry, cytokine secretion by multiplex cytokine assay, and for interferon (IFN)-gamma and IL-4 activation by flow cytometry. Homogeneous esMCs (>90% CD14-positive) that did not require any additional purification steps were produced after 18.7 +/- 7.7 days (mean +/- SD, n equals 19). Production continued for several months when growth factors were replaced, with a total yield of 3.4 x 10(5) +/- 2.0 esMCs (mean +/- SD, n equals 9) per EB. Transcriptome analysis of the esMC and the esMDM revealed a distinct myeloid signature that correlated with primary adult blood-derived monocytes and spleen tissue samples but not with other tissue samples tested. We found that esMCs and esMDMs expressed well-defined markers of the mononuclear phagocyte system including PU-1, C/EBPalpha, EMR1, and EMR2, MPEG1, CD1c, CD4, CD18, CD32, CD33, CD68, cathepsins and serine carboxypeptidase. Finally, esMCs differentiated into functional macrophages that could endocytose acetylated low-density lipoprotein, phagocytose opsonized yeast particles, secrete specific cytokines in response to lipopolysaccharide, and be activated differentially with IFN-gamma and IL-4. We have developed a simple and efficient method for producing homogeneous populations of monocytes and macrophages from hES cells. esMCs have a myeloid signature and can differentiate into functional macrophages. The method should prove useful in answering experimental questions regarding monocyte and macrophage development and biology."	9	"monocyte, ESC-derived monocyte, ESC-derived macrophage"	Microarray (Affymetrix HuGene-1_0-ST V1)		Homo sapiens	4.63	HuGene	"rgb(0,109,219)"	diamond-open	Monocyte CD14+  adult	myeloid	Monocyte	adult	monocyte	Circulating Monocyte & Granulocyte
GSM396488;6003	6003	Karlsson	GSM396488	human blood monocytes rep3	Homo sapiens	monocyte	CL:0000576		monocyte			Karlsson	"To develop a simple and efficient method for producing homogeneous populations of monocytes and macrophages from human embryonic stem cells (hES). Human embryonic stem cell lines KCL001, KCL002, and HUES-2 were differentiated into monocytes by coculture-free differentiation with two growth factors using a three-step method. The method involved embryoid body (EB) formation in hES media, directed differentiation with macrophage colony-stimulating factor and interleukin (IL)-3, and harvest of nonadherent monocytes from the culture supernatants. hES monocytes (esMCs) were analyzed by microscopy, flow cytometry, transcriptome analysis, and tested for the ability to differentiate into macrophages. hES monocyte-derived macrophages (esMDM) were analyzed for phagocytosis and endocytosis by microscopy and flow cytometry, cytokine secretion by multiplex cytokine assay, and for interferon (IFN)-gamma and IL-4 activation by flow cytometry. Homogeneous esMCs (>90% CD14-positive) that did not require any additional purification steps were produced after 18.7 +/- 7.7 days (mean +/- SD, n equals 19). Production continued for several months when growth factors were replaced, with a total yield of 3.4 x 10(5) +/- 2.0 esMCs (mean +/- SD, n equals 9) per EB. Transcriptome analysis of the esMC and the esMDM revealed a distinct myeloid signature that correlated with primary adult blood-derived monocytes and spleen tissue samples but not with other tissue samples tested. We found that esMCs and esMDMs expressed well-defined markers of the mononuclear phagocyte system including PU-1, C/EBPalpha, EMR1, and EMR2, MPEG1, CD1c, CD4, CD18, CD32, CD33, CD68, cathepsins and serine carboxypeptidase. Finally, esMCs differentiated into functional macrophages that could endocytose acetylated low-density lipoprotein, phagocytose opsonized yeast particles, secrete specific cytokines in response to lipopolysaccharide, and be activated differentially with IFN-gamma and IL-4. We have developed a simple and efficient method for producing homogeneous populations of monocytes and macrophages from hES cells. esMCs have a myeloid signature and can differentiate into functional macrophages. The method should prove useful in answering experimental questions regarding monocyte and macrophage development and biology."	9	"monocyte, ESC-derived monocyte, ESC-derived macrophage"	Microarray (Affymetrix HuGene-1_0-ST V1)		Homo sapiens	4.63	HuGene	"rgb(0,109,219)"	diamond-open	Monocyte CD14+  adult	myeloid	Monocyte	adult	monocyte	Circulating Monocyte & Granulocyte
GSM397303;7021	7021	Agerstam	GSM397303	MIG control biological replicate 1	Homo sapiens	CB CD34+ control	CL:0000837		hematopoietic multipotent progenitor			Agerstam	"The 8p11 myeloproliferative syndrome (EMS), also referred to as stem cell leukemia/lymphoma, is a chronic myeloproliferative disorder that rapidly progresses into acute leukemia. Molecularly, EMS is characterized by fusion of various partner genes to the FGFR1 gene, resulting in constitutive activation of the tyrosine kinases in FGFR1. To date, no previous study has addressed the functional consequences of ectopic FGFR1 expression in the potentially most relevant cellular context, that of normal primary human hematopoietic cells. Herein, we report that expression of ZMYM2/FGFR1 (previously known as ZNF198/FGFR1) or BCR/FGFR1 in normal human CD34(+) cells from umbilical-cord blood leads to increased cellular proliferation and differentiation toward the erythroid lineage in vitro. In immunodeficient mice, expression of ZMYM2/FGFR1 or BCR/FGFR1 in human cells induces several features of human EMS, including expansion of several myeloid cell lineages and accumulation of blasts in bone marrow. Moreover, bone marrow fibrosis together with increased extramedullary hematopoiesis is observed. This study suggests that FGFR1 fusion oncogenes, by themselves, are capable of initiating an EMS-like disorder, and provides the first humanized model of a myeloproliferative disorder transforming into acute leukemia in mice. The established in vivo EMS model should provide a valuable tool for future studies of this disorder. Abstract from Blood. 2010 Sep 23;116(12):2103-11. doi: 10.1182/blood-2009-05-217182."	12	"CB CD34+ control, CB CD34+ BCR/FGFR1, CB CD34+ BCR/ABL1, CB CD34+ ZMYM2/FGFR1"	Microarray (Affymetrix HG-U133_Plus_2 (GPL570 and A-AFFY-44))	leukomics	Homo sapiens	3	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	"CD34+ cells were prestimulated in Dulbeccos Modified Eagle Media with GlutaMAX (Invitrogen Corporation), containing 10% fetal calf serum(FCS"	hematopoietic multipotent progenitor	MHP	neonatal	hematopoietic multipotent progenitor	Progenitor
GSM397307;7021	7021	Agerstam	GSM397307	MIG control biological replicate 2	Homo sapiens	CB CD34+ control	CL:0000837		hematopoietic multipotent progenitor			Agerstam	"The 8p11 myeloproliferative syndrome (EMS), also referred to as stem cell leukemia/lymphoma, is a chronic myeloproliferative disorder that rapidly progresses into acute leukemia. Molecularly, EMS is characterized by fusion of various partner genes to the FGFR1 gene, resulting in constitutive activation of the tyrosine kinases in FGFR1. To date, no previous study has addressed the functional consequences of ectopic FGFR1 expression in the potentially most relevant cellular context, that of normal primary human hematopoietic cells. Herein, we report that expression of ZMYM2/FGFR1 (previously known as ZNF198/FGFR1) or BCR/FGFR1 in normal human CD34(+) cells from umbilical-cord blood leads to increased cellular proliferation and differentiation toward the erythroid lineage in vitro. In immunodeficient mice, expression of ZMYM2/FGFR1 or BCR/FGFR1 in human cells induces several features of human EMS, including expansion of several myeloid cell lineages and accumulation of blasts in bone marrow. Moreover, bone marrow fibrosis together with increased extramedullary hematopoiesis is observed. This study suggests that FGFR1 fusion oncogenes, by themselves, are capable of initiating an EMS-like disorder, and provides the first humanized model of a myeloproliferative disorder transforming into acute leukemia in mice. The established in vivo EMS model should provide a valuable tool for future studies of this disorder. Abstract from Blood. 2010 Sep 23;116(12):2103-11. doi: 10.1182/blood-2009-05-217182."	12	"CB CD34+ control, CB CD34+ BCR/FGFR1, CB CD34+ BCR/ABL1, CB CD34+ ZMYM2/FGFR1"	Microarray (Affymetrix HG-U133_Plus_2 (GPL570 and A-AFFY-44))	leukomics	Homo sapiens	3	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	"CD34+ cells were prestimulated in Dulbeccos Modified Eagle Media with GlutaMAX (Invitrogen Corporation), containing 10% fetal calf serum(FCS"	hematopoietic multipotent progenitor	MHP	neonatal	hematopoietic multipotent progenitor	Progenitor
GSM397311;7021	7021	Agerstam	GSM397311	MIG control biological replicate 3	Homo sapiens	CB CD34+ control	CL:0000837		hematopoietic multipotent progenitor			Agerstam	"The 8p11 myeloproliferative syndrome (EMS), also referred to as stem cell leukemia/lymphoma, is a chronic myeloproliferative disorder that rapidly progresses into acute leukemia. Molecularly, EMS is characterized by fusion of various partner genes to the FGFR1 gene, resulting in constitutive activation of the tyrosine kinases in FGFR1. To date, no previous study has addressed the functional consequences of ectopic FGFR1 expression in the potentially most relevant cellular context, that of normal primary human hematopoietic cells. Herein, we report that expression of ZMYM2/FGFR1 (previously known as ZNF198/FGFR1) or BCR/FGFR1 in normal human CD34(+) cells from umbilical-cord blood leads to increased cellular proliferation and differentiation toward the erythroid lineage in vitro. In immunodeficient mice, expression of ZMYM2/FGFR1 or BCR/FGFR1 in human cells induces several features of human EMS, including expansion of several myeloid cell lineages and accumulation of blasts in bone marrow. Moreover, bone marrow fibrosis together with increased extramedullary hematopoiesis is observed. This study suggests that FGFR1 fusion oncogenes, by themselves, are capable of initiating an EMS-like disorder, and provides the first humanized model of a myeloproliferative disorder transforming into acute leukemia in mice. The established in vivo EMS model should provide a valuable tool for future studies of this disorder. Abstract from Blood. 2010 Sep 23;116(12):2103-11. doi: 10.1182/blood-2009-05-217182."	12	"CB CD34+ control, CB CD34+ BCR/FGFR1, CB CD34+ BCR/ABL1, CB CD34+ ZMYM2/FGFR1"	Microarray (Affymetrix HG-U133_Plus_2 (GPL570 and A-AFFY-44))	leukomics	Homo sapiens	3	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	"CD34+ cells were prestimulated in Dulbeccos Modified Eagle Media with GlutaMAX (Invitrogen Corporation), containing 10% fetal calf serum(FCS"	hematopoietic multipotent progenitor	MHP	neonatal	hematopoietic multipotent progenitor	Progenitor
GSM422109;6238	6238	Ancuta	GSM422109	Peripheral blood monocytes - CD16 negative_1	Homo sapiens	CD14+ CD16- monocyte	CL:0000576		monocyte			Ancuta	"Human peripheral blood monocytes (Mo) consist of subsets distinguished by expression of CD16 (FCGRIII) and chemokine receptors. Classical CD16- Mo express CCR2 and migrate in response to CCL2, while a minor CD16+ Mo subset expresses CX3CR1 and migrates into tissues expressing CX3CL1. CD16+ Mo produce pro-inflammatory cytokines and are expanded in certain inflammatory conditions including HIV infection.To gain insight into the developmental relationship and functions of CD16+ and CD16- Mo, we examined transcriptional profiles of these Mo subsets in peripheral blood from healthy individuals.These results suggest that CD16+ and CD16- Mo originate from a common myeloid precursor, with CD16+ Mo having a more MF- and DC-like transcription program suggesting a more advanced stage of differentiation. Distinct transcriptional programs, together with their recruitment into tissues via different mechanisms, also suggest that CD16+ and CD16- Mo give rise to functionally distinct DC and MF in vivo."	7	"CD14+ CD16- monocyte, CD14+CD16+ monocyte"	Microarray (Affymetrix HG-U133_Plus_2)		Homo sapiens	5	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	Monocyte CD14+CD16-  adult	myeloid	Monocyte	adult	monocyte	Circulating Monocyte & Granulocyte
GSM422110;6238	6238	Ancuta	GSM422110	Peripheral blood monocytes - CD16 negative_2	Homo sapiens	CD14+ CD16- monocyte	CL:0000576		monocyte			Ancuta	"Human peripheral blood monocytes (Mo) consist of subsets distinguished by expression of CD16 (FCGRIII) and chemokine receptors. Classical CD16- Mo express CCR2 and migrate in response to CCL2, while a minor CD16+ Mo subset expresses CX3CR1 and migrates into tissues expressing CX3CL1. CD16+ Mo produce pro-inflammatory cytokines and are expanded in certain inflammatory conditions including HIV infection.To gain insight into the developmental relationship and functions of CD16+ and CD16- Mo, we examined transcriptional profiles of these Mo subsets in peripheral blood from healthy individuals.These results suggest that CD16+ and CD16- Mo originate from a common myeloid precursor, with CD16+ Mo having a more MF- and DC-like transcription program suggesting a more advanced stage of differentiation. Distinct transcriptional programs, together with their recruitment into tissues via different mechanisms, also suggest that CD16+ and CD16- Mo give rise to functionally distinct DC and MF in vivo."	7	"CD14+ CD16- monocyte, CD14+CD16+ monocyte"	Microarray (Affymetrix HG-U133_Plus_2)		Homo sapiens	5	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	Monocyte CD14+CD16-  adult	myeloid	Monocyte	adult	monocyte	Circulating Monocyte & Granulocyte
GSM422111;6238	6238	Ancuta	GSM422111	Peripheral blood monocytes - CD16 negative_3	Homo sapiens	CD14+ CD16- monocyte	CL:0000576		monocyte			Ancuta	"Human peripheral blood monocytes (Mo) consist of subsets distinguished by expression of CD16 (FCGRIII) and chemokine receptors. Classical CD16- Mo express CCR2 and migrate in response to CCL2, while a minor CD16+ Mo subset expresses CX3CR1 and migrates into tissues expressing CX3CL1. CD16+ Mo produce pro-inflammatory cytokines and are expanded in certain inflammatory conditions including HIV infection.To gain insight into the developmental relationship and functions of CD16+ and CD16- Mo, we examined transcriptional profiles of these Mo subsets in peripheral blood from healthy individuals.These results suggest that CD16+ and CD16- Mo originate from a common myeloid precursor, with CD16+ Mo having a more MF- and DC-like transcription program suggesting a more advanced stage of differentiation. Distinct transcriptional programs, together with their recruitment into tissues via different mechanisms, also suggest that CD16+ and CD16- Mo give rise to functionally distinct DC and MF in vivo."	7	"CD14+ CD16- monocyte, CD14+CD16+ monocyte"	Microarray (Affymetrix HG-U133_Plus_2)		Homo sapiens	5	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	Monocyte CD14+CD16-  adult	myeloid	Monocyte	adult	monocyte	Circulating Monocyte & Granulocyte
GSM422112;6238	6238	Ancuta	GSM422112	Peripheral blood monocytes - CD16 negative_4	Homo sapiens	CD14+ CD16- monocyte	CL:0000576		monocyte			Ancuta	"Human peripheral blood monocytes (Mo) consist of subsets distinguished by expression of CD16 (FCGRIII) and chemokine receptors. Classical CD16- Mo express CCR2 and migrate in response to CCL2, while a minor CD16+ Mo subset expresses CX3CR1 and migrates into tissues expressing CX3CL1. CD16+ Mo produce pro-inflammatory cytokines and are expanded in certain inflammatory conditions including HIV infection.To gain insight into the developmental relationship and functions of CD16+ and CD16- Mo, we examined transcriptional profiles of these Mo subsets in peripheral blood from healthy individuals.These results suggest that CD16+ and CD16- Mo originate from a common myeloid precursor, with CD16+ Mo having a more MF- and DC-like transcription program suggesting a more advanced stage of differentiation. Distinct transcriptional programs, together with their recruitment into tissues via different mechanisms, also suggest that CD16+ and CD16- Mo give rise to functionally distinct DC and MF in vivo."	7	"CD14+ CD16- monocyte, CD14+CD16+ monocyte"	Microarray (Affymetrix HG-U133_Plus_2)		Homo sapiens	5	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	Monocyte CD14+CD16-  adult	myeloid	Monocyte	adult	monocyte	Circulating Monocyte & Granulocyte
GSM422113;6238	6238	Ancuta	GSM422113	Peripheral blood monocytes - CD16 positive_1	Homo sapiens	CD14+CD16+ monocyte	CL:0000576		monocyte			Ancuta	"Human peripheral blood monocytes (Mo) consist of subsets distinguished by expression of CD16 (FCGRIII) and chemokine receptors. Classical CD16- Mo express CCR2 and migrate in response to CCL2, while a minor CD16+ Mo subset expresses CX3CR1 and migrates into tissues expressing CX3CL1. CD16+ Mo produce pro-inflammatory cytokines and are expanded in certain inflammatory conditions including HIV infection.To gain insight into the developmental relationship and functions of CD16+ and CD16- Mo, we examined transcriptional profiles of these Mo subsets in peripheral blood from healthy individuals.These results suggest that CD16+ and CD16- Mo originate from a common myeloid precursor, with CD16+ Mo having a more MF- and DC-like transcription program suggesting a more advanced stage of differentiation. Distinct transcriptional programs, together with their recruitment into tissues via different mechanisms, also suggest that CD16+ and CD16- Mo give rise to functionally distinct DC and MF in vivo."	7	"CD14+ CD16- monocyte, CD14+CD16+ monocyte"	Microarray (Affymetrix HG-U133_Plus_2)		Homo sapiens	5	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	Monocyte CD14+CD16+  adult	myeloid	Monocyte	adult	monocyte	Circulating Monocyte & Granulocyte
GSM422114;6238	6238	Ancuta	GSM422114	Peripheral blood monocytes - CD16 positive_2	Homo sapiens	CD14+CD16+ monocyte	CL:0000576		monocyte			Ancuta	"Human peripheral blood monocytes (Mo) consist of subsets distinguished by expression of CD16 (FCGRIII) and chemokine receptors. Classical CD16- Mo express CCR2 and migrate in response to CCL2, while a minor CD16+ Mo subset expresses CX3CR1 and migrates into tissues expressing CX3CL1. CD16+ Mo produce pro-inflammatory cytokines and are expanded in certain inflammatory conditions including HIV infection.To gain insight into the developmental relationship and functions of CD16+ and CD16- Mo, we examined transcriptional profiles of these Mo subsets in peripheral blood from healthy individuals.These results suggest that CD16+ and CD16- Mo originate from a common myeloid precursor, with CD16+ Mo having a more MF- and DC-like transcription program suggesting a more advanced stage of differentiation. Distinct transcriptional programs, together with their recruitment into tissues via different mechanisms, also suggest that CD16+ and CD16- Mo give rise to functionally distinct DC and MF in vivo."	7	"CD14+ CD16- monocyte, CD14+CD16+ monocyte"	Microarray (Affymetrix HG-U133_Plus_2)		Homo sapiens	5	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	Monocyte CD14+CD16+  adult	myeloid	Monocyte	adult	monocyte	Circulating Monocyte & Granulocyte
GSM422116;6238	6238	Ancuta	GSM422116	Peripheral blood monocytes - CD16 positive_4	Homo sapiens	CD14+CD16+ monocyte	CL:0000576		monocyte			Ancuta	"Human peripheral blood monocytes (Mo) consist of subsets distinguished by expression of CD16 (FCGRIII) and chemokine receptors. Classical CD16- Mo express CCR2 and migrate in response to CCL2, while a minor CD16+ Mo subset expresses CX3CR1 and migrates into tissues expressing CX3CL1. CD16+ Mo produce pro-inflammatory cytokines and are expanded in certain inflammatory conditions including HIV infection.To gain insight into the developmental relationship and functions of CD16+ and CD16- Mo, we examined transcriptional profiles of these Mo subsets in peripheral blood from healthy individuals.These results suggest that CD16+ and CD16- Mo originate from a common myeloid precursor, with CD16+ Mo having a more MF- and DC-like transcription program suggesting a more advanced stage of differentiation. Distinct transcriptional programs, together with their recruitment into tissues via different mechanisms, also suggest that CD16+ and CD16- Mo give rise to functionally distinct DC and MF in vivo."	7	"CD14+ CD16- monocyte, CD14+CD16+ monocyte"	Microarray (Affymetrix HG-U133_Plus_2)		Homo sapiens	5	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	Monocyte CD14+CD16+  adult	myeloid	Monocyte	adult	monocyte	Circulating Monocyte & Granulocyte
GSM609354;6324	6324	Affer	GSM609354	"Normal quiescent (G0), replicate 1"	Homo sapiens	HSC G0	CL:0000837		hematopoietic multipotent progenitor			Affer	"In comparing gene expression of normal and CML CD34+ quiescent (G0) cell, 292 genes were downregulated and 192 genes upregulated in the CML/G0 Cells. The differentially expressed genes were grouped according to their reported functions, and correlations were sought with biological differences previously observed between the same groups. The most relevant findings include the following. (i) CML G0 cells are in a more advanced stage of development and more poised to proliferate than normal G0 cells. (ii) When CML G0 cells are stimulated to proliferate, they differentiate and mature more rapidly than normal counterpart. (iii) Whereas normal G0 cells form only granulocyte/monocyte colonies when stimulated by cytokines, CML G0 cells form a combination of the above and erythroid clusters and colonies. (iv) Prominin-1 is the gene most downregulated in CML G0 cells, and this appears to be associated with the spontaneous formation of erythroid colonies by CML progenitors without EPO. Abstract from Journal of Oncology. 2011;2011:798592. doi: 10.1155/2011/798592. ComBAT was applied to correct batch effect for this dataset. Batches are [GSM609346,GSM609348,GSM609349,GSM609350,GSM609354,GSM609355,GSM609358,GSM609360,GSM609361,GSM609362,GSM609366,GSM609367] and [GSM609347,GSM609351,GSM609352,GSM609353,GSM609356,GSM609357,GSM609359,GSM609363,GSM609364,GSM609365,GSM609368,GSM609369]."	24	"HSC G0, AP-CML G0, CP-CML G0, HSC cycling, AP-CML cycling, CP-CML cycling"	Microarray (Affymetrix HG-U133_Plus_2)	leukomics	Homo sapiens	3.4	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	MHP CD34+ HST lo Py lo  adult	hematopoietic multipotent progenitor	MHP	adult	hematopoietic multipotent progenitor	Progenitor
GSM609355;6324	6324	Affer	GSM609355	"Normal quiescent (G0), replicate 2"	Homo sapiens	HSC G0	CL:0000837		hematopoietic multipotent progenitor			Affer	"In comparing gene expression of normal and CML CD34+ quiescent (G0) cell, 292 genes were downregulated and 192 genes upregulated in the CML/G0 Cells. The differentially expressed genes were grouped according to their reported functions, and correlations were sought with biological differences previously observed between the same groups. The most relevant findings include the following. (i) CML G0 cells are in a more advanced stage of development and more poised to proliferate than normal G0 cells. (ii) When CML G0 cells are stimulated to proliferate, they differentiate and mature more rapidly than normal counterpart. (iii) Whereas normal G0 cells form only granulocyte/monocyte colonies when stimulated by cytokines, CML G0 cells form a combination of the above and erythroid clusters and colonies. (iv) Prominin-1 is the gene most downregulated in CML G0 cells, and this appears to be associated with the spontaneous formation of erythroid colonies by CML progenitors without EPO. Abstract from Journal of Oncology. 2011;2011:798592. doi: 10.1155/2011/798592. ComBAT was applied to correct batch effect for this dataset. Batches are [GSM609346,GSM609348,GSM609349,GSM609350,GSM609354,GSM609355,GSM609358,GSM609360,GSM609361,GSM609362,GSM609366,GSM609367] and [GSM609347,GSM609351,GSM609352,GSM609353,GSM609356,GSM609357,GSM609359,GSM609363,GSM609364,GSM609365,GSM609368,GSM609369]."	24	"HSC G0, AP-CML G0, CP-CML G0, HSC cycling, AP-CML cycling, CP-CML cycling"	Microarray (Affymetrix HG-U133_Plus_2)	leukomics	Homo sapiens	3.4	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	MHP CD34+ HST lo Py lo  adult	hematopoietic multipotent progenitor	MHP	adult	hematopoietic multipotent progenitor	Progenitor
GSM609356;6324	6324	Affer	GSM609356	"Normal quiescent (G0), replicate 3"	Homo sapiens	HSC G0	CL:0000837		hematopoietic multipotent progenitor			Affer	"In comparing gene expression of normal and CML CD34+ quiescent (G0) cell, 292 genes were downregulated and 192 genes upregulated in the CML/G0 Cells. The differentially expressed genes were grouped according to their reported functions, and correlations were sought with biological differences previously observed between the same groups. The most relevant findings include the following. (i) CML G0 cells are in a more advanced stage of development and more poised to proliferate than normal G0 cells. (ii) When CML G0 cells are stimulated to proliferate, they differentiate and mature more rapidly than normal counterpart. (iii) Whereas normal G0 cells form only granulocyte/monocyte colonies when stimulated by cytokines, CML G0 cells form a combination of the above and erythroid clusters and colonies. (iv) Prominin-1 is the gene most downregulated in CML G0 cells, and this appears to be associated with the spontaneous formation of erythroid colonies by CML progenitors without EPO. Abstract from Journal of Oncology. 2011;2011:798592. doi: 10.1155/2011/798592. ComBAT was applied to correct batch effect for this dataset. Batches are [GSM609346,GSM609348,GSM609349,GSM609350,GSM609354,GSM609355,GSM609358,GSM609360,GSM609361,GSM609362,GSM609366,GSM609367] and [GSM609347,GSM609351,GSM609352,GSM609353,GSM609356,GSM609357,GSM609359,GSM609363,GSM609364,GSM609365,GSM609368,GSM609369]."	24	"HSC G0, AP-CML G0, CP-CML G0, HSC cycling, AP-CML cycling, CP-CML cycling"	Microarray (Affymetrix HG-U133_Plus_2)	leukomics	Homo sapiens	3.4	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	MHP CD34+ HST lo Py lo  adult	hematopoietic multipotent progenitor	MHP	adult	hematopoietic multipotent progenitor	Progenitor
GSM609357;6324	6324	Affer	GSM609357	"Normal quiescent (G0), replicate 4"	Homo sapiens	HSC G0	CL:0000837		hematopoietic multipotent progenitor			Affer	"In comparing gene expression of normal and CML CD34+ quiescent (G0) cell, 292 genes were downregulated and 192 genes upregulated in the CML/G0 Cells. The differentially expressed genes were grouped according to their reported functions, and correlations were sought with biological differences previously observed between the same groups. The most relevant findings include the following. (i) CML G0 cells are in a more advanced stage of development and more poised to proliferate than normal G0 cells. (ii) When CML G0 cells are stimulated to proliferate, they differentiate and mature more rapidly than normal counterpart. (iii) Whereas normal G0 cells form only granulocyte/monocyte colonies when stimulated by cytokines, CML G0 cells form a combination of the above and erythroid clusters and colonies. (iv) Prominin-1 is the gene most downregulated in CML G0 cells, and this appears to be associated with the spontaneous formation of erythroid colonies by CML progenitors without EPO. Abstract from Journal of Oncology. 2011;2011:798592. doi: 10.1155/2011/798592. ComBAT was applied to correct batch effect for this dataset. Batches are [GSM609346,GSM609348,GSM609349,GSM609350,GSM609354,GSM609355,GSM609358,GSM609360,GSM609361,GSM609362,GSM609366,GSM609367] and [GSM609347,GSM609351,GSM609352,GSM609353,GSM609356,GSM609357,GSM609359,GSM609363,GSM609364,GSM609365,GSM609368,GSM609369]."	24	"HSC G0, AP-CML G0, CP-CML G0, HSC cycling, AP-CML cycling, CP-CML cycling"	Microarray (Affymetrix HG-U133_Plus_2)	leukomics	Homo sapiens	3.4	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	MHP CD34+ HST lo Py lo  adult	hematopoietic multipotent progenitor	MHP	adult	hematopoietic multipotent progenitor	Progenitor
GSM609366;6324	6324	Affer	GSM609366	"Normal cycling (G1/S/G2/M), replicate 1"	Homo sapiens	HSC cycling	CL:0000837		hematopoietic multipotent progenitor			Affer	"In comparing gene expression of normal and CML CD34+ quiescent (G0) cell, 292 genes were downregulated and 192 genes upregulated in the CML/G0 Cells. The differentially expressed genes were grouped according to their reported functions, and correlations were sought with biological differences previously observed between the same groups. The most relevant findings include the following. (i) CML G0 cells are in a more advanced stage of development and more poised to proliferate than normal G0 cells. (ii) When CML G0 cells are stimulated to proliferate, they differentiate and mature more rapidly than normal counterpart. (iii) Whereas normal G0 cells form only granulocyte/monocyte colonies when stimulated by cytokines, CML G0 cells form a combination of the above and erythroid clusters and colonies. (iv) Prominin-1 is the gene most downregulated in CML G0 cells, and this appears to be associated with the spontaneous formation of erythroid colonies by CML progenitors without EPO. Abstract from Journal of Oncology. 2011;2011:798592. doi: 10.1155/2011/798592. ComBAT was applied to correct batch effect for this dataset. Batches are [GSM609346,GSM609348,GSM609349,GSM609350,GSM609354,GSM609355,GSM609358,GSM609360,GSM609361,GSM609362,GSM609366,GSM609367] and [GSM609347,GSM609351,GSM609352,GSM609353,GSM609356,GSM609357,GSM609359,GSM609363,GSM609364,GSM609365,GSM609368,GSM609369]."	24	"HSC G0, AP-CML G0, CP-CML G0, HSC cycling, AP-CML cycling, CP-CML cycling"	Microarray (Affymetrix HG-U133_Plus_2)	leukomics	Homo sapiens	3.4	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	MHP CD34+ HST+ Py+  adult	hematopoietic multipotent progenitor	MHP	adult	hematopoietic multipotent progenitor	Progenitor
GSM609367;6324	6324	Affer	GSM609367	"Normal cycling (G1/S/G2/M), replicate 2"	Homo sapiens	HSC cycling	CL:0000837		hematopoietic multipotent progenitor			Affer	"In comparing gene expression of normal and CML CD34+ quiescent (G0) cell, 292 genes were downregulated and 192 genes upregulated in the CML/G0 Cells. The differentially expressed genes were grouped according to their reported functions, and correlations were sought with biological differences previously observed between the same groups. The most relevant findings include the following. (i) CML G0 cells are in a more advanced stage of development and more poised to proliferate than normal G0 cells. (ii) When CML G0 cells are stimulated to proliferate, they differentiate and mature more rapidly than normal counterpart. (iii) Whereas normal G0 cells form only granulocyte/monocyte colonies when stimulated by cytokines, CML G0 cells form a combination of the above and erythroid clusters and colonies. (iv) Prominin-1 is the gene most downregulated in CML G0 cells, and this appears to be associated with the spontaneous formation of erythroid colonies by CML progenitors without EPO. Abstract from Journal of Oncology. 2011;2011:798592. doi: 10.1155/2011/798592. ComBAT was applied to correct batch effect for this dataset. Batches are [GSM609346,GSM609348,GSM609349,GSM609350,GSM609354,GSM609355,GSM609358,GSM609360,GSM609361,GSM609362,GSM609366,GSM609367] and [GSM609347,GSM609351,GSM609352,GSM609353,GSM609356,GSM609357,GSM609359,GSM609363,GSM609364,GSM609365,GSM609368,GSM609369]."	24	"HSC G0, AP-CML G0, CP-CML G0, HSC cycling, AP-CML cycling, CP-CML cycling"	Microarray (Affymetrix HG-U133_Plus_2)	leukomics	Homo sapiens	3.4	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	MHP CD34+ HST+ Py+  adult	hematopoietic multipotent progenitor	MHP	adult	hematopoietic multipotent progenitor	Progenitor
GSM609368;6324	6324	Affer	GSM609368	"Normal cycling (G1/S/G2/M), replicate 3"	Homo sapiens	HSC cycling	CL:0000837		hematopoietic multipotent progenitor			Affer	"In comparing gene expression of normal and CML CD34+ quiescent (G0) cell, 292 genes were downregulated and 192 genes upregulated in the CML/G0 Cells. The differentially expressed genes were grouped according to their reported functions, and correlations were sought with biological differences previously observed between the same groups. The most relevant findings include the following. (i) CML G0 cells are in a more advanced stage of development and more poised to proliferate than normal G0 cells. (ii) When CML G0 cells are stimulated to proliferate, they differentiate and mature more rapidly than normal counterpart. (iii) Whereas normal G0 cells form only granulocyte/monocyte colonies when stimulated by cytokines, CML G0 cells form a combination of the above and erythroid clusters and colonies. (iv) Prominin-1 is the gene most downregulated in CML G0 cells, and this appears to be associated with the spontaneous formation of erythroid colonies by CML progenitors without EPO. Abstract from Journal of Oncology. 2011;2011:798592. doi: 10.1155/2011/798592. ComBAT was applied to correct batch effect for this dataset. Batches are [GSM609346,GSM609348,GSM609349,GSM609350,GSM609354,GSM609355,GSM609358,GSM609360,GSM609361,GSM609362,GSM609366,GSM609367] and [GSM609347,GSM609351,GSM609352,GSM609353,GSM609356,GSM609357,GSM609359,GSM609363,GSM609364,GSM609365,GSM609368,GSM609369]."	24	"HSC G0, AP-CML G0, CP-CML G0, HSC cycling, AP-CML cycling, CP-CML cycling"	Microarray (Affymetrix HG-U133_Plus_2)	leukomics	Homo sapiens	3.4	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	MHP CD34+ HST+ Py+  adult	hematopoietic multipotent progenitor	MHP	adult	hematopoietic multipotent progenitor	Progenitor
GSM609369;6324	6324	Affer	GSM609369	"Normal cycling (G1/S/G2/M), replicate 4"	Homo sapiens	HSC cycling	CL:0000837		hematopoietic multipotent progenitor			Affer	"In comparing gene expression of normal and CML CD34+ quiescent (G0) cell, 292 genes were downregulated and 192 genes upregulated in the CML/G0 Cells. The differentially expressed genes were grouped according to their reported functions, and correlations were sought with biological differences previously observed between the same groups. The most relevant findings include the following. (i) CML G0 cells are in a more advanced stage of development and more poised to proliferate than normal G0 cells. (ii) When CML G0 cells are stimulated to proliferate, they differentiate and mature more rapidly than normal counterpart. (iii) Whereas normal G0 cells form only granulocyte/monocyte colonies when stimulated by cytokines, CML G0 cells form a combination of the above and erythroid clusters and colonies. (iv) Prominin-1 is the gene most downregulated in CML G0 cells, and this appears to be associated with the spontaneous formation of erythroid colonies by CML progenitors without EPO. Abstract from Journal of Oncology. 2011;2011:798592. doi: 10.1155/2011/798592. ComBAT was applied to correct batch effect for this dataset. Batches are [GSM609346,GSM609348,GSM609349,GSM609350,GSM609354,GSM609355,GSM609358,GSM609360,GSM609361,GSM609362,GSM609366,GSM609367] and [GSM609347,GSM609351,GSM609352,GSM609353,GSM609356,GSM609357,GSM609359,GSM609363,GSM609364,GSM609365,GSM609368,GSM609369]."	24	"HSC G0, AP-CML G0, CP-CML G0, HSC cycling, AP-CML cycling, CP-CML cycling"	Microarray (Affymetrix HG-U133_Plus_2)	leukomics	Homo sapiens	3.4	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	MHP CD34+ HST+ Py+  adult	hematopoietic multipotent progenitor	MHP	adult	hematopoietic multipotent progenitor	Progenitor
GSM812988;6661	6661	Pang	GSM812988	Young HSC Donor 26 yrs rep 1	Homo sapiens	young HSC	CL:0000837		hematopoietic multipotent progenitor			Pang	"In the human hematopoietic system, aging is associated with decreased bone marrow cellularity, decreased adaptive immune system function, and increased incidence of anemia and other hematological disorders and malignancies. Recent studies in mice suggest that changes within the hematopoietic stem cell (HSC) population during aging contribute significantly to the manifestation of these age-associated hematopoietic pathologies. Though the mouse HSC population has been shown to change both quantitatively and functionally with age, changes in the human HSC and progenitor cell populations during aging have been incompletely characterized. To elucidate the properties of an aged human hematopoietic system that may predispose to age-associated hematopoietic dysfunction, we evaluated immunophenotypic HSC and other hematopoietic progenitor populations from healthy, hematologically normal young and elderly human bone marrow samples. We found that aged immunophenotypic human HSC increase in frequency, are less quiescent, and exhibit myeloid-biased differentiation potential compared with young HSC. Gene expression profiling revealed that aged immunophenotypic human HSC transcriptionally up-regulate genes associated with cell cycle, myeloid lineage specification, and myeloid malignancies. These age-associated alterations in the frequency, developmental potential, and gene expression profile of human HSC are similar to those changes observed in mouse HSC, suggesting that hematopoietic aging is an evolutionarily conserved process. Abstract from Proc Natl Acad Sci U S A. 2011 Dec 13;108(50):20012-7. doi: 10.1073/pnas.1116110108."	27	"young HSC, middle-aged HSC, old HSC"	Microarray (Affymetrix HG-U133_Plus_2 (GPL570 and A-AFFY-44))	leukomics	Homo sapiens	4.3	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	MHP LinCD34+CD38CD90+CD45RA  adult	hematopoietic multipotent progenitor	MHP	adult	hematopoietic multipotent progenitor	Progenitor
GSM812989;6661	6661	Pang	GSM812989	Young HSC Donor 25 yrs rep 2	Homo sapiens	young HSC	CL:0000837		hematopoietic multipotent progenitor			Pang	"In the human hematopoietic system, aging is associated with decreased bone marrow cellularity, decreased adaptive immune system function, and increased incidence of anemia and other hematological disorders and malignancies. Recent studies in mice suggest that changes within the hematopoietic stem cell (HSC) population during aging contribute significantly to the manifestation of these age-associated hematopoietic pathologies. Though the mouse HSC population has been shown to change both quantitatively and functionally with age, changes in the human HSC and progenitor cell populations during aging have been incompletely characterized. To elucidate the properties of an aged human hematopoietic system that may predispose to age-associated hematopoietic dysfunction, we evaluated immunophenotypic HSC and other hematopoietic progenitor populations from healthy, hematologically normal young and elderly human bone marrow samples. We found that aged immunophenotypic human HSC increase in frequency, are less quiescent, and exhibit myeloid-biased differentiation potential compared with young HSC. Gene expression profiling revealed that aged immunophenotypic human HSC transcriptionally up-regulate genes associated with cell cycle, myeloid lineage specification, and myeloid malignancies. These age-associated alterations in the frequency, developmental potential, and gene expression profile of human HSC are similar to those changes observed in mouse HSC, suggesting that hematopoietic aging is an evolutionarily conserved process. Abstract from Proc Natl Acad Sci U S A. 2011 Dec 13;108(50):20012-7. doi: 10.1073/pnas.1116110108."	27	"young HSC, middle-aged HSC, old HSC"	Microarray (Affymetrix HG-U133_Plus_2 (GPL570 and A-AFFY-44))	leukomics	Homo sapiens	4.3	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	MHP LinCD34+CD38CD90+CD45RA  adult	hematopoietic multipotent progenitor	MHP	adult	hematopoietic multipotent progenitor	Progenitor
GSM812990;6661	6661	Pang	GSM812990	Young HSC Donor 24 yrs rep 3	Homo sapiens	young HSC	CL:0000837		hematopoietic multipotent progenitor			Pang	"In the human hematopoietic system, aging is associated with decreased bone marrow cellularity, decreased adaptive immune system function, and increased incidence of anemia and other hematological disorders and malignancies. Recent studies in mice suggest that changes within the hematopoietic stem cell (HSC) population during aging contribute significantly to the manifestation of these age-associated hematopoietic pathologies. Though the mouse HSC population has been shown to change both quantitatively and functionally with age, changes in the human HSC and progenitor cell populations during aging have been incompletely characterized. To elucidate the properties of an aged human hematopoietic system that may predispose to age-associated hematopoietic dysfunction, we evaluated immunophenotypic HSC and other hematopoietic progenitor populations from healthy, hematologically normal young and elderly human bone marrow samples. We found that aged immunophenotypic human HSC increase in frequency, are less quiescent, and exhibit myeloid-biased differentiation potential compared with young HSC. Gene expression profiling revealed that aged immunophenotypic human HSC transcriptionally up-regulate genes associated with cell cycle, myeloid lineage specification, and myeloid malignancies. These age-associated alterations in the frequency, developmental potential, and gene expression profile of human HSC are similar to those changes observed in mouse HSC, suggesting that hematopoietic aging is an evolutionarily conserved process. Abstract from Proc Natl Acad Sci U S A. 2011 Dec 13;108(50):20012-7. doi: 10.1073/pnas.1116110108."	27	"young HSC, middle-aged HSC, old HSC"	Microarray (Affymetrix HG-U133_Plus_2 (GPL570 and A-AFFY-44))	leukomics	Homo sapiens	4.3	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	MHP LinCD34+CD38CD90+CD45RA  adult	hematopoietic multipotent progenitor	MHP	adult	hematopoietic multipotent progenitor	Progenitor
GSM812991;6661	6661	Pang	GSM812991	Young HSC Donor 20 yrs rep 4	Homo sapiens	young HSC	CL:0000837		hematopoietic multipotent progenitor			Pang	"In the human hematopoietic system, aging is associated with decreased bone marrow cellularity, decreased adaptive immune system function, and increased incidence of anemia and other hematological disorders and malignancies. Recent studies in mice suggest that changes within the hematopoietic stem cell (HSC) population during aging contribute significantly to the manifestation of these age-associated hematopoietic pathologies. Though the mouse HSC population has been shown to change both quantitatively and functionally with age, changes in the human HSC and progenitor cell populations during aging have been incompletely characterized. To elucidate the properties of an aged human hematopoietic system that may predispose to age-associated hematopoietic dysfunction, we evaluated immunophenotypic HSC and other hematopoietic progenitor populations from healthy, hematologically normal young and elderly human bone marrow samples. We found that aged immunophenotypic human HSC increase in frequency, are less quiescent, and exhibit myeloid-biased differentiation potential compared with young HSC. Gene expression profiling revealed that aged immunophenotypic human HSC transcriptionally up-regulate genes associated with cell cycle, myeloid lineage specification, and myeloid malignancies. These age-associated alterations in the frequency, developmental potential, and gene expression profile of human HSC are similar to those changes observed in mouse HSC, suggesting that hematopoietic aging is an evolutionarily conserved process. Abstract from Proc Natl Acad Sci U S A. 2011 Dec 13;108(50):20012-7. doi: 10.1073/pnas.1116110108."	27	"young HSC, middle-aged HSC, old HSC"	Microarray (Affymetrix HG-U133_Plus_2 (GPL570 and A-AFFY-44))	leukomics	Homo sapiens	4.3	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	MHP LinCD34+CD38CD90+CD45RA  adult	hematopoietic multipotent progenitor	MHP	adult	hematopoietic multipotent progenitor	Progenitor
GSM812992;6661	6661	Pang	GSM812992	Young HSC Donor 21 yrs rep 5	Homo sapiens	young HSC	CL:0000837		hematopoietic multipotent progenitor			Pang	"In the human hematopoietic system, aging is associated with decreased bone marrow cellularity, decreased adaptive immune system function, and increased incidence of anemia and other hematological disorders and malignancies. Recent studies in mice suggest that changes within the hematopoietic stem cell (HSC) population during aging contribute significantly to the manifestation of these age-associated hematopoietic pathologies. Though the mouse HSC population has been shown to change both quantitatively and functionally with age, changes in the human HSC and progenitor cell populations during aging have been incompletely characterized. To elucidate the properties of an aged human hematopoietic system that may predispose to age-associated hematopoietic dysfunction, we evaluated immunophenotypic HSC and other hematopoietic progenitor populations from healthy, hematologically normal young and elderly human bone marrow samples. We found that aged immunophenotypic human HSC increase in frequency, are less quiescent, and exhibit myeloid-biased differentiation potential compared with young HSC. Gene expression profiling revealed that aged immunophenotypic human HSC transcriptionally up-regulate genes associated with cell cycle, myeloid lineage specification, and myeloid malignancies. These age-associated alterations in the frequency, developmental potential, and gene expression profile of human HSC are similar to those changes observed in mouse HSC, suggesting that hematopoietic aging is an evolutionarily conserved process. Abstract from Proc Natl Acad Sci U S A. 2011 Dec 13;108(50):20012-7. doi: 10.1073/pnas.1116110108."	27	"young HSC, middle-aged HSC, old HSC"	Microarray (Affymetrix HG-U133_Plus_2 (GPL570 and A-AFFY-44))	leukomics	Homo sapiens	4.3	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	MHP LinCD34+CD38CD90+CD45RA  adult	hematopoietic multipotent progenitor	MHP	adult	hematopoietic multipotent progenitor	Progenitor
GSM812993;6661	6661	Pang	GSM812993	Young HSC Donor 24 yrs rep 6	Homo sapiens	young HSC	CL:0000837		hematopoietic multipotent progenitor			Pang	"In the human hematopoietic system, aging is associated with decreased bone marrow cellularity, decreased adaptive immune system function, and increased incidence of anemia and other hematological disorders and malignancies. Recent studies in mice suggest that changes within the hematopoietic stem cell (HSC) population during aging contribute significantly to the manifestation of these age-associated hematopoietic pathologies. Though the mouse HSC population has been shown to change both quantitatively and functionally with age, changes in the human HSC and progenitor cell populations during aging have been incompletely characterized. To elucidate the properties of an aged human hematopoietic system that may predispose to age-associated hematopoietic dysfunction, we evaluated immunophenotypic HSC and other hematopoietic progenitor populations from healthy, hematologically normal young and elderly human bone marrow samples. We found that aged immunophenotypic human HSC increase in frequency, are less quiescent, and exhibit myeloid-biased differentiation potential compared with young HSC. Gene expression profiling revealed that aged immunophenotypic human HSC transcriptionally up-regulate genes associated with cell cycle, myeloid lineage specification, and myeloid malignancies. These age-associated alterations in the frequency, developmental potential, and gene expression profile of human HSC are similar to those changes observed in mouse HSC, suggesting that hematopoietic aging is an evolutionarily conserved process. Abstract from Proc Natl Acad Sci U S A. 2011 Dec 13;108(50):20012-7. doi: 10.1073/pnas.1116110108."	27	"young HSC, middle-aged HSC, old HSC"	Microarray (Affymetrix HG-U133_Plus_2 (GPL570 and A-AFFY-44))	leukomics	Homo sapiens	4.3	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	MHP LinCD34+CD38CD90+CD45RA  adult	hematopoietic multipotent progenitor	MHP	adult	hematopoietic multipotent progenitor	Progenitor
GSM812994;6661	6661	Pang	GSM812994	Young HSC Donor 26 yrs rep 7	Homo sapiens	young HSC	CL:0000837		hematopoietic multipotent progenitor			Pang	"In the human hematopoietic system, aging is associated with decreased bone marrow cellularity, decreased adaptive immune system function, and increased incidence of anemia and other hematological disorders and malignancies. Recent studies in mice suggest that changes within the hematopoietic stem cell (HSC) population during aging contribute significantly to the manifestation of these age-associated hematopoietic pathologies. Though the mouse HSC population has been shown to change both quantitatively and functionally with age, changes in the human HSC and progenitor cell populations during aging have been incompletely characterized. To elucidate the properties of an aged human hematopoietic system that may predispose to age-associated hematopoietic dysfunction, we evaluated immunophenotypic HSC and other hematopoietic progenitor populations from healthy, hematologically normal young and elderly human bone marrow samples. We found that aged immunophenotypic human HSC increase in frequency, are less quiescent, and exhibit myeloid-biased differentiation potential compared with young HSC. Gene expression profiling revealed that aged immunophenotypic human HSC transcriptionally up-regulate genes associated with cell cycle, myeloid lineage specification, and myeloid malignancies. These age-associated alterations in the frequency, developmental potential, and gene expression profile of human HSC are similar to those changes observed in mouse HSC, suggesting that hematopoietic aging is an evolutionarily conserved process. Abstract from Proc Natl Acad Sci U S A. 2011 Dec 13;108(50):20012-7. doi: 10.1073/pnas.1116110108."	27	"young HSC, middle-aged HSC, old HSC"	Microarray (Affymetrix HG-U133_Plus_2 (GPL570 and A-AFFY-44))	leukomics	Homo sapiens	4.3	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	MHP LinCD34+CD38CD90+CD45RA  adult	hematopoietic multipotent progenitor	MHP	adult	hematopoietic multipotent progenitor	Progenitor
GSM812995;6661	6661	Pang	GSM812995	Young HSC Donor 30 yrs rep 8	Homo sapiens	young HSC	CL:0000837		hematopoietic multipotent progenitor			Pang	"In the human hematopoietic system, aging is associated with decreased bone marrow cellularity, decreased adaptive immune system function, and increased incidence of anemia and other hematological disorders and malignancies. Recent studies in mice suggest that changes within the hematopoietic stem cell (HSC) population during aging contribute significantly to the manifestation of these age-associated hematopoietic pathologies. Though the mouse HSC population has been shown to change both quantitatively and functionally with age, changes in the human HSC and progenitor cell populations during aging have been incompletely characterized. To elucidate the properties of an aged human hematopoietic system that may predispose to age-associated hematopoietic dysfunction, we evaluated immunophenotypic HSC and other hematopoietic progenitor populations from healthy, hematologically normal young and elderly human bone marrow samples. We found that aged immunophenotypic human HSC increase in frequency, are less quiescent, and exhibit myeloid-biased differentiation potential compared with young HSC. Gene expression profiling revealed that aged immunophenotypic human HSC transcriptionally up-regulate genes associated with cell cycle, myeloid lineage specification, and myeloid malignancies. These age-associated alterations in the frequency, developmental potential, and gene expression profile of human HSC are similar to those changes observed in mouse HSC, suggesting that hematopoietic aging is an evolutionarily conserved process. Abstract from Proc Natl Acad Sci U S A. 2011 Dec 13;108(50):20012-7. doi: 10.1073/pnas.1116110108."	27	"young HSC, middle-aged HSC, old HSC"	Microarray (Affymetrix HG-U133_Plus_2 (GPL570 and A-AFFY-44))	leukomics	Homo sapiens	4.3	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	MHP LinCD34+CD38CD90+CD45RA  adult	hematopoietic multipotent progenitor	MHP	adult	hematopoietic multipotent progenitor	Progenitor
GSM812996;6661	6661	Pang	GSM812996	Young HSC Donor 31 yrs rep 9	Homo sapiens	young HSC	CL:0000837		hematopoietic multipotent progenitor			Pang	"In the human hematopoietic system, aging is associated with decreased bone marrow cellularity, decreased adaptive immune system function, and increased incidence of anemia and other hematological disorders and malignancies. Recent studies in mice suggest that changes within the hematopoietic stem cell (HSC) population during aging contribute significantly to the manifestation of these age-associated hematopoietic pathologies. Though the mouse HSC population has been shown to change both quantitatively and functionally with age, changes in the human HSC and progenitor cell populations during aging have been incompletely characterized. To elucidate the properties of an aged human hematopoietic system that may predispose to age-associated hematopoietic dysfunction, we evaluated immunophenotypic HSC and other hematopoietic progenitor populations from healthy, hematologically normal young and elderly human bone marrow samples. We found that aged immunophenotypic human HSC increase in frequency, are less quiescent, and exhibit myeloid-biased differentiation potential compared with young HSC. Gene expression profiling revealed that aged immunophenotypic human HSC transcriptionally up-regulate genes associated with cell cycle, myeloid lineage specification, and myeloid malignancies. These age-associated alterations in the frequency, developmental potential, and gene expression profile of human HSC are similar to those changes observed in mouse HSC, suggesting that hematopoietic aging is an evolutionarily conserved process. Abstract from Proc Natl Acad Sci U S A. 2011 Dec 13;108(50):20012-7. doi: 10.1073/pnas.1116110108."	27	"young HSC, middle-aged HSC, old HSC"	Microarray (Affymetrix HG-U133_Plus_2 (GPL570 and A-AFFY-44))	leukomics	Homo sapiens	4.3	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	MHP LinCD34+CD38CD90+CD45RA  adult	hematopoietic multipotent progenitor	MHP	adult	hematopoietic multipotent progenitor	Progenitor
GSM812997;6661	6661	Pang	GSM812997	Young HSC Donor 24 yrs rep 10	Homo sapiens	young HSC	CL:0000837		hematopoietic multipotent progenitor			Pang	"In the human hematopoietic system, aging is associated with decreased bone marrow cellularity, decreased adaptive immune system function, and increased incidence of anemia and other hematological disorders and malignancies. Recent studies in mice suggest that changes within the hematopoietic stem cell (HSC) population during aging contribute significantly to the manifestation of these age-associated hematopoietic pathologies. Though the mouse HSC population has been shown to change both quantitatively and functionally with age, changes in the human HSC and progenitor cell populations during aging have been incompletely characterized. To elucidate the properties of an aged human hematopoietic system that may predispose to age-associated hematopoietic dysfunction, we evaluated immunophenotypic HSC and other hematopoietic progenitor populations from healthy, hematologically normal young and elderly human bone marrow samples. We found that aged immunophenotypic human HSC increase in frequency, are less quiescent, and exhibit myeloid-biased differentiation potential compared with young HSC. Gene expression profiling revealed that aged immunophenotypic human HSC transcriptionally up-regulate genes associated with cell cycle, myeloid lineage specification, and myeloid malignancies. These age-associated alterations in the frequency, developmental potential, and gene expression profile of human HSC are similar to those changes observed in mouse HSC, suggesting that hematopoietic aging is an evolutionarily conserved process. Abstract from Proc Natl Acad Sci U S A. 2011 Dec 13;108(50):20012-7. doi: 10.1073/pnas.1116110108."	27	"young HSC, middle-aged HSC, old HSC"	Microarray (Affymetrix HG-U133_Plus_2 (GPL570 and A-AFFY-44))	leukomics	Homo sapiens	4.3	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	MHP LinCD34+CD38CD90+CD45RA  adult	hematopoietic multipotent progenitor	MHP	adult	hematopoietic multipotent progenitor	Progenitor
GSM812998;6661	6661	Pang	GSM812998	Young HSC Donor 22 yrs rep 11	Homo sapiens	young HSC	CL:0000837		hematopoietic multipotent progenitor			Pang	"In the human hematopoietic system, aging is associated with decreased bone marrow cellularity, decreased adaptive immune system function, and increased incidence of anemia and other hematological disorders and malignancies. Recent studies in mice suggest that changes within the hematopoietic stem cell (HSC) population during aging contribute significantly to the manifestation of these age-associated hematopoietic pathologies. Though the mouse HSC population has been shown to change both quantitatively and functionally with age, changes in the human HSC and progenitor cell populations during aging have been incompletely characterized. To elucidate the properties of an aged human hematopoietic system that may predispose to age-associated hematopoietic dysfunction, we evaluated immunophenotypic HSC and other hematopoietic progenitor populations from healthy, hematologically normal young and elderly human bone marrow samples. We found that aged immunophenotypic human HSC increase in frequency, are less quiescent, and exhibit myeloid-biased differentiation potential compared with young HSC. Gene expression profiling revealed that aged immunophenotypic human HSC transcriptionally up-regulate genes associated with cell cycle, myeloid lineage specification, and myeloid malignancies. These age-associated alterations in the frequency, developmental potential, and gene expression profile of human HSC are similar to those changes observed in mouse HSC, suggesting that hematopoietic aging is an evolutionarily conserved process. Abstract from Proc Natl Acad Sci U S A. 2011 Dec 13;108(50):20012-7. doi: 10.1073/pnas.1116110108."	27	"young HSC, middle-aged HSC, old HSC"	Microarray (Affymetrix HG-U133_Plus_2 (GPL570 and A-AFFY-44))	leukomics	Homo sapiens	4.3	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	MHP LinCD34+CD38CD90+CD45RA  adult	hematopoietic multipotent progenitor	MHP	adult	hematopoietic multipotent progenitor	Progenitor
GSM812999;6661	6661	Pang	GSM812999	Young HSC Donor 22 yrs rep 12	Homo sapiens	young HSC	CL:0000837		hematopoietic multipotent progenitor			Pang	"In the human hematopoietic system, aging is associated with decreased bone marrow cellularity, decreased adaptive immune system function, and increased incidence of anemia and other hematological disorders and malignancies. Recent studies in mice suggest that changes within the hematopoietic stem cell (HSC) population during aging contribute significantly to the manifestation of these age-associated hematopoietic pathologies. Though the mouse HSC population has been shown to change both quantitatively and functionally with age, changes in the human HSC and progenitor cell populations during aging have been incompletely characterized. To elucidate the properties of an aged human hematopoietic system that may predispose to age-associated hematopoietic dysfunction, we evaluated immunophenotypic HSC and other hematopoietic progenitor populations from healthy, hematologically normal young and elderly human bone marrow samples. We found that aged immunophenotypic human HSC increase in frequency, are less quiescent, and exhibit myeloid-biased differentiation potential compared with young HSC. Gene expression profiling revealed that aged immunophenotypic human HSC transcriptionally up-regulate genes associated with cell cycle, myeloid lineage specification, and myeloid malignancies. These age-associated alterations in the frequency, developmental potential, and gene expression profile of human HSC are similar to those changes observed in mouse HSC, suggesting that hematopoietic aging is an evolutionarily conserved process. Abstract from Proc Natl Acad Sci U S A. 2011 Dec 13;108(50):20012-7. doi: 10.1073/pnas.1116110108."	27	"young HSC, middle-aged HSC, old HSC"	Microarray (Affymetrix HG-U133_Plus_2 (GPL570 and A-AFFY-44))	leukomics	Homo sapiens	4.3	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	MHP LinCD34+CD38CD90+CD45RA  adult	hematopoietic multipotent progenitor	MHP	adult	hematopoietic multipotent progenitor	Progenitor
GSM813000;6661	6661	Pang	GSM813000	Young HSC Donor 19 yrs rep 13	Homo sapiens	young HSC	CL:0000837		hematopoietic multipotent progenitor			Pang	"In the human hematopoietic system, aging is associated with decreased bone marrow cellularity, decreased adaptive immune system function, and increased incidence of anemia and other hematological disorders and malignancies. Recent studies in mice suggest that changes within the hematopoietic stem cell (HSC) population during aging contribute significantly to the manifestation of these age-associated hematopoietic pathologies. Though the mouse HSC population has been shown to change both quantitatively and functionally with age, changes in the human HSC and progenitor cell populations during aging have been incompletely characterized. To elucidate the properties of an aged human hematopoietic system that may predispose to age-associated hematopoietic dysfunction, we evaluated immunophenotypic HSC and other hematopoietic progenitor populations from healthy, hematologically normal young and elderly human bone marrow samples. We found that aged immunophenotypic human HSC increase in frequency, are less quiescent, and exhibit myeloid-biased differentiation potential compared with young HSC. Gene expression profiling revealed that aged immunophenotypic human HSC transcriptionally up-regulate genes associated with cell cycle, myeloid lineage specification, and myeloid malignancies. These age-associated alterations in the frequency, developmental potential, and gene expression profile of human HSC are similar to those changes observed in mouse HSC, suggesting that hematopoietic aging is an evolutionarily conserved process. Abstract from Proc Natl Acad Sci U S A. 2011 Dec 13;108(50):20012-7. doi: 10.1073/pnas.1116110108."	27	"young HSC, middle-aged HSC, old HSC"	Microarray (Affymetrix HG-U133_Plus_2 (GPL570 and A-AFFY-44))	leukomics	Homo sapiens	4.3	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	MHP LinCD34+CD38CD90+CD45RA  adult	hematopoietic multipotent progenitor	MHP	adult	hematopoietic multipotent progenitor	Progenitor
GSM813001;6661	6661	Pang	GSM813001	Young HSC Donor 23 yrs rep 14	Homo sapiens	young HSC	CL:0000837		hematopoietic multipotent progenitor			Pang	"In the human hematopoietic system, aging is associated with decreased bone marrow cellularity, decreased adaptive immune system function, and increased incidence of anemia and other hematological disorders and malignancies. Recent studies in mice suggest that changes within the hematopoietic stem cell (HSC) population during aging contribute significantly to the manifestation of these age-associated hematopoietic pathologies. Though the mouse HSC population has been shown to change both quantitatively and functionally with age, changes in the human HSC and progenitor cell populations during aging have been incompletely characterized. To elucidate the properties of an aged human hematopoietic system that may predispose to age-associated hematopoietic dysfunction, we evaluated immunophenotypic HSC and other hematopoietic progenitor populations from healthy, hematologically normal young and elderly human bone marrow samples. We found that aged immunophenotypic human HSC increase in frequency, are less quiescent, and exhibit myeloid-biased differentiation potential compared with young HSC. Gene expression profiling revealed that aged immunophenotypic human HSC transcriptionally up-regulate genes associated with cell cycle, myeloid lineage specification, and myeloid malignancies. These age-associated alterations in the frequency, developmental potential, and gene expression profile of human HSC are similar to those changes observed in mouse HSC, suggesting that hematopoietic aging is an evolutionarily conserved process. Abstract from Proc Natl Acad Sci U S A. 2011 Dec 13;108(50):20012-7. doi: 10.1073/pnas.1116110108."	27	"young HSC, middle-aged HSC, old HSC"	Microarray (Affymetrix HG-U133_Plus_2 (GPL570 and A-AFFY-44))	leukomics	Homo sapiens	4.3	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	MHP LinCD34+CD38CD90+CD45RA  adult	hematopoietic multipotent progenitor	MHP	adult	hematopoietic multipotent progenitor	Progenitor
GSM813002;6661	6661	Pang	GSM813002	Middle HSC Donor 43yrs rep 1	Homo sapiens	middle-aged HSC	CL:0000837		hematopoietic multipotent progenitor			Pang	"In the human hematopoietic system, aging is associated with decreased bone marrow cellularity, decreased adaptive immune system function, and increased incidence of anemia and other hematological disorders and malignancies. Recent studies in mice suggest that changes within the hematopoietic stem cell (HSC) population during aging contribute significantly to the manifestation of these age-associated hematopoietic pathologies. Though the mouse HSC population has been shown to change both quantitatively and functionally with age, changes in the human HSC and progenitor cell populations during aging have been incompletely characterized. To elucidate the properties of an aged human hematopoietic system that may predispose to age-associated hematopoietic dysfunction, we evaluated immunophenotypic HSC and other hematopoietic progenitor populations from healthy, hematologically normal young and elderly human bone marrow samples. We found that aged immunophenotypic human HSC increase in frequency, are less quiescent, and exhibit myeloid-biased differentiation potential compared with young HSC. Gene expression profiling revealed that aged immunophenotypic human HSC transcriptionally up-regulate genes associated with cell cycle, myeloid lineage specification, and myeloid malignancies. These age-associated alterations in the frequency, developmental potential, and gene expression profile of human HSC are similar to those changes observed in mouse HSC, suggesting that hematopoietic aging is an evolutionarily conserved process. Abstract from Proc Natl Acad Sci U S A. 2011 Dec 13;108(50):20012-7. doi: 10.1073/pnas.1116110108."	27	"young HSC, middle-aged HSC, old HSC"	Microarray (Affymetrix HG-U133_Plus_2 (GPL570 and A-AFFY-44))	leukomics	Homo sapiens	4.3	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	MHP LinCD34+CD38CD90+CD45RA  adult	hematopoietic multipotent progenitor	MHP	adult	hematopoietic multipotent progenitor	Progenitor
GSM813003;6661	6661	Pang	GSM813003	Middle HSC Donor 61yrs rep 2	Homo sapiens	middle-aged HSC	CL:0000837		hematopoietic multipotent progenitor			Pang	"In the human hematopoietic system, aging is associated with decreased bone marrow cellularity, decreased adaptive immune system function, and increased incidence of anemia and other hematological disorders and malignancies. Recent studies in mice suggest that changes within the hematopoietic stem cell (HSC) population during aging contribute significantly to the manifestation of these age-associated hematopoietic pathologies. Though the mouse HSC population has been shown to change both quantitatively and functionally with age, changes in the human HSC and progenitor cell populations during aging have been incompletely characterized. To elucidate the properties of an aged human hematopoietic system that may predispose to age-associated hematopoietic dysfunction, we evaluated immunophenotypic HSC and other hematopoietic progenitor populations from healthy, hematologically normal young and elderly human bone marrow samples. We found that aged immunophenotypic human HSC increase in frequency, are less quiescent, and exhibit myeloid-biased differentiation potential compared with young HSC. Gene expression profiling revealed that aged immunophenotypic human HSC transcriptionally up-regulate genes associated with cell cycle, myeloid lineage specification, and myeloid malignancies. These age-associated alterations in the frequency, developmental potential, and gene expression profile of human HSC are similar to those changes observed in mouse HSC, suggesting that hematopoietic aging is an evolutionarily conserved process. Abstract from Proc Natl Acad Sci U S A. 2011 Dec 13;108(50):20012-7. doi: 10.1073/pnas.1116110108."	27	"young HSC, middle-aged HSC, old HSC"	Microarray (Affymetrix HG-U133_Plus_2 (GPL570 and A-AFFY-44))	leukomics	Homo sapiens	4.3	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	MHP LinCD34+CD38CD90+CD45RA elderly donor adult	hematopoietic multipotent progenitor	MHP	adult	hematopoietic multipotent progenitor	Progenitor
GSM813004;6661	6661	Pang	GSM813004	Middle HSC Donor 51yrs rep 3	Homo sapiens	middle-aged HSC	CL:0000837		hematopoietic multipotent progenitor			Pang	"In the human hematopoietic system, aging is associated with decreased bone marrow cellularity, decreased adaptive immune system function, and increased incidence of anemia and other hematological disorders and malignancies. Recent studies in mice suggest that changes within the hematopoietic stem cell (HSC) population during aging contribute significantly to the manifestation of these age-associated hematopoietic pathologies. Though the mouse HSC population has been shown to change both quantitatively and functionally with age, changes in the human HSC and progenitor cell populations during aging have been incompletely characterized. To elucidate the properties of an aged human hematopoietic system that may predispose to age-associated hematopoietic dysfunction, we evaluated immunophenotypic HSC and other hematopoietic progenitor populations from healthy, hematologically normal young and elderly human bone marrow samples. We found that aged immunophenotypic human HSC increase in frequency, are less quiescent, and exhibit myeloid-biased differentiation potential compared with young HSC. Gene expression profiling revealed that aged immunophenotypic human HSC transcriptionally up-regulate genes associated with cell cycle, myeloid lineage specification, and myeloid malignancies. These age-associated alterations in the frequency, developmental potential, and gene expression profile of human HSC are similar to those changes observed in mouse HSC, suggesting that hematopoietic aging is an evolutionarily conserved process. Abstract from Proc Natl Acad Sci U S A. 2011 Dec 13;108(50):20012-7. doi: 10.1073/pnas.1116110108."	27	"young HSC, middle-aged HSC, old HSC"	Microarray (Affymetrix HG-U133_Plus_2 (GPL570 and A-AFFY-44))	leukomics	Homo sapiens	4.3	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	MHP LinCD34+CD38CD90+CD45RA  adult	hematopoietic multipotent progenitor	MHP	adult	hematopoietic multipotent progenitor	Progenitor
GSM813005;6661	6661	Pang	GSM813005	Middle HSC Donor 56yrs rep 4	Homo sapiens	middle-aged HSC	CL:0000837		hematopoietic multipotent progenitor			Pang	"In the human hematopoietic system, aging is associated with decreased bone marrow cellularity, decreased adaptive immune system function, and increased incidence of anemia and other hematological disorders and malignancies. Recent studies in mice suggest that changes within the hematopoietic stem cell (HSC) population during aging contribute significantly to the manifestation of these age-associated hematopoietic pathologies. Though the mouse HSC population has been shown to change both quantitatively and functionally with age, changes in the human HSC and progenitor cell populations during aging have been incompletely characterized. To elucidate the properties of an aged human hematopoietic system that may predispose to age-associated hematopoietic dysfunction, we evaluated immunophenotypic HSC and other hematopoietic progenitor populations from healthy, hematologically normal young and elderly human bone marrow samples. We found that aged immunophenotypic human HSC increase in frequency, are less quiescent, and exhibit myeloid-biased differentiation potential compared with young HSC. Gene expression profiling revealed that aged immunophenotypic human HSC transcriptionally up-regulate genes associated with cell cycle, myeloid lineage specification, and myeloid malignancies. These age-associated alterations in the frequency, developmental potential, and gene expression profile of human HSC are similar to those changes observed in mouse HSC, suggesting that hematopoietic aging is an evolutionarily conserved process. Abstract from Proc Natl Acad Sci U S A. 2011 Dec 13;108(50):20012-7. doi: 10.1073/pnas.1116110108."	27	"young HSC, middle-aged HSC, old HSC"	Microarray (Affymetrix HG-U133_Plus_2 (GPL570 and A-AFFY-44))	leukomics	Homo sapiens	4.3	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	MHP LinCD34+CD38CD90+CD45RA  adult	hematopoietic multipotent progenitor	MHP	adult	hematopoietic multipotent progenitor	Progenitor
GSM813006;6661	6661	Pang	GSM813006	Middle HSC Donor 56yrs rep 5	Homo sapiens	middle-aged HSC	CL:0000837		hematopoietic multipotent progenitor			Pang	"In the human hematopoietic system, aging is associated with decreased bone marrow cellularity, decreased adaptive immune system function, and increased incidence of anemia and other hematological disorders and malignancies. Recent studies in mice suggest that changes within the hematopoietic stem cell (HSC) population during aging contribute significantly to the manifestation of these age-associated hematopoietic pathologies. Though the mouse HSC population has been shown to change both quantitatively and functionally with age, changes in the human HSC and progenitor cell populations during aging have been incompletely characterized. To elucidate the properties of an aged human hematopoietic system that may predispose to age-associated hematopoietic dysfunction, we evaluated immunophenotypic HSC and other hematopoietic progenitor populations from healthy, hematologically normal young and elderly human bone marrow samples. We found that aged immunophenotypic human HSC increase in frequency, are less quiescent, and exhibit myeloid-biased differentiation potential compared with young HSC. Gene expression profiling revealed that aged immunophenotypic human HSC transcriptionally up-regulate genes associated with cell cycle, myeloid lineage specification, and myeloid malignancies. These age-associated alterations in the frequency, developmental potential, and gene expression profile of human HSC are similar to those changes observed in mouse HSC, suggesting that hematopoietic aging is an evolutionarily conserved process. Abstract from Proc Natl Acad Sci U S A. 2011 Dec 13;108(50):20012-7. doi: 10.1073/pnas.1116110108."	27	"young HSC, middle-aged HSC, old HSC"	Microarray (Affymetrix HG-U133_Plus_2 (GPL570 and A-AFFY-44))	leukomics	Homo sapiens	4.3	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	MHP LinCD34+CD38CD90+CD45RA  adult	hematopoietic multipotent progenitor	MHP	adult	hematopoietic multipotent progenitor	Progenitor
GSM813007;6661	6661	Pang	GSM813007	Old HSC Donor 75 yrs rep 1	Homo sapiens	old HSC	CL:0000837		hematopoietic multipotent progenitor			Pang	"In the human hematopoietic system, aging is associated with decreased bone marrow cellularity, decreased adaptive immune system function, and increased incidence of anemia and other hematological disorders and malignancies. Recent studies in mice suggest that changes within the hematopoietic stem cell (HSC) population during aging contribute significantly to the manifestation of these age-associated hematopoietic pathologies. Though the mouse HSC population has been shown to change both quantitatively and functionally with age, changes in the human HSC and progenitor cell populations during aging have been incompletely characterized. To elucidate the properties of an aged human hematopoietic system that may predispose to age-associated hematopoietic dysfunction, we evaluated immunophenotypic HSC and other hematopoietic progenitor populations from healthy, hematologically normal young and elderly human bone marrow samples. We found that aged immunophenotypic human HSC increase in frequency, are less quiescent, and exhibit myeloid-biased differentiation potential compared with young HSC. Gene expression profiling revealed that aged immunophenotypic human HSC transcriptionally up-regulate genes associated with cell cycle, myeloid lineage specification, and myeloid malignancies. These age-associated alterations in the frequency, developmental potential, and gene expression profile of human HSC are similar to those changes observed in mouse HSC, suggesting that hematopoietic aging is an evolutionarily conserved process. Abstract from Proc Natl Acad Sci U S A. 2011 Dec 13;108(50):20012-7. doi: 10.1073/pnas.1116110108."	27	"young HSC, middle-aged HSC, old HSC"	Microarray (Affymetrix HG-U133_Plus_2 (GPL570 and A-AFFY-44))	leukomics	Homo sapiens	4.3	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	MHP LinCD34+CD38CD90+CD45RA elderly donor adult	hematopoietic multipotent progenitor	MHP	adult	hematopoietic multipotent progenitor	Progenitor
GSM813008;6661	6661	Pang	GSM813008	Old HSC Donor 73 yrs rep 2	Homo sapiens	old HSC	CL:0000837		hematopoietic multipotent progenitor			Pang	"In the human hematopoietic system, aging is associated with decreased bone marrow cellularity, decreased adaptive immune system function, and increased incidence of anemia and other hematological disorders and malignancies. Recent studies in mice suggest that changes within the hematopoietic stem cell (HSC) population during aging contribute significantly to the manifestation of these age-associated hematopoietic pathologies. Though the mouse HSC population has been shown to change both quantitatively and functionally with age, changes in the human HSC and progenitor cell populations during aging have been incompletely characterized. To elucidate the properties of an aged human hematopoietic system that may predispose to age-associated hematopoietic dysfunction, we evaluated immunophenotypic HSC and other hematopoietic progenitor populations from healthy, hematologically normal young and elderly human bone marrow samples. We found that aged immunophenotypic human HSC increase in frequency, are less quiescent, and exhibit myeloid-biased differentiation potential compared with young HSC. Gene expression profiling revealed that aged immunophenotypic human HSC transcriptionally up-regulate genes associated with cell cycle, myeloid lineage specification, and myeloid malignancies. These age-associated alterations in the frequency, developmental potential, and gene expression profile of human HSC are similar to those changes observed in mouse HSC, suggesting that hematopoietic aging is an evolutionarily conserved process. Abstract from Proc Natl Acad Sci U S A. 2011 Dec 13;108(50):20012-7. doi: 10.1073/pnas.1116110108."	27	"young HSC, middle-aged HSC, old HSC"	Microarray (Affymetrix HG-U133_Plus_2 (GPL570 and A-AFFY-44))	leukomics	Homo sapiens	4.3	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	MHP LinCD34+CD38CD90+CD45RA elderly donor adult	hematopoietic multipotent progenitor	MHP	adult	hematopoietic multipotent progenitor	Progenitor
GSM813009;6661	6661	Pang	GSM813009	Old HSC Donor 69 yrs rep 3	Homo sapiens	old HSC	CL:0000837		hematopoietic multipotent progenitor			Pang	"In the human hematopoietic system, aging is associated with decreased bone marrow cellularity, decreased adaptive immune system function, and increased incidence of anemia and other hematological disorders and malignancies. Recent studies in mice suggest that changes within the hematopoietic stem cell (HSC) population during aging contribute significantly to the manifestation of these age-associated hematopoietic pathologies. Though the mouse HSC population has been shown to change both quantitatively and functionally with age, changes in the human HSC and progenitor cell populations during aging have been incompletely characterized. To elucidate the properties of an aged human hematopoietic system that may predispose to age-associated hematopoietic dysfunction, we evaluated immunophenotypic HSC and other hematopoietic progenitor populations from healthy, hematologically normal young and elderly human bone marrow samples. We found that aged immunophenotypic human HSC increase in frequency, are less quiescent, and exhibit myeloid-biased differentiation potential compared with young HSC. Gene expression profiling revealed that aged immunophenotypic human HSC transcriptionally up-regulate genes associated with cell cycle, myeloid lineage specification, and myeloid malignancies. These age-associated alterations in the frequency, developmental potential, and gene expression profile of human HSC are similar to those changes observed in mouse HSC, suggesting that hematopoietic aging is an evolutionarily conserved process. Abstract from Proc Natl Acad Sci U S A. 2011 Dec 13;108(50):20012-7. doi: 10.1073/pnas.1116110108."	27	"young HSC, middle-aged HSC, old HSC"	Microarray (Affymetrix HG-U133_Plus_2 (GPL570 and A-AFFY-44))	leukomics	Homo sapiens	4.3	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	MHP LinCD34+CD38CD90+CD45RA elderly donor adult	hematopoietic multipotent progenitor	MHP	adult	hematopoietic multipotent progenitor	Progenitor
GSM813010;6661	6661	Pang	GSM813010	Old HSC Donor 65 yrs rep 4	Homo sapiens	old HSC	CL:0000837		hematopoietic multipotent progenitor			Pang	"In the human hematopoietic system, aging is associated with decreased bone marrow cellularity, decreased adaptive immune system function, and increased incidence of anemia and other hematological disorders and malignancies. Recent studies in mice suggest that changes within the hematopoietic stem cell (HSC) population during aging contribute significantly to the manifestation of these age-associated hematopoietic pathologies. Though the mouse HSC population has been shown to change both quantitatively and functionally with age, changes in the human HSC and progenitor cell populations during aging have been incompletely characterized. To elucidate the properties of an aged human hematopoietic system that may predispose to age-associated hematopoietic dysfunction, we evaluated immunophenotypic HSC and other hematopoietic progenitor populations from healthy, hematologically normal young and elderly human bone marrow samples. We found that aged immunophenotypic human HSC increase in frequency, are less quiescent, and exhibit myeloid-biased differentiation potential compared with young HSC. Gene expression profiling revealed that aged immunophenotypic human HSC transcriptionally up-regulate genes associated with cell cycle, myeloid lineage specification, and myeloid malignancies. These age-associated alterations in the frequency, developmental potential, and gene expression profile of human HSC are similar to those changes observed in mouse HSC, suggesting that hematopoietic aging is an evolutionarily conserved process. Abstract from Proc Natl Acad Sci U S A. 2011 Dec 13;108(50):20012-7. doi: 10.1073/pnas.1116110108."	27	"young HSC, middle-aged HSC, old HSC"	Microarray (Affymetrix HG-U133_Plus_2 (GPL570 and A-AFFY-44))	leukomics	Homo sapiens	4.3	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	MHP LinCD34+CD38CD90+CD45RA elderly donor adult	hematopoietic multipotent progenitor	MHP	adult	hematopoietic multipotent progenitor	Progenitor
GSM813011;6661	6661	Pang	GSM813011	Old HSC Donor 67 yrs rep 5	Homo sapiens	old HSC	CL:0000837		hematopoietic multipotent progenitor			Pang	"In the human hematopoietic system, aging is associated with decreased bone marrow cellularity, decreased adaptive immune system function, and increased incidence of anemia and other hematological disorders and malignancies. Recent studies in mice suggest that changes within the hematopoietic stem cell (HSC) population during aging contribute significantly to the manifestation of these age-associated hematopoietic pathologies. Though the mouse HSC population has been shown to change both quantitatively and functionally with age, changes in the human HSC and progenitor cell populations during aging have been incompletely characterized. To elucidate the properties of an aged human hematopoietic system that may predispose to age-associated hematopoietic dysfunction, we evaluated immunophenotypic HSC and other hematopoietic progenitor populations from healthy, hematologically normal young and elderly human bone marrow samples. We found that aged immunophenotypic human HSC increase in frequency, are less quiescent, and exhibit myeloid-biased differentiation potential compared with young HSC. Gene expression profiling revealed that aged immunophenotypic human HSC transcriptionally up-regulate genes associated with cell cycle, myeloid lineage specification, and myeloid malignancies. These age-associated alterations in the frequency, developmental potential, and gene expression profile of human HSC are similar to those changes observed in mouse HSC, suggesting that hematopoietic aging is an evolutionarily conserved process. Abstract from Proc Natl Acad Sci U S A. 2011 Dec 13;108(50):20012-7. doi: 10.1073/pnas.1116110108."	27	"young HSC, middle-aged HSC, old HSC"	Microarray (Affymetrix HG-U133_Plus_2 (GPL570 and A-AFFY-44))	leukomics	Homo sapiens	4.3	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	MHP LinCD34+CD38CD90+CD45RA elderly donor adult	hematopoietic multipotent progenitor	MHP	adult	hematopoietic multipotent progenitor	Progenitor
GSM813012;6661	6661	Pang	GSM813012	Old HSC Donor 84 yrs rep 6	Homo sapiens	old HSC	CL:0000837		hematopoietic multipotent progenitor			Pang	"In the human hematopoietic system, aging is associated with decreased bone marrow cellularity, decreased adaptive immune system function, and increased incidence of anemia and other hematological disorders and malignancies. Recent studies in mice suggest that changes within the hematopoietic stem cell (HSC) population during aging contribute significantly to the manifestation of these age-associated hematopoietic pathologies. Though the mouse HSC population has been shown to change both quantitatively and functionally with age, changes in the human HSC and progenitor cell populations during aging have been incompletely characterized. To elucidate the properties of an aged human hematopoietic system that may predispose to age-associated hematopoietic dysfunction, we evaluated immunophenotypic HSC and other hematopoietic progenitor populations from healthy, hematologically normal young and elderly human bone marrow samples. We found that aged immunophenotypic human HSC increase in frequency, are less quiescent, and exhibit myeloid-biased differentiation potential compared with young HSC. Gene expression profiling revealed that aged immunophenotypic human HSC transcriptionally up-regulate genes associated with cell cycle, myeloid lineage specification, and myeloid malignancies. These age-associated alterations in the frequency, developmental potential, and gene expression profile of human HSC are similar to those changes observed in mouse HSC, suggesting that hematopoietic aging is an evolutionarily conserved process. Abstract from Proc Natl Acad Sci U S A. 2011 Dec 13;108(50):20012-7. doi: 10.1073/pnas.1116110108."	27	"young HSC, middle-aged HSC, old HSC"	Microarray (Affymetrix HG-U133_Plus_2 (GPL570 and A-AFFY-44))	leukomics	Homo sapiens	4.3	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	MHP LinCD34+CD38CD90+CD45RA elderly donor adult	hematopoietic multipotent progenitor	MHP	adult	hematopoietic multipotent progenitor	Progenitor
GSM813013;6661	6661	Pang	GSM813013	Old HSC Donor 83 yrs rep 7	Homo sapiens	old HSC	CL:0000837		hematopoietic multipotent progenitor			Pang	"In the human hematopoietic system, aging is associated with decreased bone marrow cellularity, decreased adaptive immune system function, and increased incidence of anemia and other hematological disorders and malignancies. Recent studies in mice suggest that changes within the hematopoietic stem cell (HSC) population during aging contribute significantly to the manifestation of these age-associated hematopoietic pathologies. Though the mouse HSC population has been shown to change both quantitatively and functionally with age, changes in the human HSC and progenitor cell populations during aging have been incompletely characterized. To elucidate the properties of an aged human hematopoietic system that may predispose to age-associated hematopoietic dysfunction, we evaluated immunophenotypic HSC and other hematopoietic progenitor populations from healthy, hematologically normal young and elderly human bone marrow samples. We found that aged immunophenotypic human HSC increase in frequency, are less quiescent, and exhibit myeloid-biased differentiation potential compared with young HSC. Gene expression profiling revealed that aged immunophenotypic human HSC transcriptionally up-regulate genes associated with cell cycle, myeloid lineage specification, and myeloid malignancies. These age-associated alterations in the frequency, developmental potential, and gene expression profile of human HSC are similar to those changes observed in mouse HSC, suggesting that hematopoietic aging is an evolutionarily conserved process. Abstract from Proc Natl Acad Sci U S A. 2011 Dec 13;108(50):20012-7. doi: 10.1073/pnas.1116110108."	27	"young HSC, middle-aged HSC, old HSC"	Microarray (Affymetrix HG-U133_Plus_2 (GPL570 and A-AFFY-44))	leukomics	Homo sapiens	4.3	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	MHP LinCD34+CD38CD90+CD45RA elderly donor adult	hematopoietic multipotent progenitor	MHP	adult	hematopoietic multipotent progenitor	Progenitor
GSM813014;6661	6661	Pang	GSM813014	Old HSC Donor 76 yrs rep 8	Homo sapiens	old HSC	CL:0000837		hematopoietic multipotent progenitor			Pang	"In the human hematopoietic system, aging is associated with decreased bone marrow cellularity, decreased adaptive immune system function, and increased incidence of anemia and other hematological disorders and malignancies. Recent studies in mice suggest that changes within the hematopoietic stem cell (HSC) population during aging contribute significantly to the manifestation of these age-associated hematopoietic pathologies. Though the mouse HSC population has been shown to change both quantitatively and functionally with age, changes in the human HSC and progenitor cell populations during aging have been incompletely characterized. To elucidate the properties of an aged human hematopoietic system that may predispose to age-associated hematopoietic dysfunction, we evaluated immunophenotypic HSC and other hematopoietic progenitor populations from healthy, hematologically normal young and elderly human bone marrow samples. We found that aged immunophenotypic human HSC increase in frequency, are less quiescent, and exhibit myeloid-biased differentiation potential compared with young HSC. Gene expression profiling revealed that aged immunophenotypic human HSC transcriptionally up-regulate genes associated with cell cycle, myeloid lineage specification, and myeloid malignancies. These age-associated alterations in the frequency, developmental potential, and gene expression profile of human HSC are similar to those changes observed in mouse HSC, suggesting that hematopoietic aging is an evolutionarily conserved process. Abstract from Proc Natl Acad Sci U S A. 2011 Dec 13;108(50):20012-7. doi: 10.1073/pnas.1116110108."	27	"young HSC, middle-aged HSC, old HSC"	Microarray (Affymetrix HG-U133_Plus_2 (GPL570 and A-AFFY-44))	leukomics	Homo sapiens	4.3	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	MHP LinCD34+CD38CD90+CD45RA elderly donor adult	hematopoietic multipotent progenitor	MHP	adult	hematopoietic multipotent progenitor	Progenitor
GSM868877;6638	6638	Haniffa	GSM868877	Blood Monocyte CD14+ CD16- donor bd-I	Homo sapiens	CD14+ CD16- Mo	CL:0000576		monocyte			Haniffa	"Dendritic cell (DC)-mediated cross-presentation of exogenous antigens acquired in the periphery is critical for the initiation of CD8+ T cell responses. Several DC subsets are described in human tissues but migratory cross-presenting DCs have not been isolated, despite their potential importance in immunity to pathogens, vaccines, and tumors and tolerance to self. Here, we identified a CD141hi DC present in human interstitial dermis, liver, and lung that was distinct from the majority of CD1c+ and CD14+ tissue DCs and superior at cross-presenting soluble antigens. Cutaneous CD141hi DCs were closely related to blood CD141+ DCs, and migratory counterparts were found among skin-draining lymph node DCs. Comparative transcriptomic analysis with mouse showed tissue DC subsets to be conserved between species and permitted close alignment of human and mouse DC subsets. These studies inform the rational design of targeted immunotherapies and facilitate translation of mouse functional DC biology to the human setting."	49	"CD16+ CD14lo Mo, CD14+ CD16- Mo, CD14+ CD16+ Mo, blood CD1c+ DC, blood CD141+ DC, skin CD1c+ DC, skin CD1c+ CD141+ DC, skin CD141+ DC, skin CD14+ DC, pDC"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	5.7	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+ CD16-  adult	myeloid	Monocyte	adult	monocyte	Circulating Monocyte & Granulocyte
GSM868878;6638	6638	Haniffa	GSM868878	Blood Monocyte CD16+ CD14lo donor bd-I	Homo sapiens	CD16+ CD14lo Mo	CL:0000576		monocyte			Haniffa	"Dendritic cell (DC)-mediated cross-presentation of exogenous antigens acquired in the periphery is critical for the initiation of CD8+ T cell responses. Several DC subsets are described in human tissues but migratory cross-presenting DCs have not been isolated, despite their potential importance in immunity to pathogens, vaccines, and tumors and tolerance to self. Here, we identified a CD141hi DC present in human interstitial dermis, liver, and lung that was distinct from the majority of CD1c+ and CD14+ tissue DCs and superior at cross-presenting soluble antigens. Cutaneous CD141hi DCs were closely related to blood CD141+ DCs, and migratory counterparts were found among skin-draining lymph node DCs. Comparative transcriptomic analysis with mouse showed tissue DC subsets to be conserved between species and permitted close alignment of human and mouse DC subsets. These studies inform the rational design of targeted immunotherapies and facilitate translation of mouse functional DC biology to the human setting."	49	"CD16+ CD14lo Mo, CD14+ CD16- Mo, CD14+ CD16+ Mo, blood CD1c+ DC, blood CD141+ DC, skin CD1c+ DC, skin CD1c+ CD141+ DC, skin CD141+ DC, skin CD14+ DC, pDC"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	5.7	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD16+ CD14lo  adult	myeloid	Monocyte	adult	monocyte	Circulating Monocyte & Granulocyte
GSM868879;6638	6638	Haniffa	GSM868879	Blood plasmacytoid dendritic cell donor pdc-1	Homo sapiens	pDC	CL:0000784		plasmacytoid dendritic cell			Haniffa	"Dendritic cell (DC)-mediated cross-presentation of exogenous antigens acquired in the periphery is critical for the initiation of CD8+ T cell responses. Several DC subsets are described in human tissues but migratory cross-presenting DCs have not been isolated, despite their potential importance in immunity to pathogens, vaccines, and tumors and tolerance to self. Here, we identified a CD141hi DC present in human interstitial dermis, liver, and lung that was distinct from the majority of CD1c+ and CD14+ tissue DCs and superior at cross-presenting soluble antigens. Cutaneous CD141hi DCs were closely related to blood CD141+ DCs, and migratory counterparts were found among skin-draining lymph node DCs. Comparative transcriptomic analysis with mouse showed tissue DC subsets to be conserved between species and permitted close alignment of human and mouse DC subsets. These studies inform the rational design of targeted immunotherapies and facilitate translation of mouse functional DC biology to the human setting."	49	"CD16+ CD14lo Mo, CD14+ CD16- Mo, CD14+ CD16+ Mo, blood CD1c+ DC, blood CD141+ DC, skin CD1c+ DC, skin CD1c+ CD141+ DC, skin CD141+ DC, skin CD14+ DC, pDC"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	5.7	Illumina V4	"rgb(146,0,0)"	diamond	p-DC CD45+ HLA-DR+ Lin- CD14- CD16- CD123+  adult	myeloid	p-DC	adult	plasmacytoid dendritic cell	Mixed
GSM868880;6638	6638	Haniffa	GSM868880	Blood plasmacytoid dendritic cell donor pdc-2	Homo sapiens	pDC	CL:0000784		plasmacytoid dendritic cell			Haniffa	"Dendritic cell (DC)-mediated cross-presentation of exogenous antigens acquired in the periphery is critical for the initiation of CD8+ T cell responses. Several DC subsets are described in human tissues but migratory cross-presenting DCs have not been isolated, despite their potential importance in immunity to pathogens, vaccines, and tumors and tolerance to self. Here, we identified a CD141hi DC present in human interstitial dermis, liver, and lung that was distinct from the majority of CD1c+ and CD14+ tissue DCs and superior at cross-presenting soluble antigens. Cutaneous CD141hi DCs were closely related to blood CD141+ DCs, and migratory counterparts were found among skin-draining lymph node DCs. Comparative transcriptomic analysis with mouse showed tissue DC subsets to be conserved between species and permitted close alignment of human and mouse DC subsets. These studies inform the rational design of targeted immunotherapies and facilitate translation of mouse functional DC biology to the human setting."	49	"CD16+ CD14lo Mo, CD14+ CD16- Mo, CD14+ CD16+ Mo, blood CD1c+ DC, blood CD141+ DC, skin CD1c+ DC, skin CD1c+ CD141+ DC, skin CD141+ DC, skin CD14+ DC, pDC"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	5.7	Illumina V4	"rgb(146,0,0)"	diamond	p-DC CD45+ HLA-DR+ Lin- CD14- CD16- CD123+  adult	myeloid	p-DC	adult	plasmacytoid dendritic cell	Mixed
GSM868881;6638	6638	Haniffa	GSM868881	Blood plasmacytoid dendritic cell donor pdc-3	Homo sapiens	pDC	CL:0000784		plasmacytoid dendritic cell			Haniffa	"Dendritic cell (DC)-mediated cross-presentation of exogenous antigens acquired in the periphery is critical for the initiation of CD8+ T cell responses. Several DC subsets are described in human tissues but migratory cross-presenting DCs have not been isolated, despite their potential importance in immunity to pathogens, vaccines, and tumors and tolerance to self. Here, we identified a CD141hi DC present in human interstitial dermis, liver, and lung that was distinct from the majority of CD1c+ and CD14+ tissue DCs and superior at cross-presenting soluble antigens. Cutaneous CD141hi DCs were closely related to blood CD141+ DCs, and migratory counterparts were found among skin-draining lymph node DCs. Comparative transcriptomic analysis with mouse showed tissue DC subsets to be conserved between species and permitted close alignment of human and mouse DC subsets. These studies inform the rational design of targeted immunotherapies and facilitate translation of mouse functional DC biology to the human setting."	49	"CD16+ CD14lo Mo, CD14+ CD16- Mo, CD14+ CD16+ Mo, blood CD1c+ DC, blood CD141+ DC, skin CD1c+ DC, skin CD1c+ CD141+ DC, skin CD141+ DC, skin CD14+ DC, pDC"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	5.7	Illumina V4	"rgb(146,0,0)"	diamond	p-DC CD45+ HLA-DR+ Lin- CD14- CD16- CD123+  adult	myeloid	p-DC	adult	plasmacytoid dendritic cell	Mixed
GSM868882;6638	6638	Haniffa	GSM868882	Blood plasmacytoid dendritic cell donor pdc-4	Homo sapiens	pDC	CL:0000784		plasmacytoid dendritic cell			Haniffa	"Dendritic cell (DC)-mediated cross-presentation of exogenous antigens acquired in the periphery is critical for the initiation of CD8+ T cell responses. Several DC subsets are described in human tissues but migratory cross-presenting DCs have not been isolated, despite their potential importance in immunity to pathogens, vaccines, and tumors and tolerance to self. Here, we identified a CD141hi DC present in human interstitial dermis, liver, and lung that was distinct from the majority of CD1c+ and CD14+ tissue DCs and superior at cross-presenting soluble antigens. Cutaneous CD141hi DCs were closely related to blood CD141+ DCs, and migratory counterparts were found among skin-draining lymph node DCs. Comparative transcriptomic analysis with mouse showed tissue DC subsets to be conserved between species and permitted close alignment of human and mouse DC subsets. These studies inform the rational design of targeted immunotherapies and facilitate translation of mouse functional DC biology to the human setting."	49	"CD16+ CD14lo Mo, CD14+ CD16- Mo, CD14+ CD16+ Mo, blood CD1c+ DC, blood CD141+ DC, skin CD1c+ DC, skin CD1c+ CD141+ DC, skin CD141+ DC, skin CD14+ DC, pDC"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	5.7	Illumina V4	"rgb(146,0,0)"	diamond	p-DC CD45+ HLA-DR+ Lin- CD14- CD16- CD123+  adult	myeloid	p-DC	adult	plasmacytoid dendritic cell	Mixed
GSM868883;6638	6638	Haniffa	GSM868883	Blood Monocyte CD14+ CD16+ donor mono-1	Homo sapiens	CD14+ CD16+ Mo	CL:0000576		monocyte			Haniffa	"Dendritic cell (DC)-mediated cross-presentation of exogenous antigens acquired in the periphery is critical for the initiation of CD8+ T cell responses. Several DC subsets are described in human tissues but migratory cross-presenting DCs have not been isolated, despite their potential importance in immunity to pathogens, vaccines, and tumors and tolerance to self. Here, we identified a CD141hi DC present in human interstitial dermis, liver, and lung that was distinct from the majority of CD1c+ and CD14+ tissue DCs and superior at cross-presenting soluble antigens. Cutaneous CD141hi DCs were closely related to blood CD141+ DCs, and migratory counterparts were found among skin-draining lymph node DCs. Comparative transcriptomic analysis with mouse showed tissue DC subsets to be conserved between species and permitted close alignment of human and mouse DC subsets. These studies inform the rational design of targeted immunotherapies and facilitate translation of mouse functional DC biology to the human setting."	49	"CD16+ CD14lo Mo, CD14+ CD16- Mo, CD14+ CD16+ Mo, blood CD1c+ DC, blood CD141+ DC, skin CD1c+ DC, skin CD1c+ CD141+ DC, skin CD141+ DC, skin CD14+ DC, pDC"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	5.7	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+ CD16+  adult	myeloid	Monocyte	adult	monocyte	Circulating Monocyte & Granulocyte
GSM868884;6638	6638	Haniffa	GSM868884	Blood Monocyte CD14+ CD16+ donor mono-2	Homo sapiens	CD14+ CD16+ Mo	CL:0000576		monocyte			Haniffa	"Dendritic cell (DC)-mediated cross-presentation of exogenous antigens acquired in the periphery is critical for the initiation of CD8+ T cell responses. Several DC subsets are described in human tissues but migratory cross-presenting DCs have not been isolated, despite their potential importance in immunity to pathogens, vaccines, and tumors and tolerance to self. Here, we identified a CD141hi DC present in human interstitial dermis, liver, and lung that was distinct from the majority of CD1c+ and CD14+ tissue DCs and superior at cross-presenting soluble antigens. Cutaneous CD141hi DCs were closely related to blood CD141+ DCs, and migratory counterparts were found among skin-draining lymph node DCs. Comparative transcriptomic analysis with mouse showed tissue DC subsets to be conserved between species and permitted close alignment of human and mouse DC subsets. These studies inform the rational design of targeted immunotherapies and facilitate translation of mouse functional DC biology to the human setting."	49	"CD16+ CD14lo Mo, CD14+ CD16- Mo, CD14+ CD16+ Mo, blood CD1c+ DC, blood CD141+ DC, skin CD1c+ DC, skin CD1c+ CD141+ DC, skin CD141+ DC, skin CD14+ DC, pDC"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	5.7	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+ CD16+  adult	myeloid	Monocyte	adult	monocyte	Circulating Monocyte & Granulocyte
GSM868885;6638	6638	Haniffa	GSM868885	Blood Monocyte CD14+ CD16+ donor mono-3	Homo sapiens	CD14+ CD16+ Mo	CL:0000576		monocyte			Haniffa	"Dendritic cell (DC)-mediated cross-presentation of exogenous antigens acquired in the periphery is critical for the initiation of CD8+ T cell responses. Several DC subsets are described in human tissues but migratory cross-presenting DCs have not been isolated, despite their potential importance in immunity to pathogens, vaccines, and tumors and tolerance to self. Here, we identified a CD141hi DC present in human interstitial dermis, liver, and lung that was distinct from the majority of CD1c+ and CD14+ tissue DCs and superior at cross-presenting soluble antigens. Cutaneous CD141hi DCs were closely related to blood CD141+ DCs, and migratory counterparts were found among skin-draining lymph node DCs. Comparative transcriptomic analysis with mouse showed tissue DC subsets to be conserved between species and permitted close alignment of human and mouse DC subsets. These studies inform the rational design of targeted immunotherapies and facilitate translation of mouse functional DC biology to the human setting."	49	"CD16+ CD14lo Mo, CD14+ CD16- Mo, CD14+ CD16+ Mo, blood CD1c+ DC, blood CD141+ DC, skin CD1c+ DC, skin CD1c+ CD141+ DC, skin CD141+ DC, skin CD14+ DC, pDC"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	5.7	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+ CD16+  adult	myeloid	Monocyte	adult	monocyte	Circulating Monocyte & Granulocyte
GSM868886;6638	6638	Haniffa	GSM868886	Blood Monocyte CD14+ CD16+ donor mono-4	Homo sapiens	CD14+ CD16+ Mo	CL:0000576		monocyte			Haniffa	"Dendritic cell (DC)-mediated cross-presentation of exogenous antigens acquired in the periphery is critical for the initiation of CD8+ T cell responses. Several DC subsets are described in human tissues but migratory cross-presenting DCs have not been isolated, despite their potential importance in immunity to pathogens, vaccines, and tumors and tolerance to self. Here, we identified a CD141hi DC present in human interstitial dermis, liver, and lung that was distinct from the majority of CD1c+ and CD14+ tissue DCs and superior at cross-presenting soluble antigens. Cutaneous CD141hi DCs were closely related to blood CD141+ DCs, and migratory counterparts were found among skin-draining lymph node DCs. Comparative transcriptomic analysis with mouse showed tissue DC subsets to be conserved between species and permitted close alignment of human and mouse DC subsets. These studies inform the rational design of targeted immunotherapies and facilitate translation of mouse functional DC biology to the human setting."	49	"CD16+ CD14lo Mo, CD14+ CD16- Mo, CD14+ CD16+ Mo, blood CD1c+ DC, blood CD141+ DC, skin CD1c+ DC, skin CD1c+ CD141+ DC, skin CD141+ DC, skin CD14+ DC, pDC"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	5.7	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+ CD16+  adult	myeloid	Monocyte	adult	monocyte	Circulating Monocyte & Granulocyte
GSM868887;6638	6638	Haniffa	GSM868887	Blood Monocyte CD14+ CD16+ donor mono-5	Homo sapiens	CD14+ CD16+ Mo	CL:0000576		monocyte			Haniffa	"Dendritic cell (DC)-mediated cross-presentation of exogenous antigens acquired in the periphery is critical for the initiation of CD8+ T cell responses. Several DC subsets are described in human tissues but migratory cross-presenting DCs have not been isolated, despite their potential importance in immunity to pathogens, vaccines, and tumors and tolerance to self. Here, we identified a CD141hi DC present in human interstitial dermis, liver, and lung that was distinct from the majority of CD1c+ and CD14+ tissue DCs and superior at cross-presenting soluble antigens. Cutaneous CD141hi DCs were closely related to blood CD141+ DCs, and migratory counterparts were found among skin-draining lymph node DCs. Comparative transcriptomic analysis with mouse showed tissue DC subsets to be conserved between species and permitted close alignment of human and mouse DC subsets. These studies inform the rational design of targeted immunotherapies and facilitate translation of mouse functional DC biology to the human setting."	49	"CD16+ CD14lo Mo, CD14+ CD16- Mo, CD14+ CD16+ Mo, blood CD1c+ DC, blood CD141+ DC, skin CD1c+ DC, skin CD1c+ CD141+ DC, skin CD141+ DC, skin CD14+ DC, pDC"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	5.7	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+ CD16+  adult	myeloid	Monocyte	adult	monocyte	Circulating Monocyte & Granulocyte
GSM868888;6638	6638	Haniffa	GSM868888	Blood Monocyte CD14+ CD16+ donor mono-6	Homo sapiens	CD14+ CD16+ Mo	CL:0000576		monocyte			Haniffa	"Dendritic cell (DC)-mediated cross-presentation of exogenous antigens acquired in the periphery is critical for the initiation of CD8+ T cell responses. Several DC subsets are described in human tissues but migratory cross-presenting DCs have not been isolated, despite their potential importance in immunity to pathogens, vaccines, and tumors and tolerance to self. Here, we identified a CD141hi DC present in human interstitial dermis, liver, and lung that was distinct from the majority of CD1c+ and CD14+ tissue DCs and superior at cross-presenting soluble antigens. Cutaneous CD141hi DCs were closely related to blood CD141+ DCs, and migratory counterparts were found among skin-draining lymph node DCs. Comparative transcriptomic analysis with mouse showed tissue DC subsets to be conserved between species and permitted close alignment of human and mouse DC subsets. These studies inform the rational design of targeted immunotherapies and facilitate translation of mouse functional DC biology to the human setting."	49	"CD16+ CD14lo Mo, CD14+ CD16- Mo, CD14+ CD16+ Mo, blood CD1c+ DC, blood CD141+ DC, skin CD1c+ DC, skin CD1c+ CD141+ DC, skin CD141+ DC, skin CD14+ DC, pDC"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	5.7	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+ CD16+  adult	myeloid	Monocyte	adult	monocyte	Circulating Monocyte & Granulocyte
GSM868889;6638	6638	Haniffa	GSM868889	Blood Monocyte CD14+ CD16- donor mono-1	Homo sapiens	CD14+ CD16- Mo	CL:0000576		monocyte			Haniffa	"Dendritic cell (DC)-mediated cross-presentation of exogenous antigens acquired in the periphery is critical for the initiation of CD8+ T cell responses. Several DC subsets are described in human tissues but migratory cross-presenting DCs have not been isolated, despite their potential importance in immunity to pathogens, vaccines, and tumors and tolerance to self. Here, we identified a CD141hi DC present in human interstitial dermis, liver, and lung that was distinct from the majority of CD1c+ and CD14+ tissue DCs and superior at cross-presenting soluble antigens. Cutaneous CD141hi DCs were closely related to blood CD141+ DCs, and migratory counterparts were found among skin-draining lymph node DCs. Comparative transcriptomic analysis with mouse showed tissue DC subsets to be conserved between species and permitted close alignment of human and mouse DC subsets. These studies inform the rational design of targeted immunotherapies and facilitate translation of mouse functional DC biology to the human setting."	49	"CD16+ CD14lo Mo, CD14+ CD16- Mo, CD14+ CD16+ Mo, blood CD1c+ DC, blood CD141+ DC, skin CD1c+ DC, skin CD1c+ CD141+ DC, skin CD141+ DC, skin CD14+ DC, pDC"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	5.7	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+ CD16-  adult	myeloid	Monocyte	adult	monocyte	Circulating Monocyte & Granulocyte
GSM868890;6638	6638	Haniffa	GSM868890	Blood Monocyte CD14+ CD16- donor mono-2	Homo sapiens	CD14+ CD16- Mo	CL:0000576		monocyte			Haniffa	"Dendritic cell (DC)-mediated cross-presentation of exogenous antigens acquired in the periphery is critical for the initiation of CD8+ T cell responses. Several DC subsets are described in human tissues but migratory cross-presenting DCs have not been isolated, despite their potential importance in immunity to pathogens, vaccines, and tumors and tolerance to self. Here, we identified a CD141hi DC present in human interstitial dermis, liver, and lung that was distinct from the majority of CD1c+ and CD14+ tissue DCs and superior at cross-presenting soluble antigens. Cutaneous CD141hi DCs were closely related to blood CD141+ DCs, and migratory counterparts were found among skin-draining lymph node DCs. Comparative transcriptomic analysis with mouse showed tissue DC subsets to be conserved between species and permitted close alignment of human and mouse DC subsets. These studies inform the rational design of targeted immunotherapies and facilitate translation of mouse functional DC biology to the human setting."	49	"CD16+ CD14lo Mo, CD14+ CD16- Mo, CD14+ CD16+ Mo, blood CD1c+ DC, blood CD141+ DC, skin CD1c+ DC, skin CD1c+ CD141+ DC, skin CD141+ DC, skin CD14+ DC, pDC"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	5.7	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+ CD16-  adult	myeloid	Monocyte	adult	monocyte	Circulating Monocyte & Granulocyte
GSM868891;6638	6638	Haniffa	GSM868891	Blood Monocyte CD14+ CD16- donor mono-3	Homo sapiens	CD14+ CD16- Mo	CL:0000576		monocyte			Haniffa	"Dendritic cell (DC)-mediated cross-presentation of exogenous antigens acquired in the periphery is critical for the initiation of CD8+ T cell responses. Several DC subsets are described in human tissues but migratory cross-presenting DCs have not been isolated, despite their potential importance in immunity to pathogens, vaccines, and tumors and tolerance to self. Here, we identified a CD141hi DC present in human interstitial dermis, liver, and lung that was distinct from the majority of CD1c+ and CD14+ tissue DCs and superior at cross-presenting soluble antigens. Cutaneous CD141hi DCs were closely related to blood CD141+ DCs, and migratory counterparts were found among skin-draining lymph node DCs. Comparative transcriptomic analysis with mouse showed tissue DC subsets to be conserved between species and permitted close alignment of human and mouse DC subsets. These studies inform the rational design of targeted immunotherapies and facilitate translation of mouse functional DC biology to the human setting."	49	"CD16+ CD14lo Mo, CD14+ CD16- Mo, CD14+ CD16+ Mo, blood CD1c+ DC, blood CD141+ DC, skin CD1c+ DC, skin CD1c+ CD141+ DC, skin CD141+ DC, skin CD14+ DC, pDC"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	5.7	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+ CD16-  adult	myeloid	Monocyte	adult	monocyte	Circulating Monocyte & Granulocyte
GSM868892;6638	6638	Haniffa	GSM868892	Blood Monocyte CD14+ CD16- donor mono-4	Homo sapiens	CD14+ CD16- Mo	CL:0000576		monocyte			Haniffa	"Dendritic cell (DC)-mediated cross-presentation of exogenous antigens acquired in the periphery is critical for the initiation of CD8+ T cell responses. Several DC subsets are described in human tissues but migratory cross-presenting DCs have not been isolated, despite their potential importance in immunity to pathogens, vaccines, and tumors and tolerance to self. Here, we identified a CD141hi DC present in human interstitial dermis, liver, and lung that was distinct from the majority of CD1c+ and CD14+ tissue DCs and superior at cross-presenting soluble antigens. Cutaneous CD141hi DCs were closely related to blood CD141+ DCs, and migratory counterparts were found among skin-draining lymph node DCs. Comparative transcriptomic analysis with mouse showed tissue DC subsets to be conserved between species and permitted close alignment of human and mouse DC subsets. These studies inform the rational design of targeted immunotherapies and facilitate translation of mouse functional DC biology to the human setting."	49	"CD16+ CD14lo Mo, CD14+ CD16- Mo, CD14+ CD16+ Mo, blood CD1c+ DC, blood CD141+ DC, skin CD1c+ DC, skin CD1c+ CD141+ DC, skin CD141+ DC, skin CD14+ DC, pDC"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	5.7	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+ CD16-  adult	myeloid	Monocyte	adult	monocyte	Circulating Monocyte & Granulocyte
GSM868893;6638	6638	Haniffa	GSM868893	Blood Monocyte CD14+ CD16- donor mono-5	Homo sapiens	CD14+ CD16- Mo	CL:0000576		monocyte			Haniffa	"Dendritic cell (DC)-mediated cross-presentation of exogenous antigens acquired in the periphery is critical for the initiation of CD8+ T cell responses. Several DC subsets are described in human tissues but migratory cross-presenting DCs have not been isolated, despite their potential importance in immunity to pathogens, vaccines, and tumors and tolerance to self. Here, we identified a CD141hi DC present in human interstitial dermis, liver, and lung that was distinct from the majority of CD1c+ and CD14+ tissue DCs and superior at cross-presenting soluble antigens. Cutaneous CD141hi DCs were closely related to blood CD141+ DCs, and migratory counterparts were found among skin-draining lymph node DCs. Comparative transcriptomic analysis with mouse showed tissue DC subsets to be conserved between species and permitted close alignment of human and mouse DC subsets. These studies inform the rational design of targeted immunotherapies and facilitate translation of mouse functional DC biology to the human setting."	49	"CD16+ CD14lo Mo, CD14+ CD16- Mo, CD14+ CD16+ Mo, blood CD1c+ DC, blood CD141+ DC, skin CD1c+ DC, skin CD1c+ CD141+ DC, skin CD141+ DC, skin CD14+ DC, pDC"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	5.7	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD14+ CD16-  adult	myeloid	Monocyte	adult	monocyte	Circulating Monocyte & Granulocyte
GSM868894;6638	6638	Haniffa	GSM868894	Blood Dendritic Cell CD141+ donor dc-1	Homo sapiens	blood CD141+ DC	CL:0002394		CD141+ dendritic cell			Haniffa	"Dendritic cell (DC)-mediated cross-presentation of exogenous antigens acquired in the periphery is critical for the initiation of CD8+ T cell responses. Several DC subsets are described in human tissues but migratory cross-presenting DCs have not been isolated, despite their potential importance in immunity to pathogens, vaccines, and tumors and tolerance to self. Here, we identified a CD141hi DC present in human interstitial dermis, liver, and lung that was distinct from the majority of CD1c+ and CD14+ tissue DCs and superior at cross-presenting soluble antigens. Cutaneous CD141hi DCs were closely related to blood CD141+ DCs, and migratory counterparts were found among skin-draining lymph node DCs. Comparative transcriptomic analysis with mouse showed tissue DC subsets to be conserved between species and permitted close alignment of human and mouse DC subsets. These studies inform the rational design of targeted immunotherapies and facilitate translation of mouse functional DC biology to the human setting."	49	"CD16+ CD14lo Mo, CD14+ CD16- Mo, CD14+ CD16+ Mo, blood CD1c+ DC, blood CD141+ DC, skin CD1c+ DC, skin CD1c+ CD141+ DC, skin CD141+ DC, skin CD14+ DC, pDC"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	5.7	Illumina V4	"rgb(146,0,0)"	diamond	c-DC CD45+ HLA-DR+ Lin- CD14- CD16- CD141+  adult	myeloid	c-DC	adult	CD141+ dendritic cell	Mixed
GSM868895;6638	6638	Haniffa	GSM868895	Blood Dendritic Cell CD141+ donor dc-2	Homo sapiens	blood CD141+ DC	CL:0002394		CD141+ dendritic cell			Haniffa	"Dendritic cell (DC)-mediated cross-presentation of exogenous antigens acquired in the periphery is critical for the initiation of CD8+ T cell responses. Several DC subsets are described in human tissues but migratory cross-presenting DCs have not been isolated, despite their potential importance in immunity to pathogens, vaccines, and tumors and tolerance to self. Here, we identified a CD141hi DC present in human interstitial dermis, liver, and lung that was distinct from the majority of CD1c+ and CD14+ tissue DCs and superior at cross-presenting soluble antigens. Cutaneous CD141hi DCs were closely related to blood CD141+ DCs, and migratory counterparts were found among skin-draining lymph node DCs. Comparative transcriptomic analysis with mouse showed tissue DC subsets to be conserved between species and permitted close alignment of human and mouse DC subsets. These studies inform the rational design of targeted immunotherapies and facilitate translation of mouse functional DC biology to the human setting."	49	"CD16+ CD14lo Mo, CD14+ CD16- Mo, CD14+ CD16+ Mo, blood CD1c+ DC, blood CD141+ DC, skin CD1c+ DC, skin CD1c+ CD141+ DC, skin CD141+ DC, skin CD14+ DC, pDC"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	5.7	Illumina V4	"rgb(146,0,0)"	diamond	c-DC CD45+ HLA-DR+ Lin- CD14- CD16- CD141+  adult	myeloid	c-DC	adult	CD141+ dendritic cell	Mixed
GSM868896;6638	6638	Haniffa	GSM868896	Blood Dendritic Cell CD141+ donor dc-3	Homo sapiens	blood CD141+ DC	CL:0002394		CD141+ dendritic cell			Haniffa	"Dendritic cell (DC)-mediated cross-presentation of exogenous antigens acquired in the periphery is critical for the initiation of CD8+ T cell responses. Several DC subsets are described in human tissues but migratory cross-presenting DCs have not been isolated, despite their potential importance in immunity to pathogens, vaccines, and tumors and tolerance to self. Here, we identified a CD141hi DC present in human interstitial dermis, liver, and lung that was distinct from the majority of CD1c+ and CD14+ tissue DCs and superior at cross-presenting soluble antigens. Cutaneous CD141hi DCs were closely related to blood CD141+ DCs, and migratory counterparts were found among skin-draining lymph node DCs. Comparative transcriptomic analysis with mouse showed tissue DC subsets to be conserved between species and permitted close alignment of human and mouse DC subsets. These studies inform the rational design of targeted immunotherapies and facilitate translation of mouse functional DC biology to the human setting."	49	"CD16+ CD14lo Mo, CD14+ CD16- Mo, CD14+ CD16+ Mo, blood CD1c+ DC, blood CD141+ DC, skin CD1c+ DC, skin CD1c+ CD141+ DC, skin CD141+ DC, skin CD14+ DC, pDC"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	5.7	Illumina V4	"rgb(146,0,0)"	diamond	c-DC CD45+ HLA-DR+ Lin- CD14- CD16- CD141+  adult	myeloid	c-DC	adult	CD141+ dendritic cell	Mixed
GSM868897;6638	6638	Haniffa	GSM868897	Blood Dendritic Cell CD141+ donor dc-4	Homo sapiens	blood CD141+ DC	CL:0002394		CD141+ dendritic cell			Haniffa	"Dendritic cell (DC)-mediated cross-presentation of exogenous antigens acquired in the periphery is critical for the initiation of CD8+ T cell responses. Several DC subsets are described in human tissues but migratory cross-presenting DCs have not been isolated, despite their potential importance in immunity to pathogens, vaccines, and tumors and tolerance to self. Here, we identified a CD141hi DC present in human interstitial dermis, liver, and lung that was distinct from the majority of CD1c+ and CD14+ tissue DCs and superior at cross-presenting soluble antigens. Cutaneous CD141hi DCs were closely related to blood CD141+ DCs, and migratory counterparts were found among skin-draining lymph node DCs. Comparative transcriptomic analysis with mouse showed tissue DC subsets to be conserved between species and permitted close alignment of human and mouse DC subsets. These studies inform the rational design of targeted immunotherapies and facilitate translation of mouse functional DC biology to the human setting."	49	"CD16+ CD14lo Mo, CD14+ CD16- Mo, CD14+ CD16+ Mo, blood CD1c+ DC, blood CD141+ DC, skin CD1c+ DC, skin CD1c+ CD141+ DC, skin CD141+ DC, skin CD14+ DC, pDC"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	5.7	Illumina V4	"rgb(146,0,0)"	diamond	c-DC CD45+ HLA-DR+ Lin- CD14- CD16- CD141+  adult	myeloid	c-DC	adult	CD141+ dendritic cell	Mixed
GSM868898;6638	6638	Haniffa	GSM868898	Blood Dendritic Cell CD141+ donor dc-5	Homo sapiens	blood CD141+ DC	CL:0002394		CD141+ dendritic cell			Haniffa	"Dendritic cell (DC)-mediated cross-presentation of exogenous antigens acquired in the periphery is critical for the initiation of CD8+ T cell responses. Several DC subsets are described in human tissues but migratory cross-presenting DCs have not been isolated, despite their potential importance in immunity to pathogens, vaccines, and tumors and tolerance to self. Here, we identified a CD141hi DC present in human interstitial dermis, liver, and lung that was distinct from the majority of CD1c+ and CD14+ tissue DCs and superior at cross-presenting soluble antigens. Cutaneous CD141hi DCs were closely related to blood CD141+ DCs, and migratory counterparts were found among skin-draining lymph node DCs. Comparative transcriptomic analysis with mouse showed tissue DC subsets to be conserved between species and permitted close alignment of human and mouse DC subsets. These studies inform the rational design of targeted immunotherapies and facilitate translation of mouse functional DC biology to the human setting."	49	"CD16+ CD14lo Mo, CD14+ CD16- Mo, CD14+ CD16+ Mo, blood CD1c+ DC, blood CD141+ DC, skin CD1c+ DC, skin CD1c+ CD141+ DC, skin CD141+ DC, skin CD14+ DC, pDC"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	5.7	Illumina V4	"rgb(146,0,0)"	diamond	c-DC CD45+ HLA-DR+ Lin- CD14- CD16- CD141+  adult	myeloid	c-DC	adult	CD141+ dendritic cell	Mixed
GSM868899;6638	6638	Haniffa	GSM868899	Blood Monocyte CD16+ CD14lo donor mono-1	Homo sapiens	CD16+ CD14lo Mo	CL:0000576		monocyte			Haniffa	"Dendritic cell (DC)-mediated cross-presentation of exogenous antigens acquired in the periphery is critical for the initiation of CD8+ T cell responses. Several DC subsets are described in human tissues but migratory cross-presenting DCs have not been isolated, despite their potential importance in immunity to pathogens, vaccines, and tumors and tolerance to self. Here, we identified a CD141hi DC present in human interstitial dermis, liver, and lung that was distinct from the majority of CD1c+ and CD14+ tissue DCs and superior at cross-presenting soluble antigens. Cutaneous CD141hi DCs were closely related to blood CD141+ DCs, and migratory counterparts were found among skin-draining lymph node DCs. Comparative transcriptomic analysis with mouse showed tissue DC subsets to be conserved between species and permitted close alignment of human and mouse DC subsets. These studies inform the rational design of targeted immunotherapies and facilitate translation of mouse functional DC biology to the human setting."	49	"CD16+ CD14lo Mo, CD14+ CD16- Mo, CD14+ CD16+ Mo, blood CD1c+ DC, blood CD141+ DC, skin CD1c+ DC, skin CD1c+ CD141+ DC, skin CD141+ DC, skin CD14+ DC, pDC"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	5.7	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD16+ CD14lo  adult	myeloid	Monocyte	adult	monocyte	Circulating Monocyte & Granulocyte
GSM868900;6638	6638	Haniffa	GSM868900	Blood Monocyte CD16+ CD14lo donor mono-2	Homo sapiens	CD16+ CD14lo Mo	CL:0000576		monocyte			Haniffa	"Dendritic cell (DC)-mediated cross-presentation of exogenous antigens acquired in the periphery is critical for the initiation of CD8+ T cell responses. Several DC subsets are described in human tissues but migratory cross-presenting DCs have not been isolated, despite their potential importance in immunity to pathogens, vaccines, and tumors and tolerance to self. Here, we identified a CD141hi DC present in human interstitial dermis, liver, and lung that was distinct from the majority of CD1c+ and CD14+ tissue DCs and superior at cross-presenting soluble antigens. Cutaneous CD141hi DCs were closely related to blood CD141+ DCs, and migratory counterparts were found among skin-draining lymph node DCs. Comparative transcriptomic analysis with mouse showed tissue DC subsets to be conserved between species and permitted close alignment of human and mouse DC subsets. These studies inform the rational design of targeted immunotherapies and facilitate translation of mouse functional DC biology to the human setting."	49	"CD16+ CD14lo Mo, CD14+ CD16- Mo, CD14+ CD16+ Mo, blood CD1c+ DC, blood CD141+ DC, skin CD1c+ DC, skin CD1c+ CD141+ DC, skin CD141+ DC, skin CD14+ DC, pDC"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	5.7	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD16+ CD14lo  adult	myeloid	Monocyte	adult	monocyte	Circulating Monocyte & Granulocyte
GSM868901;6638	6638	Haniffa	GSM868901	Blood Monocyte CD16+ CD14lo donor mono-3	Homo sapiens	CD16+ CD14lo Mo	CL:0000576		monocyte			Haniffa	"Dendritic cell (DC)-mediated cross-presentation of exogenous antigens acquired in the periphery is critical for the initiation of CD8+ T cell responses. Several DC subsets are described in human tissues but migratory cross-presenting DCs have not been isolated, despite their potential importance in immunity to pathogens, vaccines, and tumors and tolerance to self. Here, we identified a CD141hi DC present in human interstitial dermis, liver, and lung that was distinct from the majority of CD1c+ and CD14+ tissue DCs and superior at cross-presenting soluble antigens. Cutaneous CD141hi DCs were closely related to blood CD141+ DCs, and migratory counterparts were found among skin-draining lymph node DCs. Comparative transcriptomic analysis with mouse showed tissue DC subsets to be conserved between species and permitted close alignment of human and mouse DC subsets. These studies inform the rational design of targeted immunotherapies and facilitate translation of mouse functional DC biology to the human setting."	49	"CD16+ CD14lo Mo, CD14+ CD16- Mo, CD14+ CD16+ Mo, blood CD1c+ DC, blood CD141+ DC, skin CD1c+ DC, skin CD1c+ CD141+ DC, skin CD141+ DC, skin CD14+ DC, pDC"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	5.7	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD16+ CD14lo  adult	myeloid	Monocyte	adult	monocyte	Circulating Monocyte & Granulocyte
GSM868902;6638	6638	Haniffa	GSM868902	Blood Monocyte CD16+ CD14lo donor mono-4	Homo sapiens	CD16+ CD14lo Mo	CL:0000576		monocyte			Haniffa	"Dendritic cell (DC)-mediated cross-presentation of exogenous antigens acquired in the periphery is critical for the initiation of CD8+ T cell responses. Several DC subsets are described in human tissues but migratory cross-presenting DCs have not been isolated, despite their potential importance in immunity to pathogens, vaccines, and tumors and tolerance to self. Here, we identified a CD141hi DC present in human interstitial dermis, liver, and lung that was distinct from the majority of CD1c+ and CD14+ tissue DCs and superior at cross-presenting soluble antigens. Cutaneous CD141hi DCs were closely related to blood CD141+ DCs, and migratory counterparts were found among skin-draining lymph node DCs. Comparative transcriptomic analysis with mouse showed tissue DC subsets to be conserved between species and permitted close alignment of human and mouse DC subsets. These studies inform the rational design of targeted immunotherapies and facilitate translation of mouse functional DC biology to the human setting."	49	"CD16+ CD14lo Mo, CD14+ CD16- Mo, CD14+ CD16+ Mo, blood CD1c+ DC, blood CD141+ DC, skin CD1c+ DC, skin CD1c+ CD141+ DC, skin CD141+ DC, skin CD14+ DC, pDC"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	5.7	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD16+ CD14lo  adult	myeloid	Monocyte	adult	monocyte	Circulating Monocyte & Granulocyte
GSM868903;6638	6638	Haniffa	GSM868903	Blood Monocyte CD16+ CD14lo donor mono-5	Homo sapiens	CD16+ CD14lo Mo	CL:0000576		monocyte			Haniffa	"Dendritic cell (DC)-mediated cross-presentation of exogenous antigens acquired in the periphery is critical for the initiation of CD8+ T cell responses. Several DC subsets are described in human tissues but migratory cross-presenting DCs have not been isolated, despite their potential importance in immunity to pathogens, vaccines, and tumors and tolerance to self. Here, we identified a CD141hi DC present in human interstitial dermis, liver, and lung that was distinct from the majority of CD1c+ and CD14+ tissue DCs and superior at cross-presenting soluble antigens. Cutaneous CD141hi DCs were closely related to blood CD141+ DCs, and migratory counterparts were found among skin-draining lymph node DCs. Comparative transcriptomic analysis with mouse showed tissue DC subsets to be conserved between species and permitted close alignment of human and mouse DC subsets. These studies inform the rational design of targeted immunotherapies and facilitate translation of mouse functional DC biology to the human setting."	49	"CD16+ CD14lo Mo, CD14+ CD16- Mo, CD14+ CD16+ Mo, blood CD1c+ DC, blood CD141+ DC, skin CD1c+ DC, skin CD1c+ CD141+ DC, skin CD141+ DC, skin CD14+ DC, pDC"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	5.7	Illumina V4	"rgb(146,0,0)"	diamond	Monocyte CD16+ CD14lo  adult	myeloid	Monocyte	adult	monocyte	Circulating Monocyte & Granulocyte
GSM868904;6638	6638	Haniffa	GSM868904	Blood Dendritic Cell CD1c+ donor dc-1	Homo sapiens	blood CD1c+ DC	CL:0002399		CD1c+ dendritic cell			Haniffa	"Dendritic cell (DC)-mediated cross-presentation of exogenous antigens acquired in the periphery is critical for the initiation of CD8+ T cell responses. Several DC subsets are described in human tissues but migratory cross-presenting DCs have not been isolated, despite their potential importance in immunity to pathogens, vaccines, and tumors and tolerance to self. Here, we identified a CD141hi DC present in human interstitial dermis, liver, and lung that was distinct from the majority of CD1c+ and CD14+ tissue DCs and superior at cross-presenting soluble antigens. Cutaneous CD141hi DCs were closely related to blood CD141+ DCs, and migratory counterparts were found among skin-draining lymph node DCs. Comparative transcriptomic analysis with mouse showed tissue DC subsets to be conserved between species and permitted close alignment of human and mouse DC subsets. These studies inform the rational design of targeted immunotherapies and facilitate translation of mouse functional DC biology to the human setting."	49	"CD16+ CD14lo Mo, CD14+ CD16- Mo, CD14+ CD16+ Mo, blood CD1c+ DC, blood CD141+ DC, skin CD1c+ DC, skin CD1c+ CD141+ DC, skin CD141+ DC, skin CD14+ DC, pDC"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	5.7	Illumina V4	"rgb(146,0,0)"	diamond	c-DC CD45+  HLA-DR+ CD14- CD16- CD123- CD11c+ CD1c+  adult	myeloid	c-DC	adult	CD1c+ dendritic cell	Mixed
GSM868905;6638	6638	Haniffa	GSM868905	Blood Dendritic Cell CD1c+ donor dc-2	Homo sapiens	blood CD1c+ DC	CL:0002399		CD1c+ dendritic cell			Haniffa	"Dendritic cell (DC)-mediated cross-presentation of exogenous antigens acquired in the periphery is critical for the initiation of CD8+ T cell responses. Several DC subsets are described in human tissues but migratory cross-presenting DCs have not been isolated, despite their potential importance in immunity to pathogens, vaccines, and tumors and tolerance to self. Here, we identified a CD141hi DC present in human interstitial dermis, liver, and lung that was distinct from the majority of CD1c+ and CD14+ tissue DCs and superior at cross-presenting soluble antigens. Cutaneous CD141hi DCs were closely related to blood CD141+ DCs, and migratory counterparts were found among skin-draining lymph node DCs. Comparative transcriptomic analysis with mouse showed tissue DC subsets to be conserved between species and permitted close alignment of human and mouse DC subsets. These studies inform the rational design of targeted immunotherapies and facilitate translation of mouse functional DC biology to the human setting."	49	"CD16+ CD14lo Mo, CD14+ CD16- Mo, CD14+ CD16+ Mo, blood CD1c+ DC, blood CD141+ DC, skin CD1c+ DC, skin CD1c+ CD141+ DC, skin CD141+ DC, skin CD14+ DC, pDC"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	5.7	Illumina V4	"rgb(146,0,0)"	diamond	c-DC CD45+  HLA-DR+ CD14- CD16- CD123- CD11c+ CD1c+  adult	myeloid	c-DC	adult	CD1c+ dendritic cell	Mixed
GSM868906;6638	6638	Haniffa	GSM868906	Blood Dendritic Cell CD1c+ donor dc-3	Homo sapiens	blood CD1c+ DC	CL:0002399		CD1c+ dendritic cell			Haniffa	"Dendritic cell (DC)-mediated cross-presentation of exogenous antigens acquired in the periphery is critical for the initiation of CD8+ T cell responses. Several DC subsets are described in human tissues but migratory cross-presenting DCs have not been isolated, despite their potential importance in immunity to pathogens, vaccines, and tumors and tolerance to self. Here, we identified a CD141hi DC present in human interstitial dermis, liver, and lung that was distinct from the majority of CD1c+ and CD14+ tissue DCs and superior at cross-presenting soluble antigens. Cutaneous CD141hi DCs were closely related to blood CD141+ DCs, and migratory counterparts were found among skin-draining lymph node DCs. Comparative transcriptomic analysis with mouse showed tissue DC subsets to be conserved between species and permitted close alignment of human and mouse DC subsets. These studies inform the rational design of targeted immunotherapies and facilitate translation of mouse functional DC biology to the human setting."	49	"CD16+ CD14lo Mo, CD14+ CD16- Mo, CD14+ CD16+ Mo, blood CD1c+ DC, blood CD141+ DC, skin CD1c+ DC, skin CD1c+ CD141+ DC, skin CD141+ DC, skin CD14+ DC, pDC"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	5.7	Illumina V4	"rgb(146,0,0)"	diamond	c-DC CD45+  HLA-DR+ CD14- CD16- CD123- CD11c+ CD1c+  adult	myeloid	c-DC	adult	CD1c+ dendritic cell	Mixed
GSM868907;6638	6638	Haniffa	GSM868907	Blood Dendritic Cell CD1c+ donor dc-4	Homo sapiens	blood CD1c+ DC	CL:0002399		CD1c+ dendritic cell			Haniffa	"Dendritic cell (DC)-mediated cross-presentation of exogenous antigens acquired in the periphery is critical for the initiation of CD8+ T cell responses. Several DC subsets are described in human tissues but migratory cross-presenting DCs have not been isolated, despite their potential importance in immunity to pathogens, vaccines, and tumors and tolerance to self. Here, we identified a CD141hi DC present in human interstitial dermis, liver, and lung that was distinct from the majority of CD1c+ and CD14+ tissue DCs and superior at cross-presenting soluble antigens. Cutaneous CD141hi DCs were closely related to blood CD141+ DCs, and migratory counterparts were found among skin-draining lymph node DCs. Comparative transcriptomic analysis with mouse showed tissue DC subsets to be conserved between species and permitted close alignment of human and mouse DC subsets. These studies inform the rational design of targeted immunotherapies and facilitate translation of mouse functional DC biology to the human setting."	49	"CD16+ CD14lo Mo, CD14+ CD16- Mo, CD14+ CD16+ Mo, blood CD1c+ DC, blood CD141+ DC, skin CD1c+ DC, skin CD1c+ CD141+ DC, skin CD141+ DC, skin CD14+ DC, pDC"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	5.7	Illumina V4	"rgb(146,0,0)"	diamond	c-DC CD45+  HLA-DR+ CD14- CD16- CD123- CD11c+ CD1c+  adult	myeloid	c-DC	adult	CD1c+ dendritic cell	Mixed
GSM868908;6638	6638	Haniffa	GSM868908	Blood Dendritic Cell CD1c+ donor dc-5	Homo sapiens	blood CD1c+ DC	CL:0002399		CD1c+ dendritic cell			Haniffa	"Dendritic cell (DC)-mediated cross-presentation of exogenous antigens acquired in the periphery is critical for the initiation of CD8+ T cell responses. Several DC subsets are described in human tissues but migratory cross-presenting DCs have not been isolated, despite their potential importance in immunity to pathogens, vaccines, and tumors and tolerance to self. Here, we identified a CD141hi DC present in human interstitial dermis, liver, and lung that was distinct from the majority of CD1c+ and CD14+ tissue DCs and superior at cross-presenting soluble antigens. Cutaneous CD141hi DCs were closely related to blood CD141+ DCs, and migratory counterparts were found among skin-draining lymph node DCs. Comparative transcriptomic analysis with mouse showed tissue DC subsets to be conserved between species and permitted close alignment of human and mouse DC subsets. These studies inform the rational design of targeted immunotherapies and facilitate translation of mouse functional DC biology to the human setting."	49	"CD16+ CD14lo Mo, CD14+ CD16- Mo, CD14+ CD16+ Mo, blood CD1c+ DC, blood CD141+ DC, skin CD1c+ DC, skin CD1c+ CD141+ DC, skin CD141+ DC, skin CD14+ DC, pDC"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	5.7	Illumina V4	"rgb(146,0,0)"	diamond	c-DC CD45+  HLA-DR+ CD14- CD16- CD123- CD11c+ CD1c+  adult	myeloid	c-DC	adult	CD1c+ dendritic cell	Mixed
GSM868909;6638	6638	Haniffa	GSM868909	Blood Dendritic Cell CD1c+ donor dc-6	Homo sapiens	blood CD1c+ DC	CL:0002399		CD1c+ dendritic cell			Haniffa	"Dendritic cell (DC)-mediated cross-presentation of exogenous antigens acquired in the periphery is critical for the initiation of CD8+ T cell responses. Several DC subsets are described in human tissues but migratory cross-presenting DCs have not been isolated, despite their potential importance in immunity to pathogens, vaccines, and tumors and tolerance to self. Here, we identified a CD141hi DC present in human interstitial dermis, liver, and lung that was distinct from the majority of CD1c+ and CD14+ tissue DCs and superior at cross-presenting soluble antigens. Cutaneous CD141hi DCs were closely related to blood CD141+ DCs, and migratory counterparts were found among skin-draining lymph node DCs. Comparative transcriptomic analysis with mouse showed tissue DC subsets to be conserved between species and permitted close alignment of human and mouse DC subsets. These studies inform the rational design of targeted immunotherapies and facilitate translation of mouse functional DC biology to the human setting."	49	"CD16+ CD14lo Mo, CD14+ CD16- Mo, CD14+ CD16+ Mo, blood CD1c+ DC, blood CD141+ DC, skin CD1c+ DC, skin CD1c+ CD141+ DC, skin CD141+ DC, skin CD14+ DC, pDC"	Microarray (Illumina HumanHT-12 V4)		Homo sapiens	5.7	Illumina V4	"rgb(146,0,0)"	diamond	c-DC CD45+ HLA-DR+ CD14- CD16- CD123- CD11c+ CD1c+  adult	myeloid	c-DC	adult	CD1c+ dendritic cell	Mixed
GSM994840;6463	6463	Segura	GSM994840	CD14+CD16- monocytes donor 1	Homo sapiens	CD14+CD16- Mo	CL:0000576		monocyte	female		Segura	"Dendritic cells (DCs) are critical regulators of immune responses. Under noninflammatory conditions, several human DC subsets have been identified. Little is known, however, about the human DC compartment under inflammatory conditions. Here, we characterize a DC population found in human inflammatory fluids that displayed a phenotype distinct from macrophages from the same fluids and from steady-state lymphoid organ and blood DCs. Transcriptome analysis showed that they correspond to a distinct DC subset and share gene signatures with in vitro monocyte-derived DCs. Moreover, human inflammatory DCs, but not inflammatory macrophages, stimulated autologous memory CD4(+) T cells to produce interleukin-17 and induce T helper 17 (Th17) cell differentiation from naive CD4(+) T cells through the selective secretion of Th17 cell-polarizing cytokines. We conclude that inflammatory DCs represent a distinct human DC subset and propose that they are derived from monocytes and are involved in the induction and maintenance of Th17 cell responses. Abstract from Immunity. 2013 Feb 21;38(2):336-48."	20	"CD14dim CD16- Mo, CD14+CD16- Mo, TAM, BDCA1+ DC, Ascites CD1c"	Microarray (Affymetrix HuGene-1_1-ST (GPL11532))		Homo sapiens	3.04	HuGene	"rgb(0,109,219)"	diamond-open	TRM lymph node CD14+CD16-  adult	myeloid	TRM	adult	monocyte	Circulating Monocyte & Granulocyte
GSM994841;6463	6463	Segura	GSM994841	CD14dimCD16+ monocytes donor 1	Homo sapiens	CD14dim CD16- Mo	CL:0000576		monocyte	female		Segura	"Dendritic cells (DCs) are critical regulators of immune responses. Under noninflammatory conditions, several human DC subsets have been identified. Little is known, however, about the human DC compartment under inflammatory conditions. Here, we characterize a DC population found in human inflammatory fluids that displayed a phenotype distinct from macrophages from the same fluids and from steady-state lymphoid organ and blood DCs. Transcriptome analysis showed that they correspond to a distinct DC subset and share gene signatures with in vitro monocyte-derived DCs. Moreover, human inflammatory DCs, but not inflammatory macrophages, stimulated autologous memory CD4(+) T cells to produce interleukin-17 and induce T helper 17 (Th17) cell differentiation from naive CD4(+) T cells through the selective secretion of Th17 cell-polarizing cytokines. We conclude that inflammatory DCs represent a distinct human DC subset and propose that they are derived from monocytes and are involved in the induction and maintenance of Th17 cell responses. Abstract from Immunity. 2013 Feb 21;38(2):336-48."	20	"CD14dim CD16- Mo, CD14+CD16- Mo, TAM, BDCA1+ DC, Ascites CD1c"	Microarray (Affymetrix HuGene-1_1-ST (GPL11532))		Homo sapiens	3.04	HuGene	"rgb(0,109,219)"	diamond-open	TRM lymph node CD14dimCD16+  adult	myeloid	TRM	adult	monocyte	Circulating Monocyte & Granulocyte
GSM994842;6463	6463	Segura	GSM994842	Dendritic cells BDCA1 donor 1	Homo sapiens	BDCA1+ DC	CL:0002399		CD1c+ dendritic cell	female		Segura	"Dendritic cells (DCs) are critical regulators of immune responses. Under noninflammatory conditions, several human DC subsets have been identified. Little is known, however, about the human DC compartment under inflammatory conditions. Here, we characterize a DC population found in human inflammatory fluids that displayed a phenotype distinct from macrophages from the same fluids and from steady-state lymphoid organ and blood DCs. Transcriptome analysis showed that they correspond to a distinct DC subset and share gene signatures with in vitro monocyte-derived DCs. Moreover, human inflammatory DCs, but not inflammatory macrophages, stimulated autologous memory CD4(+) T cells to produce interleukin-17 and induce T helper 17 (Th17) cell differentiation from naive CD4(+) T cells through the selective secretion of Th17 cell-polarizing cytokines. We conclude that inflammatory DCs represent a distinct human DC subset and propose that they are derived from monocytes and are involved in the induction and maintenance of Th17 cell responses. Abstract from Immunity. 2013 Feb 21;38(2):336-48."	20	"CD14dim CD16- Mo, CD14+CD16- Mo, TAM, BDCA1+ DC, Ascites CD1c"	Microarray (Affymetrix HuGene-1_1-ST (GPL11532))		Homo sapiens	3.04	HuGene	"rgb(0,109,219)"	diamond-open	c-DC HLA-DR+CD11c+CD14-CD16-CD1c+  adult	myeloid	c-DC	adult	CD1c+ dendritic cell	Mixed
GSM994843;6463	6463	Segura	GSM994843	CD14+CD16- monocytes donor 2	Homo sapiens	CD14+CD16- Mo	CL:0000576		monocyte	female		Segura	"Dendritic cells (DCs) are critical regulators of immune responses. Under noninflammatory conditions, several human DC subsets have been identified. Little is known, however, about the human DC compartment under inflammatory conditions. Here, we characterize a DC population found in human inflammatory fluids that displayed a phenotype distinct from macrophages from the same fluids and from steady-state lymphoid organ and blood DCs. Transcriptome analysis showed that they correspond to a distinct DC subset and share gene signatures with in vitro monocyte-derived DCs. Moreover, human inflammatory DCs, but not inflammatory macrophages, stimulated autologous memory CD4(+) T cells to produce interleukin-17 and induce T helper 17 (Th17) cell differentiation from naive CD4(+) T cells through the selective secretion of Th17 cell-polarizing cytokines. We conclude that inflammatory DCs represent a distinct human DC subset and propose that they are derived from monocytes and are involved in the induction and maintenance of Th17 cell responses. Abstract from Immunity. 2013 Feb 21;38(2):336-48."	20	"CD14dim CD16- Mo, CD14+CD16- Mo, TAM, BDCA1+ DC, Ascites CD1c"	Microarray (Affymetrix HuGene-1_1-ST (GPL11532))		Homo sapiens	3.04	HuGene	"rgb(0,109,219)"	diamond-open	TRM lymph node CD14+CD16-  adult	myeloid	TRM	adult	monocyte	Circulating Monocyte & Granulocyte
GSM994844;6463	6463	Segura	GSM994844	CD14dimCD16+ monocytes donor 2	Homo sapiens	CD14dim CD16- Mo	CL:0000576		monocyte	female		Segura	"Dendritic cells (DCs) are critical regulators of immune responses. Under noninflammatory conditions, several human DC subsets have been identified. Little is known, however, about the human DC compartment under inflammatory conditions. Here, we characterize a DC population found in human inflammatory fluids that displayed a phenotype distinct from macrophages from the same fluids and from steady-state lymphoid organ and blood DCs. Transcriptome analysis showed that they correspond to a distinct DC subset and share gene signatures with in vitro monocyte-derived DCs. Moreover, human inflammatory DCs, but not inflammatory macrophages, stimulated autologous memory CD4(+) T cells to produce interleukin-17 and induce T helper 17 (Th17) cell differentiation from naive CD4(+) T cells through the selective secretion of Th17 cell-polarizing cytokines. We conclude that inflammatory DCs represent a distinct human DC subset and propose that they are derived from monocytes and are involved in the induction and maintenance of Th17 cell responses. Abstract from Immunity. 2013 Feb 21;38(2):336-48."	20	"CD14dim CD16- Mo, CD14+CD16- Mo, TAM, BDCA1+ DC, Ascites CD1c"	Microarray (Affymetrix HuGene-1_1-ST (GPL11532))		Homo sapiens	3.04	HuGene	"rgb(0,109,219)"	diamond-open	TRM lymph node CD14dimCD16+  adult	myeloid	TRM	adult	monocyte	Circulating Monocyte & Granulocyte
GSM994845;6463	6463	Segura	GSM994845	Dendritic cells BDCA1 donor 2	Homo sapiens	BDCA1+ DC	CL:0002399		CD1c+ dendritic cell	female		Segura	"Dendritic cells (DCs) are critical regulators of immune responses. Under noninflammatory conditions, several human DC subsets have been identified. Little is known, however, about the human DC compartment under inflammatory conditions. Here, we characterize a DC population found in human inflammatory fluids that displayed a phenotype distinct from macrophages from the same fluids and from steady-state lymphoid organ and blood DCs. Transcriptome analysis showed that they correspond to a distinct DC subset and share gene signatures with in vitro monocyte-derived DCs. Moreover, human inflammatory DCs, but not inflammatory macrophages, stimulated autologous memory CD4(+) T cells to produce interleukin-17 and induce T helper 17 (Th17) cell differentiation from naive CD4(+) T cells through the selective secretion of Th17 cell-polarizing cytokines. We conclude that inflammatory DCs represent a distinct human DC subset and propose that they are derived from monocytes and are involved in the induction and maintenance of Th17 cell responses. Abstract from Immunity. 2013 Feb 21;38(2):336-48."	20	"CD14dim CD16- Mo, CD14+CD16- Mo, TAM, BDCA1+ DC, Ascites CD1c"	Microarray (Affymetrix HuGene-1_1-ST (GPL11532))		Homo sapiens	3.04	HuGene	"rgb(0,109,219)"	diamond-open	c-DC HLA-DR+CD11c+CD14-CD16-CD1c+  adult	myeloid	c-DC	adult	CD1c+ dendritic cell	Mixed
GSM994846;6463	6463	Segura	GSM994846	Macrophages inflammatory ascites donor 1	Homo sapiens	TAM	CL:0000235		macrophage	female		Segura	"Dendritic cells (DCs) are critical regulators of immune responses. Under noninflammatory conditions, several human DC subsets have been identified. Little is known, however, about the human DC compartment under inflammatory conditions. Here, we characterize a DC population found in human inflammatory fluids that displayed a phenotype distinct from macrophages from the same fluids and from steady-state lymphoid organ and blood DCs. Transcriptome analysis showed that they correspond to a distinct DC subset and share gene signatures with in vitro monocyte-derived DCs. Moreover, human inflammatory DCs, but not inflammatory macrophages, stimulated autologous memory CD4(+) T cells to produce interleukin-17 and induce T helper 17 (Th17) cell differentiation from naive CD4(+) T cells through the selective secretion of Th17 cell-polarizing cytokines. We conclude that inflammatory DCs represent a distinct human DC subset and propose that they are derived from monocytes and are involved in the induction and maintenance of Th17 cell responses. Abstract from Immunity. 2013 Feb 21;38(2):336-48."	20	"CD14dim CD16- Mo, CD14+CD16- Mo, TAM, BDCA1+ DC, Ascites CD1c"	Microarray (Affymetrix HuGene-1_1-ST (GPL11532))		Homo sapiens	3.04	HuGene	"rgb(0,109,219)"	diamond-open	TRM tumor ascites HLA-DR+ CD11c+ CD16+ BDCA1- FceRI-  adult	myeloid	TRM	adult	macrophage	Macrophage
GSM994847;6463	6463	Segura	GSM994847	Dendritic cells CD11c+ HLA-DR+ CD14+ BDCA1+ FcRI+ CD206+ cells from inflammatory ascites donor 1	Homo sapiens	Ascites CD1c	CL:0000451		dendritic cell	female		Segura	"Dendritic cells (DCs) are critical regulators of immune responses. Under noninflammatory conditions, several human DC subsets have been identified. Little is known, however, about the human DC compartment under inflammatory conditions. Here, we characterize a DC population found in human inflammatory fluids that displayed a phenotype distinct from macrophages from the same fluids and from steady-state lymphoid organ and blood DCs. Transcriptome analysis showed that they correspond to a distinct DC subset and share gene signatures with in vitro monocyte-derived DCs. Moreover, human inflammatory DCs, but not inflammatory macrophages, stimulated autologous memory CD4(+) T cells to produce interleukin-17 and induce T helper 17 (Th17) cell differentiation from naive CD4(+) T cells through the selective secretion of Th17 cell-polarizing cytokines. We conclude that inflammatory DCs represent a distinct human DC subset and propose that they are derived from monocytes and are involved in the induction and maintenance of Th17 cell responses. Abstract from Immunity. 2013 Feb 21;38(2):336-48."	20	"CD14dim CD16- Mo, CD14+CD16- Mo, TAM, BDCA1+ DC, Ascites CD1c"	Microarray (Affymetrix HuGene-1_1-ST (GPL11532))		Homo sapiens	3.04	HuGene	"rgb(0,109,219)"	diamond-open	TRDC synovium HLA-DR+ CD11c+ CD16- CD1c+ FceRI+  adult	myeloid	TRDC	adult	dendritic cell	Macrophage
GSM994848;6463	6463	Segura	GSM994848	Macrophages inflammatory ascites donor 2	Homo sapiens	TAM	CL:0000235		macrophage	female		Segura	"Dendritic cells (DCs) are critical regulators of immune responses. Under noninflammatory conditions, several human DC subsets have been identified. Little is known, however, about the human DC compartment under inflammatory conditions. Here, we characterize a DC population found in human inflammatory fluids that displayed a phenotype distinct from macrophages from the same fluids and from steady-state lymphoid organ and blood DCs. Transcriptome analysis showed that they correspond to a distinct DC subset and share gene signatures with in vitro monocyte-derived DCs. Moreover, human inflammatory DCs, but not inflammatory macrophages, stimulated autologous memory CD4(+) T cells to produce interleukin-17 and induce T helper 17 (Th17) cell differentiation from naive CD4(+) T cells through the selective secretion of Th17 cell-polarizing cytokines. We conclude that inflammatory DCs represent a distinct human DC subset and propose that they are derived from monocytes and are involved in the induction and maintenance of Th17 cell responses. Abstract from Immunity. 2013 Feb 21;38(2):336-48."	20	"CD14dim CD16- Mo, CD14+CD16- Mo, TAM, BDCA1+ DC, Ascites CD1c"	Microarray (Affymetrix HuGene-1_1-ST (GPL11532))		Homo sapiens	3.04	HuGene	"rgb(0,109,219)"	diamond-open	TRM tumor ascites HLA-DR+ CD11c+ CD16+ BDCA1- FceRI-  adult	myeloid	TRM	adult	macrophage	Macrophage
GSM994849;6463	6463	Segura	GSM994849	Dendritic cells CD11c+ HLA-DR+ CD14+ BDCA1+ FcRI+ CD206+ cells from inflammatory ascites donor 2	Homo sapiens	Ascites CD1c	CL:0000451		dendritic cell	female		Segura	"Dendritic cells (DCs) are critical regulators of immune responses. Under noninflammatory conditions, several human DC subsets have been identified. Little is known, however, about the human DC compartment under inflammatory conditions. Here, we characterize a DC population found in human inflammatory fluids that displayed a phenotype distinct from macrophages from the same fluids and from steady-state lymphoid organ and blood DCs. Transcriptome analysis showed that they correspond to a distinct DC subset and share gene signatures with in vitro monocyte-derived DCs. Moreover, human inflammatory DCs, but not inflammatory macrophages, stimulated autologous memory CD4(+) T cells to produce interleukin-17 and induce T helper 17 (Th17) cell differentiation from naive CD4(+) T cells through the selective secretion of Th17 cell-polarizing cytokines. We conclude that inflammatory DCs represent a distinct human DC subset and propose that they are derived from monocytes and are involved in the induction and maintenance of Th17 cell responses. Abstract from Immunity. 2013 Feb 21;38(2):336-48."	20	"CD14dim CD16- Mo, CD14+CD16- Mo, TAM, BDCA1+ DC, Ascites CD1c"	Microarray (Affymetrix HuGene-1_1-ST (GPL11532))		Homo sapiens	3.04	HuGene	"rgb(0,109,219)"	diamond-open	TRDC synovium HLA-DR+ CD11c+ CD16- CD1c+ FceRI+  adult	myeloid	TRDC	adult	dendritic cell	Macrophage
GSM994850;6463	6463	Segura	GSM994850	Dendritic cells CD11c+ HLA-DR+ CD14+ BDCA1+ FcRI+ CD206+ cells from inflammatory ascites donor 3	Homo sapiens	Ascites CD1c	CL:0000451		dendritic cell	female		Segura	"Dendritic cells (DCs) are critical regulators of immune responses. Under noninflammatory conditions, several human DC subsets have been identified. Little is known, however, about the human DC compartment under inflammatory conditions. Here, we characterize a DC population found in human inflammatory fluids that displayed a phenotype distinct from macrophages from the same fluids and from steady-state lymphoid organ and blood DCs. Transcriptome analysis showed that they correspond to a distinct DC subset and share gene signatures with in vitro monocyte-derived DCs. Moreover, human inflammatory DCs, but not inflammatory macrophages, stimulated autologous memory CD4(+) T cells to produce interleukin-17 and induce T helper 17 (Th17) cell differentiation from naive CD4(+) T cells through the selective secretion of Th17 cell-polarizing cytokines. We conclude that inflammatory DCs represent a distinct human DC subset and propose that they are derived from monocytes and are involved in the induction and maintenance of Th17 cell responses. Abstract from Immunity. 2013 Feb 21;38(2):336-48."	20	"CD14dim CD16- Mo, CD14+CD16- Mo, TAM, BDCA1+ DC, Ascites CD1c"	Microarray (Affymetrix HuGene-1_1-ST (GPL11532))		Homo sapiens	3.04	HuGene	"rgb(0,109,219)"	diamond-open	TRDC synovium HLA-DR+ CD11c+ CD16- CD1c+ FceRI+  adult	myeloid	TRDC	adult	dendritic cell	Macrophage
GSM994851;6463	6463	Segura	GSM994851	Macrophages inflammatory ascites donor 3	Homo sapiens	TAM	CL:0000235		macrophage	female		Segura	"Dendritic cells (DCs) are critical regulators of immune responses. Under noninflammatory conditions, several human DC subsets have been identified. Little is known, however, about the human DC compartment under inflammatory conditions. Here, we characterize a DC population found in human inflammatory fluids that displayed a phenotype distinct from macrophages from the same fluids and from steady-state lymphoid organ and blood DCs. Transcriptome analysis showed that they correspond to a distinct DC subset and share gene signatures with in vitro monocyte-derived DCs. Moreover, human inflammatory DCs, but not inflammatory macrophages, stimulated autologous memory CD4(+) T cells to produce interleukin-17 and induce T helper 17 (Th17) cell differentiation from naive CD4(+) T cells through the selective secretion of Th17 cell-polarizing cytokines. We conclude that inflammatory DCs represent a distinct human DC subset and propose that they are derived from monocytes and are involved in the induction and maintenance of Th17 cell responses. Abstract from Immunity. 2013 Feb 21;38(2):336-48."	20	"CD14dim CD16- Mo, CD14+CD16- Mo, TAM, BDCA1+ DC, Ascites CD1c"	Microarray (Affymetrix HuGene-1_1-ST (GPL11532))		Homo sapiens	3.04	HuGene	"rgb(0,109,219)"	diamond-open	TRM tumor ascites HLA-DR+ CD11c+ CD16+ BDCA1- FceRI-  adult	myeloid	TRM	adult	macrophage	Macrophage
GSM994852;6463	6463	Segura	GSM994852	Dendritic cells CD11c+ HLA-DR+ CD14+ BDCA1+ FcRI+ CD206+ cells from inflammatory ascites donor 4	Homo sapiens	Ascites CD1c	CL:0000451		dendritic cell	female		Segura	"Dendritic cells (DCs) are critical regulators of immune responses. Under noninflammatory conditions, several human DC subsets have been identified. Little is known, however, about the human DC compartment under inflammatory conditions. Here, we characterize a DC population found in human inflammatory fluids that displayed a phenotype distinct from macrophages from the same fluids and from steady-state lymphoid organ and blood DCs. Transcriptome analysis showed that they correspond to a distinct DC subset and share gene signatures with in vitro monocyte-derived DCs. Moreover, human inflammatory DCs, but not inflammatory macrophages, stimulated autologous memory CD4(+) T cells to produce interleukin-17 and induce T helper 17 (Th17) cell differentiation from naive CD4(+) T cells through the selective secretion of Th17 cell-polarizing cytokines. We conclude that inflammatory DCs represent a distinct human DC subset and propose that they are derived from monocytes and are involved in the induction and maintenance of Th17 cell responses. Abstract from Immunity. 2013 Feb 21;38(2):336-48."	20	"CD14dim CD16- Mo, CD14+CD16- Mo, TAM, BDCA1+ DC, Ascites CD1c"	Microarray (Affymetrix HuGene-1_1-ST (GPL11532))		Homo sapiens	3.04	HuGene	"rgb(0,109,219)"	diamond-open	TRDC tumor ascites HLA-DR+ CD11c+ CD16- CD1c+ FceRI+  adult	myeloid	TRDC	adult	dendritic cell	Macrophage
GSM994853;6463	6463	Segura	GSM994853	Macrophages inflammatory ascites donor 4	Homo sapiens	TAM	CL:0000235		macrophage	female		Segura	"Dendritic cells (DCs) are critical regulators of immune responses. Under noninflammatory conditions, several human DC subsets have been identified. Little is known, however, about the human DC compartment under inflammatory conditions. Here, we characterize a DC population found in human inflammatory fluids that displayed a phenotype distinct from macrophages from the same fluids and from steady-state lymphoid organ and blood DCs. Transcriptome analysis showed that they correspond to a distinct DC subset and share gene signatures with in vitro monocyte-derived DCs. Moreover, human inflammatory DCs, but not inflammatory macrophages, stimulated autologous memory CD4(+) T cells to produce interleukin-17 and induce T helper 17 (Th17) cell differentiation from naive CD4(+) T cells through the selective secretion of Th17 cell-polarizing cytokines. We conclude that inflammatory DCs represent a distinct human DC subset and propose that they are derived from monocytes and are involved in the induction and maintenance of Th17 cell responses. Abstract from Immunity. 2013 Feb 21;38(2):336-48."	20	"CD14dim CD16- Mo, CD14+CD16- Mo, TAM, BDCA1+ DC, Ascites CD1c"	Microarray (Affymetrix HuGene-1_1-ST (GPL11532))		Homo sapiens	3.04	HuGene	"rgb(0,109,219)"	diamond-open	TRM tumor ascites HLA-DR+ CD11c+ CD16+ BDCA1- FceRI-  adult	myeloid	TRM	adult	macrophage	Macrophage
GSM994856;6463	6463	Segura	GSM994856	CD14+CD16- monocytes donor 3	Homo sapiens	CD14+CD16- Mo	CL:0000576		monocyte	female		Segura	"Dendritic cells (DCs) are critical regulators of immune responses. Under noninflammatory conditions, several human DC subsets have been identified. Little is known, however, about the human DC compartment under inflammatory conditions. Here, we characterize a DC population found in human inflammatory fluids that displayed a phenotype distinct from macrophages from the same fluids and from steady-state lymphoid organ and blood DCs. Transcriptome analysis showed that they correspond to a distinct DC subset and share gene signatures with in vitro monocyte-derived DCs. Moreover, human inflammatory DCs, but not inflammatory macrophages, stimulated autologous memory CD4(+) T cells to produce interleukin-17 and induce T helper 17 (Th17) cell differentiation from naive CD4(+) T cells through the selective secretion of Th17 cell-polarizing cytokines. We conclude that inflammatory DCs represent a distinct human DC subset and propose that they are derived from monocytes and are involved in the induction and maintenance of Th17 cell responses. Abstract from Immunity. 2013 Feb 21;38(2):336-48."	20	"CD14dim CD16- Mo, CD14+CD16- Mo, TAM, BDCA1+ DC, Ascites CD1c"	Microarray (Affymetrix HuGene-1_1-ST (GPL11532))		Homo sapiens	3.04	HuGene	"rgb(0,109,219)"	diamond-open	TRM lymph node CD14+CD16-  adult	myeloid	TRM	adult	monocyte	Circulating Monocyte & Granulocyte
GSM994857;6463	6463	Segura	GSM994857	CD14dimCD16+ monocytes donor 3	Homo sapiens	CD14dim CD16- Mo	CL:0000576		monocyte	female		Segura	"Dendritic cells (DCs) are critical regulators of immune responses. Under noninflammatory conditions, several human DC subsets have been identified. Little is known, however, about the human DC compartment under inflammatory conditions. Here, we characterize a DC population found in human inflammatory fluids that displayed a phenotype distinct from macrophages from the same fluids and from steady-state lymphoid organ and blood DCs. Transcriptome analysis showed that they correspond to a distinct DC subset and share gene signatures with in vitro monocyte-derived DCs. Moreover, human inflammatory DCs, but not inflammatory macrophages, stimulated autologous memory CD4(+) T cells to produce interleukin-17 and induce T helper 17 (Th17) cell differentiation from naive CD4(+) T cells through the selective secretion of Th17 cell-polarizing cytokines. We conclude that inflammatory DCs represent a distinct human DC subset and propose that they are derived from monocytes and are involved in the induction and maintenance of Th17 cell responses. Abstract from Immunity. 2013 Feb 21;38(2):336-48."	20	"CD14dim CD16- Mo, CD14+CD16- Mo, TAM, BDCA1+ DC, Ascites CD1c"	Microarray (Affymetrix HuGene-1_1-ST (GPL11532))		Homo sapiens	3.04	HuGene	"rgb(0,109,219)"	diamond-open	TRM lymph node CD14dimCD16+  adult	myeloid	TRM	adult	monocyte	Circulating Monocyte & Granulocyte
GSM994858;6463	6463	Segura	GSM994858	Dendritic cells BDCA1 donor 3	Homo sapiens	BDCA1+ DC	CL:0002399		CD1c+ dendritic cell	female		Segura	"Dendritic cells (DCs) are critical regulators of immune responses. Under noninflammatory conditions, several human DC subsets have been identified. Little is known, however, about the human DC compartment under inflammatory conditions. Here, we characterize a DC population found in human inflammatory fluids that displayed a phenotype distinct from macrophages from the same fluids and from steady-state lymphoid organ and blood DCs. Transcriptome analysis showed that they correspond to a distinct DC subset and share gene signatures with in vitro monocyte-derived DCs. Moreover, human inflammatory DCs, but not inflammatory macrophages, stimulated autologous memory CD4(+) T cells to produce interleukin-17 and induce T helper 17 (Th17) cell differentiation from naive CD4(+) T cells through the selective secretion of Th17 cell-polarizing cytokines. We conclude that inflammatory DCs represent a distinct human DC subset and propose that they are derived from monocytes and are involved in the induction and maintenance of Th17 cell responses. Abstract from Immunity. 2013 Feb 21;38(2):336-48."	20	"CD14dim CD16- Mo, CD14+CD16- Mo, TAM, BDCA1+ DC, Ascites CD1c"	Microarray (Affymetrix HuGene-1_1-ST (GPL11532))		Homo sapiens	3.04	HuGene	"rgb(0,109,219)"	diamond-open	c-DC HLA-DR+CD11c+CD14-CD16-CD1c+  adult	myeloid	c-DC	adult	CD1c+ dendritic cell	Mixed
GSM994859;6463	6463	Segura	GSM994859	CD14+CD16- monocytes donor 4	Homo sapiens	CD14+CD16- Mo	CL:0000576		monocyte	female		Segura	"Dendritic cells (DCs) are critical regulators of immune responses. Under noninflammatory conditions, several human DC subsets have been identified. Little is known, however, about the human DC compartment under inflammatory conditions. Here, we characterize a DC population found in human inflammatory fluids that displayed a phenotype distinct from macrophages from the same fluids and from steady-state lymphoid organ and blood DCs. Transcriptome analysis showed that they correspond to a distinct DC subset and share gene signatures with in vitro monocyte-derived DCs. Moreover, human inflammatory DCs, but not inflammatory macrophages, stimulated autologous memory CD4(+) T cells to produce interleukin-17 and induce T helper 17 (Th17) cell differentiation from naive CD4(+) T cells through the selective secretion of Th17 cell-polarizing cytokines. We conclude that inflammatory DCs represent a distinct human DC subset and propose that they are derived from monocytes and are involved in the induction and maintenance of Th17 cell responses. Abstract from Immunity. 2013 Feb 21;38(2):336-48."	20	"CD14dim CD16- Mo, CD14+CD16- Mo, TAM, BDCA1+ DC, Ascites CD1c"	Microarray (Affymetrix HuGene-1_1-ST (GPL11532))		Homo sapiens	3.04	HuGene	"rgb(0,109,219)"	diamond-open	TRM lymph node CD14+CD16-  adult	myeloid	TRM	adult	monocyte	Circulating Monocyte & Granulocyte
GSM994860;6463	6463	Segura	GSM994860	CD14dimCD16+ monocytes donor 4	Homo sapiens	CD14dim CD16- Mo	CL:0000576		monocyte	female		Segura	"Dendritic cells (DCs) are critical regulators of immune responses. Under noninflammatory conditions, several human DC subsets have been identified. Little is known, however, about the human DC compartment under inflammatory conditions. Here, we characterize a DC population found in human inflammatory fluids that displayed a phenotype distinct from macrophages from the same fluids and from steady-state lymphoid organ and blood DCs. Transcriptome analysis showed that they correspond to a distinct DC subset and share gene signatures with in vitro monocyte-derived DCs. Moreover, human inflammatory DCs, but not inflammatory macrophages, stimulated autologous memory CD4(+) T cells to produce interleukin-17 and induce T helper 17 (Th17) cell differentiation from naive CD4(+) T cells through the selective secretion of Th17 cell-polarizing cytokines. We conclude that inflammatory DCs represent a distinct human DC subset and propose that they are derived from monocytes and are involved in the induction and maintenance of Th17 cell responses. Abstract from Immunity. 2013 Feb 21;38(2):336-48."	20	"CD14dim CD16- Mo, CD14+CD16- Mo, TAM, BDCA1+ DC, Ascites CD1c"	Microarray (Affymetrix HuGene-1_1-ST (GPL11532))		Homo sapiens	3.04	HuGene	"rgb(0,109,219)"	diamond-open	TRM lymph node CD14dimCD16+  adult	myeloid	TRM	adult	monocyte	Circulating Monocyte & Granulocyte
GSM994861;6463	6463	Segura	GSM994861	Dendritic cells BDCA1 donor 4	Homo sapiens	BDCA1+ DC	CL:0002399		CD1c+ dendritic cell	female		Segura	"Dendritic cells (DCs) are critical regulators of immune responses. Under noninflammatory conditions, several human DC subsets have been identified. Little is known, however, about the human DC compartment under inflammatory conditions. Here, we characterize a DC population found in human inflammatory fluids that displayed a phenotype distinct from macrophages from the same fluids and from steady-state lymphoid organ and blood DCs. Transcriptome analysis showed that they correspond to a distinct DC subset and share gene signatures with in vitro monocyte-derived DCs. Moreover, human inflammatory DCs, but not inflammatory macrophages, stimulated autologous memory CD4(+) T cells to produce interleukin-17 and induce T helper 17 (Th17) cell differentiation from naive CD4(+) T cells through the selective secretion of Th17 cell-polarizing cytokines. We conclude that inflammatory DCs represent a distinct human DC subset and propose that they are derived from monocytes and are involved in the induction and maintenance of Th17 cell responses. Abstract from Immunity. 2013 Feb 21;38(2):336-48."	20	"CD14dim CD16- Mo, CD14+CD16- Mo, TAM, BDCA1+ DC, Ascites CD1c"	Microarray (Affymetrix HuGene-1_1-ST (GPL11532))		Homo sapiens	3.04	HuGene	"rgb(0,109,219)"	diamond-open	c-DC HLA-DR+CD11c+CD14-CD16-CD1c+  adult	myeloid	c-DC	adult	CD1c+ dendritic cell	Mixed
GSM999015;6252	6252	Weidner	GSM999015	HSPC CD34+ Day 0 (Donor 1)	Homo sapiens	HSPC CD34+ Day 0	CL:0000837		hematopoietic multipotent progenitor			Weidner	"Hematopoietic stem and progenitor cells (HPCs) can be maintained in vitro, but the vast majority of their progeny loses stemness during culture. In this study, we compared DNA-methylation (DNAm) profiles of freshly isolated and culture-expanded HPCs. Culture conditions of CD34+ cells - either with or without mesenchymal stromal cells (MSCs) - had relatively little impact on DNAm, although proliferation is greatly increased by stromal support. However, all cultured HPCs - even those which remained CD34+ - acquired significant DNA-hypermethylation. DNA-hypermethylation occurred particularly in up-stream promoter regions, shore-regions of CpG islands, binding sites for PU.1, HOXA5 and RUNX1, and it was reflected in differential gene expression and variant transcripts of DNMT3A. Low concentrations of DNAm inhibitors slightly increased the frequency of colony-forming unit initiating cells. Our results demonstrate that HPCs acquire DNA-hypermethylation at specific sites in the genome which is relevant for the rapid loss of stemness during in vitro manipulation."	9	"HSPC CD34+ Day 0, HSPC CD34+ Day 7, HSPC CD34- Day 7"	Microarray (Affymetrix HuGene-1_0-ST V1 (GPL 6244 and A-AFFY-141))		Homo sapiens	2.84	HuGene	"rgb(0,109,219)"	diamond-open	MHP CD34+  neonatal	hematopoietic multipotent progenitor	MHP	neonatal	hematopoietic multipotent progenitor	Progenitor
GSM999016;6252	6252	Weidner	GSM999016	HSPC CD34+ Day 7 on TCP (Donor 1)	Homo sapiens	HSPC CD34+ Day 7	CL:0000837		hematopoietic multipotent progenitor			Weidner	"Hematopoietic stem and progenitor cells (HPCs) can be maintained in vitro, but the vast majority of their progeny loses stemness during culture. In this study, we compared DNA-methylation (DNAm) profiles of freshly isolated and culture-expanded HPCs. Culture conditions of CD34+ cells - either with or without mesenchymal stromal cells (MSCs) - had relatively little impact on DNAm, although proliferation is greatly increased by stromal support. However, all cultured HPCs - even those which remained CD34+ - acquired significant DNA-hypermethylation. DNA-hypermethylation occurred particularly in up-stream promoter regions, shore-regions of CpG islands, binding sites for PU.1, HOXA5 and RUNX1, and it was reflected in differential gene expression and variant transcripts of DNMT3A. Low concentrations of DNAm inhibitors slightly increased the frequency of colony-forming unit initiating cells. Our results demonstrate that HPCs acquire DNA-hypermethylation at specific sites in the genome which is relevant for the rapid loss of stemness during in vitro manipulation."	9	"HSPC CD34+ Day 0, HSPC CD34+ Day 7, HSPC CD34- Day 7"	Microarray (Affymetrix HuGene-1_0-ST V1 (GPL 6244 and A-AFFY-141))		Homo sapiens	2.84	HuGene	"rgb(0,109,219)"	diamond-open	MHP CD34+ TPO FGF1 SCF 7d neonatal	hematopoietic multipotent progenitor	MHP	neonatal	hematopoietic multipotent progenitor	Progenitor
GSM999017;6252	6252	Weidner	GSM999017	HSPC CD34- Day 7 on TCP (Donor 1)	Homo sapiens	HSPC CD34- Day 7	CL:0000837		hematopoietic multipotent progenitor			Weidner	"Hematopoietic stem and progenitor cells (HPCs) can be maintained in vitro, but the vast majority of their progeny loses stemness during culture. In this study, we compared DNA-methylation (DNAm) profiles of freshly isolated and culture-expanded HPCs. Culture conditions of CD34+ cells - either with or without mesenchymal stromal cells (MSCs) - had relatively little impact on DNAm, although proliferation is greatly increased by stromal support. However, all cultured HPCs - even those which remained CD34+ - acquired significant DNA-hypermethylation. DNA-hypermethylation occurred particularly in up-stream promoter regions, shore-regions of CpG islands, binding sites for PU.1, HOXA5 and RUNX1, and it was reflected in differential gene expression and variant transcripts of DNMT3A. Low concentrations of DNAm inhibitors slightly increased the frequency of colony-forming unit initiating cells. Our results demonstrate that HPCs acquire DNA-hypermethylation at specific sites in the genome which is relevant for the rapid loss of stemness during in vitro manipulation."	9	"HSPC CD34+ Day 0, HSPC CD34+ Day 7, HSPC CD34- Day 7"	Microarray (Affymetrix HuGene-1_0-ST V1 (GPL 6244 and A-AFFY-141))		Homo sapiens	2.84	HuGene	"rgb(0,109,219)"	diamond-open	MHP CD34- TPO FGF1 SCF coculture MSC 7d neonatal	hematopoietic multipotent progenitor	MHP	neonatal	hematopoietic multipotent progenitor	Progenitor
GSM999018;6252	6252	Weidner	GSM999018	HSPC CD34+ Day 0 (Donor 2)	Homo sapiens	HSPC CD34+ Day 0	CL:0000837		hematopoietic multipotent progenitor			Weidner	"Hematopoietic stem and progenitor cells (HPCs) can be maintained in vitro, but the vast majority of their progeny loses stemness during culture. In this study, we compared DNA-methylation (DNAm) profiles of freshly isolated and culture-expanded HPCs. Culture conditions of CD34+ cells - either with or without mesenchymal stromal cells (MSCs) - had relatively little impact on DNAm, although proliferation is greatly increased by stromal support. However, all cultured HPCs - even those which remained CD34+ - acquired significant DNA-hypermethylation. DNA-hypermethylation occurred particularly in up-stream promoter regions, shore-regions of CpG islands, binding sites for PU.1, HOXA5 and RUNX1, and it was reflected in differential gene expression and variant transcripts of DNMT3A. Low concentrations of DNAm inhibitors slightly increased the frequency of colony-forming unit initiating cells. Our results demonstrate that HPCs acquire DNA-hypermethylation at specific sites in the genome which is relevant for the rapid loss of stemness during in vitro manipulation."	9	"HSPC CD34+ Day 0, HSPC CD34+ Day 7, HSPC CD34- Day 7"	Microarray (Affymetrix HuGene-1_0-ST V1 (GPL 6244 and A-AFFY-141))		Homo sapiens	2.84	HuGene	"rgb(0,109,219)"	diamond-open	MHP CD34+  neonatal	hematopoietic multipotent progenitor	MHP	neonatal	hematopoietic multipotent progenitor	Progenitor
GSM999019;6252	6252	Weidner	GSM999019	HSPC CD34+ Day 7 on TCP (Donor 2)	Homo sapiens	HSPC CD34+ Day 7	CL:0000837		hematopoietic multipotent progenitor			Weidner	"Hematopoietic stem and progenitor cells (HPCs) can be maintained in vitro, but the vast majority of their progeny loses stemness during culture. In this study, we compared DNA-methylation (DNAm) profiles of freshly isolated and culture-expanded HPCs. Culture conditions of CD34+ cells - either with or without mesenchymal stromal cells (MSCs) - had relatively little impact on DNAm, although proliferation is greatly increased by stromal support. However, all cultured HPCs - even those which remained CD34+ - acquired significant DNA-hypermethylation. DNA-hypermethylation occurred particularly in up-stream promoter regions, shore-regions of CpG islands, binding sites for PU.1, HOXA5 and RUNX1, and it was reflected in differential gene expression and variant transcripts of DNMT3A. Low concentrations of DNAm inhibitors slightly increased the frequency of colony-forming unit initiating cells. Our results demonstrate that HPCs acquire DNA-hypermethylation at specific sites in the genome which is relevant for the rapid loss of stemness during in vitro manipulation."	9	"HSPC CD34+ Day 0, HSPC CD34+ Day 7, HSPC CD34- Day 7"	Microarray (Affymetrix HuGene-1_0-ST V1 (GPL 6244 and A-AFFY-141))		Homo sapiens	2.84	HuGene	"rgb(0,109,219)"	diamond-open	MHP CD34+ TPO FGF1 SCF 7d neonatal	hematopoietic multipotent progenitor	MHP	neonatal	hematopoietic multipotent progenitor	Progenitor
GSM999020;6252	6252	Weidner	GSM999020	HSPC CD34- Day 7 on TCP (Donor 2)	Homo sapiens	HSPC CD34- Day 7	CL:0000837		hematopoietic multipotent progenitor			Weidner	"Hematopoietic stem and progenitor cells (HPCs) can be maintained in vitro, but the vast majority of their progeny loses stemness during culture. In this study, we compared DNA-methylation (DNAm) profiles of freshly isolated and culture-expanded HPCs. Culture conditions of CD34+ cells - either with or without mesenchymal stromal cells (MSCs) - had relatively little impact on DNAm, although proliferation is greatly increased by stromal support. However, all cultured HPCs - even those which remained CD34+ - acquired significant DNA-hypermethylation. DNA-hypermethylation occurred particularly in up-stream promoter regions, shore-regions of CpG islands, binding sites for PU.1, HOXA5 and RUNX1, and it was reflected in differential gene expression and variant transcripts of DNMT3A. Low concentrations of DNAm inhibitors slightly increased the frequency of colony-forming unit initiating cells. Our results demonstrate that HPCs acquire DNA-hypermethylation at specific sites in the genome which is relevant for the rapid loss of stemness during in vitro manipulation."	9	"HSPC CD34+ Day 0, HSPC CD34+ Day 7, HSPC CD34- Day 7"	Microarray (Affymetrix HuGene-1_0-ST V1 (GPL 6244 and A-AFFY-141))		Homo sapiens	2.84	HuGene	"rgb(0,109,219)"	diamond-open	MHP CD34- TPO FGF1 SCF coculture MSC 7d neonatal	hematopoietic multipotent progenitor	MHP	neonatal	hematopoietic multipotent progenitor	Progenitor
GSM999021;6252	6252	Weidner	GSM999021	HSPC CD34+ Day 0 (Donor 3)	Homo sapiens	HSPC CD34+ Day 0	CL:0000837		hematopoietic multipotent progenitor			Weidner	"Hematopoietic stem and progenitor cells (HPCs) can be maintained in vitro, but the vast majority of their progeny loses stemness during culture. In this study, we compared DNA-methylation (DNAm) profiles of freshly isolated and culture-expanded HPCs. Culture conditions of CD34+ cells - either with or without mesenchymal stromal cells (MSCs) - had relatively little impact on DNAm, although proliferation is greatly increased by stromal support. However, all cultured HPCs - even those which remained CD34+ - acquired significant DNA-hypermethylation. DNA-hypermethylation occurred particularly in up-stream promoter regions, shore-regions of CpG islands, binding sites for PU.1, HOXA5 and RUNX1, and it was reflected in differential gene expression and variant transcripts of DNMT3A. Low concentrations of DNAm inhibitors slightly increased the frequency of colony-forming unit initiating cells. Our results demonstrate that HPCs acquire DNA-hypermethylation at specific sites in the genome which is relevant for the rapid loss of stemness during in vitro manipulation."	9	"HSPC CD34+ Day 0, HSPC CD34+ Day 7, HSPC CD34- Day 7"	Microarray (Affymetrix HuGene-1_0-ST V1 (GPL 6244 and A-AFFY-141))		Homo sapiens	2.84	HuGene	"rgb(0,109,219)"	diamond-open	MHP CD34+  neonatal	hematopoietic multipotent progenitor	MHP	neonatal	hematopoietic multipotent progenitor	Progenitor
GSM999022;6252	6252	Weidner	GSM999022	HSPC CD34+ Day 7 on TCP (Donor 3)	Homo sapiens	HSPC CD34+ Day 7	CL:0000837		hematopoietic multipotent progenitor			Weidner	"Hematopoietic stem and progenitor cells (HPCs) can be maintained in vitro, but the vast majority of their progeny loses stemness during culture. In this study, we compared DNA-methylation (DNAm) profiles of freshly isolated and culture-expanded HPCs. Culture conditions of CD34+ cells - either with or without mesenchymal stromal cells (MSCs) - had relatively little impact on DNAm, although proliferation is greatly increased by stromal support. However, all cultured HPCs - even those which remained CD34+ - acquired significant DNA-hypermethylation. DNA-hypermethylation occurred particularly in up-stream promoter regions, shore-regions of CpG islands, binding sites for PU.1, HOXA5 and RUNX1, and it was reflected in differential gene expression and variant transcripts of DNMT3A. Low concentrations of DNAm inhibitors slightly increased the frequency of colony-forming unit initiating cells. Our results demonstrate that HPCs acquire DNA-hypermethylation at specific sites in the genome which is relevant for the rapid loss of stemness during in vitro manipulation."	9	"HSPC CD34+ Day 0, HSPC CD34+ Day 7, HSPC CD34- Day 7"	Microarray (Affymetrix HuGene-1_0-ST V1 (GPL 6244 and A-AFFY-141))		Homo sapiens	2.84	HuGene	"rgb(0,109,219)"	diamond-open	MHP CD34+ TPO FGF1 SCF 7d neonatal	hematopoietic multipotent progenitor	MHP	neonatal	hematopoietic multipotent progenitor	Progenitor
GSM999023;6252	6252	Weidner	GSM999023	HSPC CD34- Day 7 on TCP (Donor 3)	Homo sapiens	HSPC CD34- Day 7	CL:0000837		hematopoietic multipotent progenitor			Weidner	"Hematopoietic stem and progenitor cells (HPCs) can be maintained in vitro, but the vast majority of their progeny loses stemness during culture. In this study, we compared DNA-methylation (DNAm) profiles of freshly isolated and culture-expanded HPCs. Culture conditions of CD34+ cells - either with or without mesenchymal stromal cells (MSCs) - had relatively little impact on DNAm, although proliferation is greatly increased by stromal support. However, all cultured HPCs - even those which remained CD34+ - acquired significant DNA-hypermethylation. DNA-hypermethylation occurred particularly in up-stream promoter regions, shore-regions of CpG islands, binding sites for PU.1, HOXA5 and RUNX1, and it was reflected in differential gene expression and variant transcripts of DNMT3A. Low concentrations of DNAm inhibitors slightly increased the frequency of colony-forming unit initiating cells. Our results demonstrate that HPCs acquire DNA-hypermethylation at specific sites in the genome which is relevant for the rapid loss of stemness during in vitro manipulation."	9	"HSPC CD34+ Day 0, HSPC CD34+ Day 7, HSPC CD34- Day 7"	Microarray (Affymetrix HuGene-1_0-ST V1 (GPL 6244 and A-AFFY-141))		Homo sapiens	2.84	HuGene	"rgb(0,109,219)"	diamond-open	MHP CD34- TPO FGF1 SCF coculture MSC 7d neonatal	hematopoietic multipotent progenitor	MHP	neonatal	hematopoietic multipotent progenitor	Progenitor
J;7002	7002	Lindstedt	J	blood plasmacytoid dendritic cell 1	Homo sapiens	blood pDC	CL:0000784		plasmacytoid dendritic cell			Lindstedt	"Human dendritic cells (DCs) are a distinct but heterogeneous lineage of APCs operating as the link between innate and adaptive immune responses, with the function to either maintain tolerance or trigger immunity. The DC lineage consists of several subpopulations with unique phenotypes; however, their functional characteristics and transcriptional similarities remain largely unknown. To further characterize the phenotypes and transcriptomes of the subsets, we purified myeloid CD16(+), blood DC Ag 1(+) (BDCA1(+)), and BDCA3(+) DC populations, as well as plasmacytoid CD123(+) DCs, from tonsillar tissue and peripheral blood. Transcriptional profiling and hierarchical clustering visualized that BDCA1(+) DCs clustered with BDCA3(+) DCs, whereas CD16(+) DCs and CD123(+) DCs clustered as distinct populations in blood. Differential expression levels of chemokines, ILs, and pattern recognition receptors were demonstrated, which emphasize innate DC subset specialization. Even though highly BDCA1(+) and BDCA3(+) DC-specific gene expression was identified in blood, the BDCA1(+) DCs and BDCA3(+) DCs from tonsils displayed similar transcriptional activity, most likely due to the pathogenic or inflammatory maturational signals present in tonsillar tissues. Of note, plasmacytoid DCs displayed less plasticity in their transcriptional activity compared with myeloid DCs. The data demonstrated a functionally distinct association of each of the seven subsets based on their signatures, involving regulatory genes in adaptive and innate immunity. Abstract from the Journal of Immunology. 2005 Oct 15;175(8):4839-46."	21	"CD16+ monocyte, blood BDCA1+ DC, tonsil BDCA1+ DC, blood BDCA3+ DC, tonsil BDCA3+ DC, blood pDC, tonsil pDC"	Microarray (Affymetrix HG-U133_Plus_2 (GPL570 and A-AFFY-44))		Homo sapiens	3.6	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	pDC CD123+  adult	myeloid	p-DC	adult	plasmacytoid dendritic cell	Mixed
K;7002	7002	Lindstedt	K	blood plasmacytoid dendritic cell 2	Homo sapiens	blood pDC	CL:0000784		plasmacytoid dendritic cell			Lindstedt	"Human dendritic cells (DCs) are a distinct but heterogeneous lineage of APCs operating as the link between innate and adaptive immune responses, with the function to either maintain tolerance or trigger immunity. The DC lineage consists of several subpopulations with unique phenotypes; however, their functional characteristics and transcriptional similarities remain largely unknown. To further characterize the phenotypes and transcriptomes of the subsets, we purified myeloid CD16(+), blood DC Ag 1(+) (BDCA1(+)), and BDCA3(+) DC populations, as well as plasmacytoid CD123(+) DCs, from tonsillar tissue and peripheral blood. Transcriptional profiling and hierarchical clustering visualized that BDCA1(+) DCs clustered with BDCA3(+) DCs, whereas CD16(+) DCs and CD123(+) DCs clustered as distinct populations in blood. Differential expression levels of chemokines, ILs, and pattern recognition receptors were demonstrated, which emphasize innate DC subset specialization. Even though highly BDCA1(+) and BDCA3(+) DC-specific gene expression was identified in blood, the BDCA1(+) DCs and BDCA3(+) DCs from tonsils displayed similar transcriptional activity, most likely due to the pathogenic or inflammatory maturational signals present in tonsillar tissues. Of note, plasmacytoid DCs displayed less plasticity in their transcriptional activity compared with myeloid DCs. The data demonstrated a functionally distinct association of each of the seven subsets based on their signatures, involving regulatory genes in adaptive and innate immunity. Abstract from the Journal of Immunology. 2005 Oct 15;175(8):4839-46."	21	"CD16+ monocyte, blood BDCA1+ DC, tonsil BDCA1+ DC, blood BDCA3+ DC, tonsil BDCA3+ DC, blood pDC, tonsil pDC"	Microarray (Affymetrix HG-U133_Plus_2 (GPL570 and A-AFFY-44))		Homo sapiens	3.6	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	pDC CD123+  adult	myeloid	p-DC	adult	plasmacytoid dendritic cell	Mixed
KK1HSC1_1;6610	6610	Scott	KK1HSC1_1	"Normal HSC, replicate 1_technical replicate 1"	Homo sapiens	CD34+ CD38- HSC	CL:0000837		hematopoietic multipotent progenitor			Scott	"A major obstacle to curing chronic myeloid leukemia (CML) is residual disease maintained by tyrosine kinase inhibitor (TKI)persistent leukemic stem cells (LSC). These are BCRABL1 kinase independent, refractory to apoptosis, and serve as a reservoir to drive relapse or TKI resistance. We demonstrate that Polycomb Repressive Complex 2 is misregulated in chronic phase CML LSCs. This is associated with extensive reprogramming of H3K27me3 targets in LSCs, thus sensitizing them to apoptosis upon treatment with an EZH2-specific inhibitor (EZH2i). EZH2i does not impair normal hematopoietic stem cell survival. Strikingly, treatment of primary CML cells with either EZH2i or TKI alone caused significant upregulation of H3K27me3 targets, and combined treatment further potentiated these effects and resulted in significant loss of LSCs compared to TKI alone, in vitro, and in long-term bone marrow murine xenografts. Our findings point to a promising epigenetic-based therapeutic strategy to more effectively target LSCs in patients with CML receiving TKIs. Significance: In CML, TKI-persistent LSCs remain an obstacle to cure, and approaches to eradicate them remain a significant unmet clinical need. We demonstrate that EZH2 and H3K27me3 reprogramming is important for LSC survival, but renders LSCs sensitive to the combined effects of EZH2i and TKI. This represents a novel approach to more effectively target LSCs in patients receiving TKI treatment. Abstract from Cancer Discov. 2016 Nov;6(11):1248-1257."	24	"CD34+ CD38- HSC, CML CD34+ CD38-, CD34+ CD38+ HSP, CML CD34+ CD38+"	Microarray (Affymetrix HuGene-1_0-ST V1 (GPL 6244 and A-AFFY-141))	leukomics	Homo sapiens	4.62	HuGene	"rgb(0,109,219)"	diamond-open	MHP CD34+ CD38-  adult	hematopoietic multipotent progenitor	MHP	adult	hematopoietic multipotent progenitor	Progenitor
KK1HSC1_2;6610	6610	Scott	KK1HSC1_2	"Normal HSC, replicate 1_technical replicate 2"	Homo sapiens	CD34+ CD38- HSC	CL:0000837		hematopoietic multipotent progenitor			Scott	"A major obstacle to curing chronic myeloid leukemia (CML) is residual disease maintained by tyrosine kinase inhibitor (TKI)persistent leukemic stem cells (LSC). These are BCRABL1 kinase independent, refractory to apoptosis, and serve as a reservoir to drive relapse or TKI resistance. We demonstrate that Polycomb Repressive Complex 2 is misregulated in chronic phase CML LSCs. This is associated with extensive reprogramming of H3K27me3 targets in LSCs, thus sensitizing them to apoptosis upon treatment with an EZH2-specific inhibitor (EZH2i). EZH2i does not impair normal hematopoietic stem cell survival. Strikingly, treatment of primary CML cells with either EZH2i or TKI alone caused significant upregulation of H3K27me3 targets, and combined treatment further potentiated these effects and resulted in significant loss of LSCs compared to TKI alone, in vitro, and in long-term bone marrow murine xenografts. Our findings point to a promising epigenetic-based therapeutic strategy to more effectively target LSCs in patients with CML receiving TKIs. Significance: In CML, TKI-persistent LSCs remain an obstacle to cure, and approaches to eradicate them remain a significant unmet clinical need. We demonstrate that EZH2 and H3K27me3 reprogramming is important for LSC survival, but renders LSCs sensitive to the combined effects of EZH2i and TKI. This represents a novel approach to more effectively target LSCs in patients receiving TKI treatment. Abstract from Cancer Discov. 2016 Nov;6(11):1248-1257."	24	"CD34+ CD38- HSC, CML CD34+ CD38-, CD34+ CD38+ HSP, CML CD34+ CD38+"	Microarray (Affymetrix HuGene-1_0-ST V1 (GPL 6244 and A-AFFY-141))	leukomics	Homo sapiens	4.62	HuGene	"rgb(0,109,219)"	diamond-open	MHP CD34+ CD38-  adult	hematopoietic multipotent progenitor	MHP	adult	hematopoietic multipotent progenitor	Progenitor
KK1HSC2_1;6610	6610	Scott	KK1HSC2_1	"Normal HSC, replicate 2_technical replicate 1"	Homo sapiens	CD34+ CD38- HSC	CL:0000837		hematopoietic multipotent progenitor			Scott	"A major obstacle to curing chronic myeloid leukemia (CML) is residual disease maintained by tyrosine kinase inhibitor (TKI)persistent leukemic stem cells (LSC). These are BCRABL1 kinase independent, refractory to apoptosis, and serve as a reservoir to drive relapse or TKI resistance. We demonstrate that Polycomb Repressive Complex 2 is misregulated in chronic phase CML LSCs. This is associated with extensive reprogramming of H3K27me3 targets in LSCs, thus sensitizing them to apoptosis upon treatment with an EZH2-specific inhibitor (EZH2i). EZH2i does not impair normal hematopoietic stem cell survival. Strikingly, treatment of primary CML cells with either EZH2i or TKI alone caused significant upregulation of H3K27me3 targets, and combined treatment further potentiated these effects and resulted in significant loss of LSCs compared to TKI alone, in vitro, and in long-term bone marrow murine xenografts. Our findings point to a promising epigenetic-based therapeutic strategy to more effectively target LSCs in patients with CML receiving TKIs. Significance: In CML, TKI-persistent LSCs remain an obstacle to cure, and approaches to eradicate them remain a significant unmet clinical need. We demonstrate that EZH2 and H3K27me3 reprogramming is important for LSC survival, but renders LSCs sensitive to the combined effects of EZH2i and TKI. This represents a novel approach to more effectively target LSCs in patients receiving TKI treatment. Abstract from Cancer Discov. 2016 Nov;6(11):1248-1257."	24	"CD34+ CD38- HSC, CML CD34+ CD38-, CD34+ CD38+ HSP, CML CD34+ CD38+"	Microarray (Affymetrix HuGene-1_0-ST V1 (GPL 6244 and A-AFFY-141))	leukomics	Homo sapiens	4.62	HuGene	"rgb(0,109,219)"	diamond-open	MHP CD34+ CD38-  adult	hematopoietic multipotent progenitor	MHP	adult	hematopoietic multipotent progenitor	Progenitor
KK1HSC2_2;6610	6610	Scott	KK1HSC2_2	"Normal HSC, replicate 2_technical replicate 2"	Homo sapiens	CD34+ CD38- HSC	CL:0000837		hematopoietic multipotent progenitor			Scott	"A major obstacle to curing chronic myeloid leukemia (CML) is residual disease maintained by tyrosine kinase inhibitor (TKI)persistent leukemic stem cells (LSC). These are BCRABL1 kinase independent, refractory to apoptosis, and serve as a reservoir to drive relapse or TKI resistance. We demonstrate that Polycomb Repressive Complex 2 is misregulated in chronic phase CML LSCs. This is associated with extensive reprogramming of H3K27me3 targets in LSCs, thus sensitizing them to apoptosis upon treatment with an EZH2-specific inhibitor (EZH2i). EZH2i does not impair normal hematopoietic stem cell survival. Strikingly, treatment of primary CML cells with either EZH2i or TKI alone caused significant upregulation of H3K27me3 targets, and combined treatment further potentiated these effects and resulted in significant loss of LSCs compared to TKI alone, in vitro, and in long-term bone marrow murine xenografts. Our findings point to a promising epigenetic-based therapeutic strategy to more effectively target LSCs in patients with CML receiving TKIs. Significance: In CML, TKI-persistent LSCs remain an obstacle to cure, and approaches to eradicate them remain a significant unmet clinical need. We demonstrate that EZH2 and H3K27me3 reprogramming is important for LSC survival, but renders LSCs sensitive to the combined effects of EZH2i and TKI. This represents a novel approach to more effectively target LSCs in patients receiving TKI treatment. Abstract from Cancer Discov. 2016 Nov;6(11):1248-1257."	24	"CD34+ CD38- HSC, CML CD34+ CD38-, CD34+ CD38+ HSP, CML CD34+ CD38+"	Microarray (Affymetrix HuGene-1_0-ST V1 (GPL 6244 and A-AFFY-141))	leukomics	Homo sapiens	4.62	HuGene	"rgb(0,109,219)"	diamond-open	MHP CD34+ CD38-  adult	hematopoietic multipotent progenitor	MHP	adult	hematopoietic multipotent progenitor	Progenitor
KK1HSC3_1;6610	6610	Scott	KK1HSC3_1	"Normal HSC, replicate 3_technical replicate 1"	Homo sapiens	CD34+ CD38- HSC	CL:0000837		hematopoietic multipotent progenitor			Scott	"A major obstacle to curing chronic myeloid leukemia (CML) is residual disease maintained by tyrosine kinase inhibitor (TKI)persistent leukemic stem cells (LSC). These are BCRABL1 kinase independent, refractory to apoptosis, and serve as a reservoir to drive relapse or TKI resistance. We demonstrate that Polycomb Repressive Complex 2 is misregulated in chronic phase CML LSCs. This is associated with extensive reprogramming of H3K27me3 targets in LSCs, thus sensitizing them to apoptosis upon treatment with an EZH2-specific inhibitor (EZH2i). EZH2i does not impair normal hematopoietic stem cell survival. Strikingly, treatment of primary CML cells with either EZH2i or TKI alone caused significant upregulation of H3K27me3 targets, and combined treatment further potentiated these effects and resulted in significant loss of LSCs compared to TKI alone, in vitro, and in long-term bone marrow murine xenografts. Our findings point to a promising epigenetic-based therapeutic strategy to more effectively target LSCs in patients with CML receiving TKIs. Significance: In CML, TKI-persistent LSCs remain an obstacle to cure, and approaches to eradicate them remain a significant unmet clinical need. We demonstrate that EZH2 and H3K27me3 reprogramming is important for LSC survival, but renders LSCs sensitive to the combined effects of EZH2i and TKI. This represents a novel approach to more effectively target LSCs in patients receiving TKI treatment. Abstract from Cancer Discov. 2016 Nov;6(11):1248-1257."	24	"CD34+ CD38- HSC, CML CD34+ CD38-, CD34+ CD38+ HSP, CML CD34+ CD38+"	Microarray (Affymetrix HuGene-1_0-ST V1 (GPL 6244 and A-AFFY-141))	leukomics	Homo sapiens	4.62	HuGene	"rgb(0,109,219)"	diamond-open	MHP CD34+ CD38-  adult	hematopoietic multipotent progenitor	MHP	adult	hematopoietic multipotent progenitor	Progenitor
KK1HSC3_2;6610	6610	Scott	KK1HSC3_2	"Normal HSC, replicate 3_technical replicate 2"	Homo sapiens	CD34+ CD38- HSC	CL:0000837		hematopoietic multipotent progenitor			Scott	"A major obstacle to curing chronic myeloid leukemia (CML) is residual disease maintained by tyrosine kinase inhibitor (TKI)persistent leukemic stem cells (LSC). These are BCRABL1 kinase independent, refractory to apoptosis, and serve as a reservoir to drive relapse or TKI resistance. We demonstrate that Polycomb Repressive Complex 2 is misregulated in chronic phase CML LSCs. This is associated with extensive reprogramming of H3K27me3 targets in LSCs, thus sensitizing them to apoptosis upon treatment with an EZH2-specific inhibitor (EZH2i). EZH2i does not impair normal hematopoietic stem cell survival. Strikingly, treatment of primary CML cells with either EZH2i or TKI alone caused significant upregulation of H3K27me3 targets, and combined treatment further potentiated these effects and resulted in significant loss of LSCs compared to TKI alone, in vitro, and in long-term bone marrow murine xenografts. Our findings point to a promising epigenetic-based therapeutic strategy to more effectively target LSCs in patients with CML receiving TKIs. Significance: In CML, TKI-persistent LSCs remain an obstacle to cure, and approaches to eradicate them remain a significant unmet clinical need. We demonstrate that EZH2 and H3K27me3 reprogramming is important for LSC survival, but renders LSCs sensitive to the combined effects of EZH2i and TKI. This represents a novel approach to more effectively target LSCs in patients receiving TKI treatment. Abstract from Cancer Discov. 2016 Nov;6(11):1248-1257."	24	"CD34+ CD38- HSC, CML CD34+ CD38-, CD34+ CD38+ HSP, CML CD34+ CD38+"	Microarray (Affymetrix HuGene-1_0-ST V1 (GPL 6244 and A-AFFY-141))	leukomics	Homo sapiens	4.62	HuGene	"rgb(0,109,219)"	diamond-open	MHP CD34+ CD38-  adult	hematopoietic multipotent progenitor	MHP	adult	hematopoietic multipotent progenitor	Progenitor
KK3HPC1_1;6610	6610	Scott	KK3HPC1_1	"Normal HPC, replicate 1_technical replicate 1"	Homo sapiens	CD34+ CD38+ HSP	CL:0000837		hematopoietic multipotent progenitor			Scott	"A major obstacle to curing chronic myeloid leukemia (CML) is residual disease maintained by tyrosine kinase inhibitor (TKI)persistent leukemic stem cells (LSC). These are BCRABL1 kinase independent, refractory to apoptosis, and serve as a reservoir to drive relapse or TKI resistance. We demonstrate that Polycomb Repressive Complex 2 is misregulated in chronic phase CML LSCs. This is associated with extensive reprogramming of H3K27me3 targets in LSCs, thus sensitizing them to apoptosis upon treatment with an EZH2-specific inhibitor (EZH2i). EZH2i does not impair normal hematopoietic stem cell survival. Strikingly, treatment of primary CML cells with either EZH2i or TKI alone caused significant upregulation of H3K27me3 targets, and combined treatment further potentiated these effects and resulted in significant loss of LSCs compared to TKI alone, in vitro, and in long-term bone marrow murine xenografts. Our findings point to a promising epigenetic-based therapeutic strategy to more effectively target LSCs in patients with CML receiving TKIs. Significance: In CML, TKI-persistent LSCs remain an obstacle to cure, and approaches to eradicate them remain a significant unmet clinical need. We demonstrate that EZH2 and H3K27me3 reprogramming is important for LSC survival, but renders LSCs sensitive to the combined effects of EZH2i and TKI. This represents a novel approach to more effectively target LSCs in patients receiving TKI treatment. Abstract from Cancer Discov. 2016 Nov;6(11):1248-1257."	24	"CD34+ CD38- HSC, CML CD34+ CD38-, CD34+ CD38+ HSP, CML CD34+ CD38+"	Microarray (Affymetrix HuGene-1_0-ST V1 (GPL 6244 and A-AFFY-141))	leukomics	Homo sapiens	4.62	HuGene	"rgb(0,109,219)"	diamond-open	MHP CD34+ CD38+  adult	hematopoietic multipotent progenitor	MHP	adult	hematopoietic multipotent progenitor	Progenitor
KK3HPC1_2;6610	6610	Scott	KK3HPC1_2	"Normal HPC, replicate 1_technical replicate 2"	Homo sapiens	CD34+ CD38+ HSP	CL:0000837		hematopoietic multipotent progenitor			Scott	"A major obstacle to curing chronic myeloid leukemia (CML) is residual disease maintained by tyrosine kinase inhibitor (TKI)persistent leukemic stem cells (LSC). These are BCRABL1 kinase independent, refractory to apoptosis, and serve as a reservoir to drive relapse or TKI resistance. We demonstrate that Polycomb Repressive Complex 2 is misregulated in chronic phase CML LSCs. This is associated with extensive reprogramming of H3K27me3 targets in LSCs, thus sensitizing them to apoptosis upon treatment with an EZH2-specific inhibitor (EZH2i). EZH2i does not impair normal hematopoietic stem cell survival. Strikingly, treatment of primary CML cells with either EZH2i or TKI alone caused significant upregulation of H3K27me3 targets, and combined treatment further potentiated these effects and resulted in significant loss of LSCs compared to TKI alone, in vitro, and in long-term bone marrow murine xenografts. Our findings point to a promising epigenetic-based therapeutic strategy to more effectively target LSCs in patients with CML receiving TKIs. Significance: In CML, TKI-persistent LSCs remain an obstacle to cure, and approaches to eradicate them remain a significant unmet clinical need. We demonstrate that EZH2 and H3K27me3 reprogramming is important for LSC survival, but renders LSCs sensitive to the combined effects of EZH2i and TKI. This represents a novel approach to more effectively target LSCs in patients receiving TKI treatment. Abstract from Cancer Discov. 2016 Nov;6(11):1248-1257."	24	"CD34+ CD38- HSC, CML CD34+ CD38-, CD34+ CD38+ HSP, CML CD34+ CD38+"	Microarray (Affymetrix HuGene-1_0-ST V1 (GPL 6244 and A-AFFY-141))	leukomics	Homo sapiens	4.62	HuGene	"rgb(0,109,219)"	diamond-open	MHP CD34+ CD38+  adult	hematopoietic multipotent progenitor	MHP	adult	hematopoietic multipotent progenitor	Progenitor
KK3HPC2_1;6610	6610	Scott	KK3HPC2_1	"Normal HPC, replicate 2_technical replicate 1"	Homo sapiens	CD34+ CD38+ HSP	CL:0000837		hematopoietic multipotent progenitor			Scott	"A major obstacle to curing chronic myeloid leukemia (CML) is residual disease maintained by tyrosine kinase inhibitor (TKI)persistent leukemic stem cells (LSC). These are BCRABL1 kinase independent, refractory to apoptosis, and serve as a reservoir to drive relapse or TKI resistance. We demonstrate that Polycomb Repressive Complex 2 is misregulated in chronic phase CML LSCs. This is associated with extensive reprogramming of H3K27me3 targets in LSCs, thus sensitizing them to apoptosis upon treatment with an EZH2-specific inhibitor (EZH2i). EZH2i does not impair normal hematopoietic stem cell survival. Strikingly, treatment of primary CML cells with either EZH2i or TKI alone caused significant upregulation of H3K27me3 targets, and combined treatment further potentiated these effects and resulted in significant loss of LSCs compared to TKI alone, in vitro, and in long-term bone marrow murine xenografts. Our findings point to a promising epigenetic-based therapeutic strategy to more effectively target LSCs in patients with CML receiving TKIs. Significance: In CML, TKI-persistent LSCs remain an obstacle to cure, and approaches to eradicate them remain a significant unmet clinical need. We demonstrate that EZH2 and H3K27me3 reprogramming is important for LSC survival, but renders LSCs sensitive to the combined effects of EZH2i and TKI. This represents a novel approach to more effectively target LSCs in patients receiving TKI treatment. Abstract from Cancer Discov. 2016 Nov;6(11):1248-1257."	24	"CD34+ CD38- HSC, CML CD34+ CD38-, CD34+ CD38+ HSP, CML CD34+ CD38+"	Microarray (Affymetrix HuGene-1_0-ST V1 (GPL 6244 and A-AFFY-141))	leukomics	Homo sapiens	4.62	HuGene	"rgb(0,109,219)"	diamond-open	MHP CD34+ CD38+  adult	hematopoietic multipotent progenitor	MHP	adult	hematopoietic multipotent progenitor	Progenitor
KK3HPC2_2;6610	6610	Scott	KK3HPC2_2	"Normal HPC, replicate 2_technical replicate 2"	Homo sapiens	CD34+ CD38+ HSP	CL:0000837		hematopoietic multipotent progenitor			Scott	"A major obstacle to curing chronic myeloid leukemia (CML) is residual disease maintained by tyrosine kinase inhibitor (TKI)persistent leukemic stem cells (LSC). These are BCRABL1 kinase independent, refractory to apoptosis, and serve as a reservoir to drive relapse or TKI resistance. We demonstrate that Polycomb Repressive Complex 2 is misregulated in chronic phase CML LSCs. This is associated with extensive reprogramming of H3K27me3 targets in LSCs, thus sensitizing them to apoptosis upon treatment with an EZH2-specific inhibitor (EZH2i). EZH2i does not impair normal hematopoietic stem cell survival. Strikingly, treatment of primary CML cells with either EZH2i or TKI alone caused significant upregulation of H3K27me3 targets, and combined treatment further potentiated these effects and resulted in significant loss of LSCs compared to TKI alone, in vitro, and in long-term bone marrow murine xenografts. Our findings point to a promising epigenetic-based therapeutic strategy to more effectively target LSCs in patients with CML receiving TKIs. Significance: In CML, TKI-persistent LSCs remain an obstacle to cure, and approaches to eradicate them remain a significant unmet clinical need. We demonstrate that EZH2 and H3K27me3 reprogramming is important for LSC survival, but renders LSCs sensitive to the combined effects of EZH2i and TKI. This represents a novel approach to more effectively target LSCs in patients receiving TKI treatment. Abstract from Cancer Discov. 2016 Nov;6(11):1248-1257."	24	"CD34+ CD38- HSC, CML CD34+ CD38-, CD34+ CD38+ HSP, CML CD34+ CD38+"	Microarray (Affymetrix HuGene-1_0-ST V1 (GPL 6244 and A-AFFY-141))	leukomics	Homo sapiens	4.62	HuGene	"rgb(0,109,219)"	diamond-open	MHP CD34+ CD38+  adult	hematopoietic multipotent progenitor	MHP	adult	hematopoietic multipotent progenitor	Progenitor
KK3HPC3_1;6610	6610	Scott	KK3HPC3_1	"Normal HPC, replicate 3_technical replicate 1"	Homo sapiens	CD34+ CD38+ HSP	CL:0000837		hematopoietic multipotent progenitor			Scott	"A major obstacle to curing chronic myeloid leukemia (CML) is residual disease maintained by tyrosine kinase inhibitor (TKI)persistent leukemic stem cells (LSC). These are BCRABL1 kinase independent, refractory to apoptosis, and serve as a reservoir to drive relapse or TKI resistance. We demonstrate that Polycomb Repressive Complex 2 is misregulated in chronic phase CML LSCs. This is associated with extensive reprogramming of H3K27me3 targets in LSCs, thus sensitizing them to apoptosis upon treatment with an EZH2-specific inhibitor (EZH2i). EZH2i does not impair normal hematopoietic stem cell survival. Strikingly, treatment of primary CML cells with either EZH2i or TKI alone caused significant upregulation of H3K27me3 targets, and combined treatment further potentiated these effects and resulted in significant loss of LSCs compared to TKI alone, in vitro, and in long-term bone marrow murine xenografts. Our findings point to a promising epigenetic-based therapeutic strategy to more effectively target LSCs in patients with CML receiving TKIs. Significance: In CML, TKI-persistent LSCs remain an obstacle to cure, and approaches to eradicate them remain a significant unmet clinical need. We demonstrate that EZH2 and H3K27me3 reprogramming is important for LSC survival, but renders LSCs sensitive to the combined effects of EZH2i and TKI. This represents a novel approach to more effectively target LSCs in patients receiving TKI treatment. Abstract from Cancer Discov. 2016 Nov;6(11):1248-1257."	24	"CD34+ CD38- HSC, CML CD34+ CD38-, CD34+ CD38+ HSP, CML CD34+ CD38+"	Microarray (Affymetrix HuGene-1_0-ST V1 (GPL 6244 and A-AFFY-141))	leukomics	Homo sapiens	4.62	HuGene	"rgb(0,109,219)"	diamond-open	MHP CD34+ CD38+  adult	hematopoietic multipotent progenitor	MHP	adult	hematopoietic multipotent progenitor	Progenitor
KK3HPC3_2;6610	6610	Scott	KK3HPC3_2	"Normal HPC, replicate 3_technical replicate 2"	Homo sapiens	CD34+ CD38+ HSP	CL:0000837		hematopoietic multipotent progenitor			Scott	"A major obstacle to curing chronic myeloid leukemia (CML) is residual disease maintained by tyrosine kinase inhibitor (TKI)persistent leukemic stem cells (LSC). These are BCRABL1 kinase independent, refractory to apoptosis, and serve as a reservoir to drive relapse or TKI resistance. We demonstrate that Polycomb Repressive Complex 2 is misregulated in chronic phase CML LSCs. This is associated with extensive reprogramming of H3K27me3 targets in LSCs, thus sensitizing them to apoptosis upon treatment with an EZH2-specific inhibitor (EZH2i). EZH2i does not impair normal hematopoietic stem cell survival. Strikingly, treatment of primary CML cells with either EZH2i or TKI alone caused significant upregulation of H3K27me3 targets, and combined treatment further potentiated these effects and resulted in significant loss of LSCs compared to TKI alone, in vitro, and in long-term bone marrow murine xenografts. Our findings point to a promising epigenetic-based therapeutic strategy to more effectively target LSCs in patients with CML receiving TKIs. Significance: In CML, TKI-persistent LSCs remain an obstacle to cure, and approaches to eradicate them remain a significant unmet clinical need. We demonstrate that EZH2 and H3K27me3 reprogramming is important for LSC survival, but renders LSCs sensitive to the combined effects of EZH2i and TKI. This represents a novel approach to more effectively target LSCs in patients receiving TKI treatment. Abstract from Cancer Discov. 2016 Nov;6(11):1248-1257."	24	"CD34+ CD38- HSC, CML CD34+ CD38-, CD34+ CD38+ HSP, CML CD34+ CD38+"	Microarray (Affymetrix HuGene-1_0-ST V1 (GPL 6244 and A-AFFY-141))	leukomics	Homo sapiens	4.62	HuGene	"rgb(0,109,219)"	diamond-open	MHP CD34+ CD38+  adult	hematopoietic multipotent progenitor	MHP	adult	hematopoietic multipotent progenitor	Progenitor
L;7002	7002	Lindstedt	L	blood plasmacytoid dendritic cell 3	Homo sapiens	blood pDC	CL:0000784		plasmacytoid dendritic cell			Lindstedt	"Human dendritic cells (DCs) are a distinct but heterogeneous lineage of APCs operating as the link between innate and adaptive immune responses, with the function to either maintain tolerance or trigger immunity. The DC lineage consists of several subpopulations with unique phenotypes; however, their functional characteristics and transcriptional similarities remain largely unknown. To further characterize the phenotypes and transcriptomes of the subsets, we purified myeloid CD16(+), blood DC Ag 1(+) (BDCA1(+)), and BDCA3(+) DC populations, as well as plasmacytoid CD123(+) DCs, from tonsillar tissue and peripheral blood. Transcriptional profiling and hierarchical clustering visualized that BDCA1(+) DCs clustered with BDCA3(+) DCs, whereas CD16(+) DCs and CD123(+) DCs clustered as distinct populations in blood. Differential expression levels of chemokines, ILs, and pattern recognition receptors were demonstrated, which emphasize innate DC subset specialization. Even though highly BDCA1(+) and BDCA3(+) DC-specific gene expression was identified in blood, the BDCA1(+) DCs and BDCA3(+) DCs from tonsils displayed similar transcriptional activity, most likely due to the pathogenic or inflammatory maturational signals present in tonsillar tissues. Of note, plasmacytoid DCs displayed less plasticity in their transcriptional activity compared with myeloid DCs. The data demonstrated a functionally distinct association of each of the seven subsets based on their signatures, involving regulatory genes in adaptive and innate immunity. Abstract from the Journal of Immunology. 2005 Oct 15;175(8):4839-46."	21	"CD16+ monocyte, blood BDCA1+ DC, tonsil BDCA1+ DC, blood BDCA3+ DC, tonsil BDCA3+ DC, blood pDC, tonsil pDC"	Microarray (Affymetrix HG-U133_Plus_2 (GPL570 and A-AFFY-44))		Homo sapiens	3.6	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	pDC CD123+  adult	myeloid	p-DC	adult	plasmacytoid dendritic cell	Mixed
M;7002	7002	Lindstedt	M	blood BDCA1+ dendritic cell 1	Homo sapiens	blood BDCA1+ DC	CL:0002399		CD1c+ dendritic cell			Lindstedt	"Human dendritic cells (DCs) are a distinct but heterogeneous lineage of APCs operating as the link between innate and adaptive immune responses, with the function to either maintain tolerance or trigger immunity. The DC lineage consists of several subpopulations with unique phenotypes; however, their functional characteristics and transcriptional similarities remain largely unknown. To further characterize the phenotypes and transcriptomes of the subsets, we purified myeloid CD16(+), blood DC Ag 1(+) (BDCA1(+)), and BDCA3(+) DC populations, as well as plasmacytoid CD123(+) DCs, from tonsillar tissue and peripheral blood. Transcriptional profiling and hierarchical clustering visualized that BDCA1(+) DCs clustered with BDCA3(+) DCs, whereas CD16(+) DCs and CD123(+) DCs clustered as distinct populations in blood. Differential expression levels of chemokines, ILs, and pattern recognition receptors were demonstrated, which emphasize innate DC subset specialization. Even though highly BDCA1(+) and BDCA3(+) DC-specific gene expression was identified in blood, the BDCA1(+) DCs and BDCA3(+) DCs from tonsils displayed similar transcriptional activity, most likely due to the pathogenic or inflammatory maturational signals present in tonsillar tissues. Of note, plasmacytoid DCs displayed less plasticity in their transcriptional activity compared with myeloid DCs. The data demonstrated a functionally distinct association of each of the seven subsets based on their signatures, involving regulatory genes in adaptive and innate immunity. Abstract from the Journal of Immunology. 2005 Oct 15;175(8):4839-46."	21	"CD16+ monocyte, blood BDCA1+ DC, tonsil BDCA1+ DC, blood BDCA3+ DC, tonsil BDCA3+ DC, blood pDC, tonsil pDC"	Microarray (Affymetrix HG-U133_Plus_2 (GPL570 and A-AFFY-44))		Homo sapiens	3.6	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	c-DC HLA-DR+ CD1c+  adult	myeloid	c-DC	adult	CD1c+ dendritic cell	Mixed
N;7002	7002	Lindstedt	N	blood BDCA1+ dendritic cell 2	Homo sapiens	blood BDCA1+ DC	CL:0002399		CD1c+ dendritic cell			Lindstedt	"Human dendritic cells (DCs) are a distinct but heterogeneous lineage of APCs operating as the link between innate and adaptive immune responses, with the function to either maintain tolerance or trigger immunity. The DC lineage consists of several subpopulations with unique phenotypes; however, their functional characteristics and transcriptional similarities remain largely unknown. To further characterize the phenotypes and transcriptomes of the subsets, we purified myeloid CD16(+), blood DC Ag 1(+) (BDCA1(+)), and BDCA3(+) DC populations, as well as plasmacytoid CD123(+) DCs, from tonsillar tissue and peripheral blood. Transcriptional profiling and hierarchical clustering visualized that BDCA1(+) DCs clustered with BDCA3(+) DCs, whereas CD16(+) DCs and CD123(+) DCs clustered as distinct populations in blood. Differential expression levels of chemokines, ILs, and pattern recognition receptors were demonstrated, which emphasize innate DC subset specialization. Even though highly BDCA1(+) and BDCA3(+) DC-specific gene expression was identified in blood, the BDCA1(+) DCs and BDCA3(+) DCs from tonsils displayed similar transcriptional activity, most likely due to the pathogenic or inflammatory maturational signals present in tonsillar tissues. Of note, plasmacytoid DCs displayed less plasticity in their transcriptional activity compared with myeloid DCs. The data demonstrated a functionally distinct association of each of the seven subsets based on their signatures, involving regulatory genes in adaptive and innate immunity. Abstract from the Journal of Immunology. 2005 Oct 15;175(8):4839-46."	21	"CD16+ monocyte, blood BDCA1+ DC, tonsil BDCA1+ DC, blood BDCA3+ DC, tonsil BDCA3+ DC, blood pDC, tonsil pDC"	Microarray (Affymetrix HG-U133_Plus_2 (GPL570 and A-AFFY-44))		Homo sapiens	3.6	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	c-DC HLA-DR+ CD1c+  adult	myeloid	c-DC	adult	CD1c+ dendritic cell	Mixed
O;7002	7002	Lindstedt	O	blood BDCA1+ dendritic cell 3	Homo sapiens	blood BDCA1+ DC	CL:0002399		CD1c+ dendritic cell			Lindstedt	"Human dendritic cells (DCs) are a distinct but heterogeneous lineage of APCs operating as the link between innate and adaptive immune responses, with the function to either maintain tolerance or trigger immunity. The DC lineage consists of several subpopulations with unique phenotypes; however, their functional characteristics and transcriptional similarities remain largely unknown. To further characterize the phenotypes and transcriptomes of the subsets, we purified myeloid CD16(+), blood DC Ag 1(+) (BDCA1(+)), and BDCA3(+) DC populations, as well as plasmacytoid CD123(+) DCs, from tonsillar tissue and peripheral blood. Transcriptional profiling and hierarchical clustering visualized that BDCA1(+) DCs clustered with BDCA3(+) DCs, whereas CD16(+) DCs and CD123(+) DCs clustered as distinct populations in blood. Differential expression levels of chemokines, ILs, and pattern recognition receptors were demonstrated, which emphasize innate DC subset specialization. Even though highly BDCA1(+) and BDCA3(+) DC-specific gene expression was identified in blood, the BDCA1(+) DCs and BDCA3(+) DCs from tonsils displayed similar transcriptional activity, most likely due to the pathogenic or inflammatory maturational signals present in tonsillar tissues. Of note, plasmacytoid DCs displayed less plasticity in their transcriptional activity compared with myeloid DCs. The data demonstrated a functionally distinct association of each of the seven subsets based on their signatures, involving regulatory genes in adaptive and innate immunity. Abstract from the Journal of Immunology. 2005 Oct 15;175(8):4839-46."	21	"CD16+ monocyte, blood BDCA1+ DC, tonsil BDCA1+ DC, blood BDCA3+ DC, tonsil BDCA3+ DC, blood pDC, tonsil pDC"	Microarray (Affymetrix HG-U133_Plus_2 (GPL570 and A-AFFY-44))		Homo sapiens	3.6	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	c-DC HLA-DR+ CD1c+  adult	myeloid	c-DC	adult	CD1c+ dendritic cell	Mixed
P;7002	7002	Lindstedt	P	blood BDCA3+ dendritic cell 1	Homo sapiens	blood BDCA3+ DC	CL:0002394		CD141+ dendritic cell			Lindstedt	"Human dendritic cells (DCs) are a distinct but heterogeneous lineage of APCs operating as the link between innate and adaptive immune responses, with the function to either maintain tolerance or trigger immunity. The DC lineage consists of several subpopulations with unique phenotypes; however, their functional characteristics and transcriptional similarities remain largely unknown. To further characterize the phenotypes and transcriptomes of the subsets, we purified myeloid CD16(+), blood DC Ag 1(+) (BDCA1(+)), and BDCA3(+) DC populations, as well as plasmacytoid CD123(+) DCs, from tonsillar tissue and peripheral blood. Transcriptional profiling and hierarchical clustering visualized that BDCA1(+) DCs clustered with BDCA3(+) DCs, whereas CD16(+) DCs and CD123(+) DCs clustered as distinct populations in blood. Differential expression levels of chemokines, ILs, and pattern recognition receptors were demonstrated, which emphasize innate DC subset specialization. Even though highly BDCA1(+) and BDCA3(+) DC-specific gene expression was identified in blood, the BDCA1(+) DCs and BDCA3(+) DCs from tonsils displayed similar transcriptional activity, most likely due to the pathogenic or inflammatory maturational signals present in tonsillar tissues. Of note, plasmacytoid DCs displayed less plasticity in their transcriptional activity compared with myeloid DCs. The data demonstrated a functionally distinct association of each of the seven subsets based on their signatures, involving regulatory genes in adaptive and innate immunity. Abstract from the Journal of Immunology. 2005 Oct 15;175(8):4839-46."	21	"CD16+ monocyte, blood BDCA1+ DC, tonsil BDCA1+ DC, blood BDCA3+ DC, tonsil BDCA3+ DC, blood pDC, tonsil pDC"	Microarray (Affymetrix HG-U133_Plus_2 (GPL570 and A-AFFY-44))		Homo sapiens	3.6	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	c-DC HLA-DR+ CD141+  adult	myeloid	c-DC	adult	CD141+ dendritic cell	Mixed
Q;7002	7002	Lindstedt	Q	blood BDCA3+ dendritic cell 2	Homo sapiens	blood BDCA3+ DC	CL:0002394		CD141+ dendritic cell			Lindstedt	"Human dendritic cells (DCs) are a distinct but heterogeneous lineage of APCs operating as the link between innate and adaptive immune responses, with the function to either maintain tolerance or trigger immunity. The DC lineage consists of several subpopulations with unique phenotypes; however, their functional characteristics and transcriptional similarities remain largely unknown. To further characterize the phenotypes and transcriptomes of the subsets, we purified myeloid CD16(+), blood DC Ag 1(+) (BDCA1(+)), and BDCA3(+) DC populations, as well as plasmacytoid CD123(+) DCs, from tonsillar tissue and peripheral blood. Transcriptional profiling and hierarchical clustering visualized that BDCA1(+) DCs clustered with BDCA3(+) DCs, whereas CD16(+) DCs and CD123(+) DCs clustered as distinct populations in blood. Differential expression levels of chemokines, ILs, and pattern recognition receptors were demonstrated, which emphasize innate DC subset specialization. Even though highly BDCA1(+) and BDCA3(+) DC-specific gene expression was identified in blood, the BDCA1(+) DCs and BDCA3(+) DCs from tonsils displayed similar transcriptional activity, most likely due to the pathogenic or inflammatory maturational signals present in tonsillar tissues. Of note, plasmacytoid DCs displayed less plasticity in their transcriptional activity compared with myeloid DCs. The data demonstrated a functionally distinct association of each of the seven subsets based on their signatures, involving regulatory genes in adaptive and innate immunity. Abstract from the Journal of Immunology. 2005 Oct 15;175(8):4839-46."	21	"CD16+ monocyte, blood BDCA1+ DC, tonsil BDCA1+ DC, blood BDCA3+ DC, tonsil BDCA3+ DC, blood pDC, tonsil pDC"	Microarray (Affymetrix HG-U133_Plus_2 (GPL570 and A-AFFY-44))		Homo sapiens	3.6	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	c-DC HLA-DR+ CD141+  adult	myeloid	c-DC	adult	CD141+ dendritic cell	Mixed
R;7002	7002	Lindstedt	R	blood BDCA3+ dendritic cell 3	Homo sapiens	blood BDCA3+ DC	CL:0002394		CD141+ dendritic cell			Lindstedt	"Human dendritic cells (DCs) are a distinct but heterogeneous lineage of APCs operating as the link between innate and adaptive immune responses, with the function to either maintain tolerance or trigger immunity. The DC lineage consists of several subpopulations with unique phenotypes; however, their functional characteristics and transcriptional similarities remain largely unknown. To further characterize the phenotypes and transcriptomes of the subsets, we purified myeloid CD16(+), blood DC Ag 1(+) (BDCA1(+)), and BDCA3(+) DC populations, as well as plasmacytoid CD123(+) DCs, from tonsillar tissue and peripheral blood. Transcriptional profiling and hierarchical clustering visualized that BDCA1(+) DCs clustered with BDCA3(+) DCs, whereas CD16(+) DCs and CD123(+) DCs clustered as distinct populations in blood. Differential expression levels of chemokines, ILs, and pattern recognition receptors were demonstrated, which emphasize innate DC subset specialization. Even though highly BDCA1(+) and BDCA3(+) DC-specific gene expression was identified in blood, the BDCA1(+) DCs and BDCA3(+) DCs from tonsils displayed similar transcriptional activity, most likely due to the pathogenic or inflammatory maturational signals present in tonsillar tissues. Of note, plasmacytoid DCs displayed less plasticity in their transcriptional activity compared with myeloid DCs. The data demonstrated a functionally distinct association of each of the seven subsets based on their signatures, involving regulatory genes in adaptive and innate immunity. Abstract from the Journal of Immunology. 2005 Oct 15;175(8):4839-46."	21	"CD16+ monocyte, blood BDCA1+ DC, tonsil BDCA1+ DC, blood BDCA3+ DC, tonsil BDCA3+ DC, blood pDC, tonsil pDC"	Microarray (Affymetrix HG-U133_Plus_2 (GPL570 and A-AFFY-44))		Homo sapiens	3.6	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	c-DC HLA-DR+ CD141+  adult	myeloid	c-DC	adult	CD141+ dendritic cell	Mixed
S;7002	7002	Lindstedt	S	blood CD16+ dendritic cell 1	Homo sapiens	CD16+ monocyte	CL:0000576		monocyte			Lindstedt	"Human dendritic cells (DCs) are a distinct but heterogeneous lineage of APCs operating as the link between innate and adaptive immune responses, with the function to either maintain tolerance or trigger immunity. The DC lineage consists of several subpopulations with unique phenotypes; however, their functional characteristics and transcriptional similarities remain largely unknown. To further characterize the phenotypes and transcriptomes of the subsets, we purified myeloid CD16(+), blood DC Ag 1(+) (BDCA1(+)), and BDCA3(+) DC populations, as well as plasmacytoid CD123(+) DCs, from tonsillar tissue and peripheral blood. Transcriptional profiling and hierarchical clustering visualized that BDCA1(+) DCs clustered with BDCA3(+) DCs, whereas CD16(+) DCs and CD123(+) DCs clustered as distinct populations in blood. Differential expression levels of chemokines, ILs, and pattern recognition receptors were demonstrated, which emphasize innate DC subset specialization. Even though highly BDCA1(+) and BDCA3(+) DC-specific gene expression was identified in blood, the BDCA1(+) DCs and BDCA3(+) DCs from tonsils displayed similar transcriptional activity, most likely due to the pathogenic or inflammatory maturational signals present in tonsillar tissues. Of note, plasmacytoid DCs displayed less plasticity in their transcriptional activity compared with myeloid DCs. The data demonstrated a functionally distinct association of each of the seven subsets based on their signatures, involving regulatory genes in adaptive and innate immunity. Abstract from the Journal of Immunology. 2005 Oct 15;175(8):4839-46."	21	"CD16+ monocyte, blood BDCA1+ DC, tonsil BDCA1+ DC, blood BDCA3+ DC, tonsil BDCA3+ DC, blood pDC, tonsil pDC"	Microarray (Affymetrix HG-U133_Plus_2 (GPL570 and A-AFFY-44))		Homo sapiens	3.6	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	c-DC CD16+  adult	myeloid	c-DC	adult	monocyte	Circulating Monocyte & Granulocyte
T;7002	7002	Lindstedt	T	blood CD16+ dendritic cell 2	Homo sapiens	CD16+ monocyte	CL:0000576		monocyte			Lindstedt	"Human dendritic cells (DCs) are a distinct but heterogeneous lineage of APCs operating as the link between innate and adaptive immune responses, with the function to either maintain tolerance or trigger immunity. The DC lineage consists of several subpopulations with unique phenotypes; however, their functional characteristics and transcriptional similarities remain largely unknown. To further characterize the phenotypes and transcriptomes of the subsets, we purified myeloid CD16(+), blood DC Ag 1(+) (BDCA1(+)), and BDCA3(+) DC populations, as well as plasmacytoid CD123(+) DCs, from tonsillar tissue and peripheral blood. Transcriptional profiling and hierarchical clustering visualized that BDCA1(+) DCs clustered with BDCA3(+) DCs, whereas CD16(+) DCs and CD123(+) DCs clustered as distinct populations in blood. Differential expression levels of chemokines, ILs, and pattern recognition receptors were demonstrated, which emphasize innate DC subset specialization. Even though highly BDCA1(+) and BDCA3(+) DC-specific gene expression was identified in blood, the BDCA1(+) DCs and BDCA3(+) DCs from tonsils displayed similar transcriptional activity, most likely due to the pathogenic or inflammatory maturational signals present in tonsillar tissues. Of note, plasmacytoid DCs displayed less plasticity in their transcriptional activity compared with myeloid DCs. The data demonstrated a functionally distinct association of each of the seven subsets based on their signatures, involving regulatory genes in adaptive and innate immunity. Abstract from the Journal of Immunology. 2005 Oct 15;175(8):4839-46."	21	"CD16+ monocyte, blood BDCA1+ DC, tonsil BDCA1+ DC, blood BDCA3+ DC, tonsil BDCA3+ DC, blood pDC, tonsil pDC"	Microarray (Affymetrix HG-U133_Plus_2 (GPL570 and A-AFFY-44))		Homo sapiens	3.6	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	c-DC CD16+  adult	myeloid	c-DC	adult	monocyte	Circulating Monocyte & Granulocyte
U;7002	7002	Lindstedt	U	blood CD16+ dendritic cell 3	Homo sapiens	CD16+ monocyte	CL:0000576		monocyte			Lindstedt	"Human dendritic cells (DCs) are a distinct but heterogeneous lineage of APCs operating as the link between innate and adaptive immune responses, with the function to either maintain tolerance or trigger immunity. The DC lineage consists of several subpopulations with unique phenotypes; however, their functional characteristics and transcriptional similarities remain largely unknown. To further characterize the phenotypes and transcriptomes of the subsets, we purified myeloid CD16(+), blood DC Ag 1(+) (BDCA1(+)), and BDCA3(+) DC populations, as well as plasmacytoid CD123(+) DCs, from tonsillar tissue and peripheral blood. Transcriptional profiling and hierarchical clustering visualized that BDCA1(+) DCs clustered with BDCA3(+) DCs, whereas CD16(+) DCs and CD123(+) DCs clustered as distinct populations in blood. Differential expression levels of chemokines, ILs, and pattern recognition receptors were demonstrated, which emphasize innate DC subset specialization. Even though highly BDCA1(+) and BDCA3(+) DC-specific gene expression was identified in blood, the BDCA1(+) DCs and BDCA3(+) DCs from tonsils displayed similar transcriptional activity, most likely due to the pathogenic or inflammatory maturational signals present in tonsillar tissues. Of note, plasmacytoid DCs displayed less plasticity in their transcriptional activity compared with myeloid DCs. The data demonstrated a functionally distinct association of each of the seven subsets based on their signatures, involving regulatory genes in adaptive and innate immunity. Abstract from the Journal of Immunology. 2005 Oct 15;175(8):4839-46."	21	"CD16+ monocyte, blood BDCA1+ DC, tonsil BDCA1+ DC, blood BDCA3+ DC, tonsil BDCA3+ DC, blood pDC, tonsil pDC"	Microarray (Affymetrix HG-U133_Plus_2 (GPL570 and A-AFFY-44))		Homo sapiens	3.6	HG-U133_Plus_2	"rgb(255,109,182)"	circle-open	c-DC CD16+  adult	myeloid	c-DC	adult	monocyte	Circulating Monocyte & Granulocyte